| CAS No. | Saflık | Ürün Adı | BOSTON KODU |
|---|---|---|---|
| Cas.: 27943-46-0 | Purity: 97% | 2-((2-Methylbut-3-yn-2-yl)oxy)tetrahydro-2H-pyran | ESD-932151-1G |
| Cas.: 27943-46-0 | Purity: 97% | 2-((2-Methylbut-3-yn-2-yl)oxy)tetrahydro-2H-pyran | ESD-932151-5G |
| Cas.: 54118-75-1 | Purity: 98% | (4-Bromophenyl)(4-methoxyphenyl)methanone | ESD-932152-250MG |
| Cas.: 54118-75-1 | Purity: 98% | (4-Bromophenyl)(4-methoxyphenyl)methanone | ESD-932152-1G |
| Cas.: 54118-75-1 | Purity: 98% | (4-Bromophenyl)(4-methoxyphenyl)methanone | ESD-932152-5G |
| Cas.: 62307-74-8 | Purity: 95% | Sodium 2-acetamido-3-(1H-indol-3-yl)propanoate | ESD-932153-250MG |
| Cas.: 62307-74-8 | Purity: 95% | Sodium 2-acetamido-3-(1H-indol-3-yl)propanoate | ESD-932153-1G |
| Cas.: 169674-35-5 | Purity: 98% | 5,6-Difluoro-1H-indole-2-carboxylic acid | ESD-932154-250MG |
| Cas.: 169674-35-5 | Purity: 98% | 5,6-Difluoro-1H-indole-2-carboxylic acid | ESD-932154-1G |
| Cas.: 169674-35-5 | Purity: 98% | 5,6-Difluoro-1H-indole-2-carboxylic acid | ESD-932154-5G |
| Cas.: 15062-88-1 | Purity: 98% | 2-Hydrazino-1,3-benzoxazole | ESD-932155-250MG |
| Cas.: 15062-88-1 | Purity: 98% | 2-Hydrazino-1,3-benzoxazole | ESD-932155-1G |
| Cas.: 15062-88-1 | Purity: 98% | 2-Hydrazino-1,3-benzoxazole | ESD-932155-5G |
| Cas.: 38471-47-5 | Purity: 98% | 2-(Undecyloxy)ethanol | ESD-932156-250MG |
| Cas.: 38471-47-5 | Purity: 98% | 2-(Undecyloxy)ethanol | ESD-932156-1G |
| Cas.: 38471-47-5 | Purity: 98% | 2-(Undecyloxy)ethanol | ESD-932156-5G |
| Cas.: 120289-22-7 | Purity: 95% | 2-[2-(Tert-butoxy)-2-oxoethoxy]acetic acid | ESD-932157-250MG |
| Cas.: 120289-22-7 | Purity: 95% | 2-[2-(Tert-butoxy)-2-oxoethoxy]acetic acid | ESD-932157-1G |
| Cas.: 120289-22-7 | Purity: 95% | 2-[2-(Tert-butoxy)-2-oxoethoxy]acetic acid | ESD-932157-5G |
| Cas.: 37859-25-9 | Purity: 95% | 2-(Naphthalen-2-yl)acetyl chloride | ESD-932158-250MG |
| Cas.: 37859-25-9 | Purity: 95% | 2-(Naphthalen-2-yl)acetyl chloride | ESD-932158-1G |
| Cas.: 37859-25-9 | Purity: 95% | 2-(Naphthalen-2-yl)acetyl chloride | ESD-932158-5G |
| Cas.: 40610-41-1 | Purity: 97% | (R)-2-Phenyl-2-pivalamidoacetic acid | ESD-932159-250MG |
| Cas.: 40610-41-1 | Purity: 97% | (R)-2-Phenyl-2-pivalamidoacetic acid | ESD-932159-1G |
| Cas.: 40610-41-1 | Purity: 97% | (R)-2-Phenyl-2-pivalamidoacetic acid | ESD-932159-5G |
| Cas.: 22775-90-2 | Purity: ≥99% | (2,2′-Bipyridine)nickel dichloride | ESD-932160-250MG |
| Cas.: 22775-90-2 | Purity: ≥99% | (2,2′-Bipyridine)nickel dichloride | ESD-932160-1G |
| Cas.: 22775-90-2 | Purity: ≥99% | (2,2′-Bipyridine)nickel dichloride | ESD-932160-5G |
| Cas.: 33993-24-7 | Purity: 90% | Cyclopropanecarboxylic anhydride | ESD-932161-250MG |
| Cas.: 33993-24-7 | Purity: 90% | Cyclopropanecarboxylic anhydride | ESD-932161-1G |
| Cas.: 33993-24-7 | Purity: 90% | Cyclopropanecarboxylic anhydride | ESD-932161-5G |
| Cas.: 56051-32-2 | Purity: 98% | 3-Bromo-7-methylimidazo[1,2-a]pyridine | ESD-932162-250MG |
| Cas.: 56051-32-2 | Purity: 98% | 3-Bromo-7-methylimidazo[1,2-a]pyridine | ESD-932162-1G |
| Cas.: 56051-32-2 | Purity: 98% | 3-Bromo-7-methylimidazo[1,2-a]pyridine | ESD-932162-5G |
| Cas.: 151937-09-6 | Purity: 95% | 4-(2-Carboxyethyl)benzoic Acid Methyl Ester | ESD-932163-250MG |
| Cas.: 151937-09-6 | Purity: 95% | 4-(2-Carboxyethyl)benzoic Acid Methyl Ester | ESD-932163-1G |
| Cas.: 151937-09-6 | Purity: 95% | 4-(2-Carboxyethyl)benzoic Acid Methyl Ester | ESD-932163-5G |
| Cas.: 454678-87-6 | Purity: 95% | (4-Cyclopropylphenyl)methanol | ESD-932164-250MG |
| Cas.: 454678-87-6 | Purity: 95% | (4-Cyclopropylphenyl)methanol | ESD-932164-1G |
| Cas.: 454678-87-6 | Purity: 95% | (4-Cyclopropylphenyl)methanol | ESD-932164-5G |
| Cas.: 2142-66-7 | Purity: 95% | 1-([1,1′-Biphenyl]-2-yl)ethanone | ESD-932165-250MG |
| Cas.: 2142-66-7 | Purity: 95% | 1-([1,1′-Biphenyl]-2-yl)ethanone | ESD-932165-1G |
| Cas.: 2142-66-7 | Purity: 95% | 1-([1,1′-Biphenyl]-2-yl)ethanone | ESD-932165-5G |
| Cas.: 89691-67-8 | Purity: 98% | 2′-Bromo-4′-methoxyacetophenone | ESD-932166-250MG |
| Cas.: 89691-67-8 | Purity: 98% | 2′-Bromo-4′-methoxyacetophenone | ESD-932166-1G |
| Cas.: 89691-67-8 | Purity: 98% | 2′-Bromo-4′-methoxyacetophenone | ESD-932166-5G |
| Cas.: 52310-46-0 | Purity: 98% | 8-Nitroimidazo[1,2-a]pyridine | ESD-932167-250MG |
| Cas.: 52310-46-0 | Purity: 98% | 8-Nitroimidazo[1,2-a]pyridine | ESD-932167-1G |
| Cas.: 52310-46-0 | Purity: 98% | 8-Nitroimidazo[1,2-a]pyridine | ESD-932167-5G |
| Cas.: 90767-17-2 | Purity: 95% | 3-Bromonaphthalen-1-ol | ESD-932168-250MG |
| Cas.: 90767-17-2 | Purity: 95% | 3-Bromonaphthalen-1-ol | ESD-932168-1G |
| Cas.: 90767-17-2 | Purity: 95% | 3-Bromonaphthalen-1-ol | ESD-932168-5G |
| Cas.: 26395-26-6 | Purity: 98% | 3-Methoxy-2-methylpyridine | ESD-932169-250MG |
| Cas.: 26395-26-6 | Purity: 98% | 3-Methoxy-2-methylpyridine | ESD-932169-1G |
| Cas.: 26395-26-6 | Purity: 98% | 3-Methoxy-2-methylpyridine | ESD-932169-5G |
| Cas.: 394-64-9 | Purity: 95% | 1-Fluoro-2,3-dimethoxybenzene | ESD-932170-250MG |
| Cas.: 394-64-9 | Purity: 95% | 1-Fluoro-2,3-dimethoxybenzene | ESD-932170-1G |
| Cas.: 394-64-9 | Purity: 95% | 1-Fluoro-2,3-dimethoxybenzene | ESD-932170-5G |
| Cas.: 302800-13-1 | Purity: 98% | 5-Bromo-N-methyl-2-nitroaniline | ESD-932171-250MG |
| Cas.: 302800-13-1 | Purity: 98% | 5-Bromo-N-methyl-2-nitroaniline | ESD-932171-1G |
| Cas.: 302800-13-1 | Purity: 98% | 5-Bromo-N-methyl-2-nitroaniline | ESD-932171-5G |
| Cas.: 167479-01-8 | Purity: 95% | Tert-butyl (3-iodopropyl)carbamate | ESD-932172-250MG |
| Cas.: 167479-01-8 | Purity: 95% | Tert-butyl (3-iodopropyl)carbamate | ESD-932172-1G |
| Cas.: 167479-01-8 | Purity: 95% | Tert-butyl (3-iodopropyl)carbamate | ESD-932172-5G |
| Cas.: 218797-71-8 | Purity: 95% | 1-Bromo-3-chloro-5-fluoro-4-nitrobenzene | ESD-932173-250MG |
| Cas.: 218797-71-8 | Purity: 95% | 1-Bromo-3-chloro-5-fluoro-4-nitrobenzene | ESD-932173-1G |
| Cas.: 218797-71-8 | Purity: 95% | 1-Bromo-3-chloro-5-fluoro-4-nitrobenzene | ESD-932173-5G |
| Cas.: 67367-24-2 | Purity: 98% | Methyl 4-hydroxynicotinate | ESD-932174-250MG |
| Cas.: 67367-24-2 | Purity: 98% | Methyl 4-hydroxynicotinate | ESD-932174-1G |
| Cas.: 67367-24-2 | Purity: 98% | Methyl 4-hydroxynicotinate | ESD-932174-5G |
| Cas.: 187998-35-2 | Purity: 95% | 1-(4-Chlorophenyl)-5-methyl-1H-pyrazole-4-carboxylic acid | ESD-932175-250MG |
| Cas.: 187998-35-2 | Purity: 95% | 1-(4-Chlorophenyl)-5-methyl-1H-pyrazole-4-carboxylic acid | ESD-932175-1G |
| Cas.: 187998-35-2 | Purity: 95% | 1-(4-Chlorophenyl)-5-methyl-1H-pyrazole-4-carboxylic acid | ESD-932175-5G |
| Cas.: 139743-08-1 | Purity: 95% | (2-Amino-3-nitrophenyl)methanol | ESD-932176-250MG |
| Cas.: 139743-08-1 | Purity: 95% | (2-Amino-3-nitrophenyl)methanol | ESD-932176-1G |
| Cas.: 139743-08-1 | Purity: 95% | (2-Amino-3-nitrophenyl)methanol | ESD-932176-5G |
| Cas.: 256376-65-5 | Purity: 95% | 1-(2-Fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carbonitrile | ESD-932177-250MG |
| Cas.: 256376-65-5 | Purity: 95% | 1-(2-Fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carbonitrile | ESD-932177-1G |
| Cas.: 256376-65-5 | Purity: 95% | 1-(2-Fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carbonitrile | ESD-932177-5G |
| Cas.: 209960-91-8 | Purity: 95% | 2-Methoxy-4-morpholinoaniline | ESD-932178-250MG |
| Cas.: 209960-91-8 | Purity: 95% | 2-Methoxy-4-morpholinoaniline | ESD-932178-1G |
| Cas.: 209960-91-8 | Purity: 95% | 2-Methoxy-4-morpholinoaniline | ESD-932178-5G |
| Cas.: 68208-21-9 | Purity: 98% | 3-Amino-3-(3-chlorophenyl)propanoic acid | ESD-932179-250MG |
| Cas.: 68208-21-9 | Purity: 98% | 3-Amino-3-(3-chlorophenyl)propanoic acid | ESD-932179-1G |
| Cas.: 68208-21-9 | Purity: 98% | 3-Amino-3-(3-chlorophenyl)propanoic acid | ESD-932179-5G |
| Cas.: 129301-42-4 | Purity: 98% | 2,2′-((Perfluoroethane-1,2-diyl)bis(oxy))bis(2,2-difluoroethanol) | ESD-932180-250MG |
| Cas.: 129301-42-4 | Purity: 98% | 2,2′-((Perfluoroethane-1,2-diyl)bis(oxy))bis(2,2-difluoroethanol) | ESD-932180-1G |
| Cas.: 129301-42-4 | Purity: 98% | 2,2′-((Perfluoroethane-1,2-diyl)bis(oxy))bis(2,2-difluoroethanol) | ESD-932180-5G |
| Cas.: 54127-31-0 | Purity: 95% | 2,3-Dichloro-5-(chloromethyl)pyridine | ESD-932181-250MG |
| Cas.: 54127-31-0 | Purity: 95% | 2,3-Dichloro-5-(chloromethyl)pyridine | ESD-932181-1G |
| Cas.: 54127-31-0 | Purity: 95% | 2,3-Dichloro-5-(chloromethyl)pyridine | ESD-932181-5G |
| Cas.: 28025-61-8 | Purity: 95% | 2-Chloro-n-(2-hydroxyethyl)-n-phenylacetamide | ESD-932182-250MG |
| Cas.: 28025-61-8 | Purity: 95% | 2-Chloro-n-(2-hydroxyethyl)-n-phenylacetamide | ESD-932182-1G |
| Cas.: 28025-61-8 | Purity: 95% | 2-Chloro-n-(2-hydroxyethyl)-n-phenylacetamide | ESD-932182-5G |
| Cas.: 223734-62-1 | Purity: 95% | 2-((S)-Dec-1-yn-5-yloxy)tetrahydro-2H-pyran | ESD-932183-250MG |
| Cas.: 223734-62-1 | Purity: 95% | 2-((S)-Dec-1-yn-5-yloxy)tetrahydro-2H-pyran | ESD-932183-1G |
| Cas.: 223734-62-1 | Purity: 95% | 2-((S)-Dec-1-yn-5-yloxy)tetrahydro-2H-pyran | ESD-932183-5G |
| Cas.: 874880-58-7 | Purity: 98% | 4-Amino-3-bromo-5-fluorobenzonitrile | ESD-932184-250MG |
| Cas.: 874880-58-7 | Purity: 98% | 4-Amino-3-bromo-5-fluorobenzonitrile | ESD-932184-1G |
| Cas.: 874880-58-7 | Purity: 98% | 4-Amino-3-bromo-5-fluorobenzonitrile | ESD-932184-5G |
| Cas.: 103863-15-6 | Purity: 96% | 3-Phenylpicolinic acid | ESD-932185-250MG |
| Cas.: 103863-15-6 | Purity: 96% | 3-Phenylpicolinic acid | ESD-932185-1G |
| Cas.: 103863-15-6 | Purity: 96% | 3-Phenylpicolinic acid | ESD-932185-5G |
| Cas.: 17828-53-4 | Purity: 98% | 5,5′-(1,4-Phenylenebis(oxy))bis(isobenzofuran-1,3-dione) | ESD-932186-250MG |
| Cas.: 17828-53-4 | Purity: 98% | 5,5′-(1,4-Phenylenebis(oxy))bis(isobenzofuran-1,3-dione) | ESD-932186-1G |
| Cas.: 17828-53-4 | Purity: 98% | 5,5′-(1,4-Phenylenebis(oxy))bis(isobenzofuran-1,3-dione) | ESD-932186-5G |
| Cas.: 50595-38-5 | Purity: 98% | (Oxybis(ethane-2,1-diyl))bis(diphenylphosphine) | ESD-932187-250MG |
| Cas.: 50595-38-5 | Purity: 98% | (Oxybis(ethane-2,1-diyl))bis(diphenylphosphine) | ESD-932187-1G |
| Cas.: 50595-38-5 | Purity: 98% | (Oxybis(ethane-2,1-diyl))bis(diphenylphosphine) | ESD-932187-5G |
| Cas.: 17022-31-0 | Purity: 95% | Ethyl 2-propylpentanoate | ESD-932188-250MG |
| Cas.: 17022-31-0 | Purity: 95% | Ethyl 2-propylpentanoate | ESD-932188-1G |
| Cas.: 17022-31-0 | Purity: 95% | Ethyl 2-propylpentanoate | ESD-932188-5G |
| Cas.: 14791-78-7 | Purity: 95% | 2-Fluorobenzene-1,4-diamine | ESD-932189-250MG |
| Cas.: 14791-78-7 | Purity: 95% | 2-Fluorobenzene-1,4-diamine | ESD-932189-1G |
| Cas.: 14791-78-7 | Purity: 95% | 2-Fluorobenzene-1,4-diamine | ESD-932189-5G |
| Cas.: 1173081-96-3 | Purity: 95% | 3-(Aminomethyl)-4,6-dimethylpyridin-2(1H)-one hydrochloride | ESD-932190-250MG |
| Cas.: 1173081-96-3 | Purity: 95% | 3-(Aminomethyl)-4,6-dimethylpyridin-2(1H)-one hydrochloride | ESD-932190-1G |
| Cas.: 1173081-96-3 | Purity: 95% | 3-(Aminomethyl)-4,6-dimethylpyridin-2(1H)-one hydrochloride | ESD-932190-5G |
| Cas.: 868599-73-9 | Purity: 95% | (9H-Fluoren-9-yl)methyl (2-(2-(2-aminoethoxy)ethoxy)ethyl)carbamate hydrochloride | ESD-932191-250MG |
| Cas.: 868599-73-9 | Purity: 95% | (9H-Fluoren-9-yl)methyl (2-(2-(2-aminoethoxy)ethoxy)ethyl)carbamate hydrochloride | ESD-932191-1G |
| Cas.: 868599-73-9 | Purity: 95% | (9H-Fluoren-9-yl)methyl (2-(2-(2-aminoethoxy)ethoxy)ethyl)carbamate hydrochloride | ESD-932191-5G |
| Cas.: 406-91-7 | Purity: 95% | 4,4,4-TRifluorobutanoyl chloride | ESD-932192-250MG |
| Cas.: 406-91-7 | Purity: 95% | 4,4,4-TRifluorobutanoyl chloride | ESD-932192-1G |
| Cas.: 406-91-7 | Purity: 95% | 4,4,4-TRifluorobutanoyl chloride | ESD-932192-5G |
| Cas.: 7661-32-7 | Purity: 98% | 1-(4-Bromophenyl)pyrrolidin-2-one | ESD-932193-250MG |
| Cas.: 7661-32-7 | Purity: 98% | 1-(4-Bromophenyl)pyrrolidin-2-one | ESD-932193-1G |
| Cas.: 7661-32-7 | Purity: 98% | 1-(4-Bromophenyl)pyrrolidin-2-one | ESD-932193-5G |
| Cas.: 248274-16-0 | Purity: 97% | 1-(5-(Trifluoromethyl)pyridin-2-yl)ethanone | ESD-932194-250MG |
| Cas.: 248274-16-0 | Purity: 97% | 1-(5-(Trifluoromethyl)pyridin-2-yl)ethanone | ESD-932194-1G |
| Cas.: 248274-16-0 | Purity: 97% | 1-(5-(Trifluoromethyl)pyridin-2-yl)ethanone | ESD-932194-5G |
| Cas.: 259860-00-9 | Purity: 97% | 2-Fluoro-4-methyl-5-nitroaniline | ESD-932195-250MG |
| Cas.: 259860-00-9 | Purity: 97% | 2-Fluoro-4-methyl-5-nitroaniline | ESD-932195-1G |
| Cas.: 259860-00-9 | Purity: 97% | 2-Fluoro-4-methyl-5-nitroaniline | ESD-932195-5G |
| Cas.: 88353-04-2 | Purity: 97% | 12-(Benzyloxy)-12-oxododecanoic acid | ESD-932196-250MG |
| Cas.: 88353-04-2 | Purity: 97% | 12-(Benzyloxy)-12-oxododecanoic acid | ESD-932196-1G |
| Cas.: 88353-04-2 | Purity: 97% | 12-(Benzyloxy)-12-oxododecanoic acid | ESD-932196-5G |
| Cas.: 861601-15-2 | Purity: 97% | 1-Bromo-3-iodo-5-nitrobenzene | ESD-932197-250MG |
| Cas.: 861601-15-2 | Purity: 97% | 1-Bromo-3-iodo-5-nitrobenzene | ESD-932197-1G |
| Cas.: 861601-15-2 | Purity: 97% | 1-Bromo-3-iodo-5-nitrobenzene | ESD-932197-5G |
| Cas.: 1150561-77-5 | Purity: 98% | Methyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)propanoate | ESD-932198-250MG |
| Cas.: 1150561-77-5 | Purity: 98% | Methyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)propanoate | ESD-932198-1G |
| Cas.: 1150561-77-5 | Purity: 98% | Methyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)propanoate | ESD-932198-5G |
| Cas.: 393-56-6 | Purity: 95% | 2-Fluoro-N,N-dimethylaniline | ESD-932199-250MG |
| Cas.: 393-56-6 | Purity: 95% | 2-Fluoro-N,N-dimethylaniline | ESD-932199-1G |
| Cas.: 393-56-6 | Purity: 95% | 2-Fluoro-N,N-dimethylaniline | ESD-932199-5G |
| Cas.: 71260-16-7 | Purity: 97% | 2-Methyl-1-(piperazin-1-yl)propan-1-one | ESD-932200-250MG |
| Cas.: 71260-16-7 | Purity: 97% | 2-Methyl-1-(piperazin-1-yl)propan-1-one | ESD-932200-1G |
| Cas.: 71260-16-7 | Purity: 97% | 2-Methyl-1-(piperazin-1-yl)propan-1-one | ESD-932200-5G |
| Cas.: 20896-27-9 | Purity: 96% | Methyl 4-amino-5-chloro-2-methoxybenzoate | ESD-932201-250MG |
| Cas.: 20896-27-9 | Purity: 96% | Methyl 4-amino-5-chloro-2-methoxybenzoate | ESD-932201-1G |
| Cas.: 20896-27-9 | Purity: 96% | Methyl 4-amino-5-chloro-2-methoxybenzoate | ESD-932201-5G |
| Cas.: 7126-41-2 | Purity: 97% | Phenyl(1H-pyrrol-3-yl)methanone | ESD-932202-250MG |
| Cas.: 214262-87-0 | Purity: 95% | 2-(2-Chloro-4-fluorophenyl)ethanol | ESD-932203-250MG |
| Cas.: 214262-87-0 | Purity: 95% | 2-(2-Chloro-4-fluorophenyl)ethanol | ESD-932203-1G |
| Cas.: 214262-87-0 | Purity: 95% | 2-(2-Chloro-4-fluorophenyl)ethanol | ESD-932203-5G |
| Cas.: 55121-99-8 | Purity: 95% | (4-Aminophenyl)(4-methylpiperazin-1-yl)methanone | ESD-932204-250MG |
| Cas.: 55121-99-8 | Purity: 95% | (4-Aminophenyl)(4-methylpiperazin-1-yl)methanone | ESD-932204-1G |
| Cas.: 55121-99-8 | Purity: 95% | (4-Aminophenyl)(4-methylpiperazin-1-yl)methanone | ESD-932204-5G |
| Cas.: 103015-84-5 | Purity: 95% | 2,5-Dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)aniline | ESD-932205-250MG |
| Cas.: 103015-84-5 | Purity: 95% | 2,5-Dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)aniline | ESD-932205-1G |
| Cas.: 103015-84-5 | Purity: 95% | 2,5-Dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)aniline | ESD-932205-5G |
| Cas.: 37592-53-3 | Purity: 97% | (S)-Isopropyl 2-amino-3-hydroxypropanoate hydrochloride | ESD-932206-250MG |
| Cas.: 37592-53-3 | Purity: 97% | (S)-Isopropyl 2-amino-3-hydroxypropanoate hydrochloride | ESD-932206-1G |
| Cas.: 37592-53-3 | Purity: 97% | (S)-Isopropyl 2-amino-3-hydroxypropanoate hydrochloride | ESD-932206-5G |
| Cas.: 13472-83-8 | Purity: 95% | 2-Methoxypyridin-3-ol | ESD-932207-250MG |
| Cas.: 13472-83-8 | Purity: 95% | 2-Methoxypyridin-3-ol | ESD-932207-1G |
| Cas.: 13472-83-8 | Purity: 95% | 2-Methoxypyridin-3-ol | ESD-932207-5G |
| Cas.: 135048-32-7 | Purity: 95% | 2-Cyanoisonicotinohydrazide | ESD-932208-250MG |
| Cas.: 135048-32-7 | Purity: 95% | 2-Cyanoisonicotinohydrazide | ESD-932208-1G |
| Cas.: 135048-32-7 | Purity: 95% | 2-Cyanoisonicotinohydrazide | ESD-932208-5G |
| Cas.: 33322-60-0 | Purity: 95% | 3-Amino-N,N-dimethylbenzamide | ESD-932209-250MG |
| Cas.: 33322-60-0 | Purity: 95% | 3-Amino-N,N-dimethylbenzamide | ESD-932209-1G |
| Cas.: 33322-60-0 | Purity: 95% | 3-Amino-N,N-dimethylbenzamide | ESD-932209-5G |
| Cas.: 15754-51-5 | Purity: 95% | Bis(4-methoxyphenyl)phosphine oxide | ESD-932210-250MG |
| Cas.: 15754-51-5 | Purity: 95% | Bis(4-methoxyphenyl)phosphine oxide | ESD-932210-1G |
| Cas.: 15754-51-5 | Purity: 95% | Bis(4-methoxyphenyl)phosphine oxide | ESD-932210-5G |
| Cas.: 77191-38-9 | Purity: 97% | 3-(2-Oxopyrrolidin-1-yl)propanoic acid | ESD-932211-250MG |
| Cas.: 77191-38-9 | Purity: 97% | 3-(2-Oxopyrrolidin-1-yl)propanoic acid | ESD-932211-1G |
| Cas.: 77191-38-9 | Purity: 97% | 3-(2-Oxopyrrolidin-1-yl)propanoic acid | ESD-932211-5G |
| Cas.: 6274-57-3 | Purity: 95% | 1-(4-Bromophenyl)-N,N-dimethylmethanamine | ESD-932212-250MG |
| Cas.: 6274-57-3 | Purity: 95% | 1-(4-Bromophenyl)-N,N-dimethylmethanamine | ESD-932212-1G |
| Cas.: 6274-57-3 | Purity: 95% | 1-(4-Bromophenyl)-N,N-dimethylmethanamine | ESD-932212-5G |
| Cas.: 796851-05-3 | Purity: 95% | 3-Chloro-2-fluoro-4-iodopyridine | ESD-932213-250MG |
| Cas.: 796851-05-3 | Purity: 95% | 3-Chloro-2-fluoro-4-iodopyridine | ESD-932213-1G |
| Cas.: 796851-05-3 | Purity: 95% | 3-Chloro-2-fluoro-4-iodopyridine | ESD-932213-5G |
| Cas.: 7223-42-9 | Purity: 95% | 1-(Prop-2-yn-1-yl)pyrrolidine | ESD-932214-250MG |
| Cas.: 7223-42-9 | Purity: 95% | 1-(Prop-2-yn-1-yl)pyrrolidine | ESD-932214-1G |
| Cas.: 7223-42-9 | Purity: 95% | 1-(Prop-2-yn-1-yl)pyrrolidine | ESD-932214-5G |
| Cas.: 89197-62-6 | Purity: 95% | 5-Fluorobenzofuran-2-carboxylic acid | ESD-932215-250MG |
| Cas.: 89197-62-6 | Purity: 95% | 5-Fluorobenzofuran-2-carboxylic acid | ESD-932215-1G |
| Cas.: 89197-62-6 | Purity: 95% | 5-Fluorobenzofuran-2-carboxylic acid | ESD-932215-5G |
| Cas.: 6925-48-0 | Purity: 97% | 4-((4-Aminophenyl)diazenyl)benzoic acid | ESD-932216-250MG |
| Cas.: 6925-48-0 | Purity: 97% | 4-((4-Aminophenyl)diazenyl)benzoic acid | ESD-932216-1G |
| Cas.: 6925-48-0 | Purity: 97% | 4-((4-Aminophenyl)diazenyl)benzoic acid | ESD-932216-5G |
| Cas.: 925646-13-5 | Purity: 97% | 3-Nitro-1H-pyrazole-5-carboxylic acid | ESD-932217-250MG |
| Cas.: 925646-13-5 | Purity: 97% | 3-Nitro-1H-pyrazole-5-carboxylic acid | ESD-932217-1G |
| Cas.: 925646-13-5 | Purity: 97% | 3-Nitro-1H-pyrazole-5-carboxylic acid | ESD-932217-5G |
| Cas.: 14189-82-3 | Purity: 98% | 3-(Methyl(phenyl)amino)acrylaldehyde | ESD-932218-250MG |
| Cas.: 14189-82-3 | Purity: 98% | 3-(Methyl(phenyl)amino)acrylaldehyde | ESD-932218-1G |
| Cas.: 14189-82-3 | Purity: 98% | 3-(Methyl(phenyl)amino)acrylaldehyde | ESD-932218-5G |
| Cas.: 91949-95-0 | Purity: 98% | 4-Isopropoxybenzonitrile | ESD-932219-250MG |
| Cas.: 91949-95-0 | Purity: 98% | 4-Isopropoxybenzonitrile | ESD-932219-1G |
| Cas.: 91949-95-0 | Purity: 98% | 4-Isopropoxybenzonitrile | ESD-932219-5G |
| Cas.: 276248-50-1 | Purity: 98% | (S)-Methyl piperidine-3-carboxylate | ESD-932220-250MG |
| Cas.: 276248-50-1 | Purity: 98% | (S)-Methyl piperidine-3-carboxylate | ESD-932220-1G |
| Cas.: 276248-50-1 | Purity: 98% | (S)-Methyl piperidine-3-carboxylate | ESD-932220-5G |
| Cas.: 108281-78-3 | Purity: 98% | 6-Bromo-3-methyl-[1,2,4]triazolo[4,3-a]pyridine | ESD-932221-250MG |
| Cas.: 108281-78-3 | Purity: 98% | 6-Bromo-3-methyl-[1,2,4]triazolo[4,3-a]pyridine | ESD-932221-1G |
| Cas.: 108281-78-3 | Purity: 98% | 6-Bromo-3-methyl-[1,2,4]triazolo[4,3-a]pyridine | ESD-932221-5G |
| Cas.: 127000-90-2 | Purity: 98% | 1-{[(2R,3S)-2-(2,4-Difluorophenyl)-3-methyloxiran-2-yl]methyl}-1H-1,2,4-triazole | ESD-932222-250MG |
| Cas.: 127000-90-2 | Purity: 98% | 1-{[(2R,3S)-2-(2,4-Difluorophenyl)-3-methyloxiran-2-yl]methyl}-1H-1,2,4-triazole | ESD-932222-1G |
| Cas.: 127000-90-2 | Purity: 98% | 1-{[(2R,3S)-2-(2,4-Difluorophenyl)-3-methyloxiran-2-yl]methyl}-1H-1,2,4-triazole | ESD-932222-5G |
| Cas.: 208259-57-8 | Purity: 97% | Ethyl 2-(3,5-difluorophenyl)-2-oxoacetate | ESD-932223-250MG |
| Cas.: 208259-57-8 | Purity: 97% | Ethyl 2-(3,5-difluorophenyl)-2-oxoacetate | ESD-932223-1G |
| Cas.: 208259-57-8 | Purity: 97% | Ethyl 2-(3,5-difluorophenyl)-2-oxoacetate | ESD-932223-5G |
| Cas.: 21452-14-2 | Purity: 97% | 2-Amino-4-methyl-N-phenyl-5-thiazolecarboxamide | ESD-932224-250MG |
| Cas.: 21452-14-2 | Purity: 97% | 2-Amino-4-methyl-N-phenyl-5-thiazolecarboxamide | ESD-932224-1G |
| Cas.: 21452-14-2 | Purity: 97% | 2-Amino-4-methyl-N-phenyl-5-thiazolecarboxamide | ESD-932224-5G |
| Cas.: 49845-69-4 | Purity: 97% | (R)-2-Chloro-2-oxo-1-phenylethyl acetate | ESD-932225-250MG |
| Cas.: 49845-69-4 | Purity: 97% | (R)-2-Chloro-2-oxo-1-phenylethyl acetate | ESD-932225-1G |
| Cas.: 49845-69-4 | Purity: 97% | (R)-2-Chloro-2-oxo-1-phenylethyl acetate | ESD-932225-5G |
| Cas.: 811842-60-1 | Purity: 97% | 3′-Chloro-[1,1′-biphenyl]-4-amine hydrochloride | ESD-932226-250MG |
| Cas.: 811842-60-1 | Purity: 97% | 3′-Chloro-[1,1′-biphenyl]-4-amine hydrochloride | ESD-932226-1G |
| Cas.: 811842-60-1 | Purity: 97% | 3′-Chloro-[1,1′-biphenyl]-4-amine hydrochloride | ESD-932226-5G |
| Cas.: 62323-44-8 | Purity: ≥95% | 2-Bromo-5-ethylthiophene | ESD-932227-250MG |
| Cas.: 62323-44-8 | Purity: ≥95% | 2-Bromo-5-ethylthiophene | ESD-932227-1G |
| Cas.: 62323-44-8 | Purity: ≥95% | 2-Bromo-5-ethylthiophene | ESD-932227-5G |
| Cas.: 261951-70-6 | Purity: 98% | 4-(Bromomethyl)-1-fluoro-2-methylbenzene | ESD-932228-250MG |
| Cas.: 261951-70-6 | Purity: 98% | 4-(Bromomethyl)-1-fluoro-2-methylbenzene | ESD-932228-1G |
| Cas.: 261951-70-6 | Purity: 98% | 4-(Bromomethyl)-1-fluoro-2-methylbenzene | ESD-932228-5G |
| Cas.: 3284-79-5 | Purity: 97% | 3-(4-Chlorophenoxy)propanoic acid | ESD-932229-250MG |
| Cas.: 3284-79-5 | Purity: 97% | 3-(4-Chlorophenoxy)propanoic acid | ESD-932229-1G |
| Cas.: 3284-79-5 | Purity: 97% | 3-(4-Chlorophenoxy)propanoic acid | ESD-932229-5G |
| Cas.: 7149-18-0 | Purity: 95% | Ethyl 2-aminocyclopent-1-enecarboxylate | ESD-932230-250MG |
| Cas.: 7149-18-0 | Purity: 95% | Ethyl 2-aminocyclopent-1-enecarboxylate | ESD-932230-1G |
| Cas.: 7149-18-0 | Purity: 95% | Ethyl 2-aminocyclopent-1-enecarboxylate | ESD-932230-5G |
| Cas.: 55403-35-5 | Purity: 98% | 6-(4-Methylpiperazin-1-yl)pyridin-3-amine | ESD-932231-250MG |
| Cas.: 55403-35-5 | Purity: 98% | 6-(4-Methylpiperazin-1-yl)pyridin-3-amine | ESD-932231-1G |
| Cas.: 55403-35-5 | Purity: 98% | 6-(4-Methylpiperazin-1-yl)pyridin-3-amine | ESD-932231-5G |
| Cas.: 2622-67-5 | Purity: 95% | 1,2-Diphenyl-1H-benzo[d]imidazole | ESD-932232-250MG |
| Cas.: 2622-67-5 | Purity: 95% | 1,2-Diphenyl-1H-benzo[d]imidazole | ESD-932232-1G |
| Cas.: 2622-67-5 | Purity: 95% | 1,2-Diphenyl-1H-benzo[d]imidazole | ESD-932232-5G |
| Cas.: 665033-21-6 | Purity: 98% | 3-Amino-4-iodobenzonitrile | ESD-932233-250MG |
| Cas.: 665033-21-6 | Purity: 98% | 3-Amino-4-iodobenzonitrile | ESD-932233-1G |
| Cas.: 665033-21-6 | Purity: 98% | 3-Amino-4-iodobenzonitrile | ESD-932233-5G |
| Cas.: 265664-63-9 | Purity: ≥95% | Pyridin-3-ylboronic acid hydrochloride | ESD-932234-250MG |
| Cas.: 265664-63-9 | Purity: ≥95% | Pyridin-3-ylboronic acid hydrochloride | ESD-932234-1G |
| Cas.: 265664-63-9 | Purity: ≥95% | Pyridin-3-ylboronic acid hydrochloride | ESD-932234-5G |
| Cas.: 3619-73-6 | Purity: 98% | 1-Ethyl-1,4-diazepane | ESD-932235-250MG |
| Cas.: 3619-73-6 | Purity: 98% | 1-Ethyl-1,4-diazepane | ESD-932235-1G |
| Cas.: 3619-73-6 | Purity: 98% | 1-Ethyl-1,4-diazepane | ESD-932235-5G |
| Cas.: 207861-61-8 | Purity: 98% | Cobalt bis(trifluoromethylsulfonyl)imide | ESD-932236-250MG |
| Cas.: 207861-61-8 | Purity: 98% | Cobalt bis(trifluoromethylsulfonyl)imide | ESD-932236-500MG |
| Cas.: 207861-61-8 | Purity: 98% | Cobalt bis(trifluoromethylsulfonyl)imide | ESD-932236-1G |
| Cas.: 77876-39-2 | Purity: 98% | (2S,4S)-Pentane-2,4-diylbis(diphenylphosphine) | ESD-932237-100MG |
| Cas.: 77876-39-2 | Purity: 98% | (2S,4S)-Pentane-2,4-diylbis(diphenylphosphine) | ESD-932237-250MG |
| Cas.: 77876-39-2 | Purity: 98% | (2S,4S)-Pentane-2,4-diylbis(diphenylphosphine) | ESD-932237-1G |
| Cas.: 1196154-75-2 | Purity: 95% | 2-Amino-3,3,3-trifluoropropan-1-ol hydrochloride | ESD-932238-100MG |
| Cas.: 1196154-75-2 | Purity: 95% | 2-Amino-3,3,3-trifluoropropan-1-ol hydrochloride | ESD-932238-250MG |
| Cas.: 1196154-75-2 | Purity: 95% | 2-Amino-3,3,3-trifluoropropan-1-ol hydrochloride | ESD-932238-1G |
| Cas.: 104518-25-4 | Purity: 95% | 22-Bromo-2,5,8,11,14,17,20-heptaoxadocosane | ESD-932239-100MG |
| Cas.: 104518-25-4 | Purity: 95% | 22-Bromo-2,5,8,11,14,17,20-heptaoxadocosane | ESD-932239-250MG |
| Cas.: 104518-25-4 | Purity: 95% | 22-Bromo-2,5,8,11,14,17,20-heptaoxadocosane | ESD-932239-1G |
| Cas.: 139308-52-4 | Purity: 95% | Ethyl 3-bromo-1-methyl-1H-pyrazole-4-carboxylate | ESD-932240-100MG |
| Cas.: 139308-52-4 | Purity: 95% | Ethyl 3-bromo-1-methyl-1H-pyrazole-4-carboxylate | ESD-932240-250MG |
| Cas.: 139308-52-4 | Purity: 95% | Ethyl 3-bromo-1-methyl-1H-pyrazole-4-carboxylate | ESD-932240-1G |
| Cas.: 56820-70-3 | Purity: 95% | 6-Chloronaphthalen-1-ol | ESD-932241-100MG |
| Cas.: 56820-70-3 | Purity: 95% | 6-Chloronaphthalen-1-ol | ESD-932241-250MG |
| Cas.: 56820-70-3 | Purity: 95% | 6-Chloronaphthalen-1-ol | ESD-932241-1G |
| Cas.: 1428629-70-2 | Purity: ≥98% | 2,5-Dioxopyrrolidin-1-yl 4,7,10,13-tetraoxahexadec-15-yn-1-oate | ESD-932242-100MG |
| Cas.: 1428629-70-2 | Purity: ≥98% | 2,5-Dioxopyrrolidin-1-yl 4,7,10,13-tetraoxahexadec-15-yn-1-oate | ESD-932242-250MG |
| Cas.: 1428629-70-2 | Purity: ≥98% | 2,5-Dioxopyrrolidin-1-yl 4,7,10,13-tetraoxahexadec-15-yn-1-oate | ESD-932242-1G |
| Cas.: 157665-52-6 | Purity: ≥95% | Tert-butyl 3-fluoro-4-nitrobenzoate | ESD-932243-100MG |
| Cas.: 157665-52-6 | Purity: ≥95% | Tert-butyl 3-fluoro-4-nitrobenzoate | ESD-932243-250MG |
| Cas.: 157665-52-6 | Purity: ≥95% | Tert-butyl 3-fluoro-4-nitrobenzoate | ESD-932243-1G |
| Cas.: 1378888-43-7 | Purity: 95% | 1-(3-Ethyl-4-(hydroxymethyl)phenyl)ethanone | ESD-932244-100MG |
| Cas.: 1378888-43-7 | Purity: 95% | 1-(3-Ethyl-4-(hydroxymethyl)phenyl)ethanone | ESD-932244-250MG |
| Cas.: 1378888-43-7 | Purity: 95% | 1-(3-Ethyl-4-(hydroxymethyl)phenyl)ethanone | ESD-932244-1G |
| Cas.: 4747-72-2 | Purity: 98% | Isocyanatocyclopropane | ESD-932245-100MG |
| Cas.: 4747-72-2 | Purity: 98% | Isocyanatocyclopropane | ESD-932245-250MG |
| Cas.: 284493-52-3 | Purity: ≥95% | 3-((Tert-butoxycarbonyl)amino)-3-(2-methoxyphenyl)propanoic acid | ESD-932246-100MG |
| Cas.: 284493-52-3 | Purity: ≥95% | 3-((Tert-butoxycarbonyl)amino)-3-(2-methoxyphenyl)propanoic acid | ESD-932246-250MG |
| Cas.: 284493-52-3 | Purity: ≥95% | 3-((Tert-butoxycarbonyl)amino)-3-(2-methoxyphenyl)propanoic acid | ESD-932246-1G |
| Cas.: 433939-28-7 | Purity: 97% | 1-Bromo-3-(difluoromethoxy)-5-fluorobenzene | ESD-932247-100MG |
| Cas.: 433939-28-7 | Purity: 97% | 1-Bromo-3-(difluoromethoxy)-5-fluorobenzene | ESD-932247-250MG |
| Cas.: 433939-28-7 | Purity: 97% | 1-Bromo-3-(difluoromethoxy)-5-fluorobenzene | ESD-932247-1G |
| Cas.: 23894-82-8 | Purity: 95% (GC) | 4,4,6-Trimethyl-1,3,2-dioxaborinane | ESD-932248-100MG |
| Cas.: 23894-82-8 | Purity: 95% (GC) | 4,4,6-Trimethyl-1,3,2-dioxaborinane | ESD-932248-250MG |
| Cas.: 23894-82-8 | Purity: 95% (GC) | 4,4,6-Trimethyl-1,3,2-dioxaborinane | ESD-932248-1G |
| Cas.: 1227160-18-0 | Purity: 95% | 1-Bromo-4-(1-(trifluoromethyl)cyclopropyl)benzene | ESD-932249-100MG |
| Cas.: 1227160-18-0 | Purity: 95% | 1-Bromo-4-(1-(trifluoromethyl)cyclopropyl)benzene | ESD-932249-250MG |
| Cas.: 1227160-18-0 | Purity: 95% | 1-Bromo-4-(1-(trifluoromethyl)cyclopropyl)benzene | ESD-932249-1G |
| Cas.: 828927-97-5 | Purity: 98% | (R)-4-[2-(Diphenylphosphino)-1-naphthalenyl]-N-[(R)-1-phenylethyl]-1-phthalazinamine | ESD-932250-100MG |
| Cas.: 828927-97-5 | Purity: 98% | (R)-4-[2-(Diphenylphosphino)-1-naphthalenyl]-N-[(R)-1-phenylethyl]-1-phthalazinamine | ESD-932250-250MG |
| Cas.: 828927-97-5 | Purity: 98% | (R)-4-[2-(Diphenylphosphino)-1-naphthalenyl]-N-[(R)-1-phenylethyl]-1-phthalazinamine | ESD-932250-1G |
| Cas.: 5731-11-3 | Purity: 95% | 4′-Bromo-[1,1′-biphenyl]-4-carboxylic acid | ESD-932251-100MG |
| Cas.: 5731-11-3 | Purity: 95% | 4′-Bromo-[1,1′-biphenyl]-4-carboxylic acid | ESD-932251-250MG |
| Cas.: 5731-11-3 | Purity: 95% | 4′-Bromo-[1,1′-biphenyl]-4-carboxylic acid | ESD-932251-1G |
| Cas.: 15897-81-1 | Purity: 95% | Adamantane-2-carboxylic acid | ESD-932252-100MG |
| Cas.: 15897-81-1 | Purity: 95% | Adamantane-2-carboxylic acid | ESD-932252-250MG |
| Cas.: 15897-81-1 | Purity: 95% | Adamantane-2-carboxylic acid | ESD-932252-1G |
| Cas.: 69682-13-9 | Purity: 95% | 4-(Tert-butyl)piperidine hydrochloride | ESD-932253-100MG |
| Cas.: 69682-13-9 | Purity: 95% | 4-(Tert-butyl)piperidine hydrochloride | ESD-932253-250MG |
| Cas.: 69682-13-9 | Purity: 95% | 4-(Tert-butyl)piperidine hydrochloride | ESD-932253-1G |
| Cas.: 1590-22-3 | Purity: 95% | 4-(Naphthalen-2-yl)-4-oxobutanoic acid | ESD-932254-100MG |
| Cas.: 1590-22-3 | Purity: 95% | 4-(Naphthalen-2-yl)-4-oxobutanoic acid | ESD-932254-250MG |
| Cas.: 1590-22-3 | Purity: 95% | 4-(Naphthalen-2-yl)-4-oxobutanoic acid | ESD-932254-1G |
| Cas.: 7311-95-7 | Purity: 98% | Ethyl 2-aminobenzo[b]thiophene-3-carboxylate | ESD-932255-100MG |
| Cas.: 7311-95-7 | Purity: 98% | Ethyl 2-aminobenzo[b]thiophene-3-carboxylate | ESD-932255-250MG |
| Cas.: 7311-95-7 | Purity: 98% | Ethyl 2-aminobenzo[b]thiophene-3-carboxylate | ESD-932255-1G |
| Cas.: 36116-18-4 | Purity: 98% | Cyclopropyl(4-hydroxyphenyl)methanone | ESD-932256-100MG |
| Cas.: 36116-18-4 | Purity: 98% | Cyclopropyl(4-hydroxyphenyl)methanone | ESD-932256-250MG |
| Cas.: 36116-18-4 | Purity: 98% | Cyclopropyl(4-hydroxyphenyl)methanone | ESD-932256-1G |
| Cas.: 846023-58-3 | Purity: 97% | 4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)furan-2-carbaldehyde | ESD-932257-100MG |
| Cas.: 846023-58-3 | Purity: 97% | 4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)furan-2-carbaldehyde | ESD-932257-250MG |
| Cas.: 846023-58-3 | Purity: 97% | 4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)furan-2-carbaldehyde | ESD-932257-1G |
| Cas.: 100319-40-2 | Purity: 97% | 1-Ethyl-4-isobutylbenzene | ESD-932258-100MG |
| Cas.: 100319-40-2 | Purity: 97% | 1-Ethyl-4-isobutylbenzene | ESD-932258-250MG |
| Cas.: 100319-40-2 | Purity: 97% | 1-Ethyl-4-isobutylbenzene | ESD-932258-1G |
| Cas.: 1028-33-7 | Purity: 98% | 1-Hexyl-3,7-dimethyl-1H-purine-2,6(3H,7H)-dione | ESD-932259-100MG |
| Cas.: 1028-33-7 | Purity: 98% | 1-Hexyl-3,7-dimethyl-1H-purine-2,6(3H,7H)-dione | ESD-932259-250MG |
| Cas.: 1028-33-7 | Purity: 98% | 1-Hexyl-3,7-dimethyl-1H-purine-2,6(3H,7H)-dione | ESD-932259-1G |
| Cas.: 53590-47-9 | Purity: ≥98% | (5-Chloro-1H-indol-2-yl)methanol | ESD-932260-100MG |
| Cas.: 53590-47-9 | Purity: ≥98% | (5-Chloro-1H-indol-2-yl)methanol | ESD-932260-250MG |
| Cas.: 53590-47-9 | Purity: ≥98% | (5-Chloro-1H-indol-2-yl)methanol | ESD-932260-1G |
| Cas.: 3340-78-1 | Purity: 95% | 2-Phenyl-1,2,3,4-tetrahydroisoquinoline | ESD-932261-100MG |
| Cas.: 3340-78-1 | Purity: 95% | 2-Phenyl-1,2,3,4-tetrahydroisoquinoline | ESD-932261-250MG |
| Cas.: 3340-78-1 | Purity: 95% | 2-Phenyl-1,2,3,4-tetrahydroisoquinoline | ESD-932261-1G |
| Cas.: 220362-31-2 | Purity: 97% | 2-(3,4-Difluorophenyl)ethanamine | ESD-932262-100MG |
| Cas.: 220362-31-2 | Purity: 97% | 2-(3,4-Difluorophenyl)ethanamine | ESD-932262-250MG |
| Cas.: 220362-31-2 | Purity: 97% | 2-(3,4-Difluorophenyl)ethanamine | ESD-932262-1G |
| Cas.: 1643141-20-1 | Purity: 98% | 1-Methyl-3-((methylamino)methyl)-1H-pyrazole-5-carbonitrile hydrochloride | ESD-932263-100MG |
| Cas.: 1643141-20-1 | Purity: 98% | 1-Methyl-3-((methylamino)methyl)-1H-pyrazole-5-carbonitrile hydrochloride | ESD-932263-250MG |
| Cas.: 1643141-20-1 | Purity: 98% | 1-Methyl-3-((methylamino)methyl)-1H-pyrazole-5-carbonitrile hydrochloride | ESD-932263-1G |
| Cas.: 931-54-4 | Purity: 97% | Isocyanobenzene | ESD-932264-100MG |
| Cas.: 931-54-4 | Purity: 97% | Isocyanobenzene | ESD-932264-250MG |
| Cas.: 931-54-4 | Purity: 97% | Isocyanobenzene | ESD-932264-1G |
| Cas.: 942070-47-5 | Purity: 98% | Tert-butyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[2,3-b]pyridine-1-carboxylate | ESD-932265-100MG |
| Cas.: 942070-47-5 | Purity: 98% | Tert-butyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[2,3-b]pyridine-1-carboxylate | ESD-932265-250MG |
| Cas.: 942070-47-5 | Purity: 98% | Tert-butyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[2,3-b]pyridine-1-carboxylate | ESD-932265-1G |
| Cas.: 7450-63-7 | Purity: 95% | Dimethyl (methylenebis(4,1-phenylene))dicarbamate | ESD-932266-100MG |
| Cas.: 7450-63-7 | Purity: 95% | Dimethyl (methylenebis(4,1-phenylene))dicarbamate | ESD-932266-250MG |
| Cas.: 7450-63-7 | Purity: 95% | Dimethyl (methylenebis(4,1-phenylene))dicarbamate | ESD-932266-1G |
| Cas.: 210346-49-9 | Purity: 97% | 8-Amino-3,4-dihydronaphthalen-1(2H)-one | ESD-932267-100MG |
| Cas.: 210346-49-9 | Purity: 97% | 8-Amino-3,4-dihydronaphthalen-1(2H)-one | ESD-932267-250MG |
| Cas.: 210346-49-9 | Purity: 97% | 8-Amino-3,4-dihydronaphthalen-1(2H)-one | ESD-932267-1G |
| Cas.: 45682-36-8 | Purity: 95% | (R)-1-(4-Pyridyl)ethylamine | ESD-932268-100MG |
| Cas.: 45682-36-8 | Purity: 95% | (R)-1-(4-Pyridyl)ethylamine | ESD-932268-250MG |
| Cas.: 45682-36-8 | Purity: 95% | (R)-1-(4-Pyridyl)ethylamine | ESD-932268-1G |
| Cas.: 27692-74-6 | Purity: 95% | 4-(Pyridin-4-ylmethyl)aniline | ESD-932269-100MG |
| Cas.: 27692-74-6 | Purity: 95% | 4-(Pyridin-4-ylmethyl)aniline | ESD-932269-250MG |
| Cas.: 27692-74-6 | Purity: 95% | 4-(Pyridin-4-ylmethyl)aniline | ESD-932269-1G |
| Cas.: 121689-23-4 | Purity: 98% | 8-Aminoquinoline-4-carboxylic acid | ESD-932270-100MG |
| Cas.: 121689-23-4 | Purity: 98% | 8-Aminoquinoline-4-carboxylic acid | ESD-932270-250MG |
| Cas.: 121689-23-4 | Purity: 98% | 8-Aminoquinoline-4-carboxylic acid | ESD-932270-1G |
| Cas.: 528570-55-0 | Purity: 97% | 2,6-Dibromo-4,4-dihexyl-4H-cyclopenta[1,2-b:5,4-b’]dithiophene | ESD-932271-100MG |
| Cas.: 528570-55-0 | Purity: 97% | 2,6-Dibromo-4,4-dihexyl-4H-cyclopenta[1,2-b:5,4-b’]dithiophene | ESD-932271-250MG |
| Cas.: 528570-55-0 | Purity: 97% | 2,6-Dibromo-4,4-dihexyl-4H-cyclopenta[1,2-b:5,4-b’]dithiophene | ESD-932271-1G |
| Cas.: 5908-87-2 | Purity: ≥95% | Ethyl docosanoate | ESD-932272-100MG |
| Cas.: 5908-87-2 | Purity: ≥95% | Ethyl docosanoate | ESD-932272-250MG |
| Cas.: 5908-87-2 | Purity: ≥95% | Ethyl docosanoate | ESD-932272-1G |
| Cas.: 64142-23-0 | Purity: 97% | 1-(4-Hydroxy-3-methoxyphenyl)butan-1-one | ESD-932273-100MG |
| Cas.: 64142-23-0 | Purity: 97% | 1-(4-Hydroxy-3-methoxyphenyl)butan-1-one | ESD-932273-250MG |
| Cas.: 64142-23-0 | Purity: 97% | 1-(4-Hydroxy-3-methoxyphenyl)butan-1-one | ESD-932273-1G |
| Cas.: 57663-05-5 | Purity: 97% | 6-Methyl-4-(methylthio)-2-oxo-1,2-dihydropyridine-3-carbonitrile | ESD-932274-100MG |
| Cas.: 57663-05-5 | Purity: 97% | 6-Methyl-4-(methylthio)-2-oxo-1,2-dihydropyridine-3-carbonitrile | ESD-932274-250MG |
| Cas.: 57663-05-5 | Purity: 97% | 6-Methyl-4-(methylthio)-2-oxo-1,2-dihydropyridine-3-carbonitrile | ESD-932274-1G |
| Cas.: 957205-14-0 | Purity: 96% | 14-Bromo-3,6,9,12-tetraoxatetradecan-1-ol | ESD-932275-100MG |
| Cas.: 957205-14-0 | Purity: 96% | 14-Bromo-3,6,9,12-tetraoxatetradecan-1-ol | ESD-932275-250MG |
| Cas.: 957205-14-0 | Purity: 96% | 14-Bromo-3,6,9,12-tetraoxatetradecan-1-ol | ESD-932275-1G |
| Cas.: 65645-52-5 | Purity: 97% | Ethyl 2-(3-nitropyridin-4-yl)acetate | ESD-932276-100MG |
| Cas.: 65645-52-5 | Purity: 97% | Ethyl 2-(3-nitropyridin-4-yl)acetate | ESD-932276-250MG |
| Cas.: 65645-52-5 | Purity: 97% | Ethyl 2-(3-nitropyridin-4-yl)acetate | ESD-932276-1G |
| Cas.: 34010-21-4 | Purity: 98% | (Z)-Hexadec-11-en-1-yl acetate | ESD-932277-100MG |
| Cas.: 34010-21-4 | Purity: 98% | (Z)-Hexadec-11-en-1-yl acetate | ESD-932277-250MG |
| Cas.: 34010-21-4 | Purity: 98% | (Z)-Hexadec-11-en-1-yl acetate | ESD-932277-1G |
| Cas.: 6240-01-3 | Purity: 95% | 3-Aminoadamantane-1-carboxylic acid hydrochloride | ESD-932278-100MG |
| Cas.: 6240-01-3 | Purity: 95% | 3-Aminoadamantane-1-carboxylic acid hydrochloride | ESD-932278-250MG |
| Cas.: 6240-01-3 | Purity: 95% | 3-Aminoadamantane-1-carboxylic acid hydrochloride | ESD-932278-1G |
| Cas.: 20056-92-2 | Purity: 90% | Cis-7-dodecen-1-ol | ESD-932279-100MG |
| Cas.: 20056-92-2 | Purity: 90% | Cis-7-dodecen-1-ol | ESD-932279-250MG |
| Cas.: 20056-92-2 | Purity: 90% | Cis-7-dodecen-1-ol | ESD-932279-1G |
| Cas.: 41658-60-0 | Purity: 97% | (2S)-2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]butanedioic acid | ESD-932280-100MG |
| Cas.: 41658-60-0 | Purity: 97% | (2S)-2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]butanedioic acid | ESD-932280-250MG |
| Cas.: 41658-60-0 | Purity: 97% | (2S)-2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]butanedioic acid | ESD-932280-1G |
| Cas.: 20696-60-0 | Purity: 97% | (2S)-2-[[(2S)-2-amino-3-(1H-indol-3-yl)propanoyl]amino]-3-(1H-indol-3-yl)propanoic acid | ESD-932281-100MG |
| Cas.: 20696-60-0 | Purity: 97% | (2S)-2-[[(2S)-2-amino-3-(1H-indol-3-yl)propanoyl]amino]-3-(1H-indol-3-yl)propanoic acid | ESD-932281-250MG |
| Cas.: 20696-60-0 | Purity: 97% | (2S)-2-[[(2S)-2-amino-3-(1H-indol-3-yl)propanoyl]amino]-3-(1H-indol-3-yl)propanoic acid | ESD-932281-1G |
| Cas.: 1246888-90-3 | Purity: 97% | 3-(Tert-butyl)-4-(2,6-dimethoxyphenyl)-2,3-dihydrobenzo[d][1,3]oxaphosphole | ESD-932282-100MG |
| Cas.: 1246888-90-3 | Purity: 97% | 3-(Tert-butyl)-4-(2,6-dimethoxyphenyl)-2,3-dihydrobenzo[d][1,3]oxaphosphole | ESD-932282-250MG |
| Cas.: 1246888-90-3 | Purity: 97% | 3-(Tert-butyl)-4-(2,6-dimethoxyphenyl)-2,3-dihydrobenzo[d][1,3]oxaphosphole | ESD-932282-1G |
| Cas.: 257288-19-0 | Purity: 98% | (S)-Methyl 2-amino-5-(3-((2,2,4,6,7-pentamethyl-2,3-dihydrobenzofuran-5-yl)sulfonyl)guanidino)pentanoate hydrochloride | ESD-932283-100MG |
| Cas.: 257288-19-0 | Purity: 98% | (S)-Methyl 2-amino-5-(3-((2,2,4,6,7-pentamethyl-2,3-dihydrobenzofuran-5-yl)sulfonyl)guanidino)pentanoate hydrochloride | ESD-932283-250MG |
| Cas.: 257288-19-0 | Purity: 98% | (S)-Methyl 2-amino-5-(3-((2,2,4,6,7-pentamethyl-2,3-dihydrobenzofuran-5-yl)sulfonyl)guanidino)pentanoate hydrochloride | ESD-932283-1G |
| Cas.: 3343-24-6 | Purity: 95% | Benzeneundecanoic acid | ESD-932284-100MG |
| Cas.: 3343-24-6 | Purity: 95% | Benzeneundecanoic acid | ESD-932284-250MG |
| Cas.: 3343-24-6 | Purity: 95% | Benzeneundecanoic acid | ESD-932284-1G |
| Cas.: 53242-78-7 | Purity: 97% | 4-Hydrazinyl-1-methylpiperidine dihydrochloride | ESD-932285-100MG |
| Cas.: 53242-78-7 | Purity: 97% | 4-Hydrazinyl-1-methylpiperidine dihydrochloride | ESD-932285-250MG |
| Cas.: 53242-78-7 | Purity: 97% | 4-Hydrazinyl-1-methylpiperidine dihydrochloride | ESD-932285-1G |
| Cas.: 4746-63-8 | Purity: 97% | 2-Hydroxy-2,2-di(thiophen-2-yl)acetic acid | ESD-932286-100MG |
| Cas.: 4746-63-8 | Purity: 97% | 2-Hydroxy-2,2-di(thiophen-2-yl)acetic acid | ESD-932286-250MG |
| Cas.: 4746-63-8 | Purity: 97% | 2-Hydroxy-2,2-di(thiophen-2-yl)acetic acid | ESD-932286-1G |
| Cas.: 1449110-90-0 | Purity: 98% | [2,2′-Bis(4-tert-butylpyridine)]bis[2-(4-fluorophenyl)pyridine]iridium(III) hexafluorophosphate | ESD-932287-100MG |
| Cas.: 1449110-90-0 | Purity: 98% | [2,2′-Bis(4-tert-butylpyridine)]bis[2-(4-fluorophenyl)pyridine]iridium(III) hexafluorophosphate | ESD-932287-250MG |
| Cas.: 1449110-90-0 | Purity: 98% | [2,2′-Bis(4-tert-butylpyridine)]bis[2-(4-fluorophenyl)pyridine]iridium(III) hexafluorophosphate | ESD-932287-1G |
| Cas.: 1008788-39-3 | Purity: 97% | 4′-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,1′-biphenyl]-4-amine | ESD-932288-100MG |
| Cas.: 1008788-39-3 | Purity: 97% | 4′-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,1′-biphenyl]-4-amine | ESD-932288-250MG |
| Cas.: 1008788-39-3 | Purity: 97% | 4′-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,1′-biphenyl]-4-amine | ESD-932288-1G |
| Cas.: 30894-84-9 | Purity: 97% | 2-Chloro-4,6-dimethyl-1,3,5-triazine | ESD-932289-100MG |
| Cas.: 30894-84-9 | Purity: 97% | 2-Chloro-4,6-dimethyl-1,3,5-triazine | ESD-932289-250MG |
| Cas.: 30894-84-9 | Purity: 97% | 2-Chloro-4,6-dimethyl-1,3,5-triazine | ESD-932289-1G |
| Cas.: 852445-84-2 | Purity: 95% | Chloro{1,3-bis[2,6-bis(1-methylethyl)phenyl]-4,5-dihydroimidazol-2-ylidene}gold(I) | ESD-932290-100MG |
| Cas.: 852445-84-2 | Purity: 95% | Chloro{1,3-bis[2,6-bis(1-methylethyl)phenyl]-4,5-dihydroimidazol-2-ylidene}gold(I) | ESD-932290-250MG |
| Cas.: 852445-84-2 | Purity: 95% | Chloro{1,3-bis[2,6-bis(1-methylethyl)phenyl]-4,5-dihydroimidazol-2-ylidene}gold(I) | ESD-932290-1G |
| Cas.: 132898-95-4 | Purity: 96% | [2,2′-Bithiophen]-5-ylboronic acid | ESD-932291-100MG |
| Cas.: 132898-95-4 | Purity: 96% | [2,2′-Bithiophen]-5-ylboronic acid | ESD-932291-250MG |
| Cas.: 132898-95-4 | Purity: 96% | [2,2′-Bithiophen]-5-ylboronic acid | ESD-932291-1G |
| Cas.: 497959-39-4 | Purity: 97% | Ethyl 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)cyclohex-1-enecarboxylate | ESD-932292-100MG |
| Cas.: 497959-39-4 | Purity: 97% | Ethyl 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)cyclohex-1-enecarboxylate | ESD-932292-250MG |
| Cas.: 497959-39-4 | Purity: 97% | Ethyl 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)cyclohex-1-enecarboxylate | ESD-932292-1G |
| Cas.: 884048-45-7 | Purity: 95% | (3S,4R)-1-(Tert-butoxycarbonyl)-4-phenylpyrrolidine-3-carboxylic acid | ESD-932293-100MG |
| Cas.: 884048-45-7 | Purity: 95% | (3S,4R)-1-(Tert-butoxycarbonyl)-4-phenylpyrrolidine-3-carboxylic acid | ESD-932293-250MG |
| Cas.: 884048-45-7 | Purity: 95% | (3S,4R)-1-(Tert-butoxycarbonyl)-4-phenylpyrrolidine-3-carboxylic acid | ESD-932293-1G |
| Cas.: 14984-26-0 | Purity: ≥95% (TBC as stabilizer) | 2-Vinyl-1H-benzo[d]imidazole | ESD-932294-100MG |
| Cas.: 14984-26-0 | Purity: ≥95% (TBC as stabilizer) | 2-Vinyl-1H-benzo[d]imidazole | ESD-932294-250MG |
| Cas.: 14984-26-0 | Purity: ≥95% (TBC as stabilizer) | 2-Vinyl-1H-benzo[d]imidazole | ESD-932294-1G |
| Cas.: 1620483-21-7 | Purity: 95% | Tert-butyl 1,2,6-triazaspiro[2.5]oct-1-ene-6-carboxylate | ESD-932295-100MG |
| Cas.: 1620483-21-7 | Purity: 95% | Tert-butyl 1,2,6-triazaspiro[2.5]oct-1-ene-6-carboxylate | ESD-932295-250MG |
| Cas.: 1620483-21-7 | Purity: 95% | Tert-butyl 1,2,6-triazaspiro[2.5]oct-1-ene-6-carboxylate | ESD-932295-1G |
| Cas.: 114757-66-3 | Purity: 98% | Bis(acetonitrile)palladium(II) p-toluenesulfonate | ESD-932296-100MG |
| Cas.: 114757-66-3 | Purity: 98% | Bis(acetonitrile)palladium(II) p-toluenesulfonate | ESD-932296-250MG |
| Cas.: 114757-66-3 | Purity: 98% | Bis(acetonitrile)palladium(II) p-toluenesulfonate | ESD-932296-1G |
| Cas.: 17324-04-8 | Purity: 98% | 3-Methylnaphthalen-2-ol | ESD-932297-100MG |
| Cas.: 17324-04-8 | Purity: 98% | 3-Methylnaphthalen-2-ol | ESD-932297-250MG |
| Cas.: 17324-04-8 | Purity: 98% | 3-Methylnaphthalen-2-ol | ESD-932297-1G |
| Cas.: 142314-72-5 | Purity: 95% | Methyl 2-(bromomethyl)-3-fluorobenzoate | ESD-932298-100MG |
| Cas.: 142314-72-5 | Purity: 95% | Methyl 2-(bromomethyl)-3-fluorobenzoate | ESD-932298-250MG |
| Cas.: 142314-72-5 | Purity: 95% | Methyl 2-(bromomethyl)-3-fluorobenzoate | ESD-932298-1G |
| Cas.: 2494-12-4 | Purity: 97% | N-(3,4-Dihydroxyphenethyl)acetamide | ESD-932299-100MG |
| Cas.: 2494-12-4 | Purity: 97% | N-(3,4-Dihydroxyphenethyl)acetamide | ESD-932299-250MG |
| Cas.: 2494-12-4 | Purity: 97% | N-(3,4-Dihydroxyphenethyl)acetamide | ESD-932299-1G |
| Cas.: 1677-36-7 | Purity: 95% | 6-Chloro-4-hydroxyquinolin-2(1H)-one | ESD-932300-100MG |
| Cas.: 1677-36-7 | Purity: 95% | 6-Chloro-4-hydroxyquinolin-2(1H)-one | ESD-932300-250MG |
| Cas.: 1677-36-7 | Purity: 95% | 6-Chloro-4-hydroxyquinolin-2(1H)-one | ESD-932300-1G |
| Cas.: 153312-86-8 | Purity: ≥95% | 4,4-Dihexyl-4H-cyclopenta[1,2-b:5,4-b’]dithiophene | ESD-932301-100MG |
| Cas.: 153312-86-8 | Purity: ≥95% | 4,4-Dihexyl-4H-cyclopenta[1,2-b:5,4-b’]dithiophene | ESD-932301-250MG |
| Cas.: 153312-86-8 | Purity: ≥95% | 4,4-Dihexyl-4H-cyclopenta[1,2-b:5,4-b’]dithiophene | ESD-932301-1G |
| Cas.: 89284-85-5 | Purity: 95% | Methyl 2,5,6-trichloropyrimidine-4-carboxylate | ESD-932302-100MG |
| Cas.: 89284-85-5 | Purity: 95% | Methyl 2,5,6-trichloropyrimidine-4-carboxylate | ESD-932302-250MG |
| Cas.: 89284-85-5 | Purity: 95% | Methyl 2,5,6-trichloropyrimidine-4-carboxylate | ESD-932302-1G |
| Cas.: 1097803-59-2 | Purity: ≥95% | 8-Bromothiochroman-4-one | ESD-932303-100MG |
| Cas.: 1097803-59-2 | Purity: ≥95% | 8-Bromothiochroman-4-one | ESD-932303-250MG |
| Cas.: 1097803-59-2 | Purity: ≥95% | 8-Bromothiochroman-4-one | ESD-932303-1G |
| Cas.: 74877-10-4 | Purity: 95% | 1-(4-Fluorophenyl)propan-1-amine | ESD-932304-100MG |
| Cas.: 74877-10-4 | Purity: 95% | 1-(4-Fluorophenyl)propan-1-amine | ESD-932304-250MG |
| Cas.: 74877-10-4 | Purity: 95% | 1-(4-Fluorophenyl)propan-1-amine | ESD-932304-1G |
| Cas.: 3403-82-5 | Purity: 95% | 4,4′-Oxybis(butan-1-ol) | ESD-932305-100MG |
| Cas.: 3403-82-5 | Purity: 95% | 4,4′-Oxybis(butan-1-ol) | ESD-932305-250MG |
| Cas.: 3403-82-5 | Purity: 95% | 4,4′-Oxybis(butan-1-ol) | ESD-932305-1G |
| Cas.: 944347-13-1 | Purity: 97% | 2-Fluoro-1H-indole | ESD-932306-100MG |
| Cas.: 944347-13-1 | Purity: 97% | 2-Fluoro-1H-indole | ESD-932306-250MG |
| Cas.: 944347-13-1 | Purity: 97% | 2-Fluoro-1H-indole | ESD-932306-1G |
| Cas.: 171290-53-2 | Purity: 98% | 3-Ethynylbenzonitrile | ESD-932307-100MG |
| Cas.: 171290-53-2 | Purity: 98% | 3-Ethynylbenzonitrile | ESD-932307-250MG |
| Cas.: 171290-53-2 | Purity: 98% | 3-Ethynylbenzonitrile | ESD-932307-1G |
| Cas.: 75318-43-3 | Purity: 95% | 4,5-Dichloro-1,2,3-dithiazol-1-ium chloride | ESD-932308-100MG |
| Cas.: 75318-43-3 | Purity: 95% | 4,5-Dichloro-1,2,3-dithiazol-1-ium chloride | ESD-932308-250MG |
| Cas.: 75318-43-3 | Purity: 95% | 4,5-Dichloro-1,2,3-dithiazol-1-ium chloride | ESD-932308-1G |
| Cas.: 1365531-98-1 | Purity: 98% | (R)-2,2′-Bis[bis(4-methoxy-3,5-di-t-butylphenyl)phosphino]-4,4′,6,6′-tetramethoxy)-1,1′-biphenyl | ESD-932309-100MG |
| Cas.: 1365531-98-1 | Purity: 98% | (R)-2,2′-Bis[bis(4-methoxy-3,5-di-t-butylphenyl)phosphino]-4,4′,6,6′-tetramethoxy)-1,1′-biphenyl | ESD-932309-250MG |
| Cas.: 1365531-98-1 | Purity: 98% | (R)-2,2′-Bis[bis(4-methoxy-3,5-di-t-butylphenyl)phosphino]-4,4′,6,6′-tetramethoxy)-1,1′-biphenyl | ESD-932309-1G |
| Cas.: 31519-50-3 | Purity: 97% | (S)-Butan-2-amine hydrochloride | ESD-932310-100MG |
| Cas.: 31519-50-3 | Purity: 97% | (S)-Butan-2-amine hydrochloride | ESD-932310-250MG |
| Cas.: 31519-50-3 | Purity: 97% | (S)-Butan-2-amine hydrochloride | ESD-932310-1G |
| Cas.: 86101-48-6 | Purity: 95% | 2,2-Dimethylpent-4-ynoic acid | ESD-932311-100MG |
| Cas.: 86101-48-6 | Purity: 95% | 2,2-Dimethylpent-4-ynoic acid | ESD-932311-250MG |
| Cas.: 86101-48-6 | Purity: 95% | 2,2-Dimethylpent-4-ynoic acid | ESD-932311-1G |
| Cas.: 1378865-93-0 | Purity: 95% | 4-Methyl-2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridine | ESD-932312-100MG |
| Cas.: 1378865-93-0 | Purity: 95% | 4-Methyl-2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridine | ESD-932312-250MG |
| Cas.: 1378865-93-0 | Purity: 95% | 4-Methyl-2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridine | ESD-932312-1G |
| Cas.: 580-48-3 | Purity: 97% | 6-Chloro-N2,N2,N4,N4-tetraethyl-1,3,5-triazine-2,4-diamine | ESD-932313-100MG |
| Cas.: 580-48-3 | Purity: 97% | 6-Chloro-N2,N2,N4,N4-tetraethyl-1,3,5-triazine-2,4-diamine | ESD-932313-250MG |
| Cas.: 580-48-3 | Purity: 97% | 6-Chloro-N2,N2,N4,N4-tetraethyl-1,3,5-triazine-2,4-diamine | ESD-932313-1G |
| Cas.: 954222-10-7 | Purity: 95% | 4-Chloro-6-isopropylpyrimidine | ESD-932314-100MG |
| Cas.: 954222-10-7 | Purity: 95% | 4-Chloro-6-isopropylpyrimidine | ESD-932314-250MG |
| Cas.: 954222-10-7 | Purity: 95% | 4-Chloro-6-isopropylpyrimidine | ESD-932314-1G |
| Cas.: 169751-73-9 | Purity: 95% | Tert-butyl 14-(tosyloxy)-3,6,9,12-tetraoxatetradecan-1-oate | ESD-932315-100MG |
| Cas.: 169751-73-9 | Purity: 95% | Tert-butyl 14-(tosyloxy)-3,6,9,12-tetraoxatetradecan-1-oate | ESD-932315-250MG |
| Cas.: 169751-73-9 | Purity: 95% | Tert-butyl 14-(tosyloxy)-3,6,9,12-tetraoxatetradecan-1-oate | ESD-932315-1G |
| Cas.: 623586-02-7 | Purity: 95% | (2R)-1,2-Dimethylpiperazine | ESD-932316-100MG |
| Cas.: 623586-02-7 | Purity: 95% | (2R)-1,2-Dimethylpiperazine | ESD-932316-250MG |
| Cas.: 623586-02-7 | Purity: 95% | (2R)-1,2-Dimethylpiperazine | ESD-932316-1G |
| Cas.: 1583244-07-8 | Purity: 98% | 1-(2,4,6-Trimethylphenyl)-3-(adamantyl)imidazolium chloride | ESD-932317-100MG |
| Cas.: 1583244-07-8 | Purity: 98% | 1-(2,4,6-Trimethylphenyl)-3-(adamantyl)imidazolium chloride | ESD-932317-250MG |
| Cas.: 1583244-07-8 | Purity: 98% | 1-(2,4,6-Trimethylphenyl)-3-(adamantyl)imidazolium chloride | ESD-932317-1G |
| Cas.: 1599466-87-1 | Purity: 98% | Methanesulfonato(2-dicyclohexylphosphino-2′,6′-dimethoxy-1,1′-biphenyl)(2′-methylamino-1,1′-biphenyl-2-yl)palladium(II) | ESD-932318-100MG |
| Cas.: 1599466-87-1 | Purity: 98% | Methanesulfonato(2-dicyclohexylphosphino-2′,6′-dimethoxy-1,1′-biphenyl)(2′-methylamino-1,1′-biphenyl-2-yl)palladium(II) | ESD-932318-250MG |
| Cas.: 1599466-87-1 | Purity: 98% | Methanesulfonato(2-dicyclohexylphosphino-2′,6′-dimethoxy-1,1′-biphenyl)(2′-methylamino-1,1′-biphenyl-2-yl)palladium(II) | ESD-932318-1G |
| Cas.: 1416438-31-7 | Purity: ≥95% | 4-Bromoquinolin-8-amine | ESD-932319-100MG |
| Cas.: 1416438-31-7 | Purity: ≥95% | 4-Bromoquinolin-8-amine | ESD-932319-250MG |
| Cas.: 1416438-31-7 | Purity: ≥95% | 4-Bromoquinolin-8-amine | ESD-932319-1G |
| Cas.: 623558-68-9 | Purity: 98% | 2-(3-Ethyl-4-oxothiazolidin-2-ylidene)malononitrile | ESD-932320-100MG |
| Cas.: 623558-68-9 | Purity: 98% | 2-(3-Ethyl-4-oxothiazolidin-2-ylidene)malononitrile | ESD-932320-250MG |
| Cas.: 623558-68-9 | Purity: 98% | 2-(3-Ethyl-4-oxothiazolidin-2-ylidene)malononitrile | ESD-932320-1G |
| Cas.: 1260112-05-7 | Purity: 95% | Potassium tert-butyltrifluoroborate | ESD-932321-100MG |
| Cas.: 1260112-05-7 | Purity: 95% | Potassium tert-butyltrifluoroborate | ESD-932321-250MG |
| Cas.: 1260112-05-7 | Purity: 95% | Potassium tert-butyltrifluoroborate | ESD-932321-1G |
| Cas.: 185122-74-1 | Purity: 95% | 5-Bromo-2,3-dihydro-1H-inden-1-amine | ESD-932322-100MG |
| Cas.: 185122-74-1 | Purity: 95% | 5-Bromo-2,3-dihydro-1H-inden-1-amine | ESD-932322-250MG |
| Cas.: 185122-74-1 | Purity: 95% | 5-Bromo-2,3-dihydro-1H-inden-1-amine | ESD-932322-1G |
| Cas.: 1539-39-5 | Purity: 95% | Bis(pyridin-4-ylmethyl)amine | ESD-932323-100MG |
| Cas.: 1539-39-5 | Purity: 95% | Bis(pyridin-4-ylmethyl)amine | ESD-932323-250MG |
| Cas.: 1539-39-5 | Purity: 95% | Bis(pyridin-4-ylmethyl)amine | ESD-932323-1G |
| Cas.: 842949-48-8 | Purity: 95% | 4-Methylmorpholine-2-carboxylic acid | ESD-932324-100MG |
| Cas.: 842949-48-8 | Purity: 95% | 4-Methylmorpholine-2-carboxylic acid | ESD-932324-250MG |
| Cas.: 842949-48-8 | Purity: 95% | 4-Methylmorpholine-2-carboxylic acid | ESD-932324-1G |
| Cas.: 267650-37-3 | Purity: 98% | L-Styrylalanine | ESD-932325-100MG |
| Cas.: 267650-37-3 | Purity: 98% | L-Styrylalanine | ESD-932325-250MG |
| Cas.: 267650-37-3 | Purity: 98% | L-Styrylalanine | ESD-932325-1G |
| Cas.: 1485536-93-3 | Purity: 97% | 2-(Dibromomethyl)-4-fluorobenzonitrile | ESD-932326-100MG |
| Cas.: 1485536-93-3 | Purity: 97% | 2-(Dibromomethyl)-4-fluorobenzonitrile | ESD-932326-250MG |
| Cas.: 1485536-93-3 | Purity: 97% | 2-(Dibromomethyl)-4-fluorobenzonitrile | ESD-932326-1G |
| Cas.: 126534-33-6 | Purity: ≥98% | (R)-1-(3-Fluorophenyl)ethanol | ESD-932327-100MG |
| Cas.: 126534-33-6 | Purity: ≥98% | (R)-1-(3-Fluorophenyl)ethanol | ESD-932327-250MG |
| Cas.: 126534-33-6 | Purity: ≥98% | (R)-1-(3-Fluorophenyl)ethanol | ESD-932327-1G |
| Cas.: 70705-30-5 | Purity: 98% | Ethyl 6-methylimidazo[1,2-a]pyridine-2-carboxylate | ESD-932328-100MG |
| Cas.: 70705-30-5 | Purity: 98% | Ethyl 6-methylimidazo[1,2-a]pyridine-2-carboxylate | ESD-932328-250MG |
| Cas.: 70705-30-5 | Purity: 98% | Ethyl 6-methylimidazo[1,2-a]pyridine-2-carboxylate | ESD-932328-1G |
| Cas.: 326921-37-3 | Purity: 97% | Bis(4-(tert-butyl)phenyl)phosphine oxide | ESD-932329-100MG |
| Cas.: 326921-37-3 | Purity: 97% | Bis(4-(tert-butyl)phenyl)phosphine oxide | ESD-932329-250MG |
| Cas.: 326921-37-3 | Purity: 97% | Bis(4-(tert-butyl)phenyl)phosphine oxide | ESD-932329-1G |
| Cas.: 874804-25-8 | Purity: 95% | 2-Amino-5-fluoro-3-methylbenzoic acid | ESD-932330-100MG |
| Cas.: 874804-25-8 | Purity: 95% | 2-Amino-5-fluoro-3-methylbenzoic acid | ESD-932330-250MG |
| Cas.: 874804-25-8 | Purity: 95% | 2-Amino-5-fluoro-3-methylbenzoic acid | ESD-932330-1G |
| Cas.: 29504-81-2 | Purity: 98% | 2-Bromo-5-iodothiophene | ESD-932331-100MG |
| Cas.: 29504-81-2 | Purity: 98% | 2-Bromo-5-iodothiophene | ESD-932331-250MG |
| Cas.: 29504-81-2 | Purity: 98% | 2-Bromo-5-iodothiophene | ESD-932331-1G |
| Cas.: 189808-70-6 | Purity: 95% (GC) | Tert-butyl 2-(2-(2-(2-aminoethoxy)ethoxy)ethoxy)acetate | ESD-932332-100MG |
| Cas.: 189808-70-6 | Purity: 95% (GC) | Tert-butyl 2-(2-(2-(2-aminoethoxy)ethoxy)ethoxy)acetate | ESD-932332-250MG |
| Cas.: 189808-70-6 | Purity: 95% (GC) | Tert-butyl 2-(2-(2-(2-aminoethoxy)ethoxy)ethoxy)acetate | ESD-932332-1G |
| Cas.: 69312-43-2 | Purity: 95% | Isopropyl 2,4-dichloropyrimidine-5-carboxylate | ESD-932333-100MG |
| Cas.: 69312-43-2 | Purity: 95% | Isopropyl 2,4-dichloropyrimidine-5-carboxylate | ESD-932333-250MG |
| Cas.: 69312-43-2 | Purity: 95% | Isopropyl 2,4-dichloropyrimidine-5-carboxylate | ESD-932333-1G |
| Cas.: 1329620-17-8 | Purity: 97% | 4′,4”’-(2,2-Diphenylethene-1,1-diyl)bis([1,1′-biphenyl]-4-amine) | ESD-932334-100MG |
| Cas.: 1329620-17-8 | Purity: 97% | 4′,4”’-(2,2-Diphenylethene-1,1-diyl)bis([1,1′-biphenyl]-4-amine) | ESD-932334-250MG |
| Cas.: 1329620-17-8 | Purity: 97% | 4′,4”’-(2,2-Diphenylethene-1,1-diyl)bis([1,1′-biphenyl]-4-amine) | ESD-932334-1G |
| Cas.: 13323-66-5 | Purity: 95% | 1-(2-Hydroxyphenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one | ESD-932335-100MG |
| Cas.: 13323-66-5 | Purity: 95% | 1-(2-Hydroxyphenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one | ESD-932335-250MG |
| Cas.: 13323-66-5 | Purity: 95% | 1-(2-Hydroxyphenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one | ESD-932335-1G |
| Cas.: 152537-04-7 | Purity: 95% | Tert-butyl 3-(2-oxoethyl)azetidine-1-carboxylate | ESD-932336-100MG |
| Cas.: 152537-04-7 | Purity: 95% | Tert-butyl 3-(2-oxoethyl)azetidine-1-carboxylate | ESD-932336-250MG |
| Cas.: 152537-04-7 | Purity: 95% | Tert-butyl 3-(2-oxoethyl)azetidine-1-carboxylate | ESD-932336-1G |
| Cas.: 2344685-49-8 | Purity: 97% | 7-Azaspiro[3.5]nonan-6-one | ESD-932337-100MG |
| Cas.: 2344685-49-8 | Purity: 97% | 7-Azaspiro[3.5]nonan-6-one | ESD-932337-250MG |
| Cas.: 2344685-49-8 | Purity: 97% | 7-Azaspiro[3.5]nonan-6-one | ESD-932337-1G |
| Cas.: 72130-68-8 | Purity: 95% | Ethyl 7-hydroxy-5-oxo-1,2,3,5-tetrahydroindolizine-8-carboxylate | ESD-932338-100MG |
| Cas.: 72130-68-8 | Purity: 95% | Ethyl 7-hydroxy-5-oxo-1,2,3,5-tetrahydroindolizine-8-carboxylate | ESD-932338-250MG |
| Cas.: 72130-68-8 | Purity: 95% | Ethyl 7-hydroxy-5-oxo-1,2,3,5-tetrahydroindolizine-8-carboxylate | ESD-932338-1G |
| Cas.: 67081-98-5 | Purity: 95% | 1-(4-(Trifluoromethyl)phenyl)propan-1-ol | ESD-932339-100MG |
| Cas.: 67081-98-5 | Purity: 95% | 1-(4-(Trifluoromethyl)phenyl)propan-1-ol | ESD-932339-250MG |
| Cas.: 67081-98-5 | Purity: 95% | 1-(4-(Trifluoromethyl)phenyl)propan-1-ol | ESD-932339-1G |
| Cas.: 1523530-57-5 | Purity: 95% | Tert-butyl ((3R,5S)-5-(trifluoromethyl)piperidin-3-yl)carbamate | ESD-932340-100MG |
| Cas.: 1523530-57-5 | Purity: 95% | Tert-butyl ((3R,5S)-5-(trifluoromethyl)piperidin-3-yl)carbamate | ESD-932340-250MG |
| Cas.: 1523530-57-5 | Purity: 95% | Tert-butyl ((3R,5S)-5-(trifluoromethyl)piperidin-3-yl)carbamate | ESD-932340-1G |
| Cas.: 21296-94-6 | Purity: ≥95% | 2,3-Dimethyl-5-nitro-1H-indole | ESD-932341-100MG |
| Cas.: 21296-94-6 | Purity: ≥95% | 2,3-Dimethyl-5-nitro-1H-indole | ESD-932341-250MG |
| Cas.: 21296-94-6 | Purity: ≥95% | 2,3-Dimethyl-5-nitro-1H-indole | ESD-932341-1G |
| Cas.: 5055-39-0 | Purity: 97% | 1H-Indole-2-carbohydrazide | ESD-932342-100MG |
| Cas.: 5055-39-0 | Purity: 97% | 1H-Indole-2-carbohydrazide | ESD-932342-250MG |
| Cas.: 5055-39-0 | Purity: 97% | 1H-Indole-2-carbohydrazide | ESD-932342-1G |
| Cas.: 3624-90-6 | Purity: ≥95% | N-(2-Aminophenyl)-4-methylbenzenesulfonamide | ESD-932343-100MG |
| Cas.: 3624-90-6 | Purity: ≥95% | N-(2-Aminophenyl)-4-methylbenzenesulfonamide | ESD-932343-250MG |
| Cas.: 3624-90-6 | Purity: ≥95% | N-(2-Aminophenyl)-4-methylbenzenesulfonamide | ESD-932343-1G |
| Cas.: 915720-54-6 | Purity: 97% | 1-(5-Fluoropyridin-2-yl)ethanone | ESD-932344-100MG |
| Cas.: 915720-54-6 | Purity: 97% | 1-(5-Fluoropyridin-2-yl)ethanone | ESD-932344-250MG |
| Cas.: 915720-54-6 | Purity: 97% | 1-(5-Fluoropyridin-2-yl)ethanone | ESD-932344-1G |
| Cas.: 117428-49-6 | Purity: 95% | (E)-Methyl 2-(2-(bromomethyl)phenyl)-3-methoxyacrylate | ESD-932345-100MG |
| Cas.: 117428-49-6 | Purity: 95% | (E)-Methyl 2-(2-(bromomethyl)phenyl)-3-methoxyacrylate | ESD-932345-250MG |
| Cas.: 117428-49-6 | Purity: 95% | (E)-Methyl 2-(2-(bromomethyl)phenyl)-3-methoxyacrylate | ESD-932345-1G |
| Cas.: 56196-53-3 | Purity: 90% | Ethyl 4-methyloctanoate | ESD-932346-100MG |
| Cas.: 56196-53-3 | Purity: 90% | Ethyl 4-methyloctanoate | ESD-932346-250MG |
| Cas.: 56196-53-3 | Purity: 90% | Ethyl 4-methyloctanoate | ESD-932346-1G |
| Cas.: 49609-15-6 | Purity: 97% | 2-Chloro-7-methoxyquinoline | ESD-932347-100MG |
| Cas.: 49609-15-6 | Purity: 97% | 2-Chloro-7-methoxyquinoline | ESD-932347-250MG |
| Cas.: 49609-15-6 | Purity: 97% | 2-Chloro-7-methoxyquinoline | ESD-932347-1G |
| Cas.: 883236-47-3 | Purity: 97% | 5,5′,5”-(Nitrilotris(benzene-4,1-diyl))tris(thiophene-2-carbaldehyde) | ESD-932348-100MG |
| Cas.: 883236-47-3 | Purity: 97% | 5,5′,5”-(Nitrilotris(benzene-4,1-diyl))tris(thiophene-2-carbaldehyde) | ESD-932348-250MG |
| Cas.: 883236-47-3 | Purity: 97% | 5,5′,5”-(Nitrilotris(benzene-4,1-diyl))tris(thiophene-2-carbaldehyde) | ESD-932348-1G |
| Cas.: 1336963-95-1 | Purity: 97% | 6-Bromo-7-fluoroindoline-2,3-dione | ESD-932349-100MG |
| Cas.: 1336963-95-1 | Purity: 97% | 6-Bromo-7-fluoroindoline-2,3-dione | ESD-932349-250MG |
| Cas.: 1336963-95-1 | Purity: 97% | 6-Bromo-7-fluoroindoline-2,3-dione | ESD-932349-1G |
| Cas.: 96517-92-9 | Purity: 95% | 3,3′-((Oxybis(ethane-2,1-diyl))bis(oxy))dipropanoic acid | ESD-932350-100MG |
| Cas.: 96517-92-9 | Purity: 95% | 3,3′-((Oxybis(ethane-2,1-diyl))bis(oxy))dipropanoic acid | ESD-932350-250MG |
| Cas.: 96517-92-9 | Purity: 95% | 3,3′-((Oxybis(ethane-2,1-diyl))bis(oxy))dipropanoic acid | ESD-932350-1G |
| Cas.: 102502-64-7 | Purity: 95% | (S)-2-(Adamantan-1-yl)-2-aminoacetic acid hydrochloride | ESD-932351-100MG |
| Cas.: 102502-64-7 | Purity: 95% | (S)-2-(Adamantan-1-yl)-2-aminoacetic acid hydrochloride | ESD-932351-250MG |
| Cas.: 102502-64-7 | Purity: 95% | (S)-2-(Adamantan-1-yl)-2-aminoacetic acid hydrochloride | ESD-932351-1G |
| Cas.: 143572-60-5 | Purity: 97% | Methyl 4-(bromomethyl)-2-chlorobenzoate | ESD-932352-100MG |
| Cas.: 143572-60-5 | Purity: 97% | Methyl 4-(bromomethyl)-2-chlorobenzoate | ESD-932352-250MG |
| Cas.: 143572-60-5 | Purity: 97% | Methyl 4-(bromomethyl)-2-chlorobenzoate | ESD-932352-1G |
| Cas.: 186393-31-7 | Purity: 95% | (3R,4R)-Pyrrolidine-3,4-diol | ESD-932353-100MG |
| Cas.: 186393-31-7 | Purity: 95% | (3R,4R)-Pyrrolidine-3,4-diol | ESD-932353-250MG |
| Cas.: 186393-31-7 | Purity: 95% | (3R,4R)-Pyrrolidine-3,4-diol | ESD-932353-1G |
| Cas.: 1261742-22-6 | Purity: 98% | 2-(Chloromethyl)-4-fluorobenzonitrile | ESD-932354-100MG |
| Cas.: 1261742-22-6 | Purity: 98% | 2-(Chloromethyl)-4-fluorobenzonitrile | ESD-932354-250MG |
| Cas.: 1261742-22-6 | Purity: 98% | 2-(Chloromethyl)-4-fluorobenzonitrile | ESD-932354-1G |
| Cas.: 426842-85-5 | Purity: 95% | 3-Fluoro-6-methoxyquinoline | ESD-932355-100MG |
| Cas.: 426842-85-5 | Purity: 95% | 3-Fluoro-6-methoxyquinoline | ESD-932355-250MG |
| Cas.: 426842-85-5 | Purity: 95% | 3-Fluoro-6-methoxyquinoline | ESD-932355-1G |
| Cas.: 133850-81-4 | Purity: 98% | 4,6-Bis(diphenylphosphino)dibenzofuran | ESD-932356-100MG |
| Cas.: 133850-81-4 | Purity: 98% | 4,6-Bis(diphenylphosphino)dibenzofuran | ESD-932356-250MG |
| Cas.: 133850-81-4 | Purity: 98% | 4,6-Bis(diphenylphosphino)dibenzofuran | ESD-932356-1G |
| Cas.: 31165-13-6 | Purity: 98% | 6,7-Dimethoxy-1H-indole | ESD-932357-100MG |
| Cas.: 31165-13-6 | Purity: 98% | 6,7-Dimethoxy-1H-indole | ESD-932357-250MG |
| Cas.: 31165-13-6 | Purity: 98% | 6,7-Dimethoxy-1H-indole | ESD-932357-1G |
| Cas.: 83553-60-0 | Purity: 97% | 4-(Methylthio)-1H-imidazole | ESD-932358-100MG |
| Cas.: 83553-60-0 | Purity: 97% | 4-(Methylthio)-1H-imidazole | ESD-932358-250MG |
| Cas.: 83553-60-0 | Purity: 97% | 4-(Methylthio)-1H-imidazole | ESD-932358-1G |
| Cas.: 1259034-35-9 | Purity: 98% | Tert-butyl 3-ethynyl-3-hydroxyazetidine-1-carboxylate | ESD-932359-100MG |
| Cas.: 1259034-35-9 | Purity: 98% | Tert-butyl 3-ethynyl-3-hydroxyazetidine-1-carboxylate | ESD-932359-250MG |
| Cas.: 1259034-35-9 | Purity: 98% | Tert-butyl 3-ethynyl-3-hydroxyazetidine-1-carboxylate | ESD-932359-1G |
| Cas.: 4793-38-8 | Purity: 97% | 4-Chloro-5-sulfamoyl-2-(((tetrahydrofuran-2-yl)methyl)amino)benzoic acid | ESD-932360-100MG |
| Cas.: 4793-38-8 | Purity: 97% | 4-Chloro-5-sulfamoyl-2-(((tetrahydrofuran-2-yl)methyl)amino)benzoic acid | ESD-932360-250MG |
| Cas.: 172913-96-1 | Purity: 97% | (S)-Tert-butyl (6-oxopiperidin-3-yl)carbamate | ESD-932361-100MG |
| Cas.: 172913-96-1 | Purity: 97% | (S)-Tert-butyl (6-oxopiperidin-3-yl)carbamate | ESD-932361-250MG |
| Cas.: 172913-96-1 | Purity: 97% | (S)-Tert-butyl (6-oxopiperidin-3-yl)carbamate | ESD-932361-1G |
| Cas.: 250274-91-0 | Purity: 98% | Azetidin-2-ylmethanol | ESD-932362-100MG |
| Cas.: 250274-91-0 | Purity: 98% | Azetidin-2-ylmethanol | ESD-932362-250MG |
| Cas.: 250274-91-0 | Purity: 98% | Azetidin-2-ylmethanol | ESD-932362-1G |
| Cas.: 33704-19-7 | Purity: 98% | 3-(Tert-butoxycarbonyl)benzoic acid | ESD-932363-100MG |
| Cas.: 33704-19-7 | Purity: 98% | 3-(Tert-butoxycarbonyl)benzoic acid | ESD-932363-250MG |
| Cas.: 33704-19-7 | Purity: 98% | 3-(Tert-butoxycarbonyl)benzoic acid | ESD-932363-1G |
| Cas.: 1189106-50-0 | Purity: ≥95% | 7-Bromo-4-chloro-8-methylquinoline | ESD-932364-100MG |
| Cas.: 1189106-50-0 | Purity: ≥95% | 7-Bromo-4-chloro-8-methylquinoline | ESD-932364-250MG |
| Cas.: 1189106-50-0 | Purity: ≥95% | 7-Bromo-4-chloro-8-methylquinoline | ESD-932364-1G |
| Cas.: 631911-01-8 | Purity: 96% | 3-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline | ESD-932365-100MG |
| Cas.: 631911-01-8 | Purity: 96% | 3-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline | ESD-932365-250MG |
| Cas.: 631911-01-8 | Purity: 96% | 3-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline | ESD-932365-1G |
| Cas.: 1634-09-9 | Purity: 95% | 1-Butylnaphthalene | ESD-932366-100MG |
| Cas.: 1634-09-9 | Purity: 95% | 1-Butylnaphthalene | ESD-932366-250MG |
| Cas.: 1634-09-9 | Purity: 95% | 1-Butylnaphthalene | ESD-932366-1G |
| Cas.: 6328-48-9 | Purity: 96% | 3-(Benzyloxy)propanenitrile | ESD-932367-100MG |
| Cas.: 6328-48-9 | Purity: 96% | 3-(Benzyloxy)propanenitrile | ESD-932367-250MG |
| Cas.: 6328-48-9 | Purity: 96% | 3-(Benzyloxy)propanenitrile | ESD-932367-1G |
| Cas.: 10011-39-9 | Purity: 95% | Butyl 2-fluoroacrylate | ESD-932368-100MG |
| Cas.: 10011-39-9 | Purity: 95% | Butyl 2-fluoroacrylate | ESD-932368-250MG |
| Cas.: 10011-39-9 | Purity: 95% | Butyl 2-fluoroacrylate | ESD-932368-1G |
| Cas.: 875640-20-3 | Purity: 97%, 99%ee | (4S,4’S,5R,5’R)-2,2′-(Pentane-3,3-diyl)bis(4,5-diphenyl-4,5-dihydrooxazole) | ESD-932369-100MG |
| Cas.: 875640-20-3 | Purity: 97%, 99%ee | (4S,4’S,5R,5’R)-2,2′-(Pentane-3,3-diyl)bis(4,5-diphenyl-4,5-dihydrooxazole) | ESD-932369-250MG |
| Cas.: 875640-20-3 | Purity: 97%, 99%ee | (4S,4’S,5R,5’R)-2,2′-(Pentane-3,3-diyl)bis(4,5-diphenyl-4,5-dihydrooxazole) | ESD-932369-1G |
| Cas.: 3057-45-2 | Purity: 97% | 1,4-Phenylenedimethanamine dihydrochloride | ESD-932370-100MG |
| Cas.: 3057-45-2 | Purity: 97% | 1,4-Phenylenedimethanamine dihydrochloride | ESD-932370-250MG |
| Cas.: 3057-45-2 | Purity: 97% | 1,4-Phenylenedimethanamine dihydrochloride | ESD-932370-1G |
| Cas.: 107757-06-2 | Purity: 98% | 3-Methyl-5-nitrobenzaldehyde | ESD-932371-100MG |
| Cas.: 107757-06-2 | Purity: 98% | 3-Methyl-5-nitrobenzaldehyde | ESD-932371-250MG |
| Cas.: 107757-06-2 | Purity: 98% | 3-Methyl-5-nitrobenzaldehyde | ESD-932371-1G |
| Cas.: 493-08-3 | Purity: 98% | 3,4-Dihydro-1-benzopyran | ESD-932372-100MG |
| Cas.: 493-08-3 | Purity: 98% | 3,4-Dihydro-1-benzopyran | ESD-932372-250MG |
| Cas.: 493-08-3 | Purity: 98% | 3,4-Dihydro-1-benzopyran | ESD-932372-1G |
| Cas.: 1022931-83-4 | Purity: 95% | 4-(Bromomethyl)-2-Fluoro-1-Iodobenzene | ESD-932373-100MG |
| Cas.: 1022931-83-4 | Purity: 95% | 4-(Bromomethyl)-2-Fluoro-1-Iodobenzene | ESD-932373-250MG |
| Cas.: 1022931-83-4 | Purity: 95% | 4-(Bromomethyl)-2-Fluoro-1-Iodobenzene | ESD-932373-1G |
| Cas.: 89283-90-9 | Purity: 97% | 3-Bromo-6-chloro-4-methylpyridazine | ESD-932374-100MG |
| Cas.: 89283-90-9 | Purity: 97% | 3-Bromo-6-chloro-4-methylpyridazine | ESD-932374-250MG |
| Cas.: 89283-90-9 | Purity: 97% | 3-Bromo-6-chloro-4-methylpyridazine | ESD-932374-1G |
| Cas.: 330976-39-1 | Purity: 97% | 2-(2-Methoxyethyl)phenol | ESD-932375-100MG |
| Cas.: 330976-39-1 | Purity: 97% | 2-(2-Methoxyethyl)phenol | ESD-932375-250MG |
| Cas.: 330976-39-1 | Purity: 97% | 2-(2-Methoxyethyl)phenol | ESD-932375-1G |
| Cas.: 2362-50-7 | Purity: 97% | Thianthrene 5-oxide | ESD-932376-100MG |
| Cas.: 2362-50-7 | Purity: 97% | Thianthrene 5-oxide | ESD-932376-250MG |
| Cas.: 2362-50-7 | Purity: 97% | Thianthrene 5-oxide | ESD-932376-1G |
| Cas.: 90819-30-0 | Purity: 98% | Boc-LM-Tyrosine | ESD-932377-100MG |
| Cas.: 90819-30-0 | Purity: 98% | Boc-LM-Tyrosine | ESD-932377-250MG |
| Cas.: 90819-30-0 | Purity: 98% | Boc-LM-Tyrosine | ESD-932377-1G |
| Cas.: 85698-56-2 | Purity: 98% | 4,4′ -Bis(N,N-dimethylamino)-2,2′ -bipyridine | ESD-932378-100MG |
| Cas.: 85698-56-2 | Purity: 98% | 4,4′ -Bis(N,N-dimethylamino)-2,2′ -bipyridine | ESD-932378-250MG |
| Cas.: 85698-56-2 | Purity: 98% | 4,4′ -Bis(N,N-dimethylamino)-2,2′ -bipyridine | ESD-932378-1G |
| Cas.: 19256-31-6 | Purity: ≥95% | 1,1-Diethoxy-3-phenylpropan-2-one | ESD-932379-100MG |
| Cas.: 19256-31-6 | Purity: ≥95% | 1,1-Diethoxy-3-phenylpropan-2-one | ESD-932379-250MG |
| Cas.: 19256-31-6 | Purity: ≥95% | 1,1-Diethoxy-3-phenylpropan-2-one | ESD-932379-1G |
| Cas.: 1177269-07-6 | Purity: 95% | 2-Bromo-5-cyclobutoxypyridine | ESD-932380-100MG |
| Cas.: 1177269-07-6 | Purity: 95% | 2-Bromo-5-cyclobutoxypyridine | ESD-932380-250MG |
| Cas.: 1177269-07-6 | Purity: 95% | 2-Bromo-5-cyclobutoxypyridine | ESD-932380-1G |
| Cas.: 899806-45-2 | Purity: 97% | 2-(trans-4-Aminocyclohexyl)propan-2-ol | ESD-932381-100MG |
| Cas.: 899806-45-2 | Purity: 97% | 2-(trans-4-Aminocyclohexyl)propan-2-ol | ESD-932381-250MG |
| Cas.: 899806-45-2 | Purity: 97% | 2-(trans-4-Aminocyclohexyl)propan-2-ol | ESD-932381-1G |
| Cas.: 62348-13-4 | Purity: 97% | Isoxazole-5-carbonyl chloride | ESD-932382-100MG |
| Cas.: 62348-13-4 | Purity: 97% | Isoxazole-5-carbonyl chloride | ESD-932382-250MG |
| Cas.: 62348-13-4 | Purity: 97% | Isoxazole-5-carbonyl chloride | ESD-932382-1G |
| Cas.: 125639-64-7 | Purity: ≥98% | (S)-Ethyl 2-hydroxy-4-phenylbutanoate | ESD-932383-100MG |
| Cas.: 125639-64-7 | Purity: ≥98% | (S)-Ethyl 2-hydroxy-4-phenylbutanoate | ESD-932383-250MG |
| Cas.: 125639-64-7 | Purity: ≥98% | (S)-Ethyl 2-hydroxy-4-phenylbutanoate | ESD-932383-1G |
| Cas.: 18423-42-2 | Purity: 98% | Cytidine 5′-(tetrahydrogen triphosphate), sodium salt | ESD-932384-100MG |
| Cas.: 18423-42-2 | Purity: 98% | Cytidine 5′-(tetrahydrogen triphosphate), sodium salt | ESD-932384-250MG |
| Cas.: 18423-42-2 | Purity: 98% | Cytidine 5′-(tetrahydrogen triphosphate), sodium salt | ESD-932384-1G |
| Cas.: 1629-78-3 | Purity: 95% | 1-(Benzo[d]thiazol-2-yl)ethanone | ESD-932385-100MG |
| Cas.: 1629-78-3 | Purity: 95% | 1-(Benzo[d]thiazol-2-yl)ethanone | ESD-932385-250MG |
| Cas.: 1629-78-3 | Purity: 95% | 1-(Benzo[d]thiazol-2-yl)ethanone | ESD-932385-1G |
| Cas.: 1042385-75-0 | Purity: 98% | (E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)-4-(pipidin-1-yl)but-2-enamide hydrate | ESD-932386-100MG |
| Cas.: 1042385-75-0 | Purity: 98% | (E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)-4-(pipidin-1-yl)but-2-enamide hydrate | ESD-932386-250MG |
| Cas.: 1042385-75-0 | Purity: 98% | (E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)-4-(pipidin-1-yl)but-2-enamide hydrate | ESD-932386-1G |
| Cas.: 546115-43-9 | Purity: 98% | (S)-Methyl3-(3-bromophenyl)-2-((tert-butoxycarbonyl)amino)propanoate | ESD-932387-100MG |
| Cas.: 546115-43-9 | Purity: 98% | (S)-Methyl3-(3-bromophenyl)-2-((tert-butoxycarbonyl)amino)propanoate | ESD-932387-250MG |
| Cas.: 546115-43-9 | Purity: 98% | (S)-Methyl3-(3-bromophenyl)-2-((tert-butoxycarbonyl)amino)propanoate | ESD-932387-1G |
| Cas.: 530081-14-2 | Purity: 95% | 1-(4-Bromophenyl)imidazolidin-2-one | ESD-932388-100MG |
| Cas.: 530081-14-2 | Purity: 95% | 1-(4-Bromophenyl)imidazolidin-2-one | ESD-932388-250MG |
| Cas.: 530081-14-2 | Purity: 95% | 1-(4-Bromophenyl)imidazolidin-2-one | ESD-932388-1G |
| Cas.: 4919-00-0 | Purity: 95% | Methyl 5-amino-1H-imidazole-4-carboxylate | ESD-932389-100MG |
| Cas.: 4919-00-0 | Purity: 95% | Methyl 5-amino-1H-imidazole-4-carboxylate | ESD-932389-250MG |
| Cas.: 4919-00-0 | Purity: 95% | Methyl 5-amino-1H-imidazole-4-carboxylate | ESD-932389-1G |
| Cas.: 84499-75-2 | Purity: 95% | (S)-1-(3,5-Dichlorophenyl)ethanamine | ESD-932390-100MG |
| Cas.: 84499-75-2 | Purity: 95% | (S)-1-(3,5-Dichlorophenyl)ethanamine | ESD-932390-250MG |
| Cas.: 84499-75-2 | Purity: 95% | (S)-1-(3,5-Dichlorophenyl)ethanamine | ESD-932390-1G |
| Cas.: 108787-91-3 | Purity: 95% | (S)-2-((Tert-butoxycarbonyl)amino)-5-((2,2,10,10-tetramethyl-4,8-dioxo-3,9-dioxa-5,7-diazaundecan-6-ylidene )amino)pentanoic acid | ESD-932391-100MG |
| Cas.: 108787-91-3 | Purity: 95% | (S)-2-((Tert-butoxycarbonyl)amino)-5-((2,2,10,10-tetramethyl-4,8-dioxo-3,9-dioxa-5,7-diazaundecan-6-ylidene )amino)pentanoic acid | ESD-932391-250MG |
| Cas.: 108787-91-3 | Purity: 95% | (S)-2-((Tert-butoxycarbonyl)amino)-5-((2,2,10,10-tetramethyl-4,8-dioxo-3,9-dioxa-5,7-diazaundecan-6-ylidene )amino)pentanoic acid | ESD-932391-1G |
| Cas.: 160240-15-3 | Purity: 98% | 5,10,15,20-Tetrakis(4-ethynylphenyl)-21H,23H-porphine | ESD-932392-100MG |
| Cas.: 160240-15-3 | Purity: 98% | 5,10,15,20-Tetrakis(4-ethynylphenyl)-21H,23H-porphine | ESD-932392-250MG |
| Cas.: 160240-15-3 | Purity: 98% | 5,10,15,20-Tetrakis(4-ethynylphenyl)-21H,23H-porphine | ESD-932392-1G |
| Cas.: 832734-15-3 | Purity: 98% | 3-Bromo-10H-phenoxazine | ESD-932393-100MG |
| Cas.: 832734-15-3 | Purity: 98% | 3-Bromo-10H-phenoxazine | ESD-932393-250MG |
| Cas.: 832734-15-3 | Purity: 98% | 3-Bromo-10H-phenoxazine | ESD-932393-1G |
| Cas.: 57743-63-2 | Purity: 95% | 3,6-Dimethyl-3,3a,4,5-tetrahydrobenzofuran-2(7aH)-one | ESD-932394-100MG |
| Cas.: 57743-63-2 | Purity: 95% | 3,6-Dimethyl-3,3a,4,5-tetrahydrobenzofuran-2(7aH)-one | ESD-932394-250MG |
| Cas.: 57743-63-2 | Purity: 95% | 3,6-Dimethyl-3,3a,4,5-tetrahydrobenzofuran-2(7aH)-one | ESD-932394-1G |
| Cas.: 1257072-34-6 | Purity: 97% | 6-Bromo-3-chloropyrazine-2-carbonitrile | ESD-932395-100MG |
| Cas.: 1257072-34-6 | Purity: 97% | 6-Bromo-3-chloropyrazine-2-carbonitrile | ESD-932395-250MG |
| Cas.: 1257072-34-6 | Purity: 97% | 6-Bromo-3-chloropyrazine-2-carbonitrile | ESD-932395-1G |
| Cas.: 2288710-39-2 | Purity: 99% | 6-(2-(Methylsulfonyl)pyrimidin-5-yl)-N-(prop-2-yn-1-yl)hex-5-ynamide | ESD-932396-100MG |
| Cas.: 2288710-39-2 | Purity: 99% | 6-(2-(Methylsulfonyl)pyrimidin-5-yl)-N-(prop-2-yn-1-yl)hex-5-ynamide | ESD-932396-250MG |
| Cas.: 2288710-39-2 | Purity: 99% | 6-(2-(Methylsulfonyl)pyrimidin-5-yl)-N-(prop-2-yn-1-yl)hex-5-ynamide | ESD-932396-1G |
| Cas.: 152300-60-2 | Purity: 98% | Ethyl 4-bromothiazole-5-carboxylate | ESD-932397-100MG |
| Cas.: 152300-60-2 | Purity: 98% | Ethyl 4-bromothiazole-5-carboxylate | ESD-932397-250MG |
| Cas.: 152300-60-2 | Purity: 98% | Ethyl 4-bromothiazole-5-carboxylate | ESD-932397-1G |
| Cas.: 25711-72-2 | Purity: 97% | 1-(3-Aminophenyl)urea | ESD-932398-100MG |
| Cas.: 25711-72-2 | Purity: 97% | 1-(3-Aminophenyl)urea | ESD-932398-250MG |
| Cas.: 25711-72-2 | Purity: 97% | 1-(3-Aminophenyl)urea | ESD-932398-1G |
| Cas.: 1438382-15-0 | Purity: 95% | 3-(Aminomethyl)-4-methoxy-6-methylpyridin-2-ol | ESD-932399-100MG |
| Cas.: 1438382-15-0 | Purity: 95% | 3-(Aminomethyl)-4-methoxy-6-methylpyridin-2-ol | ESD-932399-250MG |
| Cas.: 1438382-15-0 | Purity: 95% | 3-(Aminomethyl)-4-methoxy-6-methylpyridin-2-ol | ESD-932399-1G |
| Cas.: 65862-01-3 | Purity: 98% | 3-Methylbicyclo[1.1.1]pentane-1-carboxylic acid | ESD-932400-100MG |
| Cas.: 65862-01-3 | Purity: 98% | 3-Methylbicyclo[1.1.1]pentane-1-carboxylic acid | ESD-932400-250MG |
| Cas.: 65862-01-3 | Purity: 98% | 3-Methylbicyclo[1.1.1]pentane-1-carboxylic acid | ESD-932400-1G |
| Cas.: 1015-38-9 | Purity: 95% | Diphenylphosphinodithioic acid | ESD-932401-100MG |
| Cas.: 1015-38-9 | Purity: 95% | Diphenylphosphinodithioic acid | ESD-932401-250MG |
| Cas.: 1015-38-9 | Purity: 95% | Diphenylphosphinodithioic acid | ESD-932401-1G |
| Cas.: 5840-76-6 | Purity: 97% | 3-Methyloxazolidine-2,5-dione | ESD-932402-100MG |
| Cas.: 5840-76-6 | Purity: 97% | 3-Methyloxazolidine-2,5-dione | ESD-932402-250MG |
| Cas.: 5840-76-6 | Purity: 97% | 3-Methyloxazolidine-2,5-dione | ESD-932402-1G |
| Cas.: 6710-62-9 | Purity: 95% | 1-Phenylbut-2-yn-1-one | ESD-932403-100MG |
| Cas.: 6710-62-9 | Purity: 95% | 1-Phenylbut-2-yn-1-one | ESD-932403-250MG |
| Cas.: 6710-62-9 | Purity: 95% | 1-Phenylbut-2-yn-1-one | ESD-932403-1G |
| Cas.: 1632075-13-8 | Purity: 97% | (2S)-2-[9H-Fluoren-9-ylmethoxycarbonyl(methyl)amino]-5-oxo-5-(tritylamino)pentanoic acid | ESD-932404-100MG |
| Cas.: 1632075-13-8 | Purity: 97% | (2S)-2-[9H-Fluoren-9-ylmethoxycarbonyl(methyl)amino]-5-oxo-5-(tritylamino)pentanoic acid | ESD-932404-250MG |
| Cas.: 1632075-13-8 | Purity: 97% | (2S)-2-[9H-Fluoren-9-ylmethoxycarbonyl(methyl)amino]-5-oxo-5-(tritylamino)pentanoic acid | ESD-932404-1G |
| Cas.: 5382-42-3 | Purity: 97% | Quinoline-2-carboxamide | ESD-932405-100MG |
| Cas.: 5382-42-3 | Purity: 97% | Quinoline-2-carboxamide | ESD-932405-250MG |
| Cas.: 5382-42-3 | Purity: 97% | Quinoline-2-carboxamide | ESD-932405-1G |
| Cas.: 65292-99-1 | Purity: 95% | 2-(3-Methoxyphenyl)acetaldehyde | ESD-932406-100MG |
| Cas.: 65292-99-1 | Purity: 95% | 2-(3-Methoxyphenyl)acetaldehyde | ESD-932406-250MG |
| Cas.: 65292-99-1 | Purity: 95% | 2-(3-Methoxyphenyl)acetaldehyde | ESD-932406-1G |
| Cas.: 210537-32-9 | Purity: 98% | 2,6-Bis[1-(2-methylphenylimino)ethyl]pyridine | ESD-932407-100MG |
| Cas.: 210537-32-9 | Purity: 98% | 2,6-Bis[1-(2-methylphenylimino)ethyl]pyridine | ESD-932407-250MG |
| Cas.: 210537-32-9 | Purity: 98% | 2,6-Bis[1-(2-methylphenylimino)ethyl]pyridine | ESD-932407-1G |
| Cas.: 84758-55-4 | Purity: 95% | Methyl 2-((tert-butoxycarbonyl)amino)-2-methylpropanoate | ESD-932408-100MG |
| Cas.: 84758-55-4 | Purity: 95% | Methyl 2-((tert-butoxycarbonyl)amino)-2-methylpropanoate | ESD-932408-250MG |
| Cas.: 84758-55-4 | Purity: 95% | Methyl 2-((tert-butoxycarbonyl)amino)-2-methylpropanoate | ESD-932408-1G |
| Cas.: 14226-97-2 | Purity: ≥95% | 5-Oxo-thiomorpholine-3-carboxylic acid | ESD-932409-100MG |
| Cas.: 14226-97-2 | Purity: ≥95% | 5-Oxo-thiomorpholine-3-carboxylic acid | ESD-932409-250MG |
| Cas.: 14226-97-2 | Purity: ≥95% | 5-Oxo-thiomorpholine-3-carboxylic acid | ESD-932409-1G |
| Cas.: 32018-87-4 | Purity: 95% | 4-Amino-1-naphthoic acid | ESD-932410-100MG |
| Cas.: 32018-87-4 | Purity: 95% | 4-Amino-1-naphthoic acid | ESD-932410-250MG |
| Cas.: 32018-87-4 | Purity: 95% | 4-Amino-1-naphthoic acid | ESD-932410-1G |
| Cas.: 3437-33-0 | Purity: ≥93% | 3-(Azepan-1-yl)propan-1-amine | ESD-932411-100MG |
| Cas.: 3437-33-0 | Purity: ≥93% | 3-(Azepan-1-yl)propan-1-amine | ESD-932411-250MG |
| Cas.: 3437-33-0 | Purity: ≥93% | 3-(Azepan-1-yl)propan-1-amine | ESD-932411-1G |
| Cas.: 115651-29-1 | Purity: 95% | 5-Acetyl-2-amino-4-hydroxybenzoic acid | ESD-932412-100MG |
| Cas.: 115651-29-1 | Purity: 95% | 5-Acetyl-2-amino-4-hydroxybenzoic acid | ESD-932412-250MG |
| Cas.: 115651-29-1 | Purity: 95% | 5-Acetyl-2-amino-4-hydroxybenzoic acid | ESD-932412-1G |
| Cas.: 58577-88-1 | Purity: 98% | (S)-2-Amino-3-(benzyloxy)propan-1-ol | ESD-932413-100MG |
| Cas.: 58577-88-1 | Purity: 98% | (S)-2-Amino-3-(benzyloxy)propan-1-ol | ESD-932413-250MG |
| Cas.: 58577-88-1 | Purity: 98% | (S)-2-Amino-3-(benzyloxy)propan-1-ol | ESD-932413-1G |
| Cas.: 5661-55-2 | Purity: 98% | 4-Phenylazetidin-2-one | ESD-932414-100MG |
| Cas.: 5661-55-2 | Purity: 98% | 4-Phenylazetidin-2-one | ESD-932414-250MG |
| Cas.: 5661-55-2 | Purity: 98% | 4-Phenylazetidin-2-one | ESD-932414-1G |
| Cas.: 96183-46-9 | Purity: 98% | (2R,4R)-Pentane-2,4-diylbis(diphenylphosphine) | ESD-932415-100MG |
| Cas.: 96183-46-9 | Purity: 98% | (2R,4R)-Pentane-2,4-diylbis(diphenylphosphine) | ESD-932415-250MG |
| Cas.: 96183-46-9 | Purity: 98% | (2R,4R)-Pentane-2,4-diylbis(diphenylphosphine) | ESD-932415-1G |
| Cas.: 62171-59-9 | Purity: 95% | 1-(Tert-butyl)-2-iodobenzene | ESD-932416-100MG |
| Cas.: 62171-59-9 | Purity: 95% | 1-(Tert-butyl)-2-iodobenzene | ESD-932416-250MG |
| Cas.: 62171-59-9 | Purity: 95% | 1-(Tert-butyl)-2-iodobenzene | ESD-932416-1G |
| Cas.: 68631-52-7 | Purity: 95% | Diethyl 4-hydroxypyridine-2,6-dicarboxylate | ESD-932417-100MG |
| Cas.: 68631-52-7 | Purity: 95% | Diethyl 4-hydroxypyridine-2,6-dicarboxylate | ESD-932417-250MG |
| Cas.: 68631-52-7 | Purity: 95% | Diethyl 4-hydroxypyridine-2,6-dicarboxylate | ESD-932417-1G |
| Cas.: 306935-33-1 | Purity: ≥98% | Methyl 2-chloro-4,4-dimethyl-3-oxopentanoate | ESD-932418-100MG |
| Cas.: 306935-33-1 | Purity: ≥98% | Methyl 2-chloro-4,4-dimethyl-3-oxopentanoate | ESD-932418-250MG |
| Cas.: 306935-33-1 | Purity: ≥98% | Methyl 2-chloro-4,4-dimethyl-3-oxopentanoate | ESD-932418-1G |
| Cas.: 53911-68-5 | Purity: 96% | 4-(4-Chlorophenyl)dihydro-2H-pyran-2,6(3H)-dione | ESD-932419-100MG |
| Cas.: 53911-68-5 | Purity: 96% | 4-(4-Chlorophenyl)dihydro-2H-pyran-2,6(3H)-dione | ESD-932419-250MG |
| Cas.: 53911-68-5 | Purity: 96% | 4-(4-Chlorophenyl)dihydro-2H-pyran-2,6(3H)-dione | ESD-932419-1G |
| Cas.: 13257-67-5 | Purity: 98% | Methyl-2-amino-2-methylpropanoate | ESD-932420-100MG |
| Cas.: 13257-67-5 | Purity: 98% | Methyl-2-amino-2-methylpropanoate | ESD-932420-250MG |
| Cas.: 13257-67-5 | Purity: 98% | Methyl-2-amino-2-methylpropanoate | ESD-932420-1G |
| Cas.: 14844-73-6 | Purity: 95% | 2,3-Dimethyl-1H-indole-5-carboxylic acid | ESD-932421-100MG |
| Cas.: 14844-73-6 | Purity: 95% | 2,3-Dimethyl-1H-indole-5-carboxylic acid | ESD-932421-250MG |
| Cas.: 14844-73-6 | Purity: 95% | 2,3-Dimethyl-1H-indole-5-carboxylic acid | ESD-932421-1G |
| Cas.: 55382-52-0 | Purity: 97% | Methyl 2,4-dihydroxy-6-propylbenzoate | ESD-932422-100MG |
| Cas.: 55382-52-0 | Purity: 97% | Methyl 2,4-dihydroxy-6-propylbenzoate | ESD-932422-250MG |
| Cas.: 55382-52-0 | Purity: 97% | Methyl 2,4-dihydroxy-6-propylbenzoate | ESD-932422-1G |
| Cas.: 21269-34-1 | Purity: 98% | 4-Hydroxy-8-methoxyquinoline | ESD-932423-100MG |
| Cas.: 21269-34-1 | Purity: 98% | 4-Hydroxy-8-methoxyquinoline | ESD-932423-250MG |
| Cas.: 21269-34-1 | Purity: 98% | 4-Hydroxy-8-methoxyquinoline | ESD-932423-1G |
| Cas.: 3907-02-6 | Purity: 95% | 2-Amino-3,3-dimethylbutan-1-ol | ESD-932424-100MG |
| Cas.: 3907-02-6 | Purity: 95% | 2-Amino-3,3-dimethylbutan-1-ol | ESD-932424-250MG |
| Cas.: 3907-02-6 | Purity: 95% | 2-Amino-3,3-dimethylbutan-1-ol | ESD-932424-1G |
| Cas.: 28948-60-9 | Purity: 97% | 2-Bromothieno[3,2-c]pyridin-4-ol | ESD-932425-100MG |
| Cas.: 28948-60-9 | Purity: 97% | 2-Bromothieno[3,2-c]pyridin-4-ol | ESD-932425-250MG |
| Cas.: 28948-60-9 | Purity: 97% | 2-Bromothieno[3,2-c]pyridin-4-ol | ESD-932425-1G |
| Cas.: 136735-95-0 | Purity: 98% | 1,2-Bis((2S,5S)-2,5-dimethylphospholan-1-yl)benzene | ESD-932426-100MG |
| Cas.: 136735-95-0 | Purity: 98% | 1,2-Bis((2S,5S)-2,5-dimethylphospholan-1-yl)benzene | ESD-932426-250MG |
| Cas.: 136735-95-0 | Purity: 98% | 1,2-Bis((2S,5S)-2,5-dimethylphospholan-1-yl)benzene | ESD-932426-1G |
| Cas.: 347146-33-2 | Purity: 97% | 1-Chloroisoquinolin-6-amine | ESD-932427-100MG |
| Cas.: 347146-33-2 | Purity: 97% | 1-Chloroisoquinolin-6-amine | ESD-932427-250MG |
| Cas.: 347146-33-2 | Purity: 97% | 1-Chloroisoquinolin-6-amine | ESD-932427-1G |
| Cas.: 164648-64-0 | Purity: 97% | 4-(Aminomethyl)-N-methylbenzamide | ESD-932428-100MG |
| Cas.: 164648-64-0 | Purity: 97% | 4-(Aminomethyl)-N-methylbenzamide | ESD-932428-250MG |
| Cas.: 164648-64-0 | Purity: 97% | 4-(Aminomethyl)-N-methylbenzamide | ESD-932428-1G |
| Cas.: 90892-99-2 | Purity: 96% | Ethyl 4-methyloxazole-2-carboxylate | ESD-932429-100MG |
| Cas.: 90892-99-2 | Purity: 96% | Ethyl 4-methyloxazole-2-carboxylate | ESD-932429-250MG |
| Cas.: 90892-99-2 | Purity: 96% | Ethyl 4-methyloxazole-2-carboxylate | ESD-932429-1G |
| Cas.: 3400-26-8 | Purity: 98% | N-Methyl-3-nitrobenzamide | ESD-932430-100MG |
| Cas.: 3400-26-8 | Purity: 98% | N-Methyl-3-nitrobenzamide | ESD-932430-250MG |
| Cas.: 3400-26-8 | Purity: 98% | N-Methyl-3-nitrobenzamide | ESD-932430-1G |
| Cas.: 74609-49-7 | Purity: 98% | (R)-2-(Benzylamino)propan-1-ol | ESD-932431-100MG |
| Cas.: 74609-49-7 | Purity: 98% | (R)-2-(Benzylamino)propan-1-ol | ESD-932431-250MG |
| Cas.: 74609-49-7 | Purity: 98% | (R)-2-(Benzylamino)propan-1-ol | ESD-932431-1G |
| Cas.: 133463-89-5 | Purity: 97% | (4S,4’S)-4,4′-Di((S)-sec-butyl)-4,4′,5,5′-tetrahydro-2,2′-bioxazole | ESD-932432-100MG |
| Cas.: 133463-89-5 | Purity: 97% | (4S,4’S)-4,4′-Di((S)-sec-butyl)-4,4′,5,5′-tetrahydro-2,2′-bioxazole | ESD-932432-250MG |
| Cas.: 133463-89-5 | Purity: 97% | (4S,4’S)-4,4′-Di((S)-sec-butyl)-4,4′,5,5′-tetrahydro-2,2′-bioxazole | ESD-932432-1G |
| Cas.: 51336-97-1 | Purity: 95% | 2-Chloro-1-(3,4-difluorophenyl)ethanol | ESD-932433-100MG |
| Cas.: 51336-97-1 | Purity: 95% | 2-Chloro-1-(3,4-difluorophenyl)ethanol | ESD-932433-250MG |
| Cas.: 51336-97-1 | Purity: 95% | 2-Chloro-1-(3,4-difluorophenyl)ethanol | ESD-932433-1G |
| Cas.: 321601-48-3 | Purity: 98% | Methyl 6-bromo-3-hydroxypicolinate | ESD-932434-100MG |
| Cas.: 321601-48-3 | Purity: 98% | Methyl 6-bromo-3-hydroxypicolinate | ESD-932434-250MG |
| Cas.: 321601-48-3 | Purity: 98% | Methyl 6-bromo-3-hydroxypicolinate | ESD-932434-1G |
| Cas.: 1501945-23-8 | Purity: 97% | Chloro(2-methylphenyl)[1,1′-bis(diphenylphosphino)ferrocene]nickel (II) | ESD-932435-100MG |
| Cas.: 1501945-23-8 | Purity: 97% | Chloro(2-methylphenyl)[1,1′-bis(diphenylphosphino)ferrocene]nickel (II) | ESD-932435-250MG |
| Cas.: 1501945-23-8 | Purity: 97% | Chloro(2-methylphenyl)[1,1′-bis(diphenylphosphino)ferrocene]nickel (II) | ESD-932435-1G |
| Cas.: 92822-02-1 | Purity: 97% | 4-(4′-Fluorobenzyl)piperidine | ESD-932436-100MG |
| Cas.: 92822-02-1 | Purity: 97% | 4-(4′-Fluorobenzyl)piperidine | ESD-932436-250MG |
| Cas.: 92822-02-1 | Purity: 97% | 4-(4′-Fluorobenzyl)piperidine | ESD-932436-1G |
| Cas.: 63089-56-5 | Purity: 98% | 1,2,3,5,6,7-Hexahydro-S-5-indacen-4yl-amine | ESD-932437-100MG |
| Cas.: 63089-56-5 | Purity: 98% | 1,2,3,5,6,7-Hexahydro-S-5-indacen-4yl-amine | ESD-932437-250MG |
| Cas.: 63089-56-5 | Purity: 98% | 1,2,3,5,6,7-Hexahydro-S-5-indacen-4yl-amine | ESD-932437-1G |
| Cas.: 1158735-09-1 | Purity: 95% | (2-Methoxypyrimidin-5-yl)methanol | ESD-932438-100MG |
| Cas.: 1158735-09-1 | Purity: 95% | (2-Methoxypyrimidin-5-yl)methanol | ESD-932438-250MG |
| Cas.: 1158735-09-1 | Purity: 95% | (2-Methoxypyrimidin-5-yl)methanol | ESD-932438-1G |
| Cas.: 5195-29-9 | Purity: 95% | 2-(4-Bromophenyl)-2-oxoacetaldehyde | ESD-932439-100MG |
| Cas.: 5195-29-9 | Purity: 95% | 2-(4-Bromophenyl)-2-oxoacetaldehyde | ESD-932439-250MG |
| Cas.: 5195-29-9 | Purity: 95% | 2-(4-Bromophenyl)-2-oxoacetaldehyde | ESD-932439-1G |
| Cas.: 601514-58-3 | Purity: 95% | 6-Benzyl-5,6,7,8-tetrahydro-1,6-naphthyridin-2(1H)-one | ESD-932440-100MG |
| Cas.: 601514-58-3 | Purity: 95% | 6-Benzyl-5,6,7,8-tetrahydro-1,6-naphthyridin-2(1H)-one | ESD-932440-250MG |
| Cas.: 601514-58-3 | Purity: 95% | 6-Benzyl-5,6,7,8-tetrahydro-1,6-naphthyridin-2(1H)-one | ESD-932440-1G |
| Cas.: 2942-14-5 | Purity: 95% | 5-Methoxybenzo[d]thiazole | ESD-932441-100MG |
| Cas.: 2942-14-5 | Purity: 95% | 5-Methoxybenzo[d]thiazole | ESD-932441-250MG |
| Cas.: 2942-14-5 | Purity: 95% | 5-Methoxybenzo[d]thiazole | ESD-932441-1G |
| Cas.: 10300-27-3 | Purity: 98% | 3′-O-Methylguanosine | ESD-932442-100MG |
| Cas.: 10300-27-3 | Purity: 98% | 3′-O-Methylguanosine | ESD-932442-250MG |
| Cas.: 10300-27-3 | Purity: 98% | 3′-O-Methylguanosine | ESD-932442-1G |
| Cas.: 4265-59-2 | Purity: 96% | 3,3′-(Propane-2,2-diylbis(sulfanediyl))dipropionic acid | ESD-932443-100MG |
| Cas.: 4265-59-2 | Purity: 96% | 3,3′-(Propane-2,2-diylbis(sulfanediyl))dipropionic acid | ESD-932443-250MG |
| Cas.: 4265-59-2 | Purity: 96% | 3,3′-(Propane-2,2-diylbis(sulfanediyl))dipropionic acid | ESD-932443-1G |
| Cas.: 113136-77-9 | Purity: 95% | 1-((2,4-Dichlorophenyl)carbamoyl)cyclopropanecarboxylic acid | ESD-932444-100MG |
| Cas.: 113136-77-9 | Purity: 95% | 1-((2,4-Dichlorophenyl)carbamoyl)cyclopropanecarboxylic acid | ESD-932444-250MG |
| Cas.: 113136-77-9 | Purity: 95% | 1-((2,4-Dichlorophenyl)carbamoyl)cyclopropanecarboxylic acid | ESD-932444-1G |
| Cas.: 157904-66-0 | Purity: 97% | Bis((4S,5R)-4,5-diphenyl-4,5-dihydrooxazol-2-yl)methane | ESD-932445-100MG |
| Cas.: 157904-66-0 | Purity: 97% | Bis((4S,5R)-4,5-diphenyl-4,5-dihydrooxazol-2-yl)methane | ESD-932445-250MG |
| Cas.: 157904-66-0 | Purity: 97% | Bis((4S,5R)-4,5-diphenyl-4,5-dihydrooxazol-2-yl)methane | ESD-932445-1G |
| Cas.: 51649-35-5 | Purity: 95% | 4,5,6,7-Tetrahydro-2H-isoindole | ESD-932446-100MG |
| Cas.: 51649-35-5 | Purity: 95% | 4,5,6,7-Tetrahydro-2H-isoindole | ESD-932446-250MG |
| Cas.: 51649-35-5 | Purity: 95% | 4,5,6,7-Tetrahydro-2H-isoindole | ESD-932446-1G |
| Cas.: 5884-48-0 | Purity: 95% | 2-(4-(Benzyloxy)-3-bromophenyl)acetic acid | ESD-932447-100MG |
| Cas.: 5884-48-0 | Purity: 95% | 2-(4-(Benzyloxy)-3-bromophenyl)acetic acid | ESD-932447-250MG |
| Cas.: 5884-48-0 | Purity: 95% | 2-(4-(Benzyloxy)-3-bromophenyl)acetic acid | ESD-932447-1G |
| Cas.: 117736-74-0 | Purity: 97% | 3-(Methylthio)-1H-pyrazol-5-amine | ESD-932448-100MG |
| Cas.: 117736-74-0 | Purity: 97% | 3-(Methylthio)-1H-pyrazol-5-amine | ESD-932448-250MG |
| Cas.: 117736-74-0 | Purity: 97% | 3-(Methylthio)-1H-pyrazol-5-amine | ESD-932448-1G |
| Cas.: 1902955-29-6 | Purity: 98% | Methyl 5-(2,4-difluorophenyl)-4-methoxy-1H-pyrrole-3-carboxylate | ESD-932449-100MG |
| Cas.: 1902955-29-6 | Purity: 98% | Methyl 5-(2,4-difluorophenyl)-4-methoxy-1H-pyrrole-3-carboxylate | ESD-932449-250MG |
| Cas.: 1902955-29-6 | Purity: 98% | Methyl 5-(2,4-difluorophenyl)-4-methoxy-1H-pyrrole-3-carboxylate | ESD-932449-1G |
| Cas.: 1213352-71-6 | Purity: 97% | (S)-2-((Tert-butoxycarbonyl)amino)-3-(2,5-dichlorophenyl)propanoic acid | ESD-932450-100MG |
| Cas.: 1213352-71-6 | Purity: 97% | (S)-2-((Tert-butoxycarbonyl)amino)-3-(2,5-dichlorophenyl)propanoic acid | ESD-932450-250MG |
| Cas.: 1213352-71-6 | Purity: 97% | (S)-2-((Tert-butoxycarbonyl)amino)-3-(2,5-dichlorophenyl)propanoic acid | ESD-932450-1G |
| Cas.: 40642-40-8 | Purity: 90% | Z-8-dodecen-1-ol | ESD-932451-100MG |
| Cas.: 40642-40-8 | Purity: 90% | Z-8-dodecen-1-ol | ESD-932451-250MG |
| Cas.: 40642-40-8 | Purity: 90% | Z-8-dodecen-1-ol | ESD-932451-1G |
| Cas.: 73873-91-3 | Purity: ≥98% | 4-Aminoquinoline-6-carboxylic acid | ESD-932452-100MG |
| Cas.: 73873-91-3 | Purity: ≥98% | 4-Aminoquinoline-6-carboxylic acid | ESD-932452-250MG |
| Cas.: 73873-91-3 | Purity: ≥98% | 4-Aminoquinoline-6-carboxylic acid | ESD-932452-1G |
| Cas.: 196601-69-1 | Purity: 95% | (R)-2-Amino-N-benzyl-3-methoxypropanamide | ESD-932453-100MG |
| Cas.: 196601-69-1 | Purity: 95% | (R)-2-Amino-N-benzyl-3-methoxypropanamide | ESD-932453-250MG |
| Cas.: 196601-69-1 | Purity: 95% | (R)-2-Amino-N-benzyl-3-methoxypropanamide | ESD-932453-1G |
| Cas.: 4735-50-6 | Purity: 95% | 2-(Naphthalen-1-yl)ethanamine | ESD-932454-100MG |
| Cas.: 4735-50-6 | Purity: 95% | 2-(Naphthalen-1-yl)ethanamine | ESD-932454-250MG |
| Cas.: 4735-50-6 | Purity: 95% | 2-(Naphthalen-1-yl)ethanamine | ESD-932454-1G |
| Cas.: 905926-85-4 | Purity: 98% | (2-Ethynylphenyl)boronic acid | ESD-932455-100MG |
| Cas.: 905926-85-4 | Purity: 98% | (2-Ethynylphenyl)boronic acid | ESD-932455-250MG |
| Cas.: 905926-85-4 | Purity: 98% | (2-Ethynylphenyl)boronic acid | ESD-932455-1G |
| Cas.: 478183-62-9 | Purity: 98% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-cyclobutylpropanoic acid | ESD-932456-100MG |
| Cas.: 478183-62-9 | Purity: 98% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-cyclobutylpropanoic acid | ESD-932456-250MG |
| Cas.: 478183-62-9 | Purity: 98% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-cyclobutylpropanoic acid | ESD-932456-1G |
| Cas.: 98243-83-5 | Purity: 95% | (R)-Methyl 2-(N-(2,6-dimethylphenyl)-2-phenylacetamido)propanoate | ESD-932457-100MG |
| Cas.: 98243-83-5 | Purity: 95% | (R)-Methyl 2-(N-(2,6-dimethylphenyl)-2-phenylacetamido)propanoate | ESD-932457-250MG |
| Cas.: 98243-83-5 | Purity: 95% | (R)-Methyl 2-(N-(2,6-dimethylphenyl)-2-phenylacetamido)propanoate | ESD-932457-1G |
| Cas.: 180698-19-5 | Purity: 97% | 1-Biphenyl-4-yl-piperazine | ESD-932458-100MG |
| Cas.: 180698-19-5 | Purity: 97% | 1-Biphenyl-4-yl-piperazine | ESD-932458-250MG |
| Cas.: 180698-19-5 | Purity: 97% | 1-Biphenyl-4-yl-piperazine | ESD-932458-1G |
| Cas.: 1040683-15-5 | Purity: 98% | 3-Fluoro-5-(trifluoromethyl)pyridin-2-ol | ESD-932459-100MG |
| Cas.: 1040683-15-5 | Purity: 98% | 3-Fluoro-5-(trifluoromethyl)pyridin-2-ol | ESD-932459-250MG |
| Cas.: 1040683-15-5 | Purity: 98% | 3-Fluoro-5-(trifluoromethyl)pyridin-2-ol | ESD-932459-1G |
| Cas.: 880870-66-6 | Purity: 98% | 5-Bromo-2-fluoro-3-methoxypyridine | ESD-932460-100MG |
| Cas.: 880870-66-6 | Purity: 98% | 5-Bromo-2-fluoro-3-methoxypyridine | ESD-932460-250MG |
| Cas.: 880870-66-6 | Purity: 98% | 5-Bromo-2-fluoro-3-methoxypyridine | ESD-932460-1G |
| Cas.: 135565-31-0 | Purity: 97% | (4S,4’S)-4,4′-Bis(1,1-dimethylethyl)-4,4′,5,5′-tetrahydro-2,2′-bioxazole | ESD-932461-100MG |
| Cas.: 135565-31-0 | Purity: 97% | (4S,4’S)-4,4′-Bis(1,1-dimethylethyl)-4,4′,5,5′-tetrahydro-2,2′-bioxazole | ESD-932461-250MG |
| Cas.: 135565-31-0 | Purity: 97% | (4S,4’S)-4,4′-Bis(1,1-dimethylethyl)-4,4′,5,5′-tetrahydro-2,2′-bioxazole | ESD-932461-1G |
| Cas.: 18471-99-3 | Purity: 95% | 1-Methyl-4-oxo-1,4-dihydroquinoline-3-carboxylic acid | ESD-932462-100MG |
| Cas.: 18471-99-3 | Purity: 95% | 1-Methyl-4-oxo-1,4-dihydroquinoline-3-carboxylic acid | ESD-932462-250MG |
| Cas.: 18471-99-3 | Purity: 95% | 1-Methyl-4-oxo-1,4-dihydroquinoline-3-carboxylic acid | ESD-932462-1G |
| Cas.: 202584-14-3 | Purity: 98% | 1,6-Dimethyl-1H-indole-3-carbaldehyde | ESD-932463-100MG |
| Cas.: 202584-14-3 | Purity: 98% | 1,6-Dimethyl-1H-indole-3-carbaldehyde | ESD-932463-250MG |
| Cas.: 202584-14-3 | Purity: 98% | 1,6-Dimethyl-1H-indole-3-carbaldehyde | ESD-932463-1G |
| Cas.: 17361-44-3 | Purity: 95% | Ditetradecylamine | ESD-932464-100MG |
| Cas.: 17361-44-3 | Purity: 95% | Ditetradecylamine | ESD-932464-250MG |
| Cas.: 17361-44-3 | Purity: 95% | Ditetradecylamine | ESD-932464-1G |
| Cas.: 15399-05-0 | Purity: 98% | Ethyl 2-hydroxy-3-phenylpropanoate | ESD-932465-100MG |
| Cas.: 15399-05-0 | Purity: 98% | Ethyl 2-hydroxy-3-phenylpropanoate | ESD-932465-250MG |
| Cas.: 15399-05-0 | Purity: 98% | Ethyl 2-hydroxy-3-phenylpropanoate | ESD-932465-1G |
| Cas.: 2097518-76-6 | Purity: 98% | ((2R,7aS)-2-Fluorohexahydro-1H-pyrrolizin-7a-yl)methanol | ESD-932466-100MG |
| Cas.: 2097518-76-6 | Purity: 98% | ((2R,7aS)-2-Fluorohexahydro-1H-pyrrolizin-7a-yl)methanol | ESD-932466-250MG |
| Cas.: 2097518-76-6 | Purity: 98% | ((2R,7aS)-2-Fluorohexahydro-1H-pyrrolizin-7a-yl)methanol | ESD-932466-1G |
| Cas.: 26095-97-6 | Purity: 95% | Furan-2,5-dicarbohydrazide | ESD-932467-100MG |
| Cas.: 26095-97-6 | Purity: 95% | Furan-2,5-dicarbohydrazide | ESD-932467-250MG |
| Cas.: 26095-97-6 | Purity: 95% | Furan-2,5-dicarbohydrazide | ESD-932467-1G |
| Cas.: 53136-21-3 | Purity: 98% | Benzyl(4-bromophenyl)sulfane | ESD-932468-100MG |
| Cas.: 53136-21-3 | Purity: 98% | Benzyl(4-bromophenyl)sulfane | ESD-932468-250MG |
| Cas.: 53136-21-3 | Purity: 98% | Benzyl(4-bromophenyl)sulfane | ESD-932468-1G |
| Cas.: 228728-32-3 | Purity: 98% | Ethyl 6-(tert-butyl)-4-hydroxyquinoline-3-carboxylate | ESD-932469-100MG |
| Cas.: 228728-32-3 | Purity: 98% | Ethyl 6-(tert-butyl)-4-hydroxyquinoline-3-carboxylate | ESD-932469-250MG |
| Cas.: 228728-32-3 | Purity: 98% | Ethyl 6-(tert-butyl)-4-hydroxyquinoline-3-carboxylate | ESD-932469-1G |
| Cas.: 4707-46-4 | Purity: 95% | 2,4-Dihydroxy-3,6-dimethylbenzoic acid | ESD-932470-100MG |
| Cas.: 4707-46-4 | Purity: 95% | 2,4-Dihydroxy-3,6-dimethylbenzoic acid | ESD-932470-250MG |
| Cas.: 4707-46-4 | Purity: 95% | 2,4-Dihydroxy-3,6-dimethylbenzoic acid | ESD-932470-1G |
| Cas.: 344957-25-1 | Purity: 97% | 2-(Aminomethyl)benzonitrile | ESD-932471-100MG |
| Cas.: 344957-25-1 | Purity: 97% | 2-(Aminomethyl)benzonitrile | ESD-932471-250MG |
| Cas.: 344957-25-1 | Purity: 97% | 2-(Aminomethyl)benzonitrile | ESD-932471-1G |
| Cas.: 1420478-88-1 | Purity: 97% | (S)-Benzyl 2-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)pyrrolidine-1-carboxylate | ESD-932472-100MG |
| Cas.: 1420478-88-1 | Purity: 97% | (S)-Benzyl 2-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)pyrrolidine-1-carboxylate | ESD-932472-250MG |
| Cas.: 1420478-88-1 | Purity: 97% | (S)-Benzyl 2-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)pyrrolidine-1-carboxylate | ESD-932472-1G |
| Cas.: 1252046-16-4 | Purity: 98% | 6-Bromo-3-chloropicolinonitrile | ESD-932473-100MG |
| Cas.: 1252046-16-4 | Purity: 98% | 6-Bromo-3-chloropicolinonitrile | ESD-932473-250MG |
| Cas.: 1252046-16-4 | Purity: 98% | 6-Bromo-3-chloropicolinonitrile | ESD-932473-1G |
| Cas.: 117426-12-7 | Purity: 95% | 2-(Bromomethyl)-N,N-dimethylaniline | ESD-932474-100MG |
| Cas.: 117426-12-7 | Purity: 95% | 2-(Bromomethyl)-N,N-dimethylaniline | ESD-932474-250MG |
| Cas.: 117426-12-7 | Purity: 95% | 2-(Bromomethyl)-N,N-dimethylaniline | ESD-932474-1G |
| Cas.: 1642844-33-4 | Purity: 97% | 6-Bromo-5-(trifluoromethyl)pyridin-3-amine | ESD-932475-100MG |
| Cas.: 1642844-33-4 | Purity: 97% | 6-Bromo-5-(trifluoromethyl)pyridin-3-amine | ESD-932475-250MG |
| Cas.: 1642844-33-4 | Purity: 97% | 6-Bromo-5-(trifluoromethyl)pyridin-3-amine | ESD-932475-1G |
| Cas.: 96016-96-5 | Purity: 95% | Isoindoline-1-carboxylic acid hydrochloride | ESD-932476-100MG |
| Cas.: 96016-96-5 | Purity: 95% | Isoindoline-1-carboxylic acid hydrochloride | ESD-932476-250MG |
| Cas.: 96016-96-5 | Purity: 95% | Isoindoline-1-carboxylic acid hydrochloride | ESD-932476-1G |
| Cas.: 175358-01-7 | Purity: 98% | 3-Amino-6-chloropicolinamide | ESD-932477-100MG |
| Cas.: 175358-01-7 | Purity: 98% | 3-Amino-6-chloropicolinamide | ESD-932477-250MG |
| Cas.: 175358-01-7 | Purity: 98% | 3-Amino-6-chloropicolinamide | ESD-932477-1G |
| Cas.: 73955-53-0 | Purity: 98% | Methyl 6-methylpyrimidine-4-carboxylate | ESD-932478-100MG |
| Cas.: 73955-53-0 | Purity: 98% | Methyl 6-methylpyrimidine-4-carboxylate | ESD-932478-250MG |
| Cas.: 73955-53-0 | Purity: 98% | Methyl 6-methylpyrimidine-4-carboxylate | ESD-932478-1G |
| Cas.: 858956-08-8 | Purity: 95% | 6-Amino-5-chloro-2-cyclopropylpyrimidine-4-carboxylic acid | ESD-932479-100MG |
| Cas.: 858956-08-8 | Purity: 95% | 6-Amino-5-chloro-2-cyclopropylpyrimidine-4-carboxylic acid | ESD-932479-250MG |
| Cas.: 858956-08-8 | Purity: 95% | 6-Amino-5-chloro-2-cyclopropylpyrimidine-4-carboxylic acid | ESD-932479-1G |
| Cas.: 1242320-57-5 | Purity: 97% | Methyl 5-bromo-3-hydroxypicolinate | ESD-932480-100MG |
| Cas.: 1242320-57-5 | Purity: 97% | Methyl 5-bromo-3-hydroxypicolinate | ESD-932480-250MG |
| Cas.: 1242320-57-5 | Purity: 97% | Methyl 5-bromo-3-hydroxypicolinate | ESD-932480-1G |
| Cas.: 22138-72-3 | Purity: ≥95% | 3-(4-Fluorophenyl)-2-methylacrylic acid | ESD-932481-100MG |
| Cas.: 22138-72-3 | Purity: ≥95% | 3-(4-Fluorophenyl)-2-methylacrylic acid | ESD-932481-250MG |
| Cas.: 22138-72-3 | Purity: ≥95% | 3-(4-Fluorophenyl)-2-methylacrylic acid | ESD-932481-1G |
| Cas.: 137525-51-0 | Purity: 99% | BPC-157 | ESD-932482-100MG |
| Cas.: 137525-51-0 | Purity: 99% | BPC-157 | ESD-932482-250MG |
| Cas.: 137525-51-0 | Purity: 99% | BPC-157 | ESD-932482-1G |
| Cas.: 478183-65-2 | Purity: 98% | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2-iodophenyl)propanoic acid | ESD-932483-100MG |
| Cas.: 478183-65-2 | Purity: 98% | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2-iodophenyl)propanoic acid | ESD-932483-250MG |
| Cas.: 478183-65-2 | Purity: 98% | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2-iodophenyl)propanoic acid | ESD-932483-1G |
| Cas.: 224449-33-6 | Purity: 95% | Ethyl 4-bromothiophene-3-carboxylate | ESD-932484-100MG |
| Cas.: 224449-33-6 | Purity: 95% | Ethyl 4-bromothiophene-3-carboxylate | ESD-932484-250MG |
| Cas.: 224449-33-6 | Purity: 95% | Ethyl 4-bromothiophene-3-carboxylate | ESD-932484-1G |
| Cas.: 165196-44-1 | Purity: 95% | Tert-butyl (2-acrylamidoethyl)carbamate | ESD-932485-100MG |
| Cas.: 165196-44-1 | Purity: 95% | Tert-butyl (2-acrylamidoethyl)carbamate | ESD-932485-250MG |
| Cas.: 165196-44-1 | Purity: 95% | Tert-butyl (2-acrylamidoethyl)carbamate | ESD-932485-1G |
| Cas.: 955029-44-4 | Purity: 97% | Tert-butyl trans-3-fluoro-4-hydroxypiperidine-1-carboxylate | ESD-932486-100MG |
| Cas.: 955029-44-4 | Purity: 97% | Tert-butyl trans-3-fluoro-4-hydroxypiperidine-1-carboxylate | ESD-932486-250MG |
| Cas.: 955029-44-4 | Purity: 97% | Tert-butyl trans-3-fluoro-4-hydroxypiperidine-1-carboxylate | ESD-932486-1G |
| Cas.: 34033-41-5 | Purity: 98% | 4-Bromo-2-chloro-6-nitroaniline | ESD-932487-100MG |
| Cas.: 34033-41-5 | Purity: 98% | 4-Bromo-2-chloro-6-nitroaniline | ESD-932487-250MG |
| Cas.: 34033-41-5 | Purity: 98% | 4-Bromo-2-chloro-6-nitroaniline | ESD-932487-1G |
| Cas.: 807-19-2 | Purity: 98% | 4,4′,4”-Phosphoryltribenzoic acid | ESD-932488-100MG |
| Cas.: 807-19-2 | Purity: 98% | 4,4′,4”-Phosphoryltribenzoic acid | ESD-932488-250MG |
| Cas.: 807-19-2 | Purity: 98% | 4,4′,4”-Phosphoryltribenzoic acid | ESD-932488-1G |
| Cas.: 51549-32-7 | Purity: 98% | 9-((2R,4S,5R)-4-((Tert-butyldimethylsilyl)oxy)-5-(((tert-butyldimethylsilyl)oxy)methyl)tetrahydrofuran-2-yl)-9H-purin-6-amine | ESD-932489-100MG |
| Cas.: 51549-32-7 | Purity: 98% | 9-((2R,4S,5R)-4-((Tert-butyldimethylsilyl)oxy)-5-(((tert-butyldimethylsilyl)oxy)methyl)tetrahydrofuran-2-yl)-9H-purin-6-amine | ESD-932489-250MG |
| Cas.: 51549-32-7 | Purity: 98% | 9-((2R,4S,5R)-4-((Tert-butyldimethylsilyl)oxy)-5-(((tert-butyldimethylsilyl)oxy)methyl)tetrahydrofuran-2-yl)-9H-purin-6-amine | ESD-932489-1G |
| Cas.: 37429-48-4 | Purity: 95% | 2-(Benzyl(methyl)amino)acetic acid | ESD-932490-100MG |
| Cas.: 37429-48-4 | Purity: 95% | 2-(Benzyl(methyl)amino)acetic acid | ESD-932490-250MG |
| Cas.: 37429-48-4 | Purity: 95% | 2-(Benzyl(methyl)amino)acetic acid | ESD-932490-1G |
| Cas.: 109555-87-5 | Purity: 95% | 3-(1-Naphthoyl)indole | ESD-932491-100MG |
| Cas.: 109555-87-5 | Purity: 95% | 3-(1-Naphthoyl)indole | ESD-932491-250MG |
| Cas.: 109555-87-5 | Purity: 95% | 3-(1-Naphthoyl)indole | ESD-932491-1G |
| Cas.: 24623-61-8 | Purity: 95% | 2-Hydroxy-3,5-dimethylbenzaldehyde | ESD-932492-100MG |
| Cas.: 24623-61-8 | Purity: 95% | 2-Hydroxy-3,5-dimethylbenzaldehyde | ESD-932492-250MG |
| Cas.: 24623-61-8 | Purity: 95% | 2-Hydroxy-3,5-dimethylbenzaldehyde | ESD-932492-1G |
| Cas.: 14568-68-4 | Purity: 95% | 1,4-Dimethoxy-2-vinylbenzol | ESD-932493-100MG |
| Cas.: 14568-68-4 | Purity: 95% | 1,4-Dimethoxy-2-vinylbenzol | ESD-932493-250MG |
| Cas.: 14568-68-4 | Purity: 95% | 1,4-Dimethoxy-2-vinylbenzol | ESD-932493-1G |
| Cas.: 55687-00-8 | Purity: 95% | 2-Chloro-6-methylquinoxaline | ESD-932494-100MG |
| Cas.: 55687-00-8 | Purity: 95% | 2-Chloro-6-methylquinoxaline | ESD-932494-250MG |
| Cas.: 55687-00-8 | Purity: 95% | 2-Chloro-6-methylquinoxaline | ESD-932494-1G |
| Cas.: 73075-45-3 | Purity: 95% | 7-Chloro-1,2,3,4-tetrahydroisoquinoline hydrochloride | ESD-932495-100MG |
| Cas.: 73075-45-3 | Purity: 95% | 7-Chloro-1,2,3,4-tetrahydroisoquinoline hydrochloride | ESD-932495-250MG |
| Cas.: 73075-45-3 | Purity: 95% | 7-Chloro-1,2,3,4-tetrahydroisoquinoline hydrochloride | ESD-932495-1G |
| Cas.: 1427382-24-8 | Purity: 97% | 6-Bromo-7-methylpyrazolo[1,5-a]pyridine | ESD-932496-100MG |
| Cas.: 1427382-24-8 | Purity: 97% | 6-Bromo-7-methylpyrazolo[1,5-a]pyridine | ESD-932496-250MG |
| Cas.: 1427382-24-8 | Purity: 97% | 6-Bromo-7-methylpyrazolo[1,5-a]pyridine | ESD-932496-1G |
| Cas.: 34625-23-5 | Purity: 95% | (3R,4S,5S,6R)-2-Ethoxy-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol | ESD-932497-100MG |
| Cas.: 34625-23-5 | Purity: 95% | (3R,4S,5S,6R)-2-Ethoxy-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol | ESD-932497-250MG |
| Cas.: 34625-23-5 | Purity: 95% | (3R,4S,5S,6R)-2-Ethoxy-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol | ESD-932497-1G |
| Cas.: 872366-63-7 | Purity: 97% | 3-Fluoro-2-nitrobenzaldehyde | ESD-932498-100MG |
| Cas.: 872366-63-7 | Purity: 97% | 3-Fluoro-2-nitrobenzaldehyde | ESD-932498-250MG |
| Cas.: 872366-63-7 | Purity: 97% | 3-Fluoro-2-nitrobenzaldehyde | ESD-932498-1G |
| Cas.: 2039-90-9 | Purity: 95% blend (TBC as stabilizer) | 2,6-Dimethylstyrene | ESD-932499-100MG |
| Cas.: 2039-90-9 | Purity: 95% blend (TBC as stabilizer) | 2,6-Dimethylstyrene | ESD-932499-250MG |
| Cas.: 2039-90-9 | Purity: 95% blend (TBC as stabilizer) | 2,6-Dimethylstyrene | ESD-932499-1G |
| Cas.: 1260587-88-9 | Purity: 95% | (3R,4S)-4-(4-Fluorophenyl)pyrrolidine-3-carboxylic acid | ESD-932500-100MG |
| Cas.: 1260587-88-9 | Purity: 95% | (3R,4S)-4-(4-Fluorophenyl)pyrrolidine-3-carboxylic acid | ESD-932500-250MG |
| Cas.: 1260587-88-9 | Purity: 95% | (3R,4S)-4-(4-Fluorophenyl)pyrrolidine-3-carboxylic acid | ESD-932500-1G |
| Cas.: 117069-75-7 | Purity: 95% | 3-Aminoindolin-2-one | ESD-932501-100MG |
| Cas.: 117069-75-7 | Purity: 95% | 3-Aminoindolin-2-one | ESD-932501-250MG |
| Cas.: 117069-75-7 | Purity: 95% | 3-Aminoindolin-2-one | ESD-932501-1G |
| Cas.: 1895296-01-1 | Purity: 95% | 3,3,3-Trifluoro-2,2-dimethylpropan-1-ol | ESD-932502-100MG |
| Cas.: 1895296-01-1 | Purity: 95% | 3,3,3-Trifluoro-2,2-dimethylpropan-1-ol | ESD-932502-250MG |
| Cas.: 1895296-01-1 | Purity: 95% | 3,3,3-Trifluoro-2,2-dimethylpropan-1-ol | ESD-932502-1G |
| Cas.: 518044-49-0 | Purity: 95% | 3-(2-[2-(2-Hydroxyethoxy)ethoxy]ethoxy)propanoic acid | ESD-932503-100MG |
| Cas.: 518044-49-0 | Purity: 95% | 3-(2-[2-(2-Hydroxyethoxy)ethoxy]ethoxy)propanoic acid | ESD-932503-250MG |
| Cas.: 518044-49-0 | Purity: 95% | 3-(2-[2-(2-Hydroxyethoxy)ethoxy]ethoxy)propanoic acid | ESD-932503-1G |
| Cas.: 142047-97-0 | Purity: 95% | Sodium 2-(2-hydroxyethoxy)acetate | ESD-932504-100MG |
| Cas.: 142047-97-0 | Purity: 95% | Sodium 2-(2-hydroxyethoxy)acetate | ESD-932504-250MG |
| Cas.: 142047-97-0 | Purity: 95% | Sodium 2-(2-hydroxyethoxy)acetate | ESD-932504-1G |
| Cas.: 526-86-3 | Purity: 95% | 2,3-Dimethylcyclohexa-2,5-diene-1,4-dione | ESD-932505-100MG |
| Cas.: 526-86-3 | Purity: 95% | 2,3-Dimethylcyclohexa-2,5-diene-1,4-dione | ESD-932505-250MG |
| Cas.: 526-86-3 | Purity: 95% | 2,3-Dimethylcyclohexa-2,5-diene-1,4-dione | ESD-932505-1G |
| Cas.: 1190862-33-9 | Purity: 98% | 6-Bromo-3,3-dimethyl-1H,2H,3H-pyrrolo[3,2-b]pyridin-2-one | ESD-932506-100MG |
| Cas.: 1190862-33-9 | Purity: 98% | 6-Bromo-3,3-dimethyl-1H,2H,3H-pyrrolo[3,2-b]pyridin-2-one | ESD-932506-250MG |
| Cas.: 1190862-33-9 | Purity: 98% | 6-Bromo-3,3-dimethyl-1H,2H,3H-pyrrolo[3,2-b]pyridin-2-one | ESD-932506-1G |
| Cas.: 2441-46-5 | Purity: 97% | 1,2,4,5-Tetramethoxybenzene | ESD-932507-100MG |
| Cas.: 2441-46-5 | Purity: 97% | 1,2,4,5-Tetramethoxybenzene | ESD-932507-250MG |
| Cas.: 2441-46-5 | Purity: 97% | 1,2,4,5-Tetramethoxybenzene | ESD-932507-1G |
| Cas.: 99738-99-5 | Purity: 97% | Methyl 2-(2-aminobenzo[d]thiazol-6-yl)acetate | ESD-932508-100MG |
| Cas.: 99738-99-5 | Purity: 97% | Methyl 2-(2-aminobenzo[d]thiazol-6-yl)acetate | ESD-932508-250MG |
| Cas.: 99738-99-5 | Purity: 97% | Methyl 2-(2-aminobenzo[d]thiazol-6-yl)acetate | ESD-932508-1G |
| Cas.: 1209012-31-6 | Purity: 97% | 4,9-Dihydro-s-indaceno[1,2-b:5,6-b’]dithiophene | ESD-932509-100MG |
| Cas.: 1209012-31-6 | Purity: 97% | 4,9-Dihydro-s-indaceno[1,2-b:5,6-b’]dithiophene | ESD-932509-250MG |
| Cas.: 1209012-31-6 | Purity: 97% | 4,9-Dihydro-s-indaceno[1,2-b:5,6-b’]dithiophene | ESD-932509-1G |
| Cas.: 1022128-96-6 | Purity: 95% | 2-Bromo-6-iodobenzoic acid | ESD-932510-100MG |
| Cas.: 1022128-96-6 | Purity: 95% | 2-Bromo-6-iodobenzoic acid | ESD-932510-250MG |
| Cas.: 1022128-96-6 | Purity: 95% | 2-Bromo-6-iodobenzoic acid | ESD-932510-1G |
| Cas.: 190903-71-0 | Purity: 97% | (2,2-Difluorobenzo[d][1,3]dioxol-5-yl)boronic acid | ESD-932511-100MG |
| Cas.: 190903-71-0 | Purity: 97% | (2,2-Difluorobenzo[d][1,3]dioxol-5-yl)boronic acid | ESD-932511-250MG |
| Cas.: 190903-71-0 | Purity: 97% | (2,2-Difluorobenzo[d][1,3]dioxol-5-yl)boronic acid | ESD-932511-1G |
| Cas.: 1055331-73-1 | Purity: 95% | 2-Bromo-5-fluoro-3-nitrobenzoic acid | ESD-932512-100MG |
| Cas.: 1055331-73-1 | Purity: 95% | 2-Bromo-5-fluoro-3-nitrobenzoic acid | ESD-932512-250MG |
| Cas.: 1055331-73-1 | Purity: 95% | 2-Bromo-5-fluoro-3-nitrobenzoic acid | ESD-932512-1G |
| Cas.: 3652-92-4 | Purity: 97% | 1,3-Dimethyl-2-phenyl-2,3-dihydro-1H-benzo[d]imidazole | ESD-932513-100MG |
| Cas.: 3652-92-4 | Purity: 97% | 1,3-Dimethyl-2-phenyl-2,3-dihydro-1H-benzo[d]imidazole | ESD-932513-250MG |
| Cas.: 3652-92-4 | Purity: 97% | 1,3-Dimethyl-2-phenyl-2,3-dihydro-1H-benzo[d]imidazole | ESD-932513-1G |
| Cas.: 59320-76-2 | Purity: 98% | (E)-5-Methylhex-3-enoic acid | ESD-932514-100MG |
| Cas.: 59320-76-2 | Purity: 98% | (E)-5-Methylhex-3-enoic acid | ESD-932514-250MG |
| Cas.: 59320-76-2 | Purity: 98% | (E)-5-Methylhex-3-enoic acid | ESD-932514-1G |
| Cas.: 1116691-26-9 | Purity: 95% | 3-Bromoimidazo[1,2-a]pyridine-8-carboxylic acid | ESD-932515-100MG |
| Cas.: 1116691-26-9 | Purity: 95% | 3-Bromoimidazo[1,2-a]pyridine-8-carboxylic acid | ESD-932515-250MG |
| Cas.: 1116691-26-9 | Purity: 95% | 3-Bromoimidazo[1,2-a]pyridine-8-carboxylic acid | ESD-932515-1G |
| Cas.: 139013-68-6 | Purity: 95% | (S)-4-Chlorobutane-1,3-diol | ESD-932516-100MG |
| Cas.: 139013-68-6 | Purity: 95% | (S)-4-Chlorobutane-1,3-diol | ESD-932516-250MG |
| Cas.: 139013-68-6 | Purity: 95% | (S)-4-Chlorobutane-1,3-diol | ESD-932516-1G |
| Cas.: 69363-85-5 | Purity: 95% | Methyl 4-aminothiophene-3-carboxylate | ESD-932517-100MG |
| Cas.: 69363-85-5 | Purity: 95% | Methyl 4-aminothiophene-3-carboxylate | ESD-932517-250MG |
| Cas.: 69363-85-5 | Purity: 95% | Methyl 4-aminothiophene-3-carboxylate | ESD-932517-1G |
| Cas.: 4873-09-0 | Purity: 98% | Allyl p-toluenesulphonate | ESD-932518-100MG |
| Cas.: 4873-09-0 | Purity: 98% | Allyl p-toluenesulphonate | ESD-932518-250MG |
| Cas.: 4873-09-0 | Purity: 98% | Allyl p-toluenesulphonate | ESD-932518-1G |
| Cas.: 935455-27-9 | Purity: 95% | (R)-3-Aminotetrahydrothiophene 1,1-dioxide hydrochloride | ESD-932519-100MG |
| Cas.: 935455-27-9 | Purity: 95% | (R)-3-Aminotetrahydrothiophene 1,1-dioxide hydrochloride | ESD-932519-250MG |
| Cas.: 935455-27-9 | Purity: 95% | (R)-3-Aminotetrahydrothiophene 1,1-dioxide hydrochloride | ESD-932519-1G |
| Cas.: 191152-70-2 | Purity: 95% | Methyl 3-chloro-2-oxo-3-(p-tolyl)propanoate | ESD-932520-100MG |
| Cas.: 191152-70-2 | Purity: 95% | Methyl 3-chloro-2-oxo-3-(p-tolyl)propanoate | ESD-932520-250MG |
| Cas.: 191152-70-2 | Purity: 95% | Methyl 3-chloro-2-oxo-3-(p-tolyl)propanoate | ESD-932520-1G |
| Cas.: 89976-43-2 | Purity: 98% | 4-Iodo-N-methylbenzamide | ESD-932521-100MG |
| Cas.: 89976-43-2 | Purity: 98% | 4-Iodo-N-methylbenzamide | ESD-932521-250MG |
| Cas.: 89976-43-2 | Purity: 98% | 4-Iodo-N-methylbenzamide | ESD-932521-1G |
| Cas.: 1010-93-1 | Purity: 97% | 2-(2-Methyl-5-nitro-1H-imidazol-1-yl)acetic acid | ESD-932522-100MG |
| Cas.: 1010-93-1 | Purity: 97% | 2-(2-Methyl-5-nitro-1H-imidazol-1-yl)acetic acid | ESD-932522-250MG |
| Cas.: 1010-93-1 | Purity: 97% | 2-(2-Methyl-5-nitro-1H-imidazol-1-yl)acetic acid | ESD-932522-1G |
| Cas.: 745047-51-2 | Purity: 95% | N-(Heptan-4-yl)benzo[d][1,3]dioxole-5-carboxamide | ESD-932523-100MG |
| Cas.: 745047-51-2 | Purity: 95% | N-(Heptan-4-yl)benzo[d][1,3]dioxole-5-carboxamide | ESD-932523-250MG |
| Cas.: 745047-51-2 | Purity: 95% | N-(Heptan-4-yl)benzo[d][1,3]dioxole-5-carboxamide | ESD-932523-1G |
| Cas.: 86156-93-6 | Purity: 95% | 3-Fluoro-4-nitrobenzene-1-sulfonyl chloride | ESD-932524-100MG |
| Cas.: 86156-93-6 | Purity: 95% | 3-Fluoro-4-nitrobenzene-1-sulfonyl chloride | ESD-932524-250MG |
| Cas.: 86156-93-6 | Purity: 95% | 3-Fluoro-4-nitrobenzene-1-sulfonyl chloride | ESD-932524-1G |
| Cas.: 33759-44-3 | Purity: 95% | 3-((2-Hydroxyethyl)amino)propanenitrile | ESD-932525-100MG |
| Cas.: 33759-44-3 | Purity: 95% | 3-((2-Hydroxyethyl)amino)propanenitrile | ESD-932525-250MG |
| Cas.: 33759-44-3 | Purity: 95% | 3-((2-Hydroxyethyl)amino)propanenitrile | ESD-932525-1G |
| Cas.: 6033-24-5 | Purity: 95% | (R)-Heptan-2-ol | ESD-932526-100MG |
| Cas.: 6033-24-5 | Purity: 95% | (R)-Heptan-2-ol | ESD-932526-250MG |
| Cas.: 6033-24-5 | Purity: 95% | (R)-Heptan-2-ol | ESD-932526-1G |
| Cas.: 24358-43-8 | Purity: 95% | 1-(3-Chlorophenyl)ethan-1-amine | ESD-932527-100MG |
| Cas.: 24358-43-8 | Purity: 95% | 1-(3-Chlorophenyl)ethan-1-amine | ESD-932527-250MG |
| Cas.: 24358-43-8 | Purity: 95% | 1-(3-Chlorophenyl)ethan-1-amine | ESD-932527-1G |
| Cas.: 57802-79-6 | Purity: 98% | (4-Butylphenyl)methanamine | ESD-932528-100MG |
| Cas.: 57802-79-6 | Purity: 98% | (4-Butylphenyl)methanamine | ESD-932528-250MG |
| Cas.: 57802-79-6 | Purity: 98% | (4-Butylphenyl)methanamine | ESD-932528-1G |
| Cas.: 928007-64-1 | Purity: ≥98% | Acetyl Tetrapeptide-15 | ESD-932529-100MG |
| Cas.: 928007-64-1 | Purity: ≥98% | Acetyl Tetrapeptide-15 | ESD-932529-250MG |
| Cas.: 928007-64-1 | Purity: ≥98% | Acetyl Tetrapeptide-15 | ESD-932529-1G |
| Cas.: 261380-28-3 | Purity: 95% | (R)-2-((Tert-butoxycarbonyl)amino)-3-(2-cyanophenyl)propanoic acid | ESD-932530-100MG |
| Cas.: 261380-28-3 | Purity: 95% | (R)-2-((Tert-butoxycarbonyl)amino)-3-(2-cyanophenyl)propanoic acid | ESD-932530-250MG |
| Cas.: 261380-28-3 | Purity: 95% | (R)-2-((Tert-butoxycarbonyl)amino)-3-(2-cyanophenyl)propanoic acid | ESD-932530-1G |
| Cas.: 1135131-50-8 | Purity: 98% | 2-(2-Bromoethoxy)acetic acid | ESD-932531-100MG |
| Cas.: 1135131-50-8 | Purity: 98% | 2-(2-Bromoethoxy)acetic acid | ESD-932531-250MG |
| Cas.: 1135131-50-8 | Purity: 98% | 2-(2-Bromoethoxy)acetic acid | ESD-932531-1G |
| Cas.: 1313372-75-6 | Purity: 95% | 3-Methyl-6-nitro-2H-indazole | ESD-932532-100MG |
| Cas.: 1313372-75-6 | Purity: 95% | 3-Methyl-6-nitro-2H-indazole | ESD-932532-250MG |
| Cas.: 1313372-75-6 | Purity: 95% | 3-Methyl-6-nitro-2H-indazole | ESD-932532-1G |
| Cas.: 23084-36-8 | Purity: 95% | 5-Methoxy-1H-indole-3-carbonitrile | ESD-932533-100MG |
| Cas.: 23084-36-8 | Purity: 95% | 5-Methoxy-1H-indole-3-carbonitrile | ESD-932533-250MG |
| Cas.: 23084-36-8 | Purity: 95% | 5-Methoxy-1H-indole-3-carbonitrile | ESD-932533-1G |
| Cas.: 202982-72-7 | Purity: 98% | 4-Chloro-3-iodophenol | ESD-932534-100MG |
| Cas.: 202982-72-7 | Purity: 98% | 4-Chloro-3-iodophenol | ESD-932534-250MG |
| Cas.: 202982-72-7 | Purity: 98% | 4-Chloro-3-iodophenol | ESD-932534-1G |
| Cas.: 24134-65-4 | Purity: 95% | 1,3-Dimethyl-2-oxo-2,3-dihydro-1H-benzo[d]imidazole-5-sulfonyl chloride | ESD-932535-100MG |
| Cas.: 24134-65-4 | Purity: 95% | 1,3-Dimethyl-2-oxo-2,3-dihydro-1H-benzo[d]imidazole-5-sulfonyl chloride | ESD-932535-250MG |
| Cas.: 24134-65-4 | Purity: 95% | 1,3-Dimethyl-2-oxo-2,3-dihydro-1H-benzo[d]imidazole-5-sulfonyl chloride | ESD-932535-1G |
| Cas.: 74788-46-8 | Purity: 95% | 1-(4-Chlorophenyl)propan-1-amine | ESD-932536-100MG |
| Cas.: 74788-46-8 | Purity: 95% | 1-(4-Chlorophenyl)propan-1-amine | ESD-932536-250MG |
| Cas.: 74788-46-8 | Purity: 95% | 1-(4-Chlorophenyl)propan-1-amine | ESD-932536-1G |
| Cas.: 2256715-14-5 | Purity: 95% | Endo-6-Amino-3-boc-3-azabicyclo[3.1.0]hexane | ESD-932537-100MG |
| Cas.: 2256715-14-5 | Purity: 95% | Endo-6-Amino-3-boc-3-azabicyclo[3.1.0]hexane | ESD-932537-250MG |
| Cas.: 2256715-14-5 | Purity: 95% | Endo-6-Amino-3-boc-3-azabicyclo[3.1.0]hexane | ESD-932537-1G |
| Cas.: 88210-96-2 | Purity: 95% | 5,6-Dimethoxy-1H-indole-2-carboxylic acid | ESD-932538-100MG |
| Cas.: 88210-96-2 | Purity: 95% | 5,6-Dimethoxy-1H-indole-2-carboxylic acid | ESD-932538-250MG |
| Cas.: 88210-96-2 | Purity: 95% | 5,6-Dimethoxy-1H-indole-2-carboxylic acid | ESD-932538-1G |
| Cas.: 1167414-87-0 | Purity: 95% | (R)-1-(4-Chlorophenyl)ethanamine hydrochloride | ESD-932539-100MG |
| Cas.: 1167414-87-0 | Purity: 95% | (R)-1-(4-Chlorophenyl)ethanamine hydrochloride | ESD-932539-250MG |
| Cas.: 1167414-87-0 | Purity: 95% | (R)-1-(4-Chlorophenyl)ethanamine hydrochloride | ESD-932539-1G |
| Cas.: 873697-68-8 | Purity: 96% | 3-Amino-2-fluorobenzonitrile | ESD-932540-100MG |
| Cas.: 873697-68-8 | Purity: 96% | 3-Amino-2-fluorobenzonitrile | ESD-932540-250MG |
| Cas.: 873697-68-8 | Purity: 96% | 3-Amino-2-fluorobenzonitrile | ESD-932540-1G |
| Cas.: 7383-01-9 | Purity: 95% | Methyl 5-(aminomethyl)-2-hydroxybenzoate | ESD-932541-100MG |
| Cas.: 7383-01-9 | Purity: 95% | Methyl 5-(aminomethyl)-2-hydroxybenzoate | ESD-932541-250MG |
| Cas.: 7383-01-9 | Purity: 95% | Methyl 5-(aminomethyl)-2-hydroxybenzoate | ESD-932541-1G |
| Cas.: 70110-65-5 | Purity: 97% | 2-Phenoxy-1-phenylpropane-1,3-diol | ESD-932542-100MG |
| Cas.: 70110-65-5 | Purity: 97% | 2-Phenoxy-1-phenylpropane-1,3-diol | ESD-932542-250MG |
| Cas.: 70110-65-5 | Purity: 97% | 2-Phenoxy-1-phenylpropane-1,3-diol | ESD-932542-1G |
| Cas.: 173315-54-3 | Purity: 98% | 2-Chloro-4-fluoro-3-methylbenzoic acid | ESD-932543-100MG |
| Cas.: 173315-54-3 | Purity: 98% | 2-Chloro-4-fluoro-3-methylbenzoic acid | ESD-932543-250MG |
| Cas.: 173315-54-3 | Purity: 98% | 2-Chloro-4-fluoro-3-methylbenzoic acid | ESD-932543-1G |
| Cas.: 1207175-08-3 | Purity: 95% | Ethyl 5,6,7,8-tetrahydro-1,7-naphthyridine-3-carboxylate hydrochloride | ESD-932544-100MG |
| Cas.: 1207175-08-3 | Purity: 95% | Ethyl 5,6,7,8-tetrahydro-1,7-naphthyridine-3-carboxylate hydrochloride | ESD-932544-250MG |
| Cas.: 1207175-08-3 | Purity: 95% | Ethyl 5,6,7,8-tetrahydro-1,7-naphthyridine-3-carboxylate hydrochloride | ESD-932544-1G |
| Cas.: 939968-60-2 | Purity: 98% | 2-(3-Fluoro-4-nitrophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-932545-100MG |
| Cas.: 939968-60-2 | Purity: 98% | 2-(3-Fluoro-4-nitrophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-932545-250MG |
| Cas.: 939968-60-2 | Purity: 98% | 2-(3-Fluoro-4-nitrophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-932545-1G |
| Cas.: 869489-04-3 | Purity: 95% | (S)-4,4-Difluoropyrrolidine-2-carbonitrile hydrochloride | ESD-932546-100MG |
| Cas.: 869489-04-3 | Purity: 95% | (S)-4,4-Difluoropyrrolidine-2-carbonitrile hydrochloride | ESD-932546-250MG |
| Cas.: 869489-04-3 | Purity: 95% | (S)-4,4-Difluoropyrrolidine-2-carbonitrile hydrochloride | ESD-932546-1G |
| Cas.: 65626-23-5 | Purity: 95% | 2-(Tetrahydro-2H-pyran-4-yl)acetaldehyde | ESD-932547-100MG |
| Cas.: 65626-23-5 | Purity: 95% | 2-(Tetrahydro-2H-pyran-4-yl)acetaldehyde | ESD-932547-250MG |
| Cas.: 65626-23-5 | Purity: 95% | 2-(Tetrahydro-2H-pyran-4-yl)acetaldehyde | ESD-932547-1G |
| Cas.: 86150-61-0 | Purity: 95% | (S)-2-Hydroxyethyl 2-amino-3-methylbutanoate 4-methylbenzenesulfonate | ESD-932548-100MG |
| Cas.: 86150-61-0 | Purity: 95% | (S)-2-Hydroxyethyl 2-amino-3-methylbutanoate 4-methylbenzenesulfonate | ESD-932548-250MG |
| Cas.: 86150-61-0 | Purity: 95% | (S)-2-Hydroxyethyl 2-amino-3-methylbutanoate 4-methylbenzenesulfonate | ESD-932548-1G |
| Cas.: 7717-76-2 | Purity: 98% | 4,4′-Oxydiphthalic acid | ESD-932549-100MG |
| Cas.: 7717-76-2 | Purity: 98% | 4,4′-Oxydiphthalic acid | ESD-932549-250MG |
| Cas.: 7717-76-2 | Purity: 98% | 4,4′-Oxydiphthalic acid | ESD-932549-1G |
| Cas.: 59311-67-0 | Purity: 95% | 2-(3-Thienyl)ethylamine | ESD-932550-100MG |
| Cas.: 59311-67-0 | Purity: 95% | 2-(3-Thienyl)ethylamine | ESD-932550-250MG |
| Cas.: 59311-67-0 | Purity: 95% | 2-(3-Thienyl)ethylamine | ESD-932550-1G |
| Cas.: 64567-60-8 | Purity: 95% | 2-(2,6-Dioxopiperidin-3-yl)-5-hydroxyisoindoline-1,3-dione | ESD-932551-100MG |
| Cas.: 64567-60-8 | Purity: 95% | 2-(2,6-Dioxopiperidin-3-yl)-5-hydroxyisoindoline-1,3-dione | ESD-932551-250MG |
| Cas.: 64567-60-8 | Purity: 95% | 2-(2,6-Dioxopiperidin-3-yl)-5-hydroxyisoindoline-1,3-dione | ESD-932551-1G |
| Cas.: 1072951-51-9 | Purity: 98% | (3,4-Bis(methoxycarbonyl)phenyl)boronic acid | ESD-932552-100MG |
| Cas.: 1072951-51-9 | Purity: 98% | (3,4-Bis(methoxycarbonyl)phenyl)boronic acid | ESD-932552-250MG |
| Cas.: 1072951-51-9 | Purity: 98% | (3,4-Bis(methoxycarbonyl)phenyl)boronic acid | ESD-932552-1G |
| Cas.: 135145-34-5 | Purity: 95% | (S)-1-(3-Chlorophenyl)ethanol | ESD-932553-100MG |
| Cas.: 135145-34-5 | Purity: 95% | (S)-1-(3-Chlorophenyl)ethanol | ESD-932553-250MG |
| Cas.: 135145-34-5 | Purity: 95% | (S)-1-(3-Chlorophenyl)ethanol | ESD-932553-1G |
| Cas.: 5765-65-1 | Purity: 95% | Morpholino benzoate | ESD-932554-100MG |
| Cas.: 5765-65-1 | Purity: 95% | Morpholino benzoate | ESD-932554-250MG |
| Cas.: 5765-65-1 | Purity: 95% | Morpholino benzoate | ESD-932554-1G |
| Cas.: 912342-10-0 | Purity: 98% | (R)-Methyl 4-(1-aminoethyl)benzoate | ESD-932555-100MG |
| Cas.: 912342-10-0 | Purity: 98% | (R)-Methyl 4-(1-aminoethyl)benzoate | ESD-932555-250MG |
| Cas.: 912342-10-0 | Purity: 98% | (R)-Methyl 4-(1-aminoethyl)benzoate | ESD-932555-1G |
| Cas.: 2252246-01-6 | Purity: 95% | (R)-1-(Thiophen-2-yl)ethanamine hydrochloride | ESD-932556-100MG |
| Cas.: 2252246-01-6 | Purity: 95% | (R)-1-(Thiophen-2-yl)ethanamine hydrochloride | ESD-932556-250MG |
| Cas.: 2252246-01-6 | Purity: 95% | (R)-1-(Thiophen-2-yl)ethanamine hydrochloride | ESD-932556-1G |
| Cas.: 883858-08-0 | Purity: 95% | 2-Methyl-2-((5-methylpyridin-2-yl)oxy)propanoic acid | ESD-932557-100MG |
| Cas.: 883858-08-0 | Purity: 95% | 2-Methyl-2-((5-methylpyridin-2-yl)oxy)propanoic acid | ESD-932557-250MG |
| Cas.: 883858-08-0 | Purity: 95% | 2-Methyl-2-((5-methylpyridin-2-yl)oxy)propanoic acid | ESD-932557-1G |
| Cas.: 4786-76-9 | Purity: 98% | 4-Methoxy-7H-pyrrolo[2,3-d]pyrimidine | ESD-932558-100MG |
| Cas.: 4786-76-9 | Purity: 98% | 4-Methoxy-7H-pyrrolo[2,3-d]pyrimidine | ESD-932558-250MG |
| Cas.: 4786-76-9 | Purity: 98% | 4-Methoxy-7H-pyrrolo[2,3-d]pyrimidine | ESD-932558-1G |
| Cas.: 22632-10-6 | Purity: 95% | N-Methylpyrimidin-4-amine | ESD-932559-100MG |
| Cas.: 22632-10-6 | Purity: 95% | N-Methylpyrimidin-4-amine | ESD-932559-250MG |
| Cas.: 22632-10-6 | Purity: 95% | N-Methylpyrimidin-4-amine | ESD-932559-1G |
| Cas.: 90098-05-8 | Purity: 98% | 2-(3-Chlorobenzamido)-3-(2-oxo-1,2-dihydroquinolin-4-yl)propanoic acid | ESD-932560-100MG |
| Cas.: 90098-05-8 | Purity: 98% | 2-(3-Chlorobenzamido)-3-(2-oxo-1,2-dihydroquinolin-4-yl)propanoic acid | ESD-932560-250MG |
| Cas.: 90098-05-8 | Purity: 98% | 2-(3-Chlorobenzamido)-3-(2-oxo-1,2-dihydroquinolin-4-yl)propanoic acid | ESD-932560-1G |
| Cas.: 954240-89-2 | Purity: 97% | 5-Bromo-3-nitropicolinic acid | ESD-932561-100MG |
| Cas.: 954240-89-2 | Purity: 97% | 5-Bromo-3-nitropicolinic acid | ESD-932561-250MG |
| Cas.: 954240-89-2 | Purity: 97% | 5-Bromo-3-nitropicolinic acid | ESD-932561-1G |
| Cas.: 52130-87-7 | Purity: 95% | 2-Bromo-N-(2-(2-chlorobenzoyl)-4-nitrophenyl)acetamide | ESD-932562-100MG |
| Cas.: 52130-87-7 | Purity: 95% | 2-Bromo-N-(2-(2-chlorobenzoyl)-4-nitrophenyl)acetamide | ESD-932562-250MG |
| Cas.: 52130-87-7 | Purity: 95% | 2-Bromo-N-(2-(2-chlorobenzoyl)-4-nitrophenyl)acetamide | ESD-932562-1G |
| Cas.: 14959-86-5 | Purity: 90% | (Z)-Dodec-7-en-1-yl acetate | ESD-932563-100MG |
| Cas.: 14959-86-5 | Purity: 90% | (Z)-Dodec-7-en-1-yl acetate | ESD-932563-250MG |
| Cas.: 14959-86-5 | Purity: 90% | (Z)-Dodec-7-en-1-yl acetate | ESD-932563-1G |
| Cas.: 882518-89-0 | Purity: 97% | Tert-butyl 2-(2-(2-(tosyloxy)ethoxy)ethoxy)acetate | ESD-932564-100MG |
| Cas.: 882518-89-0 | Purity: 97% | Tert-butyl 2-(2-(2-(tosyloxy)ethoxy)ethoxy)acetate | ESD-932564-250MG |
| Cas.: 882518-89-0 | Purity: 97% | Tert-butyl 2-(2-(2-(tosyloxy)ethoxy)ethoxy)acetate | ESD-932564-1G |
| Cas.: 3322-62-1 | Purity: 95% | Octadec-9-enamide | ESD-932565-100MG |
| Cas.: 3322-62-1 | Purity: 95% | Octadec-9-enamide | ESD-932565-250MG |
| Cas.: 3322-62-1 | Purity: 95% | Octadec-9-enamide | ESD-932565-1G |
| Cas.: 25752-90-3 | Purity: 97% | 1-Bromo-4-(tert-butylsulfanyl)benzene | ESD-932566-100MG |
| Cas.: 25752-90-3 | Purity: 97% | 1-Bromo-4-(tert-butylsulfanyl)benzene | ESD-932566-250MG |
| Cas.: 25752-90-3 | Purity: 97% | 1-Bromo-4-(tert-butylsulfanyl)benzene | ESD-932566-1G |
| Cas.: 1251017-66-9 | Purity: 98% | Tert-butyl 3,6-diazabicyclo[3.1.1]heptane-3-carboxylate | ESD-932567-100MG |
| Cas.: 1251017-66-9 | Purity: 98% | Tert-butyl 3,6-diazabicyclo[3.1.1]heptane-3-carboxylate | ESD-932567-250MG |
| Cas.: 1251017-66-9 | Purity: 98% | Tert-butyl 3,6-diazabicyclo[3.1.1]heptane-3-carboxylate | ESD-932567-1G |
| Cas.: 159350-38-6 | Purity: 95% | 10-((2,5-Dioxopyrrolidin-1-yl)oxy)-10-oxodecanoic acid | ESD-932568-100MG |
| Cas.: 159350-38-6 | Purity: 95% | 10-((2,5-Dioxopyrrolidin-1-yl)oxy)-10-oxodecanoic acid | ESD-932568-250MG |
| Cas.: 159350-38-6 | Purity: 95% | 10-((2,5-Dioxopyrrolidin-1-yl)oxy)-10-oxodecanoic acid | ESD-932568-1G |
| Cas.: 153476-68-7 | Purity: 97% | 2-(Chloromethyl)-3,5-dimethyl-4-nitropyridine | ESD-932569-100MG |
| Cas.: 153476-68-7 | Purity: 97% | 2-(Chloromethyl)-3,5-dimethyl-4-nitropyridine | ESD-932569-250MG |
| Cas.: 153476-68-7 | Purity: 97% | 2-(Chloromethyl)-3,5-dimethyl-4-nitropyridine | ESD-932569-1G |
| Cas.: 13484-50-9 | Purity: 97% | Perchloropyrazine | ESD-932570-100MG |
| Cas.: 13484-50-9 | Purity: 97% | Perchloropyrazine | ESD-932570-250MG |
| Cas.: 13484-50-9 | Purity: 97% | Perchloropyrazine | ESD-932570-1G |
| Cas.: 61542-10-7 | Purity: 96% | 1-Iodo-3-methoxypropane | ESD-932571-100MG |
| Cas.: 61542-10-7 | Purity: 96% | 1-Iodo-3-methoxypropane | ESD-932571-250MG |
| Cas.: 61542-10-7 | Purity: 96% | 1-Iodo-3-methoxypropane | ESD-932571-1G |
| Cas.: 2049127-88-8 | Purity: 97% | (R)-Benzyl 2-amino-3-(3-(methylsulfonyl)phenyl)propanoate hydrochloride | ESD-932572-100MG |
| Cas.: 2049127-88-8 | Purity: 97% | (R)-Benzyl 2-amino-3-(3-(methylsulfonyl)phenyl)propanoate hydrochloride | ESD-932572-250MG |
| Cas.: 2049127-88-8 | Purity: 97% | (R)-Benzyl 2-amino-3-(3-(methylsulfonyl)phenyl)propanoate hydrochloride | ESD-932572-1G |
| Cas.: 1361019-05-7 | Purity: 98% | 3,5-Dibromo-1-methyl-1H-pyrazole | ESD-932573-100MG |
| Cas.: 1361019-05-7 | Purity: 98% | 3,5-Dibromo-1-methyl-1H-pyrazole | ESD-932573-250MG |
| Cas.: 1361019-05-7 | Purity: 98% | 3,5-Dibromo-1-methyl-1H-pyrazole | ESD-932573-1G |
| Cas.: 52601-23-7 | Purity: 97% | 1-Azabicyclo[2.2.2]octane-2-carboxylic acid hydrochloride | ESD-932574-100MG |
| Cas.: 52601-23-7 | Purity: 97% | 1-Azabicyclo[2.2.2]octane-2-carboxylic acid hydrochloride | ESD-932574-250MG |
| Cas.: 52601-23-7 | Purity: 97% | 1-Azabicyclo[2.2.2]octane-2-carboxylic acid hydrochloride | ESD-932574-1G |
| Cas.: 55038-01-2 | Purity: 95% | Benzofuran-2-ylmethanol | ESD-932575-100MG |
| Cas.: 55038-01-2 | Purity: 95% | Benzofuran-2-ylmethanol | ESD-932575-250MG |
| Cas.: 55038-01-2 | Purity: 95% | Benzofuran-2-ylmethanol | ESD-932575-1G |
| Cas.: 84746-24-7 | Purity: 95% | 2-[4-(Pyrimidin-2-yl)piperazin-1-yl]pyrimidine | ESD-932576-100MG |
| Cas.: 84746-24-7 | Purity: 95% | 2-[4-(Pyrimidin-2-yl)piperazin-1-yl]pyrimidine | ESD-932576-250MG |
| Cas.: 84746-24-7 | Purity: 95% | 2-[4-(Pyrimidin-2-yl)piperazin-1-yl]pyrimidine | ESD-932576-1G |
| Cas.: 1053053-92-1 | Purity: 98% | (3-Bromopyridin-2-yl)methanamine | ESD-932577-100MG |
| Cas.: 1053053-92-1 | Purity: 98% | (3-Bromopyridin-2-yl)methanamine | ESD-932577-250MG |
| Cas.: 1053053-92-1 | Purity: 98% | (3-Bromopyridin-2-yl)methanamine | ESD-932577-1G |
| Cas.: 300801-03-0 | Purity: 98% | GHK-Cu acetate | ESD-932578-100MG |
| Cas.: 300801-03-0 | Purity: 98% | GHK-Cu acetate | ESD-932578-250MG |
| Cas.: 300801-03-0 | Purity: 98% | GHK-Cu acetate | ESD-932578-1G |
| Cas.: 89803-71-4 | Purity: 98% | 2,2′-Bis(trifluoromethyl)-[1,1′-biphenyl]-4,4′-dicarboxylic acid | ESD-932579-100MG |
| Cas.: 89803-71-4 | Purity: 98% | 2,2′-Bis(trifluoromethyl)-[1,1′-biphenyl]-4,4′-dicarboxylic acid | ESD-932579-250MG |
| Cas.: 89803-71-4 | Purity: 98% | 2,2′-Bis(trifluoromethyl)-[1,1′-biphenyl]-4,4′-dicarboxylic acid | ESD-932579-1G |
| Cas.: 888327-50-2 | Purity: 96% | (3S,5S)-tert-Butyl 3,5-dimethylpiperazine-1-carboxylate | ESD-932580-100MG |
| Cas.: 888327-50-2 | Purity: 96% | (3S,5S)-tert-Butyl 3,5-dimethylpiperazine-1-carboxylate | ESD-932580-250MG |
| Cas.: 888327-50-2 | Purity: 96% | (3S,5S)-tert-Butyl 3,5-dimethylpiperazine-1-carboxylate | ESD-932580-1G |
| Cas.: 1121-57-9 | Purity: 90% | 1-Cyclohexenylisocyanide | ESD-932581-100MG |
| Cas.: 1121-57-9 | Purity: 90% | 1-Cyclohexenylisocyanide | ESD-932581-250MG |
| Cas.: 1121-57-9 | Purity: 90% | 1-Cyclohexenylisocyanide | ESD-932581-1G |
| Cas.: 159533-68-3 | Purity: 95% | 1-(5-Bromopyridin-2-yl)ethanol | ESD-932582-100MG |
| Cas.: 159533-68-3 | Purity: 95% | 1-(5-Bromopyridin-2-yl)ethanol | ESD-932582-250MG |
| Cas.: 159533-68-3 | Purity: 95% | 1-(5-Bromopyridin-2-yl)ethanol | ESD-932582-1G |
| Cas.: 325141-71-7 | Purity: 98% | 2-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetonitrile | ESD-932583-100MG |
| Cas.: 325141-71-7 | Purity: 98% | 2-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetonitrile | ESD-932583-250MG |
| Cas.: 325141-71-7 | Purity: 98% | 2-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetonitrile | ESD-932583-1G |
| Cas.: 74316-29-3 | Purity: ≥97% | trans-Methyl 3-aminocyclobutanecarboxylate hydrochloride | ESD-932584-100MG |
| Cas.: 74316-29-3 | Purity: ≥97% | trans-Methyl 3-aminocyclobutanecarboxylate hydrochloride | ESD-932584-250MG |
| Cas.: 74316-29-3 | Purity: ≥97% | trans-Methyl 3-aminocyclobutanecarboxylate hydrochloride | ESD-932584-1G |
| Cas.: 1119-16-0 | Purity: 98% | 4-Methylvaleraldehyde | ESD-932585-100MG |
| Cas.: 1119-16-0 | Purity: 98% | 4-Methylvaleraldehyde | ESD-932585-250MG |
| Cas.: 1119-16-0 | Purity: 98% | 4-Methylvaleraldehyde | ESD-932585-1G |
| Cas.: 1005508-80-4 | Purity: 97% | Methyl 2-amino-6-chloroisonicotinate | ESD-932586-100MG |
| Cas.: 1005508-80-4 | Purity: 97% | Methyl 2-amino-6-chloroisonicotinate | ESD-932586-250MG |
| Cas.: 1005508-80-4 | Purity: 97% | Methyl 2-amino-6-chloroisonicotinate | ESD-932586-1G |
| Cas.: 886766-60-5 | Purity: 98% | Tert-butyl 2-phenylpiperazine-1-carboxylate | ESD-932587-100MG |
| Cas.: 886766-60-5 | Purity: 98% | Tert-butyl 2-phenylpiperazine-1-carboxylate | ESD-932587-250MG |
| Cas.: 886766-60-5 | Purity: 98% | Tert-butyl 2-phenylpiperazine-1-carboxylate | ESD-932587-1G |
| Cas.: 75370-65-9 | Purity: 98% | 4-Amino-1H-benzo[d]imidazol-2(3H)-one | ESD-932588-100MG |
| Cas.: 75370-65-9 | Purity: 98% | 4-Amino-1H-benzo[d]imidazol-2(3H)-one | ESD-932588-250MG |
| Cas.: 75370-65-9 | Purity: 98% | 4-Amino-1H-benzo[d]imidazol-2(3H)-one | ESD-932588-1G |
| Cas.: 27343-98-2 | Purity: 97% | 3,3′-Dimethoxy-[1,1′-biphenyl]-4,4′-dicarbaldehyde | ESD-932589-100MG |
| Cas.: 27343-98-2 | Purity: 97% | 3,3′-Dimethoxy-[1,1′-biphenyl]-4,4′-dicarbaldehyde | ESD-932589-250MG |
| Cas.: 27343-98-2 | Purity: 97% | 3,3′-Dimethoxy-[1,1′-biphenyl]-4,4′-dicarbaldehyde | ESD-932589-1G |
| Cas.: 14112-98-2 | Purity: 96% | 7-Oxooctanoic acid | ESD-932590-100MG |
| Cas.: 14112-98-2 | Purity: 96% | 7-Oxooctanoic acid | ESD-932590-250MG |
| Cas.: 14112-98-2 | Purity: 96% | 7-Oxooctanoic acid | ESD-932590-1G |
| Cas.: 149299-82-1 | Purity: 95% | Tert-butyl 2-(2-(2-hydroxyethoxy)ethoxy)acetate | ESD-932591-100MG |
| Cas.: 149299-82-1 | Purity: 95% | Tert-butyl 2-(2-(2-hydroxyethoxy)ethoxy)acetate | ESD-932591-250MG |
| Cas.: 149299-82-1 | Purity: 95% | Tert-butyl 2-(2-(2-hydroxyethoxy)ethoxy)acetate | ESD-932591-1G |
| Cas.: 138133-34-3 | Purity: 95% | (2S,5S)-2,5-Dimethylpyrrolidine hydrochloride | ESD-932592-100MG |
| Cas.: 138133-34-3 | Purity: 95% | (2S,5S)-2,5-Dimethylpyrrolidine hydrochloride | ESD-932592-250MG |
| Cas.: 138133-34-3 | Purity: 95% | (2S,5S)-2,5-Dimethylpyrrolidine hydrochloride | ESD-932592-1G |
| Cas.: 37478-58-3 | Purity: 95% | 2-(Piperazin-1-yl)acetic acid | ESD-932593-100MG |
| Cas.: 37478-58-3 | Purity: 95% | 2-(Piperazin-1-yl)acetic acid | ESD-932593-250MG |
| Cas.: 37478-58-3 | Purity: 95% | 2-(Piperazin-1-yl)acetic acid | ESD-932593-1G |
| Cas.: 163837-57-8 | Purity: 95% | (R)-(4-Chlorophenyl)(phenyl)methanamine | ESD-932594-100MG |
| Cas.: 163837-57-8 | Purity: 95% | (R)-(4-Chlorophenyl)(phenyl)methanamine | ESD-932594-250MG |
| Cas.: 163837-57-8 | Purity: 95% | (R)-(4-Chlorophenyl)(phenyl)methanamine | ESD-932594-1G |
| Cas.: 116153-81-2 | Purity: 97% | 5-(Furan-2-yl)-1H-pyrazole-3-carboxylic acid | ESD-932595-100MG |
| Cas.: 116153-81-2 | Purity: 97% | 5-(Furan-2-yl)-1H-pyrazole-3-carboxylic acid | ESD-932595-250MG |
| Cas.: 116153-81-2 | Purity: 97% | 5-(Furan-2-yl)-1H-pyrazole-3-carboxylic acid | ESD-932595-1G |
| Cas.: 61324-89-8 | Purity: 95% | 4-(Difluoromethyl)-1-fluoro-2-nitrobenzene | ESD-932596-100MG |
| Cas.: 61324-89-8 | Purity: 95% | 4-(Difluoromethyl)-1-fluoro-2-nitrobenzene | ESD-932596-250MG |
| Cas.: 61324-89-8 | Purity: 95% | 4-(Difluoromethyl)-1-fluoro-2-nitrobenzene | ESD-932596-1G |
| Cas.: 63176-44-3 | Purity: 95% | 2-Methyl-1H-indole-3-carboxylic acid | ESD-932597-100MG |
| Cas.: 63176-44-3 | Purity: 95% | 2-Methyl-1H-indole-3-carboxylic acid | ESD-932597-250MG |
| Cas.: 63176-44-3 | Purity: 95% | 2-Methyl-1H-indole-3-carboxylic acid | ESD-932597-1G |
| Cas.: 13570-00-8 | Purity: 98% | 3-(1H-Imidazol-2-yl)pyridine | ESD-932598-100MG |
| Cas.: 13570-00-8 | Purity: 98% | 3-(1H-Imidazol-2-yl)pyridine | ESD-932598-250MG |
| Cas.: 13570-00-8 | Purity: 98% | 3-(1H-Imidazol-2-yl)pyridine | ESD-932598-1G |
| Cas.: 1072413-83-2 | Purity: 98% | Hexakis[μ-[[1,1′-biphenyl]-4,4′-dicarboxylato(2-)-κO4:κO’4]]tetra-μ3-hydroxytetra-μ3-oxohexazirconium | ESD-932599-100MG |
| Cas.: 1072413-83-2 | Purity: 98% | Hexakis[μ-[[1,1′-biphenyl]-4,4′-dicarboxylato(2-)-κO4:κO’4]]tetra-μ3-hydroxytetra-μ3-oxohexazirconium | ESD-932599-250MG |
| Cas.: 1072413-83-2 | Purity: 98% | Hexakis[μ-[[1,1′-biphenyl]-4,4′-dicarboxylato(2-)-κO4:κO’4]]tetra-μ3-hydroxytetra-μ3-oxohexazirconium | ESD-932599-1G |
| Cas.: 493-33-4 | Purity: 95% | 1-(4-Hydroxy-2-methoxyphenyl)ethanone | ESD-932600-100MG |
| Cas.: 493-33-4 | Purity: 95% | 1-(4-Hydroxy-2-methoxyphenyl)ethanone | ESD-932600-250MG |
| Cas.: 493-33-4 | Purity: 95% | 1-(4-Hydroxy-2-methoxyphenyl)ethanone | ESD-932600-1G |
| Cas.: 57728-59-3 | Purity: ≥95% | 2-(3-Chlorobenzamido)acetic acid | ESD-932601-100MG |
| Cas.: 57728-59-3 | Purity: ≥95% | 2-(3-Chlorobenzamido)acetic acid | ESD-932601-250MG |
| Cas.: 57728-59-3 | Purity: ≥95% | 2-(3-Chlorobenzamido)acetic acid | ESD-932601-1G |
| Cas.: 1169748-84-8 | Purity: 97% | (5-Aminopyridin-3-yl)boronic acid | ESD-932602-100MG |
| Cas.: 1169748-84-8 | Purity: 97% | (5-Aminopyridin-3-yl)boronic acid | ESD-932602-250MG |
| Cas.: 1169748-84-8 | Purity: 97% | (5-Aminopyridin-3-yl)boronic acid | ESD-932602-1G |
| Cas.: 338452-92-9 | Purity: 95% | 4-Amino-2-chloronicotinaldehyde | ESD-932603-100MG |
| Cas.: 338452-92-9 | Purity: 95% | 4-Amino-2-chloronicotinaldehyde | ESD-932603-250MG |
| Cas.: 338452-92-9 | Purity: 95% | 4-Amino-2-chloronicotinaldehyde | ESD-932603-1G |
| Cas.: 511256-37-4 | Purity: ≥98% | (S)-1-(4-Tert-butylphenyl)ethanamine | ESD-932604-100MG |
| Cas.: 511256-37-4 | Purity: ≥98% | (S)-1-(4-Tert-butylphenyl)ethanamine | ESD-932604-250MG |
| Cas.: 511256-37-4 | Purity: ≥98% | (S)-1-(4-Tert-butylphenyl)ethanamine | ESD-932604-1G |
| Cas.: 16112-21-3 | Purity: 98% | 2-(4-Methylphenyl)benzothiazole | ESD-932605-100MG |
| Cas.: 16112-21-3 | Purity: 98% | 2-(4-Methylphenyl)benzothiazole | ESD-932605-250MG |
| Cas.: 16112-21-3 | Purity: 98% | 2-(4-Methylphenyl)benzothiazole | ESD-932605-1G |
| Cas.: 233691-67-3 | Purity: 95% | (S)-Tert-butyl (6-acetamido-1-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-1-oxohexan-2-yl)carbamate | ESD-932606-100MG |
| Cas.: 233691-67-3 | Purity: 95% | (S)-Tert-butyl (6-acetamido-1-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-1-oxohexan-2-yl)carbamate | ESD-932606-250MG |
| Cas.: 233691-67-3 | Purity: 95% | (S)-Tert-butyl (6-acetamido-1-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-1-oxohexan-2-yl)carbamate | ESD-932606-1G |
| Cas.: 7627-44-3 | Purity: 95% | 2,4-Dichloro-5-(iodomethyl)pyrimidine | ESD-932607-100MG |
| Cas.: 7627-44-3 | Purity: 95% | 2,4-Dichloro-5-(iodomethyl)pyrimidine | ESD-932607-250MG |
| Cas.: 7627-44-3 | Purity: 95% | 2,4-Dichloro-5-(iodomethyl)pyrimidine | ESD-932607-1G |
| Cas.: 1033203-46-1 | Purity: 95% | 2,5-Dibromo-4-fluoropyridine | ESD-932608-100MG |
| Cas.: 1033203-46-1 | Purity: 95% | 2,5-Dibromo-4-fluoropyridine | ESD-932608-250MG |
| Cas.: 1033203-46-1 | Purity: 95% | 2,5-Dibromo-4-fluoropyridine | ESD-932608-1G |
| Cas.: 109862-53-5 | Purity: 97% | Dimethyl 5-(hydroxymethyl)isophthalate | ESD-932609-100MG |
| Cas.: 109862-53-5 | Purity: 97% | Dimethyl 5-(hydroxymethyl)isophthalate | ESD-932609-250MG |
| Cas.: 109862-53-5 | Purity: 97% | Dimethyl 5-(hydroxymethyl)isophthalate | ESD-932609-1G |
| Cas.: 78197-27-0 | Purity: 98% | 4-Fluoropiperidine | ESD-932610-100MG |
| Cas.: 78197-27-0 | Purity: 98% | 4-Fluoropiperidine | ESD-932610-250MG |
| Cas.: 78197-27-0 | Purity: 98% | 4-Fluoropiperidine | ESD-932610-1G |
| Cas.: 1736-67-0 | Purity: 98% | 2-(4-Fluorophenyl)acetaldehyde | ESD-932611-100MG |
| Cas.: 1736-67-0 | Purity: 98% | 2-(4-Fluorophenyl)acetaldehyde | ESD-932611-250MG |
| Cas.: 1736-67-0 | Purity: 98% | 2-(4-Fluorophenyl)acetaldehyde | ESD-932611-1G |
| Cas.: 477600-74-1 | Purity: 95% | N-Methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine | ESD-932612-100MG |
| Cas.: 477600-74-1 | Purity: 95% | N-Methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine | ESD-932612-250MG |
| Cas.: 477600-74-1 | Purity: 95% | N-Methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine | ESD-932612-1G |
| Cas.: 674792-06-4 | Purity: 97% | (S)-tert-Butyl 2-isobutylpiperazine-1-carboxylate | ESD-932613-100MG |
| Cas.: 674792-06-4 | Purity: 97% | (S)-tert-Butyl 2-isobutylpiperazine-1-carboxylate | ESD-932613-250MG |
| Cas.: 674792-06-4 | Purity: 97% | (S)-tert-Butyl 2-isobutylpiperazine-1-carboxylate | ESD-932613-1G |
| Cas.: 546141-56-4 | Purity: 98% | 4-Amino-6-chloropicolinic acid | ESD-932614-100MG |
| Cas.: 546141-56-4 | Purity: 98% | 4-Amino-6-chloropicolinic acid | ESD-932614-250MG |
| Cas.: 546141-56-4 | Purity: 98% | 4-Amino-6-chloropicolinic acid | ESD-932614-1G |
| Cas.: 90564-02-6 | Purity: 95% | Methyl 2-Carbamoylbenzoate | ESD-932615-100MG |
| Cas.: 90564-02-6 | Purity: 95% | Methyl 2-Carbamoylbenzoate | ESD-932615-250MG |
| Cas.: 90564-02-6 | Purity: 95% | Methyl 2-Carbamoylbenzoate | ESD-932615-1G |
| Cas.: 5614-64-2 | Purity: 90% | 2-Amino-8-hydroxy-1H-purin-6(7H)-one | ESD-932616-100MG |
| Cas.: 5614-64-2 | Purity: 90% | 2-Amino-8-hydroxy-1H-purin-6(7H)-one | ESD-932616-250MG |
| Cas.: 1361055-04-0 | Purity: 97% | (11aR)-5-(4,5,6,7-Tetrahydrodiindeno[7,1-de:1′,7′-fg][1,3,2]dioxaphosphocin-12-yl)-5H-dibenzo[b ,f]azepine | ESD-932617-100MG |
| Cas.: 1361055-04-0 | Purity: 97% | (11aR)-5-(4,5,6,7-Tetrahydrodiindeno[7,1-de:1′,7′-fg][1,3,2]dioxaphosphocin-12-yl)-5H-dibenzo[b ,f]azepine | ESD-932617-250MG |
| Cas.: 1361055-04-0 | Purity: 97% | (11aR)-5-(4,5,6,7-Tetrahydrodiindeno[7,1-de:1′,7′-fg][1,3,2]dioxaphosphocin-12-yl)-5H-dibenzo[b ,f]azepine | ESD-932617-1G |
| Cas.: 42137-24-6 | Purity: 95% | 4-Nitrothiophene-2-carbonitrile | ESD-932618-100MG |
| Cas.: 42137-24-6 | Purity: 95% | 4-Nitrothiophene-2-carbonitrile | ESD-932618-250MG |
| Cas.: 42137-24-6 | Purity: 95% | 4-Nitrothiophene-2-carbonitrile | ESD-932618-1G |
| Cas.: 3718-04-5 | Purity: 95% blend (TBC as stabilizer) | 5-Vinyl-1H-imidazole | ESD-932619-100MG |
| Cas.: 3718-04-5 | Purity: 95% blend (TBC as stabilizer) | 5-Vinyl-1H-imidazole | ESD-932619-250MG |
| Cas.: 3718-04-5 | Purity: 95% blend (TBC as stabilizer) | 5-Vinyl-1H-imidazole | ESD-932619-1G |
| Cas.: 858515-77-2 | Purity: 98% | Methyl 4-methyl-1H-indole-3-carboxylate | ESD-932620-100MG |
| Cas.: 858515-77-2 | Purity: 98% | Methyl 4-methyl-1H-indole-3-carboxylate | ESD-932620-250MG |
| Cas.: 858515-77-2 | Purity: 98% | Methyl 4-methyl-1H-indole-3-carboxylate | ESD-932620-1G |
| Cas.: 6217-22-7 | Purity: 95% | Pyrene-4,5-dione | ESD-932621-100MG |
| Cas.: 6217-22-7 | Purity: 95% | Pyrene-4,5-dione | ESD-932621-250MG |
| Cas.: 6217-22-7 | Purity: 95% | Pyrene-4,5-dione | ESD-932621-1G |
| Cas.: 5870-29-1 | Purity: 98% | Cyclopentolate hydrochloride | ESD-932622-100MG |
| Cas.: 5870-29-1 | Purity: 98% | Cyclopentolate hydrochloride | ESD-932622-250MG |
| Cas.: 5870-29-1 | Purity: 98% | Cyclopentolate hydrochloride | ESD-932622-1G |
| Cas.: 1044210-58-3 | Purity: 95% | 5-Cyclopropylpyridin-3-ylboronic acid | ESD-932623-100MG |
| Cas.: 1044210-58-3 | Purity: 95% | 5-Cyclopropylpyridin-3-ylboronic acid | ESD-932623-250MG |
| Cas.: 1044210-58-3 | Purity: 95% | 5-Cyclopropylpyridin-3-ylboronic acid | ESD-932623-1G |
| Cas.: 23000-14-8 | Purity: 98% | 2,5-Dimethyloxazole-4-carboxylic acid | ESD-932624-100MG |
| Cas.: 23000-14-8 | Purity: 98% | 2,5-Dimethyloxazole-4-carboxylic acid | ESD-932624-250MG |
| Cas.: 23000-14-8 | Purity: 98% | 2,5-Dimethyloxazole-4-carboxylic acid | ESD-932624-1G |
| Cas.: 107-68-6 | Purity: 95% | 2-(Methylamino)ethanesulfonic acid | ESD-932625-100MG |
| Cas.: 107-68-6 | Purity: 95% | 2-(Methylamino)ethanesulfonic acid | ESD-932625-250MG |
| Cas.: 107-68-6 | Purity: 95% | 2-(Methylamino)ethanesulfonic acid | ESD-932625-1G |
| Cas.: 223655-16-1 | Purity: 98% | Di-tert-butylphosphinylferrocene | ESD-932626-100MG |
| Cas.: 223655-16-1 | Purity: 98% | Di-tert-butylphosphinylferrocene | ESD-932626-250MG |
| Cas.: 223655-16-1 | Purity: 98% | Di-tert-butylphosphinylferrocene | ESD-932626-1G |
| Cas.: 258331-10-1 | Purity: 97% | Tert-butyl 2-(2-hydroxyphenyl)acetate | ESD-932627-100MG |
| Cas.: 258331-10-1 | Purity: 97% | Tert-butyl 2-(2-hydroxyphenyl)acetate | ESD-932627-250MG |
| Cas.: 258331-10-1 | Purity: 97% | Tert-butyl 2-(2-hydroxyphenyl)acetate | ESD-932627-1G |
| Cas.: 14969-32-5 | Purity: 97% | 3,3′-Dihydroxy-[1,1′-biphenyl]-4,4′-dicarbaldehyde | ESD-932628-100MG |
| Cas.: 14969-32-5 | Purity: 97% | 3,3′-Dihydroxy-[1,1′-biphenyl]-4,4′-dicarbaldehyde | ESD-932628-250MG |
| Cas.: 14969-32-5 | Purity: 97% | 3,3′-Dihydroxy-[1,1′-biphenyl]-4,4′-dicarbaldehyde | ESD-932628-1G |
| Cas.: 1060814-53-0 | Purity: 95% | (5-Chloropyrazin-2-yl)methanamine | ESD-932629-100MG |
| Cas.: 1060814-53-0 | Purity: 95% | (5-Chloropyrazin-2-yl)methanamine | ESD-932629-250MG |
| Cas.: 1060814-53-0 | Purity: 95% | (5-Chloropyrazin-2-yl)methanamine | ESD-932629-1G |
| Cas.: 837-18-3 | Purity: 95% | N-Benzylbenzenesulfonamide | ESD-932630-100MG |
| Cas.: 837-18-3 | Purity: 95% | N-Benzylbenzenesulfonamide | ESD-932630-250MG |
| Cas.: 837-18-3 | Purity: 95% | N-Benzylbenzenesulfonamide | ESD-932630-1G |
| Cas.: 139399-64-7 | Purity: 95% | 6-Bromoquinolin-8-ol | ESD-932631-100MG |
| Cas.: 139399-64-7 | Purity: 95% | 6-Bromoquinolin-8-ol | ESD-932631-250MG |
| Cas.: 139399-64-7 | Purity: 95% | 6-Bromoquinolin-8-ol | ESD-932631-1G |
| Cas.: 870822-79-0 | Purity: 98% | 3-Chloro-4-(trifluoromethoxy)phenylboronic acid | ESD-932632-100MG |
| Cas.: 870822-79-0 | Purity: 98% | 3-Chloro-4-(trifluoromethoxy)phenylboronic acid | ESD-932632-250MG |
| Cas.: 870822-79-0 | Purity: 98% | 3-Chloro-4-(trifluoromethoxy)phenylboronic acid | ESD-932632-1G |
| Cas.: 872091-85-5 | Purity: 95% | Methyl 3-(2-cyanopropan-2-yl)benzoate | ESD-932633-100MG |
| Cas.: 872091-85-5 | Purity: 95% | Methyl 3-(2-cyanopropan-2-yl)benzoate | ESD-932633-250MG |
| Cas.: 872091-85-5 | Purity: 95% | Methyl 3-(2-cyanopropan-2-yl)benzoate | ESD-932633-1G |
| Cas.: 13599-22-9 | Purity: 96% | 1,5-Diphenyl-1H-pyrazole-3-carboxylic acid | ESD-932634-100MG |
| Cas.: 13599-22-9 | Purity: 96% | 1,5-Diphenyl-1H-pyrazole-3-carboxylic acid | ESD-932634-250MG |
| Cas.: 13599-22-9 | Purity: 96% | 1,5-Diphenyl-1H-pyrazole-3-carboxylic acid | ESD-932634-1G |
| Cas.: 46389-47-3 | Purity: 97% | (2,2′-Bipyridine)nickel(II) dibromide | ESD-932635-100MG |
| Cas.: 46389-47-3 | Purity: 97% | (2,2′-Bipyridine)nickel(II) dibromide | ESD-932635-250MG |
| Cas.: 46389-47-3 | Purity: 97% | (2,2′-Bipyridine)nickel(II) dibromide | ESD-932635-1G |
| Cas.: 60189-97-1 | Purity: 95% | Methyl 2-amino-2-iminoacetate hydrochloride | ESD-932636-100MG |
| Cas.: 60189-97-1 | Purity: 95% | Methyl 2-amino-2-iminoacetate hydrochloride | ESD-932636-250MG |
| Cas.: 60189-97-1 | Purity: 95% | Methyl 2-amino-2-iminoacetate hydrochloride | ESD-932636-1G |
| Cas.: 33787-05-2 | Purity: 95% | (S)-2-Amino-3-(2,6-difluorophenyl)propanoic acid | ESD-932637-100MG |
| Cas.: 33787-05-2 | Purity: 95% | (S)-2-Amino-3-(2,6-difluorophenyl)propanoic acid | ESD-932637-250MG |
| Cas.: 33787-05-2 | Purity: 95% | (S)-2-Amino-3-(2,6-difluorophenyl)propanoic acid | ESD-932637-1G |
| Cas.: 1113049-90-3 | Purity: 95% | 6-Chloro-5-(trifluoromethyl)nicotinaldehyde | ESD-932638-100MG |
| Cas.: 1113049-90-3 | Purity: 95% | 6-Chloro-5-(trifluoromethyl)nicotinaldehyde | ESD-932638-250MG |
| Cas.: 1113049-90-3 | Purity: 95% | 6-Chloro-5-(trifluoromethyl)nicotinaldehyde | ESD-932638-1G |
| Cas.: 328956-60-1 | Purity: 95% | (3-Fluoro-5-formylphenyl)boronic acid | ESD-932639-100MG |
| Cas.: 328956-60-1 | Purity: 95% | (3-Fluoro-5-formylphenyl)boronic acid | ESD-932639-250MG |
| Cas.: 328956-60-1 | Purity: 95% | (3-Fluoro-5-formylphenyl)boronic acid | ESD-932639-1G |
| Cas.: 167275-44-7 | Purity: 95% | 8-Bromonaphthalen-2-amine | ESD-932640-100MG |
| Cas.: 167275-44-7 | Purity: 95% | 8-Bromonaphthalen-2-amine | ESD-932640-250MG |
| Cas.: 167275-44-7 | Purity: 95% | 8-Bromonaphthalen-2-amine | ESD-932640-1G |
| Cas.: 4425-82-5 | Purity: 97% | 9-Methylene-9H-fluorene | ESD-932641-100MG |
| Cas.: 4425-82-5 | Purity: 97% | 9-Methylene-9H-fluorene | ESD-932641-250MG |
| Cas.: 4425-82-5 | Purity: 97% | 9-Methylene-9H-fluorene | ESD-932641-1G |
| Cas.: 1126432-04-9 | Purity: 95% | (R)-Octahydropyrazino[2,1-c][1,4]oxazine dihydrochloride | ESD-932642-100MG |
| Cas.: 1126432-04-9 | Purity: 95% | (R)-Octahydropyrazino[2,1-c][1,4]oxazine dihydrochloride | ESD-932642-250MG |
| Cas.: 1126432-04-9 | Purity: 95% | (R)-Octahydropyrazino[2,1-c][1,4]oxazine dihydrochloride | ESD-932642-1G |
| Cas.: 201007-86-5 | Purity: 98% | Nepsilon-Boc-D-lysine t-butyl ester hydrochloride | ESD-932643-100MG |
| Cas.: 201007-86-5 | Purity: 98% | Nepsilon-Boc-D-lysine t-butyl ester hydrochloride | ESD-932643-250MG |
| Cas.: 201007-86-5 | Purity: 98% | Nepsilon-Boc-D-lysine t-butyl ester hydrochloride | ESD-932643-1G |
| Cas.: 40964-56-5 | Purity: 95% | 5-Bromo-1H-1,2,3-triazole | ESD-932644-100MG |
| Cas.: 40964-56-5 | Purity: 95% | 5-Bromo-1H-1,2,3-triazole | ESD-932644-250MG |
| Cas.: 40964-56-5 | Purity: 95% | 5-Bromo-1H-1,2,3-triazole | ESD-932644-1G |
| Cas.: 1221343-14-1 | Purity: 97% | 1-Hydroxy-1,3-dihydrobenzo[c][1,2]oxaborole-6-carboxylic acid | ESD-932645-100MG |
| Cas.: 1221343-14-1 | Purity: 97% | 1-Hydroxy-1,3-dihydrobenzo[c][1,2]oxaborole-6-carboxylic acid | ESD-932645-250MG |
| Cas.: 1221343-14-1 | Purity: 97% | 1-Hydroxy-1,3-dihydrobenzo[c][1,2]oxaborole-6-carboxylic acid | ESD-932645-1G |
| Cas.: 952518-97-7 | Purity: 97% | 4-(1H-Pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidine | ESD-932646-100MG |
| Cas.: 952518-97-7 | Purity: 97% | 4-(1H-Pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidine | ESD-932646-250MG |
| Cas.: 952518-97-7 | Purity: 97% | 4-(1H-Pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidine | ESD-932646-1G |
| Cas.: 1284293-45-3 | Purity: 98% | (11bR)-4-Hydroxy-2,6-bis(perfluorophenyl)dinaphtho[2,1-d:1′,2′-f][1,3,2]dioxaphosphepine 4-oxide | ESD-932647-100MG |
| Cas.: 1284293-45-3 | Purity: 98% | (11bR)-4-Hydroxy-2,6-bis(perfluorophenyl)dinaphtho[2,1-d:1′,2′-f][1,3,2]dioxaphosphepine 4-oxide | ESD-932647-250MG |
| Cas.: 1284293-45-3 | Purity: 98% | (11bR)-4-Hydroxy-2,6-bis(perfluorophenyl)dinaphtho[2,1-d:1′,2′-f][1,3,2]dioxaphosphepine 4-oxide | ESD-932647-1G |
| Cas.: 15991-59-0 | Purity: 95% | 2-Propylpiperidine hydrochloride | ESD-932648-100MG |
| Cas.: 15991-59-0 | Purity: 95% | 2-Propylpiperidine hydrochloride | ESD-932648-250MG |
| Cas.: 15991-59-0 | Purity: 95% | 2-Propylpiperidine hydrochloride | ESD-932648-1G |
| Cas.: 62150-46-3 | Purity: 98% | 4-Bromopicolinamide | ESD-932649-100MG |
| Cas.: 62150-46-3 | Purity: 98% | 4-Bromopicolinamide | ESD-932649-250MG |
| Cas.: 62150-46-3 | Purity: 98% | 4-Bromopicolinamide | ESD-932649-1G |
| Cas.: 63909-55-7 | Purity: 95% | Diethyl (2-Bromobenzyl)phosphonate | ESD-932650-100MG |
| Cas.: 63909-55-7 | Purity: 95% | Diethyl (2-Bromobenzyl)phosphonate | ESD-932650-250MG |
| Cas.: 63909-55-7 | Purity: 95% | Diethyl (2-Bromobenzyl)phosphonate | ESD-932650-1G |
| Cas.: 181289-23-6 | Purity: 97% | (S)-4-Isobutylpyrrolidin-2-one | ESD-932651-100MG |
| Cas.: 181289-23-6 | Purity: 97% | (S)-4-Isobutylpyrrolidin-2-one | ESD-932651-250MG |
| Cas.: 181289-23-6 | Purity: 97% | (S)-4-Isobutylpyrrolidin-2-one | ESD-932651-1G |
| Cas.: 52571-71-8 | Purity: 95% | (2R,3R,4S,5R,6R)-2-(Hydroxymethyl)-6-(3-nitrophenoxy)tetrahydro-2H-pyran-3,4,5-triol | ESD-932652-100MG |
| Cas.: 52571-71-8 | Purity: 95% | (2R,3R,4S,5R,6R)-2-(Hydroxymethyl)-6-(3-nitrophenoxy)tetrahydro-2H-pyran-3,4,5-triol | ESD-932652-250MG |
| Cas.: 52571-71-8 | Purity: 95% | (2R,3R,4S,5R,6R)-2-(Hydroxymethyl)-6-(3-nitrophenoxy)tetrahydro-2H-pyran-3,4,5-triol | ESD-932652-1G |
| Cas.: 1621274-19-8 | Purity: 98% | Methanesulfonato[9,9-dimethyl-4,5-bis(diphenylphosphino)xanthene](2′-methylamino-1,1′-biphenyl-2-yl)palladium(II) | ESD-932653-100MG |
| Cas.: 1621274-19-8 | Purity: 98% | Methanesulfonato[9,9-dimethyl-4,5-bis(diphenylphosphino)xanthene](2′-methylamino-1,1′-biphenyl-2-yl)palladium(II) | ESD-932653-250MG |
| Cas.: 1621274-19-8 | Purity: 98% | Methanesulfonato[9,9-dimethyl-4,5-bis(diphenylphosphino)xanthene](2′-methylamino-1,1′-biphenyl-2-yl)palladium(II) | ESD-932653-1G |
| Cas.: 193354-13-1 | Purity: 95% | 5-Iodoindolin-2-one | ESD-932654-100MG |
| Cas.: 193354-13-1 | Purity: 95% | 5-Iodoindolin-2-one | ESD-932654-250MG |
| Cas.: 193354-13-1 | Purity: 95% | 5-Iodoindolin-2-one | ESD-932654-1G |
| Cas.: 15403-46-0 | Purity: 95% | Diethyl 2,5-diaminoterephthalate | ESD-932655-100MG |
| Cas.: 15403-46-0 | Purity: 95% | Diethyl 2,5-diaminoterephthalate | ESD-932655-250MG |
| Cas.: 15403-46-0 | Purity: 95% | Diethyl 2,5-diaminoterephthalate | ESD-932655-1G |
| Cas.: 19591-17-4 | Purity: 98% | N-(2-Iodophenyl)acetamide | ESD-932656-100MG |
| Cas.: 19591-17-4 | Purity: 98% | N-(2-Iodophenyl)acetamide | ESD-932656-250MG |
| Cas.: 19591-17-4 | Purity: 98% | N-(2-Iodophenyl)acetamide | ESD-932656-1G |
| Cas.: 75665-73-5 | Purity: 97% | 1-(2-Amino-4-(benzyloxy)-5-methoxyphenyl)ethanone | ESD-932657-100MG |
| Cas.: 75665-73-5 | Purity: 97% | 1-(2-Amino-4-(benzyloxy)-5-methoxyphenyl)ethanone | ESD-932657-250MG |
| Cas.: 75665-73-5 | Purity: 97% | 1-(2-Amino-4-(benzyloxy)-5-methoxyphenyl)ethanone | ESD-932657-1G |
| Cas.: 63628-63-7 | Purity: 98% | (S)-Tert-butyl 2-amino-6-(((benzyloxy)carbonyl)amino)hexanoate | ESD-932658-100MG |
| Cas.: 63628-63-7 | Purity: 98% | (S)-Tert-butyl 2-amino-6-(((benzyloxy)carbonyl)amino)hexanoate | ESD-932658-250MG |
| Cas.: 63628-63-7 | Purity: 98% | (S)-Tert-butyl 2-amino-6-(((benzyloxy)carbonyl)amino)hexanoate | ESD-932658-1G |
| Cas.: 86026-81-5 | Purity: 98% | 2,5-Diiodo-1-methylimidazole | ESD-932659-100MG |
| Cas.: 86026-81-5 | Purity: 98% | 2,5-Diiodo-1-methylimidazole | ESD-932659-250MG |
| Cas.: 86026-81-5 | Purity: 98% | 2,5-Diiodo-1-methylimidazole | ESD-932659-1G |
| Cas.: 1204818-19-8 | Purity: 97% | (R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoic acid hydrochloride | ESD-932660-100MG |
| Cas.: 1204818-19-8 | Purity: 97% | (R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoic acid hydrochloride | ESD-932660-250MG |
| Cas.: 1204818-19-8 | Purity: 97% | (R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoic acid hydrochloride | ESD-932660-1G |
| Cas.: 221241-31-2 | Purity: 98% | 2,5-Dibromo-4-nitropyridine | ESD-932661-100MG |
| Cas.: 221241-31-2 | Purity: 98% | 2,5-Dibromo-4-nitropyridine | ESD-932661-250MG |
| Cas.: 221241-31-2 | Purity: 98% | 2,5-Dibromo-4-nitropyridine | ESD-932661-1G |
| Cas.: 866144-03-8 | Purity: 98% | 4-Fluoro-1H-indazol-7-amine | ESD-932662-100MG |
| Cas.: 866144-03-8 | Purity: 98% | 4-Fluoro-1H-indazol-7-amine | ESD-932662-250MG |
| Cas.: 866144-03-8 | Purity: 98% | 4-Fluoro-1H-indazol-7-amine | ESD-932662-1G |
| Cas.: 280762-00-7 | Purity: 97% | exo-8-(Tert-butoxycarbonyl)-8-azabicyclo[3.2.1]octane-3-carboxylic acid | ESD-932663-100MG |
| Cas.: 280762-00-7 | Purity: 97% | exo-8-(Tert-butoxycarbonyl)-8-azabicyclo[3.2.1]octane-3-carboxylic acid | ESD-932663-250MG |
| Cas.: 280762-00-7 | Purity: 97% | exo-8-(Tert-butoxycarbonyl)-8-azabicyclo[3.2.1]octane-3-carboxylic acid | ESD-932663-1G |
| Cas.: 888720-29-4 | Purity: 95% | 4-Chloropyrrolo[2,1-f][1,2,4]triazine | ESD-932664-100MG |
| Cas.: 888720-29-4 | Purity: 95% | 4-Chloropyrrolo[2,1-f][1,2,4]triazine | ESD-932664-250MG |
| Cas.: 888720-29-4 | Purity: 95% | 4-Chloropyrrolo[2,1-f][1,2,4]triazine | ESD-932664-1G |
| Cas.: 949159-95-9 | Purity: 98% | 4′-Fluoro-3′-hydroxyacetophenone | ESD-932665-100MG |
| Cas.: 949159-95-9 | Purity: 98% | 4′-Fluoro-3′-hydroxyacetophenone | ESD-932665-250MG |
| Cas.: 949159-95-9 | Purity: 98% | 4′-Fluoro-3′-hydroxyacetophenone | ESD-932665-1G |
| Cas.: 782475-37-0 | Purity: 95% | 2-Methyl-2-propanyl 3-{2-[2-(2-bromoethoxy)ethoxy]ethoxy}propanoate | ESD-932666-100MG |
| Cas.: 782475-37-0 | Purity: 95% | 2-Methyl-2-propanyl 3-{2-[2-(2-bromoethoxy)ethoxy]ethoxy}propanoate | ESD-932666-250MG |
| Cas.: 782475-37-0 | Purity: 95% | 2-Methyl-2-propanyl 3-{2-[2-(2-bromoethoxy)ethoxy]ethoxy}propanoate | ESD-932666-1G |
| Cas.: 1826-12-6 | Purity: 98% | 4-Phenylthiazole | ESD-932667-100MG |
| Cas.: 1826-12-6 | Purity: 98% | 4-Phenylthiazole | ESD-932667-250MG |
| Cas.: 1826-12-6 | Purity: 98% | 4-Phenylthiazole | ESD-932667-1G |
| Cas.: 114745-26-5 | Purity: 95% | N-(9-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-methoxytetrahydrofuran-2-yl)-6-oxo -6,9-dihydro-1H-purin-2-yl)isobutyramide | ESD-932668-100MG |
| Cas.: 114745-26-5 | Purity: 95% | N-(9-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-methoxytetrahydrofuran-2-yl)-6-oxo -6,9-dihydro-1H-purin-2-yl)isobutyramide | ESD-932668-250MG |
| Cas.: 114745-26-5 | Purity: 95% | N-(9-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-methoxytetrahydrofuran-2-yl)-6-oxo -6,9-dihydro-1H-purin-2-yl)isobutyramide | ESD-932668-1G |
| Cas.: 467-63-0 | Purity: 98% | Tris(4-(dimethylamino)phenyl)methanol | ESD-932669-100MG |
| Cas.: 467-63-0 | Purity: 98% | Tris(4-(dimethylamino)phenyl)methanol | ESD-932669-250MG |
| Cas.: 467-63-0 | Purity: 98% | Tris(4-(dimethylamino)phenyl)methanol | ESD-932669-1G |
| Cas.: 22358-80-1 | Purity: 95% | Thiazole-4,5-dicarboxylic acid | ESD-932670-100MG |
| Cas.: 22358-80-1 | Purity: 95% | Thiazole-4,5-dicarboxylic acid | ESD-932670-250MG |
| Cas.: 22358-80-1 | Purity: 95% | Thiazole-4,5-dicarboxylic acid | ESD-932670-1G |
| Cas.: 187794-49-6 | Purity: 99,9% | (S)-12-Benzyl-2,2-dimethyl-4,7,10,13-tetraoxo-3-oxa-5,8,11,14-tetraazahexadecan-16-oic acid | ESD-932671-100MG |
| Cas.: 187794-49-6 | Purity: 99,9% | (S)-12-Benzyl-2,2-dimethyl-4,7,10,13-tetraoxo-3-oxa-5,8,11,14-tetraazahexadecan-16-oic acid | ESD-932671-250MG |
| Cas.: 187794-49-6 | Purity: 99,9% | (S)-12-Benzyl-2,2-dimethyl-4,7,10,13-tetraoxo-3-oxa-5,8,11,14-tetraazahexadecan-16-oic acid | ESD-932671-1G |
| Cas.: 30011-36-0 | Purity: ≥95% | 3-Phenylprop-2-yn-1-amine hydrochloride | ESD-932672-100MG |
| Cas.: 30011-36-0 | Purity: ≥95% | 3-Phenylprop-2-yn-1-amine hydrochloride | ESD-932672-250MG |
| Cas.: 30011-36-0 | Purity: ≥95% | 3-Phenylprop-2-yn-1-amine hydrochloride | ESD-932672-1G |
| Cas.: 42309-92-2 | Purity: 95% | 2-Fluoro-1H-imidazole hydrochloride | ESD-932673-100MG |
| Cas.: 42309-92-2 | Purity: 95% | 2-Fluoro-1H-imidazole hydrochloride | ESD-932673-250MG |
| Cas.: 42309-92-2 | Purity: 95% | 2-Fluoro-1H-imidazole hydrochloride | ESD-932673-1G |
| Cas.: 19989-66-3 | Purity: 95% | Benzo[d]thiazol-6-ylmethanol | ESD-932674-100MG |
| Cas.: 19989-66-3 | Purity: 95% | Benzo[d]thiazol-6-ylmethanol | ESD-932674-250MG |
| Cas.: 19989-66-3 | Purity: 95% | Benzo[d]thiazol-6-ylmethanol | ESD-932674-1G |
| Cas.: 1710765-27-7 | Purity: 98% | (2R,5R)-1-(2-(1,3-dioxolan-2-yl)phenyl)-2,5-diethylphospholane | ESD-932675-100MG |
| Cas.: 1710765-27-7 | Purity: 98% | (2R,5R)-1-(2-(1,3-dioxolan-2-yl)phenyl)-2,5-diethylphospholane | ESD-932675-250MG |
| Cas.: 1710765-27-7 | Purity: 98% | (2R,5R)-1-(2-(1,3-dioxolan-2-yl)phenyl)-2,5-diethylphospholane | ESD-932675-1G |
| Cas.: 1456816-37-7 | Purity: 97% | (R)-4-(Anthracen-9-yl)-3-(tert-butyl)-2,3-dihydrobenzo[d][1,3]oxaphosphole | ESD-932676-100MG |
| Cas.: 1456816-37-7 | Purity: 97% | (R)-4-(Anthracen-9-yl)-3-(tert-butyl)-2,3-dihydrobenzo[d][1,3]oxaphosphole | ESD-932676-250MG |
| Cas.: 1456816-37-7 | Purity: 97% | (R)-4-(Anthracen-9-yl)-3-(tert-butyl)-2,3-dihydrobenzo[d][1,3]oxaphosphole | ESD-932676-1G |
| Cas.: 50592-87-5 | Purity: 95% | 1-Bromo-6-methoxyhexane | ESD-932677-100MG |
| Cas.: 50592-87-5 | Purity: 95% | 1-Bromo-6-methoxyhexane | ESD-932677-250MG |
| Cas.: 50592-87-5 | Purity: 95% | 1-Bromo-6-methoxyhexane | ESD-932677-1G |
| Cas.: 1020056-33-0 | Purity: ≥90% | 1H-Pyrrolo[3,2-b]pyridine-6-carbaldehyde | ESD-932678-100MG |
| Cas.: 1020056-33-0 | Purity: ≥90% | 1H-Pyrrolo[3,2-b]pyridine-6-carbaldehyde | ESD-932678-250MG |
| Cas.: 1020056-33-0 | Purity: ≥90% | 1H-Pyrrolo[3,2-b]pyridine-6-carbaldehyde | ESD-932678-1G |
| Cas.: 40452-20-8 | Purity: 95% | Phenanthrene-2-carboxylic acid | ESD-932679-100MG |
| Cas.: 40452-20-8 | Purity: 95% | Phenanthrene-2-carboxylic acid | ESD-932679-250MG |
| Cas.: 40452-20-8 | Purity: 95% | Phenanthrene-2-carboxylic acid | ESD-932679-1G |
| Cas.: 596819-12-4 | Purity: 95% | 2-(5-Methoxythiophen-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-932680-100MG |
| Cas.: 596819-12-4 | Purity: 95% | 2-(5-Methoxythiophen-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-932680-250MG |
| Cas.: 596819-12-4 | Purity: 95% | 2-(5-Methoxythiophen-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-932680-1G |
| Cas.: 5203-15-6 | Purity: 98% | 4-iso-Butoxybenzonitrile | ESD-932681-100MG |
| Cas.: 5203-15-6 | Purity: 98% | 4-iso-Butoxybenzonitrile | ESD-932681-250MG |
| Cas.: 5203-15-6 | Purity: 98% | 4-iso-Butoxybenzonitrile | ESD-932681-1G |
| Cas.: 20876-99-7 | Purity: 98% | 4-Hydroxy-N,N-dimethylbenzamide | ESD-932682-100MG |
| Cas.: 20876-99-7 | Purity: 98% | 4-Hydroxy-N,N-dimethylbenzamide | ESD-932682-250MG |
| Cas.: 20876-99-7 | Purity: 98% | 4-Hydroxy-N,N-dimethylbenzamide | ESD-932682-1G |
| Cas.: 72652-32-5 | Purity: 95% | 1-(4-Bromo-1H-pyrrol-2-yl)-2,2,2-trichloroethanone | ESD-932683-100MG |
| Cas.: 72652-32-5 | Purity: 95% | 1-(4-Bromo-1H-pyrrol-2-yl)-2,2,2-trichloroethanone | ESD-932683-250MG |
| Cas.: 72652-32-5 | Purity: 95% | 1-(4-Bromo-1H-pyrrol-2-yl)-2,2,2-trichloroethanone | ESD-932683-1G |
| Cas.: 766515-35-9 | Purity: 95% | 5-Iodo-1-methyl-1H-pyrazolo[3,4-b]pyridin-3-amine | ESD-932684-100MG |
| Cas.: 766515-35-9 | Purity: 95% | 5-Iodo-1-methyl-1H-pyrazolo[3,4-b]pyridin-3-amine | ESD-932684-250MG |
| Cas.: 766515-35-9 | Purity: 95% | 5-Iodo-1-methyl-1H-pyrazolo[3,4-b]pyridin-3-amine | ESD-932684-1G |
| Cas.: 273207-57-1 | Purity: 96% | 3-Methylene-8-Boc-8-azabicyclo[3.2.1]octane | ESD-932685-100MG |
| Cas.: 273207-57-1 | Purity: 96% | 3-Methylene-8-Boc-8-azabicyclo[3.2.1]octane | ESD-932685-250MG |
| Cas.: 273207-57-1 | Purity: 96% | 3-Methylene-8-Boc-8-azabicyclo[3.2.1]octane | ESD-932685-1G |
| Cas.: 3770-22-7 | Purity: 95% | 6-Oxo-piperidine-2-carboxylic acid | ESD-932686-100MG |
| Cas.: 3770-22-7 | Purity: 95% | 6-Oxo-piperidine-2-carboxylic acid | ESD-932686-250MG |
| Cas.: 3770-22-7 | Purity: 95% | 6-Oxo-piperidine-2-carboxylic acid | ESD-932686-1G |
| Cas.: 80466-78-0 | Purity: 95% | 3,5-Dimethyl-1H-pyrazole-4-sulfonyl chloride | ESD-932687-100MG |
| Cas.: 80466-78-0 | Purity: 95% | 3,5-Dimethyl-1H-pyrazole-4-sulfonyl chloride | ESD-932687-250MG |
| Cas.: 80466-78-0 | Purity: 95% | 3,5-Dimethyl-1H-pyrazole-4-sulfonyl chloride | ESD-932687-1G |
| Cas.: 92806-98-9 | Purity: 97% | 2-Mercapto-1H-benzo[d]imidazol-5-ol | ESD-932688-100MG |
| Cas.: 92806-98-9 | Purity: 97% | 2-Mercapto-1H-benzo[d]imidazol-5-ol | ESD-932688-250MG |
| Cas.: 92806-98-9 | Purity: 97% | 2-Mercapto-1H-benzo[d]imidazol-5-ol | ESD-932688-1G |
| Cas.: 1365531-84-5 | Purity: 98% | (R)-2,2′-Bis[bis(3,5-trifluoromethylphenyl)phosphino]-4,4′,6,6′-tetramethoxy)-1,1′-biphenyl | ESD-932689-100MG |
| Cas.: 1365531-84-5 | Purity: 98% | (R)-2,2′-Bis[bis(3,5-trifluoromethylphenyl)phosphino]-4,4′,6,6′-tetramethoxy)-1,1′-biphenyl | ESD-932689-250MG |
| Cas.: 1365531-84-5 | Purity: 98% | (R)-2,2′-Bis[bis(3,5-trifluoromethylphenyl)phosphino]-4,4′,6,6′-tetramethoxy)-1,1′-biphenyl | ESD-932689-1G |
| Cas.: 1644575-06-3 | Purity: 97% | Tert-butyl 10-bromodecanoate | ESD-932690-100MG |
| Cas.: 1644575-06-3 | Purity: 97% | Tert-butyl 10-bromodecanoate | ESD-932690-250MG |
| Cas.: 1644575-06-3 | Purity: 97% | Tert-butyl 10-bromodecanoate | ESD-932690-1G |
| Cas.: 110764-72-2 | Purity: 95% | N-(9-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-methoxytetrahydrofuran-2-yl)-9H-purin -6-yl)benzamide | ESD-932691-100MG |
| Cas.: 110764-72-2 | Purity: 95% | N-(9-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-methoxytetrahydrofuran-2-yl)-9H-purin -6-yl)benzamide | ESD-932691-250MG |
| Cas.: 110764-72-2 | Purity: 95% | N-(9-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-methoxytetrahydrofuran-2-yl)-9H-purin -6-yl)benzamide | ESD-932691-1G |
| Cas.: 16150-44-0 | Purity: 95% | 1,1′-(((2-Hydroxypropane-1,3-diyl)bis(oxy))bis(2-hydroxy-6,1-phenylene))diethanone | ESD-932692-100MG |
| Cas.: 16150-44-0 | Purity: 95% | 1,1′-(((2-Hydroxypropane-1,3-diyl)bis(oxy))bis(2-hydroxy-6,1-phenylene))diethanone | ESD-932692-250MG |
| Cas.: 16150-44-0 | Purity: 95% | 1,1′-(((2-Hydroxypropane-1,3-diyl)bis(oxy))bis(2-hydroxy-6,1-phenylene))diethanone | ESD-932692-1G |
| Cas.: 64951-11-7 | Purity: 97% | Imidazo[1,2-a]pyrimidine-3-carboxylic acid | ESD-932693-100MG |
| Cas.: 64951-11-7 | Purity: 97% | Imidazo[1,2-a]pyrimidine-3-carboxylic acid | ESD-932693-250MG |
| Cas.: 64951-11-7 | Purity: 97% | Imidazo[1,2-a]pyrimidine-3-carboxylic acid | ESD-932693-1G |
| Cas.: 887471-69-4 | Purity: 95% | (2-Fluoro-6-methylphenyl)boronic acid | ESD-932694-100MG |
| Cas.: 887471-69-4 | Purity: 95% | (2-Fluoro-6-methylphenyl)boronic acid | ESD-932694-250MG |
| Cas.: 887471-69-4 | Purity: 95% | (2-Fluoro-6-methylphenyl)boronic acid | ESD-932694-1G |
| Cas.: 167859-41-8 | Purity: 97% | 4,4′-((4-Bromophenyl)azanediyl)dibenzaldehyde | ESD-932695-100MG |
| Cas.: 167859-41-8 | Purity: 97% | 4,4′-((4-Bromophenyl)azanediyl)dibenzaldehyde | ESD-932695-250MG |
| Cas.: 167859-41-8 | Purity: 97% | 4,4′-((4-Bromophenyl)azanediyl)dibenzaldehyde | ESD-932695-1G |
| Cas.: 741698-94-2 | Purity: ≥95% | 4-Bromo-3-isopropylbenzoic acid | ESD-932696-100MG |
| Cas.: 741698-94-2 | Purity: ≥95% | 4-Bromo-3-isopropylbenzoic acid | ESD-932696-250MG |
| Cas.: 741698-94-2 | Purity: ≥95% | 4-Bromo-3-isopropylbenzoic acid | ESD-932696-1G |
| Cas.: 146610-21-1 | Purity: 95% | (S)-2-((Tert-butoxycarbonyl)amino)-3-(1H-pyrrolo[2,3-b]pyridin-3-yl)propanoic acid | ESD-932697-100MG |
| Cas.: 146610-21-1 | Purity: 95% | (S)-2-((Tert-butoxycarbonyl)amino)-3-(1H-pyrrolo[2,3-b]pyridin-3-yl)propanoic acid | ESD-932697-250MG |
| Cas.: 146610-21-1 | Purity: 95% | (S)-2-((Tert-butoxycarbonyl)amino)-3-(1H-pyrrolo[2,3-b]pyridin-3-yl)propanoic acid | ESD-932697-1G |
| Cas.: 874792-20-8 | Purity: 98% | 6-Bromo-4-methoxyquinoline | ESD-932698-100MG |
| Cas.: 874792-20-8 | Purity: 98% | 6-Bromo-4-methoxyquinoline | ESD-932698-250MG |
| Cas.: 874792-20-8 | Purity: 98% | 6-Bromo-4-methoxyquinoline | ESD-932698-1G |
| Cas.: 1035690-24-4 | Purity: 95% | 3-Cyclopropoxyphenylboronic acid pinacol ester | ESD-932699-100MG |
| Cas.: 1035690-24-4 | Purity: 95% | 3-Cyclopropoxyphenylboronic acid pinacol ester | ESD-932699-250MG |
| Cas.: 1035690-24-4 | Purity: 95% | 3-Cyclopropoxyphenylboronic acid pinacol ester | ESD-932699-1G |
| Cas.: 26118-14-9 | Purity: 95% | 2-(2-Chlorophenyl)-2-oxoacetic acid | ESD-932700-100MG |
| Cas.: 26118-14-9 | Purity: 95% | 2-(2-Chlorophenyl)-2-oxoacetic acid | ESD-932700-250MG |
| Cas.: 26118-14-9 | Purity: 95% | 2-(2-Chlorophenyl)-2-oxoacetic acid | ESD-932700-1G |
| Cas.: 939758-78-8 | Purity: 95% | 5,7-Difluoro-1,2,3,4-tetrahydroquinoline | ESD-932701-100MG |
| Cas.: 939758-78-8 | Purity: 95% | 5,7-Difluoro-1,2,3,4-tetrahydroquinoline | ESD-932701-250MG |
| Cas.: 939758-78-8 | Purity: 95% | 5,7-Difluoro-1,2,3,4-tetrahydroquinoline | ESD-932701-1G |
| Cas.: 20383-28-2 | Purity: 95% | N,N-Diisopropylbenzamide | ESD-932702-100MG |
| Cas.: 20383-28-2 | Purity: 95% | N,N-Diisopropylbenzamide | ESD-932702-250MG |
| Cas.: 20383-28-2 | Purity: 95% | N,N-Diisopropylbenzamide | ESD-932702-1G |
| Cas.: 23046-03-9 | Purity: 95% | 5,6-Dimethoxybenzo[b]thiophene-2-carboxylic acid | ESD-932703-100MG |
| Cas.: 23046-03-9 | Purity: 95% | 5,6-Dimethoxybenzo[b]thiophene-2-carboxylic acid | ESD-932703-250MG |
| Cas.: 23046-03-9 | Purity: 95% | 5,6-Dimethoxybenzo[b]thiophene-2-carboxylic acid | ESD-932703-1G |
| Cas.: 10199-53-8 | Purity: 96% | 1-Methyl-5-phenyl-1H-pyrazole-3-carboxylic acid | ESD-932704-100MG |
| Cas.: 10199-53-8 | Purity: 96% | 1-Methyl-5-phenyl-1H-pyrazole-3-carboxylic acid | ESD-932704-250MG |
| Cas.: 10199-53-8 | Purity: 96% | 1-Methyl-5-phenyl-1H-pyrazole-3-carboxylic acid | ESD-932704-1G |
| Cas.: 62516-08-9 | Purity: 95% | 5-Bromo-2-methyl-4-nitropyridine 1-oxide | ESD-932705-100MG |
| Cas.: 62516-08-9 | Purity: 95% | 5-Bromo-2-methyl-4-nitropyridine 1-oxide | ESD-932705-250MG |
| Cas.: 62516-08-9 | Purity: 95% | 5-Bromo-2-methyl-4-nitropyridine 1-oxide | ESD-932705-1G |
| Cas.: 213382-45-7 | Purity: 95% | 5-Bromo-4-fluoro-2-nitrobenzaldehyde | ESD-932706-100MG |
| Cas.: 213382-45-7 | Purity: 95% | 5-Bromo-4-fluoro-2-nitrobenzaldehyde | ESD-932706-250MG |
| Cas.: 213382-45-7 | Purity: 95% | 5-Bromo-4-fluoro-2-nitrobenzaldehyde | ESD-932706-1G |
| Cas.: 1430837-91-4 | Purity: 98% | 4-(1,3,5-Triaza-7-phosphaadamantan-1-ium-1-yl)butane-1-sulfonate | ESD-932707-100MG |
| Cas.: 1430837-91-4 | Purity: 98% | 4-(1,3,5-Triaza-7-phosphaadamantan-1-ium-1-yl)butane-1-sulfonate | ESD-932707-250MG |
| Cas.: 1430837-91-4 | Purity: 98% | 4-(1,3,5-Triaza-7-phosphaadamantan-1-ium-1-yl)butane-1-sulfonate | ESD-932707-1G |
| Cas.: 365432-21-9 | Purity: 95% | 4-Chloro-N-methylbutan-1-amine hydrochloride | ESD-932708-100MG |
| Cas.: 365432-21-9 | Purity: 95% | 4-Chloro-N-methylbutan-1-amine hydrochloride | ESD-932708-250MG |
| Cas.: 365432-21-9 | Purity: 95% | 4-Chloro-N-methylbutan-1-amine hydrochloride | ESD-932708-1G |
| Cas.: 873450-61-4 | Purity: 98% | Ethyl 4,6-dichloropicolinate | ESD-932709-100MG |
| Cas.: 873450-61-4 | Purity: 98% | Ethyl 4,6-dichloropicolinate | ESD-932709-250MG |
| Cas.: 873450-61-4 | Purity: 98% | Ethyl 4,6-dichloropicolinate | ESD-932709-1G |
| Cas.: 871723-37-4 | Purity: 95% | 4-Chloro-2,3-dihydroisoindol-1-one | ESD-932710-100MG |
| Cas.: 871723-37-4 | Purity: 95% | 4-Chloro-2,3-dihydroisoindol-1-one | ESD-932710-250MG |
| Cas.: 871723-37-4 | Purity: 95% | 4-Chloro-2,3-dihydroisoindol-1-one | ESD-932710-1G |
| Cas.: 166964-09-6 | Purity: 98% | 4-Chloro-3-methylisoxazol-5-amine | ESD-932711-100MG |
| Cas.: 166964-09-6 | Purity: 98% | 4-Chloro-3-methylisoxazol-5-amine | ESD-932711-250MG |
| Cas.: 166964-09-6 | Purity: 98% | 4-Chloro-3-methylisoxazol-5-amine | ESD-932711-1G |
| Cas.: 494833-75-9 | Purity: 97% | 2-Bromo-4-(N-tert-butyloxycarbonylamino)thiophene | ESD-932712-100MG |
| Cas.: 494833-75-9 | Purity: 97% | 2-Bromo-4-(N-tert-butyloxycarbonylamino)thiophene | ESD-932712-250MG |
| Cas.: 494833-75-9 | Purity: 97% | 2-Bromo-4-(N-tert-butyloxycarbonylamino)thiophene | ESD-932712-1G |
| Cas.: 23519-90-6 | Purity: 95% | Cyclobut-1-enecarboxylic acid | ESD-932713-100MG |
| Cas.: 23519-90-6 | Purity: 95% | Cyclobut-1-enecarboxylic acid | ESD-932713-250MG |
| Cas.: 23519-90-6 | Purity: 95% | Cyclobut-1-enecarboxylic acid | ESD-932713-1G |
| Cas.: 1248548-23-3 | Purity: 95% | Methyl 2-(1-methyl-1H-pyrazol-4-yl)acetate | ESD-932714-100MG |
| Cas.: 1248548-23-3 | Purity: 95% | Methyl 2-(1-methyl-1H-pyrazol-4-yl)acetate | ESD-932714-250MG |
| Cas.: 1248548-23-3 | Purity: 95% | Methyl 2-(1-methyl-1H-pyrazol-4-yl)acetate | ESD-932714-1G |
| Cas.: 609783-45-1 | Purity: 97% | 4-Amino-2-fluorobenzamide | ESD-932715-100MG |
| Cas.: 609783-45-1 | Purity: 97% | 4-Amino-2-fluorobenzamide | ESD-932715-250MG |
| Cas.: 609783-45-1 | Purity: 97% | 4-Amino-2-fluorobenzamide | ESD-932715-1G |
| Cas.: 2458125-05-6 | Purity: 97% | 4′,5′-Bis(4-aminophenyl)-[1,1′:2′,1”-terphenyl]-4,4”-diamine | ESD-932716-100MG |
| Cas.: 2458125-05-6 | Purity: 97% | 4′,5′-Bis(4-aminophenyl)-[1,1′:2′,1”-terphenyl]-4,4”-diamine | ESD-932716-250MG |
| Cas.: 2458125-05-6 | Purity: 97% | 4′,5′-Bis(4-aminophenyl)-[1,1′:2′,1”-terphenyl]-4,4”-diamine | ESD-932716-1G |
| Cas.: 133604-58-7 | Purity: 95% | 2,5,8,11,14,17,20,23,26,29,32,35,38,41,44,47-Hexadecaoxanonatetracontan-49-ol | ESD-932717-100MG |
| Cas.: 133604-58-7 | Purity: 95% | 2,5,8,11,14,17,20,23,26,29,32,35,38,41,44,47-Hexadecaoxanonatetracontan-49-ol | ESD-932717-250MG |
| Cas.: 133604-58-7 | Purity: 95% | 2,5,8,11,14,17,20,23,26,29,32,35,38,41,44,47-Hexadecaoxanonatetracontan-49-ol | ESD-932717-1G |
| Cas.: 875-30-9 | Purity: 95% | 1,3-Dimethyl-1H-indole | ESD-932718-100MG |
| Cas.: 875-30-9 | Purity: 95% | 1,3-Dimethyl-1H-indole | ESD-932718-250MG |
| Cas.: 875-30-9 | Purity: 95% | 1,3-Dimethyl-1H-indole | ESD-932718-1G |
| Cas.: 862893-80-9 | Purity: 97% | 2-Mesiyl-6,7-dihydro-5H-pyrrolo[2,1-c][1,2,4]triazol-2-ium tetrafluoroborate | ESD-932719-100MG |
| Cas.: 862893-80-9 | Purity: 97% | 2-Mesiyl-6,7-dihydro-5H-pyrrolo[2,1-c][1,2,4]triazol-2-ium tetrafluoroborate | ESD-932719-250MG |
| Cas.: 862893-80-9 | Purity: 97% | 2-Mesiyl-6,7-dihydro-5H-pyrrolo[2,1-c][1,2,4]triazol-2-ium tetrafluoroborate | ESD-932719-1G |
| Cas.: 1253282-31-3 | Purity: 98%(mix2%EA) | N-[(9H-Fluoren-9-ylMethoxy)carbonyl]-4-[[[(4S)-hexahydro-2,6-dioxo-4-pyriMidinyl]carbonyl]aMino]-L-phenylalanine | ESD-932720-100MG |
| Cas.: 1253282-31-3 | Purity: 98%(mix2%EA) | N-[(9H-Fluoren-9-ylMethoxy)carbonyl]-4-[[[(4S)-hexahydro-2,6-dioxo-4-pyriMidinyl]carbonyl]aMino]-L-phenylalanine | ESD-932720-250MG |
| Cas.: 1253282-31-3 | Purity: 98%(mix2%EA) | N-[(9H-Fluoren-9-ylMethoxy)carbonyl]-4-[[[(4S)-hexahydro-2,6-dioxo-4-pyriMidinyl]carbonyl]aMino]-L-phenylalanine | ESD-932720-1G |
| Cas.: 90778-25-9 | Purity: 98% | 3-Amino-5-(trifluoromethyl)pyridin-2-ol | ESD-932721-100MG |
| Cas.: 90778-25-9 | Purity: 98% | 3-Amino-5-(trifluoromethyl)pyridin-2-ol | ESD-932721-250MG |
| Cas.: 90778-25-9 | Purity: 98% | 3-Amino-5-(trifluoromethyl)pyridin-2-ol | ESD-932721-1G |
| Cas.: 1246372-66-6 | Purity: 98% | 2-Amino-3-cyanopyridine-5-boronic Acid Pinacol Ester | ESD-932722-100MG |
| Cas.: 1246372-66-6 | Purity: 98% | 2-Amino-3-cyanopyridine-5-boronic Acid Pinacol Ester | ESD-932722-250MG |
| Cas.: 1246372-66-6 | Purity: 98% | 2-Amino-3-cyanopyridine-5-boronic Acid Pinacol Ester | ESD-932722-1G |
| Cas.: 24623-25-4 | Purity: 97% | 4-Nitroindan-1-one | ESD-932723-100MG |
| Cas.: 24623-25-4 | Purity: 97% | 4-Nitroindan-1-one | ESD-932723-250MG |
| Cas.: 24623-25-4 | Purity: 97% | 4-Nitroindan-1-one | ESD-932723-1G |
| Cas.: 1384972-86-4 | Purity: 95% | 5-(Bromomethyl)pyridin-3-amine hydrobromide | ESD-932724-100MG |
| Cas.: 1384972-86-4 | Purity: 95% | 5-(Bromomethyl)pyridin-3-amine hydrobromide | ESD-932724-250MG |
| Cas.: 1384972-86-4 | Purity: 95% | 5-(Bromomethyl)pyridin-3-amine hydrobromide | ESD-932724-1G |
| Cas.: 2092807-41-3 | Purity: 95% | 6,8-Dichloro-[1,2,4]triazolo[1,5-a]pyrazine | ESD-932725-100MG |
| Cas.: 2092807-41-3 | Purity: 95% | 6,8-Dichloro-[1,2,4]triazolo[1,5-a]pyrazine | ESD-932725-250MG |
| Cas.: 2092807-41-3 | Purity: 95% | 6,8-Dichloro-[1,2,4]triazolo[1,5-a]pyrazine | ESD-932725-1G |
| Cas.: 1338454-03-7 | Purity: 97% | (R)-3-(Tert-butyl)-4-(2,6-dimethoxyphenyl)-2,3-dihydrobenzo[d][1,3]oxaphosphole | ESD-932726-100MG |
| Cas.: 1338454-03-7 | Purity: 97% | (R)-3-(Tert-butyl)-4-(2,6-dimethoxyphenyl)-2,3-dihydrobenzo[d][1,3]oxaphosphole | ESD-932726-250MG |
| Cas.: 1338454-03-7 | Purity: 97% | (R)-3-(Tert-butyl)-4-(2,6-dimethoxyphenyl)-2,3-dihydrobenzo[d][1,3]oxaphosphole | ESD-932726-1G |
| Cas.: 1261478-26-5 | Purity: 97% | Methyl 2-hydroxy-5-(trifluoromethyl)benzoate | ESD-932727-100MG |
| Cas.: 1261478-26-5 | Purity: 97% | Methyl 2-hydroxy-5-(trifluoromethyl)benzoate | ESD-932727-250MG |
| Cas.: 1261478-26-5 | Purity: 97% | Methyl 2-hydroxy-5-(trifluoromethyl)benzoate | ESD-932727-1G |
| Cas.: 1368855-13-3 | Purity: 97% | 1-(2-Methoxyethyl)-1H-imidazole-4-carboxylic acid | ESD-932728-100MG |
| Cas.: 1368855-13-3 | Purity: 97% | 1-(2-Methoxyethyl)-1H-imidazole-4-carboxylic acid | ESD-932728-250MG |
| Cas.: 1368855-13-3 | Purity: 97% | 1-(2-Methoxyethyl)-1H-imidazole-4-carboxylic acid | ESD-932728-1G |
| Cas.: 1275612-13-9 | Purity: 97% | (S)-3-Amino-6-(tert-butoxy)-6-oxohexanoic acid | ESD-932729-100MG |
| Cas.: 1275612-13-9 | Purity: 97% | (S)-3-Amino-6-(tert-butoxy)-6-oxohexanoic acid | ESD-932729-250MG |
| Cas.: 1275612-13-9 | Purity: 97% | (S)-3-Amino-6-(tert-butoxy)-6-oxohexanoic acid | ESD-932729-1G |
| Cas.: 21419-24-9 | Purity: 95% | 3-Aminobutan-2-one hydrochloride | ESD-932730-100MG |
| Cas.: 21419-24-9 | Purity: 95% | 3-Aminobutan-2-one hydrochloride | ESD-932730-250MG |
| Cas.: 21419-24-9 | Purity: 95% | 3-Aminobutan-2-one hydrochloride | ESD-932730-1G |
| Cas.: 1218790-22-7 | Purity: 97% | 4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)naphthalen-1-amine | ESD-932731-100MG |
| Cas.: 1218790-22-7 | Purity: 97% | 4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)naphthalen-1-amine | ESD-932731-250MG |
| Cas.: 1218790-22-7 | Purity: 97% | 4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)naphthalen-1-amine | ESD-932731-1G |
| Cas.: 1373223-84-7 | Purity: 95% | 4-(Bromomethyl)pyrimidine hydrobromide | ESD-932732-100MG |
| Cas.: 1373223-84-7 | Purity: 95% | 4-(Bromomethyl)pyrimidine hydrobromide | ESD-932732-250MG |
| Cas.: 1373223-84-7 | Purity: 95% | 4-(Bromomethyl)pyrimidine hydrobromide | ESD-932732-1G |
| Cas.: 701907-44-0 | Purity: 98% | (S)-3-Amino-3-(m-tolyl)propanoic acid | ESD-932733-100MG |
| Cas.: 701907-44-0 | Purity: 98% | (S)-3-Amino-3-(m-tolyl)propanoic acid | ESD-932733-250MG |
| Cas.: 701907-44-0 | Purity: 98% | (S)-3-Amino-3-(m-tolyl)propanoic acid | ESD-932733-1G |
| Cas.: 120511-92-4 | Purity: 97% | 2,2′-(5-((4H-1,2,4-Triazol-4-yl)methyl)-1,3-phenylene)bis(2-methylpropanenitrile) | ESD-932734-100MG |
| Cas.: 120511-92-4 | Purity: 97% | 2,2′-(5-((4H-1,2,4-Triazol-4-yl)methyl)-1,3-phenylene)bis(2-methylpropanenitrile) | ESD-932734-250MG |
| Cas.: 120511-92-4 | Purity: 97% | 2,2′-(5-((4H-1,2,4-Triazol-4-yl)methyl)-1,3-phenylene)bis(2-methylpropanenitrile) | ESD-932734-1G |
| Cas.: 16600-22-9 | Purity: 95% | Ethyl 7-chloro-4-hydroxyquinoline-3-carboxylate | ESD-932735-100MG |
| Cas.: 16600-22-9 | Purity: 95% | Ethyl 7-chloro-4-hydroxyquinoline-3-carboxylate | ESD-932735-250MG |
| Cas.: 16600-22-9 | Purity: 95% | Ethyl 7-chloro-4-hydroxyquinoline-3-carboxylate | ESD-932735-1G |
| Cas.: 50427-77-5 | Purity: ≥95% | 5-Amino-1-phenyl-1H-pyrazole-4-carboxamide | ESD-932736-100MG |
| Cas.: 50427-77-5 | Purity: ≥95% | 5-Amino-1-phenyl-1H-pyrazole-4-carboxamide | ESD-932736-250MG |
| Cas.: 50427-77-5 | Purity: ≥95% | 5-Amino-1-phenyl-1H-pyrazole-4-carboxamide | ESD-932736-1G |
| Cas.: 60843-63-2 | Purity: 97% | N-Methyl-1-(quinolin-8-yl)methanamine | ESD-932737-100MG |
| Cas.: 60843-63-2 | Purity: 97% | N-Methyl-1-(quinolin-8-yl)methanamine | ESD-932737-250MG |
| Cas.: 60843-63-2 | Purity: 97% | N-Methyl-1-(quinolin-8-yl)methanamine | ESD-932737-1G |
| Cas.: 603130-12-7 | Purity: 98% | Tert-butyl ((3R,6S)-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)carbamate | ESD-932738-100MG |
| Cas.: 603130-12-7 | Purity: 98% | Tert-butyl ((3R,6S)-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)carbamate | ESD-932738-250MG |
| Cas.: 603130-12-7 | Purity: 98% | Tert-butyl ((3R,6S)-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)carbamate | ESD-932738-1G |
| Cas.: 610275-82-6 | Purity: 95% | 4-(2-Aminothiazol-4-yl)-N,N-dimethylbenzenesulfonamide | ESD-932739-100MG |
| Cas.: 610275-82-6 | Purity: 95% | 4-(2-Aminothiazol-4-yl)-N,N-dimethylbenzenesulfonamide | ESD-932739-250MG |
| Cas.: 610275-82-6 | Purity: 95% | 4-(2-Aminothiazol-4-yl)-N,N-dimethylbenzenesulfonamide | ESD-932739-1G |
| Cas.: 142547-15-7 | Purity: ≥98% | (1R,2S)-rel-Ethyl 2-aminocyclopentanecarboxylate hydrochloride | ESD-932740-100MG |
| Cas.: 142547-15-7 | Purity: ≥98% | (1R,2S)-rel-Ethyl 2-aminocyclopentanecarboxylate hydrochloride | ESD-932740-250MG |
| Cas.: 142547-15-7 | Purity: ≥98% | (1R,2S)-rel-Ethyl 2-aminocyclopentanecarboxylate hydrochloride | ESD-932740-1G |
| Cas.: 2043962-01-0 | Purity: 95% | 4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)naphthalen-2-ol | ESD-932741-100MG |
| Cas.: 2043962-01-0 | Purity: 95% | 4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)naphthalen-2-ol | ESD-932741-250MG |
| Cas.: 2043962-01-0 | Purity: 95% | 4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)naphthalen-2-ol | ESD-932741-1G |
| Cas.: 612-76-0 | Purity: 95% | [1,1′-Biphenyl]-3,3′-diol | ESD-932742-100MG |
| Cas.: 612-76-0 | Purity: 95% | [1,1′-Biphenyl]-3,3′-diol | ESD-932742-250MG |
| Cas.: 612-76-0 | Purity: 95% | [1,1′-Biphenyl]-3,3′-diol | ESD-932742-1G |
| Cas.: 65399-02-2 | Purity: 95% | 7-Methylisoindolin-1-one | ESD-932743-100MG |
| Cas.: 65399-02-2 | Purity: 95% | 7-Methylisoindolin-1-one | ESD-932743-250MG |
| Cas.: 65399-02-2 | Purity: 95% | 7-Methylisoindolin-1-one | ESD-932743-1G |
| Cas.: 13588-28-8 | Purity: 97% | 2-(2-Methoxypropoxy)propan-1-ol | ESD-932744-100MG |
| Cas.: 13588-28-8 | Purity: 97% | 2-(2-Methoxypropoxy)propan-1-ol | ESD-932744-250MG |
| Cas.: 13588-28-8 | Purity: 97% | 2-(2-Methoxypropoxy)propan-1-ol | ESD-932744-1G |
| Cas.: 868403-91-2 | Purity: 97% | 4′,4”’-(Thiophene-2,5-diyl)bis(([1,1′-biphenyl]-4-carbonitrile)) | ESD-932745-100MG |
| Cas.: 868403-91-2 | Purity: 97% | 4′,4”’-(Thiophene-2,5-diyl)bis(([1,1′-biphenyl]-4-carbonitrile)) | ESD-932745-250MG |
| Cas.: 868403-91-2 | Purity: 97% | 4′,4”’-(Thiophene-2,5-diyl)bis(([1,1′-biphenyl]-4-carbonitrile)) | ESD-932745-1G |
| Cas.: 29333-41-3 | Purity: 97% | Methyl 3,5-bis(bromomethyl)benzoate | ESD-932746-100MG |
| Cas.: 29333-41-3 | Purity: 97% | Methyl 3,5-bis(bromomethyl)benzoate | ESD-932746-250MG |
| Cas.: 29333-41-3 | Purity: 97% | Methyl 3,5-bis(bromomethyl)benzoate | ESD-932746-1G |
| Cas.: 1228943-80-3 | Purity: 97% | 2-Chloro-4,4-dimethylcyclohex-1-enecarbaldehyde | ESD-932747-100MG |
| Cas.: 1228943-80-3 | Purity: 97% | 2-Chloro-4,4-dimethylcyclohex-1-enecarbaldehyde | ESD-932747-250MG |
| Cas.: 1228943-80-3 | Purity: 97% | 2-Chloro-4,4-dimethylcyclohex-1-enecarbaldehyde | ESD-932747-1G |
| Cas.: 7315-32-4 | Purity: 95% blend (TBC as stabilizer) | 5-Vinylbenzo[d][1,3]dioxole | ESD-932748-100MG |
| Cas.: 7315-32-4 | Purity: 95% blend (TBC as stabilizer) | 5-Vinylbenzo[d][1,3]dioxole | ESD-932748-250MG |
| Cas.: 7315-32-4 | Purity: 95% blend (TBC as stabilizer) | 5-Vinylbenzo[d][1,3]dioxole | ESD-932748-1G |
| Cas.: 932033-58-4 | Purity: ≥95% | [2,2′-Binaphthalene]-6,6′-dicarboxylic acid | ESD-932749-100MG |
| Cas.: 932033-58-4 | Purity: ≥95% | [2,2′-Binaphthalene]-6,6′-dicarboxylic acid | ESD-932749-250MG |
| Cas.: 932033-58-4 | Purity: ≥95% | [2,2′-Binaphthalene]-6,6′-dicarboxylic acid | ESD-932749-1G |
| Cas.: 1144-36-1 | Purity: 95% | 4,4-Dibromo-2,6-di-tert-butylcyclohexa-2,5-dienone | ESD-932750-100MG |
| Cas.: 1144-36-1 | Purity: 95% | 4,4-Dibromo-2,6-di-tert-butylcyclohexa-2,5-dienone | ESD-932750-250MG |
| Cas.: 1144-36-1 | Purity: 95% | 4,4-Dibromo-2,6-di-tert-butylcyclohexa-2,5-dienone | ESD-932750-1G |
| Cas.: 1355248-05-3 | Purity: 98% | 1-(4-Formylphenyl)azetidine-3-carboxylic acid | ESD-932751-100MG |
| Cas.: 1355248-05-3 | Purity: 98% | 1-(4-Formylphenyl)azetidine-3-carboxylic acid | ESD-932751-250MG |
| Cas.: 1355248-05-3 | Purity: 98% | 1-(4-Formylphenyl)azetidine-3-carboxylic acid | ESD-932751-1G |
| Cas.: 1206694-32-7 | Purity: 98% | 4-Chloro-7-fluoro-2-methylquinazoline | ESD-932752-100MG |
| Cas.: 1206694-32-7 | Purity: 98% | 4-Chloro-7-fluoro-2-methylquinazoline | ESD-932752-250MG |
| Cas.: 1206694-32-7 | Purity: 98% | 4-Chloro-7-fluoro-2-methylquinazoline | ESD-932752-1G |
| Cas.: 953075-90-6 | Purity: 97% | (2,6-Diethyl-4-methylphenyl)boronic acid | ESD-932753-100MG |
| Cas.: 953075-90-6 | Purity: 97% | (2,6-Diethyl-4-methylphenyl)boronic acid | ESD-932753-250MG |
| Cas.: 953075-90-6 | Purity: 97% | (2,6-Diethyl-4-methylphenyl)boronic acid | ESD-932753-1G |
| Cas.: 103441-60-7 | Purity: 98% | Methyl 2-iodo-3-methylbenzoate | ESD-932754-100MG |
| Cas.: 103441-60-7 | Purity: 98% | Methyl 2-iodo-3-methylbenzoate | ESD-932754-250MG |
| Cas.: 103441-60-7 | Purity: 98% | Methyl 2-iodo-3-methylbenzoate | ESD-932754-1G |
| Cas.: 948-03-8 | Purity: 95% | Methyl 1-hydroxy-2-naphthoate | ESD-932755-100MG |
| Cas.: 948-03-8 | Purity: 95% | Methyl 1-hydroxy-2-naphthoate | ESD-932755-250MG |
| Cas.: 948-03-8 | Purity: 95% | Methyl 1-hydroxy-2-naphthoate | ESD-932755-1G |
| Cas.: 23354-94-1 | Purity: 93% | 2-(4-(Thien-2-yl)phenyl)thiophene | ESD-932756-100MG |
| Cas.: 23354-94-1 | Purity: 93% | 2-(4-(Thien-2-yl)phenyl)thiophene | ESD-932756-250MG |
| Cas.: 23354-94-1 | Purity: 93% | 2-(4-(Thien-2-yl)phenyl)thiophene | ESD-932756-1G |
| Cas.: 120868-66-8 | Purity: 97% | 1-((6-Chloropyridin-3-yl)methyl)imidazolidin-2-one | ESD-932757-100MG |
| Cas.: 120868-66-8 | Purity: 97% | 1-((6-Chloropyridin-3-yl)methyl)imidazolidin-2-one | ESD-932757-250MG |
| Cas.: 120868-66-8 | Purity: 97% | 1-((6-Chloropyridin-3-yl)methyl)imidazolidin-2-one | ESD-932757-1G |
| Cas.: 13044-37-6 | Purity: 97% | (6Z,9Z)-18-Bromooctadeca-6,9-diene | ESD-932758-100MG |
| Cas.: 13044-37-6 | Purity: 97% | (6Z,9Z)-18-Bromooctadeca-6,9-diene | ESD-932758-250MG |
| Cas.: 13044-37-6 | Purity: 97% | (6Z,9Z)-18-Bromooctadeca-6,9-diene | ESD-932758-1G |
| Cas.: 42105-26-0 | Purity: 95% | But-3-yn-2-amine hydrochloride | ESD-932759-100MG |
| Cas.: 42105-26-0 | Purity: 95% | But-3-yn-2-amine hydrochloride | ESD-932759-250MG |
| Cas.: 42105-26-0 | Purity: 95% | But-3-yn-2-amine hydrochloride | ESD-932759-1G |
| Cas.: 175885-18-4 | Purity: 95% | 2-Methyl-2-propanyl (2-{2-[2-({5-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanoyl }amino)ethoxy]ethoxy}ethyl)carbamate | ESD-932760-100MG |
| Cas.: 175885-18-4 | Purity: 95% | 2-Methyl-2-propanyl (2-{2-[2-({5-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanoyl }amino)ethoxy]ethoxy}ethyl)carbamate | ESD-932760-250MG |
| Cas.: 175885-18-4 | Purity: 95% | 2-Methyl-2-propanyl (2-{2-[2-({5-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanoyl }amino)ethoxy]ethoxy}ethyl)carbamate | ESD-932760-1G |
| Cas.: 22132-97-4 | Purity: 98% | Imino(methyl)(4-methylphenyl)-lambda6-sulfanone | ESD-932761-100MG |
| Cas.: 22132-97-4 | Purity: 98% | Imino(methyl)(4-methylphenyl)-lambda6-sulfanone | ESD-932761-250MG |
| Cas.: 22132-97-4 | Purity: 98% | Imino(methyl)(4-methylphenyl)-lambda6-sulfanone | ESD-932761-1G |
| Cas.: 556-21-8 | Purity: 97% | 4-(Methylamino)benzaldehyde | ESD-932762-100MG |
| Cas.: 556-21-8 | Purity: 97% | 4-(Methylamino)benzaldehyde | ESD-932762-250MG |
| Cas.: 556-21-8 | Purity: 97% | 4-(Methylamino)benzaldehyde | ESD-932762-1G |
| Cas.: 129833-29-0 | Purity: 95% | 2-Amino-4-bromo-3-methylbenzoic acid | ESD-932763-100MG |
| Cas.: 129833-29-0 | Purity: 95% | 2-Amino-4-bromo-3-methylbenzoic acid | ESD-932763-250MG |
| Cas.: 129833-29-0 | Purity: 95% | 2-Amino-4-bromo-3-methylbenzoic acid | ESD-932763-1G |
| Cas.: 1053655-78-9 | Purity: ≥98% | 3-Bromo-4-methoxy-1H-pyrrolo[2,3-b]pyridine | ESD-932764-100MG |
| Cas.: 1053655-78-9 | Purity: ≥98% | 3-Bromo-4-methoxy-1H-pyrrolo[2,3-b]pyridine | ESD-932764-250MG |
| Cas.: 1053655-78-9 | Purity: ≥98% | 3-Bromo-4-methoxy-1H-pyrrolo[2,3-b]pyridine | ESD-932764-1G |
| Cas.: 933752-32-0 | Purity: 95% | 1,2,3,4-Tetrahydroisoquinoline-6-carboxylic acid | ESD-932765-100MG |
| Cas.: 933752-32-0 | Purity: 95% | 1,2,3,4-Tetrahydroisoquinoline-6-carboxylic acid | ESD-932765-250MG |
| Cas.: 933752-32-0 | Purity: 95% | 1,2,3,4-Tetrahydroisoquinoline-6-carboxylic acid | ESD-932765-1G |
| Cas.: 2101563-45-3 | Purity: 97% | FMOC-PEG10-CH2CH2COOH | ESD-932766-100MG |
| Cas.: 2101563-45-3 | Purity: 97% | FMOC-PEG10-CH2CH2COOH | ESD-932766-250MG |
| Cas.: 2101563-45-3 | Purity: 97% | FMOC-PEG10-CH2CH2COOH | ESD-932766-1G |
| Cas.: 253685-27-7 | Purity: 95% | (2R)-3-(((2-Aminoethoxy)(hydroxy)phosphoryl)oxy)propane-1,2-diyl bis(decanoate) | ESD-932767-100MG |
| Cas.: 253685-27-7 | Purity: 95% | (2R)-3-(((2-Aminoethoxy)(hydroxy)phosphoryl)oxy)propane-1,2-diyl bis(decanoate) | ESD-932767-250MG |
| Cas.: 253685-27-7 | Purity: 95% | (2R)-3-(((2-Aminoethoxy)(hydroxy)phosphoryl)oxy)propane-1,2-diyl bis(decanoate) | ESD-932767-1G |
| Cas.: 4086-73-1 | Purity: 97% | 1-Octylpyridin-1-ium chloride | ESD-932768-100MG |
| Cas.: 4086-73-1 | Purity: 97% | 1-Octylpyridin-1-ium chloride | ESD-932768-250MG |
| Cas.: 4086-73-1 | Purity: 97% | 1-Octylpyridin-1-ium chloride | ESD-932768-1G |
| Cas.: 52813-63-5 | Purity: 95% | (R)-5-(Hydroxymethyl)dihydrofuran-2(3H)-one | ESD-932769-100MG |
| Cas.: 52813-63-5 | Purity: 95% | (R)-5-(Hydroxymethyl)dihydrofuran-2(3H)-one | ESD-932769-250MG |
| Cas.: 52813-63-5 | Purity: 95% | (R)-5-(Hydroxymethyl)dihydrofuran-2(3H)-one | ESD-932769-1G |
| Cas.: 5538-41-0 | Purity: 95% | 2-Chloro-3,5-dimethylphenol | ESD-932770-100MG |
| Cas.: 5538-41-0 | Purity: 95% | 2-Chloro-3,5-dimethylphenol | ESD-932770-250MG |
| Cas.: 5538-41-0 | Purity: 95% | 2-Chloro-3,5-dimethylphenol | ESD-932770-1G |
| Cas.: 1869-45-0 | Purity: 96% | 2,2,2-Trifluoro-N-(2-mercaptoethyl)acetamide | ESD-932771-100MG |
| Cas.: 1869-45-0 | Purity: 96% | 2,2,2-Trifluoro-N-(2-mercaptoethyl)acetamide | ESD-932771-250MG |
| Cas.: 1869-45-0 | Purity: 96% | 2,2,2-Trifluoro-N-(2-mercaptoethyl)acetamide | ESD-932771-1G |
| Cas.: 56820-58-7 | Purity: 95% | 7-Chloronaphthalen-1-ol | ESD-932772-100MG |
| Cas.: 56820-58-7 | Purity: 95% | 7-Chloronaphthalen-1-ol | ESD-932772-250MG |
| Cas.: 56820-58-7 | Purity: 95% | 7-Chloronaphthalen-1-ol | ESD-932772-1G |
| Cas.: 365245-83-6 | Purity: 95% | (2-((Methylamino)methyl)phenyl)boronic acid | ESD-932773-100MG |
| Cas.: 365245-83-6 | Purity: 95% | (2-((Methylamino)methyl)phenyl)boronic acid | ESD-932773-250MG |
| Cas.: 365245-83-6 | Purity: 95% | (2-((Methylamino)methyl)phenyl)boronic acid | ESD-932773-1G |
| Cas.: 134464-79-2 | Purity: ≥98% | 4-Mercapto-piperidine-1-carboxylic acid tert-butyl ester | ESD-932774-100MG |
| Cas.: 134464-79-2 | Purity: ≥98% | 4-Mercapto-piperidine-1-carboxylic acid tert-butyl ester | ESD-932774-250MG |
| Cas.: 134464-79-2 | Purity: ≥98% | 4-Mercapto-piperidine-1-carboxylic acid tert-butyl ester | ESD-932774-1G |
| Cas.: 5439-08-7 | Purity: 98% | Methyl 3,5-dichloropicolinate | ESD-932775-100MG |
| Cas.: 5439-08-7 | Purity: 98% | Methyl 3,5-dichloropicolinate | ESD-932775-250MG |
| Cas.: 5439-08-7 | Purity: 98% | Methyl 3,5-dichloropicolinate | ESD-932775-1G |
| Cas.: 771555-21-6 | Purity: 96% | 2-Chloroquinolin-4-ol | ESD-932776-100MG |
| Cas.: 771555-21-6 | Purity: 96% | 2-Chloroquinolin-4-ol | ESD-932776-250MG |
| Cas.: 771555-21-6 | Purity: 96% | 2-Chloroquinolin-4-ol | ESD-932776-1G |
| Cas.: 31719-76-3 | Purity: ≥95% | 4-(Phenoxymethyl)benzoic acid | ESD-932777-100MG |
| Cas.: 31719-76-3 | Purity: ≥95% | 4-(Phenoxymethyl)benzoic acid | ESD-932777-250MG |
| Cas.: 31719-76-3 | Purity: ≥95% | 4-(Phenoxymethyl)benzoic acid | ESD-932777-1G |
| Cas.: 926307-72-4 | Purity: 96% | Methyl 1-oxoisoindoline-5-carboxylate | ESD-932778-100MG |
| Cas.: 926307-72-4 | Purity: 96% | Methyl 1-oxoisoindoline-5-carboxylate | ESD-932778-250MG |
| Cas.: 926307-72-4 | Purity: 96% | Methyl 1-oxoisoindoline-5-carboxylate | ESD-932778-1G |
| Cas.: 51839-16-8 | Purity: 97% | 5-Iodoisophthalic acid | ESD-932779-100MG |
| Cas.: 51839-16-8 | Purity: 97% | 5-Iodoisophthalic acid | ESD-932779-250MG |
| Cas.: 51839-16-8 | Purity: 97% | 5-Iodoisophthalic acid | ESD-932779-1G |
| Cas.: 122151-32-0 | Purity: 95% | (S)-2-(Benzyloxy)-1-(pyrrolidin-1-yl)propan-1-one | ESD-932780-100MG |
| Cas.: 122151-32-0 | Purity: 95% | (S)-2-(Benzyloxy)-1-(pyrrolidin-1-yl)propan-1-one | ESD-932780-250MG |
| Cas.: 122151-32-0 | Purity: 95% | (S)-2-(Benzyloxy)-1-(pyrrolidin-1-yl)propan-1-one | ESD-932780-1G |
| Cas.: 917024-58-9 | Purity: 95% | Methyl 3-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propanoate | ESD-932781-100MG |
| Cas.: 917024-58-9 | Purity: 95% | Methyl 3-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propanoate | ESD-932781-250MG |
| Cas.: 917024-58-9 | Purity: 95% | Methyl 3-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propanoate | ESD-932781-1G |
| Cas.: 2230887-26-8 | Purity: 98% | 4,4′,4”-(Pyridine-2,4,6-triyl)tribenzaldehyde | ESD-932782-100MG |
| Cas.: 2230887-26-8 | Purity: 98% | 4,4′,4”-(Pyridine-2,4,6-triyl)tribenzaldehyde | ESD-932782-250MG |
| Cas.: 2230887-26-8 | Purity: 98% | 4,4′,4”-(Pyridine-2,4,6-triyl)tribenzaldehyde | ESD-932782-1G |
| Cas.: 5326-87-4 | Purity: 97% | 2-Bromo-N-phenylacetamide | ESD-932783-100MG |
| Cas.: 5326-87-4 | Purity: 97% | 2-Bromo-N-phenylacetamide | ESD-932783-250MG |
| Cas.: 5326-87-4 | Purity: 97% | 2-Bromo-N-phenylacetamide | ESD-932783-1G |
| Cas.: 509143-00-4 | Purity: 98% | Tert-butyl (cis-4-(aminomethyl)cyclohexyl)carbamate | ESD-932784-100MG |
| Cas.: 509143-00-4 | Purity: 98% | Tert-butyl (cis-4-(aminomethyl)cyclohexyl)carbamate | ESD-932784-250MG |
| Cas.: 509143-00-4 | Purity: 98% | Tert-butyl (cis-4-(aminomethyl)cyclohexyl)carbamate | ESD-932784-1G |
| Cas.: 164323-85-7 | Purity: 96% | (R)-Methyl piperidine-3-carboxylate | ESD-932785-100MG |
| Cas.: 164323-85-7 | Purity: 96% | (R)-Methyl piperidine-3-carboxylate | ESD-932785-250MG |
| Cas.: 164323-85-7 | Purity: 96% | (R)-Methyl piperidine-3-carboxylate | ESD-932785-1G |
| Cas.: 884494-66-0 | Purity: 95% | 2-Ethyl 5-methyl 1H-indole-2,5-dicarboxylate | ESD-932786-100MG |
| Cas.: 884494-66-0 | Purity: 95% | 2-Ethyl 5-methyl 1H-indole-2,5-dicarboxylate | ESD-932786-250MG |
| Cas.: 884494-66-0 | Purity: 95% | 2-Ethyl 5-methyl 1H-indole-2,5-dicarboxylate | ESD-932786-1G |
| Cas.: 5427-93-0 | Purity: 95% | 4-Bromo-2-phenylquinoline | ESD-932787-100MG |
| Cas.: 5427-93-0 | Purity: 95% | 4-Bromo-2-phenylquinoline | ESD-932787-250MG |
| Cas.: 5427-93-0 | Purity: 95% | 4-Bromo-2-phenylquinoline | ESD-932787-1G |
| Cas.: 4649-12-1 | Purity: 98% | 2-(1H-Pyrrolo[2,3-b]pyridin-3-yl)ethanamine | ESD-932788-100MG |
| Cas.: 4649-12-1 | Purity: 98% | 2-(1H-Pyrrolo[2,3-b]pyridin-3-yl)ethanamine | ESD-932788-250MG |
| Cas.: 4649-12-1 | Purity: 98% | 2-(1H-Pyrrolo[2,3-b]pyridin-3-yl)ethanamine | ESD-932788-1G |
| Cas.: 18065-04-8 | Purity: 95% | 2-(2-Methoxyphenoxy)-1-phenylethanol | ESD-932789-100MG |
| Cas.: 18065-04-8 | Purity: 95% | 2-(2-Methoxyphenoxy)-1-phenylethanol | ESD-932789-250MG |
| Cas.: 18065-04-8 | Purity: 95% | 2-(2-Methoxyphenoxy)-1-phenylethanol | ESD-932789-1G |
| Cas.: 18951-85-4 | Purity: 98% | (R)-3,7-Dimethyloct-6-enoic acid | ESD-932790-100MG |
| Cas.: 18951-85-4 | Purity: 98% | (R)-3,7-Dimethyloct-6-enoic acid | ESD-932790-250MG |
| Cas.: 18951-85-4 | Purity: 98% | (R)-3,7-Dimethyloct-6-enoic acid | ESD-932790-1G |
| Cas.: 13005-11-3 | Purity: 97% | (1-Methylpyrrolidin-3-yl)methanamine | ESD-932791-100MG |
| Cas.: 13005-11-3 | Purity: 97% | (1-Methylpyrrolidin-3-yl)methanamine | ESD-932791-250MG |
| Cas.: 13005-11-3 | Purity: 97% | (1-Methylpyrrolidin-3-yl)methanamine | ESD-932791-1G |
| Cas.: 1373253-25-8 | Purity: 97% | 2-Bromooxazole-5-carboxylic acid | ESD-932792-100MG |
| Cas.: 1373253-25-8 | Purity: 97% | 2-Bromooxazole-5-carboxylic acid | ESD-932792-250MG |
| Cas.: 1373253-25-8 | Purity: 97% | 2-Bromooxazole-5-carboxylic acid | ESD-932792-1G |
| Cas.: 57825-30-6 | Purity: 95% | 1-(Bromomethyl)-4-ethylbenzene | ESD-932793-100MG |
| Cas.: 57825-30-6 | Purity: 95% | 1-(Bromomethyl)-4-ethylbenzene | ESD-932793-250MG |
| Cas.: 57825-30-6 | Purity: 95% | 1-(Bromomethyl)-4-ethylbenzene | ESD-932793-1G |
| Cas.: 2169-25-7 | Purity: 95% | Methyl 3-hydroxy-2-methoxybenzoate | ESD-932794-100MG |
| Cas.: 2169-25-7 | Purity: 95% | Methyl 3-hydroxy-2-methoxybenzoate | ESD-932794-250MG |
| Cas.: 2169-25-7 | Purity: 95% | Methyl 3-hydroxy-2-methoxybenzoate | ESD-932794-1G |
| Cas.: 89269-64-7 | Purity: 95% | (Z)-4,6-Dimethyl-2-(2-(1-(o-tolyl)ethylidene)hydrazinyl)pyrimidine | ESD-932795-100MG |
| Cas.: 89269-64-7 | Purity: 95% | (Z)-4,6-Dimethyl-2-(2-(1-(o-tolyl)ethylidene)hydrazinyl)pyrimidine | ESD-932795-250MG |
| Cas.: 89269-64-7 | Purity: 95% | (Z)-4,6-Dimethyl-2-(2-(1-(o-tolyl)ethylidene)hydrazinyl)pyrimidine | ESD-932795-1G |
| Cas.: 1908-61-8 | Purity: 98% | 4-Bromo[2.2]paracyclophane | ESD-932796-100MG |
| Cas.: 1908-61-8 | Purity: 98% | 4-Bromo[2.2]paracyclophane | ESD-932796-250MG |
| Cas.: 1908-61-8 | Purity: 98% | 4-Bromo[2.2]paracyclophane | ESD-932796-1G |
| Cas.: 764-37-4 | Purity: 98% | (E)-Pent-3-en-1-ol | ESD-932797-100MG |
| Cas.: 764-37-4 | Purity: 98% | (E)-Pent-3-en-1-ol | ESD-932797-250MG |
| Cas.: 764-37-4 | Purity: 98% | (E)-Pent-3-en-1-ol | ESD-932797-1G |
| Cas.: 5227-53-2 | Purity: 95% | Azepane-2-carboxylic acid | ESD-932798-100MG |
| Cas.: 5227-53-2 | Purity: 95% | Azepane-2-carboxylic acid | ESD-932798-250MG |
| Cas.: 5227-53-2 | Purity: 95% | Azepane-2-carboxylic acid | ESD-932798-1G |
| Cas.: 1130156-23-8 | Purity: 95% | Tert-butyl 3-hydroxy-4-oxopiperidine-1-carboxylate | ESD-932799-100MG |
| Cas.: 1130156-23-8 | Purity: 95% | Tert-butyl 3-hydroxy-4-oxopiperidine-1-carboxylate | ESD-932799-250MG |
| Cas.: 1130156-23-8 | Purity: 95% | Tert-butyl 3-hydroxy-4-oxopiperidine-1-carboxylate | ESD-932799-1G |
| Cas.: 5459-50-7 | Purity: 97% | 2-Iodo-5-nitroaniline | ESD-932800-100MG |
| Cas.: 5459-50-7 | Purity: 97% | 2-Iodo-5-nitroaniline | ESD-932800-250MG |
| Cas.: 5459-50-7 | Purity: 97% | 2-Iodo-5-nitroaniline | ESD-932800-1G |
| Cas.: 1445-15-4 | Purity: 95% | 2-(Dimethylamino)-7H-purin-6-ol | ESD-932801-100MG |
| Cas.: 1445-15-4 | Purity: 95% | 2-(Dimethylamino)-7H-purin-6-ol | ESD-932801-250MG |
| Cas.: 1445-15-4 | Purity: 95% | 2-(Dimethylamino)-7H-purin-6-ol | ESD-932801-1G |
| Cas.: 34535-98-3 | Purity: 95% | N-Cyclopropylaniline | ESD-932802-100MG |
| Cas.: 34535-98-3 | Purity: 95% | N-Cyclopropylaniline | ESD-932802-250MG |
| Cas.: 34535-98-3 | Purity: 95% | N-Cyclopropylaniline | ESD-932802-1G |
| Cas.: 1398053-00-3 | Purity: 97% | 1,3,6,8-Tetrakis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrene | ESD-932803-100MG |
| Cas.: 1398053-00-3 | Purity: 97% | 1,3,6,8-Tetrakis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrene | ESD-932803-250MG |
| Cas.: 1398053-00-3 | Purity: 97% | 1,3,6,8-Tetrakis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrene | ESD-932803-1G |
| Cas.: 1589565-36-5 | Purity: 98% | Tert-butyl(S)-2-(cyanomethyl)piperazine-1-carboxylate | ESD-932804-100MG |
| Cas.: 1589565-36-5 | Purity: 98% | Tert-butyl(S)-2-(cyanomethyl)piperazine-1-carboxylate | ESD-932804-250MG |
| Cas.: 1589565-36-5 | Purity: 98% | Tert-butyl(S)-2-(cyanomethyl)piperazine-1-carboxylate | ESD-932804-1G |
| Cas.: 2099010-83-8 | Purity: 99% | 2-(6-Oxo-5,6-dihydro-4H-cyclopenta[c]thiophen-4-ylidene)malononitrile | ESD-932805-100MG |
| Cas.: 2099010-83-8 | Purity: 99% | 2-(6-Oxo-5,6-dihydro-4H-cyclopenta[c]thiophen-4-ylidene)malononitrile | ESD-932805-250MG |
| Cas.: 2099010-83-8 | Purity: 99% | 2-(6-Oxo-5,6-dihydro-4H-cyclopenta[c]thiophen-4-ylidene)malononitrile | ESD-932805-1G |
| Cas.: 1081-17-0 | Purity: 95% | 1-(4-Methoxyphenyl)-1H-pyrrole-2,5-dione | ESD-932806-100MG |
| Cas.: 1081-17-0 | Purity: 95% | 1-(4-Methoxyphenyl)-1H-pyrrole-2,5-dione | ESD-932806-250MG |
| Cas.: 1081-17-0 | Purity: 95% | 1-(4-Methoxyphenyl)-1H-pyrrole-2,5-dione | ESD-932806-1G |
| Cas.: 13423-73-9 | Purity: 95% | 4-Hydroxy-3,5-diisopropylbenzoic acid | ESD-932807-100MG |
| Cas.: 13423-73-9 | Purity: 95% | 4-Hydroxy-3,5-diisopropylbenzoic acid | ESD-932807-250MG |
| Cas.: 13423-73-9 | Purity: 95% | 4-Hydroxy-3,5-diisopropylbenzoic acid | ESD-932807-1G |
| Cas.: 167548-89-2 | Purity: 97% | 4-(Trifluoromethyl)thiazole-5-carboxylic acid | ESD-932808-100MG |
| Cas.: 167548-89-2 | Purity: 97% | 4-(Trifluoromethyl)thiazole-5-carboxylic acid | ESD-932808-250MG |
| Cas.: 167548-89-2 | Purity: 97% | 4-(Trifluoromethyl)thiazole-5-carboxylic acid | ESD-932808-1G |
| Cas.: 42757-55-1 | Purity: 95% | 5,5′-Sulfonylbis(1,3-dibromo-2-(2,3-dibromopropoxy)benzene) | ESD-932809-100MG |
| Cas.: 42757-55-1 | Purity: 95% | 5,5′-Sulfonylbis(1,3-dibromo-2-(2,3-dibromopropoxy)benzene) | ESD-932809-250MG |
| Cas.: 42757-55-1 | Purity: 95% | 5,5′-Sulfonylbis(1,3-dibromo-2-(2,3-dibromopropoxy)benzene) | ESD-932809-1G |
| Cas.: 13252-84-1 | Purity: 95% | 4-Hydroxy-6-methoxy-2H-chromen-2-one | ESD-932810-100MG |
| Cas.: 13252-84-1 | Purity: 95% | 4-Hydroxy-6-methoxy-2H-chromen-2-one | ESD-932810-250MG |
| Cas.: 13252-84-1 | Purity: 95% | 4-Hydroxy-6-methoxy-2H-chromen-2-one | ESD-932810-1G |
| Cas.: 1197992-32-7 | Purity: 97% | 5-(4-(Bis(4-bromophenyl)amino)phenyl)thiophene-2-carbaldehyde | ESD-932811-100MG |
| Cas.: 1197992-32-7 | Purity: 97% | 5-(4-(Bis(4-bromophenyl)amino)phenyl)thiophene-2-carbaldehyde | ESD-932811-250MG |
| Cas.: 1197992-32-7 | Purity: 97% | 5-(4-(Bis(4-bromophenyl)amino)phenyl)thiophene-2-carbaldehyde | ESD-932811-1G |
| Cas.: 84437-12-7 | Purity: 97% | Methyl 5-cyano-2-hydroxybenzoate | ESD-932812-100MG |
| Cas.: 84437-12-7 | Purity: 97% | Methyl 5-cyano-2-hydroxybenzoate | ESD-932812-250MG |
| Cas.: 84437-12-7 | Purity: 97% | Methyl 5-cyano-2-hydroxybenzoate | ESD-932812-1G |
| Cas.: 1187929-21-0 | Purity: 97% | Methyl 2-(morpholin-3-yl)acetate hydrochloride | ESD-932813-100MG |
| Cas.: 1187929-21-0 | Purity: 97% | Methyl 2-(morpholin-3-yl)acetate hydrochloride | ESD-932813-250MG |
| Cas.: 1187929-21-0 | Purity: 97% | Methyl 2-(morpholin-3-yl)acetate hydrochloride | ESD-932813-1G |
| Cas.: 83-75-0 | Purity: 97% | Ethyl ((R)-(6-methoxyquinolin-4-yl)((1S,2S,4S,5R)-5-vinylquinuclidin-2-yl)methyl) carbonate | ESD-932814-100MG |
| Cas.: 83-75-0 | Purity: 97% | Ethyl ((R)-(6-methoxyquinolin-4-yl)((1S,2S,4S,5R)-5-vinylquinuclidin-2-yl)methyl) carbonate | ESD-932814-250MG |
| Cas.: 83-75-0 | Purity: 97% | Ethyl ((R)-(6-methoxyquinolin-4-yl)((1S,2S,4S,5R)-5-vinylquinuclidin-2-yl)methyl) carbonate | ESD-932814-1G |
| Cas.: 4720-68-7 | Purity: 97% | 6-Hydroxybenzo[d][1,3]dioxole-5-carbaldehyde | ESD-932815-100MG |
| Cas.: 4720-68-7 | Purity: 97% | 6-Hydroxybenzo[d][1,3]dioxole-5-carbaldehyde | ESD-932815-250MG |
| Cas.: 4720-68-7 | Purity: 97% | 6-Hydroxybenzo[d][1,3]dioxole-5-carbaldehyde | ESD-932815-1G |
| Cas.: 1261775-55-6 | Purity: 95% | 2-(2-Bromo-3-chlorophenyl)acetic acid | ESD-932816-100MG |
| Cas.: 1261775-55-6 | Purity: 95% | 2-(2-Bromo-3-chlorophenyl)acetic acid | ESD-932816-250MG |
| Cas.: 1261775-55-6 | Purity: 95% | 2-(2-Bromo-3-chlorophenyl)acetic acid | ESD-932816-1G |
| Cas.: 18653-98-0 | Purity: 98% | 2,2′-((Ethane-1,2-diylbis(azanediyl))bis(methylene))diphenol | ESD-932817-100MG |
| Cas.: 18653-98-0 | Purity: 98% | 2,2′-((Ethane-1,2-diylbis(azanediyl))bis(methylene))diphenol | ESD-932817-250MG |
| Cas.: 18653-98-0 | Purity: 98% | 2,2′-((Ethane-1,2-diylbis(azanediyl))bis(methylene))diphenol | ESD-932817-1G |
| Cas.: 847818-49-9 | Purity: 97% | 4-Bromo-1-(2-methoxyethyl)-1H-pyrazole | ESD-932818-100MG |
| Cas.: 847818-49-9 | Purity: 97% | 4-Bromo-1-(2-methoxyethyl)-1H-pyrazole | ESD-932818-250MG |
| Cas.: 847818-49-9 | Purity: 97% | 4-Bromo-1-(2-methoxyethyl)-1H-pyrazole | ESD-932818-1G |
| Cas.: 1000340-33-9 | Purity: 95% | 3,4-Dibromo-7-azindole | ESD-932819-100MG |
| Cas.: 1000340-33-9 | Purity: 95% | 3,4-Dibromo-7-azindole | ESD-932819-250MG |
| Cas.: 1000340-33-9 | Purity: 95% | 3,4-Dibromo-7-azindole | ESD-932819-1G |
| Cas.: 1001336-16-8 | Purity: 95% | Methyl 4-chloro-2-formylbenzoate | ESD-932820-100MG |
| Cas.: 1001336-16-8 | Purity: 95% | Methyl 4-chloro-2-formylbenzoate | ESD-932820-250MG |
| Cas.: 1001336-16-8 | Purity: 95% | Methyl 4-chloro-2-formylbenzoate | ESD-932820-1G |
| Cas.: 52920-02-2 | Purity: ≥98% | Trans-2-(methoxycarbonyl)cyclopropane-1-carboxylic acid | ESD-932821-100MG |
| Cas.: 52920-02-2 | Purity: ≥98% | Trans-2-(methoxycarbonyl)cyclopropane-1-carboxylic acid | ESD-932821-250MG |
| Cas.: 52920-02-2 | Purity: ≥98% | Trans-2-(methoxycarbonyl)cyclopropane-1-carboxylic acid | ESD-932821-1G |
| Cas.: 5006-68-8 | Purity: 95% | 2-(5-Nitro-1H-imidazol-1-yl)ethanol | ESD-932822-100MG |
| Cas.: 5006-68-8 | Purity: 95% | 2-(5-Nitro-1H-imidazol-1-yl)ethanol | ESD-932822-250MG |
| Cas.: 5006-68-8 | Purity: 95% | 2-(5-Nitro-1H-imidazol-1-yl)ethanol | ESD-932822-1G |
| Cas.: 24410-55-7 | Purity: 96% | 7-Chlorobenzofuran | ESD-932823-100MG |
| Cas.: 24410-55-7 | Purity: 96% | 7-Chlorobenzofuran | ESD-932823-250MG |
| Cas.: 24410-55-7 | Purity: 96% | 7-Chlorobenzofuran | ESD-932823-1G |
| Cas.: 1703808-52-9 | Purity: 97% | 5-Bromo-1H-pyrazole-4-carbonitrile | ESD-932824-100MG |
| Cas.: 1703808-52-9 | Purity: 97% | 5-Bromo-1H-pyrazole-4-carbonitrile | ESD-932824-250MG |
| Cas.: 1703808-52-9 | Purity: 97% | 5-Bromo-1H-pyrazole-4-carbonitrile | ESD-932824-1G |
| Cas.: 58751-62-5 | Purity: 97% | 4-(2-Nitrophenyl)butan-2-one | ESD-932825-100MG |
| Cas.: 58751-62-5 | Purity: 97% | 4-(2-Nitrophenyl)butan-2-one | ESD-932825-250MG |
| Cas.: 58751-62-5 | Purity: 97% | 4-(2-Nitrophenyl)butan-2-one | ESD-932825-1G |
| Cas.: 1207175-04-9 | Purity: 98% | Ethyl 2-(oxetan-3-yl)acetate | ESD-932826-100MG |
| Cas.: 1207175-04-9 | Purity: 98% | Ethyl 2-(oxetan-3-yl)acetate | ESD-932826-250MG |
| Cas.: 1207175-04-9 | Purity: 98% | Ethyl 2-(oxetan-3-yl)acetate | ESD-932826-1G |
| Cas.: 142356-34-1 | Purity: 95% | Tert-butyl (7-bromoheptyl)carbamate | ESD-932827-100MG |
| Cas.: 142356-34-1 | Purity: 95% | Tert-butyl (7-bromoheptyl)carbamate | ESD-932827-250MG |
| Cas.: 142356-34-1 | Purity: 95% | Tert-butyl (7-bromoheptyl)carbamate | ESD-932827-1G |
| Cas.: 663948-85-4 | Purity: 98% | Tert-butyl ((3S,5S)-5-(hydroxymethyl)pyrrolidin-3-yl)carbamate | ESD-932828-100MG |
| Cas.: 663948-85-4 | Purity: 98% | Tert-butyl ((3S,5S)-5-(hydroxymethyl)pyrrolidin-3-yl)carbamate | ESD-932828-250MG |
| Cas.: 663948-85-4 | Purity: 98% | Tert-butyl ((3S,5S)-5-(hydroxymethyl)pyrrolidin-3-yl)carbamate | ESD-932828-1G |
| Cas.: 17078-76-1 | Purity: 95% | 4-Ethyl-4′-iodobiphenyl | ESD-932829-100MG |
| Cas.: 17078-76-1 | Purity: 95% | 4-Ethyl-4′-iodobiphenyl | ESD-932829-250MG |
| Cas.: 17078-76-1 | Purity: 95% | 4-Ethyl-4′-iodobiphenyl | ESD-932829-1G |
| Cas.: 40150-92-3 | Purity: 97% | α-(4-Isobutylphenyl)ethanol | ESD-932830-100MG |
| Cas.: 40150-92-3 | Purity: 97% | α-(4-Isobutylphenyl)ethanol | ESD-932830-250MG |
| Cas.: 40150-92-3 | Purity: 97% | α-(4-Isobutylphenyl)ethanol | ESD-932830-1G |
| Cas.: 69641-93-6 | Purity: 98% | Dibutyl [2,2′-bipyridine]-4,4′-dicarboxylate | ESD-932831-100MG |
| Cas.: 69641-93-6 | Purity: 98% | Dibutyl [2,2′-bipyridine]-4,4′-dicarboxylate | ESD-932831-250MG |
| Cas.: 69641-93-6 | Purity: 98% | Dibutyl [2,2′-bipyridine]-4,4′-dicarboxylate | ESD-932831-1G |
| Cas.: 70190-72-6 | Purity: 97% | Chloromethyl 2,4-dichlorobenzoate | ESD-932832-100MG |
| Cas.: 70190-72-6 | Purity: 97% | Chloromethyl 2,4-dichlorobenzoate | ESD-932832-250MG |
| Cas.: 70190-72-6 | Purity: 97% | Chloromethyl 2,4-dichlorobenzoate | ESD-932832-1G |
| Cas.: 606-84-8 | Purity: 95% | 3,3-Diphenylacrylic acid | ESD-932833-100MG |
| Cas.: 606-84-8 | Purity: 95% | 3,3-Diphenylacrylic acid | ESD-932833-250MG |
| Cas.: 606-84-8 | Purity: 95% | 3,3-Diphenylacrylic acid | ESD-932833-1G |
| Cas.: 6456-44-6 | Purity: 97% | 3-Carbamoyl-1-methylpyridin-1-ium iodide | ESD-932834-100MG |
| Cas.: 6456-44-6 | Purity: 97% | 3-Carbamoyl-1-methylpyridin-1-ium iodide | ESD-932834-250MG |
| Cas.: 6456-44-6 | Purity: 97% | 3-Carbamoyl-1-methylpyridin-1-ium iodide | ESD-932834-1G |
| Cas.: 4392-54-5 | Purity: 96% | 4-Hydrazinylbenzenesulfonamide | ESD-932835-100MG |
| Cas.: 4392-54-5 | Purity: 96% | 4-Hydrazinylbenzenesulfonamide | ESD-932835-250MG |
| Cas.: 4392-54-5 | Purity: 96% | 4-Hydrazinylbenzenesulfonamide | ESD-932835-1G |
| Cas.: 897665-73-5 | Purity: ≥98% | Tris(1-adamantyl)phosphine | ESD-932836-100MG |
| Cas.: 897665-73-5 | Purity: ≥98% | Tris(1-adamantyl)phosphine | ESD-932836-250MG |
| Cas.: 897665-73-5 | Purity: ≥98% | Tris(1-adamantyl)phosphine | ESD-932836-1G |
| Cas.: 51583-97-2 | Purity: 97% | 1,3-Di(naphthalen-2-yl)propane-1,3-dione | ESD-932837-100MG |
| Cas.: 51583-97-2 | Purity: 97% | 1,3-Di(naphthalen-2-yl)propane-1,3-dione | ESD-932837-250MG |
| Cas.: 51583-97-2 | Purity: 97% | 1,3-Di(naphthalen-2-yl)propane-1,3-dione | ESD-932837-1G |
| Cas.: 4045-30-1 | Purity: 98% | 4,4-Dimethylpiperidine | ESD-932838-100MG |
| Cas.: 4045-30-1 | Purity: 98% | 4,4-Dimethylpiperidine | ESD-932838-250MG |
| Cas.: 4045-30-1 | Purity: 98% | 4,4-Dimethylpiperidine | ESD-932838-1G |
| Cas.: 148857-42-5 | Purity: 95% | (S)-2-(3-Chloro-2-hydroxypropyl)isoindoline-1,3-dione | ESD-932839-100MG |
| Cas.: 148857-42-5 | Purity: 95% | (S)-2-(3-Chloro-2-hydroxypropyl)isoindoline-1,3-dione | ESD-932839-250MG |
| Cas.: 148857-42-5 | Purity: 95% | (S)-2-(3-Chloro-2-hydroxypropyl)isoindoline-1,3-dione | ESD-932839-1G |
| Cas.: 10040-95-6 | Purity: 98% | 1-(4-Methoxyphenyl)-1H-imidazole | ESD-932840-100MG |
| Cas.: 10040-95-6 | Purity: 98% | 1-(4-Methoxyphenyl)-1H-imidazole | ESD-932840-250MG |
| Cas.: 10040-95-6 | Purity: 98% | 1-(4-Methoxyphenyl)-1H-imidazole | ESD-932840-1G |
| Cas.: 16695-41-3 | Purity: 90% | (E)-7-Dodecen-1-ol acetate | ESD-932841-100MG |
| Cas.: 16695-41-3 | Purity: 90% | (E)-7-Dodecen-1-ol acetate | ESD-932841-250MG |
| Cas.: 16695-41-3 | Purity: 90% | (E)-7-Dodecen-1-ol acetate | ESD-932841-1G |
| Cas.: 7093-67-6 | Purity: 95% | Pentaglycine | ESD-932842-100MG |
| Cas.: 7093-67-6 | Purity: 95% | Pentaglycine | ESD-932842-250MG |
| Cas.: 7093-67-6 | Purity: 95% | Pentaglycine | ESD-932842-1G |
| Cas.: 31295-54-2 | Purity: ≥95% | N1-(2-(4-(2-Aminoethyl)piperazin-1-yl)ethyl)ethane-1,2-diamine | ESD-932843-100MG |
| Cas.: 31295-54-2 | Purity: ≥95% | N1-(2-(4-(2-Aminoethyl)piperazin-1-yl)ethyl)ethane-1,2-diamine | ESD-932843-250MG |
| Cas.: 31295-54-2 | Purity: ≥95% | N1-(2-(4-(2-Aminoethyl)piperazin-1-yl)ethyl)ethane-1,2-diamine | ESD-932843-1G |
| Cas.: 144342-48-3 | Purity: 98% | 4,4′-Di(furan-2-yl)-6,6′-dimethyl-2,2′-bipyridine | ESD-932844-100MG |
| Cas.: 144342-48-3 | Purity: 98% | 4,4′-Di(furan-2-yl)-6,6′-dimethyl-2,2′-bipyridine | ESD-932844-250MG |
| Cas.: 144342-48-3 | Purity: 98% | 4,4′-Di(furan-2-yl)-6,6′-dimethyl-2,2′-bipyridine | ESD-932844-1G |
| Cas.: 65058-23-3 | Purity: 95% | (R)-2-Amino-2-(thiophen-2-yl)acetic acid | ESD-932845-100MG |
| Cas.: 65058-23-3 | Purity: 95% | (R)-2-Amino-2-(thiophen-2-yl)acetic acid | ESD-932845-250MG |
| Cas.: 65058-23-3 | Purity: 95% | (R)-2-Amino-2-(thiophen-2-yl)acetic acid | ESD-932845-1G |
| Cas.: 1123169-27-6 | Purity: 95% | 1-(Hydroxymethyl)cyclopropanecarboxamide | ESD-932846-100MG |
| Cas.: 1123169-27-6 | Purity: 95% | 1-(Hydroxymethyl)cyclopropanecarboxamide | ESD-932846-250MG |
| Cas.: 1123169-27-6 | Purity: 95% | 1-(Hydroxymethyl)cyclopropanecarboxamide | ESD-932846-1G |
| Cas.: 191348-04-6 | Purity: 98% | (S)-Tert-butyl 3-formylpyrrolidine-1-carboxylate | ESD-932847-100MG |
| Cas.: 191348-04-6 | Purity: 98% | (S)-Tert-butyl 3-formylpyrrolidine-1-carboxylate | ESD-932847-250MG |
| Cas.: 191348-04-6 | Purity: 98% | (S)-Tert-butyl 3-formylpyrrolidine-1-carboxylate | ESD-932847-1G |
| Cas.: 1022-45-3 | Purity: 97% | 2-Phenylquinazolin-4-ol | ESD-932848-100MG |
| Cas.: 1022-45-3 | Purity: 97% | 2-Phenylquinazolin-4-ol | ESD-932848-250MG |
| Cas.: 1022-45-3 | Purity: 97% | 2-Phenylquinazolin-4-ol | ESD-932848-1G |
| Cas.: 127512-29-2 | Purity: 98% | (Z)-3-(Dimethylamino)propane-1,2-diyl dioleate | ESD-932849-100MG |
| Cas.: 127512-29-2 | Purity: 98% | (Z)-3-(Dimethylamino)propane-1,2-diyl dioleate | ESD-932849-250MG |
| Cas.: 127512-29-2 | Purity: 98% | (Z)-3-(Dimethylamino)propane-1,2-diyl dioleate | ESD-932849-1G |
| Cas.: 2256046-71-4 | Purity: 98%, 99%ee | (2S)-1-[(4R)-4,5-Dihydro-4-phenylmethyl-2-oxazolyl]-2-(diphenylphosphino)ferrocene | ESD-932850-100MG |
| Cas.: 2256046-71-4 | Purity: 98%, 99%ee | (2S)-1-[(4R)-4,5-Dihydro-4-phenylmethyl-2-oxazolyl]-2-(diphenylphosphino)ferrocene | ESD-932850-250MG |
| Cas.: 2256046-71-4 | Purity: 98%, 99%ee | (2S)-1-[(4R)-4,5-Dihydro-4-phenylmethyl-2-oxazolyl]-2-(diphenylphosphino)ferrocene | ESD-932850-1G |
| Cas.: 2003-79-4 | Purity: 98% | 2-Hydroxyquinoline-3-carboxylic acid | ESD-932851-100MG |
| Cas.: 2003-79-4 | Purity: 98% | 2-Hydroxyquinoline-3-carboxylic acid | ESD-932851-250MG |
| Cas.: 2003-79-4 | Purity: 98% | 2-Hydroxyquinoline-3-carboxylic acid | ESD-932851-1G |
| Cas.: 2525-02-2 | Purity: 95% | 4-Propylbenzene-1,2-diol | ESD-932852-100MG |
| Cas.: 2525-02-2 | Purity: 95% | 4-Propylbenzene-1,2-diol | ESD-932852-250MG |
| Cas.: 2525-02-2 | Purity: 95% | 4-Propylbenzene-1,2-diol | ESD-932852-1G |
| Cas.: 287394-20-1 | Purity: 95% | (S)-2-Amino-2-(4-(trifluoromethyl)phenyl)ethanol | ESD-932853-100MG |
| Cas.: 287394-20-1 | Purity: 95% | (S)-2-Amino-2-(4-(trifluoromethyl)phenyl)ethanol | ESD-932853-250MG |
| Cas.: 287394-20-1 | Purity: 95% | (S)-2-Amino-2-(4-(trifluoromethyl)phenyl)ethanol | ESD-932853-1G |
| Cas.: 160241-65-6 | Purity: 97% | 2-(2-Methylthiazol-4-yl)phenol | ESD-932854-100MG |
| Cas.: 160241-65-6 | Purity: 97% | 2-(2-Methylthiazol-4-yl)phenol | ESD-932854-250MG |
| Cas.: 160241-65-6 | Purity: 97% | 2-(2-Methylthiazol-4-yl)phenol | ESD-932854-1G |
| Cas.: 66067-44-5 | Purity: 98% | 1-(3-Benzoylphenyl)ethanone | ESD-932855-100MG |
| Cas.: 66067-44-5 | Purity: 98% | 1-(3-Benzoylphenyl)ethanone | ESD-932855-250MG |
| Cas.: 66067-44-5 | Purity: 98% | 1-(3-Benzoylphenyl)ethanone | ESD-932855-1G |
| Cas.: 84350-73-2 | Purity: 98% | Tris(2-fluorophenyl)phosphine | ESD-932856-100MG |
| Cas.: 84350-73-2 | Purity: 98% | Tris(2-fluorophenyl)phosphine | ESD-932856-250MG |
| Cas.: 84350-73-2 | Purity: 98% | Tris(2-fluorophenyl)phosphine | ESD-932856-1G |
| Cas.: 1909333-82-9 | Purity: 98% | N1-Benzyl-N2-(5-methyl-[1,1′-biphenyl]-2-yl)oxalamide | ESD-932857-100MG |
| Cas.: 1909333-82-9 | Purity: 98% | N1-Benzyl-N2-(5-methyl-[1,1′-biphenyl]-2-yl)oxalamide | ESD-932857-250MG |
| Cas.: 1909333-82-9 | Purity: 98% | N1-Benzyl-N2-(5-methyl-[1,1′-biphenyl]-2-yl)oxalamide | ESD-932857-1G |
| Cas.: 957062-72-5 | Purity: 95% | Methyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)picolinate | ESD-932858-100MG |
| Cas.: 957062-72-5 | Purity: 95% | Methyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)picolinate | ESD-932858-250MG |
| Cas.: 957062-72-5 | Purity: 95% | Methyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)picolinate | ESD-932858-1G |
| Cas.: 21778-81-4 | Purity: 95% | 5-Methoxy-1H-indole-2-carbaldehyde | ESD-932859-100MG |
| Cas.: 21778-81-4 | Purity: 95% | 5-Methoxy-1H-indole-2-carbaldehyde | ESD-932859-250MG |
| Cas.: 21778-81-4 | Purity: 95% | 5-Methoxy-1H-indole-2-carbaldehyde | ESD-932859-1G |
| Cas.: 89281-73-2 | Purity: 95% | ((1,3-Dichloropropan-2-yl)oxy)methyl acetate | ESD-932860-100MG |
| Cas.: 89281-73-2 | Purity: 95% | ((1,3-Dichloropropan-2-yl)oxy)methyl acetate | ESD-932860-250MG |
| Cas.: 89281-73-2 | Purity: 95% | ((1,3-Dichloropropan-2-yl)oxy)methyl acetate | ESD-932860-1G |
| Cas.: 4836-69-5 | Purity: 95% | 2,4-Dinitrophenylethylalcohol | ESD-932861-100MG |
| Cas.: 4836-69-5 | Purity: 95% | 2,4-Dinitrophenylethylalcohol | ESD-932861-250MG |
| Cas.: 4836-69-5 | Purity: 95% | 2,4-Dinitrophenylethylalcohol | ESD-932861-1G |
| Cas.: 1052271-58-5 | Purity: 95% | (3-Bromopyridin-2-yl)methanamine hydrochloride | ESD-932862-100MG |
| Cas.: 1052271-58-5 | Purity: 95% | (3-Bromopyridin-2-yl)methanamine hydrochloride | ESD-932862-250MG |
| Cas.: 1052271-58-5 | Purity: 95% | (3-Bromopyridin-2-yl)methanamine hydrochloride | ESD-932862-1G |
| Cas.: 942603-58-9 | Purity: 97% | Ethyl 2,5-dioxohexahydro-1H-pyrrolizine-7a-carboxylate | ESD-932863-100MG |
| Cas.: 942603-58-9 | Purity: 97% | Ethyl 2,5-dioxohexahydro-1H-pyrrolizine-7a-carboxylate | ESD-932863-250MG |
| Cas.: 942603-58-9 | Purity: 97% | Ethyl 2,5-dioxohexahydro-1H-pyrrolizine-7a-carboxylate | ESD-932863-1G |
| Cas.: 6526-79-0 | Purity: 95% | 2-(4-Methylphenyl)propan-2-amine | ESD-932864-100MG |
| Cas.: 6526-79-0 | Purity: 95% | 2-(4-Methylphenyl)propan-2-amine | ESD-932864-250MG |
| Cas.: 6526-79-0 | Purity: 95% | 2-(4-Methylphenyl)propan-2-amine | ESD-932864-1G |
| Cas.: 851670-19-4 | Purity: ≥90% | 2-(3-Methylpyridin-2-yl)ethanamine | ESD-932865-100MG |
| Cas.: 851670-19-4 | Purity: ≥90% | 2-(3-Methylpyridin-2-yl)ethanamine | ESD-932865-250MG |
| Cas.: 851670-19-4 | Purity: ≥90% | 2-(3-Methylpyridin-2-yl)ethanamine | ESD-932865-1G |
| Cas.: 3122-84-7 | Purity: 97% | 4-Chloro-6-(methoxymethyl)pyrimidine | ESD-932866-100MG |
| Cas.: 3122-84-7 | Purity: 97% | 4-Chloro-6-(methoxymethyl)pyrimidine | ESD-932866-250MG |
| Cas.: 3122-84-7 | Purity: 97% | 4-Chloro-6-(methoxymethyl)pyrimidine | ESD-932866-1G |
| Cas.: 1212862-77-5 | Purity: 97% | (R)-1-(2-Methyl-3-(trifluoromethyl)phenyl)ethanamine | ESD-932867-100MG |
| Cas.: 1212862-77-5 | Purity: 97% | (R)-1-(2-Methyl-3-(trifluoromethyl)phenyl)ethanamine | ESD-932867-250MG |
| Cas.: 1212862-77-5 | Purity: 97% | (R)-1-(2-Methyl-3-(trifluoromethyl)phenyl)ethanamine | ESD-932867-1G |
| Cas.: 38953-42-3 | Purity: 96% | 4-Amino-6-chloropyrimidin-5-ol | ESD-932868-100MG |
| Cas.: 38953-42-3 | Purity: 96% | 4-Amino-6-chloropyrimidin-5-ol | ESD-932868-250MG |
| Cas.: 38953-42-3 | Purity: 96% | 4-Amino-6-chloropyrimidin-5-ol | ESD-932868-1G |
| Cas.: 7661-33-8 | Purity: 95% | 1-(4-Chlorophenyl)pyrrolidin-2-one | ESD-932869-100MG |
| Cas.: 7661-33-8 | Purity: 95% | 1-(4-Chlorophenyl)pyrrolidin-2-one | ESD-932869-250MG |
| Cas.: 7661-33-8 | Purity: 95% | 1-(4-Chlorophenyl)pyrrolidin-2-one | ESD-932869-1G |
| Cas.: 29802-22-0 | Purity: 98% | (S)-N,N-Dimethylpyrrolidine-2-carboxamide | ESD-932870-100MG |
| Cas.: 29802-22-0 | Purity: 98% | (S)-N,N-Dimethylpyrrolidine-2-carboxamide | ESD-932870-250MG |
| Cas.: 29802-22-0 | Purity: 98% | (S)-N,N-Dimethylpyrrolidine-2-carboxamide | ESD-932870-1G |
| Cas.: 301206-84-8 | Purity: 98% | Tetrasodium,4-(1,10-phenanthrolin-4-yl)benzenesulfonate,ruthenium((II)) | ESD-932871-100MG |
| Cas.: 301206-84-8 | Purity: 98% | Tetrasodium,4-(1,10-phenanthrolin-4-yl)benzenesulfonate,ruthenium((II)) | ESD-932871-250MG |
| Cas.: 301206-84-8 | Purity: 98% | Tetrasodium,4-(1,10-phenanthrolin-4-yl)benzenesulfonate,ruthenium((II)) | ESD-932871-1G |
| Cas.: 2061897-68-3 | Purity: 98% | (S)-2-(2-((tert-Butoxycarbonyl)amino)-3-(1-trityl-1H-imidazol-4-yl)propanamido)-2-methylpropanoic acid | ESD-932872-100MG |
| Cas.: 2061897-68-3 | Purity: 98% | (S)-2-(2-((tert-Butoxycarbonyl)amino)-3-(1-trityl-1H-imidazol-4-yl)propanamido)-2-methylpropanoic acid | ESD-932872-250MG |
| Cas.: 2061897-68-3 | Purity: 98% | (S)-2-(2-((tert-Butoxycarbonyl)amino)-3-(1-trityl-1H-imidazol-4-yl)propanamido)-2-methylpropanoic acid | ESD-932872-1G |
| Cas.: 19125-84-9 | Purity: 95% | 1,6-Dibromonaphthalene | ESD-932873-100MG |
| Cas.: 19125-84-9 | Purity: 95% | 1,6-Dibromonaphthalene | ESD-932873-250MG |
| Cas.: 19125-84-9 | Purity: 95% | 1,6-Dibromonaphthalene | ESD-932873-1G |
| Cas.: 46000-11-7 | Purity: 95% | N-Methylisoquinolin-1-amine | ESD-932874-100MG |
| Cas.: 46000-11-7 | Purity: 95% | N-Methylisoquinolin-1-amine | ESD-932874-250MG |
| Cas.: 46000-11-7 | Purity: 95% | N-Methylisoquinolin-1-amine | ESD-932874-1G |
| Cas.: 1226781-80-1 | Purity: 95% | 2-(Methylsulfonyl)-2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole | ESD-932875-100MG |
| Cas.: 1226781-80-1 | Purity: 95% | 2-(Methylsulfonyl)-2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole | ESD-932875-250MG |
| Cas.: 1226781-80-1 | Purity: 95% | 2-(Methylsulfonyl)-2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole | ESD-932875-1G |
| Cas.: 1589540-62-4 | Purity: 95% | 4,6-Dichloro-2-methylnicotinaldehyde | ESD-932876-100MG |
| Cas.: 1589540-62-4 | Purity: 95% | 4,6-Dichloro-2-methylnicotinaldehyde | ESD-932876-250MG |
| Cas.: 1589540-62-4 | Purity: 95% | 4,6-Dichloro-2-methylnicotinaldehyde | ESD-932876-1G |
| Cas.: 1688598-83-5 | Purity: 97% | Bis(2,5-dioxopyrrolidin-1-yl) (disulfanediylbis(ethane-2,1-diyl)) dicarbonate | ESD-932877-100MG |
| Cas.: 1688598-83-5 | Purity: 97% | Bis(2,5-dioxopyrrolidin-1-yl) (disulfanediylbis(ethane-2,1-diyl)) dicarbonate | ESD-932877-250MG |
| Cas.: 1688598-83-5 | Purity: 97% | Bis(2,5-dioxopyrrolidin-1-yl) (disulfanediylbis(ethane-2,1-diyl)) dicarbonate | ESD-932877-1G |
| Cas.: 923036-25-3 | Purity: ≥95% | N-((3R,4R)-1-Benzyl-4-methylpiperidin-3-yl)-2-chloro-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine | ESD-932878-100MG |
| Cas.: 923036-25-3 | Purity: ≥95% | N-((3R,4R)-1-Benzyl-4-methylpiperidin-3-yl)-2-chloro-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine | ESD-932878-250MG |
| Cas.: 923036-25-3 | Purity: ≥95% | N-((3R,4R)-1-Benzyl-4-methylpiperidin-3-yl)-2-chloro-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine | ESD-932878-1G |
| Cas.: 115845-51-7 | Purity: 98% | Oxetan-2-ylmethyl 4-methylbenzenesulfonate | ESD-932879-100MG |
| Cas.: 115845-51-7 | Purity: 98% | Oxetan-2-ylmethyl 4-methylbenzenesulfonate | ESD-932879-250MG |
| Cas.: 115845-51-7 | Purity: 98% | Oxetan-2-ylmethyl 4-methylbenzenesulfonate | ESD-932879-1G |
| Cas.: 41242-94-8 | Purity: 98% | Quinoxalin-2-ylmethanol | ESD-932880-100MG |
| Cas.: 41242-94-8 | Purity: 98% | Quinoxalin-2-ylmethanol | ESD-932880-250MG |
| Cas.: 41242-94-8 | Purity: 98% | Quinoxalin-2-ylmethanol | ESD-932880-1G |
| Cas.: 837-45-6 | Purity: 97% | Phenanthrene-9-carboxylic acid | ESD-932881-100MG |
| Cas.: 837-45-6 | Purity: 97% | Phenanthrene-9-carboxylic acid | ESD-932881-250MG |
| Cas.: 837-45-6 | Purity: 97% | Phenanthrene-9-carboxylic acid | ESD-932881-1G |
| Cas.: 1449112-32-6 | Purity: 95% | 3-Bromo-5-iodopyrazin-2-amine | ESD-932882-100MG |
| Cas.: 1449112-32-6 | Purity: 95% | 3-Bromo-5-iodopyrazin-2-amine | ESD-932882-250MG |
| Cas.: 1449112-32-6 | Purity: 95% | 3-Bromo-5-iodopyrazin-2-amine | ESD-932882-1G |
| Cas.: 255897-36-0 | Purity: 98% | 2,2′-Bis(dicyclohexylphosphino)-1,1′-biphenyl | ESD-932883-100MG |
| Cas.: 255897-36-0 | Purity: 98% | 2,2′-Bis(dicyclohexylphosphino)-1,1′-biphenyl | ESD-932883-250MG |
| Cas.: 255897-36-0 | Purity: 98% | 2,2′-Bis(dicyclohexylphosphino)-1,1′-biphenyl | ESD-932883-1G |
| Cas.: 1599466-89-3 | Purity: 98% | Methanesulfonato(2-di-t-butylphosphino-2′,4′,6′-tri-i-propyl-1,1′-biphenyl)(2′-methylamino-1,1′-biphenyl-2-yl)palladium (II) dichloromethane adduct | ESD-932884-100MG |
| Cas.: 1599466-89-3 | Purity: 98% | Methanesulfonato(2-di-t-butylphosphino-2′,4′,6′-tri-i-propyl-1,1′-biphenyl)(2′-methylamino-1,1′-biphenyl-2-yl)palladium (II) dichloromethane adduct | ESD-932884-250MG |
| Cas.: 1599466-89-3 | Purity: 98% | Methanesulfonato(2-di-t-butylphosphino-2′,4′,6′-tri-i-propyl-1,1′-biphenyl)(2′-methylamino-1,1′-biphenyl-2-yl)palladium (II) dichloromethane adduct | ESD-932884-1G |
| Cas.: 5631-67-4 | Purity: 95% | 7-Hydroxychroman-2-one | ESD-932885-100MG |
| Cas.: 5631-67-4 | Purity: 95% | 7-Hydroxychroman-2-one | ESD-932885-250MG |
| Cas.: 5631-67-4 | Purity: 95% | 7-Hydroxychroman-2-one | ESD-932885-1G |
| Cas.: 1072945-04-0 | Purity: 95% | 2-(4-(Chloromethyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-932886-100MG |
| Cas.: 1072945-04-0 | Purity: 95% | 2-(4-(Chloromethyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-932886-250MG |
| Cas.: 1072945-04-0 | Purity: 95% | 2-(4-(Chloromethyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-932886-1G |
| Cas.: 10150-93-3 | Purity: 97% | (E)-Ethyl 4-oxopent-2-enoate | ESD-932887-100MG |
| Cas.: 10150-93-3 | Purity: 97% | (E)-Ethyl 4-oxopent-2-enoate | ESD-932887-250MG |
| Cas.: 10150-93-3 | Purity: 97% | (E)-Ethyl 4-oxopent-2-enoate | ESD-932887-1G |
| Cas.: 54177-02-5 | Purity: 95% | Methyl 3-(2-methoxyphenyl)-3-oxopropanoate | ESD-932888-100MG |
| Cas.: 54177-02-5 | Purity: 95% | Methyl 3-(2-methoxyphenyl)-3-oxopropanoate | ESD-932888-250MG |
| Cas.: 54177-02-5 | Purity: 95% | Methyl 3-(2-methoxyphenyl)-3-oxopropanoate | ESD-932888-1G |
| Cas.: 21314-17-0 | Purity: 98% | 1-Phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-ol | ESD-932889-100MG |
| Cas.: 21314-17-0 | Purity: 98% | 1-Phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-ol | ESD-932889-250MG |
| Cas.: 21314-17-0 | Purity: 98% | 1-Phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-ol | ESD-932889-1G |
| Cas.: 264903-53-9 | Purity: 98% | (R)-2-Amino-5-phenylpent-4-enoic acid | ESD-932890-100MG |
| Cas.: 264903-53-9 | Purity: 98% | (R)-2-Amino-5-phenylpent-4-enoic acid | ESD-932890-250MG |
| Cas.: 264903-53-9 | Purity: 98% | (R)-2-Amino-5-phenylpent-4-enoic acid | ESD-932890-1G |
| Cas.: 325-13-3 | Purity: 95% | 6-(Trifluoromethyl)quinoline | ESD-932891-100MG |
| Cas.: 325-13-3 | Purity: 95% | 6-(Trifluoromethyl)quinoline | ESD-932891-250MG |
| Cas.: 325-13-3 | Purity: 95% | 6-(Trifluoromethyl)quinoline | ESD-932891-1G |
| Cas.: 4375-15-9 | Purity: 98% | 3-Methylindoline | ESD-932892-100MG |
| Cas.: 4375-15-9 | Purity: 98% | 3-Methylindoline | ESD-932892-250MG |
| Cas.: 4375-15-9 | Purity: 98% | 3-Methylindoline | ESD-932892-1G |
| Cas.: 66616-72-6 | Purity: 95% | 5-Phenyl-1H-indole | ESD-932893-100MG |
| Cas.: 66616-72-6 | Purity: 95% | 5-Phenyl-1H-indole | ESD-932893-250MG |
| Cas.: 66616-72-6 | Purity: 95% | 5-Phenyl-1H-indole | ESD-932893-1G |
| Cas.: 102170-39-8 | Purity: 95% | 4-Amino-2-nitrobenzaldehyde | ESD-932894-100MG |
| Cas.: 102170-39-8 | Purity: 95% | 4-Amino-2-nitrobenzaldehyde | ESD-932894-250MG |
| Cas.: 102170-39-8 | Purity: 95% | 4-Amino-2-nitrobenzaldehyde | ESD-932894-1G |
| Cas.: 1088118-97-1 | Purity: 95% | 4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[c][1,2,5]thiadiazole | ESD-932895-100MG |
| Cas.: 1088118-97-1 | Purity: 95% | 4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[c][1,2,5]thiadiazole | ESD-932895-250MG |
| Cas.: 1088118-97-1 | Purity: 95% | 4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[c][1,2,5]thiadiazole | ESD-932895-1G |
| Cas.: 13169-71-6 | Purity: 95% | (4-Chlorophenyl)(1H-pyrrol-2-yl)methanone | ESD-932896-100MG |
| Cas.: 13169-71-6 | Purity: 95% | (4-Chlorophenyl)(1H-pyrrol-2-yl)methanone | ESD-932896-250MG |
| Cas.: 13169-71-6 | Purity: 95% | (4-Chlorophenyl)(1H-pyrrol-2-yl)methanone | ESD-932896-1G |
| Cas.: 253-50-9 | Purity: 95% | 2,6-Naphthyridine | ESD-932897-100MG |
| Cas.: 253-50-9 | Purity: 95% | 2,6-Naphthyridine | ESD-932897-1G |
| Cas.: 865869-27-8 | Purity: 98% | Tert-butyldimethyl((4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)cyclohex-3-en-1-yl)oxy) | ESD-932898-100MG |
| Cas.: 865869-27-8 | Purity: 98% | Tert-butyldimethyl((4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)cyclohex-3-en-1-yl)oxy) | ESD-932898-250MG |
| Cas.: 865869-27-8 | Purity: 98% | Tert-butyldimethyl((4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)cyclohex-3-en-1-yl)oxy) | ESD-932898-1G |
| Cas.: 1214323-39-3 | Purity: 98% | 2-Bromo-3-(trifluoromethyl)phenol | ESD-932899-100MG |
| Cas.: 1214323-39-3 | Purity: 98% | 2-Bromo-3-(trifluoromethyl)phenol | ESD-932899-250MG |
| Cas.: 1214323-39-3 | Purity: 98% | 2-Bromo-3-(trifluoromethyl)phenol | ESD-932899-1G |
| Cas.: 1196154-87-6 | Purity: 98% | 3-Bromo-6,7-dihydro-5H-cyclopenta[b]pyridin-5-one | ESD-932900-100MG |
| Cas.: 1196154-87-6 | Purity: 98% | 3-Bromo-6,7-dihydro-5H-cyclopenta[b]pyridin-5-one | ESD-932900-250MG |
| Cas.: 1196154-87-6 | Purity: 98% | 3-Bromo-6,7-dihydro-5H-cyclopenta[b]pyridin-5-one | ESD-932900-1G |
| Cas.: 869942-88-1 | Purity: 98% | (3,4-Diethoxyphenyl)methanamine | ESD-932901-100MG |
| Cas.: 869942-88-1 | Purity: 98% | (3,4-Diethoxyphenyl)methanamine | ESD-932901-250MG |
| Cas.: 869942-88-1 | Purity: 98% | (3,4-Diethoxyphenyl)methanamine | ESD-932901-1G |
| Cas.: 6729-79-9 | Purity: 97% | 1,4-Phenylene diacrylate | ESD-932902-100MG |
| Cas.: 6729-79-9 | Purity: 97% | 1,4-Phenylene diacrylate | ESD-932902-250MG |
| Cas.: 6729-79-9 | Purity: 97% | 1,4-Phenylene diacrylate | ESD-932902-1G |
| Cas.: 18677-41-3 | Purity: 97% | 2,6-Dimethoxy-3-nitropyridine | ESD-932903-100MG |
| Cas.: 18677-41-3 | Purity: 97% | 2,6-Dimethoxy-3-nitropyridine | ESD-932903-250MG |
| Cas.: 18677-41-3 | Purity: 97% | 2,6-Dimethoxy-3-nitropyridine | ESD-932903-1G |
| Cas.: 404366-59-2 | Purity: 95% | Sodium 5-bromo-6-chloro-1H-indol-3-yl phosphate | ESD-932904-100MG |
| Cas.: 404366-59-2 | Purity: 95% | Sodium 5-bromo-6-chloro-1H-indol-3-yl phosphate | ESD-932904-250MG |
| Cas.: 404366-59-2 | Purity: 95% | Sodium 5-bromo-6-chloro-1H-indol-3-yl phosphate | ESD-932904-1G |
| Cas.: 2095678-97-8 | Purity: 95% | Isopropyl 4-hydroxy-3,5-diisopropylbenzoate | ESD-932905-100MG |
| Cas.: 2095678-97-8 | Purity: 95% | Isopropyl 4-hydroxy-3,5-diisopropylbenzoate | ESD-932905-250MG |
| Cas.: 2095678-97-8 | Purity: 95% | Isopropyl 4-hydroxy-3,5-diisopropylbenzoate | ESD-932905-1G |
| Cas.: 632628-07-0 | Purity: ≥97% | 3,5-Dibromo-2-fluoro-6-methylpyridine | ESD-932906-100MG |
| Cas.: 632628-07-0 | Purity: ≥97% | 3,5-Dibromo-2-fluoro-6-methylpyridine | ESD-932906-250MG |
| Cas.: 632628-07-0 | Purity: ≥97% | 3,5-Dibromo-2-fluoro-6-methylpyridine | ESD-932906-1G |
| Cas.: 945971-14-2 | Purity: 95% | 2-Bromo-3-fluoro-5-nitrophenol | ESD-932907-100MG |
| Cas.: 945971-14-2 | Purity: 95% | 2-Bromo-3-fluoro-5-nitrophenol | ESD-932907-250MG |
| Cas.: 945971-14-2 | Purity: 95% | 2-Bromo-3-fluoro-5-nitrophenol | ESD-932907-1G |
| Cas.: 913836-11-0 | Purity: 95% | 5-Boronopicolinic acid | ESD-932908-100MG |
| Cas.: 913836-11-0 | Purity: 95% | 5-Boronopicolinic acid | ESD-932908-250MG |
| Cas.: 913836-11-0 | Purity: 95% | 5-Boronopicolinic acid | ESD-932908-1G |
| Cas.: 1894189-67-3 | Purity: 97% | (SP-4-2)-[4,4′-bis(1,1-dimethylethyl)-2,2′-bipyridine-κN1,κN1′]dibromo-Nickel | ESD-932909-100MG |
| Cas.: 1894189-67-3 | Purity: 97% | (SP-4-2)-[4,4′-bis(1,1-dimethylethyl)-2,2′-bipyridine-κN1,κN1′]dibromo-Nickel | ESD-932909-250MG |
| Cas.: 1894189-67-3 | Purity: 97% | (SP-4-2)-[4,4′-bis(1,1-dimethylethyl)-2,2′-bipyridine-κN1,κN1′]dibromo-Nickel | ESD-932909-1G |
| Cas.: 1235475-17-8 | Purity: 94% | Methyl 4-amino-6-chloropyridine-2-carboxylate | ESD-932910-100MG |
| Cas.: 1235475-17-8 | Purity: 94% | Methyl 4-amino-6-chloropyridine-2-carboxylate | ESD-932910-250MG |
| Cas.: 1235475-17-8 | Purity: 94% | Methyl 4-amino-6-chloropyridine-2-carboxylate | ESD-932910-1G |
| Cas.: 672948-03-7 | Purity: 95% | 2-Oxazolecarboxylic acid | ESD-932911-100MG |
| Cas.: 672948-03-7 | Purity: 95% | 2-Oxazolecarboxylic acid | ESD-932911-250MG |
| Cas.: 672948-03-7 | Purity: 95% | 2-Oxazolecarboxylic acid | ESD-932911-1G |
| Cas.: 1260857-14-4 | Purity: 97% | 1-(4-Bromo-3-fluorophenyl)-2-chloroethanone | ESD-932912-100MG |
| Cas.: 1260857-14-4 | Purity: 97% | 1-(4-Bromo-3-fluorophenyl)-2-chloroethanone | ESD-932912-250MG |
| Cas.: 1260857-14-4 | Purity: 97% | 1-(4-Bromo-3-fluorophenyl)-2-chloroethanone | ESD-932912-1G |
| Cas.: 303121-11-1 | Purity: 95% | 6-Ethoxyquinolin-4-ol | ESD-932913-100MG |
| Cas.: 303121-11-1 | Purity: 95% | 6-Ethoxyquinolin-4-ol | ESD-932913-250MG |
| Cas.: 303121-11-1 | Purity: 95% | 6-Ethoxyquinolin-4-ol | ESD-932913-1G |
| Cas.: 56464-74-5 | Purity: 98% | 1-(2-Chlorophenyl)butane-1,3-dione | ESD-932914-100MG |
| Cas.: 56464-74-5 | Purity: 98% | 1-(2-Chlorophenyl)butane-1,3-dione | ESD-932914-250MG |
| Cas.: 56464-74-5 | Purity: 98% | 1-(2-Chlorophenyl)butane-1,3-dione | ESD-932914-1G |
| Cas.: 16357-68-9 | Purity: 98% | 4-Chloro-5-pyrimidinecarbonitrile | ESD-932915-100MG |
| Cas.: 16357-68-9 | Purity: 98% | 4-Chloro-5-pyrimidinecarbonitrile | ESD-932915-250MG |
| Cas.: 16357-68-9 | Purity: 98% | 4-Chloro-5-pyrimidinecarbonitrile | ESD-932915-1G |
| Cas.: 305346-13-8 | Purity: 97% | N-(4-Acetylphenyl)-1H-pyrazole-3-carboxamide | ESD-932916-100MG |
| Cas.: 305346-13-8 | Purity: 97% | N-(4-Acetylphenyl)-1H-pyrazole-3-carboxamide | ESD-932916-250MG |
| Cas.: 305346-13-8 | Purity: 97% | N-(4-Acetylphenyl)-1H-pyrazole-3-carboxamide | ESD-932916-1G |
| Cas.: 2785-78-6 | Purity: 97% | 3,6-Dimethylbenzene-1,2-diol | ESD-932917-100MG |
| Cas.: 2785-78-6 | Purity: 97% | 3,6-Dimethylbenzene-1,2-diol | ESD-932917-250MG |
| Cas.: 2785-78-6 | Purity: 97% | 3,6-Dimethylbenzene-1,2-diol | ESD-932917-1G |
| Cas.: 502546-41-0 | Purity: 95% | 5-Cyclopropyl-4H-1,2,4-triazol-3-amine | ESD-932918-100MG |
| Cas.: 502546-41-0 | Purity: 95% | 5-Cyclopropyl-4H-1,2,4-triazol-3-amine | ESD-932918-250MG |
| Cas.: 502546-41-0 | Purity: 95% | 5-Cyclopropyl-4H-1,2,4-triazol-3-amine | ESD-932918-1G |
| Cas.: 60577-28-8 | Purity: 97% | 2-(Dimethylamino)-3-phenylpropan-1-ol | ESD-932919-100MG |
| Cas.: 60577-28-8 | Purity: 97% | 2-(Dimethylamino)-3-phenylpropan-1-ol | ESD-932919-250MG |
| Cas.: 60577-28-8 | Purity: 97% | 2-(Dimethylamino)-3-phenylpropan-1-ol | ESD-932919-1G |
| Cas.: 10191-24-9 | Purity: 97% | 3-Hydroxyhexanoic acid | ESD-932920-100MG |
| Cas.: 10191-24-9 | Purity: 97% | 3-Hydroxyhexanoic acid | ESD-932920-250MG |
| Cas.: 10191-24-9 | Purity: 97% | 3-Hydroxyhexanoic acid | ESD-932920-1G |
| Cas.: 1865-29-8 | Purity: 95% (TBC as stabilizer) | Methyl 2-phenylacrylate | ESD-932921-100MG |
| Cas.: 1865-29-8 | Purity: 95% (TBC as stabilizer) | Methyl 2-phenylacrylate | ESD-932921-250MG |
| Cas.: 1865-29-8 | Purity: 95% (TBC as stabilizer) | Methyl 2-phenylacrylate | ESD-932921-1G |
| Cas.: 3066-84-0 | Purity: 95% | 8-Bromoguanine | ESD-932922-100MG |
| Cas.: 3066-84-0 | Purity: 95% | 8-Bromoguanine | ESD-932922-250MG |
| Cas.: 3066-84-0 | Purity: 95% | 8-Bromoguanine | ESD-932922-1G |
| Cas.: 723280-94-2 | Purity: 97% | 7-Bromo-3-nitroquinolin-4-ol | ESD-932923-100MG |
| Cas.: 723280-94-2 | Purity: 97% | 7-Bromo-3-nitroquinolin-4-ol | ESD-932923-250MG |
| Cas.: 723280-94-2 | Purity: 97% | 7-Bromo-3-nitroquinolin-4-ol | ESD-932923-1G |
| Cas.: 58677-34-2 | Purity: 98% | 4-Methyl-1,2,5-oxadiazole-3-carboxylic acid | ESD-932924-100MG |
| Cas.: 58677-34-2 | Purity: 98% | 4-Methyl-1,2,5-oxadiazole-3-carboxylic acid | ESD-932924-250MG |
| Cas.: 58677-34-2 | Purity: 98% | 4-Methyl-1,2,5-oxadiazole-3-carboxylic acid | ESD-932924-1G |
| Cas.: 54245-33-9 | Purity: 95% | 3-Bromonaphthalen-2-amine | ESD-932925-100MG |
| Cas.: 54245-33-9 | Purity: 95% | 3-Bromonaphthalen-2-amine | ESD-932925-250MG |
| Cas.: 54245-33-9 | Purity: 95% | 3-Bromonaphthalen-2-amine | ESD-932925-1G |
| Cas.: 5465-28-1 | Purity: 96% | 2-Ethyl-2-phenylbutanoic acid | ESD-932926-100MG |
| Cas.: 5465-28-1 | Purity: 96% | 2-Ethyl-2-phenylbutanoic acid | ESD-932926-250MG |
| Cas.: 5465-28-1 | Purity: 96% | 2-Ethyl-2-phenylbutanoic acid | ESD-932926-1G |
| Cas.: 281655-61-6 | Purity: 95% | (2S)-2-([(9H-fluoren-9-ylmethoxy)carbonyl]amino)-3-(quinolin-3-yl)propanoic acid | ESD-932927-100MG |
| Cas.: 281655-61-6 | Purity: 95% | (2S)-2-([(9H-fluoren-9-ylmethoxy)carbonyl]amino)-3-(quinolin-3-yl)propanoic acid | ESD-932927-250MG |
| Cas.: 281655-61-6 | Purity: 95% | (2S)-2-([(9H-fluoren-9-ylmethoxy)carbonyl]amino)-3-(quinolin-3-yl)propanoic acid | ESD-932927-1G |
| Cas.: 29949-81-3 | Purity: 95% | Tris(4-bromophenyl)phosphane | ESD-932928-100MG |
| Cas.: 29949-81-3 | Purity: 95% | Tris(4-bromophenyl)phosphane | ESD-932928-250MG |
| Cas.: 29949-81-3 | Purity: 95% | Tris(4-bromophenyl)phosphane | ESD-932928-1G |
| Cas.: 81449-01-6 | Purity: 97% | (4-(Hydroxymethyl)phenyl)(phenyl)methanone | ESD-932929-100MG |
| Cas.: 81449-01-6 | Purity: 97% | (4-(Hydroxymethyl)phenyl)(phenyl)methanone | ESD-932929-250MG |
| Cas.: 81449-01-6 | Purity: 97% | (4-(Hydroxymethyl)phenyl)(phenyl)methanone | ESD-932929-1G |
| Cas.: 132335-49-0 | Purity: 95% | (R)-3-(Dimethylamino)-1-(thiophen-2-yl)propan-1-ol | ESD-932930-100MG |
| Cas.: 132335-49-0 | Purity: 95% | (R)-3-(Dimethylamino)-1-(thiophen-2-yl)propan-1-ol | ESD-932930-250MG |
| Cas.: 132335-49-0 | Purity: 95% | (R)-3-(Dimethylamino)-1-(thiophen-2-yl)propan-1-ol | ESD-932930-1G |
| Cas.: 17113-33-6 | Purity: 95% | 2-Phenylfuran | ESD-932931-100MG |
| Cas.: 17113-33-6 | Purity: 95% | 2-Phenylfuran | ESD-932931-250MG |
| Cas.: 17113-33-6 | Purity: 95% | 2-Phenylfuran | ESD-932931-1G |
| Cas.: 19641-29-3 | Purity: 95% | 6-Chloroisobenzofuran-1(3H)-one | ESD-932932-100MG |
| Cas.: 19641-29-3 | Purity: 95% | 6-Chloroisobenzofuran-1(3H)-one | ESD-932932-250MG |
| Cas.: 19641-29-3 | Purity: 95% | 6-Chloroisobenzofuran-1(3H)-one | ESD-932932-1G |
| Cas.: 849950-54-5 | Purity: 97%, 99%ee | 1,1-Bis((2R,5R)-2,5-di-i-propylphospholano)ferrocene | ESD-932933-100MG |
| Cas.: 849950-54-5 | Purity: 97%, 99%ee | 1,1-Bis((2R,5R)-2,5-di-i-propylphospholano)ferrocene | ESD-932933-250MG |
| Cas.: 849950-54-5 | Purity: 97%, 99%ee | 1,1-Bis((2R,5R)-2,5-di-i-propylphospholano)ferrocene | ESD-932933-1G |
| Cas.: 130981-12-3 | Purity: 98% | (1R,2S)-2-((Tert-butoxycarbonyl)amino)cyclopentanecarboxylic acid | ESD-932934-100MG |
| Cas.: 130981-12-3 | Purity: 98% | (1R,2S)-2-((Tert-butoxycarbonyl)amino)cyclopentanecarboxylic acid | ESD-932934-250MG |
| Cas.: 130981-12-3 | Purity: 98% | (1R,2S)-2-((Tert-butoxycarbonyl)amino)cyclopentanecarboxylic acid | ESD-932934-1G |
| Cas.: 889884-94-0 | Purity: 95% | 7-Fluoronaphthalen-2-ol | ESD-932935-100MG |
| Cas.: 889884-94-0 | Purity: 95% | 7-Fluoronaphthalen-2-ol | ESD-932935-250MG |
| Cas.: 889884-94-0 | Purity: 95% | 7-Fluoronaphthalen-2-ol | ESD-932935-1G |
| Cas.: 1820979-19-8 | Purity: 97% | 6-Aminospiro[3.3]heptan-2-ol hydrochloride | ESD-932936-100MG |
| Cas.: 1820979-19-8 | Purity: 97% | 6-Aminospiro[3.3]heptan-2-ol hydrochloride | ESD-932936-250MG |
| Cas.: 1820979-19-8 | Purity: 97% | 6-Aminospiro[3.3]heptan-2-ol hydrochloride | ESD-932936-1G |
| Cas.: 38895-88-4 | Purity: 97% | 1-Hydroxy-3,3-dimethylbutan-2-one | ESD-932937-100MG |
| Cas.: 38895-88-4 | Purity: 97% | 1-Hydroxy-3,3-dimethylbutan-2-one | ESD-932937-250MG |
| Cas.: 38895-88-4 | Purity: 97% | 1-Hydroxy-3,3-dimethylbutan-2-one | ESD-932937-1G |
| Cas.: 17640-29-8 | Purity: 95% | Ethyl 2-(ethylthio)acetate | ESD-932938-100MG |
| Cas.: 17640-29-8 | Purity: 95% | Ethyl 2-(ethylthio)acetate | ESD-932938-250MG |
| Cas.: 17640-29-8 | Purity: 95% | Ethyl 2-(ethylthio)acetate | ESD-932938-1G |
| Cas.: 32775-08-9 | Purity: 95% | 3,6,9,12-Tetraoxatetradecane-1,14-dioic acid | ESD-932939-100MG |
| Cas.: 32775-08-9 | Purity: 95% | 3,6,9,12-Tetraoxatetradecane-1,14-dioic acid | ESD-932939-250MG |
| Cas.: 32775-08-9 | Purity: 95% | 3,6,9,12-Tetraoxatetradecane-1,14-dioic acid | ESD-932939-1G |
| Cas.: 116206-75-8 | Purity: 98% | 4,4-(10,20-Diphenyl-21H ,23H-porphine-5,15-diyl)bis[benzenamine] | ESD-932940-100MG |
| Cas.: 116206-75-8 | Purity: 98% | 4,4-(10,20-Diphenyl-21H ,23H-porphine-5,15-diyl)bis[benzenamine] | ESD-932940-250MG |
| Cas.: 116206-75-8 | Purity: 98% | 4,4-(10,20-Diphenyl-21H ,23H-porphine-5,15-diyl)bis[benzenamine] | ESD-932940-1G |
| Cas.: 310466-37-6 | Purity: 95% | 4-Fluorobenzo[b]thiophene-2-carboxylic acid | ESD-932941-100MG |
| Cas.: 310466-37-6 | Purity: 95% | 4-Fluorobenzo[b]thiophene-2-carboxylic acid | ESD-932941-250MG |
| Cas.: 310466-37-6 | Purity: 95% | 4-Fluorobenzo[b]thiophene-2-carboxylic acid | ESD-932941-1G |
| Cas.: 21691-50-9 | Purity: 95% | (S)-Tert-butyl 2-aminopropanoate | ESD-932942-100MG |
| Cas.: 21691-50-9 | Purity: 95% | (S)-Tert-butyl 2-aminopropanoate | ESD-932942-250MG |
| Cas.: 21691-50-9 | Purity: 95% | (S)-Tert-butyl 2-aminopropanoate | ESD-932942-1G |
| Cas.: 936850-33-8 | Purity: 95% | 3-Methylazetidine-3-carbonitrile hydrochloride | ESD-932943-100MG |
| Cas.: 936850-33-8 | Purity: 95% | 3-Methylazetidine-3-carbonitrile hydrochloride | ESD-932943-250MG |
| Cas.: 936850-33-8 | Purity: 95% | 3-Methylazetidine-3-carbonitrile hydrochloride | ESD-932943-1G |
| Cas.: 20969-02-2 | Purity: 95% | 3-Azabicyclo[3.2.1]octane hydrochloride | ESD-932944-100MG |
| Cas.: 20969-02-2 | Purity: 95% | 3-Azabicyclo[3.2.1]octane hydrochloride | ESD-932944-250MG |
| Cas.: 20969-02-2 | Purity: 95% | 3-Azabicyclo[3.2.1]octane hydrochloride | ESD-932944-1G |
| Cas.: 76150-91-9 | Purity: 97% | 1,4-Bis((3,5-dichloropyridin-2-yl)oxy)benzene | ESD-932945-100MG |
| Cas.: 76150-91-9 | Purity: 97% | 1,4-Bis((3,5-dichloropyridin-2-yl)oxy)benzene | ESD-932945-250MG |
| Cas.: 76150-91-9 | Purity: 97% | 1,4-Bis((3,5-dichloropyridin-2-yl)oxy)benzene | ESD-932945-1G |
| Cas.: 135654-16-9 | Purity: 98% | 3-(Chloromethyl)benzamide | ESD-932946-100MG |
| Cas.: 135654-16-9 | Purity: 98% | 3-(Chloromethyl)benzamide | ESD-932946-250MG |
| Cas.: 135654-16-9 | Purity: 98% | 3-(Chloromethyl)benzamide | ESD-932946-1G |
| Cas.: 24423-11-8 | Purity: 95% | 2-Chlorophenanthrene | ESD-932947-100MG |
| Cas.: 24423-11-8 | Purity: 95% | 2-Chlorophenanthrene | ESD-932947-250MG |
| Cas.: 24423-11-8 | Purity: 95% | 2-Chlorophenanthrene | ESD-932947-1G |
| Cas.: 1201935-85-4 | Purity: 95% | 3-Methoxy-1-methyl-4-nitro-1H-pyrazole | ESD-932948-100MG |
| Cas.: 1201935-85-4 | Purity: 95% | 3-Methoxy-1-methyl-4-nitro-1H-pyrazole | ESD-932948-250MG |
| Cas.: 1201935-85-4 | Purity: 95% | 3-Methoxy-1-methyl-4-nitro-1H-pyrazole | ESD-932948-1G |
| Cas.: 178396-28-6 | Purity: 97% | 6-Bromo-2,5-dimethylbenzo[d]thiazole | ESD-932949-100MG |
| Cas.: 178396-28-6 | Purity: 97% | 6-Bromo-2,5-dimethylbenzo[d]thiazole | ESD-932949-250MG |
| Cas.: 178396-28-6 | Purity: 97% | 6-Bromo-2,5-dimethylbenzo[d]thiazole | ESD-932949-1G |
| Cas.: 151521-49-2 | Purity: 95% | 4-Isopropyl-1H-pyrazol-5-amine | ESD-932950-100MG |
| Cas.: 151521-49-2 | Purity: 95% | 4-Isopropyl-1H-pyrazol-5-amine | ESD-932950-250MG |
| Cas.: 151521-49-2 | Purity: 95% | 4-Isopropyl-1H-pyrazol-5-amine | ESD-932950-1G |
| Cas.: 131042-78-9 | Purity: 98% | 1,3-Di(adamantan-1-yl)-1H-imidazol-3-ium chloride | ESD-932951-100MG |
| Cas.: 131042-78-9 | Purity: 98% | 1,3-Di(adamantan-1-yl)-1H-imidazol-3-ium chloride | ESD-932951-250MG |
| Cas.: 131042-78-9 | Purity: 98% | 1,3-Di(adamantan-1-yl)-1H-imidazol-3-ium chloride | ESD-932951-1G |
| Cas.: 799274-08-1 | Purity: 95% | 6-Fluoro-1,2,3,4-tetrahydroisoquinoline hydrochloride | ESD-932952-100MG |
| Cas.: 799274-08-1 | Purity: 95% | 6-Fluoro-1,2,3,4-tetrahydroisoquinoline hydrochloride | ESD-932952-250MG |
| Cas.: 799274-08-1 | Purity: 95% | 6-Fluoro-1,2,3,4-tetrahydroisoquinoline hydrochloride | ESD-932952-1G |
| Cas.: 10548-77-3 | Purity: 97% | 1-(3,4-Dimethoxyphenyl)-3-hydroxy-2-(2-methoxyphenoxy)propan-1-one | ESD-932953-100MG |
| Cas.: 10548-77-3 | Purity: 97% | 1-(3,4-Dimethoxyphenyl)-3-hydroxy-2-(2-methoxyphenoxy)propan-1-one | ESD-932953-250MG |
| Cas.: 10548-77-3 | Purity: 97% | 1-(3,4-Dimethoxyphenyl)-3-hydroxy-2-(2-methoxyphenoxy)propan-1-one | ESD-932953-1G |
| Cas.: 1391381-36-4 | Purity: 95% | Methyl (R)-2-amino-2-(2-bromo-4-fluorophenyl)acetate HCl | ESD-932954-100MG |
| Cas.: 1391381-36-4 | Purity: 95% | Methyl (R)-2-amino-2-(2-bromo-4-fluorophenyl)acetate HCl | ESD-932954-250MG |
| Cas.: 1391381-36-4 | Purity: 95% | Methyl (R)-2-amino-2-(2-bromo-4-fluorophenyl)acetate HCl | ESD-932954-1G |
| Cas.: 364750-80-1 | Purity: 97% | (2S,4R)-1-(Tert-butoxycarbonyl)-4-methylpyrrolidine-2-carboxylic acid | ESD-932955-100MG |
| Cas.: 364750-80-1 | Purity: 97% | (2S,4R)-1-(Tert-butoxycarbonyl)-4-methylpyrrolidine-2-carboxylic acid | ESD-932955-250MG |
| Cas.: 364750-80-1 | Purity: 97% | (2S,4R)-1-(Tert-butoxycarbonyl)-4-methylpyrrolidine-2-carboxylic acid | ESD-932955-1G |
| Cas.: 1224727-08-5 | Purity: 98%, 99%ee | (1S,2S)-N,N-Bis[2-(di-p-tolylphosphino)benzyl]cyclohexane-1,2-diamine | ESD-932956-100MG |
| Cas.: 1224727-08-5 | Purity: 98%, 99%ee | (1S,2S)-N,N-Bis[2-(di-p-tolylphosphino)benzyl]cyclohexane-1,2-diamine | ESD-932956-250MG |
| Cas.: 1224727-08-5 | Purity: 98%, 99%ee | (1S,2S)-N,N-Bis[2-(di-p-tolylphosphino)benzyl]cyclohexane-1,2-diamine | ESD-932956-1G |
| Cas.: 51761-07-0 | Purity: 97% | 9H-Carbazole-3-carbaldehyde | ESD-932957-100MG |
| Cas.: 51761-07-0 | Purity: 97% | 9H-Carbazole-3-carbaldehyde | ESD-932957-250MG |
| Cas.: 51761-07-0 | Purity: 97% | 9H-Carbazole-3-carbaldehyde | ESD-932957-1G |
| Cas.: 10240-08-1 | Purity: 97% | 4-Methylnaphthalen-1-ol | ESD-932958-100MG |
| Cas.: 10240-08-1 | Purity: 97% | 4-Methylnaphthalen-1-ol | ESD-932958-250MG |
| Cas.: 25947-11-9 | Purity: 95% | 2-(4-Oxo-3,4-dihydrophthalazin-1-yl)acetic acid | ESD-932959-100MG |
| Cas.: 25947-11-9 | Purity: 95% | 2-(4-Oxo-3,4-dihydrophthalazin-1-yl)acetic acid | ESD-932959-250MG |
| Cas.: 25947-11-9 | Purity: 95% | 2-(4-Oxo-3,4-dihydrophthalazin-1-yl)acetic acid | ESD-932959-1G |
| Cas.: 1996-23-2 | Purity: 97% | 3,4,5,6-Tetrafluorobenzene-1,2-diol | ESD-932960-100MG |
| Cas.: 1996-23-2 | Purity: 97% | 3,4,5,6-Tetrafluorobenzene-1,2-diol | ESD-932960-250MG |
| Cas.: 1996-23-2 | Purity: 97% | 3,4,5,6-Tetrafluorobenzene-1,2-diol | ESD-932960-1G |
| Cas.: 119-43-7 | Purity: 95% | Ethyl 2-phenylbutanoate | ESD-932961-100MG |
| Cas.: 119-43-7 | Purity: 95% | Ethyl 2-phenylbutanoate | ESD-932961-250MG |
| Cas.: 119-43-7 | Purity: 95% | Ethyl 2-phenylbutanoate | ESD-932961-1G |
| Cas.: 1347750-72-4 | Purity: 95% | 2,5,8,11,14,17-Hexaoxaicosan-20-oic acid | ESD-932962-100MG |
| Cas.: 1347750-72-4 | Purity: 95% | 2,5,8,11,14,17-Hexaoxaicosan-20-oic acid | ESD-932962-250MG |
| Cas.: 1347750-72-4 | Purity: 95% | 2,5,8,11,14,17-Hexaoxaicosan-20-oic acid | ESD-932962-1G |
| Cas.: 51980-60-0 | Purity: 97% | 4-(2-Methoxyethoxy)phenol | ESD-932963-100MG |
| Cas.: 51980-60-0 | Purity: 97% | 4-(2-Methoxyethoxy)phenol | ESD-932963-250MG |
| Cas.: 51980-60-0 | Purity: 97% | 4-(2-Methoxyethoxy)phenol | ESD-932963-1G |
| Cas.: 176022-47-2 | Purity: 97% | (S)-(4-Chlorophenyl)(pyridin-2-yl)methanol | ESD-932964-100MG |
| Cas.: 176022-47-2 | Purity: 97% | (S)-(4-Chlorophenyl)(pyridin-2-yl)methanol | ESD-932964-250MG |
| Cas.: 176022-47-2 | Purity: 97% | (S)-(4-Chlorophenyl)(pyridin-2-yl)methanol | ESD-932964-1G |
| Cas.: 4764-13-0 | Purity: 95% | 2-(Piperidin-1-ylmethyl)phenol | ESD-932965-100MG |
| Cas.: 4764-13-0 | Purity: 95% | 2-(Piperidin-1-ylmethyl)phenol | ESD-932965-250MG |
| Cas.: 4764-13-0 | Purity: 95% | 2-(Piperidin-1-ylmethyl)phenol | ESD-932965-1G |
| Cas.: 486459-98-7 | Purity: 95% | (R)-b-(Boc-amino)-2,5-difluorobenzenebutanoic acid | ESD-932966-100MG |
| Cas.: 486459-98-7 | Purity: 95% | (R)-b-(Boc-amino)-2,5-difluorobenzenebutanoic acid | ESD-932966-250MG |
| Cas.: 486459-98-7 | Purity: 95% | (R)-b-(Boc-amino)-2,5-difluorobenzenebutanoic acid | ESD-932966-1G |
| Cas.: 64951-10-6 | Purity: 97% | Imidazo[1,2-a]pyrimidine-2-carboxylic acid | ESD-932967-100MG |
| Cas.: 64951-10-6 | Purity: 97% | Imidazo[1,2-a]pyrimidine-2-carboxylic acid | ESD-932967-250MG |
| Cas.: 64951-10-6 | Purity: 97% | Imidazo[1,2-a]pyrimidine-2-carboxylic acid | ESD-932967-1G |
| Cas.: 23058-81-3 | Purity: 98% | 1-Bromo-3,5-diisopropylbenzene | ESD-932968-100MG |
| Cas.: 23058-81-3 | Purity: 98% | 1-Bromo-3,5-diisopropylbenzene | ESD-932968-250MG |
| Cas.: 23058-81-3 | Purity: 98% | 1-Bromo-3,5-diisopropylbenzene | ESD-932968-1G |
| Cas.: 82846-28-4 | Purity: 98% | 6-(Dimethylamino)nicotinic acid | ESD-932969-100MG |
| Cas.: 82846-28-4 | Purity: 98% | 6-(Dimethylamino)nicotinic acid | ESD-932969-250MG |
| Cas.: 82846-28-4 | Purity: 98% | 6-(Dimethylamino)nicotinic acid | ESD-932969-1G |
| Cas.: 19075-32-2 | Purity: 95% | Benzo[b]thiophen-4-amine hydrochloride | ESD-932970-100MG |
| Cas.: 19075-32-2 | Purity: 95% | Benzo[b]thiophen-4-amine hydrochloride | ESD-932970-250MG |
| Cas.: 19075-32-2 | Purity: 95% | Benzo[b]thiophen-4-amine hydrochloride | ESD-932970-1G |
| Cas.: 52415-00-6 | Purity: 97% | 4-Iodo-2-methyl-1-nitrobenzene | ESD-932971-100MG |
| Cas.: 52415-00-6 | Purity: 97% | 4-Iodo-2-methyl-1-nitrobenzene | ESD-932971-250MG |
| Cas.: 52415-00-6 | Purity: 97% | 4-Iodo-2-methyl-1-nitrobenzene | ESD-932971-1G |
| Cas.: 1807740-34-6 | Purity: 97% | (S)-4-(Anthracen-9-yl)-3-(tert-butyl)-2,3-dihydrobenzo[d][1,3]oxaphosphole | ESD-932972-100MG |
| Cas.: 1807740-34-6 | Purity: 97% | (S)-4-(Anthracen-9-yl)-3-(tert-butyl)-2,3-dihydrobenzo[d][1,3]oxaphosphole | ESD-932972-250MG |
| Cas.: 1807740-34-6 | Purity: 97% | (S)-4-(Anthracen-9-yl)-3-(tert-butyl)-2,3-dihydrobenzo[d][1,3]oxaphosphole | ESD-932972-1G |
| Cas.: 10354-53-7 | Purity: 95% | N-Phenylpicolinamide | ESD-932973-100MG |
| Cas.: 10354-53-7 | Purity: 95% | N-Phenylpicolinamide | ESD-932973-250MG |
| Cas.: 10354-53-7 | Purity: 95% | N-Phenylpicolinamide | ESD-932973-1G |
| Cas.: 15978-93-5 | Purity: 98% | cis-Diiododiammineplatinum(II) | ESD-932974-100MG |
| Cas.: 15978-93-5 | Purity: 98% | cis-Diiododiammineplatinum(II) | ESD-932974-250MG |
| Cas.: 15978-93-5 | Purity: 98% | cis-Diiododiammineplatinum(II) | ESD-932974-1G |
| Cas.: 38146-42-8 | Purity: 95% | N1,N10-Bis(2-((2-isopropyl-5-methylcyclohexyl)oxy)-2-oxoethyl)-N1,N1,N10,N10-tetramethyldecane-1,10-diaminium chloride | ESD-932975-100MG |
| Cas.: 38146-42-8 | Purity: 95% | N1,N10-Bis(2-((2-isopropyl-5-methylcyclohexyl)oxy)-2-oxoethyl)-N1,N1,N10,N10-tetramethyldecane-1,10-diaminium chloride | ESD-932975-250MG |
| Cas.: 38146-42-8 | Purity: 95% | N1,N10-Bis(2-((2-isopropyl-5-methylcyclohexyl)oxy)-2-oxoethyl)-N1,N1,N10,N10-tetramethyldecane-1,10-diaminium chloride | ESD-932975-1G |
| Cas.: 67139-22-4 | Purity: 95% | 5,6,7,8-Tetrahydroimidazo[1,2-a]pyrimidine | ESD-932976-100MG |
| Cas.: 67139-22-4 | Purity: 95% | 5,6,7,8-Tetrahydroimidazo[1,2-a]pyrimidine | ESD-932976-250MG |
| Cas.: 67139-22-4 | Purity: 95% | 5,6,7,8-Tetrahydroimidazo[1,2-a]pyrimidine | ESD-932976-1G |
| Cas.: 393-78-2 | Purity: 95% | Methyl 3-fluoro-2-iodobenzoate | ESD-932977-100MG |
| Cas.: 393-78-2 | Purity: 95% | Methyl 3-fluoro-2-iodobenzoate | ESD-932977-250MG |
| Cas.: 393-78-2 | Purity: 95% | Methyl 3-fluoro-2-iodobenzoate | ESD-932977-1G |
| Cas.: 171670-07-8 | Purity: 95% | 6-(((Tert-butoxycarbonyl)amino)methyl)picolinic acid | ESD-932978-100MG |
| Cas.: 171670-07-8 | Purity: 95% | 6-(((Tert-butoxycarbonyl)amino)methyl)picolinic acid | ESD-932978-250MG |
| Cas.: 171670-07-8 | Purity: 95% | 6-(((Tert-butoxycarbonyl)amino)methyl)picolinic acid | ESD-932978-1G |
| Cas.: 1829-26-1 | Purity: 97% | 1-Acetoxy-1,2-benziodoxol-3-(1H)-one | ESD-932979-100MG |
| Cas.: 1829-26-1 | Purity: 97% | 1-Acetoxy-1,2-benziodoxol-3-(1H)-one | ESD-932979-250MG |
| Cas.: 1829-26-1 | Purity: 97% | 1-Acetoxy-1,2-benziodoxol-3-(1H)-one | ESD-932979-1G |
| Cas.: 98406-04-3 | Purity: 98% | Methyl 3-chloro-5-hydroxybenzoate | ESD-932980-100MG |
| Cas.: 98406-04-3 | Purity: 98% | Methyl 3-chloro-5-hydroxybenzoate | ESD-932980-250MG |
| Cas.: 98406-04-3 | Purity: 98% | Methyl 3-chloro-5-hydroxybenzoate | ESD-932980-1G |
| Cas.: 12073-36-8 | Purity: 98% | Di-μ-chlorodichlorobis(ethylene)diplatinum(II) | ESD-932981-100MG |
| Cas.: 12073-36-8 | Purity: 98% | Di-μ-chlorodichlorobis(ethylene)diplatinum(II) | ESD-932981-250MG |
| Cas.: 12073-36-8 | Purity: 98% | Di-μ-chlorodichlorobis(ethylene)diplatinum(II) | ESD-932981-1G |
| Cas.: 99455-08-0 | Purity: 97% | 7-Bromo-2-methoxyquinoline | ESD-932982-100MG |
| Cas.: 99455-08-0 | Purity: 97% | 7-Bromo-2-methoxyquinoline | ESD-932982-250MG |
| Cas.: 99455-08-0 | Purity: 97% | 7-Bromo-2-methoxyquinoline | ESD-932982-1G |
| Cas.: 184838-77-5 | Purity: 90% | (1R,5S)-Ethyl 2-oxo-3-oxabicyclo[3.1.0]hexane-1-carboxylate | ESD-932983-100MG |
| Cas.: 184838-77-5 | Purity: 90% | (1R,5S)-Ethyl 2-oxo-3-oxabicyclo[3.1.0]hexane-1-carboxylate | ESD-932983-250MG |
| Cas.: 184838-77-5 | Purity: 90% | (1R,5S)-Ethyl 2-oxo-3-oxabicyclo[3.1.0]hexane-1-carboxylate | ESD-932983-1G |
| Cas.: 302333-80-8 | Purity: 97% | (4-Cyclopropylphenyl)boronic acid | ESD-932984-100MG |
| Cas.: 302333-80-8 | Purity: 97% | (4-Cyclopropylphenyl)boronic acid | ESD-932984-250MG |
| Cas.: 302333-80-8 | Purity: 97% | (4-Cyclopropylphenyl)boronic acid | ESD-932984-1G |
| Cas.: 163839-73-4 | Purity: 97% | 2-(4-(Trifluoromethyl)phenoxy)acetic acid | ESD-932985-100MG |
| Cas.: 163839-73-4 | Purity: 97% | 2-(4-(Trifluoromethyl)phenoxy)acetic acid | ESD-932985-250MG |
| Cas.: 163839-73-4 | Purity: 97% | 2-(4-(Trifluoromethyl)phenoxy)acetic acid | ESD-932985-1G |
| Cas.: 54364-62-4 | Purity: ≥98% | (7E,9Z)-Dodeca-7,9-dien-1-yl acetate | ESD-932986-100MG |
| Cas.: 54364-62-4 | Purity: ≥98% | (7E,9Z)-Dodeca-7,9-dien-1-yl acetate | ESD-932986-250MG |
| Cas.: 54364-62-4 | Purity: ≥98% | (7E,9Z)-Dodeca-7,9-dien-1-yl acetate | ESD-932986-1G |
| Cas.: 7766-51-0 | Purity: 95% | 4-Iodobut-1-ene | ESD-932987-100MG |
| Cas.: 7766-51-0 | Purity: 95% | 4-Iodobut-1-ene | ESD-932987-250MG |
| Cas.: 7766-51-0 | Purity: 95% | 4-Iodobut-1-ene | ESD-932987-1G |
| Cas.: 158329-07-8 | Purity: 95% | 4-Amino-6-methyl-4,5-dihydro-1,2,4-triazin-3(2H)-one hydrochloride | ESD-932988-100MG |
| Cas.: 158329-07-8 | Purity: 95% | 4-Amino-6-methyl-4,5-dihydro-1,2,4-triazin-3(2H)-one hydrochloride | ESD-932988-250MG |
| Cas.: 158329-07-8 | Purity: 95% | 4-Amino-6-methyl-4,5-dihydro-1,2,4-triazin-3(2H)-one hydrochloride | ESD-932988-1G |
| Cas.: 607-31-8 | Purity: 98% | 4-Methoxyquinoline | ESD-932989-100MG |
| Cas.: 607-31-8 | Purity: 98% | 4-Methoxyquinoline | ESD-932989-250MG |
| Cas.: 607-31-8 | Purity: 98% | 4-Methoxyquinoline | ESD-932989-1G |
| Cas.: 63024-25-9 | Purity: 95% | (S)-Methyl 2-amino-3-(naphthalen-1-yl)propanoate hydrochloride | ESD-932990-100MG |
| Cas.: 63024-25-9 | Purity: 95% | (S)-Methyl 2-amino-3-(naphthalen-1-yl)propanoate hydrochloride | ESD-932990-250MG |
| Cas.: 63024-25-9 | Purity: 95% | (S)-Methyl 2-amino-3-(naphthalen-1-yl)propanoate hydrochloride | ESD-932990-1G |
| Cas.: 876506-51-3 | Purity: 95% | 3-(2-Oxooxazolidin-3-yl)propanoic acid | ESD-932991-100MG |
| Cas.: 876506-51-3 | Purity: 95% | 3-(2-Oxooxazolidin-3-yl)propanoic acid | ESD-932991-250MG |
| Cas.: 876506-51-3 | Purity: 95% | 3-(2-Oxooxazolidin-3-yl)propanoic acid | ESD-932991-1G |
| Cas.: 834-14-0 | Purity: 97% | 1-Benzyl-4-methoxybenzene | ESD-932992-100MG |
| Cas.: 834-14-0 | Purity: 97% | 1-Benzyl-4-methoxybenzene | ESD-932992-250MG |
| Cas.: 834-14-0 | Purity: 97% | 1-Benzyl-4-methoxybenzene | ESD-932992-1G |
| Cas.: 238428-27-8 | Purity: 97% | N-(3-(Aminomethyl)phenyl)acetamide hydrochloride | ESD-932993-100MG |
| Cas.: 238428-27-8 | Purity: 97% | N-(3-(Aminomethyl)phenyl)acetamide hydrochloride | ESD-932993-250MG |
| Cas.: 238428-27-8 | Purity: 97% | N-(3-(Aminomethyl)phenyl)acetamide hydrochloride | ESD-932993-1G |
| Cas.: 638192-65-1 | Purity: 96% | Benzo[d]oxazole-5-carbaldehyde | ESD-932994-100MG |
| Cas.: 638192-65-1 | Purity: 96% | Benzo[d]oxazole-5-carbaldehyde | ESD-932994-250MG |
| Cas.: 638192-65-1 | Purity: 96% | Benzo[d]oxazole-5-carbaldehyde | ESD-932994-1G |
| Cas.: 78267-15-9 | Purity: 95% | Ethyl 4-oxo-2-(phenylamino)-4,5-dihydrothiophene-3-carboxylate | ESD-932995-100MG |
| Cas.: 78267-15-9 | Purity: 95% | Ethyl 4-oxo-2-(phenylamino)-4,5-dihydrothiophene-3-carboxylate | ESD-932995-250MG |
| Cas.: 78267-15-9 | Purity: 95% | Ethyl 4-oxo-2-(phenylamino)-4,5-dihydrothiophene-3-carboxylate | ESD-932995-1G |
| Cas.: 154590-66-6 | Purity: 95% | (S)-N-((3-(3-Fluoro-4-(piperazin-1-yl)phenyl)-2-oxooxazolidin-5-yl)methyl)acetamide | ESD-932996-100MG |
| Cas.: 154590-66-6 | Purity: 95% | (S)-N-((3-(3-Fluoro-4-(piperazin-1-yl)phenyl)-2-oxooxazolidin-5-yl)methyl)acetamide | ESD-932996-250MG |
| Cas.: 154590-66-6 | Purity: 95% | (S)-N-((3-(3-Fluoro-4-(piperazin-1-yl)phenyl)-2-oxooxazolidin-5-yl)methyl)acetamide | ESD-932996-1G |
| Cas.: 1369766-72-2 | Purity: 95% | 5-Methoxy-2,4-dimethylpyrimidine | ESD-932997-100MG |
| Cas.: 1369766-72-2 | Purity: 95% | 5-Methoxy-2,4-dimethylpyrimidine | ESD-932997-250MG |
| Cas.: 1369766-72-2 | Purity: 95% | 5-Methoxy-2,4-dimethylpyrimidine | ESD-932997-1G |
| Cas.: 106034-22-4 | Purity: ≥95% | (S)-2-Amino-3-(4-fluoro-1H-indol-3-yl)propanoic acid | ESD-932998-100MG |
| Cas.: 106034-22-4 | Purity: ≥95% | (S)-2-Amino-3-(4-fluoro-1H-indol-3-yl)propanoic acid | ESD-932998-250MG |
| Cas.: 106034-22-4 | Purity: ≥95% | (S)-2-Amino-3-(4-fluoro-1H-indol-3-yl)propanoic acid | ESD-932998-1G |
| Cas.: 135689-93-9 | Purity: ≥95% | 4′-Formyl-[1,1′-biphenyl]-2-carbonitrile | ESD-932999-100MG |
| Cas.: 135689-93-9 | Purity: ≥95% | 4′-Formyl-[1,1′-biphenyl]-2-carbonitrile | ESD-932999-250MG |
| Cas.: 135689-93-9 | Purity: ≥95% | 4′-Formyl-[1,1′-biphenyl]-2-carbonitrile | ESD-932999-1G |
| Cas.: 917806-24-7 | Purity: 95% | 2-Chloro-3-methyl-4-(trifluoromethyl)pyridine | ESD-933000-100MG |
| Cas.: 917806-24-7 | Purity: 95% | 2-Chloro-3-methyl-4-(trifluoromethyl)pyridine | ESD-933000-250MG |
| Cas.: 917806-24-7 | Purity: 95% | 2-Chloro-3-methyl-4-(trifluoromethyl)pyridine | ESD-933000-1G |
| Cas.: 885168-12-7 | Purity: 98% | 2,3-Dichloro-5-methoxypyridine | ESD-933001-100MG |
| Cas.: 885168-12-7 | Purity: 98% | 2,3-Dichloro-5-methoxypyridine | ESD-933001-250MG |
| Cas.: 885168-12-7 | Purity: 98% | 2,3-Dichloro-5-methoxypyridine | ESD-933001-1G |
| Cas.: 605-87-8 | Purity: 95% | Phenanthren-3-ol | ESD-933002-100MG |
| Cas.: 605-87-8 | Purity: 95% | Phenanthren-3-ol | ESD-933002-250MG |
| Cas.: 605-87-8 | Purity: 95% | Phenanthren-3-ol | ESD-933002-1G |
| Cas.: 886050-51-7 | Purity: 95% | 2-(Trifluoromethoxy)ethanamine hydrochloride | ESD-933003-100MG |
| Cas.: 886050-51-7 | Purity: 95% | 2-(Trifluoromethoxy)ethanamine hydrochloride | ESD-933003-250MG |
| Cas.: 886050-51-7 | Purity: 95% | 2-(Trifluoromethoxy)ethanamine hydrochloride | ESD-933003-1G |
| Cas.: 5196-20-3 | Purity: 95% | 6-Methyl-1,3-dihydrofuro[3,4-c]pyridin-7-ol | ESD-933004-100MG |
| Cas.: 5196-20-3 | Purity: 95% | 6-Methyl-1,3-dihydrofuro[3,4-c]pyridin-7-ol | ESD-933004-250MG |
| Cas.: 5196-20-3 | Purity: 95% | 6-Methyl-1,3-dihydrofuro[3,4-c]pyridin-7-ol | ESD-933004-1G |
| Cas.: 905273-87-2 | Purity: ≥95% | 6-Chloro-N,N-diisopropylnicotinamide | ESD-933005-100MG |
| Cas.: 905273-87-2 | Purity: ≥95% | 6-Chloro-N,N-diisopropylnicotinamide | ESD-933005-250MG |
| Cas.: 905273-87-2 | Purity: ≥95% | 6-Chloro-N,N-diisopropylnicotinamide | ESD-933005-1G |
| Cas.: 117832-17-4 | Purity: 98% | 2-Iodo-4,5-dimethylaniline | ESD-933006-100MG |
| Cas.: 117832-17-4 | Purity: 98% | 2-Iodo-4,5-dimethylaniline | ESD-933006-250MG |
| Cas.: 117832-17-4 | Purity: 98% | 2-Iodo-4,5-dimethylaniline | ESD-933006-1G |
| Cas.: 359821-38-8 | Purity: 95% | 2-Amino-N-(2,2,2-trifluoroethyl)acetamide | ESD-933007-100MG |
| Cas.: 359821-38-8 | Purity: 95% | 2-Amino-N-(2,2,2-trifluoroethyl)acetamide | ESD-933007-250MG |
| Cas.: 359821-38-8 | Purity: 95% | 2-Amino-N-(2,2,2-trifluoroethyl)acetamide | ESD-933007-1G |
| Cas.: 194427-15-1 | Purity: ≥98% | 1-(Azetidin-3-yl)-4-fluoropiperidine dihydrochloride | ESD-933008-100MG |
| Cas.: 194427-15-1 | Purity: ≥98% | 1-(Azetidin-3-yl)-4-fluoropiperidine dihydrochloride | ESD-933008-250MG |
| Cas.: 194427-15-1 | Purity: ≥98% | 1-(Azetidin-3-yl)-4-fluoropiperidine dihydrochloride | ESD-933008-1G |
| Cas.: 16332-06-2 | Purity: 97% | 2-Methoxyacetamide | ESD-933009-100MG |
| Cas.: 16332-06-2 | Purity: 97% | 2-Methoxyacetamide | ESD-933009-250MG |
| Cas.: 16332-06-2 | Purity: 97% | 2-Methoxyacetamide | ESD-933009-1G |
| Cas.: 85943-26-6 | Purity: 98% | 5-(Tert-butyl)-2-methoxybenzaldehyde | ESD-933010-100MG |
| Cas.: 85943-26-6 | Purity: 98% | 5-(Tert-butyl)-2-methoxybenzaldehyde | ESD-933010-250MG |
| Cas.: 85943-26-6 | Purity: 98% | 5-(Tert-butyl)-2-methoxybenzaldehyde | ESD-933010-1G |
| Cas.: 13755-95-8 | Purity: 95% | 2,3-Diaminonaphthalene-1,4-dione | ESD-933011-100MG |
| Cas.: 13755-95-8 | Purity: 95% | 2,3-Diaminonaphthalene-1,4-dione | ESD-933011-250MG |
| Cas.: 13755-95-8 | Purity: 95% | 2,3-Diaminonaphthalene-1,4-dione | ESD-933011-1G |
| Cas.: 215872-62-1 | Purity: 95% (contains with <3%H2O) | (1-Ethyl-1H-imidazol-5-yl)methanol | ESD-933012-100MG |
| Cas.: 215872-62-1 | Purity: 95% (contains with <3%H2O) | (1-Ethyl-1H-imidazol-5-yl)methanol | ESD-933012-250MG |
| Cas.: 215872-62-1 | Purity: 95% (contains with <3%H2O) | (1-Ethyl-1H-imidazol-5-yl)methanol | ESD-933012-1G |
| Cas.: 29419-15-6 | Purity: 95% | 7-Fluoro-3,4-dihydro-1H-naphthalen-2-one | ESD-933013-100MG |
| Cas.: 29419-15-6 | Purity: 95% | 7-Fluoro-3,4-dihydro-1H-naphthalen-2-one | ESD-933013-250MG |
| Cas.: 29419-15-6 | Purity: 95% | 7-Fluoro-3,4-dihydro-1H-naphthalen-2-one | ESD-933013-1G |
| Cas.: 944835-85-2 | Purity: 97% | 2-((1H-Indazol-6-yl)thio)-N-methylbenzamide | ESD-933014-100MG |
| Cas.: 944835-85-2 | Purity: 97% | 2-((1H-Indazol-6-yl)thio)-N-methylbenzamide | ESD-933014-250MG |
| Cas.: 944835-85-2 | Purity: 97% | 2-((1H-Indazol-6-yl)thio)-N-methylbenzamide | ESD-933014-1G |
| Cas.: 2411634-43-8 | Purity: ≥95% | Methyl 2-amino-2-(3-bromo-4-chlorophenyl)acetate hydrochloride | ESD-933015-100MG |
| Cas.: 2411634-43-8 | Purity: ≥95% | Methyl 2-amino-2-(3-bromo-4-chlorophenyl)acetate hydrochloride | ESD-933015-250MG |
| Cas.: 2411634-43-8 | Purity: ≥95% | Methyl 2-amino-2-(3-bromo-4-chlorophenyl)acetate hydrochloride | ESD-933015-1G |
| Cas.: 1334169-93-5 | Purity: 95% | 2,2-Dimethyl-4-oxo-3,8,11,14,17,20,23,26,29-nonaoxa-5-azadotriacontan-32-oic acid | ESD-933016-100MG |
| Cas.: 1334169-93-5 | Purity: 95% | 2,2-Dimethyl-4-oxo-3,8,11,14,17,20,23,26,29-nonaoxa-5-azadotriacontan-32-oic acid | ESD-933016-250MG |
| Cas.: 1334169-93-5 | Purity: 95% | 2,2-Dimethyl-4-oxo-3,8,11,14,17,20,23,26,29-nonaoxa-5-azadotriacontan-32-oic acid | ESD-933016-1G |
| Cas.: 1957235-82-3 | Purity: 97% | 4-Aminopiperidine-2,6-dione hydrochloride | ESD-933017-100MG |
| Cas.: 1957235-82-3 | Purity: 97% | 4-Aminopiperidine-2,6-dione hydrochloride | ESD-933017-250MG |
| Cas.: 1957235-82-3 | Purity: 97% | 4-Aminopiperidine-2,6-dione hydrochloride | ESD-933017-1G |
| Cas.: 383128-14-1 | Purity: 97% | 2-(4-Bromophenyl)piperidine | ESD-933018-100MG |
| Cas.: 383128-14-1 | Purity: 97% | 2-(4-Bromophenyl)piperidine | ESD-933018-250MG |
| Cas.: 383128-14-1 | Purity: 97% | 2-(4-Bromophenyl)piperidine | ESD-933018-1G |
| Cas.: 1413732-47-4 | Purity: 97% | Copper(1+)trifluoromethanethiolate-2,2′-bipyridine | ESD-933019-100MG |
| Cas.: 1413732-47-4 | Purity: 97% | Copper(1+)trifluoromethanethiolate-2,2′-bipyridine | ESD-933019-250MG |
| Cas.: 1413732-47-4 | Purity: 97% | Copper(1+)trifluoromethanethiolate-2,2′-bipyridine | ESD-933019-1G |
| Cas.: 676515-34-7 | Purity: 95% | 6-Bromo-2,3-dihydro-1,8-naphthyridin-4(1H)-one | ESD-933020-100MG |
| Cas.: 676515-34-7 | Purity: 95% | 6-Bromo-2,3-dihydro-1,8-naphthyridin-4(1H)-one | ESD-933020-250MG |
| Cas.: 676515-34-7 | Purity: 95% | 6-Bromo-2,3-dihydro-1,8-naphthyridin-4(1H)-one | ESD-933020-1G |
| Cas.: 915411-02-8 | Purity: 97% | 7-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole | ESD-933021-100MG |
| Cas.: 915411-02-8 | Purity: 97% | 7-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole | ESD-933021-250MG |
| Cas.: 915411-02-8 | Purity: 97% | 7-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole | ESD-933021-1G |
| Cas.: 74844-93-2 | Purity: 95% (TBC as stabilizer) | (S)-1-Tert-butyl 2-methyl 1H-pyrrole-1,2(2H,5H)-dicarboxylate | ESD-933022-100MG |
| Cas.: 74844-93-2 | Purity: 95% (TBC as stabilizer) | (S)-1-Tert-butyl 2-methyl 1H-pyrrole-1,2(2H,5H)-dicarboxylate | ESD-933022-250MG |
| Cas.: 74844-93-2 | Purity: 95% (TBC as stabilizer) | (S)-1-Tert-butyl 2-methyl 1H-pyrrole-1,2(2H,5H)-dicarboxylate | ESD-933022-1G |
| Cas.: 78581-99-4 | Purity: 95% | 5,6-Difluorobenzimidazole | ESD-933023-100MG |
| Cas.: 78581-99-4 | Purity: 95% | 5,6-Difluorobenzimidazole | ESD-933023-250MG |
| Cas.: 78581-99-4 | Purity: 95% | 5,6-Difluorobenzimidazole | ESD-933023-1G |
| Cas.: 38233-47-5 | Purity: 98% | 2,3,4-Trifluoro-5-methoxybenzoic acid | ESD-933024-100MG |
| Cas.: 38233-47-5 | Purity: 98% | 2,3,4-Trifluoro-5-methoxybenzoic acid | ESD-933024-250MG |
| Cas.: 38233-47-5 | Purity: 98% | 2,3,4-Trifluoro-5-methoxybenzoic acid | ESD-933024-1G |
| Cas.: 1094555-68-6 | Purity: 95% | (3-Bromo-5-fluorophenyl)methanamine | ESD-933025-100MG |
| Cas.: 1094555-68-6 | Purity: 95% | (3-Bromo-5-fluorophenyl)methanamine | ESD-933025-250MG |
| Cas.: 1094555-68-6 | Purity: 95% | (3-Bromo-5-fluorophenyl)methanamine | ESD-933025-1G |
| Cas.: 394730-71-3 | Purity: 98% | 1-(2,6-Dichloro-4-(trifluoromethyl)phenyl)-4-((difluoromethyl)thio)-5-((pyridin-2-ylmethyl)amino)-1H-pyrazole-3-carbonitrile | ESD-933026-100MG |
| Cas.: 394730-71-3 | Purity: 98% | 1-(2,6-Dichloro-4-(trifluoromethyl)phenyl)-4-((difluoromethyl)thio)-5-((pyridin-2-ylmethyl)amino)-1H-pyrazole-3-carbonitrile | ESD-933026-250MG |
| Cas.: 394730-71-3 | Purity: 98% | 1-(2,6-Dichloro-4-(trifluoromethyl)phenyl)-4-((difluoromethyl)thio)-5-((pyridin-2-ylmethyl)amino)-1H-pyrazole-3-carbonitrile | ESD-933026-1G |
| Cas.: 1009075-44-8 | Purity: 98% | Tert-butyl ((1R,3R)-3-aminocyclopentyl)carbamate | ESD-933027-100MG |
| Cas.: 1009075-44-8 | Purity: 98% | Tert-butyl ((1R,3R)-3-aminocyclopentyl)carbamate | ESD-933027-250MG |
| Cas.: 1009075-44-8 | Purity: 98% | Tert-butyl ((1R,3R)-3-aminocyclopentyl)carbamate | ESD-933027-1G |
| Cas.: 1122484-77-8 | Purity: 97% | 8-Amino-3,6-dioxaoctanoic acid tert-butyl ester | ESD-933028-100MG |
| Cas.: 1122484-77-8 | Purity: 97% | 8-Amino-3,6-dioxaoctanoic acid tert-butyl ester | ESD-933028-250MG |
| Cas.: 1122484-77-8 | Purity: 97% | 8-Amino-3,6-dioxaoctanoic acid tert-butyl ester | ESD-933028-1G |
| Cas.: 58328-39-5 | Purity: 96% | 5-Bromo-2,3-dihydro-1,4-benzodioxane | ESD-933029-100MG |
| Cas.: 58328-39-5 | Purity: 96% | 5-Bromo-2,3-dihydro-1,4-benzodioxane | ESD-933029-250MG |
| Cas.: 58328-39-5 | Purity: 96% | 5-Bromo-2,3-dihydro-1,4-benzodioxane | ESD-933029-1G |
| Cas.: 42791-51-5 | Purity: 95% | 1-(4-Nitrothiophen-2-yl)ethanone | ESD-933030-100MG |
| Cas.: 42791-51-5 | Purity: 95% | 1-(4-Nitrothiophen-2-yl)ethanone | ESD-933030-250MG |
| Cas.: 42791-51-5 | Purity: 95% | 1-(4-Nitrothiophen-2-yl)ethanone | ESD-933030-1G |
| Cas.: 6253-28-7 | Purity: 95% | 10-Oxa-4-azatricyclo[5.2.1.0,2,6]dec-8-ene-3,5-dione | ESD-933031-100MG |
| Cas.: 6253-28-7 | Purity: 95% | 10-Oxa-4-azatricyclo[5.2.1.0,2,6]dec-8-ene-3,5-dione | ESD-933031-250MG |
| Cas.: 6253-28-7 | Purity: 95% | 10-Oxa-4-azatricyclo[5.2.1.0,2,6]dec-8-ene-3,5-dione | ESD-933031-1G |
| Cas.: 1018987-47-7 | Purity: 98% | (3S,5R)-5-(Hydroxymethyl)pyrrolidin-3-ol hydrochloride | ESD-933032-100MG |
| Cas.: 1018987-47-7 | Purity: 98% | (3S,5R)-5-(Hydroxymethyl)pyrrolidin-3-ol hydrochloride | ESD-933032-250MG |
| Cas.: 1018987-47-7 | Purity: 98% | (3S,5R)-5-(Hydroxymethyl)pyrrolidin-3-ol hydrochloride | ESD-933032-1G |
| Cas.: 67491-43-4 | Purity: 97% | [2,2′-Bipyridine]-4,4′-dicarbonitrile | ESD-933033-100MG |
| Cas.: 67491-43-4 | Purity: 97% | [2,2′-Bipyridine]-4,4′-dicarbonitrile | ESD-933033-250MG |
| Cas.: 67491-43-4 | Purity: 97% | [2,2′-Bipyridine]-4,4′-dicarbonitrile | ESD-933033-1G |
| Cas.: 57103-03-4 | Purity: 97% | 9H-Carbazole-3,6-dicarbonitrile | ESD-933034-100MG |
| Cas.: 57103-03-4 | Purity: 97% | 9H-Carbazole-3,6-dicarbonitrile | ESD-933034-250MG |
| Cas.: 57103-03-4 | Purity: 97% | 9H-Carbazole-3,6-dicarbonitrile | ESD-933034-1G |
| Cas.: 15058-15-8 | Purity: 97% | 2-(2-Methyl-4H-chromen-4-ylidene)malononitrile | ESD-933035-100MG |
| Cas.: 15058-15-8 | Purity: 97% | 2-(2-Methyl-4H-chromen-4-ylidene)malononitrile | ESD-933035-250MG |
| Cas.: 15058-15-8 | Purity: 97% | 2-(2-Methyl-4H-chromen-4-ylidene)malononitrile | ESD-933035-1G |
| Cas.: 36321-43-4 | Purity: 95% | N-(2-Aminoethyl)-2-(naphthalen-1-yl)acetamide | ESD-933036-100MG |
| Cas.: 36321-43-4 | Purity: 95% | N-(2-Aminoethyl)-2-(naphthalen-1-yl)acetamide | ESD-933036-250MG |
| Cas.: 36321-43-4 | Purity: 95% | N-(2-Aminoethyl)-2-(naphthalen-1-yl)acetamide | ESD-933036-1G |
| Cas.: 712-09-4 | Purity: 97% | 2-(5-Methoxy-1H-indol-3-yl)ethanol | ESD-933037-100MG |
| Cas.: 712-09-4 | Purity: 97% | 2-(5-Methoxy-1H-indol-3-yl)ethanol | ESD-933037-250MG |
| Cas.: 712-09-4 | Purity: 97% | 2-(5-Methoxy-1H-indol-3-yl)ethanol | ESD-933037-1G |
| Cas.: 71146-13-9 | Purity: 98% | Dimethyl 2-(4-methoxyphenyl)malonate | ESD-933038-100MG |
| Cas.: 71146-13-9 | Purity: 98% | Dimethyl 2-(4-methoxyphenyl)malonate | ESD-933038-250MG |
| Cas.: 71146-13-9 | Purity: 98% | Dimethyl 2-(4-methoxyphenyl)malonate | ESD-933038-1G |
| Cas.: 77745-32-5 | Purity: 98% | 8-Oxabicyclo[3.2.1]octan-3-one | ESD-933039-100MG |
| Cas.: 77745-32-5 | Purity: 98% | 8-Oxabicyclo[3.2.1]octan-3-one | ESD-933039-250MG |
| Cas.: 77745-32-5 | Purity: 98% | 8-Oxabicyclo[3.2.1]octan-3-one | ESD-933039-1G |
| Cas.: 457613-78-4 | Purity: 98% | (4-[4-(Tert-butoxycarbonyl)piperazin-1-yl]phenyl)boronic acid | ESD-933040-100MG |
| Cas.: 457613-78-4 | Purity: 98% | (4-[4-(Tert-butoxycarbonyl)piperazin-1-yl]phenyl)boronic acid | ESD-933040-250MG |
| Cas.: 457613-78-4 | Purity: 98% | (4-[4-(Tert-butoxycarbonyl)piperazin-1-yl]phenyl)boronic acid | ESD-933040-1G |
| Cas.: 167626-26-8 | Purity: 95% | Methyl 3-hydrazinylbenzoate hydrochloride | ESD-933041-100MG |
| Cas.: 167626-26-8 | Purity: 95% | Methyl 3-hydrazinylbenzoate hydrochloride | ESD-933041-250MG |
| Cas.: 167626-26-8 | Purity: 95% | Methyl 3-hydrazinylbenzoate hydrochloride | ESD-933041-1G |
| Cas.: 33420-37-0 | Purity: 95% | Pyrazine-2,3,5,6-tetracarbonitrile | ESD-933042-100MG |
| Cas.: 33420-37-0 | Purity: 95% | Pyrazine-2,3,5,6-tetracarbonitrile | ESD-933042-250MG |
| Cas.: 33420-37-0 | Purity: 95% | Pyrazine-2,3,5,6-tetracarbonitrile | ESD-933042-1G |
| Cas.: 149978-42-7 | Purity: 95% | 1-Methyl-5-(trifluoromethyl)-1H-pyrazol-3-amine | ESD-933043-100MG |
| Cas.: 149978-42-7 | Purity: 95% | 1-Methyl-5-(trifluoromethyl)-1H-pyrazol-3-amine | ESD-933043-250MG |
| Cas.: 149978-42-7 | Purity: 95% | 1-Methyl-5-(trifluoromethyl)-1H-pyrazol-3-amine | ESD-933043-1G |
| Cas.: 1062368-70-0 | Purity: 98% | Methyl 6-bromopyrazolo[1,5-a]pyridine-3-carboxylate | ESD-933044-100MG |
| Cas.: 1062368-70-0 | Purity: 98% | Methyl 6-bromopyrazolo[1,5-a]pyridine-3-carboxylate | ESD-933044-250MG |
| Cas.: 1062368-70-0 | Purity: 98% | Methyl 6-bromopyrazolo[1,5-a]pyridine-3-carboxylate | ESD-933044-1G |
| Cas.: 1286754-61-7 | Purity: 95% | Tert-butyl 4-bromo-1H-pyrazolo[3,4-b]pyridine-1-carboxylate | ESD-933045-100MG |
| Cas.: 1286754-61-7 | Purity: 95% | Tert-butyl 4-bromo-1H-pyrazolo[3,4-b]pyridine-1-carboxylate | ESD-933045-250MG |
| Cas.: 1286754-61-7 | Purity: 95% | Tert-butyl 4-bromo-1H-pyrazolo[3,4-b]pyridine-1-carboxylate | ESD-933045-1G |
| Cas.: 6145-42-2 | Purity: 95% | 1,1-Dimethylguanidine | ESD-933046-100MG |
| Cas.: 6145-42-2 | Purity: 95% | 1,1-Dimethylguanidine | ESD-933046-250MG |
| Cas.: 6145-42-2 | Purity: 95% | 1,1-Dimethylguanidine | ESD-933046-1G |
| Cas.: 886498-61-9 | Purity: ≥98% | 2-(4-Fluoro-2-methoxyphenyl)acetic acid | ESD-933047-100MG |
| Cas.: 886498-61-9 | Purity: ≥98% | 2-(4-Fluoro-2-methoxyphenyl)acetic acid | ESD-933047-250MG |
| Cas.: 886498-61-9 | Purity: ≥98% | 2-(4-Fluoro-2-methoxyphenyl)acetic acid | ESD-933047-1G |
| Cas.: 51529-97-6 | Purity: 95% | 5,6,7,8-Tetrahydronaphthalene-2-carbaldehyde | ESD-933048-100MG |
| Cas.: 51529-97-6 | Purity: 95% | 5,6,7,8-Tetrahydronaphthalene-2-carbaldehyde | ESD-933048-250MG |
| Cas.: 51529-97-6 | Purity: 95% | 5,6,7,8-Tetrahydronaphthalene-2-carbaldehyde | ESD-933048-1G |
| Cas.: 1132-37-2 | Purity: 95% | Dipyridin-2-ylmethane | ESD-933049-100MG |
| Cas.: 1132-37-2 | Purity: 95% | Dipyridin-2-ylmethane | ESD-933049-250MG |
| Cas.: 1132-37-2 | Purity: 95% | Dipyridin-2-ylmethane | ESD-933049-1G |
| Cas.: 456-16-6 | Purity: 95% | 1-(1-Chloroethyl)-4-fluorobenzene | ESD-933050-100MG |
| Cas.: 456-16-6 | Purity: 95% | 1-(1-Chloroethyl)-4-fluorobenzene | ESD-933050-250MG |
| Cas.: 456-16-6 | Purity: 95% | 1-(1-Chloroethyl)-4-fluorobenzene | ESD-933050-1G |
| Cas.: 7482-91-9 | Purity: 95% | 2-(Pyridin-3-yl)quinoline-4-carboxylic acid | ESD-933051-100MG |
| Cas.: 7482-91-9 | Purity: 95% | 2-(Pyridin-3-yl)quinoline-4-carboxylic acid | ESD-933051-250MG |
| Cas.: 7482-91-9 | Purity: 95% | 2-(Pyridin-3-yl)quinoline-4-carboxylic acid | ESD-933051-1G |
| Cas.: 219823-47-9 | Purity: 97% | (R)-Tetrahydrofuran-3-yl 4-methylbenzenesulfonate | ESD-933052-100MG |
| Cas.: 219823-47-9 | Purity: 97% | (R)-Tetrahydrofuran-3-yl 4-methylbenzenesulfonate | ESD-933052-250MG |
| Cas.: 219823-47-9 | Purity: 97% | (R)-Tetrahydrofuran-3-yl 4-methylbenzenesulfonate | ESD-933052-1G |
| Cas.: 68634-03-7 | Purity: 95% | Methyl 3-oxo-2,3-dihydro-1H-indene-5-carboxylate | ESD-933053-100MG |
| Cas.: 68634-03-7 | Purity: 95% | Methyl 3-oxo-2,3-dihydro-1H-indene-5-carboxylate | ESD-933053-250MG |
| Cas.: 68634-03-7 | Purity: 95% | Methyl 3-oxo-2,3-dihydro-1H-indene-5-carboxylate | ESD-933053-1G |
| Cas.: 293298-33-6 | Purity: 95% | 3-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)propanehydrazide hydrochloride | ESD-933054-100MG |
| Cas.: 293298-33-6 | Purity: 95% | 3-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)propanehydrazide hydrochloride | ESD-933054-250MG |
| Cas.: 293298-33-6 | Purity: 95% | 3-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)propanehydrazide hydrochloride | ESD-933054-1G |
| Cas.: 52061-75-3 | Purity: 95% | 2,2-Dipropylpentanoic acid | ESD-933055-100MG |
| Cas.: 52061-75-3 | Purity: 95% | 2,2-Dipropylpentanoic acid | ESD-933055-250MG |
| Cas.: 52061-75-3 | Purity: 95% | 2,2-Dipropylpentanoic acid | ESD-933055-1G |
| Cas.: 123572-65-6 | Purity: 95% | 4-Fluoro-1-nitro-2-(trifluoromethoxy)benzene | ESD-933056-100MG |
| Cas.: 123572-65-6 | Purity: 95% | 4-Fluoro-1-nitro-2-(trifluoromethoxy)benzene | ESD-933056-250MG |
| Cas.: 123572-65-6 | Purity: 95% | 4-Fluoro-1-nitro-2-(trifluoromethoxy)benzene | ESD-933056-1G |
| Cas.: 1357476-67-5 | Purity: 98% | 4-Bromo-2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridine | ESD-933057-100MG |
| Cas.: 1357476-67-5 | Purity: 98% | 4-Bromo-2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridine | ESD-933057-250MG |
| Cas.: 1357476-67-5 | Purity: 98% | 4-Bromo-2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridine | ESD-933057-1G |
| Cas.: 824-21-5 | Purity: 95% | 1-Methylindoline | ESD-933058-100MG |
| Cas.: 824-21-5 | Purity: 95% | 1-Methylindoline | ESD-933058-250MG |
| Cas.: 824-21-5 | Purity: 95% | 1-Methylindoline | ESD-933058-1G |
| Cas.: 33424-83-8 | Purity: 97% | Cyclohexane-1,4-dicarbaldehyde | ESD-933059-100MG |
| Cas.: 33424-83-8 | Purity: 97% | Cyclohexane-1,4-dicarbaldehyde | ESD-933059-250MG |
| Cas.: 33424-83-8 | Purity: 97% | Cyclohexane-1,4-dicarbaldehyde | ESD-933059-1G |
| Cas.: 7292-74-2 | Purity: 98% | 2-Amino-2-(3-fluorophenyl)acetic acid | ESD-933060-100MG |
| Cas.: 7292-74-2 | Purity: 98% | 2-Amino-2-(3-fluorophenyl)acetic acid | ESD-933060-250MG |
| Cas.: 7292-74-2 | Purity: 98% | 2-Amino-2-(3-fluorophenyl)acetic acid | ESD-933060-1G |
| Cas.: 627-98-5 | Purity: 97% | 5-Methylhexanol | ESD-933061-100MG |
| Cas.: 627-98-5 | Purity: 97% | 5-Methylhexanol | ESD-933061-250MG |
| Cas.: 627-98-5 | Purity: 97% | 5-Methylhexanol | ESD-933061-1G |
| Cas.: 16874-81-0 | Purity: 97% | Histidylphenylalanine | ESD-933062-100MG |
| Cas.: 16874-81-0 | Purity: 97% | Histidylphenylalanine | ESD-933062-250MG |
| Cas.: 16874-81-0 | Purity: 97% | Histidylphenylalanine | ESD-933062-1G |
| Cas.: 1260663-68-0 | Purity: 97% | 3-Amino-5-chloropyrazine-2-carboxylic acid | ESD-933063-100MG |
| Cas.: 1260663-68-0 | Purity: 97% | 3-Amino-5-chloropyrazine-2-carboxylic acid | ESD-933063-250MG |
| Cas.: 1260663-68-0 | Purity: 97% | 3-Amino-5-chloropyrazine-2-carboxylic acid | ESD-933063-1G |
| Cas.: 21535-44-4 | Purity: 95% | 6-(Chloromethyl)-11H-dibenzo[b,e]azepine | ESD-933064-100MG |
| Cas.: 21535-44-4 | Purity: 95% | 6-(Chloromethyl)-11H-dibenzo[b,e]azepine | ESD-933064-250MG |
| Cas.: 21535-44-4 | Purity: 95% | 6-(Chloromethyl)-11H-dibenzo[b,e]azepine | ESD-933064-1G |
| Cas.: 89364-06-7 | Purity: 97% | 5-Chloro-[1,2,4]triazolo[1,5-a]pyrimidine | ESD-933065-100MG |
| Cas.: 89364-06-7 | Purity: 97% | 5-Chloro-[1,2,4]triazolo[1,5-a]pyrimidine | ESD-933065-250MG |
| Cas.: 89364-06-7 | Purity: 97% | 5-Chloro-[1,2,4]triazolo[1,5-a]pyrimidine | ESD-933065-1G |
| Cas.: 372136-76-0 | Purity: 95% | N-Methyl-N-isopropylsulfamoyl amide | ESD-933066-100MG |
| Cas.: 372136-76-0 | Purity: 95% | N-Methyl-N-isopropylsulfamoyl amide | ESD-933066-250MG |
| Cas.: 372136-76-0 | Purity: 95% | N-Methyl-N-isopropylsulfamoyl amide | ESD-933066-1G |
| Cas.: 31661-59-3 | Purity: 97% | 3,3′-(Buta-1,3-diyne-1,4-diyl)dianiline | ESD-933067-100MG |
| Cas.: 31661-59-3 | Purity: 97% | 3,3′-(Buta-1,3-diyne-1,4-diyl)dianiline | ESD-933067-250MG |
| Cas.: 31661-59-3 | Purity: 97% | 3,3′-(Buta-1,3-diyne-1,4-diyl)dianiline | ESD-933067-1G |
| Cas.: 1000578-04-0 | Purity: 98% | 2,4-Dibromo-5-fluoroaniline | ESD-933068-100MG |
| Cas.: 1000578-04-0 | Purity: 98% | 2,4-Dibromo-5-fluoroaniline | ESD-933068-250MG |
| Cas.: 1000578-04-0 | Purity: 98% | 2,4-Dibromo-5-fluoroaniline | ESD-933068-1G |
| Cas.: 88016-31-3 | Purity: 95% | Methyl 2-(((trifluoromethyl)sulfonyl)oxy)acetate | ESD-933069-100MG |
| Cas.: 88016-31-3 | Purity: 95% | Methyl 2-(((trifluoromethyl)sulfonyl)oxy)acetate | ESD-933069-250MG |
| Cas.: 88016-31-3 | Purity: 95% | Methyl 2-(((trifluoromethyl)sulfonyl)oxy)acetate | ESD-933069-1G |
| Cas.: 26825-92-3 | Purity: 98% | Methyl8-bromooctanoate | ESD-933070-100MG |
| Cas.: 26825-92-3 | Purity: 98% | Methyl8-bromooctanoate | ESD-933070-250MG |
| Cas.: 26825-92-3 | Purity: 98% | Methyl8-bromooctanoate | ESD-933070-1G |
| Cas.: 697739-04-1 | Purity: 97% | Methyl 3-amino-5-fluoro-2-methylbenzoate | ESD-933071-100MG |
| Cas.: 697739-04-1 | Purity: 97% | Methyl 3-amino-5-fluoro-2-methylbenzoate | ESD-933071-250MG |
| Cas.: 697739-04-1 | Purity: 97% | Methyl 3-amino-5-fluoro-2-methylbenzoate | ESD-933071-1G |
| Cas.: 1228427-07-3 | Purity: 98% | 3-Bromo-5-methyl-1,2,4-oxadiazole | ESD-933072-100MG |
| Cas.: 1228427-07-3 | Purity: 98% | 3-Bromo-5-methyl-1,2,4-oxadiazole | ESD-933072-250MG |
| Cas.: 1228427-07-3 | Purity: 98% | 3-Bromo-5-methyl-1,2,4-oxadiazole | ESD-933072-1G |
| Cas.: 167015-84-1 | Purity: 98% | Tert-butyl 3-(2-aminoethyl)-1H-indole-1-carboxylate | ESD-933073-100MG |
| Cas.: 167015-84-1 | Purity: 98% | Tert-butyl 3-(2-aminoethyl)-1H-indole-1-carboxylate | ESD-933073-250MG |
| Cas.: 167015-84-1 | Purity: 98% | Tert-butyl 3-(2-aminoethyl)-1H-indole-1-carboxylate | ESD-933073-1G |
| Cas.: 888967-63-3 | Purity: 97% | 4-(3-(Hydroxymethyl)phenoxy)benzonitrile | ESD-933074-100MG |
| Cas.: 888967-63-3 | Purity: 97% | 4-(3-(Hydroxymethyl)phenoxy)benzonitrile | ESD-933074-250MG |
| Cas.: 888967-63-3 | Purity: 97% | 4-(3-(Hydroxymethyl)phenoxy)benzonitrile | ESD-933074-1G |
| Cas.: 39273-39-7 | Purity: 95% | 1-Butylbenzo[cd]indol-2(1H)-one | ESD-933075-100MG |
| Cas.: 39273-39-7 | Purity: 95% | 1-Butylbenzo[cd]indol-2(1H)-one | ESD-933075-250MG |
| Cas.: 39273-39-7 | Purity: 95% | 1-Butylbenzo[cd]indol-2(1H)-one | ESD-933075-1G |
| Cas.: 163271-80-5 | Purity: 95% | 3-(Triisopropylsilyl)propiolaldehyde | ESD-933076-100MG |
| Cas.: 163271-80-5 | Purity: 95% | 3-(Triisopropylsilyl)propiolaldehyde | ESD-933076-250MG |
| Cas.: 163271-80-5 | Purity: 95% | 3-(Triisopropylsilyl)propiolaldehyde | ESD-933076-1G |
| Cas.: 73427-92-6 | Purity: 97% | Methyl-6-cyano-1-hydroxy-7-methyl-5-oxo-3,5-dihydroindolizine-2-carboxylate | ESD-933077-100MG |
| Cas.: 73427-92-6 | Purity: 97% | Methyl-6-cyano-1-hydroxy-7-methyl-5-oxo-3,5-dihydroindolizine-2-carboxylate | ESD-933077-250MG |
| Cas.: 73427-92-6 | Purity: 97% | Methyl-6-cyano-1-hydroxy-7-methyl-5-oxo-3,5-dihydroindolizine-2-carboxylate | ESD-933077-1G |
| Cas.: 66533-31-1 | Purity: 97% | 2-Bromo-4,5-dimethylpyridine | ESD-933078-100MG |
| Cas.: 66533-31-1 | Purity: 97% | 2-Bromo-4,5-dimethylpyridine | ESD-933078-250MG |
| Cas.: 66533-31-1 | Purity: 97% | 2-Bromo-4,5-dimethylpyridine | ESD-933078-1G |
| Cas.: 24195-07-1 | Purity: 96% | 2-(Methoxycarbonyl)nicotinic acid | ESD-933079-100MG |
| Cas.: 24195-07-1 | Purity: 96% | 2-(Methoxycarbonyl)nicotinic acid | ESD-933079-250MG |
| Cas.: 24195-07-1 | Purity: 96% | 2-(Methoxycarbonyl)nicotinic acid | ESD-933079-1G |
| Cas.: 127791-54-2 | Purity: 98% | (E)-3-(3,5-Dihydroxyphenyl)acrylic acid | ESD-933080-100MG |
| Cas.: 127791-54-2 | Purity: 98% | (E)-3-(3,5-Dihydroxyphenyl)acrylic acid | ESD-933080-250MG |
| Cas.: 127791-54-2 | Purity: 98% | (E)-3-(3,5-Dihydroxyphenyl)acrylic acid | ESD-933080-1G |
| Cas.: 6976-72-3 | Purity: 97% | Heptyl hexanoate | ESD-933081-100MG |
| Cas.: 6976-72-3 | Purity: 97% | Heptyl hexanoate | ESD-933081-250MG |
| Cas.: 6976-72-3 | Purity: 97% | Heptyl hexanoate | ESD-933081-1G |
| Cas.: 3064-56-0 | Purity: 90% | 2-(Diphenylphosphino)acetic acid | ESD-933082-100MG |
| Cas.: 3064-56-0 | Purity: 90% | 2-(Diphenylphosphino)acetic acid | ESD-933082-250MG |
| Cas.: 3064-56-0 | Purity: 90% | 2-(Diphenylphosphino)acetic acid | ESD-933082-1G |
| Cas.: 782475-37-0 | Purity: 97% | Br-PEG3-C2-Boc | ESD-933083-100MG |
| Cas.: 782475-37-0 | Purity: 97% | Br-PEG3-C2-Boc | ESD-933083-250MG |
| Cas.: 782475-37-0 | Purity: 97% | Br-PEG3-C2-Boc | ESD-933083-1G |
| Cas.: 2144777-77-3 | Purity: 97% | Azido-PEG5-CH2CO2-NHS | ESD-933084-250MG |
| Cas.: 2144777-77-3 | Purity: 97% | Azido-PEG5-CH2CO2-NHS | ESD-933084-500MG |
| Cas.: 83824-29-7 | Purity: 97% | CH2COOH-PEG6-CH2COOH | ESD-933085-250MG |
| Cas.: 83824-29-7 | Purity: 97% | CH2COOH-PEG6-CH2COOH | ESD-933085-500MG |
| Cas.: 2378590-46-4 | Purity: 97% | Fmoc-NH-PEG15-CH2CH2COOH | ESD-933086-250MG |
| Cas.: 2378590-46-4 | Purity: 97% | Fmoc-NH-PEG15-CH2CH2COOH | ESD-933086-500MG |
| Cas.: 361543-07-9 | Purity: ≥95% | Azido-PEG8-azide | ESD-933087-250MG |
| Cas.: 361543-07-9 | Purity: ≥95% | Azido-PEG8-azide | ESD-933087-500MG |
| Cas.: 182760-73-2 | Purity: 95% | Azido-PEG4-azide | ESD-933088-250MG |
| Cas.: 182760-73-2 | Purity: 95% | Azido-PEG4-azide | ESD-933088-500MG |
| Cas.: 1207714-69-9 | Purity: 97% | Azido-PEG9-amine | ESD-933089-250MG |
| Cas.: 1207714-69-9 | Purity: 97% | Azido-PEG9-amine | ESD-933089-500MG |
| Cas.: 1957235-66-3 | Purity: ≥95% | Pomalidomide-C2-NH2 | ESD-933090-250MG |
| Cas.: 1957235-66-3 | Purity: ≥95% | Pomalidomide-C2-NH2 | ESD-933090-500MG |
| Cas.: 1884680-48-1 | Purity: 97% | (2R,2’R,3R,3’R)-3,3′-Di-tert-butyl-4,4′-bis(2,6-dimethoxyphenyl)-2,2′,3,3′-tetrahydro -2,2′-bibenzo[d][1,3]oxaphosphole | ESD-933091-100MG |
| Cas.: 1884680-48-1 | Purity: 97% | (2R,2’R,3R,3’R)-3,3′-Di-tert-butyl-4,4′-bis(2,6-dimethoxyphenyl)-2,2′,3,3′-tetrahydro -2,2′-bibenzo[d][1,3]oxaphosphole | ESD-933091-250MG |
| Cas.: 113231-04-2 | Purity: 97% | (S)-2,2′-((5-(((Benzyloxy)carbonyl)amino)-1-carboxypentyl)azanediyl)diacetic acid | ESD-933092-100MG |
| Cas.: 113231-04-2 | Purity: 97% | (S)-2,2′-((5-(((Benzyloxy)carbonyl)amino)-1-carboxypentyl)azanediyl)diacetic acid | ESD-933092-250MG |
| Cas.: 201212-79-5 | Purity: 97% | (R)-3-Acetoxy-2-aminopropanoic acid hydrochloride | ESD-933093-100MG |
| Cas.: 201212-79-5 | Purity: 97% | (R)-3-Acetoxy-2-aminopropanoic acid hydrochloride | ESD-933093-250MG |
| Cas.: 72698-30-7 | Purity: 98% | (E)-Hexadec-10-enal | ESD-933094-100MG |
| Cas.: 72698-30-7 | Purity: 98% | (E)-Hexadec-10-enal | ESD-933094-250MG |
| Cas.: 1470249-17-2 | Purity: 95% | 2,4,8-Trichloropyrido[3,4-d]pyrimidine | ESD-933095-100MG |
| Cas.: 1470249-17-2 | Purity: 95% | 2,4,8-Trichloropyrido[3,4-d]pyrimidine | ESD-933095-250MG |
| Cas.: 1309981-43-8 | Purity: 95% | (4-(2-Hydroxypropan-2-yl)pyridin-3-yl)boronic acid | ESD-933096-100MG |
| Cas.: 1309981-43-8 | Purity: 95% | (4-(2-Hydroxypropan-2-yl)pyridin-3-yl)boronic acid | ESD-933096-250MG |
| Cas.: 118175-11-4 | Purity: 98% | 2-Amino-3-methyl-3-sulfino-4-(1H-1,2,3-triazol-1-yl)butanoic acid | ESD-933097-100MG |
| Cas.: 118175-11-4 | Purity: 98% | 2-Amino-3-methyl-3-sulfino-4-(1H-1,2,3-triazol-1-yl)butanoic acid | ESD-933097-250MG |
| Cas.: 2903-45-9 | Purity: 98% | Lidocaine N-Oxide | ESD-933098-100MG |
| Cas.: 2903-45-9 | Purity: 98% | Lidocaine N-Oxide | ESD-933098-250MG |
| Cas.: 806-29-1 | Purity: 97% | 6-alpha-Fluoro-isoflupredone | ESD-933099-100MG |
| Cas.: 806-29-1 | Purity: 97% | 6-alpha-Fluoro-isoflupredone | ESD-933099-250MG |
| Cas.: 261764-92-5 | Purity: 95% | 2-Chloro-4-nitro-m-phenylenediamine | ESD-933100-100MG |
| Cas.: 261764-92-5 | Purity: 95% | 2-Chloro-4-nitro-m-phenylenediamine | ESD-933100-250MG |
| Cas.: 1202766-19-5 | Purity: 98% | 6-Bromo-4-methoxy-1H-indole-3-carbaldehyde | ESD-933101-100MG |
| Cas.: 1202766-19-5 | Purity: 98% | 6-Bromo-4-methoxy-1H-indole-3-carbaldehyde | ESD-933101-250MG |
| Cas.: 5132-81-0 | Purity: 97% | Methyl acridine-9-carboxylate | ESD-933102-100MG |
| Cas.: 5132-81-0 | Purity: 97% | Methyl acridine-9-carboxylate | ESD-933102-250MG |
| Cas.: 35273-90-6 | Purity: 90% | Chloromethyl propyl carbonate | ESD-933103-100MG |
| Cas.: 35273-90-6 | Purity: 90% | Chloromethyl propyl carbonate | ESD-933103-250MG |
| Cas.: 148900-69-0 | Purity: 98% | (2-Methoxypyridin-4-yl)methanamine | ESD-933104-100MG |
| Cas.: 148900-69-0 | Purity: 98% | (2-Methoxypyridin-4-yl)methanamine | ESD-933104-250MG |
| Cas.: 1273609-67-8 | Purity: 95% | 5-Bromo-7-methyl-2,3-dihydro-1H-inden-1-one | ESD-933105-100MG |
| Cas.: 1273609-67-8 | Purity: 95% | 5-Bromo-7-methyl-2,3-dihydro-1H-inden-1-one | ESD-933105-250MG |
| Cas.: 183187-82-8 | Purity: 95% | 5,5”-Bis(bromomethyl)-2,2′:6′,2”-terpyridine | ESD-933106-100MG |
| Cas.: 183187-82-8 | Purity: 95% | 5,5”-Bis(bromomethyl)-2,2′:6′,2”-terpyridine | ESD-933106-250MG |
| Cas.: 2245697-85-0 | Purity: 95% | N-(14-Amino-3,6,9,12-tetraoxatetradecyl)-2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetamide hydrochloride | ESD-933107-100MG |
| Cas.: 2245697-85-0 | Purity: 95% | N-(14-Amino-3,6,9,12-tetraoxatetradecyl)-2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetamide hydrochloride | ESD-933107-250MG |
| Cas.: 146665-77-2 | Purity: 98% | Heptaplatin | ESD-933108-100MG |
| Cas.: 146665-77-2 | Purity: 98% | Heptaplatin | ESD-933108-250MG |
| Cas.: 5306-96-7 | Purity: 95% | 2,3-Dimethylbenzene-1,4-diamine | ESD-933109-100MG |
| Cas.: 5306-96-7 | Purity: 95% | 2,3-Dimethylbenzene-1,4-diamine | ESD-933109-250MG |
| Cas.: 4167-74-2 | Purity: 97% | 4-Isobutylphenol | ESD-933110-100MG |
| Cas.: 4167-74-2 | Purity: 97% | 4-Isobutylphenol | ESD-933110-250MG |
| Cas.: 2112737-19-4 | Purity: 97% | N-(Aminooxy-PEG3)-N-bis(PEG4-Boc) | ESD-933111-100MG |
| Cas.: 2112737-19-4 | Purity: 97% | N-(Aminooxy-PEG3)-N-bis(PEG4-Boc) | ESD-933111-250MG |
| Cas.: 2112734-70-8 | Purity: 97% | N-(Hydroxy-PEG3)-N-bis(PEG4-Boc) | ESD-933112-100MG |
| Cas.: 2112734-70-8 | Purity: 97% | N-(Hydroxy-PEG3)-N-bis(PEG4-Boc) | ESD-933112-250MG |
| Cas.: 2055042-60-7 | Purity: 97% | N-(Boc-PEG3)-N-bis(PEG2-alcohol) | ESD-933113-100MG |
| Cas.: 2055042-60-7 | Purity: 97% | N-(Boc-PEG3)-N-bis(PEG2-alcohol) | ESD-933113-250MG |
| Cas.: 2100306-63-4 | Purity: 97% | N-(Boc-PEG1)-N-bis(PEG2-propargyl) | ESD-933114-100MG |
| Cas.: 2100306-63-4 | Purity: 97% | N-(Boc-PEG1)-N-bis(PEG2-propargyl) | ESD-933114-250MG |
| Cas.: 2353409-90-0 | Purity: 97% | N-(Azido-PEG4)-N-bis(PEG4-NHS ester) | ESD-933115-100MG |
| Cas.: 2353409-90-0 | Purity: 97% | N-(Azido-PEG4)-N-bis(PEG4-NHS ester) | ESD-933115-250MG |
| Cas.: 2112731-81-2 | Purity: 97% | N-(Azido-PEG2)-N-bis(PEG4-Boc) | ESD-933116-100MG |
| Cas.: 2112731-81-2 | Purity: 97% | N-(Azido-PEG2)-N-bis(PEG4-Boc) | ESD-933116-250MG |
| Cas.: 2512227-13-1 | Purity: 97% | Mal-PEG4-C2-NH2 TFA | ESD-933117-100MG |
| Cas.: 2512227-13-1 | Purity: 97% | Mal-PEG4-C2-NH2 TFA | ESD-933117-250MG |
| Cas.: 2112737-17-2 | Purity: 97% | N-(Boc-PEG4)-NH-PEG4-NH-Boc | ESD-933118-100MG |
| Cas.: 2112737-17-2 | Purity: 97% | N-(Boc-PEG4)-NH-PEG4-NH-Boc | ESD-933118-250MG |
| Cas.: 2112731-94-7 | Purity: 97% | N-(Azido-PEG3)-N-Boc-PEG4-Boc | ESD-933119-100MG |
| Cas.: 2112731-94-7 | Purity: 97% | N-(Azido-PEG3)-N-Boc-PEG4-Boc | ESD-933119-250MG |
| Cas.: 2100306-69-0 | Purity: 97% | N-(PEG2-Boc)-N-bis(PEG2-propargyl) | ESD-933120-100MG |
| Cas.: 2100306-69-0 | Purity: 97% | N-(PEG2-Boc)-N-bis(PEG2-propargyl) | ESD-933120-250MG |
| Cas.: 2093153-83-2 | N-(Azido-PEG2)-N-Boc-PEG4-Boc | ESD-933121-100MG | |
| Cas.: 2093153-83-2 | N-(Azido-PEG2)-N-Boc-PEG4-Boc | ESD-933121-250MG | |
| Cas.: 1353011-89-8 | Purity: 97% | DNP-NH-PEG2-C2-acid | ESD-933122-100MG |
| Cas.: 1353011-89-8 | Purity: 97% | DNP-NH-PEG2-C2-acid | ESD-933122-250MG |
| Cas.: 2112737-71-8 | Purity: 97% | N-(Aminooxy-PEG2)-N-bis(PEG3-propargyl) | ESD-933123-100MG |
| Cas.: 2112737-71-8 | Purity: 97% | N-(Aminooxy-PEG2)-N-bis(PEG3-propargyl) | ESD-933123-250MG |
| Cas.: 1530777-90-2 | Purity: 97% | Tos-PEG6-CH2-Boc | ESD-933124-100MG |
| Cas.: 1530777-90-2 | Purity: 97% | Tos-PEG6-CH2-Boc | ESD-933124-250MG |
| Cas.: 297162-50-6 | Purity: 97% | NH2-PEG6-C1-Boc | ESD-933125-100MG |
| Cas.: 297162-50-6 | Purity: 97% | NH2-PEG6-C1-Boc | ESD-933125-250MG |
| Cas.: 2093153-95-6 | Purity: 97% | N-(Azido-PEG2)-N-Boc-PEG4-NHS ester | ESD-933126-100MG |
| Cas.: 2093153-95-6 | Purity: 97% | N-(Azido-PEG2)-N-Boc-PEG4-NHS ester | ESD-933126-250MG |
| Cas.: 14663-53-7 | Purity: 97% | (4-Oxo-4H-quinazolin-3-yl)-acetic acid | ESD-933127-100MG |
| Cas.: 14663-53-7 | Purity: 97% | (4-Oxo-4H-quinazolin-3-yl)-acetic acid | ESD-933127-250MG |
| Cas.: 2093152-85-1 | Purity: 97% | N-Azido-PEG4-N-Boc-N-PEG3-Boc | ESD-933128-100MG |
| Cas.: 2093152-85-1 | Purity: 97% | N-Azido-PEG4-N-Boc-N-PEG3-Boc | ESD-933128-250MG |
| Cas.: 2100306-79-2 | Purity: 95% | N-Boc-N-bis(C2-PEG1-azide) | ESD-933129-100MG |
| Cas.: 2100306-79-2 | Purity: 95% | N-Boc-N-bis(C2-PEG1-azide) | ESD-933129-250MG |
| Cas.: 2112732-01-9 | Purity: 97% | N-(Propargyl-PEG4-carbonyl)-N-bis(PEG1-methyl ester) | ESD-933130-100MG |
| Cas.: 2112732-01-9 | Purity: 97% | N-(Propargyl-PEG4-carbonyl)-N-bis(PEG1-methyl ester) | ESD-933130-250MG |
| Cas.: 32775-08-9 | Purity: 97% | CH2COOH-PEG3-CH2COOH | ESD-933131-100MG |
| Cas.: 32775-08-9 | Purity: 97% | CH2COOH-PEG3-CH2COOH | ESD-933131-250MG |
| Cas.: 2093152-79-3 | N-(Azido-PEG4)-N-bis(PEG4-t-butyl ester) | ESD-933132-100MG | |
| Cas.: 2093152-79-3 | N-(Azido-PEG4)-N-bis(PEG4-t-butyl ester) | ESD-933132-250MG | |
| Cas.: 1415981-79-1 | Purity: 97% | Boc-NH-PEG12-CH2CH2COOH | ESD-933133-100MG |
| Cas.: 1415981-79-1 | Purity: 97% | Boc-NH-PEG12-CH2CH2COOH | ESD-933133-250MG |
| Cas.: 1343476-41-4 | Purity: 97% | Acid-C2-PEG4-C2-NHS ester | ESD-933134-100MG |
| Cas.: 1343476-41-4 | Purity: 97% | Acid-C2-PEG4-C2-NHS ester | ESD-933134-250MG |
| Cas.: 2112737-60-5 | Purity: 97% | N-(t-Boc-Aminooxy-PEG2)-N-bis(PEG3-propargyl) | ESD-933135-100MG |
| Cas.: 2112737-60-5 | Purity: 97% | N-(t-Boc-Aminooxy-PEG2)-N-bis(PEG3-propargyl) | ESD-933135-250MG |
| Cas.: 1253389-31-9 | Purity: 97% | Azido-PEG3-CH2CO2Me | ESD-933136-100MG |
| Cas.: 1253389-31-9 | Purity: 97% | Azido-PEG3-CH2CO2Me | ESD-933136-250MG |
| Cas.: 2086689-00-9 | Purity: 97% | N-(Azido-PEG3)-N-bis(PEG1-t-butyl ester) | ESD-933137-100MG |
| Cas.: 2086689-00-9 | Purity: 97% | N-(Azido-PEG3)-N-bis(PEG1-t-butyl ester) | ESD-933137-250MG |
| Cas.: 86770-71-0 | Purity: 95% | Benzyl-PEG4-Azido | ESD-933138-100MG |
| Cas.: 86770-71-0 | Purity: 95% | Benzyl-PEG4-Azido | ESD-933138-250MG |
| Cas.: 89346-82-7 | Purity: 97% | Benzyl-PEG4-Ots | ESD-933139-100MG |
| Cas.: 89346-82-7 | Purity: 97% | Benzyl-PEG4-Ots | ESD-933139-250MG |
| Cas.: 2055023-14-6 | Purity: 97% | Mal-NH-PEG8-CH2CH2COOPFP ester | ESD-933140-100MG |
| Cas.: 2055023-14-6 | Purity: 97% | Mal-NH-PEG8-CH2CH2COOPFP ester | ESD-933140-250MG |
| Cas.: 129086-10-8 | Purity: 95% | Benzyl-PEG5-Ots | ESD-933141-100MG |
| Cas.: 129086-10-8 | Purity: 95% | Benzyl-PEG5-Ots | ESD-933141-250MG |
| Cas.: 1807540-88-0 | Purity: 97% | Ald-Ph-amido-C2-PEG3-azide | ESD-933142-100MG |
| Cas.: 1807540-88-0 | Purity: 97% | Ald-Ph-amido-C2-PEG3-azide | ESD-933142-250MG |
| Cas.: 1189760-69-7 | Purity: ≥95% | HS-PEG3-CH2CH2NH2 | ESD-933143-100MG |
| Cas.: 1189760-69-7 | Purity: ≥95% | HS-PEG3-CH2CH2NH2 | ESD-933143-250MG |
| Cas.: 1820673-42-4 | Purity: 97% | Hydroxy-PEG2-C2-PFP ester | ESD-933144-100MG |
| Cas.: 1820673-42-4 | Purity: 97% | Hydroxy-PEG2-C2-PFP ester | ESD-933144-250MG |
| Cas.: 102013-72-9 | Purity: 97% | m-PEG8-CH2COOH | ESD-933145-100MG |
| Cas.: 102013-72-9 | Purity: 97% | m-PEG8-CH2COOH | ESD-933145-250MG |
| Cas.: 1449390-11-7 | Purity: 95% | HS-PEG5-CH2CH2N3 | ESD-933146-100MG |
| Cas.: 1449390-11-7 | Purity: 95% | HS-PEG5-CH2CH2N3 | ESD-933146-250MG |
| Cas.: 16024-66-1 | Purity: 98% | m-PEG4-CH2COOH | ESD-933147-100MG |
| Cas.: 16024-66-1 | Purity: 98% | m-PEG4-CH2COOH | ESD-933147-250MG |
| Cas.: 2222114-64-7 | Purity: ≥98% | Thalidomide-piperazine-Boc | ESD-933148-100MG |
| Cas.: 2222114-64-7 | Purity: ≥98% | Thalidomide-piperazine-Boc | ESD-933148-250MG |
| Cas.: 530151-56-5 | Purity: 97% | Bromo-PEG2-C2-azide | ESD-933149-100MG |
| Cas.: 530151-56-5 | Purity: 97% | Bromo-PEG2-C2-azide | ESD-933149-250MG |
| Cas.: 1002342-83-7 | Purity: ≥95% | Ald-CH2-PEG3-azide | ESD-933150-100MG |
| Cas.: 1002342-83-7 | Purity: ≥95% | Ald-CH2-PEG3-azide | ESD-933150-250MG |
| Cas.: 1416990-08-3 | Purity: ≥98% | Lenalidomide-OH | ESD-933151-100MG |
| Cas.: 1416990-08-3 | Purity: ≥98% | Lenalidomide-OH | ESD-933151-250MG |
| Cas.: 1347750-80-4 | Purity: 97% | Propargyl-PEG4-thiol | ESD-933152-100MG |
| Cas.: 1347750-80-4 | Purity: 97% | Propargyl-PEG4-thiol | ESD-933152-250MG |
| Cas.: 1308299-09-3 | Purity: 97% | Propargyl-PEG4-Br | ESD-933153-100MG |
| Cas.: 1308299-09-3 | Purity: 97% | Propargyl-PEG4-Br | ESD-933153-250MG |
| Cas.: 760952-64-5 | Purity: ≥98% | Mal-PEG1-acid | ESD-933154-100MG |
| Cas.: 760952-64-5 | Purity: ≥98% | Mal-PEG1-acid | ESD-933154-250MG |
| Cas.: 437655-96-4 | Purity: 98% | Fmoc-NH-PEG6-CH2COOH | ESD-933155-100MG |
| Cas.: 437655-96-4 | Purity: 98% | Fmoc-NH-PEG6-CH2COOH | ESD-933155-250MG |
| Cas.: 1245823-51-1 | Purity: ≥95% | Propargyl-PEG4-C2-acid | ESD-933156-100MG |
| Cas.: 1245823-51-1 | Purity: ≥95% | Propargyl-PEG4-C2-acid | ESD-933156-250MG |
| Cas.: 130955-37-2 | Purity: 97% | m-PEG4-Ms | ESD-933157-100MG |
| Cas.: 130955-37-2 | Purity: 97% | m-PEG4-Ms | ESD-933157-250MG |
| Cas.: 1058691-77-2 | Purity: 97% | m-PEG6-CH2CH2CHO | ESD-933158-100MG |
| Cas.: 1058691-77-2 | Purity: 97% | m-PEG6-CH2CH2CHO | ESD-933158-250MG |
| Cas.: 1255942-12-1 | Purity: 97% | DBCO-NHCO-PEG4-NH-Boc | ESD-933159-100MG |
| Cas.: 1255942-12-1 | Purity: 97% | DBCO-NHCO-PEG4-NH-Boc | ESD-933159-250MG |
| Cas.: 1496997-41-1 | Purity: ≥98% | Thalidomide-5,6-F | ESD-933160-100MG |
| Cas.: 1496997-41-1 | Purity: ≥98% | Thalidomide-5,6-F | ESD-933160-250MG |
| Cas.: 1191078-74-6 | Purity: 97% | Amino-PEG5-C2-acid | ESD-933161-100MG |
| Cas.: 1191078-74-6 | Purity: 97% | Amino-PEG5-C2-acid | ESD-933161-250MG |
| Cas.: 275385-03-0 | Purity: 97% | N-Boc-N-bis(PEG2-OH) | ESD-933162-100MG |
| Cas.: 275385-03-0 | Purity: 97% | N-Boc-N-bis(PEG2-OH) | ESD-933162-250MG |
| Cas.: 2245697-85-0 | Purity: 97% | Thalidomide-O-amido-PEG4-C2-NH2 hydrochloride | ESD-933163-100MG |
| Cas.: 2245697-85-0 | Purity: 97% | Thalidomide-O-amido-PEG4-C2-NH2 hydrochloride | ESD-933163-250MG |
| Cas.: 2341841-02-7 | Purity: ≥95% | Thalidomide 4′-oxyacetamide-alkyl-C2-amine hydrochloride | ESD-933164-100MG |
| Cas.: 2341841-02-7 | Purity: ≥95% | Thalidomide 4′-oxyacetamide-alkyl-C2-amine hydrochloride | ESD-933164-250MG |
| Cas.: 2093416-32-9 | Purity: 97% | Thalidomide-PEG2-C2-NH2 | ESD-933165-100MG |
| Cas.: 2093416-32-9 | Purity: 97% | Thalidomide-PEG2-C2-NH2 | ESD-933165-250MG |
| Cas.: 77855-75-5 | Purity: ≥95% | HOOCCH2O-PEG4-CH2COOH | ESD-933166-100MG |
| Cas.: 77855-75-5 | Purity: ≥95% | HOOCCH2O-PEG4-CH2COOH | ESD-933166-250MG |
| Cas.: 2245697-88-3 | Purity: 98% | Thalidomide-O-C6-NH2 hydrochloride | ESD-933167-100MG |
| Cas.: 2245697-88-3 | Purity: 98% | Thalidomide-O-C6-NH2 hydrochloride | ESD-933167-250MG |
| Cas.: 2245697-87-2 | Purity: 97% | Thalidomide-PEG2-C2-NH2 hydrochloride | ESD-933168-100MG |
| Cas.: 2245697-87-2 | Purity: 97% | Thalidomide-PEG2-C2-NH2 hydrochloride | ESD-933168-250MG |
| Cas.: 2097509-40-3 | Purity: 98% | Thalidomide-NH-PEG2-C2-NH-Boc | ESD-933169-100MG |
| Cas.: 2097509-40-3 | Purity: 98% | Thalidomide-NH-PEG2-C2-NH-Boc | ESD-933169-250MG |
| Cas.: 2411681-87-1 | Purity: 97% | Thalidomide-O-PEG4-Boc | ESD-933170-100MG |
| Cas.: 2411681-87-1 | Purity: 97% | Thalidomide-O-PEG4-Boc | ESD-933170-250MG |
| Cas.: 2401832-00-4 | Purity: 97% | Thalidomide-O-PEG4-amine | ESD-933171-100MG |
| Cas.: 2401832-00-4 | Purity: 97% | Thalidomide-O-PEG4-amine | ESD-933171-250MG |
| Cas.: 208522-13-8 | Purity: 95% | (S)-2-((tert-Butoxycarbonyl)amino)hex-5-enoic acid | ESD-933172-50MG |
| Cas.: 208522-13-8 | Purity: 95% | (S)-2-((tert-Butoxycarbonyl)amino)hex-5-enoic acid | ESD-933172-100MG |
| Cas.: 1639408-64-2 | Purity: 98% | Bis [2-(2,4-difluorophenyl)-5-trifluoromethylpyridine] [1,10-phenanthroline] iridium hexafluorophosphate | ESD-933173-50MG |
| Cas.: 1639408-64-2 | Purity: 98% | Bis [2-(2,4-difluorophenyl)-5-trifluoromethylpyridine] [1,10-phenanthroline] iridium hexafluorophosphate | ESD-933173-100MG |
| Cas.: 698-52-2 | Purity: 95% | 1,4-Diamino-2,5-difluorobenzene | ESD-933174-50MG |
| Cas.: 698-52-2 | Purity: 95% | 1,4-Diamino-2,5-difluorobenzene | ESD-933174-100MG |
| Cas.: 1580501-97-8 | Purity: 95% | (E)-Cyclooct-2-en-1-yl (4-nitrophenyl) carbonate | ESD-933175-50MG |
| Cas.: 1580501-97-8 | Purity: 95% | (E)-Cyclooct-2-en-1-yl (4-nitrophenyl) carbonate | ESD-933175-100MG |
| Cas.: 776230-17-2 | Purity: 98% | Acetonitrilebis[2-diphenylphosphino-6-t-butylpyridine]cyclopentadienylruthenium(II) hexafluorophosphate | ESD-933176-50MG |
| Cas.: 776230-17-2 | Purity: 98% | Acetonitrilebis[2-diphenylphosphino-6-t-butylpyridine]cyclopentadienylruthenium(II) hexafluorophosphate | ESD-933176-100MG |
| Cas.: 141282-35-1 | Purity: ≥95% | Amino-PEG5-CH2COOH | ESD-933177-50MG |
| Cas.: 141282-35-1 | Purity: ≥95% | Amino-PEG5-CH2COOH | ESD-933177-100MG |
| Cas.: 1392499-33-0 | Purity: 97% | BocNH-PEG5-CH2CH2Br | ESD-933178-50MG |
| Cas.: 1392499-33-0 | Purity: 97% | BocNH-PEG5-CH2CH2Br | ESD-933178-100MG |
| Cas.: 144598-03-8 | Purity: 97% | Amino-PEG4-(CH2)3CO2H | ESD-933179-50MG |
| Cas.: 144598-03-8 | Purity: 97% | Amino-PEG4-(CH2)3CO2H | ESD-933179-100MG |
| Cas.: 1214319-92-2 | Purity: ≥95% | Azido-PEG8-acid | ESD-933180-50MG |
| Cas.: 1214319-92-2 | Purity: ≥95% | Azido-PEG8-acid | ESD-933180-100MG |
| Cas.: 1334170-02-3 | Purity: 98% | Bis-PEG7-NHS ester | ESD-933181-50MG |
| Cas.: 1334170-02-3 | Purity: 98% | Bis-PEG7-NHS ester | ESD-933181-100MG |
| Cas.: 34562-31-7 | Purity: 75% (GC) | 3,5-Diethyl-1-phenyl-2-propyl-1,2-dihydropyridine | ESD-933182-25G |
| Cas.: 34562-31-7 | Purity: 75% (GC) | 3,5-Diethyl-1-phenyl-2-propyl-1,2-dihydropyridine | ESD-933182-100G |
| Cas.: 123334-05-4 | Purity: 98% | Zinc p-toluenesulfonate xhydrate | ESD-933183-25G |
| Cas.: 123334-05-4 | Purity: 98% | Zinc p-toluenesulfonate xhydrate | ESD-933183-100G |
| Cas.: 59382-60-4 | Purity: 97% | Ethyl 2-methyl-3-nitrobenzoate | ESD-933184-25G |
| Cas.: 59382-60-4 | Purity: 97% | Ethyl 2-methyl-3-nitrobenzoate | ESD-933184-100G |
| Cas.: 60208-45-9 | Purity: 98% | N1,N3-Bis(1,3-dihydroxypropan-2-yl)-5-(2-hydroxypropanamido)-2,4,6-triiodoisophthalamide | ESD-933185-25G |
| Cas.: 60208-45-9 | Purity: 98% | N1,N3-Bis(1,3-dihydroxypropan-2-yl)-5-(2-hydroxypropanamido)-2,4,6-triiodoisophthalamide | ESD-933185-100G |
| Cas.: 70217-36-6 | Purity: 98% | 1-(2,4-Dichlorophenyl)-4,4-dimethyl-2-(1H-1,2,4-triazol-1-yl)pent-1-en-3-ol | ESD-933186-25G |
| Cas.: 70217-36-6 | Purity: 98% | 1-(2,4-Dichlorophenyl)-4,4-dimethyl-2-(1H-1,2,4-triazol-1-yl)pent-1-en-3-ol | ESD-933186-100G |
| Cas.: 83282-91-1 | Purity: 98% | (2,3,5,6-Tetrafluoro-4-(methoxymethyl)phenyl)methanol | ESD-933187-25G |
| Cas.: 83282-91-1 | Purity: 98% | (2,3,5,6-Tetrafluoro-4-(methoxymethyl)phenyl)methanol | ESD-933187-100G |
| Cas.: 64452-96-6 | Purity: 98% | Chromium nicotinate | ESD-933188-25G |
| Cas.: 64452-96-6 | Purity: 98% | Chromium nicotinate | ESD-933188-100G |
| Cas.: 3459-20-9 | Purity: ≥95% | Glymidine sodium | ESD-933189-25MG |
| Cas.: 3459-20-9 | Purity: ≥95% | Glymidine sodium | ESD-933189-100MG |
| Cas.: 181765-30-0 | Purity: ≥95% | PD 151746 | ESD-933190-25MG |
| Cas.: 181765-30-0 | Purity: ≥95% | PD 151746 | ESD-933190-100MG |
| Cas.: 110448-31-2 | Purity: ≥98% | ML-9 | ESD-933191-25MG |
| Cas.: 110448-31-2 | Purity: ≥98% | ML-9 | ESD-933191-100MG |
| Cas.: 1419320-73-2 | Purity: ≥98% | Pitstop 2 | ESD-933192-25MG |
| Cas.: 1419320-73-2 | Purity: ≥98% | Pitstop 2 | ESD-933192-100MG |
| Cas.: 853929-59-6 | Purity: ≥98% | OGT 2115 | ESD-933193-25MG |
| Cas.: 853929-59-6 | Purity: ≥98% | OGT 2115 | ESD-933193-100MG |
| Cas.: 452967-14-5 | Purity: ≥98% | IR415 | ESD-933194-25MG |
| Cas.: 452967-14-5 | Purity: ≥98% | IR415 | ESD-933194-100MG |
| Cas.: 41876-72-6 | Purity: 95% | 4-(4-Ethynylphenyl)morpholine | ESD-933195-25MG |
| Cas.: 41876-72-6 | Purity: 95% | 4-(4-Ethynylphenyl)morpholine | ESD-933195-50MG |
| Cas.: 87564-74-7 | Purity: 98% | Bis(2,2′-bipyridine-κN1,κN1′)(dipyrido[3,2-a:2′,3′-c]phenazine-κN4,κN5)ruthenium(2+) | ESD-933196-25MG |
| Cas.: 87564-74-7 | Purity: 98% | Bis(2,2′-bipyridine-κN1,κN1′)(dipyrido[3,2-a:2′,3′-c]phenazine-κN4,κN5)ruthenium(2+) | ESD-933196-50MG |
| Cas.: 68521-88-0 | Purity: ≥99% | Angiotensin II human acetate | ESD-933197-10MG |
| Cas.: 68521-88-0 | Purity: ≥99% | Angiotensin II human acetate | ESD-933197-50MG |
| Cas.: 877950-01-1 | Purity: 98% | LtaS-IN-1 | ESD-933198-10MG |
| Cas.: 877950-01-1 | Purity: 98% | LtaS-IN-1 | ESD-933198-50MG |
| Cas.: 310460-39-0 | Purity: ≥98% | CPYPP | ESD-933199-10MG |
| Cas.: 310460-39-0 | Purity: ≥98% | CPYPP | ESD-933199-50MG |
| Cas.: 1706522-79-3 | Purity: ≥98% | PF-543 hydrochloride | ESD-933200-10MG |
| Cas.: 1706522-79-3 | Purity: ≥98% | PF-543 hydrochloride | ESD-933200-50MG |
| Cas.: 883-84-1 | Purity: ≥98% | 4-Deoxypyridoxine 5′-phosphate | ESD-933201-10MG |
| Cas.: 883-84-1 | Purity: ≥98% | 4-Deoxypyridoxine 5′-phosphate | ESD-933201-25MG |
| Cas.: 122520-79-0 | Purity: ≥98% | Tyrphostin AG30 | ESD-933202-10MG |
| Cas.: 122520-79-0 | Purity: ≥98% | Tyrphostin AG30 | ESD-933202-25MG |
| Cas.: 187739-60-2 | Purity: ≥98% | Carboxyamidotriazole Orotate | ESD-933203-10MG |
| Cas.: 187739-60-2 | Purity: ≥98% | Carboxyamidotriazole Orotate | ESD-933203-25MG |
| Cas.: 2244678-29-1 | Purity: ≥98% | TH-257 | ESD-933204-10MG |
| Cas.: 2244678-29-1 | Purity: ≥98% | TH-257 | ESD-933204-25MG |
| Cas.: 27750-10-3 | Purity: ≥98% | (-)-Hydroxycitric acid | ESD-933205-10MG |
| Cas.: 27750-10-3 | Purity: ≥98% | (-)-Hydroxycitric acid | ESD-933205-25MG |
| Cas.: 103878-83-7 | Purity: ≥98% | Lazabemide hydrochloride | ESD-933206-10MG |
| Cas.: 103878-83-7 | Purity: ≥98% | Lazabemide hydrochloride | ESD-933206-25MG |
| Cas.: 2309172-44-7 | Purity: ≥98% | RO2959 monohydrochloride | ESD-933207-10MG |
| Cas.: 2309172-44-7 | Purity: ≥98% | RO2959 monohydrochloride | ESD-933207-25MG |
| Cas.: 1219184-91-4 | Purity: ≥98% | CCT031374 hydrobromide | ESD-933208-10MG |
| Cas.: 1219184-91-4 | Purity: ≥98% | CCT031374 hydrobromide | ESD-933208-25MG |
| Cas.: 1287665-60-4 | Purity: ≥98% | AS2444697 | ESD-933209-10MG |
| Cas.: 1287665-60-4 | Purity: ≥98% | AS2444697 | ESD-933209-25MG |
| Cas.: 1782531-99-0 | Purity: ≥98% | HLI373 dihydrochloride | ESD-933210-10MG |
| Cas.: 1782531-99-0 | Purity: ≥98% | HLI373 dihydrochloride | ESD-933210-25MG |
| Cas.: 31059-54-8 | Purity: ≥98% | β-NETA | ESD-933211-10MG |
| Cas.: 31059-54-8 | Purity: ≥98% | β-NETA | ESD-933211-25MG |
| Cas.: 1402830-75-4 | Purity: ≥98% | Ceranib-2 | ESD-933212-10MG |
| Cas.: 1402830-75-4 | Purity: ≥98% | Ceranib-2 | ESD-933212-25MG |
| Cas.: 868224-64-0 | Purity: ≥98% | SID 7969543 | ESD-933213-10MG |
| Cas.: 868224-64-0 | Purity: ≥98% | SID 7969543 | ESD-933213-25MG |
| Cas.: 382605-72-3 | Purity: ≥95% | NSC668394 | ESD-933214-10MG |
| Cas.: 382605-72-3 | Purity: ≥95% | NSC668394 | ESD-933214-25MG |
| Cas.: 2375541-45-8 | Purity: ≥98% | Autogramin-2 | ESD-933215-10MG |
| Cas.: 2375541-45-8 | Purity: ≥98% | Autogramin-2 | ESD-933215-25MG |
| Cas.: 70763-62-1 | Purity: ≥98% | 2-Deoxy-2-fluoro-L-fucose | ESD-933216-10MG |
| Cas.: 70763-62-1 | Purity: ≥98% | 2-Deoxy-2-fluoro-L-fucose | ESD-933216-25MG |
| Cas.: 366-93-8 | Purity: ≥98% | AY 9944 | ESD-933217-10MG |
| Cas.: 366-93-8 | Purity: ≥98% | AY 9944 | ESD-933217-25MG |
| Cas.: 53808-87-0 | Purity: ≥98% | Tetroxoprim | ESD-933218-10MG |
| Cas.: 53808-87-0 | Purity: ≥98% | Tetroxoprim | ESD-933218-25MG |
| Cas.: 1005775-56-3 | Purity: ≥98% | TC ASK 10 | ESD-933219-10MG |
| Cas.: 1005775-56-3 | Purity: ≥98% | TC ASK 10 | ESD-933219-25MG |
| Cas.: 674359-73-0 | Purity: ≥98% | Rasarfin | ESD-933220-10MG |
| Cas.: 674359-73-0 | Purity: ≥98% | Rasarfin | ESD-933220-25MG |
| Cas.: 93076-89-2 | Purity: ≥98% | R 59-022 | ESD-933221-10MG |
| Cas.: 93076-89-2 | Purity: ≥98% | R 59-022 | ESD-933221-25MG |
| Cas.: 1221971-47-6 | Purity: ≥98% | PF-9184 | ESD-933222-10MG |
| Cas.: 1221971-47-6 | Purity: ≥98% | PF-9184 | ESD-933222-25MG |
| Cas.: 19756-72-0 | Purity: 98% | Tert-butyl 4-nitrobenzoate | ESD-933223-5G |
| Cas.: 19756-72-0 | Purity: 98% | Tert-butyl 4-nitrobenzoate | ESD-933223-25G |
| Cas.: 2443-66-5 | Purity: 97% | 2-Hydroxy-2-phenylacetohydrazide | ESD-933224-5G |
| Cas.: 2443-66-5 | Purity: 97% | 2-Hydroxy-2-phenylacetohydrazide | ESD-933224-25G |
| Cas.: 4961-41-5 | Purity: 98% | Tetraethylenepentaminepentahydrochloride | ESD-933225-5G |
| Cas.: 4961-41-5 | Purity: 98% | Tetraethylenepentaminepentahydrochloride | ESD-933225-25G |
| Cas.: 17019-26-0 | Purity: 98% | (E)-2-(Hydroxyimino)-1-phenylpropan-1-one | ESD-933226-5G |
| Cas.: 17019-26-0 | Purity: 98% | (E)-2-(Hydroxyimino)-1-phenylpropan-1-one | ESD-933226-25G |
| Cas.: 31480-93-0 | Purity: 97% | 4-Hydroxyphenyl methacrylate | ESD-933227-5G |
| Cas.: 31480-93-0 | Purity: 97% | 4-Hydroxyphenyl methacrylate | ESD-933227-25G |
| Cas.: 1913291-02-7 | Purity: ≥98% | WRG-28 | ESD-933228-5MG |
| Cas.: 1913291-02-7 | Purity: ≥98% | WRG-28 | ESD-933228-25MG |
| Cas.: 113852-41-8 | Purity: ≥98% | PMEDAP | ESD-933229-5MG |
| Cas.: 113852-41-8 | Purity: ≥98% | PMEDAP | ESD-933229-25MG |
| Cas.: 1644443-92-4 | Purity: ≥98% | GW406108X | ESD-933230-5MG |
| Cas.: 1644443-92-4 | Purity: ≥98% | GW406108X | ESD-933230-25MG |
| Cas.: 195822-23-2 | Purity: ≥98% | LQZ-7I | ESD-933231-5MG |
| Cas.: 195822-23-2 | Purity: ≥98% | LQZ-7I | ESD-933231-25MG |
| Cas.: 1245792-51-1 | Purity: ≥98% | BCI | ESD-933232-5MG |
| Cas.: 1245792-51-1 | Purity: ≥98% | BCI | ESD-933232-25MG |
| Cas.: 405940-76-3 | Purity: ≥98% | Razaxaban hydrochloride | ESD-933233-5MG |
| Cas.: 405940-76-3 | Purity: ≥98% | Razaxaban hydrochloride | ESD-933233-25MG |
| Cas.: 330834-54-3 | Purity: ≥98% | AGX51 | ESD-933234-5MG |
| Cas.: 330834-54-3 | Purity: ≥98% | AGX51 | ESD-933234-25MG |
| Cas.: 916232-21-8 | Purity: ≥98% | 4-(3-Benzyl-4-{[5-(2-fluorophenyl)furan-2-yl]methylidene}-5-oxo-4,5-dihydro-1H-pyrazol-1-yl)benzoic acid | ESD-931586-5MG |
| Cas.: 2375482-51-0 | Purity: ≥98% | BI-2852 | ESD-933235-5MG |
| Cas.: 2375482-51-0 | Purity: ≥98% | BI-2852 | ESD-933235-25MG |
| Cas.: 688342-78-1 | Purity: ≥98% | D-I03 | ESD-933236-5MG |
| Cas.: 688342-78-1 | Purity: ≥98% | D-I03 | ESD-933236-25MG |
| Cas.: 292053-42-0 | Purity: ≥98% | CCI-006 | ESD-933237-5MG |
| Cas.: 292053-42-0 | Purity: ≥98% | CCI-006 | ESD-933237-25MG |
| Cas.: 2369751-30-2 | Purity: ≥98% | G150 | ESD-933238-5MG |
| Cas.: 2369751-30-2 | Purity: ≥98% | G150 | ESD-933238-25MG |
| Cas.: 864941-31-1 | Purity: ≥98% | EACC | ESD-933239-5MG |
| Cas.: 864941-31-1 | Purity: ≥98% | EACC | ESD-933239-25MG |
| Cas.: 1094048-77-7 | Purity: ≥98% | I-OMe-Tyrphostin AG 538 | ESD-933240-5MG |
| Cas.: 1094048-77-7 | Purity: ≥98% | I-OMe-Tyrphostin AG 538 | ESD-933240-25MG |
| Cas.: 204326-43-2 | Purity: ≥98% | NS-2028 | ESD-933241-5MG |
| Cas.: 204326-43-2 | Purity: ≥98% | NS-2028 | ESD-933241-25MG |
| Cas.: 1030203-81-6 | Purity: ≥98% | HS38 | ESD-933242-5MG |
| Cas.: 1030203-81-6 | Purity: ≥98% | HS38 | ESD-933242-25MG |
| Cas.: 2454246-18-3 | Purity: ≥98% | YQ128 | ESD-933243-5MG |
| Cas.: 2454246-18-3 | Purity: ≥98% | YQ128 | ESD-933243-25MG |
| Cas.: 1831830-20-6 | Purity: ≥98% | IL-15-IN-1 | ESD-933244-5MG |
| Cas.: 1831830-20-6 | Purity: ≥98% | IL-15-IN-1 | ESD-933244-25MG |
| Cas.: 306959-01-3 | Purity: ≥98% | MYLS22 | ESD-933245-5MG |
| Cas.: 306959-01-3 | Purity: ≥98% | MYLS22 | ESD-933245-25MG |
| Cas.: 2288709-96-4 | Purity: ≥98% | AZ32 | ESD-933246-5MG |
| Cas.: 2288709-96-4 | Purity: ≥98% | AZ32 | ESD-933246-25MG |
| Cas.: 2250019-93-1 | Purity: ≥98% | nor-NOHA monoacetate | ESD-933247-5MG |
| Cas.: 2250019-93-1 | Purity: ≥98% | nor-NOHA monoacetate | ESD-933247-25MG |
| Cas.: 222018-18-0 | Purity: ≥98% | Lyn peptide inhibitor | ESD-933248-5MG |
| Cas.: 222018-18-0 | Purity: ≥98% | Lyn peptide inhibitor | ESD-933248-25MG |
| Cas.: 1160852-22-1 | Purity: ≥98% | S130 | ESD-933249-5MG |
| Cas.: 1160852-22-1 | Purity: ≥98% | S130 | ESD-933249-25MG |
| Cas.: 2112809-98-8 | Purity: ≥98% | JC-171 | ESD-933250-5MG |
| Cas.: 2112809-98-8 | Purity: ≥98% | JC-171 | ESD-933250-25MG |
| Cas.: 2254409-25-9 | Purity: ≥98% | ALK2-IN-2 | ESD-933251-5MG |
| Cas.: 2254409-25-9 | Purity: ≥98% | ALK2-IN-2 | ESD-933251-25MG |
| Cas.: 2271081-58-2 | Purity: ≥98% | MARK4 inhibitor 1 | ESD-933252-5MG |
| Cas.: 2271081-58-2 | Purity: ≥98% | MARK4 inhibitor 1 | ESD-933252-25MG |
| Cas.: 909561-15-5 | Purity: 98% | AS1810722 | ESD-933253-5MG |
| Cas.: 909561-15-5 | Purity: 98% | AS1810722 | ESD-933253-25MG |
| Cas.: 1149348-10-6 | Purity: ≥98% | FGI-106 tetrahydrochloride | ESD-933254-5MG |
| Cas.: 1149348-10-6 | Purity: ≥98% | FGI-106 tetrahydrochloride | ESD-933254-25MG |
| Cas.: 114568-26-2 | Purity: ≥98% | Patamostat | ESD-933255-5MG |
| Cas.: 114568-26-2 | Purity: ≥98% | Patamostat | ESD-933255-25MG |
| Cas.: 925069-34-7 | Purity: ≥98% | PI-273 | ESD-933256-5MG |
| Cas.: 925069-34-7 | Purity: ≥98% | PI-273 | ESD-933256-25MG |
| Cas.: 32502-63-9 | Purity: ≥98% | 3-Phenyltoxoflavin | ESD-933257-5MG |
| Cas.: 32502-63-9 | Purity: ≥98% | 3-Phenyltoxoflavin | ESD-933257-25MG |
| Cas.: 1359431-16-5 | Purity: ≥95% | M435-1279 | ESD-933258-5MG |
| Cas.: 1359431-16-5 | Purity: ≥95% | M435-1279 | ESD-933258-25MG |
| Cas.: 188532-26-5 | Purity: ≥98% | NL-1 | ESD-933259-5MG |
| Cas.: 188532-26-5 | Purity: ≥98% | NL-1 | ESD-933259-25MG |
| Cas.: 1610516-67-0 | Purity: ≥98% | ML318 | ESD-933260-5MG |
| Cas.: 1610516-67-0 | Purity: ≥98% | ML318 | ESD-933260-25MG |
| Cas.: 1780390-65-9 | Purity: ≥98% | YM-244769 dihydrochloride | ESD-933261-5MG |
| Cas.: 1780390-65-9 | Purity: ≥98% | YM-244769 dihydrochloride | ESD-933261-25MG |
| Cas.: 15982-84-0 | Purity: 98% | (E/Z)-BCI | ESD-933262-5MG |
| Cas.: 15982-84-0 | Purity: 98% | (E/Z)-BCI | ESD-933262-25MG |
| Cas.: 2434898-43-6 | Purity: ≥98% | MRL-494 | ESD-933263-5MG |
| Cas.: 2434898-43-6 | Purity: ≥98% | MRL-494 | ESD-933263-25MG |
| Cas.: 2070014-83-2 | Purity: ≥98% | Chitinase-IN-2 hydrochloride | ESD-933264-5MG |
| Cas.: 2070014-83-2 | Purity: ≥98% | Chitinase-IN-2 hydrochloride | ESD-933264-25MG |
| Cas.: 82601-41-0 | Purity: ≥99% | Pseudolaric Acid C | ESD-933265-10MG |
| Cas.: 82601-41-0 | Purity: ≥99% | Pseudolaric Acid C | ESD-933265-20MG |
| Cas.: 1122579-42-3 | 6-(2-Hydroxy-3-methylbenzylamino)purine | ESD-933266-5MG | |
| Cas.: 1122579-42-3 | 6-(2-Hydroxy-3-methylbenzylamino)purine | ESD-933266-10MG | |
| Cas.: 1242137-15-0 | Purity: 98% | Enzalutamide Carboxylic Acid | ESD-933267-5MG |
| Cas.: 1242137-15-0 | Purity: 98% | Enzalutamide Carboxylic Acid | ESD-933267-10MG |
| Cas.: 1813-94-1 | Purity: 98% | Ethyl 2-(4-fluorophenyl)-2-oxoacetate | ESD-933268-5G |
| Cas.: 1813-94-1 | Purity: 98% | Ethyl 2-(4-fluorophenyl)-2-oxoacetate | ESD-933268-10G |
| Cas.: 1957203-01-8 | Purity: 98% | YKL-5-124 | ESD-933269-5MG |
| Cas.: 1957203-01-8 | Purity: 98% | YKL-5-124 | ESD-933269-10MG |
| Cas.: 2095719-92-7 | Purity: ≥99% | ASTX-029 | ESD-933270-5MG |
| Cas.: 2095719-92-7 | Purity: ≥99% | ASTX-029 | ESD-933270-10MG |
| Cas.: 2305936-56-3 | Purity: 98% | TD-165 | ESD-933271-5MG |
| Cas.: 2305936-56-3 | Purity: 98% | TD-165 | ESD-933271-10MG |
| Cas.: 667880-38-8 | Purity: ≥98% | ZLDI-8 | ESD-933272-5MG |
| Cas.: 667880-38-8 | Purity: ≥98% | ZLDI-8 | ESD-933272-10MG |
| Cas.: 147076-36-6 | Purity: ≥98% | Laflunimus | ESD-933273-5MG |
| Cas.: 147076-36-6 | Purity: ≥98% | Laflunimus | ESD-933273-10MG |
| Cas.: 634907-30-5 | Purity: ≥98% | Censavudine | ESD-933274-5MG |
| Cas.: 634907-30-5 | Purity: ≥98% | Censavudine | ESD-933274-10MG |
| Cas.: 1644156-80-8 | Purity: ≥98% | hDHODH-IN-3 | ESD-933275-5MG |
| Cas.: 1644156-80-8 | Purity: ≥98% | hDHODH-IN-3 | ESD-933275-10MG |
| Cas.: 182316-44-5 | Cyclotriazadisulfonamide | ESD-933276-5MG | |
| Cas.: 182316-44-5 | Cyclotriazadisulfonamide | ESD-933276-10MG | |
| Cas.: 34450-18-5 | Purity: ≥95% | 17-ODYA | ESD-933277-5MG |
| Cas.: 34450-18-5 | Purity: ≥95% | 17-ODYA | ESD-933277-10MG |
| Cas.: 1895050-66-4 | Purity: ≥98% | 6RK73 | ESD-933278-5MG |
| Cas.: 1895050-66-4 | Purity: ≥98% | 6RK73 | ESD-933278-10MG |
| Cas.: 32350-57-5 | Purity: ≥95% | Stearoyl-L-carnitine chloride | ESD-933279-5MG |
| Cas.: 32350-57-5 | Purity: ≥95% | Stearoyl-L-carnitine chloride | ESD-933279-10MG |
| Cas.: 945396-55-4 | Purity: ≥98% | AZ12672857 | ESD-933280-5MG |
| Cas.: 945396-55-4 | Purity: ≥98% | AZ12672857 | ESD-933280-10MG |
| Cas.: 2043321-54-4 | Purity: ≥98% | AZ506 | ESD-933281-5MG |
| Cas.: 2043321-54-4 | Purity: ≥98% | AZ506 | ESD-933281-10MG |
| Cas.: 260979-95-1 | Purity: ≥98% | Enfumafungin | ESD-933282-5MG |
| Cas.: 260979-95-1 | Purity: ≥98% | Enfumafungin | ESD-933282-10MG |
| Cas.: 2320274-72-2 | Purity: ≥98% | ST-193 hydrochloride | ESD-933283-5MG |
| Cas.: 2320274-72-2 | Purity: ≥98% | ST-193 hydrochloride | ESD-933283-10MG |
| Cas.: 102271-49-8 | Purity: ≥98% | PGS-IN-1 | ESD-933284-5MG |
| Cas.: 102271-49-8 | Purity: ≥98% | PGS-IN-1 | ESD-933284-10MG |
| Cas.: 2443816-45-1 | Purity: ≥98% | ULK-101 | ESD-933285-5MG |
| Cas.: 2443816-45-1 | Purity: ≥98% | ULK-101 | ESD-933285-10MG |
| Cas.: 1292300-75-4 | Purity: ≥98% | TASP0415914 | ESD-933286-5MG |
| Cas.: 1292300-75-4 | Purity: ≥98% | TASP0415914 | ESD-933286-10MG |
| Cas.: 6837-93-0 | Purity: ≥98% | NSC16168 | ESD-933287-5MG |
| Cas.: 6837-93-0 | Purity: ≥98% | NSC16168 | ESD-933287-10MG |
| Cas.: 210345-00-9 | Purity: ≥98% | Z-WEHD-FMK | ESD-933288-5MG |
| Cas.: 210345-00-9 | Purity: ≥98% | Z-WEHD-FMK | ESD-933288-10MG |
| Cas.: 956613-01-7 | Purity: ≥98% | SB-633825 | ESD-933289-5MG |
| Cas.: 956613-01-7 | Purity: ≥98% | SB-633825 | ESD-933289-10MG |
| Cas.: 2268720-62-1 | Purity: ≥98% | URAT1 inhibitor 1 | ESD-933290-5MG |
| Cas.: 2268720-62-1 | Purity: ≥98% | URAT1 inhibitor 1 | ESD-933290-10MG |
| Cas.: 608510-47-0 | Purity: ≥98% | Pactimibe sulfate | ESD-933291-5MG |
| Cas.: 608510-47-0 | Purity: ≥98% | Pactimibe sulfate | ESD-933291-10MG |
| Cas.: 1071173-56-2 | Purity: ≥98% | SN52 | ESD-933292-5MG |
| Cas.: 1071173-56-2 | Purity: ≥98% | SN52 | ESD-933292-10MG |
| Cas.: 2271413-06-8 | Purity: ≥98% | HDACs/mTOR Inhibitor 1 | ESD-933293-5MG |
| Cas.: 2271413-06-8 | Purity: ≥98% | HDACs/mTOR Inhibitor 1 | ESD-933293-10MG |
| Cas.: 1601496-05-2 | Purity: ≥98% | GSK-843 | ESD-933294-5MG |
| Cas.: 1601496-05-2 | Purity: ≥98% | GSK-843 | ESD-933294-10MG |
| Cas.: 2310262-11-2 | Purity: ≥98% | PDK4-IN-1 hydrochloride | ESD-933295-5MG |
| Cas.: 2310262-11-2 | Purity: ≥98% | PDK4-IN-1 hydrochloride | ESD-933295-10MG |
| Cas.: 1446322-66-2 | Purity: ≥98% | TAT-cyclo-CLLFVY | ESD-933296-5MG |
| Cas.: 1446322-66-2 | Purity: ≥98% | TAT-cyclo-CLLFVY | ESD-933296-10MG |
| Cas.: 341-88-8 | Purity: 97% | 2-Heptyl-4-hydroxyquinolin-1-ium-1-olate | ESD-933297-1MG |
| Cas.: 774-18-5 | Purity: 98% | 2-(2-(Trifluoromethyl)phenyl)ethanamine | ESD-933298-1G |
| Cas.: 774-18-5 | Purity: 98% | 2-(2-(Trifluoromethyl)phenyl)ethanamine | ESD-933298-5G |
| Cas.: 13019-16-4 | Purity: 95% | 2-Butyloct-2-enal | ESD-933299-1G |
| Cas.: 13019-16-4 | Purity: 95% | 2-Butyloct-2-enal | ESD-933299-5G |
| Cas.: 104222-42-6 | Purity: 98% | 3-Bromo-2,4,5-trifluorobenzoic acid | ESD-933300-1G |
| Cas.: 104222-42-6 | Purity: 98% | 3-Bromo-2,4,5-trifluorobenzoic acid | ESD-933300-5G |
| Cas.: 4830-57-3 | Purity: 95% | Sodium 2,3,4,5,6-pentafluorobenzoate | ESD-933301-1G |
| Cas.: 4830-57-3 | Purity: 95% | Sodium 2,3,4,5,6-pentafluorobenzoate | ESD-933301-5G |
| Cas.: 183871-36-5 | Purity: ≥97% | [(2S,3S)-2-(Benzyloxy)pentan-3-yl]hydrazine | ESD-933302-1G |
| Cas.: 183871-36-5 | Purity: ≥97% | [(2S,3S)-2-(Benzyloxy)pentan-3-yl]hydrazine | ESD-933302-5G |
| Cas.: 26077-31-6 | Purity: 98% | Silver2-ethylhexanoate | ESD-933303-1G |
| Cas.: 26077-31-6 | Purity: 98% | Silver2-ethylhexanoate | ESD-933303-5G |
| Cas.: 2457232-14-1 | Purity: 97% | 4-((5-Oxo-6,7,8,9-tetrahydro-5H-cyclohepta[d]pyrimidin-2-yl)amino)thiophene-2-carbonitrile | ESD-933304-1MG |
| Cas.: 2457232-14-1 | Purity: 97% | 4-((5-Oxo-6,7,8,9-tetrahydro-5H-cyclohepta[d]pyrimidin-2-yl)amino)thiophene-2-carbonitrile | ESD-933304-5MG |
| Cas.: 172282-50-7 | Purity: 95% | 4-(Difluoromethoxy)benzene-1,2-diamine | ESD-933305-1G |
| Cas.: 172282-50-7 | Purity: 95% | 4-(Difluoromethoxy)benzene-1,2-diamine | ESD-933305-5G |
| Cas.: 39630-68-7 | Purity: ≥95% | Diethyl 5-hydroxyisophthalate | ESD-933306-1G |
| Cas.: 39630-68-7 | Purity: ≥95% | Diethyl 5-hydroxyisophthalate | ESD-933306-5G |
| Cas.: 24418-86-8 | Purity: 98% | 2-(3,4-Dihydroxybenzylidene)benzofuran-3(2H)-one | ESD-933307-1MG |
| Cas.: 24418-86-8 | Purity: 98% | 2-(3,4-Dihydroxybenzylidene)benzofuran-3(2H)-one | ESD-933307-5MG |
| Cas.: 64344-45-2 | Purity: 98% | (E)-2-Ethylhex-2-enal | ESD-933308-1G |
| Cas.: 64344-45-2 | Purity: 98% | (E)-2-Ethylhex-2-enal | ESD-933308-5G |
| Cas.: 1334169-93-5 | Purity: 97% | Boc-NH-PEG8-CH2CH2COOH | ESD-933309-1G |
| Cas.: 1334169-93-5 | Purity: 97% | Boc-NH-PEG8-CH2CH2COOH | ESD-933309-5G |
| Cas.: 1205751-19-4 | Purity: 97% | Cbz-NH-PEG1-CH2CH2COOH | ESD-933310-1MG |
| Cas.: 1205751-19-4 | Purity: 97% | Cbz-NH-PEG1-CH2CH2COOH | ESD-933310-5MG |
| Cas.: 1643957-26-9 | Purity: 98% | Benzyl-PEG2-CH2-Boc | ESD-933311-500MG |
| Cas.: 1643957-26-9 | Purity: 98% | Benzyl-PEG2-CH2-Boc | ESD-933311-1G |
| Cas.: 18456-87-6 | Purity: 97% | 5-Isopropylcyclohexane-1,3-dione | ESD-933312-250MG |
| Cas.: 18456-87-6 | Purity: 97% | 5-Isopropylcyclohexane-1,3-dione | ESD-933312-1G |
| Cas.: 1496997-41-1 | Purity: 98% | 2-(2,6-Dioxopiperidin-3-yl)-5,6-difluoroisoindoline-1,3-dione | ESD-933313-250MG |
| Cas.: 1496997-41-1 | Purity: 98% | 2-(2,6-Dioxopiperidin-3-yl)-5,6-difluoroisoindoline-1,3-dione | ESD-933313-1G |
| Cas.: 120099-60-7 | Purity: 98% | (R)-3-Methoxypyrrolidine | ESD-933314-250MG |
| Cas.: 120099-60-7 | Purity: 98% | (R)-3-Methoxypyrrolidine | ESD-933314-1G |
| Cas.: 101654-28-8 | Purity: 97% | 2-Nitropyridin-4-ol | ESD-933315-250MG |
| Cas.: 101654-28-8 | Purity: 97% | 2-Nitropyridin-4-ol | ESD-933315-1G |
| Cas.: 17965-72-9 | Purity: 98% | 3,7-Dibromo-1,5-naphthyridine | ESD-933316-250MG |
| Cas.: 17965-72-9 | Purity: 98% | 3,7-Dibromo-1,5-naphthyridine | ESD-933316-1G |
| Cas.: 74641-30-8 | Purity: 98% | (1R,2S)-rel-1,2-Bis(4-chlorophenyl)ethane-1,2-diamine | ESD-933317-250MG |
| Cas.: 74641-30-8 | Purity: 98% | (1R,2S)-rel-1,2-Bis(4-chlorophenyl)ethane-1,2-diamine | ESD-933317-1G |
| Cas.: 95881-83-7 | Purity: 98% | 3-Chloro-5-methoxypyridine | ESD-933318-250MG |
| Cas.: 95881-83-7 | Purity: 98% | 3-Chloro-5-methoxypyridine | ESD-933318-1G |
| Cas.: 103346-16-3 | Purity: 95% | 3-Iodobenzylguanidinium-sulfate | ESD-933319-250MG |
| Cas.: 103346-16-3 | Purity: 95% | 3-Iodobenzylguanidinium-sulfate | ESD-933319-1G |
| Cas.: 6324-72-7 | Purity: 97% | 2-Amino-8-thioxo-3,7,8,9-tetrahydro-6H-purin-6-one | ESD-933320-250MG |
| Cas.: 6324-72-7 | Purity: 97% | 2-Amino-8-thioxo-3,7,8,9-tetrahydro-6H-purin-6-one | ESD-933320-1G |
| Cas.: 93621-64-8 | Purity: 97% | N2,N2′-Dimethyl-[1,1′-binaphthalene]-2,2′-diamine | ESD-933321-250MG |
| Cas.: 93621-64-8 | Purity: 97% | N2,N2′-Dimethyl-[1,1′-binaphthalene]-2,2′-diamine | ESD-933321-1G |
| Cas.: 1644644-96-1 | Purity: 95% | Methyltetrazine-nhs ester | ESD-933322-250MG |
| Cas.: 1644644-96-1 | Purity: 95% | Methyltetrazine-nhs ester | ESD-933322-1G |
| Cas.: 5457-29-4 | Purity: 97% | 2-(3-Iodopropyl)isoindoline-1,3-dione | ESD-933323-250MG |
| Cas.: 5457-29-4 | Purity: 97% | 2-(3-Iodopropyl)isoindoline-1,3-dione | ESD-933323-1G |
| Cas.: 96980-64-2 | Purity: 97% | 2-Chloro-N-(3-chloro-4-fluorophenyl)acetamide | ESD-933324-250MG |
| Cas.: 96980-64-2 | Purity: 97% | 2-Chloro-N-(3-chloro-4-fluorophenyl)acetamide | ESD-933324-1G |
| Cas.: 51874-27-2 | Purity: 95% | 5-Bromopentan-1-amine hydrobromide | ESD-933325-250MG |
| Cas.: 51874-27-2 | Purity: 95% | 5-Bromopentan-1-amine hydrobromide | ESD-933325-1G |
| Cas.: 480450-03-1 | Purity: 98% | 3-Methoxycyclobutanecarboxylic acid | ESD-933326-250MG |
| Cas.: 480450-03-1 | Purity: 98% | 3-Methoxycyclobutanecarboxylic acid | ESD-933326-1G |
| Cas.: 42607-87-4 | Purity: 97% | THP-PEG6-OH | ESD-933327-250MG |
| Cas.: 42607-87-4 | Purity: 97% | THP-PEG6-OH | ESD-933327-1G |
| Cas.: 195071-49-9 | Purity: ≥95% | Amino-PEG4-CH2COOH | ESD-933328-250MG |
| Cas.: 195071-49-9 | Purity: ≥95% | Amino-PEG4-CH2COOH | ESD-933328-1G |
| Cas.: 1449390-12-8 | Purity: 97% | m-PEG6-NHS ester | ESD-933329-250MG |
| Cas.: 1449390-12-8 | Purity: 97% | m-PEG6-NHS ester | ESD-933329-1G |
| Cas.: 1245823-50-0 | Purity: 97% | Propargyl-PEG4-CH2CH2-Boc | ESD-933330-250MG |
| Cas.: 1245823-50-0 | Purity: 97% | Propargyl-PEG4-CH2CH2-Boc | ESD-933330-1G |
| Cas.: 25383-07-7 | Purity: ≥98% | Fosfomycin phenylethylamine | ESD-933331-100MG |
| Cas.: 25383-07-7 | Purity: ≥98% | Fosfomycin phenylethylamine | ESD-933331-1G |
| Cas.: 395683-14-4 | Purity: ≥95% | Imrecoxib | ESD-933332-100MG |
| Cas.: 395683-14-4 | Purity: ≥95% | Imrecoxib | ESD-933332-1G |
| Cas.: 2250056-46-1 | Purity: 97% | CH2COOH-PEG9-CH2COOH | ESD-933333-500MG |
| Cas.: 176220-30-7 | Purity: 97% | Boc-NHCH2CH2-PEG1-azide | ESD-933334-500MG |
| Cas.: 1347750-20-2 | HS-PEG5-CH2CH2NH2 | ESD-933335-500MG | |
| Cas.: 1347750-72-4 | Purity: 97% | m-PEG5-CH2CH2COOH | ESD-933336-500MG |
| Cas.: 126519-80-0 | Purity: 98% | OTs-C6-OBn | ESD-933337-500MG |
| Cas.: 419532-92-6 | Purity: ≥95% | Phenylpyropene C | ESD-933338-500ΜG |
| Cas.: 67401-56-3 | Purity: ≥95% | Micrococcin P1 | ESD-933339-500ΜG |
| Cas.: 207671-44-1 | Quinine hemisulfate hydrate | ESD-933340-500MG | |
| Cas.: 1191237-80-5 | Purity: 98% | (3aR,4R,6R,6aR)-4-(4-Aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-6-(hydroxymethyl)-2,2-dimethyltetrahydrofuro[3 ,4-d][1,3]dioxole-4-carbonitrile | ESD-933341-250MG |
| Cas.: 2112738-12-0 | m-PEG10-azide | ESD-933342-250MG | |
| Cas.: 1202681-04-6 | m-PEG5-azide | ESD-933343-250MG | |
| Cas.: 1807521-01-2 | Purity: 97% | C-NH-Boc-C-Bis-(C1-PEG1-PFP) | ESD-933344-250MG |
| Cas.: 1347750-81-5 | Purity: 97% | Mal-NH-PEG2-CH2CH2COOPFP ester | ESD-933345-250MG |
| Cas.: 1818294-40-4 | Purity: 95% | HS-PEG6-CH2CH2-Boc | ESD-933346-250MG |
| Cas.: 1480545-09-2 | Purity: ≥95% | Azido-PEG1-CH2CO2-NHS | ESD-933347-250MG |
| Cas.: 1347750-84-8 | Purity: 97% | Mal-NH-PEG4-CH2CH2COOPFP ester | ESD-933348-250MG |
| Cas.: 1599432-34-4 | Purity: 97% | Mal-NH-PEG6-CH2CH2COOPFP ester | ESD-933349-250MG |
| Cas.: 1334172-59-6 | Purity: 98% | Biotin-C1-PEG3-C3-amine TFA | ESD-933350-250MG |
| Cas.: 129086-11-9 | Purity: ≥95% | Benzyl-PEG6-Ots | ESD-933351-250MG |
| Cas.: 2136296-33-6 | Purity: 97% | Mal-NH-PEG12-CH2CH2COOPFP ester | ESD-933352-250MG |
| Cas.: 1144113-17-6 | Purity: 95% | Benzyl-PEG8-Ots | ESD-933353-250MG |
| Cas.: 2231845-12-6 | Purity: 95% | Azido-PEG8-NHBoc | ESD-933354-250MG |
| Cas.: 1354521-95-1 | Purity: 97% | m-PEG9-azide | ESD-933355-250MG |
| Cas.: 2100306-49-6 | Purity: ≥95% | N-(PEG2-C2-acid)-N-bis(PEG2-propargyl) | ESD-933356-250MG |
| Cas.: 58884-35-8 | Purity: 95% | 4-(6-Methyl-1,2,4,5-tetrazin-3-yl)phenol | ESD-933357-250MG |
| Cas.: 2148986-08-5 | Purity: 97% | HS-PEG11-CH2CH2N3 | ESD-933358-250MG |
| Cas.: 2376724-97-7 | Purity: ≥95% | Boc-C1-PEG3-C4-OH | ESD-933359-250MG |
| Cas.: 2148986-06-3 | Purity: ≥95% | HS-PEG7-CH2CH2N3 | ESD-933360-250MG |
| Cas.: 1807512-35-1 | Purity: ≥95% | m-PEG7-CH2-OH | ESD-933361-250MG |
| Cas.: 15332-94-2 | Purity: 97% | Amino-PEG11-OH | ESD-933362-250MG |
| Cas.: 129449-09-8 | Purity: ≥95% | Amino-PEG10-OH | ESD-933363-250MG |
| Cas.: 2357108-99-5 | Purity: ≥98% | AM-Imidazole-PA-Boc | ESD-933364-250MG |
| Cas.: 145526-76-7 | Purity: ≥95% | m-PEG4-CH2-alcohol | ESD-933365-250MG |
| Cas.: 868594-52-9 | Purity: ≥95% | Fmoc-NH-PEG8-CH2COOH | ESD-933366-250MG |
| Cas.: 2093386-50-4 | Purity: 97% | Thalidomide-NH-C6-NH2 | ESD-933367-250MG |
| Cas.: 477775-57-8 | Purity: 95% | m-PEG7-Ms | ESD-933368-250MG |
| Cas.: 1059588-19-0 | Purity: 95% | m-PEG8-Ms | ESD-933369-250MG |
| Cas.: 130955-38-3 | Purity: 95% | m-PEG5-Ms | ESD-933370-250MG |
| Cas.: 1050500-41-8 | Purity: 97% | PEG12-Tos | ESD-933371-250MG |
| Cas.: 1144113-16-5 | Purity: 98% | Tr-PEG8-OH | ESD-933372-250MG |
| Cas.: 2055042-83-4 | Purity: 98% | Propargyl-PEG9-bromide | ESD-933373-250MG |
| Cas.: 1314378-18-1 | Purity: 97% | Bis-PEG2-PFP ester | ESD-933374-250MG |
| Cas.: 54384-47-3 | Purity: ≥95% | NH-bis-PEG2 | ESD-933375-250MG |
| Cas.: 2221949-00-2 | Purity: ≥95% | Bis-PEG13-NHS ester | ESD-933376-250MG |
| Cas.: 2221949-02-4 | Purity: ≥95% | Bis-PEG10-NHS ester | ESD-933377-250MG |
| Cas.: 2182601-74-5 | Purity: 97% | Propargyl-PEG8-NHS ester | ESD-933378-250MG |
| Cas.: 1428629-71-3 | Purity: ≥95% | Propargyl-PEG3-NHS ester | ESD-933379-250MG |
| Cas.: 2221948-93-0 | Purity: ≥95% | Bis-PEG17-NHS ester | ESD-933380-250MG |
| Cas.: 1234369-95-9 | Purity: ≥95% | m-PEG7-CH2CH2CHO | ESD-933381-250MG |
| Cas.: 2468780-87-0 | Purity: 97% | Lenalidomide-6-F | ESD-933382-250MG |
| Cas.: 1392499-32-9 | Purity: ≥95% | N-Boc-PEG5-bromide | ESD-933383-250MG |
| Cas.: 2154342-45-5 | Purity: 97% | Pomalidomide-C3-NH2 hydrochloride | ESD-933384-250MG |
| Cas.: 1957236-34-8 | Pomalidomide-C4-NH2 | ESD-933385-250MG | |
| Cas.: 2093388-20-4 | Purity: 97% | Pomalidomide-C3-NH2 | ESD-933386-250MG |
| Cas.: 2162120-73-0 | Purity: 97% | Pomalidomide-C4-NH2 hydrochloride | ESD-933387-250MG |
| Cas.: 927670-97-1 | Purity: 98% | Thalidomide-NH-CH2-COOH | ESD-933388-250MG |
| Cas.: 2648939-40-4 | Purity: ≥98% | Thalidomide-5,6-Cl | ESD-933389-250MG |
| Cas.: 2222114-22-7 | Purity: 98% | Thalidomide-Piperazine 5-fluoride | ESD-933390-250MG |
| Cas.: 682329-63-1 | Purity: ≥75% | Cytostatin | ESD-933391-250ΜG |
| Cas.: 83654-05-1 | Purity: 98% | RHC 80267 | ESD-933392-250MG |
| Cas.: 568580-02-9 | Purity: ≥95% | YM-254890 | ESD-933393-250ΜG |
| Cas.: 134869-15-1 | Purity: ≥98% | Lactimidomycin | ESD-933394-200ΜG |
| Cas.: 105994-75-0 | Purity: ≥95% | 1-Methyl-5-phenyl-1H-pyrazole-4-carboxylic acid | ESD-933395-100MG |
| Cas.: 216453-74-6 | Purity: 97% | 11-Keto Budesonide | ESD-933396-100MG |
| Cas.: 75444-65-4 | Purity: 98% | 3-(2-(4-(4-Fluorobenzoyl)piperidin-1-yl)ethyl)-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one | ESD-933397-100MG |
| Cas.: 1313730-19-6 | Purity: 99% | (S)-2-((S)-2-((2S,3R)-2-Amino-3-hydroxybutanamido)-3-phenylpropanamido)-N-((S)-1-(((S)-1 -amino-5-guanidino-1-oxopentan-2-yl)amino)-4-methyl-1-oxopentan-2-yl)-4-methylpentanamide 2,2,2-trifluoroacetate | ESD-933398-100MG |
| Cas.: 73816-42-9 | Purity: 98% | Meclocycline sulfosalicylate | ESD-933399-100MG |
| Cas.: 1542796-16-6 | Purity: 95% | 2-((2R,3R)-3-(Tert-butyl)-4-methoxy-2,3-dihydrobenzo[d][1,3]oxaphosphol-2-yl)-6-methoxypyridine | ESD-933400-100MG |
| Cas.: 1316189-13-5 | m-PEG9-NHS ester | ESD-933401-100MG | |
| Cas.: 874208-92-1 | m-PEG7-NHS ester | ESD-933402-100MG | |
| Cas.: 876746-59-7 | m-PEG3-NHS ester | ESD-933403-100MG | |
| Cas.: 1844894-82-1 | Purity: 95% | Boc-Aminooxy-PEG1-C2-NH2 | ESD-933404-100MG |
| Cas.: 2353409-72-8 | Purity: 97% | N-(DBCO-PEG4)-N-Biotin-PEG4-NHS | ESD-933405-100MG |
| Cas.: 2093153-07-0 | Purity: 97% | N-(Azido-PEG2)-N-Boc-PEG3-Boc | ESD-933406-100MG |
| Cas.: 2055042-56-1 | Purity: 97% | N-(Azido-PEG3)-N-bis(PEG3-Boc) | ESD-933407-100MG |
| Cas.: 2112737-20-7 | Purity: 97% | N-(Azido-PEG4)-N-Boc-PEG4-Boc | ESD-933408-100MG |
| Cas.: 2408741-87-5 | Purity: ≥95% | Mal-PEG4-Glu(TFP ester)-NH-m-PEG24 | ESD-933409-100MG |
| Cas.: 1415800-34-8 | Hydroxy-Amino-bis(PEG1-C2-Boc) | ESD-933410-100MG | |
| Cas.: 906126-25-8 | Fmoc-NH-PEG3-C2-NH2 | ESD-933411-100MG | |
| Cas.: 2353409-58-0 | N-(Azido-PEG3)-N-bis(PEG4-Boc) | ESD-933412-100MG | |
| Cas.: 1993134-72-7 | Purity: 98% | endo-BCN-PEG2-acid | ESD-933413-100MG |
| Cas.: 2292116-14-2 | Desmorpholinyl Quizartinib-PEG2-COOH | ESD-933414-100MG | |
| Cas.: 2055042-62-9 | Purity: 97% | N-(Amino-PEG3)-N-bis(PEG3-Boc) | ESD-933415-100MG |
| Cas.: 2100306-84-9 | Purity: 95% | N-(Amino-PEG4)-N-Biotin-PEG4-acid | ESD-933416-100MG |
| Cas.: 2028288-77-7 | TCO-C3-PEG3-C3-amine | ESD-933417-100MG | |
| Cas.: 2107273-24-3 | N-(m-PEG4)-N’-(PEG2-acid)-Cy5 | ESD-933418-100MG | |
| Cas.: 2306832-21-1 | Purity: ≥98% | Ms-PEG3-CH2CH2COOH | ESD-933419-100MG |
| Cas.: 2107273-38-9 | N-(m-PEG4)-N’-(azide-PEG4)-Cy3 | ESD-933420-100MG | |
| Cas.: 2093152-78-2 | Purity: 97% | N-(Propargyl-PEG2)-N-Boc-PEG3-t-butyl ester | ESD-933421-100MG |
| Cas.: 2107273-26-5 | Purity: 97% | N-(m-PEG9)-N’-(PEG5-acid)-Cy5 | ESD-933422-100MG |
| Cas.: 2107273-68-5 | Purity: 97% | N-(m-PEG4)-N’-(biotin-PEG3)-Cy5 | ESD-933423-100MG |
| Cas.: 2375564-62-6 | Purity: 98% | VHL Ligand-Linker Conjugates 15 | ESD-933424-100MG |
| Cas.: 2107273-32-3 | Purity: 97% | N-(m-PEG4)-N’-(PEG4-acid)-Cy5 | ESD-933425-100MG |
| Cas.: 2107273-42-5 | Purity: ≥95% | N-(Azide-PEG3)-N’-(PEG4-acid)-Cy5 | ESD-933426-100MG |
| Cas.: 1807534-84-4 | Purity: ≥95% | Ald-Ph-amido-PEG2-C2-acid | ESD-933427-100MG |
| Cas.: 1404111-56-3 | Purity: ≥95% | Ald-Ph-amido-PEG3-C2-NH2 | ESD-933428-100MG |
| Cas.: 2107273-10-7 | N-(m-PEG9)-N’-(propargyl-PEG8)-Cy5 | ESD-933429-100MG | |
| Cas.: 2112732-03-1 | Purity: 97% | N-(Azido-PEG3)-N-Boc-PEG3-t-butyl ester | ESD-933430-100MG |
| Cas.: 2028281-90-3 | Boc-Aminooxy-PEG4-CH2CO2H | ESD-933431-100MG | |
| Cas.: 2320560-36-7 | 2-(Azido-PEG3-amido)-1,3-bis(NHS ester) | ESD-933432-100MG | |
| Cas.: 2230956-95-1 | CHO-CH2-PEG1-CH2-Boc | ESD-933433-100MG | |
| Cas.: 2107272-96-6 | Purity: 97% | N-(m-PEG4)-N’-(amino-PEG3)-Cy5 | ESD-933434-100MG |
| Cas.: 2226235-96-5 | Purity: 97% | N-PEG3-N’-(azide-PEG3)-Cy5 | ESD-933435-100MG |
| Cas.: 2410598-01-3 | Purity: ≥95% | Boc-NH-PEG10-CH2CH2COOH | ESD-933436-100MG |
| Cas.: 2107273-06-1 | Purity: 97% | N-PEG3-N’-(propargyl-PEG4)-Cy5 | ESD-933437-100MG |
| Cas.: 2107273-12-9 | Purity: 97% | N-(m-PEG4)-N’-(hydroxy-PEG2)-Cy5 | ESD-933438-100MG |
| Cas.: 2107273-02-7 | Purity: ≥95% | N-(m-PEG4)-N’-(azide-PEG3)-Cy5 | ESD-933439-100MG |
| Cas.: 1205744-09-7 | Purity: ≥95% | N-Biotinyl-NH-(PEG)2-CO2H·nDIPEA | ESD-933440-100MG |
| Cas.: 382162-12-1 | Phthalimide-PEG3-C2-OTs | ESD-933441-100MG | |
| Cas.: 956472-77-8 | Purity: ≥98% | N-Boc-C1-PEG5-C3-NH2 | ESD-933442-100MG |
| Cas.: 1027371-75-0 | Purity: 97% | m-PEG1-NHS ester | ESD-933443-100MG |
| Cas.: 2395004-21-2 | Purity: 97% | Boc-NH-PEG11-CH2CH2N3 | ESD-933444-100MG |
| Cas.: 1052207-59-6 | Purity: ≥98% | Boc-NH-PEG8-CH2CH2NH2 | ESD-933445-100MG |
| Cas.: 2183440-74-4 | Purity: 97% | N-(Azido-PEG3)-N-(PEG2-NH-Boc)-PEG3-acid | ESD-933446-100MG |
| Cas.: 89520-11-6 | Purity: 97% | N-Bromoacetyl-β-alanine | ESD-933447-100MG |
| Cas.: 1807540-87-9 | Ald-Ph-amido-C2-PEG3-NH-Boc | ESD-933448-100MG | |
| Cas.: 2107273-30-1 | N-(m-PEG4)-N’-(PEG4-NHS ester)-Cy5 | ESD-933449-100MG | |
| Cas.: 1443467-88-6 | Purity: ≥95% | Benzyl-PEG3-CH2-Boc | ESD-933450-100MG |
| Cas.: 2107273-28-7 | N-(m-PEG4)-N’-(PEG2-NHS ester)-Cy5 | ESD-933451-100MG | |
| Cas.: 1807521-06-7 | Purity: 95% | Ph-Bis(C1-N-(C2-NH-Boc)2) | ESD-933452-100MG |
| Cas.: 1059189-65-9 | Purity: ≥95% | m-PEG4-CH2-aldehyde | ESD-933453-100MG |
| Cas.: 2378261-85-7 | Purity: 98% | K-Ras ligand-Linker Conjugate 5 | ESD-933454-100MG |
| Cas.: 2378261-83-5 | Purity: 98% | K-Ras ligand-Linker Conjugate 4 | ESD-933455-100MG |
| Cas.: 876345-13-0 | Purity: 98% | Boc-NH-PEG4-CH2COOH | ESD-933456-100MG |
| Cas.: 1692613-62-9 | NH2-C2-amido-C2-Boc | ESD-933457-100MG | |
| Cas.: 2093388-52-2 | Purity: ≥95% | Thalidomide-NH-C4-NH-Boc | ESD-933458-100MG |
| Cas.: 1613439-69-2 | Purity: ≥95% | TCO-PEG4-NHS ester | ESD-933459-100MG |
| Cas.: 2093386-51-5 | Purity: 97% | Thalidomide-NH-C6-NH2 TFA | ESD-933460-100MG |
| Cas.: 105589-77-3 | Purity: 95% | Tr-PEG2-OH | ESD-933461-100MG |
| Cas.: 1870899-46-9 | Purity: ≥95% | DBCO-NHCO-PEG4-acid | ESD-933462-100MG |
| Cas.: 2241489-43-8 | Purity: 97% | E3 ligase Ligand 14 | ESD-933463-100MG |
| Cas.: 2182601-68-7 | Purity: 97% | DBCO-PEG4-DBCO | ESD-933464-100MG |
| Cas.: 1073560-68-5 | Purity: 97% | E3 ligase Ligand 10 | ESD-933465-100MG |
| Cas.: 2241669-88-3 | Purity: 97% | E3 ligase Ligand 18 | ESD-933466-100MG |
| Cas.: 141282-24-8 | Purity: 98% | Tr-PEG5-OH | ESD-933467-100MG |
| Cas.: 87304-15-2 | Purity: 97% | E3 ligase Ligand 9 | ESD-933468-100MG |
| Cas.: 2055046-25-6 | Purity: 97% | Propargyl-PEG8-bromide | ESD-933469-100MG |
| Cas.: 2207541-30-6 | Purity: ≥98% | Lenalidomide-I | ESD-933470-100MG |
| Cas.: 2110444-63-6 | Boc-gly-PEG3-endo-BCN | ESD-933471-100MG | |
| Cas.: 2308496-47-9 | Purity: ≥95% | Pip-alkyne-Ph-COOCH3 | ESD-933472-100MG |
| Cas.: 2055014-94-1 | Purity: 97% | Propargyl-PEG8-acid | ESD-933473-100MG |
| Cas.: 2093152-77-1 | Purity: 97% | Propargyl-PEG7-NHS ester | ESD-933474-100MG |
| Cas.: 2221948-98-5 | Purity: ≥95% | Bis-PEG21-NHS ester | ESD-933475-100MG |
| Cas.: 1010100-22-7 | Purity: ≥95% | Thalidomide-5-CH2-NH2 hydrochloride | ESD-933476-100MG |
| Cas.: 79598-49-5 | Purity: ≥95% | Azido-PEG1-CH2COO-Cl | ESD-933477-100MG |
| Cas.: 2093153-99-0 | Purity: 97% | Propargyl-PEG6-NHS ester | ESD-933478-100MG |
| Cas.: 2221948-96-3 | Purity: ≥95% | Bis-PEG25-NHS ester | ESD-933479-100MG |
| Cas.: 2249750-27-2 | Purity: 97% | E3 ligase Ligand 16 | ESD-933480-100MG |
| Cas.: 2093154-01-7 | Purity: ≥95% | N-Boc-N-bis(PEG4-OH) | ESD-933481-100MG |
| Cas.: 1010100-28-3 | Purity: 98% | Lenalidomide-5-aminomethyl | ESD-933482-100MG |
| Cas.: 444289-05-8 | Purity: 97% | Lenalidomide-4-aminomethyl hydrochloride | ESD-933483-100MG |
| Cas.: 790652-68-5 | Purity: 97% | Lenalidomide-4-aminomethyl | ESD-933484-100MG |
| Cas.: 1807518-77-9 | Purity: 97% | Fmoc-N-methyl-PEG3-CH2CH2COOH | ESD-933485-100MG |
| Cas.: 77855-76-6 | Purity: ≥95% | PEG6-(CH2CO2H)2 | ESD-933486-100MG |
| Cas.: 2245697-86-1 | Purity: 98% | Thalidomide-O-amido-C4-NH2 hydrochloride | ESD-933487-100MG |
| Cas.: 2100306-58-7 | Purity: ≥95% | DBCO-NHCO-PEG4-NHS ester | ESD-933488-100MG |
| Cas.: 1058691-00-1 | Purity: ≥95% | m-PEG5-succinimidyl carbonate | ESD-933489-100MG |
| Cas.: 2225148-51-4 | Purity: ≥95% | Thalidomide-O-C8-COOH | ESD-933490-100MG |
| Cas.: 2375194-37-7 | Purity: ≥95% | Thalidomide-NH-C6-NH2 hydrochloride | ESD-933491-100MG |
| Cas.: 390367-50-7 | Purity: ≥95% | Thalidomide 4′-ether-alkylC2-amine | ESD-933492-100MG |
| Cas.: 2509360-22-7 | Thalidomide-O-C3-NH2 | ESD-933493-100MG | |
| Cas.: 2138439-12-8 | Purity: ≥95% | Thalidomide-NH-PEG1-NH2 | ESD-933494-100MG |
| Cas.: 2636798-38-2 | Purity: ≥95% | Thalidomide-O-C8-NH2 hydrochloride | ESD-933495-100MG |
| Cas.: 2419145-66-5 | Purity: ≥95% | Thalidomide-O-C5-NH2 hydrochloride | ESD-933496-100MG |
| Cas.: 1807518-78-0 | Purity: ≥95% | Propargyl-PEG1-SS-PEG1-C2-Boc | ESD-933497-100MG |
| Cas.: 2429878-72-6 | Purity: 98% | Lenalidomide-acetylene-C5-COOH | ESD-933498-100MG |
| Cas.: 1950635-15-0 | Purity: ≥98% | Thalidomide-O-amido-C8-NH2 TFA | ESD-933499-100MG |
| Cas.: 1799711-24-2 | Purity: ≥95% | Thalidomide-O-amido-C4-NH2 | ESD-933500-100MG |
| Cas.: 2360527-40-6 | Purity: 97% | Thalidomide-O-amide-C5-NH2 | ESD-933501-100MG |
| Cas.: 1957236-22-4 | Purity: ≥95% | Thalidomide-O-amido-PEG4-C2-NH2 | ESD-933502-100MG |
| Cas.: 2093388-67-9 | Purity: ≥95% | Thalidomide-NH-amido-C4-NH2 | ESD-933503-100MG |
| Cas.: 2306390-08-7 | Purity: 97% | E3 ligase Ligand 15 | ESD-933504-100MG |
| Cas.: 1448189-98-7 | Purity: ≥95% | (S,R,S)-AHPC-Boc | ESD-933505-100MG |
| Cas.: 2093387-50-7 | Purity: 97% | Thalidomide-NH-C4-NH2 TFA | ESD-933506-100MG |
| Cas.: 2097509-36-7 | Purity: 98% | Thalidomide-PEG2-C2-NH2 TFA | ESD-933507-100MG |
| Cas.: 2140807-24-3 | Purity: ≥95% | Thalidomide-NH-PEG4-Ms | ESD-933508-100MG |
| Cas.: 1957235-99-2 | Purity: 95% | Thalidomide-O-C6-NH2 TFA | ESD-933509-100MG |
| Cas.: 1255942-08-5 | Purity: ≥95% | DBCO-NHCO-PEG4-amine | ESD-933510-100MG |
| Cas.: 2328070-52-4 | E3 ligase Ligand-Linker Conjugates 55 | ESD-933511-100MG | |
| Cas.: 2357105-92-9 | Purity: 97% | Pomalidomide-PEG4-C2-NH2 hydrochloride | ESD-933512-100MG |
| Cas.: 2241643-69-4 | Purity: 95% | (S,R,S)-AHPC-C2-NH2 | ESD-933513-100MG |
| Cas.: 2271036-44-1 | Purity: ≥95% | Pomalidomide-PEG1-C2-N3 | ESD-933514-100MG |
| Cas.: 2353496-84-9 | Purity: ≥98% | Thalidomide-C2-amido-C2-COOH | ESD-933515-100MG |
| Cas.: 2010986-20-4 | Purity: 95% | (S,R,S)-AHPC-C1-NH2 | ESD-933516-100MG |
| Cas.: 2361120-26-3 | Purity: 95% | (S,R,S)-AHPC-C1-NH2 hydrochloride | ESD-933517-100MG |
| Cas.: 2225940-49-6 | Purity: ≥95% | Pomalidomide 4′-alkylC5-acid | ESD-933518-100MG |
| Cas.: 2162120-77-4 | Purity: 98% | Pomalidomide-amido-C3-COOH | ESD-933519-100MG |
| Cas.: 2380318-57-8 | Purity: ≥95% | Thalidomide-O-PEG4-azide | ESD-933520-100MG |
| Cas.: 2098799-77-8 | Purity: ≥95% | Thalidomide-PEG4-Propargyl | ESD-933521-100MG |
| Cas.: 2460263-40-3 | Purity: ≥95% | Thalidomide-PEG5-NH2 | ESD-933522-100MG |
| Cas.: 2022182-57-4 | Purity: ≥95% | Thalidomide-O-amido-C3-NH2 | ESD-933523-100MG |
| Cas.: 1957235-94-7 | Purity: ≥95% | Thalidomide-PEG2-NH2 | ESD-933524-100MG |
| Cas.: 1957236-10-0 | Purity: ≥95% | Thalidomide-PEG3-NH2 | ESD-933525-100MG |
| Cas.: 2357114-75-9 | E3 ligase Ligand-Linker Conjugates 41 | ESD-933526-100MG | |
| Cas.: 1957236-08-6 | Thalidomide-O-C10-NH2 | ESD-933527-100MG | |
| Cas.: 1312302-14-9 | E3 ligase Ligand-Linker Conjugates 37 | ESD-933528-100MG | |
| Cas.: 2222354-20-1 | E3 ligase Ligand-Linker Conjugates 40 | ESD-933529-100MG | |
| Cas.: 2093536-11-7 | Thalidomide-O-C7-NH2 | ESD-933530-100MG | |
| Cas.: 2113688-20-1 | E3 ligase Ligand-Linker Conjugates 39 | ESD-933531-100MG | |
| Cas.: 18080-67-6 | Purity: ≥98% | Conoidin A | ESD-933532-100MG |
| Cas.: 116680-01-4 | Purity: ≥98% | Mycophenolate mofetil hydrochloride | ESD-933533-100MG |
| Cas.: 47208-82-2 | 5MPN | ESD-933534-100MG | |
| Cas.: 341-88-8 | Purity: ≥98% | HQNO | ESD-933535-100MG |
| Cas.: 2120398-39-0 | Purity: ≥95% | Chk1-IN-5 | ESD-933536-100MG |
| Cas.: 79093-71-3 | Purity: ≥95% | 2-Hydroxy-4-methylbenzenesulphonic acid ammonium | ESD-933537-100MG |
| Cas.: 1770778-45-4 | Purity: ≥98% | 3,4,5-Trihydroxycinnamic acid decyl ester | ESD-933538-100MG |
| Cas.: 55726-47-1 | Purity: ≥95% | Enocitabine | ESD-933539-100MG |
| Cas.: 154303-05-6 | Purity: ≥95% | Echistatin | ESD-933540-100ΜG |
| Cas.: 194665-85-5 | Purity: ≥98% | GaTx2 | ESD-933541-100ΜG |
| Cas.: 1595278-21-9 | Purity: ≥98% | GSK717 | ESD-933542-100MG |
| Cas.: 109760-77-2 | Purity: ≥98% | D,L-erythro-PDMP | ESD-933543-100MG |
| Cas.: 134615-37-5 | Purity: ≥98% | Reveromycin A | ESD-933544-100ΜG |
| Cas.: 1670-87-7 | Purity: ≥98% | SD-169 | ESD-933545-100MG |
| Cas.: 14617-17-5 | Purity: ≥95% | Triperiden | ESD-933546-100MG |
| Cas.: 122752-21-0 | Purity: ≥98% | Mycalolide B | ESD-933547-100ΜG |
| Cas.: 1207113-88-9 | Purity: ≥98% | CCG-100602 | ESD-933548-100MG |
| Cas.: 7761-45-7 | Purity: ≥98% | Metoprine | ESD-933549-100MG |
| Cas.: 3545-67-3 | Purity: ≥98% | Chloroquine dihydrochloride | ESD-933550-100MG |
| Cas.: 960113-85-3 | BR351 | ESD-933551-100MG | |
| Cas.: 74258-86-9 | Purity: ≥95% | Alacepril | ESD-933552-100MG |
| Cas.: 2597-03-7 | Purity: ≥90% | Phenthoate | ESD-933553-100MG |
| Cas.: 53330-02-2 | Purity: ≥98% | S-(N-Phenethylthiocarbamoyl)-L-cysteine | ESD-933554-100MG |
| Cas.: 1346242-31-6 | Purity: ≥98% | Rivastigmine carbamate impurity | ESD-933555-100MG |
| Cas.: 10205-56-8 | Purity: ≥98% | Luciferase-IN-1 | ESD-933556-100MG |
| Cas.: 60-89-9 | Purity: ≥98% | Mepazine | ESD-933557-100MG |
| Cas.: 33068-19-8 | Purity: ≥98% | 2-Deoxy-D-glucose 6-phosphate disodium | ESD-933558-100MG |
| Cas.: 2975-36-2 | Purity: ≥98% | Mepazine hydrochloride | ESD-933559-100MG |
| Cas.: 7421-40-1 | Purity: ≥98% | Carbenoxolone disodium | ESD-933560-100MG |
| Cas.: 53995-62-3 | Purity: ≥98% | PFI-90 | ESD-933561-100MG |
| Cas.: 2702984-69-6 | Purity: ≥98% | GSK232 | ESD-933562-100MG |
| Cas.: 68573-24-0 | Purity: 97% | N-(2-(5-Hydroxy-1H-indol-3-yl)ethyl)-3-(4-hydroxyphenyl)acrylamide | ESD-933563-50MG |
| Cas.: 2376139-49-8 | Purity: 95% | (S,R,S)-AHPC-C8-NH2 (hydrochloride) | ESD-933564-50MG |
| Cas.: 2183440-70-0 | Purity: 97% | N-(Azido-PEG3)-N-(PEG2-amine)-PEG3-acid | ESD-933565-50MG |
| Cas.: 2306193-99-5 | Purity: ≥98% | VH032-cyclopropane-F | ESD-933566-50MG |
| Cas.: 2341796-73-2 | Purity: ≥95% | (S,R,S)-AHPC-C2-NH2 dihydrochloride | ESD-933567-50MG |
| Cas.: 2341796-83-4 | Purity: ≥95% | (S,R,S)-AHPC-PEG1-NH2 dihydrochloride | ESD-933568-50MG |
| Cas.: 2055041-38-6 | Purity: ≥95% | Mal-PEG2-Val-Cit-amido-PAB-OH | ESD-933569-50MG |
| Cas.: 2488761-03-9 | Purity: 97% | Pom-8PEG | ESD-933570-50MG |
| Cas.: 2341796-80-1 | Purity: ≥95% | (S,R,S)-AHPC-C8-NH2 dihydrochloride | ESD-933571-50MG |
| Cas.: 2341796-79-8 | Purity: 95% | (S,R,S)-AHPC-C8-NH2 | ESD-933572-50MG |
| Cas.: 1158264-69-7 | Purity: 98% | Lenalidomide-5-aminomethyl hydrochloride | ESD-933573-50MG |
| Cas.: 2488761-07-3 | Purity: 95% | Thalidomide-NH-PEG8-Ts | ESD-933574-50MG |
| Cas.: 2376990-31-5 | Purity: ≥95% | Thalidomide-O-amido-C6-NH2 hydrochloride | ESD-933575-50MG |
| Cas.: 2244684-42-0 | Purity: 97% | VH032-phenol | ESD-933576-50MG |
| Cas.: 2428400-33-1 | Purity: 95% | Thalidomide-NH-C10-COOH | ESD-933577-50MG |
| Cas.: 2641838-98-2 | Purity: 95% | Thalidomide-NH-PEG7 | ESD-933578-50MG |
| Cas.: 2446474-09-3 | Purity: ≥95% | Pomalidomide-PEG3-C2-NH2 hydrochloride | ESD-933579-50MG |
| Cas.: 2140807-23-2 | Purity: 95% | Thalidomide-NH-C2-PEG3-OH | ESD-933580-50MG |
| Cas.: 2229976-21-8 | Purity: ≥95% | (S,R,S)-AHPC-Me-C5-COOH | ESD-933581-50MG |
| Cas.: 2133360-04-8 | Purity: ≥95% | Pomalidomide-PEG1-azide | ESD-933582-50MG |
| Cas.: 2241641-57-4 | Purity: ≥95% | (S,R,S)-AHPC-PEG1-NH2 | ESD-933583-50MG |
| Cas.: 2306389-03-5 | Purity: ≥95% | (S,R,S)-AHPC-C6-NH2 | ESD-933584-50MG |
| Cas.: 2267282-19-7 | Purity: ≥95% | (S,R,S)-AHPC-C5-COOH | ESD-933585-50MG |
| Cas.: 2376139-52-3 | Purity: ≥95% | (S,R,S)-AHPC-Me-C10-NH2 | ESD-933586-50MG |
| Cas.: 2599846-07-6 | Purity: ≥95% | Pomalidomide-PEG2-Tos | ESD-933587-50MG |
| Cas.: 2375283-62-6 | Purity: 98% | Thalidomide-NH-PEG3-COOH | ESD-933588-50MG |
| Cas.: 2169266-69-5 | Purity: ≥95% | Thalidomide-O-C6-COOH | ESD-933589-50MG |
| Cas.: 2509093-23-4 | Purity: ≥95% | Thalidomide-O-C6-NHBoc | ESD-933590-50MG |
| Cas.: 2169266-67-3 | Purity: ≥95% | Thalidomide-O-C4-COOH | ESD-933591-50MG |
| Cas.: 2169266-64-0 | Purity: ≥95% | Thalidomide-O-C3-acid | ESD-933592-50MG |
| Cas.: 119757-73-2 | Purity: ≥95% | Tautomycetin | ESD-933593-50ΜG |
| Cas.: 306387-90-6 | Purity: 80% | KAAD-Cyclopamine | ESD-933594-50ΜG |
| Cas.: 400-52-2 | Purity: 98% | T-butyltrifluoroacetate | ESD-933595-25G |
| Cas.: 699014-53-4 | Purity: 98% | Ferrous gluconate hydrate | ESD-933596-25G |
| Cas.: 81836-41-1 | Purity: ≥98% | m-PEG5-nitrile | ESD-933597-25MG |
| Cas.: 1817735-34-4 | Purity: 97% | Pyrene-amido-PEG4-CH2CH2COOH | ESD-933598-25MG |
| Cas.: 1260247-50-4 | Purity: ≥95% | Biotin-PEG4-amino-t-Bu-DADPS-C6-azide | ESD-933599-25MG |
| Cas.: 2241685-22-1 | Purity: 95% | Biotin-PEG4-amino-t-Bu-DADPS-C3-alykne | ESD-933600-25MG |
| Cas.: 2361117-24-8 | Purity: ≥95% | (S,R,S)-AHPC-O-Ph-PEG1-NH2 | ESD-933601-25MG |
| Cas.: 2341796-77-6 | Purity: ≥95% | (S,R,S)-AHPC-C6-NH2 dihydrochloride | ESD-933602-25MG |
| Cas.: 2415263-07-7 | Purity: ≥95% | Thalidomide-O-amido-C8-NH2 hydrochloride | ESD-933603-25MG |
| Cas.: 2360522-76-3 | Purity: ≥95% | (S,R,S)-AHPC-C6-NH2 hydrochloride | ESD-933604-25MG |
| Cas.: 2204226-02-6 | Purity: ≥95% | Thalidomide-O-amido-PEG-C2-NH2 hydrochloride | ESD-933605-25MG |
| Cas.: 2380273-73-2 | Purity: ≥95% | Thalidomide-amido-PEG2-NH2 hydrochloride | ESD-933606-25MG |
| Cas.: 2341796-78-7 | Purity: ≥95% | (S,R,S)-AHPC-C4-NH2 (dihydrochloride) | ESD-933607-25MG |
| Cas.: 2380273-72-1 | Purity: ≥95% | Thalidomide-amido-PEG2-NH2 | ESD-933608-25MG |
| Cas.: 2138439-53-7 | Purity: 95% | (S,R,S)-AHPC-C4-NH2 | ESD-933609-25MG |
| Cas.: 2022182-59-6 | Purity: ≥95% | Thalidomide-O-amido-PEG-C2-NH2 | ESD-933610-25MG |
| Cas.: 1950635-13-8 | Thalidomide-O-amido-C6-NH2 | ESD-933611-25MG | |
| Cas.: 2341796-76-5 | Purity: 97% | (S,R,S)-AHPC-PEG2-NH2 dihydrochloride | ESD-933612-25MG |
| Cas.: 2409007-40-3 | Purity: 97% | (S,R,S)-AHPC-O-Ph-PEG1-NH-Boc | ESD-933613-25MG |
| Cas.: 2379870-45-6 | Purity: 98% | Thalidomide-4-O-C10-COOH | ESD-933614-25MG |
| Cas.: 2172819-78-0 | Purity: 97% | (S,R,S)-AHPC-CO-C9-acid | ESD-933615-25MG |
| Cas.: 2140807-42-5 | Purity: ≥95% | (S,R,S)-AHPC-PEG3-propionic acid | ESD-933616-25MG |
| Cas.: 2341841-01-6 | Purity: 97% | Pomalidomide-PEG6-NH2 hydrochloride | ESD-933617-25MG |
| Cas.: 2375194-03-7 | Purity: ≥98% | Thalidomide-NH-C5-NH2 hydrochloride | ESD-933618-25MG |
| Cas.: 2409538-69-6 | Purity: 95% | (S,R,S)-AHPC-Me-CO-CH2-PEG3-NH2 | ESD-933619-25MG |
| Cas.: 2376990-28-0 | Purity: ≥95% | (S,R,S)-AHPC-phenol-alkylC6-amine dihydrochloride | ESD-933620-25MG |
| Cas.: 2380273-75-4 | Purity: ≥95% | Pomalidomide-amino-PEG3-NH2 hydrochloride | ESD-933621-25MG |
| Cas.: 2519823-34-6 | Purity: ≥98% | BSJ-4-116 | ESD-933622-25MG |
| Cas.: 2380273-74-3 | Purity: ≥95% | Pomalidomide-amino-PEG3-NH2 | ESD-933623-25MG |
| Cas.: 2376990-29-1 | Purity: ≥95% | Thalidomide-O-C4-NH2 hydrochloride | ESD-933624-25MG |
| Cas.: 2341840-99-9 | Purity: ≥95% | Thalidomide 4′-ether-alkylC2-amine hydrochloride | ESD-933625-25MG |
| Cas.: 2421217-05-0 | Purity: ≥95% | Pomalidomide-amino-PEG5-NH2 hydrochloride | ESD-933626-25MG |
| Cas.: 2140807-17-4 | Purity: ≥95% | Pomalidomide 4′-PEG2-acid | ESD-933627-25MG |
| Cas.: 2331259-44-8 | Purity: ≥95% | Pomalidomide-amino-PEG4-NH2 | ESD-933628-25MG |
| Cas.: 2331259-45-9 | Purity: ≥98% | Pomalidomide-amino-PEG4-NH2 hydrochloride | ESD-933629-25MG |
| Cas.: 2421217-04-9 | Purity: ≥95% | Pomalidomide-amino-PEG5-NH2 | ESD-933630-25MG |
| Cas.: 2379404-33-6 | Purity: 95% | (S,R,S)-AHPC-C1-Br | ESD-933631-25MG |
| Cas.: 2415256-18-5 | Purity: ≥95% | Boc-A 410099.1 amide-alkylC4-amine | ESD-933632-25MG |
| Cas.: 2415256-19-6 | Purity: ≥95% | 410099.1 amide-PEG3-amine-Boc | ESD-933633-25MG |
| Cas.: 2415256-16-3 | Purity: ≥95% | A 410099.1 amide-PEG2-amine-Boc | ESD-933634-25MG |
| Cas.: 2376990-26-8 | Purity: ≥95% | (S,R,S)-AHPC-phenol-C4-NH2 dihydrochloride | ESD-933635-25MG |
| Cas.: 2412056-45-0 | Purity: ≥98% | Thalidomide-NH-PEG2-COOH | ESD-933636-25MG |
| Cas.: 2387510-82-7 | Purity: 97% | Thalidomide-PEG4-NH2 hydrochloride | ESD-933637-25MG |
| Cas.: 2369068-42-6 | Purity: ≥95% | Thalidomide-O-C2-acid | ESD-933638-25MG |
| Cas.: 2271036-45-2 | Purity: ≥95% | Pomalidomide 4′-PEG2-azide | ESD-933639-25MG |
| Cas.: 2169266-70-8 | Purity: ≥95% | Thalidomide-O-C7-acid | ESD-933640-25MG |
| Cas.: 2087490-48-8 | Purity: ≥95% | Thalidomide-O-C5-acid | ESD-933641-25MG |
| Cas.: 1309925-41-4 | Purity: ≥95% | Tubulin inhibitor 7 | ESD-933642-25MG |
| Cas.: 1309925-39-0 | Purity: ≥95% | Tubulin inhibitor 8 | ESD-933643-25MG |
| Cas.: 114289-47-3 | Purity: ≥98% | CI 976 | ESD-933644-25MG |
| Cas.: 141543-63-7 | Purity: ≥95% | HA-100 hydrochloride | ESD-933645-25MG |
| Cas.: 105925-39-1 | Purity: ≥98% | Tubulin inhibitor 6 | ESD-933646-25MG |
| Cas.: 1370554-01-0 | Purity: ≥98% | Ciliobrevin D | ESD-933647-25MG |
| Cas.: 1258836-72-4 | Purity: ≥95% | Trifludimoxazin | ESD-933648-25MG |
| Cas.: 3519-82-2 | Purity: ≥95% | INCA-6 | ESD-933649-25MG |
| Cas.: 3785-90-8 | Purity: ≥98% | Tyrphostin 8 | ESD-933650-25MG |
| Cas.: 306301-68-8 | Purity: ≥95% | SKI-I | ESD-933651-25MG |
| Cas.: 211364-06-6 | Purity: ≥98% | AT-130 | ESD-933652-25MG |
| Cas.: 1563007-08-8 | Purity: ≥95% | G244-LM | ESD-933653-25MG |
| Cas.: 380623-76-7 | Purity: ≥98% | SM-7368 | ESD-933654-25MG |
| Cas.: 693241-54-2 | Purity: ≥98% | EG1 | ESD-933655-25MG |
| Cas.: 1287585-40-3 | Purity: ≥90% | N-Acetyl lysyltyrosylcysteine amide | ESD-933656-25MG |
| Cas.: 74764-40-2 | Purity: ≥98% | Bepridil hydrochloride hydrate | ESD-933657-25MG |
| Cas.: 1261253-79-5 | Purity: ≥98% | AT-9010 | ESD-933658-25MG |
| Cas.: 109971-63-3 | Purity: 97% | Combretastatin A-1 | ESD-933659-25MG |
| Cas.: 1030123-90-0 | Purity: ≥98% | AEM1 | ESD-933660-25MG |
| Cas.: 1130067-06-9 | Purity: ≥98% | VU0155069 | ESD-933661-25MG |
| Cas.: 293762-45-5 | Purity: ≥98% | Ro 90-7501 | ESD-933662-25MG |
| Cas.: 1310744-67-2 | Purity: ≥98% | PFM39 | ESD-933663-25MG |
| Cas.: 694522-87-7 | Purity: ≥98% | (E/Z)-GO289 | ESD-933664-25MG |
| Cas.: 738-87-4 | Purity: ≥98% | Sterculic acid | ESD-933665-25MG |
| Cas.: 2713301-45-0 | Ibudilast-d7 | ESD-933666-25MG | |
| Cas.: 2055732-24-4 | Claficapavir | ESD-933667-25MG | |
| Cas.: 256497-58-2 | CMLD010509 | ESD-933668-25MG | |
| Cas.: 74226-22-5 | Purity: ≥98% | Dazoxiben | ESD-933669-25MG |
| Cas.: 1029890-89-8 | 1-[(4R,5R)-4,5-Dihydroxy-L-ornithine]echinocandin B hydrochloride | ESD-933670-10MG | |
| Cas.: 2093277-71-3 | Fmoc-NH-PEG5-C2-NH2 | ESD-933671-10MG | |
| Cas.: 1011268-29-3 | Purity: 97% | Biotin-PEG2-C6-azide | ESD-933672-10MG |
| Cas.: 2098487-39-7 | Purity: ≥95% | Thalidomide-propargyl | ESD-933673-10MG |
| Cas.: 2561529-98-2 | Purity: ≥98% | MRTX849 ethoxypropanoic acid | ESD-933674-10MG |
| Cas.: 2711006-74-3 | Purity: 97% | ZXH-4-137 | ESD-933675-10MG |
| Cas.: 1973403-00-7 | Purity: ≥98% | ARCC-4 | ESD-933676-10MG |
| Cas.: 2561529-96-0 | Purity: ≥98% | MRTX849 acid | ESD-933677-10MG |
| Cas.: 1338812-36-4 | Purity: ≥98% | Androgen receptor antagonist 1 | ESD-933678-10MG |
| Cas.: 2711006-66-3 | Purity: 97% | ZXH-4-130 | ESD-933679-10MG |
| Cas.: 2366268-80-4 | Purity: 98% | CP-10 | ESD-933680-10MG |
| Cas.: 1119249-30-7 | Purity: 98% | Tos-PEG2-O-Propargyl | ESD-933681-10MG |
| Cas.: 2599846-44-1 | Purity: ≥95% | Thalidomide-Piperazine-Piperidine hydrochloride | ESD-933682-10MG |
| Cas.: 2411022-24-5 | 2-(2,6-Dioxopiperidin-3-yl)phthalimidine-C5-Br | ESD-933683-10MG | |
| Cas.: 2229974-83-6 | Purity: 98% | XY028-140 | ESD-933684-10MG |
| Cas.: 2229974-73-4 | Purity: 98% | XY028-133 | ESD-933685-10MG |
| Cas.: 2484741-78-6 | Purity: 98% | CBP/p300 ligand 2 | ESD-933686-10MG |
| Cas.: 3542-63-0 | Purity: ≥98% | CDK9-IN-10 | ESD-933687-10MG |
| Cas.: 1683617-62-0 | Purity: ≥95% | Apcin-A | ESD-933688-10MG |
| Cas.: 2365172-82-1 | Purity: ≥98% | Desmorpholinyl Navitoclax-NH-Me | ESD-933689-10MG |
| Cas.: 2243076-67-5 | Purity: 98% | ZXH-3-26 | ESD-933690-10MG |
| Cas.: 1282513-77-2 | β-Naphthoflavone-CH2-Br | ESD-933691-10MG | |
| Cas.: 2490599-18-1 | Purity: ≥98% | GMB-475 | ESD-933692-10MG |
| Cas.: 2305379-66-0 | Purity: ≥98% | BRD7-IN-1 free base | ESD-933693-10MG |
| Cas.: 2375196-30-6 | Purity: ≥98% | KB02-COOH | ESD-933694-10MG |
| Cas.: 2376047-73-1 | Purity: ≥98% | SIAIS178 | ESD-933695-10MG |
| Cas.: 2448414-48-8 | Purity: ≥98% | BRD7-IN-1 | ESD-933696-10MG |
| Cas.: 2503017-97-6 | INY-03-041 | ESD-933697-10MG | |
| Cas.: 2320561-35-9 | Purity: ≥98% | ERD-308 | ESD-933698-10MG |
| Cas.: 2306193-61-1 | Purity: ≥98% | VZ185 | ESD-933699-10MG |
| Cas.: 2250025-88-6 | Purity: ≥98% | TL12-186 | ESD-933700-10MG |
| Cas.: 2407452-77-9 | Purity: ≥98% | MS67 | ESD-933701-10MG |
| Cas.: 2471970-56-4 | PZ703b | ESD-933702-10MG | |
| Cas.: 2229716-11-2 | Purity: ≥95% | Thalidomide-Piperazine-Piperidine | ESD-933703-10MG |
| Cas.: 2229037-19-6 | Purity: ≥98% | TL13-112 | ESD-933704-10MG |
| Cas.: 2375564-55-7 | Purity: ≥98% | ACBI1 | ESD-933705-10MG |
| Cas.: 2357111-29-4 | Thalidomide-Piperazine-PEG1-NH2 | ESD-933706-10MG | |
| Cas.: 10299-44-2 | Purity: ≥98% | 8-Azaadenosine | ESD-933707-10MG |
| Cas.: 936691-46-2 | Purity: ≥95% | Tubulysin M | ESD-933708-10MG |
| Cas.: 368870-67-1 | Purity: ≥95% | Tubulysin F | ESD-933709-10MG |
| Cas.: 799822-08-5 | Purity: ≥95% | Tubulysin G | ESD-933710-10MG |
| Cas.: 205304-88-7 | Purity: ≥95% | Tubulysin C | ESD-933711-10MG |
| Cas.: 799822-10-9 | Purity: ≥95% | Tubulysin I | ESD-933712-10MG |
| Cas.: 309935-58-8 | Purity: ≥95% | Tubulysin E | ESD-933713-10MG |
| Cas.: 799822-09-6 | Purity: ≥95% | Tubulysin H | ESD-933714-10MG |
| Cas.: 233277-99-1 | Purity: ≥98% | K777 | ESD-933715-10MG |
| Cas.: 309935-57-7 | Purity: ≥95% | Tubulysin D | ESD-933716-10MG |
| Cas.: 130800-90-7 | Purity: ≥98% | Sipatrigine | ESD-933717-10MG |
| Cas.: 2444764-03-6 | Purity: ≥98% | GKI-1 | ESD-933718-10MG |
| Cas.: 3367-88-2 | Purity: ≥98% | (E/Z)-GSK-3β inhibitor 1 | ESD-933719-10MG |
| Cas.: 118372-34-2 | Purity: ≥95% | SD-1029 | ESD-933720-10MG |
| Cas.: 1223998-29-5 | Purity: ≥98% | G0507 | ESD-933721-10MG |
| Cas.: 2158198-77-5 | Purity: 98% | Chst15-IN-1 | ESD-933722-10MG |
| Cas.: 128253-31-6 | Purity: ≥98% | Veliflapon | ESD-933723-10MG |
| Cas.: 888042-13-5 | Purity: ≥95% | GF 15 | ESD-933724-10MG |
| Cas.: 301692-76-2 | Purity: ≥98% | Polmacoxib | ESD-933725-10MG |
| Cas.: 958772-66-2 | Purity: 97% | SID 26681509 | ESD-933726-10MG |
| Cas.: 78416-81-6 | Purity: ≥95% | Trequinsin hydrochloride | ESD-933727-10MG |
| Cas.: 2161305-12-8 | Purity: ≥98% | DJ001 | ESD-933728-10MG |
| Cas.: 179343-17-0 | Purity: ≥98% | PD-089828 | ESD-933729-10MG |
| Cas.: 26472-41-3 | Purity: ≥98% | Humulone | ESD-933730-10MG |
| Cas.: 79952-42-4 | Purity: ≥95% | Monacolin J | ESD-933731-10MG |
| Cas.: 24449-39-6 | Purity: ≥98% | Tectol | ESD-933732-10MG |
| Cas.: 501104-16-1 | Purity: ≥98% | Lalistat 1 | ESD-933733-10MG |
| Cas.: 465527-94-0 | NEP-In-1 | ESD-933734-10MG | |
| Cas.: 116339-68-5 | Purity: ≥98% | SKF-86002 dihydrochloride | ESD-933735-10MG |
| Cas.: 137201-62-8 | Purity: ≥98% | Spinorphin | ESD-933736-10MG |
| Cas.: 119670-30-3 | Purity: ≥98% | Z-LVG-CHN2 | ESD-933737-10MG |
| Cas.: 158876-65-4 | Purity: ≥98% | FR 167653 free base | ESD-933738-10MG |
| Cas.: 120210-48-2 | Purity: ≥98% | Tenidap | ESD-933739-10MG |
| Cas.: 1103672-43-0 | Purity: ≥98% | S32826 disodium | ESD-933740-10MG |
| Cas.: 940290-58-4 | Purity: ≥98% | UK122 | ESD-933741-10MG |
| Cas.: 934387-35-6 | ROCK-IN-1 | ESD-933742-10MG | |
| Cas.: 1227098-15-8 | Purity: ≥98% | NF-κB-IN-1 | ESD-933743-10MG |
| Cas.: 454203-25-9 | ACAT-IN-3 | ESD-933744-10MG | |
| Cas.: 199984-38-8 | ACAT-IN-7 | ESD-933745-10MG | |
| Cas.: 199984-35-5 | ACAT-IN-8 | ESD-933746-10MG | |
| Cas.: 865273-97-8 | Purity: ≥98% | ERAP1-IN-1 | ESD-933747-10MG |
| Cas.: 1957276-35-5 | Purity: ≥98% | SHP836 | ESD-933748-10MG |
| Cas.: 2250091-96-2 | Purity: ≥98% | MS645 | ESD-933749-10MG |
| Cas.: 199984-46-8 | ACAT-IN-4 hydrochloride | ESD-933750-10MG | |
| Cas.: 454203-56-6 | ACAT-IN-4 | ESD-933751-10MG | |
| Cas.: 64009-84-3 | Purity: ≥98% | IMB-301 | ESD-933752-10MG |
| Cas.: 199983-93-2 | ACAT-IN-5 | ESD-933753-10MG | |
| Cas.: 23444-65-7 | Purity: ≥95% | Alkannin | ESD-933754-10MG |
| Cas.: 864249-60-5 | Purity: ≥98% | AMG-548 | ESD-933755-10MG |
| Cas.: 500-12-9 | Purity: ≥98% | Goitrin | ESD-933756-10MG |
| Cas.: 1236767-85-3 | Purity: ≥98% | D5D-IN-326 | ESD-933757-10MG |
| Cas.: 432037-57-5 | Purity: ≥98% | Teglarinad chloride | ESD-933758-10MG |
| Cas.: 865565-29-3 | Purity: ≥98% | TC-E 5001 | ESD-933759-10MG |
| Cas.: 1914944-54-9 | Purity: ≥98% | ROMK-IN-32 | ESD-933760-10MG |
| Cas.: 1527513-89-8 | Purity: ≥98% | TrxR inhibitor D9 | ESD-933761-10MG |
| Cas.: 1346169-63-8 | Purity: 98% | SA57 | ESD-933762-10MG |
| Cas.: 1072443-89-0 | SK1-I | ESD-933763-10MG | |
| Cas.: 336786-81-3 | Purity: ≥95% | Furamidine-d8 | ESD-933764-10MG |
| Cas.: 454203-45-3 | ACAT-IN-6 | ESD-933765-10MG | |
| Cas.: 199984-55-9 | ACAT-IN-2 | ESD-933766-10MG | |
| Cas.: 199984-40-2 | ACAT-IN-9 | ESD-933767-10MG | |
| Cas.: 2366222-05-9 | Purity: ≥98% | SK1-I hydrochloride | ESD-933768-10MG |
| Cas.: 154355-76-7 | Purity: ≥95% | Atreleuton | ESD-933769-10MG |
| Cas.: 890655-08-0 | Cetilista impurity 1 | ESD-933770-10MG | |
| Cas.: 352336-36-8 | Purity: ≥98% | MLS000544460 | ESD-933771-10MG |
| Cas.: 454203-40-8 | ACAT-IN-10 | ESD-933772-10MG | |
| Cas.: 442665-87-4 | Purity: ≥98% | OGT-IN-2 | ESD-933773-10MG |
| Cas.: 1672691-74-5 | Purity: ≥98% | JZP-430 | ESD-933774-10MG |
| Cas.: 428478-94-8 | Purity: ≥98% | cyt-PTPε Inhibitor 1 | ESD-933775-10MG |
| Cas.: 160162-42-5 | Purity: ≥98% | SR 11302 | ESD-933776-10MG |
| Cas.: 287204-45-9 | Purity: ≥98% | PD180970 | ESD-933777-10MG |
| Cas.: 67469-75-4 | Purity: ≥98% | GBR 12783 dihydrochloride | ESD-933778-10MG |
| Cas.: 207278-87-3 | Purity: ≥98% | L-threo-PPMP | ESD-933779-10MG |
| Cas.: 1702364-87-1 | Purity: ≥98% | WYE-687 dihydrochloride | ESD-933780-10MG |
| Cas.: 1421448-26-1 | Purity: ≥98% | GN44028 | ESD-933781-10MG |
| Cas.: 646530-37-2 | Purity: ≥98% | UTL-5g | ESD-933782-10MG |
| Cas.: 502137-98-6 | Purity: ≥98% | HLI373 | ESD-933783-10MG |
| Cas.: 209394-46-7 | Ladostigil hemitartrate | ESD-933784-10MG | |
| Cas.: 120615-25-0 | Purity: ≥98% | CKI-7 free base | ESD-933785-10MG |
| Cas.: 212391-63-4 | Purity: ≥98% | PD0166285 dihydrochloride | ESD-933786-10MG |
| Cas.: 837364-57-5 | Purity: ≥98% | AG-024322 | ESD-933787-10MG |
| Cas.: 253174-92-4 | Purity: ≥98% | BMS-262084 | ESD-933788-10MG |
| Cas.: 883098-58-6 | Purity: ≥98% | CCT129957 | ESD-933789-10MG |
| Cas.: 3768-14-7 | Purity: ≥98% | MethADP | ESD-933790-10MG |
| Cas.: 22567-38-0 | Purity: ≥98% | Bisabolone oxide A | ESD-933791-10MG |
| Cas.: 121-40-4 | Purity: ≥98% | (-)-Terreic acid | ESD-933792-10MG |
| Cas.: 38274-54-3 | Purity: ≥98% | Benurestat | ESD-933793-10MG |
| Cas.: 251577-09-0 | Purity: ≥98% | FTI-2148 | ESD-933794-10MG |
| Cas.: 102280-35-3 | Purity: ≥95% | Baquiloprim | ESD-933795-10MG |
| Cas.: 2361659-61-0 | Purity: ≥98% | AES-135 | ESD-933796-10MG |
| Cas.: 2310262-10-1 | Purity: ≥98% | PDK4-IN-1 | ESD-933797-10MG |
| Cas.: 32359-34-5 | Purity: ≥98% | Medifoxamine | ESD-933798-10MG |
| Cas.: 1431945-95-7 | Purity: ≥98% | FATP1-IN-1 | ESD-933799-10MG |
| Cas.: 1710337-31-7 | Purity: ≥98% | GS-493 | ESD-933800-10MG |
| Cas.: 156635-05-1 | Purity: ≥98% | BIBB 515 | ESD-933801-10MG |
| Cas.: 10497-04-8 | Purity: ≥95% | Oxythiamine diphosphate | ESD-933802-10MG |
| Cas.: 25555-57-1 | Purity: ≥98% | Cannabigerolic acid | ESD-933803-10MG |
| Cas.: 871837-60-4 | Purity: ≥98% | DRAK2-IN-1 | ESD-933804-10MG |
| Cas.: 159262-32-5 | Purity: ≥98% | MPDC | ESD-933805-10MG |
| Cas.: 516-72-3 | Purity: ≥98% | 20a-Hydroxycholesterol | ESD-933806-5MG |
| Cas.: 2093152-84-0 | Purity: 97% | N-(Mal-PEG6)-N-bis(PEG7-TCO) | ESD-933807-5MG |
| Cas.: 2107273-00-5 | Purity: 97% | N-(Ac-PEG3)-N’-(azide-PEG3)-Cy7 chloride | ESD-933808-5MG |
| Cas.: 2107273-72-1 | Purity: ≥98% | N-(m-PEG4)-N’-(4-Hydroxycyclohexyl-1-amido-PEG4)-Cy5 | ESD-933809-5MG |
| Cas.: 2429877-44-9 | Purity: ≥98% | SD 36 | ESD-933810-5MG |
| Cas.: 2209085-22-1 | Purity: 98% | JH-XI-10-02 | ESD-933811-5MG |
| Cas.: 2447066-14-8 | BMS-1166-N-piperidine-CO-N-piperazine | ESD-933812-5MG | |
| Cas.: 2408642-48-6 | Purity: ≥95% | FN-1501-propionic acid | ESD-933813-5MG |
| Cas.: 2601727-80-2 | Purity: ≥98% | MS4322 | ESD-933814-5MG |
| Cas.: 2334525-50-5 | Purity: 98% | TD-428 | ESD-933815-5MG |
| Cas.: 2407458-49-3 | Dimethyl-F-OICR-9429-COOH | ESD-933816-5MG | |
| Cas.: 2207569-08-0 | Purity: ≥98% | QCA570 | ESD-933817-5MG |
| Cas.: 2639882-68-9 | MAK683-CH2CH2COOH | ESD-933818-5MG | |
| Cas.: 2100306-50-9 | Purity: 97% | N-(Azido-PEG3)-N-Fluorescein-PEG3-acid | ESD-933819-5MG |
| Cas.: 2417371-71-0 | Purity: ≥98% | GNE-987 | ESD-933820-5MG |
| Cas.: 2484739-21-9 | Purity: ≥98% | Thalidomide-NH-CBP/p300 ligand 2 | ESD-933821-5MG |
| Cas.: 2222111-87-5 | Purity: ≥98% | ARD-2128 | ESD-933822-5MG |
| Cas.: 2349356-39-2 | Purity: 98% | BSJ-04-132 | ESD-933823-5MG |
| Cas.: 2509359-75-3 | Purity: 98% | CP5V | ESD-933824-5MG |
| Cas.: 2410557-00-3 | Purity: 98% | iRucaparib-AP6 | ESD-933825-5MG |
| Cas.: 1973408-76-2 | ABM-14 | ESD-933826-5MG | |
| Cas.: 2143096-93-7 | Purity: 98% | Navitoclax-piperazine | ESD-933827-5MG |
| Cas.: 2365172-19-4 | Purity: ≥98% | XZ739 | ESD-933828-5MG |
| Cas.: 2254609-23-7 | Purity: ≥98% | SJFδ | ESD-933829-5MG |
| Cas.: 2349356-09-6 | Purity: 98% | BSJ-03-204 | ESD-933830-5MG |
| Cas.: 2502156-03-6 | Purity: ≥95% | LC-2 | ESD-933831-5MG |
| Cas.: 2380000-55-3 | Purity: ≥98% | β-NF-JQ1 | ESD-933832-5MG |
| Cas.: 2316837-08-6 | Purity: 98% | ARD-61 | ESD-933833-5MG |
| Cas.: 2672512-44-4 | Purity: ≥98% | MS432 | ESD-933834-5MG |
| Cas.: 2384184-44-3 | Purity: 98% | KB02-JQ1 | ESD-933835-5MG |
| Cas.: 2429877-30-3 | Purity: ≥98% | SI-109 | ESD-933836-5MG |
| Cas.: 1952264-33-3 | Purity: ≥98% | ZEN-3862 | ESD-933837-5MG |
| Cas.: 2447066-00-2 | Purity: ≥95% | BMS-1166-N-piperidine-COOH | ESD-933838-5MG |
| Cas.: 2362575-45-7 | Purity: ≥95% | CRBN-6-5-5-VHL | ESD-933839-5MG |
| Cas.: 2254609-27-1 | Purity: ≥98% | SJFα | ESD-933840-5MG |
| Cas.: 2185795-67-7 | Lenalidomide-PEG1-azide | ESD-933841-5MG | |
| Cas.: 2411085-89-5 | Purity: ≥98% | MG-277 | ESD-933842-5MG |
| Cas.: 1952264-36-6 | Purity: ≥98% | ZEN-3411 | ESD-933843-5MG |
| Cas.: 1952264-34-4 | Purity: ≥98% | ZEN-3219 | ESD-933844-5MG |
| Cas.: 107077-98-5 | Purity: ≥95% | (rel)-Tranylcypromine D5 hydrochloride | ESD-933845-5MG |
| Cas.: 1132709-14-8 | Purity: ≥95% | (1S,2S)-Bortezomib | ESD-933846-5MG |
| Cas.: 392711-19-2 | Purity: ≥95% | Rapamycin-d3 | ESD-933847-5MG |
| Cas.: 38231-86-6 | Purity: ≥95% | (+)-Valienamine Hydrochloride | ESD-933848-5MG |
| Cas.: 1330052-59-9 | Purity: ≥95% | Ethacrynic acid D5 | ESD-933849-5MG |
| Cas.: 2733770-48-2 | Purity: ≥95% | GW2580-d6 | ESD-933850-5MG |
| Cas.: 139637-11-9 | Purity: ≥95% | PR-39 | ESD-933851-5MG |
| Cas.: 749179-13-3 | Purity: ≥98% | CS-722 Free base | ESD-933852-5MG |
| Cas.: 881970-80-5 | iMDK | ESD-933853-5MG | |
| Cas.: 1219795-37-5 | Trimetazidine-d8 dihydrochloride | ESD-933854-5MG | |
| Cas.: 1126721-82-1 | Purity: ≥98% | Sunitinib-d10 | ESD-933855-5MG |
| Cas.: 2084811-68-5 | Purity: ≥98% | PARP14 inhibitor H10 | ESD-933856-5MG |
| Cas.: 33012-73-6 | Purity: ≥98% | Cyanidin 3-sambubioside chloride | ESD-933857-5MG |
| Cas.: 1261395-28-1 | Purity: 98% | Omeprazole-13C-D3 | ESD-933858-5MG |
| Cas.: 56066-63-8 | Purity: ≥95% | Aditoprime | ESD-933859-5MG |
| Cas.: 1365802-18-1 | Purity: ≥98% | Imatinib Impurity E | ESD-933860-5MG |
| Cas.: 21080-31-9 | Purity: ≥98% | Angoline | ESD-933861-5MG |
| Cas.: 145599-86-6 | Purity: ≥98% | Cerivastatin | ESD-933862-5MG |
| Cas.: 52574-64-8 | Purity: ≥95% | Dihydrochlamydocin | ESD-933863-5MG |
| Cas.: 909197-38-2 | Purity: ≥98% | NSC-658497 | ESD-933864-5MG |
| Cas.: 432545-63-6 | Purity: ≥98% | Methotrexate-d3 | ESD-933865-5MG |
| Cas.: 177262-30-5 | Purity: ≥98% | Didesmethylrocaglamide | ESD-933866-5MG |
| Cas.: 2129164-91-4 | DBCO-PEG4-VC-PAB-MMAE | ESD-933867-5MG | |
| Cas.: 115787-68-3 | Purity: ≥95% | CI 972 anhydrous | ESD-933868-5MG |
| Cas.: 950913-56-1 | EFdA-TP | ESD-933869-5MG | |
| Cas.: 2216763-38-9 | Purity: ≥98% | Rheb inhibitor NR1 | ESD-933870-5MG |
| Cas.: 186610-89-9 | Purity: ≥98% | SU4984 | ESD-933871-5MG |
| Cas.: 16110-10-4 | Acetaminophen glucuronide | ESD-933872-5MG | |
| Cas.: 901260-40-0 | LpxH-IN-AZ1 | ESD-933873-5MG | |
| Cas.: 191330-56-0 | Purity: 97% | Ezetimibe ketone | ESD-933874-5MG |
| Cas.: 2585198-85-0 | Purity: ≥98% | FTO-IN-2 | ESD-933875-5MG |
| Cas.: 79467-23-5 | Purity: ≥95% | Miofrazine | ESD-933876-5MG |
| Cas.: 1071676-04-4 | Purity: ≥98% | Angoline hydrochloride | ESD-933877-5MG |
| Cas.: 1795024-97-3 | Purity: ≥98% | Setiptiline-d3 | ESD-933878-5MG |
| Cas.: 552332-71-5 | DB07107 | ESD-933879-5MG | |
| Cas.: 164301-51-3 | Purity: ≥98% | Semapimod tetrahydrochloride | ESD-933880-5MG |
| Cas.: 1376614-99-1 | Purity: ≥98% | ent-Ezetimibe | ESD-933881-5MG |
| Cas.: 37854-59-4 | Purity: ≥95% | Ro 08-2750 | ESD-933882-5MG |
| Cas.: 109826-27-9 | Purity: ≥98% | Zaldaride maleate | ESD-933883-5MG |
| Cas.: 142715-48-8 | Purity: ≥98% | CP-100356 hydrochloride | ESD-933884-5MG |
| Cas.: 1990492-86-8 | Purity: ≥95% | MARK-IN-4 | ESD-933885-5MG |
| Cas.: 463356-00-5 | Purity: ≥98% | Sordarin sodium | ESD-933886-5MG |
| Cas.: 110374-16-8 | Purity: ≥98% | 4-Desmethoxy Omeprazole | ESD-933887-5MG |
| Cas.: 344900-92-1 | Purity: ≥98% | FTI-2153 | ESD-933888-5MG |
| Cas.: 770688-66-9 | LU-32-176B | ESD-933889-5MG | |
| Cas.: 302781-98-2 | Purity: ≥95% | Desfluoro-ezetimibe | ESD-933890-5MG |
| Cas.: 2108899-91-6 | Purity: ≥98% | CPTH2 hydrochloride | ESD-933891-5MG |
| Cas.: 2734920-39-7 | Vinpocetine-d5 | ESD-933892-5MG | |
| Cas.: 351351-75-2 | Purity: ≥95% | Braco-19 | ESD-933893-5MG |
| Cas.: 7229-50-7 | Purity: ≥98% | Streptolydigin | ESD-933894-5MG |
| Cas.: 1009376-10-6 | Purity: ≥98% | RTIL 13 | ESD-933895-5MG |
| Cas.: 1177798-88-7 | Purity: ≥98% | Braco-19 trihydrochloride | ESD-933896-5MG |
| Cas.: 110659-91-1 | Purity: 97% | Psammaplin A | ESD-933897-5MG |
| Cas.: 262381-84-0 | Purity: ≥98% | JPM-OEt | ESD-933898-5MG |
| Cas.: 2211060-61-4 | Purity: ≥98% | Antifungal agent 2 | ESD-933899-5MG |
| Cas.: 1037545-61-1 | DC-Srci-6649 | ESD-933900-5MG | |
| Cas.: 197431-02-0 | Purity: ≥95% | Debutyldronedarone hydrochloride | ESD-933901-5MG |
| Cas.: 3979-00-8 | Purity: ≥95% | MEG hemisulfate | ESD-933902-5MG |
| Cas.: 132541-52-7 | Purity: ≥98% | HNMPA | ESD-933903-5MG |
| Cas.: 166734-06-1 | Purity: ≥98% | cis-Mulberroside A | ESD-933904-5MG |
| Cas.: 1435784-14-7 | Purity: ≥98% | Lometrexol hydrate | ESD-933905-5MG |
| Cas.: 301544-78-5 | Purity: ≥98% | Compstatin control peptide | ESD-933906-5MG |
| Cas.: 96301-34-7 | Purity: ≥98% | Atamestane | ESD-933907-5MG |
| Cas.: 122332-18-7 | Purity: ≥98% | Mivobulin | ESD-933908-5MG |
| Cas.: 110115-07-6 | Purity: ≥95% | Calpain inhibitor II | ESD-933909-5MG |
| Cas.: 1816272-19-1 | Purity: ≥98% | WT IDH1 Inhibitor 2 | ESD-933910-5MG |
| Cas.: 148905-78-6 | Bexlosteride | ESD-933911-5MG | |
| Cas.: 129981-36-8 | Sampatrilat | ESD-933912-5MG | |
| Cas.: 863406-85-3 | Purity: ≥98% | Zoniporide hydrochloride hydrate | ESD-933913-5MG |
| Cas.: 433937-93-0 | Atecegatran metoxil | ESD-933914-5MG | |
| Cas.: 217178-62-6 | Purity: ≥98% | Stampidine | ESD-933915-5MG |
| Cas.: 158876-66-5 | Purity: ≥95% | FR 167653 | ESD-933916-5MG |
| Cas.: 2755687-49-9 | Purity: ≥98% | PDE4-IN-3 | ESD-933917-5MG |
| Cas.: 1197896-79-9 | Purity: ≥98% | NITD-2 | ESD-933918-5MG |
| Cas.: 73819-26-8 | Furamidine | ESD-933919-5MG | |
| Cas.: 302826-61-5 | Purity: ≥98% | EPAC 5376753 | ESD-933920-5MG |
| Cas.: 1410809-37-8 | Purity: ≥95% | ACHN-975 TFA | ESD-933921-5MG |
| Cas.: 1221418-42-3 | SAR629 | ESD-933922-5MG | |
| Cas.: 1410809-36-7 | Purity: ≥95% | ACHN-975 | ESD-933923-5MG |
| Cas.: 1592908-75-2 | Purity: ≥98% | MSN-50 | ESD-933924-5MG |
| Cas.: 58337-38-5 | Purity: ≥98% | EHNA hydrochloride | ESD-933925-5MG |
| Cas.: 934295-48-4 | Purity: ≥95% | Rabeprazole-d4 | ESD-933926-5MG |
| Cas.: 81267-65-4 | Purity: ≥98% | Phenoxodiol | ESD-933927-5MG |
| Cas.: 2227019-45-4 | Purity: ≥98% | Aurora inhibitor 1 | ESD-933928-5MG |
| Cas.: 201422-03-9 | Purity: ≥98% | PKI 14-22 amide, myristoylated | ESD-933929-5MG |
| Cas.: 1402452-10-1 | Purity: ≥98% | hSMG-1 inhibitor 11e | ESD-933930-5MG |
| Cas.: 1212704-51-2 | Purity: ≥98% | Jarin-1 | ESD-933931-5MG |
| Cas.: 1219927-22-6 | RO2959 hydrochloride | ESD-933932-5MG | |
| Cas.: 2130878-25-8 | Purity: ≥98% | BCL6-IN-8c | ESD-933933-5MG |
| Cas.: 1470302-79-4 | Purity: ≥98% | ZYZ-488 | ESD-933934-5MG |
| Cas.: 67076-74-8 | Globomycin | ESD-933935-5MG | |
| Cas.: 496-93-5 | Purity: ≥98% | L-Canaline | ESD-933936-5MG |
| Cas.: 52934-83-5 | Purity: ≥98% | Nanaomycin A | ESD-933937-5MG |
| Cas.: 1388710-60-8 | Purity: ≥98% | CT-721 | ESD-933938-5MG |
| Cas.: 162054-19-5 | Purity: ≥98% | SC-58125 | ESD-933939-5MG |
| Cas.: 311309-27-0 | Purity: ≥98% | RFRP-3(human) | ESD-933940-5MG |
| Cas.: 1354448-60-4 | Purity: ≥98% | KH-CB20 | ESD-933941-5MG |
| Cas.: 2376255-48-8 | Purity: ≥98% | Ac-FLTD-CMK | ESD-933942-5MG |
| Cas.: 2097938-51-5 | Purity: ≥98% | R-10015 | ESD-933943-5MG |
| Cas.: 1049741-03-8 | Purity: ≥95% | SPD304 dihydrochloride | ESD-933944-5MG |
| Cas.: 168334-34-7 | Purity: ≥95% | PU141 | ESD-933945-5MG |
| Cas.: 2071636-15-0 | Lp-PLA2-IN-2 | ESD-933946-5MG | |
| Cas.: 71751-77-4 | Purity: ≥98% | Meleagrin | ESD-933947-5MG |
| Cas.: 340267-36-9 | Purity: ≥98% | CAY10404 | ESD-933948-5MG |
| Cas.: 142741-60-4 | Purity: ≥98% | Tenidap-d3 | ESD-933949-5MG |
| Cas.: 1934246-19-1 | DDR-TRK-1 | ESD-933950-5MG | |
| Cas.: 114568-32-0 | Purity: ≥98% | Patamostat mesylate | ESD-933951-5MG |
| Cas.: 171744-11-9 | GGTI-286 | ESD-933952-5MG | |
| Cas.: 288247-87-0 | T-2513 | ESD-933953-5MG | |
| Cas.: 69640-38-6 | Purity: ≥98% | Pentachloropseudilin | ESD-933954-5MG |
| Cas.: 1134803-16-9 | Purity: ≥98% | Imatinib D4 | ESD-933955-5MG |
| Cas.: 102676-87-9 | Purity: ≥98% | (R)-Fadrozole | ESD-933956-5MG |
| Cas.: 195720-26-4 | SJ-3366 | ESD-933957-5MG | |
| Cas.: 1092942-82-9 | Purity: ≥98% | Imatinib-d8 | ESD-933958-5MG |
| Cas.: 420089-51-6 | Purity: ≥98% | Thiophene-2 | ESD-933959-5MG |
| Cas.: 187793-52-8 | T-2513 hydrochloride | ESD-933960-5MG | |
| Cas.: 466-07-9 | Purity: ≥95% | Neriifolin | ESD-933961-5MG |
| Cas.: 1241902-40-8 | Purity: ≥98% | GNE-0439 | ESD-933962-5MG |
| Cas.: 1884710-81-9 | Purity: ≥98% | Cbz-B3A | ESD-933963-5MG |
| Cas.: 1416709-79-9 | Purity: ≥95% | PR-924 | ESD-933964-5MG |
| Cas.: 287405-51-0 | Purity: ≥98% | Apratastat | ESD-933965-5MG |
| Cas.: 40454-21-5 | IQB-782 | ESD-933966-5MG | |
| Cas.: 1210608-86-8 | Sorafenib-13C d3 | ESD-933967-5MG | |
| Cas.: 2316817-88-4 | Purity: ≥98% | CB-6644 | ESD-933968-5MG |
| Cas.: 209394-27-4 | Ladostigil | ESD-933969-5MG | |
| Cas.: 1203586-72-4 | Purity: ≥98% | Cyclotraxin B | ESD-933970-5MG |
| Cas.: 1416313-72-8 | Purity: ≥98% | Dynole 224 | ESD-933971-5MG |
| Cas.: 101236-51-5 | Purity: ≥98% | Kushenol M | ESD-933972-5MG |
| Cas.: 2623158-64-3 | Purity: ≥98% | PCC0208017 | ESD-933973-5MG |
| Cas.: 1473403-87-0 | Purity: ≥98% | MC-SN38 | ESD-933974-5MG |
| Cas.: 2362527-67-9 | Purity: ≥98% | LAS17 | ESD-933975-5MG |
| Cas.: 693794-20-6 | Purity: ≥98% | Difluoroatorvastatin | ESD-933976-5MG |
| Cas.: 2449093-46-1 | Purity: ≥95% | LV-320 | ESD-933977-5MG |
| Cas.: 1639939-56-2 | Purity: ≥98% | MC-VC-PAB-Tubulysin M | ESD-933978-5MG |
| Cas.: 1391052-30-4 | Purity: ≥95% | Lamivudine 13C, 15N2 | ESD-933979-5MG |
| Cas.: 1182129-77-6 | Purity: ≥98% | RU-302 | ESD-933980-5MG |
| Cas.: 2471981-21-0 | Purity: ≥98% | MPO-IN-1 | ESD-933981-5MG |
| Cas.: 1133706-15-6 | Purity: ≥98% | (1S,2S)-Bortezomib-d5 | ESD-933982-5MG |
| Cas.: 2408841-19-8 | PKM2-IN-3 | ESD-933983-5MG | |
| Cas.: 1854126-42-3 | Purity: ≥98% | Chloroquine-d5 diphosphate | ESD-933984-5MG |
| Cas.: 99957-90-1 | Purity: ≥95% | Org30958 | ESD-933985-5MG |
| Cas.: 113276-96-3 | Purity: ≥98% | Valilactone | ESD-933986-5MG |
| Cas.: 149301-79-1 | Purity: 97% | AACOCF3 | ESD-933987-5MG |
| Cas.: 23720-86-7 | Purity: ≥98% | (±)-Phrymarolin II | ESD-933988-5MG |
| Cas.: 1216739-35-3 | Purity: ≥98% | Bumetanide-d5 | ESD-933989-5MG |
| Cas.: 1329797-10-5 | Purity: ≥98% | Pentoxyverine-d8 | ESD-933990-5MG |
| Cas.: 1329642-60-5 | Purity: ≥98% | Enoxacin-d8 | ESD-933991-5MG |
| Cas.: 146478-72-0 | Purity: ≥98% | FR901464 | ESD-933992-5MG |
| Cas.: 2733158-65-9 | Purity: ≥98% | Damnacanthal-d3 | ESD-933993-5MG |
| Cas.: 1261393-15-0 | Purity: ≥98% | Apixaban 13C d3 | ESD-933994-5MG |
| Cas.: 71109-09-6 | Vedaprofen | ESD-933995-5MG | |
| Cas.: 2375740-98-8 | Purity: ≥98% | CSN5i-3 | ESD-933996-5MG |
| Cas.: 74857-22-0 | Purity: ≥98% | Bisdionin C | ESD-933997-5MG |
| Cas.: 817586-01-9 | Purity: ≥98% | FTI-2148 diTFA | ESD-933998-5MG |
| Cas.: 2360523-76-6 | Hu7691 | ESD-933999-5MG | |
| Cas.: 179545-77-8 | Purity: ≥95% | Tanomastat | ESD-934000-5MG |
| Cas.: 352010-68-5 | Purity: ≥98% | Bicyclopyrone | ESD-934001-5MG |
| Cas.: 1246833-26-0 | Purity: ≥95% | Curcumin-d6 | ESD-934002-5MG |
| Cas.: 1799788-94-5 | Purity: ≥98% | Trk-IN-4 | ESD-934003-5MG |
| Cas.: 2607975-44-8 | F1324 | ESD-934004-5MG | |
| Cas.: 2863-04-9 | Thymidine 3′,5′-disphosphate | ESD-934005-5MG | |
| Cas.: 1854126-41-2 | Purity: ≥98% | Chloroquine-d5 | ESD-934006-5MG |
| Cas.: 1592908-16-1 | Purity: ≥98% | MSN-125 | ESD-934007-5MG |
| Cas.: 92175-57-0 | Purity: ≥95% | Kelatorphan | ESD-934008-5MG |
| Cas.: 1330180-22-7 | Purity: ≥98% | Nimesulide d5 | ESD-934009-5MG |
| Cas.: 2377858-38-1 | Purity: ≥98% | SCR130 | ESD-934010-5MG |
| Cas.: 470-42-8 | Purity: ≥98% | marinobufogenin | ESD-934011-5MG |
| Cas.: 1205749-97-8 | Purity: 95% | 3-Methylpiperidine-3-carbonitrile hydrochloride | ESD-934012-1G |
| Cas.: 142334-69-0 | Purity: 95% | 5-(3-Nitrophenyl)-1h-pyrazol-3-amine | ESD-934013-1G |
| Cas.: 105974-64-9 | Purity: 95% | Tert-butyl 7-aminoheptanoate | ESD-934014-1G |
| Cas.: 84973-05-7 | Purity: ≥95% | 3-Bromo-7-chloroquinoline | ESD-934015-1G |
| Cas.: 89750-15-2 | Purity: 99% | Glucagon-like peptide 2 | ESD-934016-1MG |
| Cas.: 260061-31-2 | Purity: ≥98% | (R)-4-Methylpyrrolidin-2-one | ESD-934017-1G |
| Cas.: 34984-16-2 | Purity: 98% | Pyridine-2,6-diyldimethanamine | ESD-934018-1G |
| Cas.: 2107273-48-1 | Purity: ≥98% | Bis-(N,N’-PEG4-NHS ester)-Cy5 | ESD-934019-1MG |
| Cas.: 2107273-80-1 | Purity: ≥98% | N-(m-PEG4)-N’-(Acid-PEG3)-benzothiazole Cy5 | ESD-934020-1MG |
| Cas.: 2107273-74-3 | Purity: ≥90% | N-(azide-PEG3)-N’-(Mal-PEG4)-Cy5 | ESD-934021-1MG |
| Cas.: 2107273-88-9 | Purity: ≥98% | N-(azide-PEG3)-N’-(m-PEG4)-Benzothiazole Cy5 | ESD-934022-1MG |
| Cas.: 2107273-40-3 | Purity: ≥98% | N-(m-PEG4)-N’-(azide-PEG4)-Cy7 | ESD-934023-1MG |
| Cas.: 2107273-76-5 | Purity: ≥98% | N-(m-PEG4)-N’-(DBCO-PEG4)-Cy5 | ESD-934024-1MG |
| Cas.: 2107273-56-1 | Purity: ≥98% | N-methyl-N’-methyl-O-(m-PEG4)-O’-(azide-PEG4)-Cy5 | ESD-934025-1MG |
| Cas.: 2107273-64-1 | Purity: ≥98% | N-methyl-N’-methyl-O-(m-PEG4)-O’-(azide-PEG4)-Cy3 | ESD-934026-1MG |
| Cas.: 937188-60-8 | Purity: 97% | HO-PEG8-CH2CH2COOH | ESD-934027-1G |
| Cas.: 2107273-50-5 | Purity: ≥95% | N-methyl-N’-methyl-O-(m-PEG4)-O’-(propargyl-PEG4)-Cy5 | ESD-934028-1MG |
| Cas.: 1347704-59-9 | Purity: ≥95% | Boc-NH-PEG10-CH2CH2NH2 | ESD-934029-1G |
| Cas.: 2107273-70-9 | Purity: ≥98% | N-(azide-PEG3)-N’-(Amine-C3-Amide-PEG4)-Cy5 | ESD-934030-1MG |
| Cas.: 2107273-78-7 | Purity: ≥95% | N-(m-PEG4)-N’-(Biotin-PEG2-amido-PEG4)-Cy5 | ESD-934031-1MG |
| Cas.: 1162336-72-2 | Purity: 97% | Azido-C1-PEG3-C3-NH2 | ESD-934032-1G |
| Cas.: 100688-48-0 | Purity: 97% | m-PEG3-CH2-alcohol | ESD-934033-1G |
| Cas.: 1807518-67-7 | Purity: 97% | Bromoacetamido-PEG4-acid | ESD-934034-1G |
| Cas.: 2107273-62-9 | Purity: ≥95% | N-methyl-N’-methyl-O-(m-PEG4)-O’-(propargyl-PEG4)-Cy3 | ESD-934035-1MG |
| Cas.: 2378261-87-9 | Purity: 95% | K-Ras ligand-Linker Conjugate 3 | ESD-934036-1MG |
| Cas.: 2185016-39-9 | Purity: 95% | TCO-PEG12-NHS ester | ESD-934037-1G |
| Cas.: 2107273-58-3 | Purity: ≥98% | N-(m-PEG4)-N’-(m-PEG4)-O-(m-PEG4)-O’-(azide-PEG4)-Cy5 | ESD-934038-1MG |
| Cas.: 2107273-54-9 | Purity: ≥95% | N-(m-PEG4)-N’-(m-PEG4)-O-(m-PEG4)-O’-(propargyl-PEG4)-Cy5 | ESD-934039-1MG |
| Cas.: 16142-03-3 | Purity: 97% | m-PEG5-CH2COOH | ESD-934040-1G |
| Cas.: 2093154-00-6 | Purity: 97% | Propargyl-PEG7-acid | ESD-934041-1G |
| Cas.: 1191079-83-0 | Purity: ≥95% | Amino-PEG9-acid | ESD-934042-1G |
| Cas.: 2112731-44-7 | Purity: ≥95% | N-Boc-PEG9-alcohol | ESD-934043-1G |
| Cas.: 159428-42-9 | Purity: 97% | Bis-propargyl-PEG4 | ESD-934044-1G |
| Cas.: 1196732-52-1 | Purity: ≥95% | Propargyl-PEG8-NH2 | ESD-934045-1G |
| Cas.: 1547162-46-8 | Purity: 97% | CC-17369 | ESD-934046-1MG |
| Cas.: 1292268-13-3 | Purity: 97% | N-Boc-PEG7-alcohol | ESD-934047-1G |
| Cas.: 2154358-89-9 | BRD4 ligand-Linker Conjugate 1 | ESD-934048-1MG | |
| Cas.: 2230077-10-6 | Purity: ≥98% | MS4077 | ESD-934049-1MG |
| Cas.: 1957234-83-1 | Purity: ≥98% | dBET23 | ESD-934050-1MG |
| Cas.: 2384184-40-9 | Purity: ≥98% | KB02-SLF | ESD-934051-1MG |
| Cas.: 274925-86-9 | Purity: ≥95% | Nebicapone | ESD-934052-1G |
| Cas.: 142873-41-4 | Lipid peroxidation inhibitor 1 | ESD-934053-1MG | |
| Cas.: 360561-53-1 | Purity: ≥98% | Prenyl-IN-1 | ESD-934054-1MG |
| Cas.: 170376-12-2 | Purity: ≥98% | Glycosidase-IN-1 | ESD-934055-1MG |
| Cas.: 25387-67-1 | Purity: 97% | Sodium Camptothecin | ESD-934056-1G |
| Cas.: 2504147-81-1 | Purity: ≥95% | OM99-2 TFA | ESD-934057-1MG |
| Cas.: 314266-76-7 | Purity: ≥95% | OM99-2 | ESD-934058-1MG |
| Cas.: 1096770-84-1 | Purity: ≥98% | S32826 | ESD-934059-1MG |
| Cas.: 642-15-9 | Purity: ≥95% | Antimycin A1 | ESD-934060-1MG |
| Cas.: 1638281-44-3 | Purity: ≥95% | Osimertinib-d6 | ESD-934061-1MG |
| Cas.: 2050041-12-6 | Purity: ≥95% | Ledipasvir-d6 | ESD-934062-1MG |
| Cas.: 2250019-94-2 | Purity: ≥98% | AR-C141990 hydrochloride | ESD-934063-1MG |
| Cas.: 138559-60-1 | Purity: ≥95% | Antileukinate | ESD-934064-1MG |
| Cas.: 18201-65-5 | Purity: ≥98% | Dichlorophenyl-ABA | ESD-934065-1MG |
| Cas.: 1189987-23-2 | Purity: ≥98% | Leflunomide-d4 | ESD-934066-1MG |
| Cas.: 1217720-20-1 | Purity: ≥95% | Ritonavir-d6 | ESD-934067-1MG |
| Cas.: 1224729-35-4 | Purity: ≥98% | Lopinavir-d8 | ESD-934068-1MG |
| Cas.: 1356355-11-7 | Purity: ≥98% | Saquinavir-d9 | ESD-934069-1MG |
| Cas.: 203192-01-2 | Purity: ≥98% | MN58b | ESD-934070-1MG |
| Cas.: 1329568-92-4 | Purity: ≥98% | ent-Tadalafil-d3 | ESD-934071-1MG |
| Cas.: 1795134-78-9 | Purity: ≥95% | Toceranib-d8 | ESD-934072-1MG |
| Cas.: 55319-36-3 | Purity: ≥98% | Soyasaponin II | ESD-934073-1MG |
| Cas.: 16496-99-4 | Purity: 98% | Leelamine hydrochloride | ESD-934074-1G |
| Cas.: 2253744-55-5 | Purity: ≥98% | Squarunkin A hydrochloride | ESD-934075-1MG |
| Cas.: 314245-65-3 | Purity: ≥90% | Migrastatin | ESD-934076-1MG |
| Cas.: 475-25-2 | Hematein | ESD-934077-1MG | |
| Cas.: 86377-52-8 | Purity: ≥98% | Ganoderic acid Y | ESD-934078-1MG |
| Cas.: 113731-96-7 | Purity: ≥95% | Protein Kinase C (19-36) | ESD-934079-1MG |
| Cas.: 1170643-61-4 | Liproxstatin-1 analog | ESD-934080-1MG | |
| Cas.: 1189974-82-0 | Purity: ≥98% | Mitoxantrone-d8 | ESD-934081-1MG |
| Cas.: 2158336-69-5 | Purity: ≥95% | Dasabuvir-d6 | ESD-934082-1MG |
| Cas.: 1621884-18-1 | Purity: ≥98% | AT-9010 tetrasodium | ESD-934083-1MG |
| Cas.: 1133712-96-5 | Purity: ≥98% | Letrozole-d4 | ESD-934084-1MG |
| Cas.: 2648089-95-4 | Purity: ≥98% | AT-9010 triethylamine | ESD-934085-1MG |
| Cas.: 1279034-23-9 | Purity: ≥95% | Quinaprilat-d5 | ESD-934086-1MG |
| Cas.: 1217819-15-2 | Tipranavir-d4 | ESD-934087-1MG | |
| Cas.: 380488-27-7 | 187-1, N-WASP inhibitor | ESD-934088-1MG | |
| Cas.: 4695-09-4 | Purity: ≥95% | Thiomandelic acid | ESD-934089-1MG |
| Cas.: 106400-18-4 | Purity: ≥98% | LY243246 | ESD-934090-1MG |
| Cas.: 306305-07-7 | 4′-Ethynyl-2′-deoxyadenosine | ESD-934091-1MG | |
| Cas.: 1848257-52-2 | Cobomarsen | ESD-934092-1MG | |
| Cas.: 1346601-60-2 | Trovafloxacin-d4 mesylate | ESD-934093-1MG | |
| Cas.: 102064-45-9 | Ibudilast-d3 | ESD-934094-1MG | |
| Cas.: 468-53-1 | Purity: ≥98% | Mesembrine | ESD-934095-1MG |
| Cas.: 1322625-44-4 | Purity: ≥98% | Sulbactam-d5 sodium | ESD-934096-1MG |
| Cas.: 123122-55-4 | Candoxatril | ESD-934097-1MG | |
| Cas.: 153758-25-9 | Purity: ≥98% | Heparastatin | ESD-934098-1MG |
| Cas.: 1227666-13-8 | Purity: ≥98% | Nateglinide D5 | ESD-934099-1MG |
| Cas.: 131275-93-9 | Purity: ≥95% | (3R,5S)-Atorvastatin sodium | ESD-934100-1MG |
| Cas.: 2710375-18-9 | Purity: ≥98% | Ftase inhibitor III | ESD-934101-1MG |
| Cas.: 172308-76-8 | Purity: ≥98% | PKC beta pseudosubstrate | ESD-934102-1MG |
| Cas.: 1623405-28-6 | Purity: ≥98% | Celosin H | ESD-934103-10MG |
| Cas.: 1623405-28-6 | Purity: ≥98% | Celosin H | ESD-934103-20MG |
| Cas.: 1623405-28-6 | Purity: ≥98% | Celosin H | ESD-934103-50MG |
| Cas.: 6379-73-3 | Purity: ≥98% | methylcarvacrol | ESD-934104-250MG |
| Cas.: 6379-73-3 | Purity: ≥98% | methylcarvacrol | ESD-934104-1G |
| Cas.: 6379-73-3 | Purity: ≥98% | methylcarvacrol | ESD-934104-5G |
| Cas.: 18110-87-7 | Purity: ≥98% | 4,5-Dimethoxycanthin-6-one | ESD-934105-5MG |
| Cas.: 18110-87-7 | Purity: ≥98% | 4,5-Dimethoxycanthin-6-one | ESD-934105-10MG |
| Cas.: 18110-87-7 | Purity: ≥98% | 4,5-Dimethoxycanthin-6-one | ESD-934105-20MG |
| Cas.: 153127-42-5 | Purity: ≥98% | Cyclocurcumin | ESD-934106-5MG |
| Cas.: 153127-42-5 | Purity: ≥98% | Cyclocurcumin | ESD-934106-10MG |
| Cas.: 153127-42-5 | Purity: ≥98% | Cyclocurcumin | ESD-934106-20MG |
| Cas.: 117230-33-8 | Purity: ≥98% | Soyosaponin Aa | ESD-934107-5MG |
| Cas.: 117230-33-8 | Purity: ≥98% | Soyosaponin Aa | ESD-934107-10MG |
| Cas.: 117230-33-8 | Purity: ≥98% | Soyosaponin Aa | ESD-934107-20MG |
| Cas.: 105317-67-7 | Purity: ≥98% | Aloeresin D | ESD-934108-5MG |
| Cas.: 105317-67-7 | Purity: ≥98% | Aloeresin D | ESD-934108-10MG |
| Cas.: 105317-67-7 | Purity: ≥98% | Aloeresin D | ESD-934108-20MG |
| Cas.: 2673-40-7 | Purity: ≥98% | Perivine | ESD-934109-5MG |
| Cas.: 2673-40-7 | Purity: ≥98% | Perivine | ESD-934109-10MG |
| Cas.: 2673-40-7 | Purity: ≥98% | Perivine | ESD-934109-20MG |
| Cas.: 875057-87-7 | Purity: ≥98% | Tenacissoside X | ESD-934110-5MG |
| Cas.: 875057-87-7 | Purity: ≥98% | Tenacissoside X | ESD-934110-10MG |
| Cas.: 875057-87-7 | Purity: ≥98% | Tenacissoside X | ESD-934110-20MG |
| Cas.: 118994-86-8 | Purity: 98% | Oxazole-5-carbaldehyde | ESD-932122-100MG |
| Cas.: 552301-45-8 | Purity: 97% | methyl2-(4-(2-hydroxyethyl)phenyl)-2-methylpropanoate | ESD-934111-1G |
| Cas.: 552301-45-8 | Purity: 97% | methyl2-(4-(2-hydroxyethyl)phenyl)-2-methylpropanoate | ESD-934111-5G |
| Cas.: 552301-45-8 | Purity: 97% | methyl2-(4-(2-hydroxyethyl)phenyl)-2-methylpropanoate | ESD-934111-25G |
| Cas.: 107746-24-7 | Purity: 98% | (3R,5S)-5-(hydroxymethyl)-1-methylpyrrolidin-3-olhydrochloride | ESD-934112-250MG |
| Cas.: 107746-24-7 | Purity: 98% | (3R,5S)-5-(hydroxymethyl)-1-methylpyrrolidin-3-olhydrochloride | ESD-934112-1G |
| Cas.: 107746-24-7 | Purity: 98% | (3R,5S)-5-(hydroxymethyl)-1-methylpyrrolidin-3-olhydrochloride | ESD-934112-5G |
| Cas.: 23459-38-3 | Purity: 98% | cyclopropyl(phenyl)methanamine | ESD-934113-250MG |
| Cas.: 23459-38-3 | Purity: 98% | cyclopropyl(phenyl)methanamine | ESD-934113-1G |
| Cas.: 23459-38-3 | Purity: 98% | cyclopropyl(phenyl)methanamine | ESD-934113-5G |
| Cas.: 681435-09-6 | Purity: 95% | 2,4-dichloro-6-fluorobenzaldehyde | ESD-934114-250MG |
| Cas.: 681435-09-6 | Purity: 95% | 2,4-dichloro-6-fluorobenzaldehyde | ESD-934114-1G |
| Cas.: 681435-09-6 | Purity: 95% | 2,4-dichloro-6-fluorobenzaldehyde | ESD-934114-5G |
| Cas.: 663955-59-7 | Purity: 95% | 5-ethynyl-2-methoxypyridine | ESD-934115-250MG |
| Cas.: 663955-59-7 | Purity: 95% | 5-ethynyl-2-methoxypyridine | ESD-934115-1G |
| Cas.: 663955-59-7 | Purity: 95% | 5-ethynyl-2-methoxypyridine | ESD-934115-5G |
| Cas.: 38239-45-1 | Purity: 95% | 5-bromo-3-methylthiophene-2-carboxylicacid | ESD-934116-250MG |
| Cas.: 38239-45-1 | Purity: 95% | 5-bromo-3-methylthiophene-2-carboxylicacid | ESD-934116-1G |
| Cas.: 38239-45-1 | Purity: 95% | 5-bromo-3-methylthiophene-2-carboxylicacid | ESD-934116-5G |
| Cas.: 350847-80-2 | Purity: 95% | 6,7-dihydro-5H-cyclopenta[c]pyridin-5-one | ESD-934117-50MG |
| Cas.: 350847-80-2 | Purity: 95% | 6,7-dihydro-5H-cyclopenta[c]pyridin-5-one | ESD-934117-250MG |
| Cas.: 350847-80-2 | Purity: 95% | 6,7-dihydro-5H-cyclopenta[c]pyridin-5-one | ESD-934117-1G |
| Cas.: 1257520-11-8 | Purity: 95% | (E)-Methyl 4-(4-cyanophenyl)-2-oxobut-3-enoate | ESD-934118-250MG |
| Cas.: 1257520-11-8 | Purity: 95% | (E)-Methyl 4-(4-cyanophenyl)-2-oxobut-3-enoate | ESD-934118-500MG |
| Cas.: 17797-10-3 | Purity: 98% | 2-(4-Fluorophenyl)propan-2-amine | ESD-934119-250MG |
| Cas.: 17797-10-3 | Purity: 98% | 2-(4-Fluorophenyl)propan-2-amine | ESD-934119-500MG |
| Cas.: 153207-76-2 | Purity: 95% | 3-azidopropyl 4-methylbenzenesulfonate | ESD-934120-100MG |
| Cas.: 153207-76-2 | Purity: 95% | 3-azidopropyl 4-methylbenzenesulfonate | ESD-934120-500MG |
| Cas.: 182347-24-6 | Purity: 95% | 2-(2-azidoethoxy)ethyl 4-methylbenzenesulfonate | ESD-934121-100MG |
| Cas.: 182347-24-6 | Purity: 95% | 2-(2-azidoethoxy)ethyl 4-methylbenzenesulfonate | ESD-934121-500MG |
| Cas.: 2460029-00-7 | Purity: 95% | 4-nitrobenzyl 2-(((tert-butyldimethylsilyl)oxy)methyl)-6,7-dihydropyrazolo[1,5-a]pyrazine-5(4H)-carboxylate | ESD-934122-100MG |
| Cas.: 2460029-00-7 | Purity: 95% | 4-nitrobenzyl 2-(((tert-butyldimethylsilyl)oxy)methyl)-6,7-dihydropyrazolo[1,5-a]pyrazine-5(4H)-carboxylate | ESD-934122-500MG |
| Cas.: 862081-99-0 | Purity: 95% | 2,3-dibromo-6-methoxybenzo[b]thiophene 1,1-dioxide | ESD-934123-100MG |
| Cas.: 862081-99-0 | Purity: 95% | 2,3-dibromo-6-methoxybenzo[b]thiophene 1,1-dioxide | ESD-934123-500MG |
| Cas.: 1896262-04-6 | Purity: 95% | (5-fluoro-2,3-dihydrobenzofuran-4-yl)methanamine | ESD-934124-100MG |
| Cas.: 1896262-04-6 | Purity: 95% | (5-fluoro-2,3-dihydrobenzofuran-4-yl)methanamine | ESD-934124-500MG |
| Cas.: 1538-22-3 | Purity: 95% | (2S,3R)-3-methylpent-4-en-3-ol | ESD-934125-100MG |
| Cas.: 1538-22-3 | Purity: 95% | (2S,3R)-3-methylpent-4-en-3-ol | ESD-934125-500MG |
| Cas.: 2377355-49-0 | Purity: 95% | tert-butyl (5S)-5-(tert-butylsulfinylamino)spiro[5,7-dihydrocyclopenta[b]pyridine-6,4′-piperidine]-1′-carboxylate | ESD-934126-100MG |
| Cas.: 2377355-49-0 | Purity: 95% | tert-butyl (5S)-5-(tert-butylsulfinylamino)spiro[5,7-dihydrocyclopenta[b]pyridine-6,4′-piperidine]-1′-carboxylate | ESD-934126-500MG |
| Cas.: 2246363-82-4 | Purity: 95% | tert-butyl 8-methyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,3-dihydro-1H-pyrido[2,3-b][ 1,4]oxazine-1-carboxylate | ESD-934127-100MG |
| Cas.: 2246363-82-4 | Purity: 95% | tert-butyl 8-methyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,3-dihydro-1H-pyrido[2,3-b][ 1,4]oxazine-1-carboxylate | ESD-934127-500MG |
| Cas.: 2246363-84-6 | Purity: 95% | tert-butyl 7-bromo-8-methyl-2,3-dihydro-1H-pyrido[2,3-b][1,4]oxazine-1-carboxylate | ESD-934128-100MG |
| Cas.: 2246363-84-6 | Purity: 95% | tert-butyl 7-bromo-8-methyl-2,3-dihydro-1H-pyrido[2,3-b][1,4]oxazine-1-carboxylate | ESD-934128-500MG |
| Cas.: 2349395-67-9 | Purity: 97% | ((2R,5R)-5-Methylpiperazin-2-yl)methanol dihydrochloride | ESD-934129-100MG |
| Cas.: 2349395-67-9 | Purity: 97% | ((2R,5R)-5-Methylpiperazin-2-yl)methanol dihydrochloride | ESD-934129-500MG |
| Cas.: 2396750-32-4 | Purity: 95% | 3,4-Difluoropyrazolo[1,5-a]pyridine-7-carbonitrile | ESD-934130-100MG |
| Cas.: 2396750-32-4 | Purity: 95% | 3,4-Difluoropyrazolo[1,5-a]pyridine-7-carbonitrile | ESD-934130-500MG |
| Cas.: 181186-37-8 | Purity: average Mw 700-1000 | Poly(Methylsilsesquioxane), Methoxy Terminated | ESD-934131-100G |
| Cas.: 181186-37-8 | Purity: average Mw 700-1000 | Poly(Methylsilsesquioxane), Methoxy Terminated | ESD-934131-500G |
| Cas.: 68440-90-4 | Purity: viscosity 600-1000 cSt (25 C) | POLYOCTYLMETHYLSILOXANE | ESD-934132-100G |
| Cas.: 68440-90-4 | Purity: viscosity 600-1000 cSt (25 C) | POLYOCTYLMETHYLSILOXANE | ESD-934132-500G |
| Cas.: 191044-49-2 | Purity: viscosity 40-70 cSt (25 C) | (45-55% HEXADECYLMETHYLSILOXANE)-(DIMETHYLSILOXANE) COPOLYMER | ESD-934133-100G |
| Cas.: 191044-49-2 | Purity: viscosity 40-70 cSt (25 C) | (45-55% HEXADECYLMETHYLSILOXANE)-(DIMETHYLSILOXANE) COPOLYMER | ESD-934133-500G |
| Cas.: 99363-37-8 | Purity: viscosity 1800-2200cSt (25 C) | (6-7% AMINOPROPYLMETHYLSILOXANE) – DIMETHYLSILOXANE COPOLYMER | ESD-934134-100G |
| Cas.: 99363-37-8 | Purity: viscosity 1800-2200cSt (25 C) | (6-7% AMINOPROPYLMETHYLSILOXANE) – DIMETHYLSILOXANE COPOLYMER | ESD-934134-500G |
| Cas.: 71750-79-3 | Purity: viscosity 300-500cSt (25 C) | (18-24% AMINOETHYLAMINOPROPYLMETHYLSILOXANE) – DIMETHYLSILOXANE COPOLYMER | ESD-934135-100G |
| Cas.: 71750-79-3 | Purity: viscosity 300-500cSt (25 C) | (18-24% AMINOETHYLAMINOPROPYLMETHYLSILOXANE) – DIMETHYLSILOXANE COPOLYMER | ESD-934135-500G |
| Cas.: 106842-44-8 | Purity: viscosity 120-150 cSt (25 C) | (3-5% AMINOETHYLAMINOISOBUTYLMETHYLSILOXANE) – DIMETHYLSILOXANE COPOLYMER | ESD-934136-100G |
| Cas.: 106842-44-8 | Purity: viscosity 120-150 cSt (25 C) | (3-5% AMINOETHYLAMINOISOBUTYLMETHYLSILOXANE) – DIMETHYLSILOXANE COPOLYMER | ESD-934136-500G |
| Cas.: 71329-48-1 | Purity: viscosity 1000 cSt (25 C) | POLY(2-PHENYLPROPYL)METHYLSILOXANE | ESD-934137-100G |
| Cas.: 71329-48-1 | Purity: viscosity 1000 cSt (25 C) | POLY(2-PHENYLPROPYL)METHYLSILOXANE | ESD-934137-500G |
| Cas.: 68037-77-4 | Purity: viscosity 1200-1600 cSt (25 C) | (75-85% ETHYLMETHYLSILOXANE)-(15-25% 2-PHENYLPROPYLMETHYLSILOXANE) COPOLYMER | ESD-934138-100G |
| Cas.: 68037-77-4 | Purity: viscosity 1200-1600 cSt (25 C) | (75-85% ETHYLMETHYLSILOXANE)-(15-25% 2-PHENYLPROPYLMETHYLSILOXANE) COPOLYMER | ESD-934138-500G |
| Cas.: 68952-01-2 | Purity: viscosity 1500-2000cSt (25 C) | (45-55% HEXYLMETHYLSILOXANE)-(45-55% 2-PHENYLPROPYLMETHYLSILOXANE) COPOLYMER | ESD-934139-100G |
| Cas.: 68952-01-2 | Purity: viscosity 1500-2000cSt (25 C) | (45-55% HEXYLMETHYLSILOXANE)-(45-55% 2-PHENYLPROPYLMETHYLSILOXANE) COPOLYMER | ESD-934139-500G |
| Cas.: 68037-76-3 | Purity: viscosity 1100-1300 cSt (25 C) | (60-70% DODECYLMETHYLSILOXANE)-(30-40% 2-PHENYLPROPYLMETHYLSILOXANE) COPOLYMER | ESD-934140-100G |
| Cas.: 68037-76-3 | Purity: viscosity 1100-1300 cSt (25 C) | (60-70% DODECYLMETHYLSILOXANE)-(30-40% 2-PHENYLPROPYLMETHYLSILOXANE) COPOLYMER | ESD-934140-500G |
| Cas.: 67923-07-3 | Purity: viscosity 100-200cSt (25 C) | (0.5-1.5% AMINOETHYLAMINOPROPYLMETHOXYSILOXANE) – DIMETHYLSILOXANE COPOLYMER WITH BRANCH STRUCTURE | ESD-934141-100G |
| Cas.: 67923-07-3 | Purity: viscosity 100-200cSt (25 C) | (0.5-1.5% AMINOETHYLAMINOPROPYLMETHOXYSILOXANE) – DIMETHYLSILOXANE COPOLYMER WITH BRANCH STRUCTURE | ESD-934141-500G |
| Cas.: 68937-54-2 | Purity: viscosity 550-650 cSt (25 C) | (35% HYDROXYETHYLENEOXYPROPYLMETHYLSILOXANE)-(DIMETHYLSILOXANE) COPOLYMER | ESD-934142-100G |
| Cas.: 68937-54-2 | Purity: viscosity 550-650 cSt (25 C) | (35% HYDROXYETHYLENEOXYPROPYLMETHYLSILOXANE)-(DIMETHYLSILOXANE) COPOLYMER | ESD-934142-500G |
| Cas.: 68957-00-6 | Purity: viscosity 150-200cSt (25 C) | (HYDROXYPROPYLENEOXYPROPYL)METHYLSILOXANE – DIMETHYLSILOXANE COPOLYMER | ESD-934143-100G |
| Cas.: 68957-00-6 | Purity: viscosity 150-200cSt (25 C) | (HYDROXYPROPYLENEOXYPROPYL)METHYLSILOXANE – DIMETHYLSILOXANE COPOLYMER | ESD-934143-500G |
| Cas.: 200443-93-2 | Purity: viscosity 1000-2000cSt (25 C) | (HYDROXYETHYLENEOXYPROPYLMETHYLSILOXANE)-(3,4-DIMETHOXYPHENYLPROPYL)METHYLSILOXANE-DIMETHYLSILOXANE TERPOLYMER | ESD-934144-100G |
| Cas.: 200443-93-2 | Purity: viscosity 1000-2000cSt (25 C) | (HYDROXYETHYLENEOXYPROPYLMETHYLSILOXANE)-(3,4-DIMETHOXYPHENYLPROPYL)METHYLSILOXANE-DIMETHYLSILOXANE TERPOLYMER | ESD-934144-500G |
| Cas.: 68938-54-5 | Purity: viscosity 100-120 cSt (25 C) | DIMETHYLSILOXANE-(85-90% ETHYLENE OXIDE) BLOCK COPOLYMER | ESD-934145-100G |
| Cas.: 68938-54-5 | Purity: viscosity 100-120 cSt (25 C) | DIMETHYLSILOXANE-(85-90% ETHYLENE OXIDE) BLOCK COPOLYMER | ESD-934145-500G |
| Cas.: 117272-76-1 | Purity: viscosity 40-50cSt (25 C) | Dimethylsiloxane-(80% Ethylene Oxide) Block Copolymer | ESD-934146-100G |
| Cas.: 117272-76-1 | Purity: viscosity 40-50cSt (25 C) | Dimethylsiloxane-(80% Ethylene Oxide) Block Copolymer | ESD-934146-500G |
| Cas.: 68937-55-3 | Purity: viscosity 4000cSt (25 C) | DIMETHYLSILOXANE-[50-55%(60% PROPYLENE OXIDE/40% ETHYLENE OXIDE)] BLOCK COPOLYMER | ESD-934147-100G |
| Cas.: 68937-55-3 | Purity: viscosity 4000cSt (25 C) | DIMETHYLSILOXANE-[50-55%(60% PROPYLENE OXIDE/40% ETHYLENE OXIDE)] BLOCK COPOLYMER | ESD-934147-500G |
| Cas.: 67762-85-0 | Purity: viscosity 1800 cSt (25 C) | DIMETHYLSILOXANE-[65-70%(60% PROPYLENE OXIDE/40% ETHYLENE OXIDE)] BLOCK COPOLYMER | ESD-934148-100G |
| Cas.: 67762-85-0 | Purity: viscosity 1800 cSt (25 C) | DIMETHYLSILOXANE-[65-70%(60% PROPYLENE OXIDE/40% ETHYLENE OXIDE)] BLOCK COPOLYMER | ESD-934148-500G |
| Cas.: 1041421-77-5 | Purity: 95% | 3-(Pyridin-3-yl)-4H-furo[3,2-b]pyrrole-5-carboxylicacid | ESD-934149-100MG |
| Cas.: 1041421-77-5 | Purity: 95% | 3-(Pyridin-3-yl)-4H-furo[3,2-b]pyrrole-5-carboxylicacid | ESD-934149-250MG |
| Cas.: 14770-84-4 | Purity: ≥95% | 2-Amino-5-phenylthiophene-3-carboxylic acid | ESD-934150-100MG |
| Cas.: 14770-84-4 | Purity: ≥95% | 2-Amino-5-phenylthiophene-3-carboxylic acid | ESD-934150-250MG |
| Cas.: 885460-48-0 | Purity: 97% | Isopropyl2-(4-chloro-6-phenylthieno[2,3-d]pyrimidin-2-yl)acetate | ESD-934151-100MG |
| Cas.: 885460-48-0 | Purity: 97% | Isopropyl2-(4-chloro-6-phenylthieno[2,3-d]pyrimidin-2-yl)acetate | ESD-934151-250MG |
| Cas.: 130416-46-5 | Purity: ≥95% | 4-(2-Aminopropan-2-yl)benzonitrile | ESD-934152-100MG |
| Cas.: 130416-46-5 | Purity: ≥95% | 4-(2-Aminopropan-2-yl)benzonitrile | ESD-934152-250MG |
| Cas.: 79039-20-6 | Purity: 95% | 7-oxo-2-Phenyl-4,7-dihydropyrazolo[1,5-a]pyriMidine-6-carboxylic acid | ESD-934153-100MG |
| Cas.: 79039-20-6 | Purity: 95% | 7-oxo-2-Phenyl-4,7-dihydropyrazolo[1,5-a]pyriMidine-6-carboxylic acid | ESD-934153-250MG |
| Cas.: 263881-19-2 | Purity: 97% | Ethyl1-chloro-2,7-naphthyridine-3-carboxylate | ESD-934154-100MG |
| Cas.: 263881-19-2 | Purity: 97% | Ethyl1-chloro-2,7-naphthyridine-3-carboxylate | ESD-934154-250MG |
| Cas.: 79426-14-5 | Purity: 96% | 1,5-Naphthyridine-4-carboxylicacid | ESD-934155-100MG |
| Cas.: 79426-14-5 | Purity: 96% | 1,5-Naphthyridine-4-carboxylicacid | ESD-934155-250MG |
| Cas.: 855521-71-0 | Purity: 95% | 2-(Pyridin-2-yl)-1,8-naphthyridine-4-carboxylicacid | ESD-934156-100MG |
| Cas.: 855521-71-0 | Purity: 95% | 2-(Pyridin-2-yl)-1,8-naphthyridine-4-carboxylicacid | ESD-934156-250MG |
| Cas.: 1001419-37-9 | Purity: 97% | tert-Butyl5-(hydroxymethyl)thiazol-2-ylcarbamate | ESD-934157-100MG |
| Cas.: 1001419-37-9 | Purity: 97% | tert-Butyl5-(hydroxymethyl)thiazol-2-ylcarbamate | ESD-934157-250MG |
| Cas.: 391668-77-2 | Purity: 97% | tert-Butyl(5-formylthiazol-2-yl)carbamate | ESD-934158-100MG |
| Cas.: 391668-77-2 | Purity: 97% | tert-Butyl(5-formylthiazol-2-yl)carbamate | ESD-934158-250MG |
| Cas.: 21346-36-1 | Purity: 98% | 2-(Pyridin-4-yl)thiazole-5-carbaldehyde | ESD-934159-100MG |
| Cas.: 21346-36-1 | Purity: 98% | 2-(Pyridin-4-yl)thiazole-5-carbaldehyde | ESD-934159-250MG |
| Cas.: 640292-04-2 | Purity: 96% | 5-(4-Bromophenyl)isoxazole-3-carbaldehyde | ESD-934160-100MG |
| Cas.: 640292-04-2 | Purity: 96% | 5-(4-Bromophenyl)isoxazole-3-carbaldehyde | ESD-934160-250MG |
| Cas.: 886851-57-6 | Purity: 95% | (4-Methyl-2-(pyridin-3-yl)thiazol-5-yl)methanol | ESD-934161-100MG |
| Cas.: 886851-57-6 | Purity: 95% | (4-Methyl-2-(pyridin-3-yl)thiazol-5-yl)methanol | ESD-934161-250MG |
| Cas.: 217435-75-1 | Purity: 95% | (2,7-Dimethylimidazo[1,2-a]pyridin-3-yl)methanol | ESD-934162-100MG |
| Cas.: 217435-75-1 | Purity: 95% | (2,7-Dimethylimidazo[1,2-a]pyridin-3-yl)methanol | ESD-934162-250MG |
| Cas.: 820245-84-9 | Purity: 96% | 2,7-DimethylH-imidazo[1,2-a]pyridine-3-carbaldehyde | ESD-934163-100MG |
| Cas.: 820245-84-9 | Purity: 96% | 2,7-DimethylH-imidazo[1,2-a]pyridine-3-carbaldehyde | ESD-934163-250MG |
| Cas.: 400749-87-3 | Purity: 97% | 3′-Bromo-biphenyl-4-carbaldehyde | ESD-934164-100MG |
| Cas.: 400749-87-3 | Purity: 97% | 3′-Bromo-biphenyl-4-carbaldehyde | ESD-934164-250MG |
| Cas.: 1199589-63-3 | Purity: 97% | 1-Aminomethyl-cyclohexanecarboxylic acid hydrochloride | ESD-934165-100MG |
| Cas.: 1199589-63-3 | Purity: 97% | 1-Aminomethyl-cyclohexanecarboxylic acid hydrochloride | ESD-934165-250MG |
| Cas.: 274676-47-0 | Purity: 97% | 7-Methyl-1,2,3,4-tetrahydro-1,8-naphthyridine | ESD-934166-100MG |
| Cas.: 274676-47-0 | Purity: 97% | 7-Methyl-1,2,3,4-tetrahydro-1,8-naphthyridine | ESD-934166-250MG |
| Cas.: 794465-45-5 | Purity: 95% | 3-Bromo-5-(tert-butyl)benzoic acid | ESD-934167-100MG |
| Cas.: 794465-45-5 | Purity: 95% | 3-Bromo-5-(tert-butyl)benzoic acid | ESD-934167-250MG |
| Cas.: 1016552-72-9 | Purity: 95% | 3-Aminothiophene-2-carboxylic acid hydrochloride | ESD-934168-100MG |
| Cas.: 1016552-72-9 | Purity: 95% | 3-Aminothiophene-2-carboxylic acid hydrochloride | ESD-934168-250MG |
| Cas.: 1262414-96-9 | Purity: 97% | 2-Fluoro-1-isopropyl-4-methoxybenzene | ESD-934169-100MG |
| Cas.: 1262414-96-9 | Purity: 97% | 2-Fluoro-1-isopropyl-4-methoxybenzene | ESD-934169-250MG |
| Cas.: 68449-32-1 | Purity: 95% | 8-Chloro-3,4-dihydronaphthalen-1(2H)-one | ESD-934170-100MG |
| Cas.: 68449-32-1 | Purity: 95% | 8-Chloro-3,4-dihydronaphthalen-1(2H)-one | ESD-934170-250MG |
| Cas.: 202823-22-1 | Purity: 98% | 5-(4-(Trifluoromethyl)phenyl)-1,3,4-oxadiazol-2(3H)-one | ESD-934171-100MG |
| Cas.: 202823-22-1 | Purity: 98% | 5-(4-(Trifluoromethyl)phenyl)-1,3,4-oxadiazol-2(3H)-one | ESD-934171-250MG |
| Cas.: 58735-58-3 | Purity: 95% | 2-(Bromomethyl)-4-chloro-1-methoxybenzene | ESD-934172-100MG |
| Cas.: 58735-58-3 | Purity: 95% | 2-(Bromomethyl)-4-chloro-1-methoxybenzene | ESD-934172-250MG |
| Cas.: 179096-59-4 | Purity: 97% | 2-(Tetrahydro-2H-pyran-4-yl)propan-2-ol | ESD-934173-100MG |
| Cas.: 179096-59-4 | Purity: 97% | 2-(Tetrahydro-2H-pyran-4-yl)propan-2-ol | ESD-934173-250MG |
| Cas.: 1227270-42-9 | Purity: ≥95% | 6-Phenyl-1H-pyrrolo[3,2-b]pyridine-3-carboxylicacid | ESD-934174-100MG |
| Cas.: 1227270-42-9 | Purity: ≥95% | 6-Phenyl-1H-pyrrolo[3,2-b]pyridine-3-carboxylicacid | ESD-934174-250MG |
| Cas.: 261896-35-9 | Purity: 97% | 4,4-Dimethylpyrrolidine-3-carboxylicacid | ESD-934175-100MG |
| Cas.: 261896-35-9 | Purity: 97% | 4,4-Dimethylpyrrolidine-3-carboxylicacid | ESD-934175-250MG |
| Cas.: 42247-74-5 | Purity: ≥95% | 2-(2-Hydroxyethyl)benzonitrile | ESD-934176-100MG |
| Cas.: 42247-74-5 | Purity: ≥95% | 2-(2-Hydroxyethyl)benzonitrile | ESD-934176-250MG |
| Cas.: 18301-46-7 | Purity: 95% | 4-(Trimethylsilyl)pyridine | ESD-934177-100MG |
| Cas.: 18301-46-7 | Purity: 95% | 4-(Trimethylsilyl)pyridine | ESD-934177-250MG |
| Cas.: 905273-66-7 | Purity: ≥95% | 3-(Trifluoromethyl)-6,7-dihydro-5H-pyrrolo[3,4-b]pyridine | ESD-934178-100MG |
| Cas.: 905273-66-7 | Purity: ≥95% | 3-(Trifluoromethyl)-6,7-dihydro-5H-pyrrolo[3,4-b]pyridine | ESD-934178-250MG |
| Cas.: 14279-86-8 | Purity: 97% | 1-(3-Methylbut-2-enyl)guanidine | ESD-934179-100MG |
| Cas.: 14279-86-8 | Purity: 97% | 1-(3-Methylbut-2-enyl)guanidine | ESD-934179-250MG |
| Cas.: 118708-61-5 | Purity: 97% | 2-(Hydroxymethyl)-5-((4-methoxybenzyl)oxy)-4H-pyran-4-one | ESD-934180-100MG |
| Cas.: 118708-61-5 | Purity: 97% | 2-(Hydroxymethyl)-5-((4-methoxybenzyl)oxy)-4H-pyran-4-one | ESD-934180-250MG |
| Cas.: 102638-45-9 | Purity: 95% | tert-Butyl3-(aminomethyl)benzoate | ESD-934181-100MG |
| Cas.: 102638-45-9 | Purity: 95% | tert-Butyl3-(aminomethyl)benzoate | ESD-934181-250MG |
| Cas.: 99735-45-2 | Purity: 98% | (R)-5-oxo-1-((R)-1-Phenylethyl)pyrrolidine-3-carboxylicacid | ESD-934182-100MG |
| Cas.: 99735-45-2 | Purity: 98% | (R)-5-oxo-1-((R)-1-Phenylethyl)pyrrolidine-3-carboxylicacid | ESD-934182-250MG |
| Cas.: 85175-65-1 | Purity: 95% | (Z)-7,8-dimethoxy-1H-benzo[d]azepin-2(3H)-one | ESD-934183-100MG |
| Cas.: 85175-65-1 | Purity: 95% | (Z)-7,8-dimethoxy-1H-benzo[d]azepin-2(3H)-one | ESD-934183-250MG |
| Cas.: 787596-43-4 | Purity: 98% | methyl 2-chloro-5-methylisonicotinate | ESD-934184-100MG |
| Cas.: 787596-43-4 | Purity: 98% | methyl 2-chloro-5-methylisonicotinate | ESD-934184-250MG |
| Cas.: 1533443-11-6 | Purity: 98% | 5-Iodo-3,4-dimethyl-1H-pyrazole | ESD-934185-100MG |
| Cas.: 1533443-11-6 | Purity: 98% | 5-Iodo-3,4-dimethyl-1H-pyrazole | ESD-934185-250MG |
| Cas.: 72204-21-8 | Purity: 97% | (2S,4S)-1-((Benzyloxy)carbonyl)-4-fluoropyrrolidine-2-carboxylic acid | ESD-934186-100MG |
| Cas.: 72204-21-8 | Purity: 97% | (2S,4S)-1-((Benzyloxy)carbonyl)-4-fluoropyrrolidine-2-carboxylic acid | ESD-934186-250MG |
| Cas.: 67644-00-2 | Purity: ≥97% | Prolylglutamic acid | ESD-934187-50MG |
| Cas.: 67644-00-2 | Purity: ≥97% | Prolylglutamic acid | ESD-934187-100MG |
| Cas.: 2408642-17-9 | Purity: 97% | 4-bromo-3-fluorophthalic acid | ESD-934188-25MG |
| Cas.: 2408642-17-9 | Purity: 97% | 4-bromo-3-fluorophthalic acid | ESD-934188-100MG |
| Cas.: 1408168-73-9 | Purity: 95% | potassium (2-(benzyloxy)ethyl)trifluoroborate | ESD-934189-25MG |
| Cas.: 1408168-73-9 | Purity: 95% | potassium (2-(benzyloxy)ethyl)trifluoroborate | ESD-934189-100MG |
| Cas.: 74080-51-6 | Purity: 95% | (2R,3S)-3-Methylpent-4-en-2-ol | ESD-934190-25MG |
| Cas.: 74080-51-6 | Purity: 95% | (2R,3S)-3-Methylpent-4-en-2-ol | ESD-934190-100MG |
| Cas.: 2138122-16-2 | Purity: 95% | tert-Butyl 3-iodo-2-methyl-6,7-dihydropyrazolo[1,5-a]pyrazine-5(4H)-carboxylate | ESD-934191-25MG |
| Cas.: 2138122-16-2 | Purity: 95% | tert-Butyl 3-iodo-2-methyl-6,7-dihydropyrazolo[1,5-a]pyrazine-5(4H)-carboxylate | ESD-934191-100MG |
| Cas.: 1242267-82-8 | Purity: 98% | Benzyl (S)-3-(cyanomethyl)piperazine-1-carboxylate | ESD-934192-25MG |
| Cas.: 1242267-82-8 | Purity: 98% | Benzyl (S)-3-(cyanomethyl)piperazine-1-carboxylate | ESD-934192-100MG |
| Cas.: 11032-49-8 | Purity: ≥98% | VK2 | ESD-934193-10MG |
| Cas.: 11032-49-8 | Purity: ≥98% | VK2 | ESD-934193-100MG |
| Cas.: 52328-97-9 | Purity: ≥98% | Tetramethylcurcumin | ESD-934194-25MG |
| Cas.: 52328-97-9 | Purity: ≥98% | Tetramethylcurcumin | ESD-934194-100MG |
| Cas.: 70914-15-7 | Purity: 97% | POLY(BORODIPHENYLSILOXANE) | ESD-934195-25G |
| Cas.: 70914-15-7 | Purity: 97% | POLY(BORODIPHENYLSILOXANE) | ESD-934195-100G |
| Cas.: 96132-98-8 | Purity: 97% | N-(3-METHACRYLOXY-2-HYDROXYPROPYL)-3-AMINOPROPYLTRIETHOXYSILANE | ESD-934196-25G |
| Cas.: 96132-98-8 | Purity: 97% | N-(3-METHACRYLOXY-2-HYDROXYPROPYL)-3-AMINOPROPYLTRIETHOXYSILANE | ESD-934196-100G |
| Cas.: 72878-29-6 | Purity: 95% | ACETOXYETHYL TRIMETHOXYSILANE | ESD-934197-25G |
| Cas.: 72878-29-6 | Purity: 95% | ACETOXYETHYL TRIMETHOXYSILANE | ESD-934197-100G |
| Cas.: 5630-83-1 | Purity: 97% | ACETOXYMETHYLTRIETHOXYSILANE | ESD-934198-25G |
| Cas.: 5630-83-1 | Purity: 97% | ACETOXYMETHYLTRIETHOXYSILANE | ESD-934198-100G |
| Cas.: 330457-46-0 | Purity: 97% | N-(HYDROXYETHYL)-N-METHYLAMINOPROPYLTRIMETHOXYSILANE | ESD-934199-25G |
| Cas.: 330457-46-0 | Purity: 97% | N-(HYDROXYETHYL)-N-METHYLAMINOPROPYLTRIMETHOXYSILANE | ESD-934199-100G |
| Cas.: 18387-19-4 | Purity: 97% | N-METHYL-AZA-2,2,4-TRIMETHYLSILACYCLOPENTANE | ESD-934200-25G |
| Cas.: 18387-19-4 | Purity: 97% | N-METHYL-AZA-2,2,4-TRIMETHYLSILACYCLOPENTANE | ESD-934200-100G |
| Cas.: 156849-43-3 | Purity: 97% | Silquest A 2639 | ESD-934201-25G |
| Cas.: 156849-43-3 | Purity: 97% | Silquest A 2639 | ESD-934201-100G |
| Cas.: 157923-74-5 | Purity: 97% | 4-AMINO-3,3-DIMETHYLBUTYLTRIMETHOXYSILANE | ESD-934202-25G |
| Cas.: 157923-74-5 | Purity: 97% | 4-AMINO-3,3-DIMETHYLBUTYLTRIMETHOXYSILANE | ESD-934202-100G |
| Cas.: 74113-77-2 | Purity: 90% | (Aminoethylaminomethyl)phenethyltrimethoxysilane, mixture of m and p isomers | ESD-934203-25G |
| Cas.: 74113-77-2 | Purity: 90% | (Aminoethylaminomethyl)phenethyltrimethoxysilane, mixture of m and p isomers | ESD-934203-100G |
| Cas.: 15129-36-9 | Purity: 92% | N-(6-AMINOHEXYL)AMINOMETHYLTRIETHOXYSILANE | ESD-934204-25G |
| Cas.: 15129-36-9 | Purity: 92% | N-(6-AMINOHEXYL)AMINOMETHYLTRIETHOXYSILANE | ESD-934204-100G |
| Cas.: 58160-99-9 | Purity: 22-25% aqueous solution | 3-Aminopropylsilanetriol | ESD-934205-25G |
| Cas.: 58160-99-9 | Purity: 22-25% aqueous solution | 3-Aminopropylsilanetriol | ESD-934205-100G |
| Cas.: 832079-33-1 | Purity: 97% | 1,2-BIS(TRIMETHOXYSILYL)DECANE | ESD-934206-25G |
| Cas.: 832079-33-1 | Purity: 97% | 1,2-BIS(TRIMETHOXYSILYL)DECANE | ESD-934206-100G |
| Cas.: 70942-24-4 | Purity: 30-35%inwater | 3-(TRIHYDROXYSILYL) PROPANE-1-SULFONIC ACID | ESD-934207-25G |
| Cas.: 70942-24-4 | Purity: 30-35%inwater | 3-(TRIHYDROXYSILYL) PROPANE-1-SULFONIC ACID | ESD-934207-100G |
| Cas.: 18418-53-6 | Purity: 95% | N,N-bis(3-Trimethoxysilylpropyl)urea | ESD-934208-25G |
| Cas.: 18418-53-6 | Purity: 95% | N,N-bis(3-Trimethoxysilylpropyl)urea | ESD-934208-100G |
| Cas.: 60333-76-8 | Purity: 97% | 3-PHENOXYPROPYLTRICHLOROSILANE | ESD-934209-25G |
| Cas.: 60333-76-8 | Purity: 97% | 3-PHENOXYPROPYLTRICHLOROSILANE | ESD-934209-100G |
| Cas.: 70851-52-4 | Purity: 97% | TRIACONTYLDIMETHYLCHLOROSILANE | ESD-934210-25G |
| Cas.: 70851-52-4 | Purity: 97% | TRIACONTYLDIMETHYLCHLOROSILANE | ESD-934210-100G |
| Cas.: 5162-63-0 | Purity: 95% | 1,3,5,7-TETRAMETHYL-1,3,5,7-TETRAVINYLCYCLOTETRASILAZANE | ESD-934211-25G |
| Cas.: 5162-63-0 | Purity: 95% | 1,3,5,7-TETRAMETHYL-1,3,5,7-TETRAVINYLCYCLOTETRASILAZANE | ESD-934211-100G |
| Cas.: 17945-05-0 | Purity: 97% | TRIETHOXYSILYLPROPYLETHYLCARBAMATE | ESD-934212-25G |
| Cas.: 17945-05-0 | Purity: 97% | TRIETHOXYSILYLPROPYLETHYLCARBAMATE | ESD-934212-100G |
| Cas.: 6233-20-1 | Purity: 95% | 2-CHLOROETHYLTRICHLOROSILANE | ESD-934213-25G |
| Cas.: 6233-20-1 | Purity: 95% | 2-CHLOROETHYLTRICHLOROSILANE | ESD-934213-100G |
| Cas.: 22705-33-5 | Purity: 96% | BIS(DIMETHYLAMINO)METHYLSILANE | ESD-934214-25G |
| Cas.: 22705-33-5 | Purity: 96% | BIS(DIMETHYLAMINO)METHYLSILANE | ESD-934214-100G |
| Cas.: 74695-91-3 | Purity: 95% | N-(TRIETHOXYSILYLPROPYL)-O-POLYETHYLENE OXIDE URETHANE | ESD-934215-25G |
| Cas.: 74695-91-3 | Purity: 95% | N-(TRIETHOXYSILYLPROPYL)-O-POLYETHYLENE OXIDE URETHANE | ESD-934215-100G |
| Cas.: 17886-88-3 | Purity: 97% | 4-PHENYLBUTYLTRICHLOROSILANE | ESD-934216-25G |
| Cas.: 17886-88-3 | Purity: 97% | 4-PHENYLBUTYLTRICHLOROSILANE | ESD-934216-100G |
| Cas.: 18043-74-8 | Purity: 97% | 4,7-diethoxy-4,7-dimethyl-3,8-dioxa-4,7-disiladecane | ESD-934217-25G |
| Cas.: 18043-74-8 | Purity: 97% | 4,7-diethoxy-4,7-dimethyl-3,8-dioxa-4,7-disiladecane | ESD-934217-100G |
| Cas.: 79876-59-8 | Purity: 90% | 2-Hydroxy-4-(3-triethoxysilylpropoxy)diphenylketone | ESD-934218-25G |
| Cas.: 79876-59-8 | Purity: 90% | 2-Hydroxy-4-(3-triethoxysilylpropoxy)diphenylketone | ESD-934218-100G |
| Cas.: 178884-91-8 | Purity: 97% | BIS[N,N’-(TRIETHOXYSILYLPROPYL)AMINOCARBONYL]POLYETHYLENE OXIDE (10-15 EO) | ESD-934219-25G |
| Cas.: 178884-91-8 | Purity: 97% | BIS[N,N’-(TRIETHOXYSILYLPROPYL)AMINOCARBONYL]POLYETHYLENE OXIDE (10-15 EO) | ESD-934219-100G |
| Cas.: 68128-25-6 | Purity: 97% | ((CHLOROMETHYL)PHENYLETHYL)TRIMETHOXYSILANE | ESD-934220-25G |
| Cas.: 68128-25-6 | Purity: 97% | ((CHLOROMETHYL)PHENYLETHYL)TRIMETHOXYSILANE | ESD-934220-100G |
| Cas.: 220727-26-4 | Purity: 97% | S-(OCTANOYL)MERCAPTOPPROPYLTRIETHOXYSILANE | ESD-934221-25G |
| Cas.: 220727-26-4 | Purity: 97% | S-(OCTANOYL)MERCAPTOPPROPYLTRIETHOXYSILANE | ESD-934221-100G |
| Cas.: 68440-88-0 | Purity: 97% | TETRAMETHYLAMMONIUM SILOXANOLATE | ESD-934222-25G |
| Cas.: 68440-88-0 | Purity: 97% | TETRAMETHYLAMMONIUM SILOXANOLATE | ESD-934222-100G |
| Cas.: 58274-32-1 | Purity: 97% | ((CHLOROMETHYL)PHENYLETHYL)TRICHLOROSILANE | ESD-934223-25G |
| Cas.: 58274-32-1 | Purity: 97% | ((CHLOROMETHYL)PHENYLETHYL)TRICHLOROSILANE | ESD-934223-100G |
| Cas.: 6166-86-5 | Purity: 90% | PENTAMETHYLCYCLOPENTASILOXANE | ESD-934224-25G |
| Cas.: 70851-48-8 | Purity: 97% | N-TRIACONTYLTRICHLOROSILANE | ESD-934225-25G |
| Cas.: 70851-48-8 | Purity: 97% | N-TRIACONTYLTRICHLOROSILANE | ESD-934225-100G |
| Cas.: 209866-89-7 | Purity: 90% | (2-N-BENZYLAMINOETHYL)-3-AMINOPROPYL-TRIMETHOXYSILANE | ESD-934226-25G |
| Cas.: 209866-89-7 | Purity: 90% | (2-N-BENZYLAMINOETHYL)-3-AMINOPROPYL-TRIMETHOXYSILANE | ESD-934226-100G |
| Cas.: 71363-70-7 | Purity: 97% | BIS(TRIDECAFLUORO-1,1,2,2-TETRAHYDROOCTYL)TETRAMETHYLDISILOXANE | ESD-934227-25G |
| Cas.: 71363-70-7 | Purity: 97% | BIS(TRIDECAFLUORO-1,1,2,2-TETRAHYDROOCTYL)TETRAMETHYLDISILOXANE | ESD-934227-100G |
| Cas.: 1041420-54-5 | Purity: 95% | TRIETHOXYSILYLPROPOXY(POLYETHYLENEOXY)DODECANOATE | ESD-934229-25G |
| Cas.: 1041420-54-5 | Purity: 95% | TRIETHOXYSILYLPROPOXY(POLYETHYLENEOXY)DODECANOATE | ESD-934229-100G |
| Cas.: 18418-54-7 | Purity: 97% | 1-(TRIETHOXYSILYL)-2-(DIETHOXYMETHYLSILYL)ETHANE | ESD-934230-25G |
| Cas.: 18418-54-7 | Purity: 97% | 1-(TRIETHOXYSILYL)-2-(DIETHOXYMETHYLSILYL)ETHANE | ESD-934230-100G |
| Cas.: 5089-28-1 | Purity: 95% | 1,8-BIS(CHLORODIMETHYLSILYL)OCTANE | ESD-934231-25G |
| Cas.: 5089-28-1 | Purity: 95% | 1,8-BIS(CHLORODIMETHYLSILYL)OCTANE | ESD-934231-100G |
| Cas.: 690-56-2 | Purity: 97% | BIS(TRIFLUOROPROPYL)TETRAMETHYLDISILOXANE | ESD-934232-25G |
| Cas.: 690-56-2 | Purity: 97% | BIS(TRIFLUOROPROPYL)TETRAMETHYLDISILOXANE | ESD-934232-100G |
| Cas.: 15990-66-6 | Purity: 97% | TETRAKIS(TRIMETHYLSILOXY)TITANIUM | ESD-934233-25G |
| Cas.: 15990-66-6 | Purity: 97% | TETRAKIS(TRIMETHYLSILOXY)TITANIUM | ESD-934233-100G |
| Cas.: 34396-03-7 | Purity: 97% | ISOOCTYLTRIMETHOXYSILANE | ESD-934234-25G |
| Cas.: 34396-03-7 | Purity: 97% | ISOOCTYLTRIMETHOXYSILANE | ESD-934234-100G |
| Cas.: 80750-05-6 | Purity: 97% | METHACRYLOXYPROPYLTRIISOPROPOXYSILANE | ESD-934235-25G |
| Cas.: 80750-05-6 | Purity: 97% | METHACRYLOXYPROPYLTRIISOPROPOXYSILANE | ESD-934235-100G |
| Cas.: 55494-04-7 | Purity: 97% | BIS(TRIMETHYLSILYL)ITACONATE | ESD-934236-25G |
| Cas.: 55494-04-7 | Purity: 97% | BIS(TRIMETHYLSILYL)ITACONATE | ESD-934236-100G |
| Cas.: 760-32-7 | Purity: 97% | DIETHYLMETHYLSILANE | ESD-934237-25G |
| Cas.: 760-32-7 | Purity: 97% | DIETHYLMETHYLSILANE | ESD-934237-100G |
| Cas.: 17622-94-5 | Purity: 90% | TETRAGLYCOLATOSILANE | ESD-934238-25G |
| Cas.: 17622-94-5 | Purity: 90% | TETRAGLYCOLATOSILANE | ESD-934238-100G |
| Cas.: 104275-58-3 | Purity: 97% | N-(3-TRIETHOXYSILYLPROPYL)GLUCONAMIDE | ESD-934239-25G |
| Cas.: 104275-58-3 | Purity: 97% | N-(3-TRIETHOXYSILYLPROPYL)GLUCONAMIDE | ESD-934239-100G |
| Cas.: 68951-97-3 | Purity: Viscosity 5-12cSt (25 °C) | METHOXY TERMINATED POLYDIMETHYLSILOXANE | ESD-934240-25G |
| Cas.: 68951-97-3 | Purity: Viscosity 5-12cSt (25 °C) | METHOXY TERMINATED POLYDIMETHYLSILOXANE | ESD-934240-100G |
| Cas.: 195158-81-7 | Purity: Viscosity 8-12cSt (25 °C) | TRIETHOXYSILYLETHYL TERMINATED POLYDIMETHYLSILOXANE | ESD-934241-25G |
| Cas.: 195158-81-7 | Purity: Viscosity 8-12cSt (25 °C) | TRIETHOXYSILYLETHYL TERMINATED POLYDIMETHYLSILOXANE | ESD-934241-100G |
| Cas.: 161205-23-8 | Purity: Viscosity 75-100cSt (25 °C) | SUCCINIC ANHYDRIDE TERMINATED POLYDIMETHYLSILOXANE | ESD-934242-25G |
| Cas.: 161205-23-8 | Purity: Viscosity 75-100cSt (25 °C) | SUCCINIC ANHYDRIDE TERMINATED POLYDIMETHYLSILOXANE | ESD-934242-100G |
| Cas.: 69669-36-9 | Purity: Viscosity 4000-5000cSt (25 °C) | [2-3% (EPOXYCYCLOHEXYLETHYL)METHYLSILOXANE] (10-15% METHOXYPOLYALKYLENEOXYMETHYLSILOXANE) DIMETHYLSILOXANE TERPOLYMER | ESD-934243-25G |
| Cas.: 69669-36-9 | Purity: Viscosity 4000-5000cSt (25 °C) | [2-3% (EPOXYCYCLOHEXYLETHYL)METHYLSILOXANE] (10-15% METHOXYPOLYALKYLENEOXYMETHYLSILOXANE) DIMETHYLSILOXANE TERPOLYMER | ESD-934243-100G |
| Cas.: 68440-71-1 | Purity: Viscosity 200-300cSt (25 °C) | [5-7% (EPOXYPROPOXYPROPYL)METHYLSILOXANE] – DIMETHYLSILOXANE COPOLYMER | ESD-934244-25G |
| Cas.: 68440-71-1 | Purity: Viscosity 200-300cSt (25 °C) | [5-7% (EPOXYPROPOXYPROPYL)METHYLSILOXANE] – DIMETHYLSILOXANE COPOLYMER | ESD-934244-100G |
| Cas.: 115361-68-7 | Purity: Viscosity 140-200cSt (25 °C) | (48-52% TRIFLUOROPROPYLMETHYLSILOXANE) (48-52% DIMETHYLSILOXANE) COPOLYMER | ESD-934245-25G |
| Cas.: 115361-68-7 | Purity: Viscosity 140-200cSt (25 °C) | (48-52% TRIFLUOROPROPYLMETHYLSILOXANE) (48-52% DIMETHYLSILOXANE) COPOLYMER | ESD-934245-100G |
| Cas.: 882878-48-0 | Purity: Viscosity 8-12cSt (25 °C) | (25-35% NONAFLUOROHEXYLMETHYLSILOXANE) (65-75% DIMETHYLSILOXANE) COPOLYMER | ESD-934246-25G |
| Cas.: 882878-48-0 | Purity: Viscosity 8-12cSt (25 °C) | (25-35% NONAFLUOROHEXYLMETHYLSILOXANE) (65-75% DIMETHYLSILOXANE) COPOLYMER | ESD-934246-100G |
| Cas.: 115340-95-9 | Purity: Viscosity 400-7000cSt (25 °C) | (15-20% TRIDECAFLUOROOCTYLMETHYLSILOXANE) – (80-85% DIMETHYLSILOXANE) COPOLYMER | ESD-934247-25G |
| Cas.: 115340-95-9 | Purity: Viscosity 400-7000cSt (25 °C) | (15-20% TRIDECAFLUOROOCTYLMETHYLSILOXANE) – (80-85% DIMETHYLSILOXANE) COPOLYMER | ESD-934247-100G |
| Cas.: 68607-77-2 | Purity: Viscosity 50-160cSt (25 °C) | SILANOL TERMINATED POLYTRIFLUOROPROPYLMETHYLSILOXANE | ESD-934248-25G |
| Cas.: 68607-77-2 | Purity: Viscosity 50-160cSt (25 °C) | SILANOL TERMINATED POLYTRIFLUOROPROPYLMETHYLSILOXANE | ESD-934248-100G |
| Cas.: 1988741-30-5 | Purity: Viscosity 500-1000cSt (25 °C) | POLYTRIFLUOROPROPYLMETHYLSILOXANE, HYDRIDE TERMINATED | ESD-934249-25G |
| Cas.: 1988741-30-5 | Purity: Viscosity 500-1000cSt (25 °C) | POLYTRIFLUOROPROPYLMETHYLSILOXANE, HYDRIDE TERMINATED | ESD-934249-100G |
| Cas.: 908858-79-7 | Purity: Viscosity 5-15cSt (25 °C) | CHLORINE TERMINATED NONAFLUOROHEXYLMETHYLSILOXANE – DIMETHYLSILOXANE COPOLYMER | ESD-934250-25G |
| Cas.: 908858-79-7 | Purity: Viscosity 5-15cSt (25 °C) | CHLORINE TERMINATED NONAFLUOROHEXYLMETHYLSILOXANE – DIMETHYLSILOXANE COPOLYMER | ESD-934250-100G |
| Cas.: 68951-98-4 | Purity: Viscosity 4000-6000cSt (25 °C) | VINYL TERMINATED (35-45% TRIFLUOROPROPYLMETHYLSILOXANE) – DIMETHYLSILOXANE COPOLYMER | ESD-934251-25G |
| Cas.: 68951-98-4 | Purity: Viscosity 4000-6000cSt (25 °C) | VINYL TERMINATED (35-45% TRIFLUOROPROPYLMETHYLSILOXANE) – DIMETHYLSILOXANE COPOLYMER | ESD-934251-100G |
| Cas.: 609768-44-7 | (20-25% NONAFLUOROHEXYLMETHYLSILOXANE) – (75-80% DIMETHYLSILOXANE) copolymer, VINYL TERMINATED | ESD-934252-25G | |
| Cas.: 609768-44-7 | (20-25% NONAFLUOROHEXYLMETHYLSILOXANE) – (75-80% DIMETHYLSILOXANE) copolymer, VINYL TERMINATED | ESD-934252-100G | |
| Cas.: 68554-69-8 | Purity: Viscosity 30-80cSt (25 °C) | (25-30% METHYLHYDROSILOXANE) – OCTYLMETHYLSILOXANE COPOLYMER | ESD-934253-25G |
| Cas.: 68554-69-8 | Purity: Viscosity 30-80cSt (25 °C) | (25-30% METHYLHYDROSILOXANE) – OCTYLMETHYLSILOXANE COPOLYMER | ESD-934253-100G |
| Cas.: 1313730-25-4 | Purity: Viscosity 20-60cSt (25 °C) | (25-30% METHYLHYDROSILOXANE) – (30-35% OCTYLMETHYLSILOXANE) DIMETHYLHYDROSILOXANE TERPOLYMER | ESD-934254-25G |
| Cas.: 1313730-25-4 | Purity: Viscosity 20-60cSt (25 °C) | (25-30% METHYLHYDROSILOXANE) – (30-35% OCTYLMETHYLSILOXANE) DIMETHYLHYDROSILOXANE TERPOLYMER | ESD-934254-100G |
| Cas.: 115487-49-5 | Purity: Viscosity 75-110cSt (25 °C) | (45-50% METHYLHYDROSILOXANE) – PHENYLMETHYLSILOXANE COPOLYMER, HYDRIDE TERMINATED | ESD-934255-25G |
| Cas.: 115487-49-5 | Purity: Viscosity 75-110cSt (25 °C) | (45-50% METHYLHYDROSILOXANE) – PHENYLMETHYLSILOXANE COPOLYMER, HYDRIDE TERMINATED | ESD-934255-100G |
| Cas.: 68988-57-8 | Purity: Viscosity 6-8cSt (25 °C) | HYDRIDE Q RESIN | ESD-934256-25G |
| Cas.: 68988-57-8 | Purity: Viscosity 6-8cSt (25 °C) | HYDRIDE Q RESIN | ESD-934256-100G |
| Cas.: 70900-20-8 | Purity: Viscosity 300-450cSt (25 °C) | [14-16% (CHLOROPROPYL)METHYLSILOXANE] – DIMETHYLSILOXANE COPOLYMER | ESD-934257-25G |
| Cas.: 70900-20-8 | Purity: Viscosity 300-450cSt (25 °C) | [14-16% (CHLOROPROPYL)METHYLSILOXANE] – DIMETHYLSILOXANE COPOLYMER | ESD-934257-100G |
| Cas.: 207308-30-3 | Purity: Viscosity 15-20cSt (25 °C) | Monocarbinol Terminated Polydimethylsiloxane, Asymmetric | ESD-934258-25G |
| Cas.: 207308-30-3 | Purity: Viscosity 15-20cSt (25 °C) | Monocarbinol Terminated Polydimethylsiloxane, Asymmetric | ESD-934258-100G |
| Cas.: 218131-11-4 | Purity: Viscosity 50-60cSt (25 °C) | MONODICARBINOL TERMINATED POLYDIMETHYLSILOXANE, asymmetric | ESD-934259-25G |
| Cas.: 218131-11-4 | Purity: Viscosity 50-60cSt (25 °C) | MONODICARBINOL TERMINATED POLYDIMETHYLSILOXANE, asymmetric | ESD-934259-100G |
| Cas.: 127947-26-6 | Purity: Viscosity 120cSt (25 °C) | (2,3-Epoxy) n-propyl monoether-terminated, polydimethylsiloxane | ESD-934260-25G |
| Cas.: 127947-26-6 | Purity: Viscosity 120cSt (25 °C) | (2,3-Epoxy) n-propyl monoether-terminated, polydimethylsiloxane | ESD-934260-100G |
| Cas.: 1038821-58-7 | Purity: Viscosity 8-12cSt (25 °C) | MONOHYDRIDE TERMINATED POLYDIMETHYLSILOXANE, asymmetric | ESD-934261-25G |
| Cas.: 1038821-58-7 | Purity: Viscosity 8-12cSt (25 °C) | MONOHYDRIDE TERMINATED POLYDIMETHYLSILOXANE, asymmetric | ESD-934261-100G |
| Cas.: 1283601-14-8 | Purity: Viscosity 7-8cSt (25 °C) | MONOANISYL TERMINATED POLYDIMETHYLSILOXANE | ESD-934262-25G |
| Cas.: 1283601-14-8 | Purity: Viscosity 7-8cSt (25 °C) | MONOANISYL TERMINATED POLYDIMETHYLSILOXANE | ESD-934262-100G |
| Cas.: 1283601-16-0 | Purity: Viscosity 7-8cSt (25 °C) | MONOLIMONENYLTERMINATEDPOLYDIMETHYLSILOXAN | ESD-934263-25G |
| Cas.: 1283601-16-0 | Purity: Viscosity 7-8cSt (25 °C) | MONOLIMONENYLTERMINATEDPOLYDIMETHYLSILOXAN | ESD-934263-100G |
| Cas.: 68951-99-5 | Purity: Viscosity 80-120cSt (25 °C) | MONOVINYL TERMINATED POLYDIMETHYLSILOXANE, asymmetric | ESD-934264-25G |
| Cas.: 68951-99-5 | Purity: Viscosity 80-120cSt (25 °C) | MONOVINYL TERMINATED POLYDIMETHYLSILOXANE, asymmetric | ESD-934264-100G |
| Cas.: 868684-55-3 | Purity: Viscosity 7-9cSt (25 °C) | MONOMETHACRYLOXYPROPYL FUNCTIONAL POLYDIMETHYLSILOXANE, symmetric | ESD-934265-25G |
| Cas.: 868684-55-3 | Purity: Viscosity 7-9cSt (25 °C) | MONOMETHACRYLOXYPROPYL FUNCTIONAL POLYDIMETHYLSILOXANE, symmetric | ESD-934265-100G |
| Cas.: 67762-94-1 | Purity: Viscosity 800-1200cSt (25 °C) | (7.0-8.0% VINYLMETHYLSILOXANE) – DIMETHYLSILOXANE COPOLYMER, TRIMETHYLSILOXY TERMINATED | ESD-934266-25G |
| Cas.: 67762-94-1 | Purity: Viscosity 800-1200cSt (25 °C) | (7.0-8.0% VINYLMETHYLSILOXANE) – DIMETHYLSILOXANE COPOLYMER, TRIMETHYLSILOXY TERMINATED | ESD-934266-100G |
| Cas.: 1581252-46-1 | Purity: Viscosity 30-40cSt (25 °C) | monoVINYL FUNCTIONAL POLYDIMETHYLSILOXANE, TETRAHYDROFURFURYLOXYPROPYL TERMINATED – symmetric | ESD-934267-25G |
| Cas.: 1581252-46-1 | Purity: Viscosity 30-40cSt (25 °C) | monoVINYL FUNCTIONAL POLYDIMETHYLSILOXANE, TETRAHYDROFURFURYLOXYPROPYL TERMINATED – symmetric | ESD-934267-100G |
| Cas.: 1586018-77-0 | Purity: Viscosity 40-60cSt (25 °C) | MONOVINYL FUNCTIONAL POLYDIMETHYLSILOXANE, METHOXY(DIETHYLENEOXIDE)PROPYL TERMINATED, symmetric | ESD-934268-25G |
| Cas.: 1586018-77-0 | Purity: Viscosity 40-60cSt (25 °C) | MONOVINYL FUNCTIONAL POLYDIMETHYLSILOXANE, METHOXY(DIETHYLENEOXIDE)PROPYL TERMINATED, symmetric | ESD-934268-100G |
| Cas.: 90393-83-2 | Purity: 95% | TRIS(GLYCIDOXYPROPYLDIMETHYLSILOXY)PHENYLSILANE | ESD-934269-25G |
| Cas.: 90393-83-2 | Purity: 95% | TRIS(GLYCIDOXYPROPYLDIMETHYLSILOXY)PHENYLSILANE | ESD-934269-100G |
| Cas.: 68037-74-1 | Purity: Viscosity 50-80cSt (25 °C) | METHYL-T-BRANCHED POLYDIMETHYLSILOXANE | ESD-934270-25G |
| Cas.: 68037-74-1 | Purity: Viscosity 50-80cSt (25 °C) | METHYL-T-BRANCHED POLYDIMETHYLSILOXANE | ESD-934270-100G |
| Cas.: 63148-59-4 | SILANOL TERMINATED POLYDIPHENYLSILOXANE | ESD-934271-25G | |
| Cas.: 63148-59-4 | SILANOL TERMINATED POLYDIPHENYLSILOXANE | ESD-934271-100G | |
| Cas.: 25498-02-6 | Purity: Viscosity 6-9cSt (25 °C) | TETRAMETHOXYSILANE, oligomeric hydrolysate | ESD-934272-25G |
| Cas.: 25498-02-6 | Purity: Viscosity 6-9cSt (25 °C) | TETRAMETHOXYSILANE, oligomeric hydrolysate | ESD-934272-100G |
| Cas.: 30107-43-8 | POLY(DIMETHYLSILANE) | ESD-934273-10G | |
| Cas.: 30107-43-8 | POLY(DIMETHYLSILANE) | ESD-934273-100G | |
| Cas.: 67762-83-8 | Purity: viscosity 20-50 cSt (25 C) | (27-33% OCTADECYLMETHYLSILOXANE)-(DIMETHYLSILOXANE) COPOLYMER | ESD-934274-25G |
| Cas.: 67762-83-8 | Purity: viscosity 20-50 cSt (25 C) | (27-33% OCTADECYLMETHYLSILOXANE)-(DIMETHYLSILOXANE) COPOLYMER | ESD-934274-100G |
| Cas.: 175779-55-2 | Purity: viscosity 2000-4000 cSt (25 C) | (1-2% TRIACONTYLMETHYLSILOXANE)-(DIMETHYLSILOXANE) COPOLYMER | ESD-934275-25G |
| Cas.: 175779-55-2 | Purity: viscosity 2000-4000 cSt (25 C) | (1-2% TRIACONTYLMETHYLSILOXANE)-(DIMETHYLSILOXANE) COPOLYMER | ESD-934275-100G |
| Cas.: 117440-21-8 | Purity: viscosity 80-120cSt (25 C) | Acryloxy Terminated Ethyleneoxide Dimethylsiloxane-Ethyleneoxide Aba Block Copolymer | ESD-934276-25G |
| Cas.: 117440-21-8 | Purity: viscosity 80-120cSt (25 C) | Acryloxy Terminated Ethyleneoxide Dimethylsiloxane-Ethyleneoxide Aba Block Copolymer | ESD-934276-100G |
| Cas.: 161755-53-9 | Purity: viscosity 200-300cSt (25 C) | YDROXYALKYLTERMINATEDPOLY(PROPYLENEOXY)-POLYDIMETHYLSILOXANEBLOCKCOPOLYMER | ESD-934277-25G |
| Cas.: 161755-53-9 | Purity: viscosity 200-300cSt (25 C) | YDROXYALKYLTERMINATEDPOLY(PROPYLENEOXY)-POLYDIMETHYLSILOXANEBLOCKCOPOLYMER | ESD-934277-100G |
| Cas.: 26710-23-6 | Purity: viscosity 150-250cSt (25 C) | VINYL TERMNATED (70-80% POLYDIMETHYLSILOXANE)-ETHYLENE COPOLYMER | ESD-934278-25G |
| Cas.: 26710-23-6 | Purity: viscosity 150-250cSt (25 C) | VINYL TERMNATED (70-80% POLYDIMETHYLSILOXANE)-ETHYLENE COPOLYMER | ESD-934278-100G |
| Cas.: 1035218-85-9 | Purity: viscosity 80-120cSt (25 C) | (75-76%POLYDIMETHYLSILOXANE)-ETHYLENECOPOLYMER | ESD-934279-25G |
| Cas.: 1035218-85-9 | Purity: viscosity 80-120cSt (25 C) | (75-76%POLYDIMETHYLSILOXANE)-ETHYLENECOPOLYMER | ESD-934279-100G |
| Cas.: 63148-61-8 | Purity: viscosity 40-50cSt (25 C) | POLYDIETHYLSILOXANE, TRIETHYLSILOXY TERMINATED | ESD-934280-25G |
| Cas.: 63148-61-8 | Purity: viscosity 40-50cSt (25 C) | POLYDIETHYLSILOXANE, TRIETHYLSILOXY TERMINATED | ESD-934280-100G |
| Cas.: 1417861-92-7 | Purity: viscosity 10-15cSt (25 C) | BUTYLTERMINATEDPOLYDIMETHYLSILOXANE | ESD-934281-25G |
| Cas.: 1417861-92-7 | Purity: viscosity 10-15cSt (25 C) | BUTYLTERMINATEDPOLYDIMETHYLSILOXANE | ESD-934281-100G |
| Cas.: 128446-57-1 | Purity: viscosity 20-30cSt (25 C) | OCTADECYL TERMINATED POLYDIMETHYLSILOXANE | ESD-934282-25G |
| Cas.: 128446-57-1 | Purity: viscosity 20-30cSt (25 C) | OCTADECYL TERMINATED POLYDIMETHYLSILOXANE | ESD-934282-100G |
| Cas.: 254891-17-3 | Purity: viscosity 32-40 cSt (25 C) | N-Ethylaminoisobutyl Terminated Polydimethylsiloxane | ESD-934283-25G |
| Cas.: 254891-17-3 | Purity: viscosity 32-40 cSt (25 C) | N-Ethylaminoisobutyl Terminated Polydimethylsiloxane | ESD-934283-100G |
| Cas.: 104780-66-7 | Purity: viscosity 50-65cSt (25 C) | CARBINOL (HYDROXYL) TERMINATED POLYDIMETHYLSILOXANE | ESD-934284-25G |
| Cas.: 104780-66-7 | Purity: viscosity 50-65cSt (25 C) | CARBINOL (HYDROXYL) TERMINATED POLYDIMETHYLSILOXANE | ESD-934284-100G |
| Cas.: 158465-54-4 | Purity: viscosity 2000-4000 cSt (25 C) | DIACETOXYMETHYL TERMINATED POLYDIMETHYLSILOXANE | ESD-934285-25G |
| Cas.: 158465-54-4 | Purity: viscosity 2000-4000 cSt (25 C) | DIACETOXYMETHYL TERMINATED POLYDIMETHYLSILOXANE | ESD-934285-100G |
| Cas.: 188958-73-8 | Purity: viscosity 80-120cSt (25 C) | (EPOXYPROPOXYPROPYL)DIMETHOXYSILYL TERMINATED POLYDIMETHYLSILOXANE | ESD-934286-25G |
| Cas.: 188958-73-8 | Purity: viscosity 80-120cSt (25 C) | (EPOXYPROPOXYPROPYL)DIMETHOXYSILYL TERMINATED POLYDIMETHYLSILOXANE | ESD-934286-100G |
| Cas.: 70851-25-1 | Purity: viscosity 5-10cSt (25 C) | ETHOXY TERMINATED POLYDIMETHYLSILOXANE | ESD-934287-25G |
| Cas.: 70851-25-1 | Purity: viscosity 5-10cSt (25 C) | ETHOXY TERMINATED POLYDIMETHYLSILOXANE | ESD-934287-100G |
| Cas.: 1421601-23-1 | Purity: 97% | 1-(Aminomethyl)cyclopropanecarboxylic acid hydrochloride | ESD-934288-25MG |
| Cas.: 1421601-23-1 | Purity: 97% | 1-(Aminomethyl)cyclopropanecarboxylic acid hydrochloride | ESD-934288-50MG |
| Cas.: 445490-78-8 | Purity: 98% | tert-Butyl 7-(2-hydroxyethyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxylate | ESD-934289-25MG |
| Cas.: 445490-78-8 | Purity: 98% | tert-Butyl 7-(2-hydroxyethyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxylate | ESD-934289-50MG |
| Cas.: 88398-97-4 | Purity: 97% | 1-Methyl-1H-pyrazole-3-sulfonamide | ESD-934290-10MG |
| Cas.: 88398-97-4 | Purity: 97% | 1-Methyl-1H-pyrazole-3-sulfonamide | ESD-934290-50MG |
| Cas.: 65625-39-0 | Purity: 95% | ACETOXYMETHYLTRIMETHOXYSILANE | ESD-934291-10G |
| Cas.: 65625-39-0 | Purity: 95% | ACETOXYMETHYLTRIMETHOXYSILANE | ESD-934291-50G |
| Cas.: 31024-46-1 | Purity: 95% | 3-(N-ALLYLAMINO)PROPYLTRIMETHOXYSILANE | ESD-934292-10G |
| Cas.: 31024-46-1 | Purity: 95% | 3-(N-ALLYLAMINO)PROPYLTRIMETHOXYSILANE | ESD-934292-50G |
| Cas.: 3069-30-5 | Purity: 95% | 4-AMINOBUTYLTRIETHOXYSILANE | ESD-934293-10G |
| Cas.: 3069-30-5 | Purity: 95% | 4-AMINOBUTYLTRIETHOXYSILANE | ESD-934293-50G |
| Cas.: 55648-29-8 | Purity: 95% | 3-(3-AMINOPHENOXY)PROPYLTRIMETHOXYSILANE | ESD-934294-10G |
| Cas.: 55648-29-8 | Purity: 95% | 3-(3-AMINOPHENOXY)PROPYLTRIMETHOXYSILANE | ESD-934294-50G |
| Cas.: 27326-65-4 | Purity: 97% | 2-(2-PYRIDYL)ETHYLTRIMETHOXYSILANE | ESD-934295-10G |
| Cas.: 27326-65-4 | Purity: 97% | 2-(2-PYRIDYL)ETHYLTRIMETHOXYSILANE | ESD-934295-50G |
| Cas.: 156214-80-1 | Purity: 97% | N-(3-TRIETHOXYSILYLPROPYL)-4-HYDROXYBUTYRAMIDE | ESD-934296-10G |
| Cas.: 156214-80-1 | Purity: 97% | N-(3-TRIETHOXYSILYLPROPYL)-4-HYDROXYBUTYRAMIDE | ESD-934296-50G |
| Cas.: 54586-78-6 | Purity: 97% | METHACRYLOXYMETHYLTRIMETHOXYSILANE | ESD-934297-10G |
| Cas.: 54586-78-6 | Purity: 97% | METHACRYLOXYMETHYLTRIMETHOXYSILANE | ESD-934297-50G |
| Cas.: 17043-05-9 | Purity: 97% | BROMOPHENYLTRIMETHOXYSILANE | ESD-934298-10G |
| Cas.: 17043-05-9 | Purity: 97% | BROMOPHENYLTRIMETHOXYSILANE | ESD-934298-50G |
| Cas.: 14319-64-3 | Purity: 95% | NORBORNENYLETHYLTRICHLOROSILANE | ESD-934299-10G |
| Cas.: 14319-64-3 | Purity: 95% | NORBORNENYLETHYLTRICHLOROSILANE | ESD-934299-50G |
| Cas.: 52217-52-4 | Purity: 95% | 7-OCTENYLTRICHLOROSILANE | ESD-934300-10G |
| Cas.: 52217-52-4 | Purity: 95% | 7-OCTENYLTRICHLOROSILANE | ESD-934300-50G |
| Cas.: 18586-22-6 | Purity: 97% | 1,5-DIVINYL-3,3-DIPHENYL-1,1,5,5-TETRA-METHYLTRISILOXANE | ESD-934301-10G |
| Cas.: 18586-22-6 | Purity: 97% | 1,5-DIVINYL-3,3-DIPHENYL-1,1,5,5-TETRA-METHYLTRISILOXANE | ESD-934301-50G |
| Cas.: 17704-22-2 | Purity: 95% | PENTAVINYLPENTAMETHYLCYCLOPENTASILOXANE | ESD-934302-10G |
| Cas.: 17704-22-2 | Purity: 95% | PENTAVINYLPENTAMETHYLCYCLOPENTASILOXANE | ESD-934302-50G |
| Cas.: 266317-71-9 | Purity: 95% | bis(trimethoxysilylethyl)benzene | ESD-934303-10G |
| Cas.: 266317-71-9 | Purity: 95% | bis(trimethoxysilylethyl)benzene | ESD-934303-50G |
| Cas.: 17963-04-1 | Purity: 97% | (3-GLYCIDOXYPROPYL)DIMETHYLETHOXYSILANE | ESD-934304-10G |
| Cas.: 17963-04-1 | Purity: 97% | (3-GLYCIDOXYPROPYL)DIMETHYLETHOXYSILANE | ESD-934304-50G |
| Cas.: 18245-29-9 | Purity: 97% | 2-(BICYCLOHEPTYL)TRICHLOROSILANE | ESD-934305-10G |
| Cas.: 18245-29-9 | Purity: 97% | 2-(BICYCLOHEPTYL)TRICHLOROSILANE | ESD-934305-50G |
| Cas.: 18419-53-9 | Purity: 97% | DIPHENYLVINYLCHLOROSILANE | ESD-934306-10G |
| Cas.: 18419-53-9 | Purity: 97% | DIPHENYLVINYLCHLOROSILANE | ESD-934306-50G |
| Cas.: 41919-30-6 | Purity: 97% | CHLOROMETHYLTRIS(TRIMETHYLSILOXY)SILANE | ESD-934307-10G |
| Cas.: 41919-30-6 | Purity: 97% | CHLOROMETHYLTRIS(TRIMETHYLSILOXY)SILANE | ESD-934307-50G |
| Cas.: 82209-74-3 | Purity: ≥98% | Andrograpanin | ESD-934308-10MG |
| Cas.: 82209-74-3 | Purity: ≥98% | Andrograpanin | ESD-934308-25MG |
| Cas.: 59004-18-1 | Purity: 97% | ACETOXYPROPYLTRIMETHOXYSILANE | ESD-934309-5G |
| Cas.: 59004-18-1 | Purity: 97% | ACETOXYPROPYLTRIMETHOXYSILANE | ESD-934309-25G |
| Cas.: 177617-17-3 | Purity: 90% | (3-ACRYLOXYPROPYL)METHYLBIS(TRIMETHYLSILOXY)SILANE | ESD-934310-5G |
| Cas.: 177617-17-3 | Purity: 90% | (3-ACRYLOXYPROPYL)METHYLBIS(TRIMETHYLSILOXY)SILANE | ESD-934310-25G |
| Cas.: 38595-89-0 | Purity: 97% | 3-(Trichlorosilyl)propyl acrylate | ESD-934311-5G |
| Cas.: 38595-89-0 | Purity: 97% | 3-(Trichlorosilyl)propyl acrylate | ESD-934311-25G |
| Cas.: 37843-11-1 | Purity: 97% | ADAMANTYLETHYLTRICHLOROSILANE | ESD-934312-5G |
| Cas.: 37843-11-1 | Purity: 97% | ADAMANTYLETHYLTRICHLOROSILANE | ESD-934312-25G |
| Cas.: 1745-72-8 | Purity: 90% | DIVINYLDICHLOROSILANE | ESD-934313-5G |
| Cas.: 1745-72-8 | Purity: 90% | DIVINYLDICHLOROSILANE | ESD-934313-25G |
| Cas.: 117559-36-1 | Purity: 97% | 3-AMINOPROPYLDIISOPROPYLETHOXYSILAN | ESD-934314-5G |
| Cas.: 117559-36-1 | Purity: 97% | 3-AMINOPROPYLDIISOPROPYLETHOXYSILAN | ESD-934314-25G |
| Cas.: 42292-18-2 | Purity: 95% | Aminopropylbis(trimethylsiloxy)methylsilane | ESD-934315-5ML |
| Cas.: 42292-18-2 | Purity: 95% | Aminopropylbis(trimethylsiloxy)methylsilane | ESD-934315-25ML |
| Cas.: 1223-16-1 | Purity: 95% | BIS(P-AMINOPHENOXY)DIMETHYLSILANE | ESD-934316-5G |
| Cas.: 1223-16-1 | Purity: 95% | BIS(P-AMINOPHENOXY)DIMETHYLSILANE | ESD-934316-25G |
| Cas.: 28595-67-7 | Purity: 97% | Germanium(II) chloride dioxane complex (1:1) | ESD-934317-5G |
| Cas.: 28595-67-7 | Purity: 97% | Germanium(II) chloride dioxane complex (1:1) | ESD-934317-25G |
| Cas.: 1481-41-0 | Purity: 95% (GC) | CHLORODIMETHYL-3,3,3-TRIFLUOROPROPYLSILANE | ESD-934318-5G |
| Cas.: 1481-41-0 | Purity: 95% (GC) | CHLORODIMETHYL-3,3,3-TRIFLUOROPROPYLSILANE | ESD-934318-25G |
| Cas.: 80722-63-0 | Purity: 95% | 1,3-BIS(3-METHACRYLOXYPROPYL)TETRAKIS(TRIMETHYLSILOXY)DISILOXANE | ESD-934319-5G |
| Cas.: 80722-63-0 | Purity: 95% | 1,3-BIS(3-METHACRYLOXYPROPYL)TETRAKIS(TRIMETHYLSILOXY)DISILOXANE | ESD-934319-25G |
| Cas.: 73018-55-0 | Purity: 97% | PLATINUM CARBONYL CYCLOVINYLMETHYLSILOXANE COMPLEX | ESD-934320-5G |
| Cas.: 73018-55-0 | Purity: 97% | PLATINUM CARBONYL CYCLOVINYLMETHYLSILOXANE COMPLEX | ESD-934320-25G |
| Cas.: 3937-28-8 | Purity: 97% | ALLYLDICHLOROSILANE | ESD-934321-5G |
| Cas.: 3937-28-8 | Purity: 97% | ALLYLDICHLOROSILANE | ESD-934321-25G |
| Cas.: 137376-38-6 | Purity: 97% | (3-TRIETHOXYSILYLPROPYL)-T-BUTYLCARBAMATE | ESD-934322-5G |
| Cas.: 137376-38-6 | Purity: 97% | (3-TRIETHOXYSILYLPROPYL)-T-BUTYLCARBAMATE | ESD-934322-25G |
| Cas.: 66817-59-2 | Purity: 95% | 1,3-DIPHENYL-1,1,3,3-TETRAKIS(DIMETHYLSILOXY)DISILOXANE | ESD-934323-5G |
| Cas.: 66817-59-2 | Purity: 95% | 1,3-DIPHENYL-1,1,3,3-TETRAKIS(DIMETHYLSILOXY)DISILOXANE | ESD-934323-25G |
| Cas.: 145686-74-4 | Purity: viscosity 1000-4000 cSt (25 C) | DODECYLMETHYLSILOXANE-HYDROXYPOLYALKYLENEOXYPROPYL METHYLSILOXANE COPOLYMER | ESD-934324-5G |
| Cas.: 145686-74-4 | Purity: viscosity 1000-4000 cSt (25 C) | DODECYLMETHYLSILOXANE-HYDROXYPOLYALKYLENEOXYPROPYL METHYLSILOXANE COPOLYMER | ESD-934324-25G |
| Cas.: 125997-17-3 | Purity: 95% | 3-{2-[ACETOXY(POLYETHYLENEOXY)PROPYL]}HEPTAMETHYLTRISILOXANE | ESD-934325-5G |
| Cas.: 125997-17-3 | Purity: 95% | 3-{2-[ACETOXY(POLYETHYLENEOXY)PROPYL]}HEPTAMETHYLTRISILOXANE | ESD-934325-25G |
| Cas.: 120359-07-1 | MW: 7000-8000 | CARBINOL (HYDROXYL) TERMINATED POLYDIMETHYLSILOX | ESD-934326-5G |
| Cas.: 120359-07-1 | MW: 7000-8000 | CARBINOL (HYDROXYL) TERMINATED POLYDIMETHYLSILOX | ESD-934326-25G |
| Cas.: 1361237-41-3 | Purity: 97% | 3-(TETRAHYDROFURFURYLOXYPROPYL)HEPTAMETHYLTRISILOXANE | ESD-934327-5G |
| Cas.: 1361237-41-3 | Purity: 97% | 3-(TETRAHYDROFURFURYLOXYPROPYL)HEPTAMETHYLTRISILOXANE | ESD-934327-25G |
| Cas.: 102782-98-9 | Purity: viscosity 25-35cSt (25 C) | EPOXYCYCLOHEXYLETHYL TERMINATED POLYDIMETHYLSILOXANE | ESD-934328-5G |
| Cas.: 102782-98-9 | Purity: viscosity 25-35cSt (25 C) | EPOXYCYCLOHEXYLETHYL TERMINATED POLYDIMETHYLSILOXANE | ESD-934328-25G |
| Cas.: 158465-60-2 | Purity: viscosity 100-150 cSt (25 C) | CHLOROMETHYL TERMINATED POLYDIMETHYLSILOXANE | ESD-934329-5G |
| Cas.: 158465-60-2 | Purity: viscosity 100-150 cSt (25 C) | CHLOROMETHYL TERMINATED POLYDIMETHYLSILOXANE | ESD-934329-25G |
| Cas.: 67762-92-9 | Purity: viscosity 15-30cSt (25 C) | DIMETHYLAMINO TERMINATED POLYDIMETHYLSILOXANE | ESD-934330-5G |
| Cas.: 67762-92-9 | Purity: viscosity 15-30cSt (25 C) | DIMETHYLAMINO TERMINATED POLYDIMETHYLSILOXANE | ESD-934330-25G |
| Cas.: 1263044-00-3 | Purity: viscosity 4-5cSt (25 C) | LIMONENYLTRISILOXANE | ESD-934331-5G |
| Cas.: 1263044-00-3 | Purity: viscosity 4-5cSt (25 C) | LIMONENYLTRISILOXANE | ESD-934331-25G |
| Cas.: 22089-12-9 | Purity: ≥98% | 1-(2,5-Dihydroxy-4-methoxyphenyl)ethanone | ESD-934332-10MG |
| Cas.: 22089-12-9 | Purity: ≥98% | 1-(2,5-Dihydroxy-4-methoxyphenyl)ethanone | ESD-934332-20MG |
| Cas.: 13241-32-2 | Purity: ≥98% | Neoeriocitrin | ESD-934333-10MG |
| Cas.: 13241-32-2 | Purity: ≥98% | Neoeriocitrin | ESD-934333-20MG |
| Cas.: 883715-21-7 | Purity: ≥98% | Macamide Impurity | ESD-934334-10MG |
| Cas.: 883715-21-7 | Purity: ≥98% | Macamide Impurity | ESD-934334-20MG |
| Cas.: 383715-23-9 | Purity: ≥98% | N-3-methoxylBenzyllinolenicamide | ESD-934335-10MG |
| Cas.: 383715-23-9 | Purity: ≥98% | N-3-methoxylBenzyllinolenicamide | ESD-934335-20MG |
| Cas.: 76549-35-4 | Purity: ≥98% | Isovalerylshikonin | ESD-934336-10MG |
| Cas.: 76549-35-4 | Purity: ≥98% | Isovalerylshikonin | ESD-934336-20MG |
| Cas.: 112516-04-8 | Purity: ≥98% | Tubuloside B | ESD-934337-10MG |
| Cas.: 112516-04-8 | Purity: ≥98% | Tubuloside B | ESD-934337-20MG |
| Cas.: 6415-59-4 | Purity: ≥98% | Neocnidilide | ESD-934338-10MG |
| Cas.: 6415-59-4 | Purity: ≥98% | Neocnidilide | ESD-934338-20MG |
| Cas.: 1247-97-8 | Purity: ≥98% | Quercetin-3,5,7,3′,4′-pentamethyl ether | ESD-934339-10MG |
| Cas.: 1247-97-8 | Purity: ≥98% | Quercetin-3,5,7,3′,4′-pentamethyl ether | ESD-934339-20MG |
| Cas.: 1361049-59-3 | Purity: ≥98% | Lactiflorin | ESD-934340-10MG |
| Cas.: 1361049-59-3 | Purity: ≥98% | Lactiflorin | ESD-934340-20MG |
| Cas.: 163047-21-0 | Purity: ≥98% | Anemarrhenasaponin I | ESD-934341-10MG |
| Cas.: 163047-21-0 | Purity: ≥98% | Anemarrhenasaponin I | ESD-934341-20MG |
| Cas.: 874485-32-2 | Purity: ≥98% | (25RS)-Ruscogenin | ESD-934342-10MG |
| Cas.: 874485-32-2 | Purity: ≥98% | (25RS)-Ruscogenin | ESD-934342-20MG |
| Cas.: 84294-87-1 | Purity: ≥98% | 6,7-Dimethoxy-2-phenethylchromone | ESD-934343-5MG |
| Cas.: 84294-87-1 | Purity: ≥98% | 6,7-Dimethoxy-2-phenethylchromone | ESD-934343-20MG |
| Cas.: 117221-65-5 | Purity: ≥98% | Neolancerin | ESD-934344-10MG |
| Cas.: 117221-65-5 | Purity: ≥98% | Neolancerin | ESD-934344-20MG |
| Cas.: 14292-40-1 | Purity: ≥95% | Taxifolin-7-O-glucoside | ESD-934345-5MG |
| Cas.: 14292-40-1 | Purity: ≥95% | Taxifolin-7-O-glucoside | ESD-934345-20MG |
| Cas.: 1623405-29-7 | Purity: ≥98% | Celosin J | ESD-934346-10MG |
| Cas.: 1623405-29-7 | Purity: ≥98% | Celosin J | ESD-934346-20MG |
| Cas.: 34170-18-8 | Purity: ≥98% | 3,5,6,7,8,4′-Hexamethoxyflavone | ESD-934347-10MG |
| Cas.: 34170-18-8 | Purity: ≥98% | 3,5,6,7,8,4′-Hexamethoxyflavone | ESD-934347-20MG |
| Cas.: 3316-46-9 | Purity: ≥98% | Apigenintriacetate | ESD-934348-10MG |
| Cas.: 3316-46-9 | Purity: ≥98% | Apigenintriacetate | ESD-934348-20MG |
| Cas.: 16692-52-7 | Purity: ≥98% | 2-(4-Methoxyphenyl)-3,5,7-trimethoxy-4H-1-benzopyran-4-one | ESD-934349-10MG |
| Cas.: 16692-52-7 | Purity: ≥98% | 2-(4-Methoxyphenyl)-3,5,7-trimethoxy-4H-1-benzopyran-4-one | ESD-934349-20MG |
| Cas.: 6656-13-9 | Purity: ≥98% | Candicine | ESD-934350-10MG |
| Cas.: 6656-13-9 | Purity: ≥98% | Candicine | ESD-934350-20MG |
| Cas.: 525-41-7 | Purity: ≥98% | Harmalane | ESD-934351-10MG |
| Cas.: 525-41-7 | Purity: ≥98% | Harmalane | ESD-934351-20MG |
| Cas.: 35154-55-3 | Purity: ≥98% | Natsudaidain | ESD-934352-10MG |
| Cas.: 35154-55-3 | Purity: ≥98% | Natsudaidain | ESD-934352-20MG |
| Cas.: 16763-48-7 | Purity: ≥98% | Ent-6beta,14alpha-dihydroxy-1,7-epoxy-7,15-dioxo-6,20-hemiketal-6,7-seco-16-kaurene | ESD-934353-10MG |
| Cas.: 16763-48-7 | Purity: ≥98% | Ent-6beta,14alpha-dihydroxy-1,7-epoxy-7,15-dioxo-6,20-hemiketal-6,7-seco-16-kaurene | ESD-934353-20MG |
| Cas.: 25650-83-3 | Purity: ≥98% | O-Acetylgalanthamine | ESD-934354-10MG |
| Cas.: 25650-83-3 | Purity: ≥98% | O-Acetylgalanthamine | ESD-934354-20MG |
| Cas.: 24672-84-2 | Purity: ≥98% | Demethylisoencecalin | ESD-934355-10MG |
| Cas.: 24672-84-2 | Purity: ≥98% | Demethylisoencecalin | ESD-934355-20MG |
| Cas.: 134332-50-6 | Purity: ≥98% | Galanthamine-N-oxide | ESD-934356-10MG |
| Cas.: 134332-50-6 | Purity: ≥98% | Galanthamine-N-oxide | ESD-934356-20MG |
| Cas.: 6018-52-6 | Purity: ≥98% | (1R,9S)-11-Acetyl-7,11-diazatricyclo[7.3.1.02,7]trideca-2,4-dien-6-one | ESD-934357-10MG |
| Cas.: 6018-52-6 | Purity: ≥98% | (1R,9S)-11-Acetyl-7,11-diazatricyclo[7.3.1.02,7]trideca-2,4-dien-6-one | ESD-934357-20MG |
| Cas.: 681457-46-5 | Purity: ≥98% | 1-O-acetylbritannilactone | ESD-934358-10MG |
| Cas.: 681457-46-5 | Purity: ≥98% | 1-O-acetylbritannilactone | ESD-934358-20MG |
| Cas.: 107390-08-9 | Purity: ≥98% | Garcinone D | ESD-934359-5MG |
| Cas.: 107390-08-9 | Purity: ≥98% | Garcinone D | ESD-934359-20MG |
| Cas.: 757202-08-7 | Purity: ≥95% | Eupalinilide B | ESD-934360-10MG |
| Cas.: 757202-08-7 | Purity: ≥95% | Eupalinilide B | ESD-934360-20MG |
| Cas.: 3300-25-2 | Purity: ≥98% | 8-Methyl Chrysophanol | ESD-934361-10MG |
| Cas.: 3300-25-2 | Purity: ≥98% | 8-Methyl Chrysophanol | ESD-934361-20MG |
| Cas.: 500736-17-4 | Purity: ≥98% | Demethoxydeacetoxypseudolaric acid B | ESD-934362-10MG |
| Cas.: 500736-17-4 | Purity: ≥98% | Demethoxydeacetoxypseudolaric acid B | ESD-934362-20MG |
| Cas.: 185051-75-6 | Purity: ≥98% | Liquidambaric lactone | ESD-934363-10MG |
| Cas.: 185051-75-6 | Purity: ≥98% | Liquidambaric lactone | ESD-934363-20MG |
| Cas.: 38390-45-3 | Purity: ≥95% | Anhydrovinblastine | ESD-934364-10MG |
| Cas.: 38390-45-3 | Purity: ≥95% | Anhydrovinblastine | ESD-934364-20MG |
| Cas.: 620-61-1 | Purity: ≥98% | Hyoscyamine sulfate hydrate | ESD-934365-5MG |
| Cas.: 620-61-1 | Purity: ≥98% | Hyoscyamine sulfate hydrate | ESD-934365-20MG |
| Cas.: 117060-54-5 | Purity: ≥98% | 3′-Hydroxypuerarin | ESD-934366-5MG |
| Cas.: 117060-54-5 | Purity: ≥98% | 3′-Hydroxypuerarin | ESD-934366-20MG |
| Cas.: 68422-00-4 | Purity: ≥90% | Timosaponin A1 | ESD-934367-5MG |
| Cas.: 68422-00-4 | Purity: ≥90% | Timosaponin A1 | ESD-934367-20MG |
| Cas.: 98891-44-2 | Purity: ≥98% | Pseudolaric AcidA-O-beta-D-glucopyranoside | ESD-934368-5MG |
| Cas.: 98891-44-2 | Purity: ≥98% | Pseudolaric AcidA-O-beta-D-glucopyranoside | ESD-934368-20MG |
| Cas.: 96850-30-5 | Purity: ≥95% | Maoecrystal A | ESD-934369-5MG |
| Cas.: 96850-30-5 | Purity: ≥95% | Maoecrystal A | ESD-934369-20MG |
| Cas.: 206756-04-9 | Purity: ≥98% | Ecliptasaponin D | ESD-934370-5MG |
| Cas.: 206756-04-9 | Purity: ≥98% | Ecliptasaponin D | ESD-934370-20MG |
| Cas.: 6894-43-5 | Purity: ≥90% | Kahweol | ESD-934371-5MG |
| Cas.: 6894-43-5 | Purity: ≥90% | Kahweol | ESD-934371-20MG |
| Cas.: 4839-60-5 | Purity: ≥98% | Chrysophanein | ESD-934372-5MG |
| Cas.: 4839-60-5 | Purity: ≥98% | Chrysophanein | ESD-934372-10MG |
| Cas.: 211567-04-3 | Purity: ≥98% | Picroside IV | ESD-934373-5MG |
| Cas.: 211567-04-3 | Purity: ≥98% | Picroside IV | ESD-934373-10MG |
| Cas.: 29043-07-0 | Purity: ≥98% | 3′,4′,5,5′,6,7-Hexamethoxyflavone | ESD-934374-5MG |
| Cas.: 29043-07-0 | Purity: ≥98% | 3′,4′,5,5′,6,7-Hexamethoxyflavone | ESD-934374-10MG |
| Cas.: 82509-41-9 | Purity: ≥95% | 8-Epi-Loganic acid | ESD-934375-5MG |
| Cas.: 82509-41-9 | Purity: ≥95% | 8-Epi-Loganic acid | ESD-934375-10MG |
| Cas.: 75801-95-5 | Purity: ≥95% | Momordicoside A | ESD-934376-5MG |
| Cas.: 75801-95-5 | Purity: ≥95% | Momordicoside A | ESD-934376-10MG |
| Cas.: 548-08-3 | Purity: ≥98% | Roemerine | ESD-934377-5MG |
| Cas.: 548-08-3 | Purity: ≥98% | Roemerine | ESD-934377-10MG |
| Cas.: 19993-32-9 | Purity: ≥98% | Chrysoeriol-7-O-glucoside | ESD-934378-5MG |
| Cas.: 19993-32-9 | Purity: ≥98% | Chrysoeriol-7-O-glucoside | ESD-934378-10MG |
| Cas.: 109232-77-1 | Purity: ≥98% | Camellian A | ESD-934379-5MG |
| Cas.: 109232-77-1 | Purity: ≥98% | Camellian A | ESD-934379-10MG |
| Cas.: 1194056-33-1 | Purity: ≥92% | Ligupurpuroside C | ESD-934380-5MG |
| Cas.: 1194056-33-1 | Purity: ≥92% | Ligupurpuroside C | ESD-934380-10MG |
| Cas.: 78886-65-4 | Purity: ≥98% | γ-Sanshool | ESD-934381-5MG |
| Cas.: 78886-65-4 | Purity: ≥98% | γ-Sanshool | ESD-934381-10MG |
| Cas.: 127514-62-9 | Purity: ≥98% | Hydroxy-Gamma-Isosanshool | ESD-934382-5MG |
| Cas.: 127514-62-9 | Purity: ≥98% | Hydroxy-Gamma-Isosanshool | ESD-934382-10MG |
| Cas.: 989-23-1 | Purity: ≥98% | Desoxylimonin | ESD-934383-5MG |
| Cas.: 989-23-1 | Purity: ≥98% | Desoxylimonin | ESD-934383-10MG |
| Cas.: 90308-85-3 | Purity: ≥98% | Paris saponin D | ESD-934384-5MG |
| Cas.: 90308-85-3 | Purity: ≥98% | Paris saponin D | ESD-934384-10MG |
| Cas.: 13268-67-2 | Purity: ≥95% | Senecionine N-oxide | ESD-934385-5MG |
| Cas.: 13268-67-2 | Purity: ≥95% | Senecionine N-oxide | ESD-934385-10MG |
| Cas.: 52438-12-7 | Purity: ≥98% | Isobutyrylshikonin | ESD-934386-5MG |
| Cas.: 52438-12-7 | Purity: ≥98% | Isobutyrylshikonin | ESD-934386-10MG |
| Cas.: 6451-73-6 | Purity: ≥98% | Scoulerine | ESD-934387-5MG |
| Cas.: 6451-73-6 | Purity: ≥98% | Scoulerine | ESD-934387-10MG |
| Cas.: 20013-23-4 | Purity: ≥98% | Isoscoparin | ESD-934388-5MG |
| Cas.: 20013-23-4 | Purity: ≥98% | Isoscoparin | ESD-934388-10MG |
| Cas.: 109664-02-0 | Purity: ≥98% | Neocryptotanshinone | ESD-934389-5MG |
| Cas.: 109664-02-0 | Purity: ≥98% | Neocryptotanshinone | ESD-934389-10MG |
| Cas.: 22961-68-8 | Purity: ≥98% | 20-hydroxyecdysone 3-acetate | ESD-934390-5MG |
| Cas.: 22961-68-8 | Purity: ≥98% | 20-hydroxyecdysone 3-acetate | ESD-934390-10MG |
| Cas.: 19536-25-5 | Purity: ≥98% | 20-hydroxyeedysone 2-acetate | ESD-934391-5MG |
| Cas.: 19536-25-5 | Purity: ≥98% | 20-hydroxyeedysone 2-acetate | ESD-934391-10MG |
| Cas.: 60657-23-0 | Purity: ≥98% | Cinobufotenine | ESD-934392-5MG |
| Cas.: 60657-23-0 | Purity: ≥98% | Cinobufotenine | ESD-934392-10MG |
| Cas.: 155653-86-4 | Purity: ≥98% | Siaresinolic acid 28-O-β-D-glucopyranosyl ester | ESD-934393-5MG |
| Cas.: 155653-86-4 | Purity: ≥98% | Siaresinolic acid 28-O-β-D-glucopyranosyl ester | ESD-934393-10MG |
| Cas.: 2613-86-7 | Purity: ≥98% | 4-O-Ferruloylquinic acid | ESD-934394-5MG |
| Cas.: 2613-86-7 | Purity: ≥98% | 4-O-Ferruloylquinic acid | ESD-934394-10MG |
| Cas.: 4423-37-4 | Purity: ≥98% | Syringetin | ESD-934395-5MG |
| Cas.: 4423-37-4 | Purity: ≥98% | Syringetin | ESD-934395-10MG |
| Cas.: 491-69-0 | Purity: ≥98% | Isosakuranin | ESD-934396-5MG |
| Cas.: 491-69-0 | Purity: ≥98% | Isosakuranin | ESD-934396-10MG |
| Cas.: 18296-48-5 | Purity: ≥98% | Valtrate hydrine B 4 | ESD-934397-5MG |
| Cas.: 18296-48-5 | Purity: ≥98% | Valtrate hydrine B 4 | ESD-934397-10MG |
| Cas.: 1247014-34-1 | Purity: ≥98% | Volvalerenic acid A | ESD-934398-5MG |
| Cas.: 1247014-34-1 | Purity: ≥98% | Volvalerenic acid A | ESD-934398-10MG |
| Cas.: 145265-02-7 | Purity: ≥98% | (+)-Secoisolariciresinol | ESD-934399-5MG |
| Cas.: 145265-02-7 | Purity: ≥98% | (+)-Secoisolariciresinol | ESD-934399-10MG |
| Cas.: 87686-87-1 | Purity: ≥95% | 2-Methyl-1,3,6-trihydroxy-9,10-anthraquinone-3-O-α-rhamnosyl-(1→2)-β-D-glucoside | ESD-934400-5MG |
| Cas.: 87686-87-1 | Purity: ≥95% | 2-Methyl-1,3,6-trihydroxy-9,10-anthraquinone-3-O-α-rhamnosyl-(1→2)-β-D-glucoside | ESD-934400-10MG |
| Cas.: 23451-01-6 | Purity: ≥98% | Physcion 8-β-D-glucoside | ESD-934401-5MG |
| Cas.: 23451-01-6 | Purity: ≥98% | Physcion 8-β-D-glucoside | ESD-934401-10MG |
| Cas.: 181311-16-0 | Purity: ≥98% | Colutehydroquinone | ESD-934402-5MG |
| Cas.: 181311-16-0 | Purity: ≥98% | Colutehydroquinone | ESD-934402-10MG |
| Cas.: 64474-51-7 | Purity: ≥98% | Isomucronulatol | ESD-934403-5MG |
| Cas.: 64474-51-7 | Purity: ≥98% | Isomucronulatol | ESD-934403-10MG |
| Cas.: 218155-40-9 | Purity: ≥98% | Cassiaside B2 | ESD-934404-5MG |
| Cas.: 218155-40-9 | Purity: ≥98% | Cassiaside B2 | ESD-934404-10MG |
| Cas.: 2013537-81-8 | Purity: ≥95% | 1αH,5αH-guaia-6-ene-4β,10β-diol | ESD-934405-5MG |
| Cas.: 2013537-81-8 | Purity: ≥95% | 1αH,5αH-guaia-6-ene-4β,10β-diol | ESD-934405-10MG |
| Cas.: 97605-25-9 | Purity: ≥98% | Isoscoparin-2”-β-D-glucopyranoside | ESD-934406-5MG |
| Cas.: 97605-25-9 | Purity: ≥98% | Isoscoparin-2”-β-D-glucopyranoside | ESD-934406-10MG |
| Cas.: 1603-47-0 | Purity: ≥98% | 8-Hydroxybergapten | ESD-934407-5MG |
| Cas.: 1603-47-0 | Purity: ≥98% | 8-Hydroxybergapten | ESD-934407-10MG |
| Cas.: 33783-80-1 | Purity: ≥98% | Pangelin | ESD-934408-5MG |
| Cas.: 33783-80-1 | Purity: ≥98% | Pangelin | ESD-934408-10MG |
| Cas.: 104987-36-2 | Purity: ≥90% | Oenothein B | ESD-934409-5MG |
| Cas.: 104987-36-2 | Purity: ≥90% | Oenothein B | ESD-934409-10MG |
| Cas.: 899430-03-6 | Purity: ≥95% | Gymnoside III | ESD-934410-5MG |
| Cas.: 899430-03-6 | Purity: ≥95% | Gymnoside III | ESD-934410-10MG |
| Cas.: 2292159-89-6 | Purity: ≥98% | Bletilloside A | ESD-934411-5MG |
| Cas.: 2292159-89-6 | Purity: ≥98% | Bletilloside A | ESD-934411-10MG |
| Cas.: 101330-69-2 | Purity: ≥98% | 3′-O-Methylbatatasin III | ESD-934412-5MG |
| Cas.: 101330-69-2 | Purity: ≥98% | 3′-O-Methylbatatasin III | ESD-934412-10MG |
| Cas.: 75412-95-2 | Purity: ≥98% | [(1(10)E,2R,4R)]-2-Methoxy-8,12-epoxygemacra-1(10),7,11-trien-6-one | ESD-934413-5MG |
| Cas.: 75412-95-2 | Purity: ≥98% | [(1(10)E,2R,4R)]-2-Methoxy-8,12-epoxygemacra-1(10),7,11-trien-6-one | ESD-934413-10MG |
| Cas.: 36190-98-4 | Purity: ≥98% | Genistein 7,4′-di-O-β-D-glucopyranoside | ESD-934414-5MG |
| Cas.: 36190-98-4 | Purity: ≥98% | Genistein 7,4′-di-O-β-D-glucopyranoside | ESD-934414-10MG |
| Cas.: 60767-80-8 | Purity: ≥95% | Isovitexin 2-O-β-glucoside | ESD-934415-5MG |
| Cas.: 60767-80-8 | Purity: ≥95% | Isovitexin 2-O-β-glucoside | ESD-934415-10MG |
| Cas.: 72659-75-7 | Purity: ≥98% | 6-Acetylhyperin | ESD-934416-5MG |
| Cas.: 72659-75-7 | Purity: ≥98% | 6-Acetylhyperin | ESD-934416-10MG |
| Cas.: 26067-60-7 | Purity: ≥90% | Dihydropalmatine | ESD-934417-5MG |
| Cas.: 26067-60-7 | Purity: ≥90% | Dihydropalmatine | ESD-934417-10MG |
| Cas.: 6068-80-0 | Purity: ≥98% | 3′,4′,7-Trimethoxyquercetin | ESD-934418-1MG |
| Cas.: 6068-80-0 | Purity: ≥98% | 3′,4′,7-Trimethoxyquercetin | ESD-934418-10MG |
| Cas.: 26964-29-4 | Purity: ≥98% | 3,5,7-Trimethoxyflavone | ESD-934419-5MG |
| Cas.: 26964-29-4 | Purity: ≥98% | 3,5,7-Trimethoxyflavone | ESD-934419-10MG |
| Cas.: 200127-93-1 | Purity: ≥98% | Isorubrofusarin gentiobioside | ESD-934420-5MG |
| Cas.: 200127-93-1 | Purity: ≥98% | Isorubrofusarin gentiobioside | ESD-934420-10MG |
| Cas.: 40788-84-9 | Purity: ≥95% | Isoviolanthin | ESD-934421-5MG |
| Cas.: 40788-84-9 | Purity: ≥95% | Isoviolanthin | ESD-934421-10MG |
| Cas.: 791836-69-6 | Purity: ≥98% | 2-O-cinnamoyl-1-O-galloyl-β-D-glucose | ESD-934422-5MG |
| Cas.: 791836-69-6 | Purity: ≥98% | 2-O-cinnamoyl-1-O-galloyl-β-D-glucose | ESD-934422-10MG |
| Cas.: 80368-74-7 | Purity: ≥95% | 3-Hydroxymorindone | ESD-934423-5MG |
| Cas.: 80368-74-7 | Purity: ≥95% | 3-Hydroxymorindone | ESD-934423-10MG |
| Cas.: 4467-30-5 | Purity: ≥98% | 4-methyl-6-phenyl-2H-pyranone | ESD-934424-5MG |
| Cas.: 4467-30-5 | Purity: ≥98% | 4-methyl-6-phenyl-2H-pyranone | ESD-934424-10MG |
| Cas.: 62499-70-1 | Purity: ≥98% | Isofutoquinol A | ESD-934425-5MG |
| Cas.: 62499-70-1 | Purity: ≥98% | Isofutoquinol A | ESD-934425-10MG |
| Cas.: 11033-64-0 | Purity: ≥98% | N-deacetyllappaconitine | ESD-934426-5MG |
| Cas.: 11033-64-0 | Purity: ≥98% | N-deacetyllappaconitine | ESD-934426-10MG |
| Cas.: 40554-94-7 | Purity: ≥98% | 3,7-Dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-5-methoxy-4H-chromen-4-one | ESD-934427-5MG |
| Cas.: 40554-94-7 | Purity: ≥98% | 3,7-Dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-5-methoxy-4H-chromen-4-one | ESD-934427-10MG |
| Cas.: 6743-96-0 | Purity: ≥98% | Isorhamnetin 7-O-β-D-glucopyranoside | ESD-934428-5MG |
| Cas.: 6743-96-0 | Purity: ≥98% | Isorhamnetin 7-O-β-D-glucopyranoside | ESD-934428-10MG |
| Cas.: 95311-96-9 | Purity: ≥98% | Lucidenic acid C | ESD-934429-5MG |
| Cas.: 95311-96-9 | Purity: ≥98% | Lucidenic acid C | ESD-934429-10MG |
| Cas.: 95311-95-8 | Purity: ≥98% | Lucidenic acid B | ESD-934430-5MG |
| Cas.: 95311-95-8 | Purity: ≥98% | Lucidenic acid B | ESD-934430-10MG |
| Cas.: 112766-96-8 | Purity: ≥98% | Ardisiacrispin B | ESD-934431-5MG |
| Cas.: 112766-96-8 | Purity: ≥98% | Ardisiacrispin B | ESD-934431-10MG |
| Cas.: 55696-58-7 | Purity: ≥98% | Kaempferol-3-O-(2″-O-β-D-glucopyl)-β-D-rutinoside | ESD-934432-5MG |
| Cas.: 55696-58-7 | Purity: ≥98% | Kaempferol-3-O-(2″-O-β-D-glucopyl)-β-D-rutinoside | ESD-934432-10MG |
| Cas.: 477-27-0 | Purity: ≥98% | Cochineal | ESD-934433-5MG |
| Cas.: 477-27-0 | Purity: ≥98% | Cochineal | ESD-934433-10MG |
| Cas.: 178895-25-5 | Purity: ≥98% | salviaflaside | ESD-934434-5MG |
| Cas.: 178895-25-5 | Purity: ≥98% | salviaflaside | ESD-934434-10MG |
| Cas.: 99365-23-8 | Purity: ≥95% | Prosaikogenin G | ESD-934435-5MG |
| Cas.: 99365-23-8 | Purity: ≥95% | Prosaikogenin G | ESD-934435-10MG |
| Cas.: 92117-94-7 | Purity: ≥98% | 4′-Methoxypuerarin | ESD-934436-5MG |
| Cas.: 92117-94-7 | Purity: ≥98% | 4′-Methoxypuerarin | ESD-934436-10MG |
| Cas.: 116872-05-0 | Purity: ≥98% | Magnoloside B | ESD-934437-5MG |
| Cas.: 116872-05-0 | Purity: ≥98% | Magnoloside B | ESD-934437-10MG |
| Cas.: 33579-63-4 | Purity: ≥98% | 3′-Methoxy apiin | ESD-934438-5MG |
| Cas.: 33579-63-4 | Purity: ≥98% | 3′-Methoxy apiin | ESD-934438-10MG |
| Cas.: 17365-11-6 | Purity: ≥98% | 3-Galloylquinic acid | ESD-934439-5MG |
| Cas.: 17365-11-6 | Purity: ≥98% | 3-Galloylquinic acid | ESD-934439-10MG |
| Cas.: 262601-67-2 | Purity: ≥90% | Peritassine A | ESD-934440-5MG |
| Cas.: 262601-67-2 | Purity: ≥90% | Peritassine A | ESD-934440-10MG |
| Cas.: 54328-09-5 | Purity: ≥94% | Protopseudohypericin | ESD-934441-5MG |
| Cas.: 54328-09-5 | Purity: ≥94% | Protopseudohypericin | ESD-934441-10MG |
| Cas.: 1073897-80-9 | Purity: ≥98% | 1,3,5-Tricaffeoylquinic acid | ESD-934442-5MG |
| Cas.: 1073897-80-9 | Purity: ≥98% | 1,3,5-Tricaffeoylquinic acid | ESD-934442-10MG |
| Cas.: 154287-55-5 | Purity: ≥98% | 2-Cinnamoyl-3-benzoyl-(2-O-α-glucosyl)-Sucrose | ESD-934443-5MG |
| Cas.: 154287-55-5 | Purity: ≥98% | 2-Cinnamoyl-3-benzoyl-(2-O-α-glucosyl)-Sucrose | ESD-934443-10MG |
| Cas.: 74170-32-4 | Purity: ≥98% | 3-Dehydroverticine | ESD-934444-5MG |
| Cas.: 74170-32-4 | Purity: ≥98% | 3-Dehydroverticine | ESD-934444-10MG |
| Cas.: 83199-38-6 | Purity: ≥98% | Angelol G | ESD-934445-5MG |
| Cas.: 83199-38-6 | Purity: ≥98% | Angelol G | ESD-934445-10MG |
| Cas.: 41679-97-4 | Purity: ≥98% | 7-O-Methyl morroniside | ESD-934446-5MG |
| Cas.: 41679-97-4 | Purity: ≥98% | 7-O-Methyl morroniside | ESD-934446-10MG |
| Cas.: 23062-24-0 | Purity: ≥90% | Eurycomalactone | ESD-934447-5MG |
| Cas.: 23062-24-0 | Purity: ≥90% | Eurycomalactone | ESD-934447-10MG |
| Cas.: 77035-42-8 | Purity: ≥97% | Dehydroeburicoic acid monoacetate | ESD-934448-5MG |
| Cas.: 77035-42-8 | Purity: ≥97% | Dehydroeburicoic acid monoacetate | ESD-934448-10MG |
| Cas.: 116521-73-4 | Purity: ≥98% | Moluccanin | ESD-934449-5MG |
| Cas.: 116521-73-4 | Purity: ≥98% | Moluccanin | ESD-934449-10MG |
| Cas.: 156012-92-9 | Purity: ≥94% | Vina-ginsenoside R3 | ESD-934450-5MG |
| Cas.: 156012-92-9 | Purity: ≥94% | Vina-ginsenoside R3 | ESD-934450-10MG |
| Cas.: 173046-19-0 | Purity: ≥98% | Sibirioside A | ESD-934451-5MG |
| Cas.: 173046-19-0 | Purity: ≥98% | Sibirioside A | ESD-934451-10MG |
| Cas.: 1245572-24-0 | Purity: ≥98% | 6′-O-Cinnamoyl harpagide | ESD-934452-5MG |
| Cas.: 1245572-24-0 | Purity: ≥98% | 6′-O-Cinnamoyl harpagide | ESD-934452-10MG |
| Cas.: 110764-09-5 | Purity: ≥98% | Acetyl Perisesaccharide C | ESD-934453-5MG |
| Cas.: 110764-09-5 | Purity: ≥98% | Acetyl Perisesaccharide C | ESD-934453-10MG |
| Cas.: 1174388-31-8 | Purity: ≥98% | β-chamigrenic acid | ESD-934454-5MG |
| Cas.: 1174388-31-8 | Purity: ≥98% | β-chamigrenic acid | ESD-934454-10MG |
| Cas.: 1095261-93-0 | Purity: ≥98% | Perisesaccharide B | ESD-934455-5MG |
| Cas.: 1095261-93-0 | Purity: ≥98% | Perisesaccharide B | ESD-934455-10MG |
| Cas.: 196399-16-3 | Purity: ≥98% | Siegesmethyetheric acid | ESD-934456-5MG |
| Cas.: 196399-16-3 | Purity: ≥98% | Siegesmethyetheric acid | ESD-934456-10MG |
| Cas.: 6831-17-0 | Purity: ≥98% | Aristolone | ESD-934457-5MG |
| Cas.: 6831-17-0 | Purity: ≥98% | Aristolone | ESD-934457-10MG |
| Cas.: 1071-52-9 | Purity: ≥95% | Apo-12′-lycopenal | ESD-934458-5MG |
| Cas.: 1071-52-9 | Purity: ≥95% | Apo-12′-lycopenal | ESD-934458-10MG |
| Cas.: 6801-40-7 | Purity: ≥98% | Liriodenine | ESD-934459-5MG |
| Cas.: 6801-40-7 | Purity: ≥98% | Liriodenine | ESD-934459-10MG |
| Cas.: 73493-60-4 | Purity: ≥98% | 28-Demethyl-β-amyrone | ESD-934460-5MG |
| Cas.: 73493-60-4 | Purity: ≥98% | 28-Demethyl-β-amyrone | ESD-934460-10MG |
| Cas.: 80325-22-0 | Purity: ≥98% | Gypenoside XIII | ESD-934461-5MG |
| Cas.: 80325-22-0 | Purity: ≥98% | Gypenoside XIII | ESD-934461-10MG |
| Cas.: 1613527-65-3 | Purity: ≥98% | Mogroside IIA | ESD-934462-5MG |
| Cas.: 1613527-65-3 | Purity: ≥98% | Mogroside IIA | ESD-934462-10MG |
| Cas.: 88901-46-6 | Purity: ≥98% | Mogroside Ia1 | ESD-934463-5MG |
| Cas.: 88901-46-6 | Purity: ≥98% | Mogroside Ia1 | ESD-934463-10MG |
| Cas.: 88901-38-6 | Purity: ≥98% | Mogroside II E | ESD-934464-5MG |
| Cas.: 88901-38-6 | Purity: ≥98% | Mogroside II E | ESD-934464-10MG |
| Cas.: 93675-88-8 | Purity: ≥98% | Forsythoside E | ESD-934465-5MG |
| Cas.: 93675-88-8 | Purity: ≥98% | Forsythoside E | ESD-934465-10MG |
| Cas.: 35110-20-4 | Purity: ≥98% | DiosMetin 7-O-β-D-Glucuronide SodiuM Salt | ESD-934466-5MG |
| Cas.: 35110-20-4 | Purity: ≥98% | DiosMetin 7-O-β-D-Glucuronide SodiuM Salt | ESD-934466-10MG |
| Cas.: 66656-92-6 | Purity: ≥98% | Esculentoside H | ESD-934467-5MG |
| Cas.: 66656-92-6 | Purity: ≥98% | Esculentoside H | ESD-934467-10MG |
| Cas.: 164991-86-0 | Purity: ≥98% | Orcinol gentiobioside | ESD-934468-5MG |
| Cas.: 164991-86-0 | Purity: ≥98% | Orcinol gentiobioside | ESD-934468-10MG |
| Cas.: 176948-80-4 | Purity: 10wt% in heptanes | POLY(1,1-PERHYDROSILAZANE) telomer | ESD-934469-1G |
| Cas.: 176948-80-4 | Purity: 10wt% in heptanes | POLY(1,1-PERHYDROSILAZANE) telomer | ESD-934469-10G |
| Cas.: 89535-60-4 | POLY(1,1-DIMETHYLSILAZANE) telomer | ESD-934470-1G | |
| Cas.: 89535-60-4 | POLY(1,1-DIMETHYLSILAZANE) telomer | ESD-934470-10G | |
| Cas.: 143499-71-2 | (50% DIMETHYLSILANE) (50% PHENYLMETHYLSILANE) COPOLYMER | ESD-934471-1G | |
| Cas.: 143499-71-2 | (50% DIMETHYLSILANE) (50% PHENYLMETHYLSILANE) COPOLYMER | ESD-934471-10G | |
| Cas.: 146088-00-8 | POLY(PHENYLMETHYLSILANE) | ESD-934472-1G | |
| Cas.: 146088-00-8 | POLY(PHENYLMETHYLSILANE) | ESD-934472-10G | |
| Cas.: 19625-17-3 | Purity: ≥98% | Angelol A | ESD-934473-1MG |
| Cas.: 19625-17-3 | Purity: ≥98% | Angelol A | ESD-934473-5MG |
| Cas.: 83156-04-1 | Purity: ≥98% | Angelol B | ESD-934474-1MG |
| Cas.: 83156-04-1 | Purity: ≥98% | Angelol B | ESD-934474-5MG |
| Cas.: 63279-14-1 | Purity: ≥98% | Rebaudioside E | ESD-934475-1MG |
| Cas.: 63279-14-1 | Purity: ≥98% | Rebaudioside E | ESD-934475-5MG |
| Cas.: 438045-89-7 | Purity: ≥98% | Rebaudioside F | ESD-934476-1MG |
| Cas.: 438045-89-7 | Purity: ≥98% | Rebaudioside F | ESD-934476-5MG |
| Cas.: 1220616-34-1 | Purity: ≥98% | Rebaudioside I | ESD-934477-1MG |
| Cas.: 1220616-34-1 | Purity: ≥98% | Rebaudioside I | ESD-934477-5MG |
| Cas.: 1313049-59-0 | Purity: ≥98% | Rebaudioside J | ESD-934478-1MG |
| Cas.: 1313049-59-0 | Purity: ≥98% | Rebaudioside J | ESD-934478-5MG |
| Cas.: 1220616-46-5 | Purity: ≥98% | Rebaudioside N | ESD-934479-1MG |
| Cas.: 1220616-46-5 | Purity: ≥98% | Rebaudioside N | ESD-934479-5MG |
| Cas.: 106466-66-4 | Purity: ≥98% | Rankinidine | ESD-934480-1MG |
| Cas.: 106466-66-4 | Purity: ≥98% | Rankinidine | ESD-934480-5MG |
| Cas.: 82203-01-8 | Purity: ≥98% | Agrimoniin | ESD-934481-1MG |
| Cas.: 82203-01-8 | Purity: ≥98% | Agrimoniin | ESD-934481-5MG |
| Cas.: 40039-49-4 | Purity: ≥98% | Syringetin 3-O-β-D-glucoside | ESD-934482-1MG |
| Cas.: 40039-49-4 | Purity: ≥98% | Syringetin 3-O-β-D-glucoside | ESD-934482-5MG |
| Cas.: 53430-50-5 | Purity: ≥98% | Syringetin-3-O-rutinoside | ESD-934483-1MG |
| Cas.: 53430-50-5 | Purity: ≥98% | Syringetin-3-O-rutinoside | ESD-934483-5MG |
| Cas.: 443908-19-8 | Purity: ≥90% | Glycosmisic acid | ESD-934484-1MG |
| Cas.: 443908-19-8 | Purity: ≥90% | Glycosmisic acid | ESD-934484-5MG |
| Cas.: 18199-64-9 | Purity: ≥98% | Angenomalin | ESD-934485-1MG |
| Cas.: 18199-64-9 | Purity: ≥98% | Angenomalin | ESD-934485-5MG |
| Cas.: 84294-90-6 | Purity: ≥98% | 6-Hydroxy-2-(2-phenylethyl)chromone | ESD-934486-1MG |
| Cas.: 84294-90-6 | Purity: ≥98% | 6-Hydroxy-2-(2-phenylethyl)chromone | ESD-934486-5MG |
| Cas.: 125906-49-2 | Purity: ≥98% | 3-(β-D-Glucopyranosyloxy)-1,6-dihydroxy-2-methyl-9,10-anthracenedione | ESD-934487-1MG |
| Cas.: 125906-49-2 | Purity: ≥98% | 3-(β-D-Glucopyranosyloxy)-1,6-dihydroxy-2-methyl-9,10-anthracenedione | ESD-934487-5MG |
| Cas.: 1150314-34-3 | Purity: ≥98% | Neopuerarin A | ESD-934488-1MG |
| Cas.: 1150314-34-3 | Purity: ≥98% | Neopuerarin A | ESD-934488-5MG |
| Cas.: 1150314-39-8 | Purity: ≥98% | Neopuerarin B | ESD-934489-1MG |
| Cas.: 1150314-39-8 | Purity: ≥98% | Neopuerarin B | ESD-934489-5MG |
| Cas.: 17406-46-1 | Purity: ≥95% | Beta-Tomatine | ESD-934490-1MG |
| Cas.: 17406-46-1 | Purity: ≥95% | Beta-Tomatine | ESD-934490-5MG |
| Cas.: 491-60-1 | Purity: ≥98% | Emodin throne | ESD-934491-1MG |
| Cas.: 491-60-1 | Purity: ≥98% | Emodin throne | ESD-934491-5MG |
| Cas.: 72229-40-4 | Purity: ≥98% | Linusstatin | ESD-934492-1MG |
| Cas.: 72229-40-4 | Purity: ≥98% | Linusstatin | ESD-934492-5MG |
| Cas.: 487-91-2 | Purity: ≥98% | Bufotenidine | ESD-934493-1MG |
| Cas.: 487-91-2 | Purity: ≥98% | Bufotenidine | ESD-934493-5MG |
| Cas.: 523-59-1 | Purity: ≥98% | Seselin | ESD-934494-1MG |
| Cas.: 523-59-1 | Purity: ≥98% | Seselin | ESD-934494-5MG |
| Cas.: 99624-28-9 | Purity: ≥95% | Kazinol A | ESD-934495-1MG |
| Cas.: 99624-28-9 | Purity: ≥95% | Kazinol A | ESD-934495-5MG |
| Cas.: 102067-92-5 | Purity: ≥98% | Epitheaflagallin 3-O-gallate | ESD-934496-1MG |
| Cas.: 102067-92-5 | Purity: ≥98% | Epitheaflagallin 3-O-gallate | ESD-934496-5MG |
| Cas.: 1303438-51-8 | Purity: ≥98% | Cathayanon H | ESD-934497-1MG |
| Cas.: 1303438-51-8 | Purity: ≥98% | Cathayanon H | ESD-934497-5MG |
| Cas.: 162558-94-3 | Purity: ≥95% | Broussoflavonol F | ESD-934498-1MG |
| Cas.: 162558-94-3 | Purity: ≥95% | Broussoflavonol F | ESD-934498-5MG |
| Cas.: 33978-17-5 | Purity: ≥98% | Pelargonidin 3-Rutinoside | ESD-934499-1MG |
| Cas.: 33978-17-5 | Purity: ≥98% | Pelargonidin 3-Rutinoside | ESD-934499-5MG |
| Cas.: 15130-85-5 | Purity: ≥98% | Lnokosterone | ESD-934500-1MG |
| Cas.: 15130-85-5 | Purity: ≥98% | Lnokosterone | ESD-934500-5MG |
| Cas.: 58480-54-9 | Purity: ≥98% | Lemannine | ESD-934501-1MG |
| Cas.: 58480-54-9 | Purity: ≥98% | Lemannine | ESD-934501-5MG |
| Cas.: 79559-55-0 | Purity: ≥98% | 6-Ethoxychelerythrine | ESD-934502-1MG |
| Cas.: 79559-55-0 | Purity: ≥98% | 6-Ethoxychelerythrine | ESD-934502-5MG |
| Cas.: 99365-19-2 | Purity: ≥98% | Saikosaponin G | ESD-934503-1MG |
| Cas.: 99365-19-2 | Purity: ≥98% | Saikosaponin G | ESD-934503-5MG |
| Cas.: 5573-16-0 | Purity: ≥98% | SAIKOGENIN D | ESD-934504-1MG |
| Cas.: 5573-16-0 | Purity: ≥98% | SAIKOGENIN D | ESD-934504-5MG |
| Cas.: 156980-60-8 | Purity: ≥98% | Grosvenorine | ESD-934505-1G |
| Cas.: 156980-60-8 | Purity: ≥98% | Grosvenorine | ESD-934505-5G |
| Cas.: 952481-53-7 | Purity: ≥98% | 11-Oxomogroside III | ESD-934506-1MG |
| Cas.: 952481-53-7 | Purity: ≥98% | 11-Oxomogroside III | ESD-934506-5MG |
| Cas.: 126223-28-7 | Purity: ≥98% | Ginsenoside Rg4 | ESD-934507-1MG |
| Cas.: 126223-28-7 | Purity: ≥98% | Ginsenoside Rg4 | ESD-934507-5MG |
| Cas.: 69926-31-4 | Purity: ≥98% | 20(S),24(R)-Ocotilol | ESD-934508-1MG |
| Cas.: 69926-31-4 | Purity: ≥98% | 20(S),24(R)-Ocotilol | ESD-934508-5MG |
| Cas.: 156009-80-2 | Purity: ≥98% | Vina-ginsenoside R4 | ESD-934509-1MG |
| Cas.: 156009-80-2 | Purity: ≥98% | Vina-ginsenoside R4 | ESD-934509-5MG |
| Cas.: 156042-22-7 | Purity: ≥98% | Vina-ginsenoside R8 | ESD-934510-1MG |
| Cas.: 156042-22-7 | Purity: ≥98% | Vina-ginsenoside R8 | ESD-934510-5MG |
| Cas.: 22327-82-8 | Purity: ≥98% | Platycodigenin | ESD-934511-1MG |
| Cas.: 22327-82-8 | Purity: ≥98% | Platycodigenin | ESD-934511-5MG |
| Cas.: 237068-41-6 | Purity: ≥98% | Platycoside E | ESD-934512-1MG |
| Cas.: 237068-41-6 | Purity: ≥98% | Platycoside E | ESD-934512-5MG |
| Cas.: 849758-42-5 | Purity: ≥98% | Platycoside G1 | ESD-934513-1MG |
| Cas.: 849758-42-5 | Purity: ≥98% | Platycoside G1 | ESD-934513-5MG |
| Cas.: 67884-03-1 | Purity: ≥98% | Platycodin D3 | ESD-934514-1MG |
| Cas.: 67884-03-1 | Purity: ≥98% | Platycodin D3 | ESD-934514-5MG |
| Cas.: 173792-61-5 | Purity: ≥98% | Kudinoside D | ESD-934515-1MG |
| Cas.: 173792-61-5 | Purity: ≥98% | Kudinoside D | ESD-934515-5MG |
| Cas.: 103773-62-2 | Purity: ≥98% | Ganoderic acid C2 | ESD-934516-1MG |
| Cas.: 103773-62-2 | Purity: ≥98% | Ganoderic acid C2 | ESD-934516-5MG |
| Cas.: 100665-42-7 | Purity: ≥98% | Ganoderenic acid C | ESD-934517-1MG |
| Cas.: 100665-42-7 | Purity: ≥98% | Ganoderenic acid C | ESD-934517-5MG |
| Cas.: 31512-06-8 | Purity: ≥90% | Panasenoside | ESD-934518-1MG |
| Cas.: 31512-06-8 | Purity: ≥90% | Panasenoside | ESD-934518-5MG |
| Cas.: 402513-88-6 | Purity: ≥98% | 23-O-Acetylshengmanol-3-O-α-L-arabinopyranside | ESD-934519-1MG |
| Cas.: 402513-88-6 | Purity: ≥98% | 23-O-Acetylshengmanol-3-O-α-L-arabinopyranside | ESD-934519-5MG |
| Cas.: 517-66-8 | Purity: ≥95% | D-Dicentrine | ESD-934520-1MG |
| Cas.: 517-66-8 | Purity: ≥95% | D-Dicentrine | ESD-934520-5MG |
| Cas.: 55804-74-5 | Purity: ≥98% | Kaempferol 3-O-(2,6-α-L-dirhamnopyranosyl-β-Dglucopyranoside) | ESD-934521-1MG |
| Cas.: 55804-74-5 | Purity: ≥98% | Kaempferol 3-O-(2,6-α-L-dirhamnopyranosyl-β-Dglucopyranoside) | ESD-934521-5MG |
| Cas.: 59787-61-0 | Purity: ≥98% | Cyclosporin C | ESD-934522-1MG |
| Cas.: 59787-61-0 | Purity: ≥98% | Cyclosporin C | ESD-934522-5MG |
| Cas.: 128502-94-3 | Purity: ≥98% | Ophiogenin 3-O-α-L-rhamnopyranosyl-(1→2)-β-D-glucopyranoside | ESD-934523-1MG |
| Cas.: 128502-94-3 | Purity: ≥98% | Ophiogenin 3-O-α-L-rhamnopyranosyl-(1→2)-β-D-glucopyranoside | ESD-934523-5MG |
| Cas.: 108657-10-9 | Purity: ≥98% | Eupalinolide K | ESD-934524-1MG |
| Cas.: 108657-10-9 | Purity: ≥98% | Eupalinolide K | ESD-934524-5MG |
| Cas.: 506410-53-3 | Purity: ≥98% | Graveobioside A | ESD-934525-1MG |
| Cas.: 506410-53-3 | Purity: ≥98% | Graveobioside A | ESD-934525-5MG |
| Cas.: 50980-32-0 | Purity: ≥98% | Ankaflavin | ESD-934526-1MG |
| Cas.: 50980-32-0 | Purity: ≥98% | Ankaflavin | ESD-934526-5MG |
| Cas.: 142998-47-8 | Purity: ≥95% | Salvianolic acid D | ESD-934527-1MG |
| Cas.: 142998-47-8 | Purity: ≥95% | Salvianolic acid D | ESD-934527-5MG |
| Cas.: 364622-33-3 | Purity: ≥98% | Lucidenic acid LM1 | ESD-934528-1MG |
| Cas.: 364622-33-3 | Purity: ≥98% | Lucidenic acid LM1 | ESD-934528-5MG |
| Cas.: 22172-17-4 | Purity: ≥95% | Methylswertianin | ESD-934529-1MG |
| Cas.: 22172-17-4 | Purity: ≥95% | Methylswertianin | ESD-934529-5MG |
| Cas.: 565-48-0 | Purity: ≥98% | 4-p-Menthan-1,8-diol | ESD-934530-1MG |
| Cas.: 565-48-0 | Purity: ≥98% | 4-p-Menthan-1,8-diol | ESD-934530-5MG |
| Cas.: 158732-59-3 | Purity: ≥98% | Salvianolic acid F | ESD-934531-1MG |
| Cas.: 158732-59-3 | Purity: ≥98% | Salvianolic acid F | ESD-934531-5MG |
| Cas.: 108340-60-9 | Purity: ≥98% | Ganoderic acid D | ESD-934532-1MG |
| Cas.: 108340-60-9 | Purity: ≥98% | Ganoderic acid D | ESD-934532-5MG |
| Cas.: 100665-44-9 | Purity: ≥98% | Deacetyl ganoderic acid F | ESD-934533-1MG |
| Cas.: 100665-44-9 | Purity: ≥98% | Deacetyl ganoderic acid F | ESD-934533-5MG |
| Cas.: 110241-23-1 | Purity: ≥98% | Ganoderenic acid E | ESD-934534-1MG |
| Cas.: 110241-23-1 | Purity: ≥98% | Ganoderenic acid E | ESD-934534-5MG |
| Cas.: 1028449-53-7 | Purity: ≥98% | Ganolactone B | ESD-934535-1MG |
| Cas.: 1028449-53-7 | Purity: ≥98% | Ganolactone B | ESD-934535-5MG |
| Cas.: 100665-40-5 | Purity: ≥98% | Ganoderenic acid A | ESD-934536-1MG |
| Cas.: 100665-40-5 | Purity: ≥98% | Ganoderenic acid A | ESD-934536-5MG |
| Cas.: 98665-19-1 | Purity: ≥95% | Ganoderic acid H | ESD-934537-1MG |
| Cas.: 98665-19-1 | Purity: ≥95% | Ganoderic acid H | ESD-934537-5MG |
| Cas.: 17413-38-6 | Purity: ≥98% | Aristolochic acid D | ESD-934538-1MG |
| Cas.: 17413-38-6 | Purity: ≥98% | Aristolochic acid D | ESD-934538-5MG |
| Cas.: 67681-66-7 | Purity: 95% | allyldimethoxymethylsilane | ESD-934539-1G |
| Cas.: 67681-66-7 | Purity: 95% | allyldimethoxymethylsilane | ESD-934539-5G |
| Cas.: 18042-43-8 | Purity: 97% | (2-Allylphenoxy)trimethylsilan | ESD-934540-1G |
| Cas.: 18042-43-8 | Purity: 97% | (2-Allylphenoxy)trimethylsilan | ESD-934540-5G |
| Cas.: 68585-32-0 | Purity: 0.104M in methylvinylcyclosiloxanes | PLATINUM-CYCLOVINYLMETHYLSILOXANE COMPLEX | ESD-934541-1G |
| Cas.: 68585-32-0 | Purity: 0.104M in methylvinylcyclosiloxanes | PLATINUM-CYCLOVINYLMETHYLSILOXANE COMPLEX | ESD-934541-5G |
| Cas.: 75144-60-4 | Purity: 95% | HEXAVINYLDISILOXANE | ESD-934542-1G |
| Cas.: 75144-60-4 | Purity: 95% | HEXAVINYLDISILOXANE | ESD-934542-5G |
| Cas.: 21130-91-6 | Purity: 97% | TRIETHOXY(4-METHOXYPHENYL)SILANE | ESD-934543-1G |
| Cas.: 21130-91-6 | Purity: 97% | TRIETHOXY(4-METHOXYPHENYL)SILANE | ESD-934543-5G |
| Cas.: 111397-62-7 | Purity: 98% | 3,5-bis(1H-benzo[d]imidazol-2-yl)pyridine | ESD-934544-1G |
| Cas.: 111397-62-7 | Purity: 98% | 3,5-bis(1H-benzo[d]imidazol-2-yl)pyridine | ESD-934544-5G |
| Cas.: 672310-11-1 | Purity: 98% | (9H-fluoren-9-yl)methyl3-oxopiperidine-1-carboxylate | ESD-934545-1G |
| Cas.: 672310-11-1 | Purity: 98% | (9H-fluoren-9-yl)methyl3-oxopiperidine-1-carboxylate | ESD-934545-5G |
| Cas.: 73747-40-7 | Purity: 95% | benzyl1-hydroxy-3-phenylpropan-2-ylcarbamate | ESD-934546-1G |
| Cas.: 73747-40-7 | Purity: 95% | benzyl1-hydroxy-3-phenylpropan-2-ylcarbamate | ESD-934546-5G |
| Cas.: 58130-04-4 | Purity: viscosity 450-550cSt (25 C) | (CARBOXYDECYL) TERMINATED POLYDIMETHYLSILOXANE | ESD-934547-1G |
| Cas.: 58130-04-4 | Purity: viscosity 450-550cSt (25 C) | (CARBOXYDECYL) TERMINATED POLYDIMETHYLSILOXANE | ESD-934547-5G |
| Cas.: 158465-59-9 | Purity: viscosity 800-1, 200 cSt (25 C) | (CARBOXYPROPYL) TERMINATED POLYDIMETHYLSILOXANE | ESD-934548-1G |
| Cas.: 158465-59-9 | Purity: viscosity 800-1, 200 cSt (25 C) | (CARBOXYPROPYL) TERMINATED POLYDIMETHYLSILOXANE | ESD-934548-5G |
| Cas.: 945244-93-9 | Purity: viscosity 1300-1800 cSt (25 C) | (BICYCLOHEPTENYL)ETHYL TERMINATED POLYDIMETHYLSILOXANE | ESD-934549-1G |
| Cas.: 945244-93-9 | Purity: viscosity 1300-1800 cSt (25 C) | (BICYCLOHEPTENYL)ETHYL TERMINATED POLYDIMETHYLSILOXANE | ESD-934549-5G |
| Cas.: 308072-58-4 | Purity: viscosity 80-120cSt (25 C) | MERCAPTOPPROPYL TERMINATED POLYDIMETHYLSILOXANE | ESD-934550-1G |
| Cas.: 308072-58-4 | Purity: viscosity 80-120cSt (25 C) | MERCAPTOPPROPYL TERMINATED POLYDIMETHYLSILOXANE | ESD-934550-5G |
| Cas.: 128754-61-0 | Purity: viscosity 60-140cSt (25 C) | (3-ACRYLOXY-2-HYDROXYPROPOXYPROPYL) TERMINATED POLYDIMETHYLSILOXANE | ESD-934551-1G |
| Cas.: 128754-61-0 | Purity: viscosity 60-140cSt (25 C) | (3-ACRYLOXY-2-HYDROXYPROPOXYPROPYL) TERMINATED POLYDIMETHYLSILOXANE | ESD-934551-5G |
| Cas.: 68412-37-3 | Purity: Viscosity 3-5cSt (25 °C) | TETRAETHOXYSILANE, oligomeric hydrolysate | ESD-934552-100G |
| Cas.: 68412-37-3 | Purity: Viscosity 3-5cSt (25 °C) | TETRAETHOXYSILANE, oligomeric hydrolysate | ESD-934552-2KG |
| Cas.: 2373-89-9 | Purity: ≥99% | 4,4-Dimethoxychalcone | ESD-934553-100MG |
| Cas.: 2373-89-9 | Purity: ≥99% | 4,4-Dimethoxychalcone | ESD-934553-1G |
| Cas.: 41530-32-9 | Purity: 97% | Dimethyl2-(3-methoxyallylidene)malonate | ESD-934554-250MG |
| Cas.: 41530-32-9 | Purity: 97% | Dimethyl2-(3-methoxyallylidene)malonate | ESD-934554-1G |
| Cas.: 702641-05-2 | Purity: 98% | (2-Iodo-5-(trifluoromethyl)phenyl)methanol | ESD-934555-250MG |
| Cas.: 702641-05-2 | Purity: 98% | (2-Iodo-5-(trifluoromethyl)phenyl)methanol | ESD-934555-1MG |
| Cas.: 274925-56-3 | Purity: 95% | 3-Bromo-5,6-dihydrobenzo[b]thiophen-7(4H)-one | ESD-934556-500MG |
| Cas.: 274925-56-3 | Purity: 95% | 3-Bromo-5,6-dihydrobenzo[b]thiophen-7(4H)-one | ESD-934556-1G |
| Cas.: 1357384-35-0 | Purity: 95% | tert-Butyl (3S)-3-(4-bromo-1H-pyrazol-1-yl)pyrrolidine-1-carboxylate | ESD-934557-500MG |
| Cas.: 1357384-35-0 | Purity: 95% | tert-Butyl (3S)-3-(4-bromo-1H-pyrazol-1-yl)pyrrolidine-1-carboxylate | ESD-934557-1G |
| Cas.: 113738-22-0 | Purity: 95% | 1-[(2-azidoethoxy)sulfonyl]-4-methylbenzene | ESD-934558-500MG |
| Cas.: 113738-22-0 | Purity: 95% | 1-[(2-azidoethoxy)sulfonyl]-4-methylbenzene | ESD-934558-1G |
| Cas.: 1379355-21-1 | Purity: 95% | 8-Bromo-5-methyl-[1,2,4]triazolo[4,3-a]pyridine | ESD-934559-500MG |
| Cas.: 1379355-21-1 | Purity: 95% | 8-Bromo-5-methyl-[1,2,4]triazolo[4,3-a]pyridine | ESD-934559-1G |
| Cas.: 243835-70-3 | Purity: 95% | 6-chloropyridine-3,4-dicarboxylic acid | ESD-934560-500MG |
| Cas.: 243835-70-3 | Purity: 95% | 6-chloropyridine-3,4-dicarboxylic acid | ESD-934560-1G |
| Cas.: 2109-24-2 | Purity: 95% | 2-(4-Chlorophenyl)-2-methylpropane-1,3-diol | ESD-934561-500MG |
| Cas.: 2109-24-2 | Purity: 95% | 2-(4-Chlorophenyl)-2-methylpropane-1,3-diol | ESD-934561-1G |
| Cas.: 929521-54-0 | Purity: 95% | N-(2-(2-(2-aminoethoxy)ethoxy)ethyl)-2,4-dinitroaniline | ESD-934562-500MG |
| Cas.: 929521-54-0 | Purity: 95% | N-(2-(2-(2-aminoethoxy)ethoxy)ethyl)-2,4-dinitroaniline | ESD-934562-1G |
| Cas.: 937025-28-0 | Purity: 95% | 1-(6-(aminooxy)hexyl)-1H-pyrrole-2,5-dione | ESD-934563-500MG |
| Cas.: 937025-28-0 | Purity: 95% | 1-(6-(aminooxy)hexyl)-1H-pyrrole-2,5-dione | ESD-934563-1G |
| Cas.: 2198312-46-6 | Purity: 95% | tert-butyl (R)-3-(4-bromo-1H-pyrazol-1-yl)pyrrolidine-1-carboxylate | ESD-934564-500MG |
| Cas.: 2198312-46-6 | Purity: 95% | tert-butyl (R)-3-(4-bromo-1H-pyrazol-1-yl)pyrrolidine-1-carboxylate | ESD-934564-1G |
| Cas.: 178685-33-1 | Purity: 95% | 2-(2-(2-azidoethoxy)ethoxy)ethyl 4-methylbenzenesulfonate | ESD-934565-500MG |
| Cas.: 178685-33-1 | Purity: 95% | 2-(2-(2-azidoethoxy)ethoxy)ethyl 4-methylbenzenesulfonate | ESD-934565-1G |
| Cas.: 1454687-19-4 | Purity: 95% | tert-butyl (S)-3-(4-iodo-1H-pyrazol-1-yl)pyrrolidine-1-carboxylate | ESD-934566-500MG |
| Cas.: 1454687-19-4 | Purity: 95% | tert-butyl (S)-3-(4-iodo-1H-pyrazol-1-yl)pyrrolidine-1-carboxylate | ESD-934566-1G |
| Cas.: 951259-19-1 | Purity: 95% | tert-butyl 3-(4-iodo-1H-pyrazol-1-yl)azetidine-1-carboxylate | ESD-934567-500MG |
| Cas.: 951259-19-1 | Purity: 95% | tert-butyl 3-(4-iodo-1H-pyrazol-1-yl)azetidine-1-carboxylate | ESD-934567-1G |
| Cas.: 623565-15-1 | Purity: 95% | 3-ethyl 5-(4-nitrobenzyl) 6,7-dihydropyrazolo[1,5-a]pyrazine-3,5(4H)-dicarboxylate | ESD-934568-500MG |
| Cas.: 623565-15-1 | Purity: 95% | 3-ethyl 5-(4-nitrobenzyl) 6,7-dihydropyrazolo[1,5-a]pyrazine-3,5(4H)-dicarboxylate | ESD-934568-1G |
| Cas.: 1258884-26-2 | Purity: 95% | 2,6-Dichloro-4-methoxy-3-nitropyridine | ESD-934569-500MG |
| Cas.: 1258884-26-2 | Purity: 95% | 2,6-Dichloro-4-methoxy-3-nitropyridine | ESD-934569-1G |
| Cas.: 2376604-10-1 | Purity: 95% | ethyl 1,2-dimethyl-4-oxo-6-(trifluoromethoxy)-1,4-dihydroquinoline-3-carboxylate | ESD-934570-500MG |
| Cas.: 2376604-10-1 | Purity: 95% | ethyl 1,2-dimethyl-4-oxo-6-(trifluoromethoxy)-1,4-dihydroquinoline-3-carboxylate | ESD-934570-1G |
| Cas.: 1374264-44-4 | Purity: 95% | Methyl 5-amino-3-bromo-2-methylbenzoate | ESD-934571-500MG |
| Cas.: 1374264-44-4 | Purity: 95% | Methyl 5-amino-3-bromo-2-methylbenzoate | ESD-934571-1G |
| Cas.: 1257050-19-3 | Purity: 95% | 5-Chlorospiro[2.5]oct-5-ene-6-carbaldehyde | ESD-934572-500MG |
| Cas.: 1257050-19-3 | Purity: 95% | 5-Chlorospiro[2.5]oct-5-ene-6-carbaldehyde | ESD-934572-1G |
| Cas.: 2167659-32-5 | Purity: 95% | 3-bromo-6-fluorophthalic acid | ESD-934573-500MG |
| Cas.: 2167659-32-5 | Purity: 95% | 3-bromo-6-fluorophthalic acid | ESD-934573-1G |
| Cas.: 344309-11-1 | Purity: 95% | 5-bromo-3-fluorophthalic acid | ESD-934574-500MG |
| Cas.: 344309-11-1 | Purity: 95% | 5-bromo-3-fluorophthalic acid | ESD-934574-1G |
| Cas.: 864361-78-4 | Purity: 95% | 4-Amino-2-chloro-3-methylbenzonitrile hydrochloride | ESD-934575-500MG |
| Cas.: 864361-78-4 | Purity: 95% | 4-Amino-2-chloro-3-methylbenzonitrile hydrochloride | ESD-934575-1G |
| Cas.: 1883726-74-6 | Purity: 95% | (6-Chloro-1,2,3,4-tetrahydronaphthalene-1,1-diyl)dimethanol | ESD-934576-500MG |
| Cas.: 1883726-74-6 | Purity: 95% | (6-Chloro-1,2,3,4-tetrahydronaphthalene-1,1-diyl)dimethanol | ESD-934576-1G |
| Cas.: 2566662-61-9 | Purity: 95% | isobutyl 4-hydroxybut-2-ynoate | ESD-934577-500MG |
| Cas.: 2566662-61-9 | Purity: 95% | isobutyl 4-hydroxybut-2-ynoate | ESD-934577-1G |
| Cas.: 40870-15-3 | Purity: 95% | Ethyl 2-(prop-2-yn-1-yl)pent-4-ynoate | ESD-934578-500MG |
| Cas.: 40870-15-3 | Purity: 95% | Ethyl 2-(prop-2-yn-1-yl)pent-4-ynoate | ESD-934578-1G |
| Cas.: 1259512-09-8 | Purity: 95% | Methyl 2-(5-bromo-3-nitropyridin-2-yl)acetate | ESD-934579-500MG |
| Cas.: 1259512-09-8 | Purity: 95% | Methyl 2-(5-bromo-3-nitropyridin-2-yl)acetate | ESD-934579-1G |
| Cas.: 2494-12-4 | Purity: ≥95% | N-acetyldopamine | ESD-934580-250MG |
| Cas.: 2494-12-4 | Purity: ≥95% | N-acetyldopamine | ESD-934580-1G |
| Cas.: 447440-43-9 | Purity: 97% | (S,S)-2-ALLYL-2-CHLORO-3,4-DIMETHYL-5-PHENYL-[1,3,2]-OXAZASILOLIDINE | ESD-934581-1G |
| Cas.: 447440-43-9 | Purity: 97% | (S,S)-2-ALLYL-2-CHLORO-3,4-DIMETHYL-5-PHENYL-[1,3,2]-OXAZASILOLIDINE | ESD-934581-5G |
| Cas.: 1019208-04-8 | Purity: 98% | 3-benzyl-3-azaspiro[bicyclo[3,2,1]octane-8,2′-[1,3]dioxolane] | ESD-934582-250MG |
| Cas.: 1019208-04-8 | Purity: 98% | 3-benzyl-3-azaspiro[bicyclo[3,2,1]octane-8,2′-[1,3]dioxolane] | ESD-934582-1G |
| Cas.: 1009335-39-0 | Purity: 97% | (2S,4R)-benzyl4-hydroxy-2-(hydroxymethyl)pyrrolidine-1-carboxylate | ESD-934583-250MG |
| Cas.: 1009335-39-0 | Purity: 97% | (2S,4R)-benzyl4-hydroxy-2-(hydroxymethyl)pyrrolidine-1-carboxylate | ESD-934583-1G |
| Cas.: 1354017-20-1 | Purity: 95% | (S)-tert-butyl3-bromopiperidine-1-carboxylate | ESD-934584-250MG |
| Cas.: 1354017-20-1 | Purity: 95% | (S)-tert-butyl3-bromopiperidine-1-carboxylate | ESD-934584-1G |
| Cas.: 205688-13-7 | Purity: 97% | (9H-fluoren-9-yl)methyl4-aminophenylcarbamate | ESD-934585-250MG |
| Cas.: 205688-13-7 | Purity: 97% | (9H-fluoren-9-yl)methyl4-aminophenylcarbamate | ESD-934585-1G |
| Cas.: 3528-51-6 | Purity: 98% | 1-benzyl-1H-pyrazol-5-amine | ESD-934586-250MG |
| Cas.: 3528-51-6 | Purity: 98% | 1-benzyl-1H-pyrazol-5-amine | ESD-934586-1G |
| Cas.: 2625-41-4 | Purity: ≥95% | nitrocyclobutane | ESD-934587-250MG |
| Cas.: 2625-41-4 | Purity: ≥95% | nitrocyclobutane | ESD-934587-1G |
| Cas.: 1005785-85-2 | Purity: 95% | 5-tert-butylpyridine-2-carboxylicacid | ESD-934588-250MG |
| Cas.: 1005785-85-2 | Purity: 95% | 5-tert-butylpyridine-2-carboxylicacid | ESD-934588-1G |
| Cas.: 577771-09-6 | Purity: ≥95% | [1,2,3]thiadiazolo[5,4-b]pyridine-6-carboxylicacid | ESD-934589-100MG |
| Cas.: 577771-09-6 | Purity: ≥95% | [1,2,3]thiadiazolo[5,4-b]pyridine-6-carboxylicacid | ESD-934589-1G |
| Cas.: 67762-95-2 | Purity: Viscosity 300-450cSt (25 °C) | [8-10% (EPOXYCYCLOHEXYLETHYL)METHYLSILOXANE] – DIMETHYLSILOXANE COPOLYMER | ESD-934590-100G |
| Cas.: 67762-95-2 | Purity: Viscosity 300-450cSt (25 °C) | [8-10% (EPOXYCYCLOHEXYLETHYL)METHYLSILOXANE] – DIMETHYLSILOXANE COPOLYMER | ESD-934590-1KG |
| Cas.: 187593-69-7 | Purity: Viscosity 15-30cSt (25 °C) | OCTYL-T BRANCHED POLYSILSESQUIOXANE, TRIMETHYLSILYL TERMINATED | ESD-934591-100G |
| Cas.: 187593-69-7 | Purity: Viscosity 15-30cSt (25 °C) | OCTYL-T BRANCHED POLYSILSESQUIOXANE, TRIMETHYLSILYL TERMINATED | ESD-934591-1KG |
| Cas.: 68083-14-7 | Purity: Viscosity 160-230cSt (25 °C) | DIPHENYLSILOXANE – DIMETHYLSILOXANE COPOLYMER | ESD-934592-100G |
| Cas.: 68083-14-7 | Purity: Viscosity 160-230cSt (25 °C) | DIPHENYLSILOXANE – DIMETHYLSILOXANE COPOLYMER | ESD-934592-1KG |
| Cas.: 207925-46-0 | POLY(DIHEXYLSILANE) | ESD-934593-500MG | |
| Cas.: 207925-46-0 | POLY(DIHEXYLSILANE) | ESD-934593-1G | |
| Cas.: 73559-47-4 | Purity: Viscosity 150-300cSt (25 °C) | Phenyl Trimethicone | ESD-934594-25G |
| Cas.: 550-79-8 | Purity: ≥98% | Afromormosine | ESD-934595-5MG |
| Cas.: 100347-96-4 | Purity: ≥90% | Curcumenone | ESD-934596-5MG |
| Cas.: 119152-50-0 | Purity: ≥95% | Glychionide A | ESD-934597-5MG |
| Cas.: 164022-76-8 | Purity: ≥95% | 5,8-Dihydroxy-6,-methoxyflavone-7-O-glucuronide | ESD-934598-5MG |
| Cas.: 211814-30-1 | Purity: ≥98% | Angustanoic acid G | ESD-934599-5MG |
| Cas.: 10762-87-2 | Purity: ≥98% | Macamide Impurity | ESD-934600-20MG |
| Cas.: 91590-76-0 | Purity: ≥95% | Momordicine I | ESD-934601-5MG |
| Cas.: 202526-51-0 | Purity: ≥98% | Sanggenol F | ESD-934602-5MG |
| Cas.: 202526-53-2 | Purity: ≥98% | Sanggenol H | ESD-934603-5MG |
| Cas.: 64938-51-8 | Purity: ≥98% | Schisantherin C | ESD-934604-5MG |
| Cas.: 141360-90-9 | Purity: ≥98% | Polyporusterone C | ESD-934605-5MG |
| Cas.: 1401799-34-5 | Purity: ≥95% | Monnieriside G | ESD-934606-5MG |
| Cas.: 133393-81-4 | Purity: ≥98% | Brandioside | ESD-934607-5MG |
| Cas.: 35890-38-1 | Purity: >95% | 3′-Sialyllactose | ESD-934608-5MG |
| Cas.: 35890-39-2 | Purity: >95% | 6′-Sialyllactose | ESD-934609-5MG |
| Cas.: 21973-23-9 | Purity: >95% | LNFP II | ESD-934610-1MG |
| Cas.: 25541-09-7 | Purity: >95% | LNFP III | ESD-934611-1MG |
| Cas.: 1570-09-8 | Purity: ≥98% | 5,7-Dihydroxy-3,8,4′-trimethoxyflavone | ESD-934612-5MG |
| Cas.: 38990-03-3 | Purity: ≥95% | Gelsevirine | ESD-934613-5MG |
| Cas.: 25905-14-0 | Purity: ≥98%(GC) | Aceticacidlavandulylester | ESD-934614-10MG |
| Cas.: 562043-82-7 | Purity: ≥98% | Ascorbic acid | ESD-934615-10MG |
| Cas.: 142998-46-7 | Purity: ≥98% | Salvianolic acid E | ESD-934616-5MG |
| Cas.: 126485-47-0 | Purity: ≥98% | 11-O-Syringylbergenin | ESD-934617-5MG |
| Cas.: 1011711-05-9 | Purity: ≥98% | Astraisoflavan-7-O-β-D-glucoside | ESD-934618-10MG |
| Cas.: 221317-02-8 | Purity: ≥98% | Anemarrhenasaponin Ia | ESD-934619-10MG |
| Cas.: 163047-23-2 | Purity: ≥98% | Anemarrhenasaponin III | ESD-934620-10MG |
| Cas.: 215776-78-6 | Purity: ≥98% | Cyclocephaloside II | ESD-934621-5MG |
| Cas.: 68027-14-5 | Purity: ≥98% | Pulsatilloside H | ESD-934622-5MG |
| Cas.: 38710-26-2 | Purity: ≥98% | Seneciphylline N-oxide | ESD-934623-5MG |
| Cas.: 51415-00-0 | Purity: ≥95% | Batatasin I | ESD-934624-2MG |
| Cas.: 28338-59-2 | Purity: ≥98% | Cyanidin-3-Rutinosi | ESD-934625-5MG |
| Cas.: 119737-00-7 | Purity: ≥98% | 3,5-Dimethoxy-1-[(6-O-β-D-xylopyranosyl-β-D-glucopyranosyl)oxy]-9H-xanthen-9-one | ESD-934626-2MG |
| Cas.: 483-44-3 | Purity: ≥98% | Cheilanthifoline | ESD-934627-5MG |
| Cas.: 1899-29-2 | Purity: ≥98% | 3-O-Feruloylquinic acid | ESD-934628-5MG |
| Cas.: 54707-47-0 | Purity: ≥95% | Selina-4(15),7(11)-dien-8-one | ESD-934629-2MG |
| Cas.: 511-05-7 | Purity: ≥98% | Sugiol | ESD-934630-2MG |
| Cas.: 20562-03-2 | Purity: ≥98% | alpha-Chaconine | ESD-934631-5MG |
| Cas.: 54483-84-0 | Purity: ≥95% | 3alpha-Dihydrocadambine | ESD-934632-5MG |
| Cas.: 5973-06-8 | Purity: ≥95% | Palmitoylβ-amyrin | ESD-934633-5MG |
| Cas.: 528814-97-3 | Purity: ≥95% | Dehydrodiconiferyl alcohol | ESD-934634-2MG |
| Cas.: 1427162-60-4 | Purity: ≥95% | Valeriandoid F | ESD-934635-50MG |
| Cas.: 1469493-85-3 | Purity: ≥98% | Heishuixiecaoline A | ESD-934636-5MG |
| Cas.: 73256-82-3 | Purity: ≥98% | (-)-Isobicyclogermacrenal | ESD-934637-0.05ML |
| Cas.: 1042441-12-2 | Purity: ≥98% | Cyclobisdemethoxycurcumin | ESD-934638-5MG |
| Cas.: 229971-57-7 | Purity: ≥98% | Pilosidine | ESD-934639-2MG |
| Cas.: 70404-42-1 | Purity: ≥98% | Genistein 7-O-β-D-glucopyranoside-4′-O-[α-L-rhamnopyranosyl-(1→2)-β-D-glucopyranoside] | ESD-934640-5MG |
| Cas.: 60778-00-9 | Purity: ≥95% | Isorhamnetin 3-O-β-D-glucose-7-O-β-D-gentiobioside | ESD-934641-5MG |
| Cas.: 108909-02-0 | Purity: ≥98% | Confusarin | ESD-934642-5MG |
| Cas.: 86630-46-8 | Purity: ≥98% | Nudol | ESD-934643-5MG |
| Cas.: 118169-17-8 | Purity: ≥98% | Denthyrsinin | ESD-934644-5MG |
| Cas.: 94356-24-8 | Purity: ≥98% | Rhaponticin 2”-O-gallate | ESD-934645-5MG |
| Cas.: 94356-23-7 | Purity: ≥98% | Rhaponticin 6”-O-gallate | ESD-934646-5MG |
| Cas.: 101153-41-7 | Purity: ≥95% | Odoriflavene | ESD-934647-5MG |
| Cas.: 36191-03-4 | Purity: ≥98% | Pratensein 7-O-glucopyranoside | ESD-934648-5MG |
| Cas.: 69359-09-7 | Purity: ≥98% | Pendulone | ESD-934649-5MG |
| Cas.: 1181216-84-1 | Purity: ≥90% | Schisanwilsonin I | ESD-934650-2MG |
| Cas.: 119170-51-3 | Purity: ≥98% | Cassiaside B | ESD-934651-5MG |
| Cas.: 461644-90-6 | Purity: ≥95% | 4β,12-dihydroxyguaian-6,10-diene | ESD-934652-5MG |
| Cas.: 176182-06-2 | Purity: ≥98% | Depressine | ESD-934653-5MG |
| Cas.: 157722-21-9 | Purity: ≥98% | Gentiournoside D | ESD-934654-5MG |
| Cas.: 1403984-03-1 | Purity: ≥98% | 6′-O-Cinnamoyl 8-epikingisidic acid | ESD-934655-5MG |
| Cas.: 168009-90-3 | Purity: ≥98% | Achyranthoside C | ESD-934656-5MG |
| Cas.: 168009-91-4 | Purity: ≥98% | Achyranthoside D | ESD-934657-5MG |
| Cas.: 123278-01-3 | Purity: ≥90% | 4′-methoxyagarotetrol | ESD-934658-5MG |
| Cas.: 626236-06-4 | Purity: ≥95% | (5S,6S,7S,8R)-8-Chloro-5,6,7-trihydroxy-2-phenylethyl-5,6,7,8-tetrahydro-4H-chromen-4-one | ESD-934659-5MG |
| Cas.: 1961358-01-9 | Purity: ≥95% | Lanosta-8,20(22)-dien-26-oic acid, 15-hydroxy-3,11,23-trioxo-, (15α,20Z)- | ESD-934660-5MG |
| Cas.: 942936-54-1 | Purity: ≥95% | 7,15-Dihydroxy-4,4,14-trimethyl-3,11-dioxochol-8-en-24-oic acid | ESD-934661-5MG |
| Cas.: 59219-76-0 | Purity: ≥98% | Erigeroside | ESD-934662-5MG |
| Cas.: 147235-17-4 | Purity: ≥98% | Bletilol B | ESD-934663-5MG |
| Cas.: 148225-38-1 | Purity: ≥98% | Arundinin | ESD-934664-5MG |
| Cas.: 151538-56-6 | Purity: ≥98% | Isoarundinin II | ESD-934665-5MG |
| Cas.: 146019-25-2 | Purity: ≥90% | 3-O-Acetyl-11-hydroxy-beta-boswellic acid | ESD-934666-5MG |
| Cas.: 183551-83-9 | Purity: ≥98% | Myrrhone | ESD-934667-5MG |
| Cas.: 1809980-22-0 | Purity: ≥98% | 9-Methymyrrhone | ESD-934668-2MG |
| Cas.: 1809980-25-3 | Purity: ≥98% | (1(10)E,2R*,5R*)-2-methoxy-5-acetoxyfuranogermacr-1(10)-en-6-one | ESD-934669-5MG |
| Cas.: 503456-08-4 | Purity: ≥98% | Iso-sagittatoside A | ESD-934670-5MG |
| Cas.: 6691-83-4 | Purity: ≥98% | Cinobufaginol | ESD-934671-5MG |
| Cas.: 508-79-2 | Purity: ≥95% | Hellebrigenol | ESD-934672-2MG |
| Cas.: 72036-50-1 | Purity: ≥98% | 2″-O-α-L-Rhamnopyranosyl-isovitexin | ESD-934673-1MG |
| Cas.: 14364-08-0 | Purity: ≥98% | 1-caffeoyl-β-D-glucose | ESD-934674-2MG |
| Cas.: 1018898-17-3 | Purity: ≥98% | 7Z-Trifostigmanoside I | ESD-934675-5MG |
| Cas.: 60657-93-4 | Purity: ≥98% | Dihydromollugin | ESD-934676-2MG |
| Cas.: 22255-29-4 | Purity: ≥98% | Lucidin 3-O-glucoside | ESD-934677-2MG |
| Cas.: 29706-59-0 | Purity: ≥98% | Lucidin 3-O-β-primeroside | ESD-934678-2MG |
| Cas.: 517978-25-1 | Purity: ≥98% | Rubiayannone-A | ESD-934679-2MG |
| Cas.: 2170211-22-8 | Purity: ≥98% | Rubipodanone A | ESD-934680-5MG |
| Cas.: 125906-48-1 | Purity: ≥98% | 2-Naphthalenecarboxylic acid,4-(D-glucopyranosyloxy)-1-hydroxy-3-(3-hydroxy-3-methylbutyl)-,methyl ester | ESD-934681-5MG |
| Cas.: 448962-05-8 | Purity: ≥98% | Rubinaphthin A | ESD-934682-5MG |
| Cas.: 87686-88-2 | Purity: ≥95% | 1,3,6-trihydroxy-2-methyl-9,10-anthraquinone-3-O-α-L-rhamnopyranosyl-(1->2)-β-D-glucopyranoside | ESD-934683-5MG |
| Cas.: 173043-38-4 | Purity: ≥98% | 2-Amino-3-carboxy-1,4-naphthoquinone | ESD-934684-5MG |
| Cas.: 1415729-43-9 | Purity: ≥95% | 1,4-dihydroxy-2-carbomethoxy-3-prenylnaphthalene-1-O-β-D-glucopyranoside | ESD-934685-5MG |
| Cas.: 143615-75-2 | Purity: ≥95% | Diacetoxy-6-gingerdiol | ESD-934686-5MG |
| Cas.: 864779-30-6 | Purity: ≥98% | Stachyanthuside A | ESD-934687-2MG |
| Cas.: 1431536-92-3 | Purity: ≥98% | 6-Iodo Diosmin | ESD-934688-1MG |
| Cas.: 117457-34-8 | Purity: ≥95% | (3β,25R)-26-(β-D-Glucopyranosyloxy)furosta-5,20(22)-dien-3-yl 4-O-(6-deoxy-α-L-mannopyranosyl)-β-D-glucopyranoside | ESD-934689-5MG |
| Cas.: 78229-03-5 | Purity: ≥98% | (3β,25R)-26-(β-D-Glucopyranosyloxy)furosta-5,20(22)-dien-3-yl 2-O-(6-deoxy-α-L-mannopyranosyl)-β-D-glucopyranoside | ESD-934690-5MG |
| Cas.: 791849-22-4 | Purity: ≥98% | OphiopogonosideA | ESD-934691-2MG |
| Cas.: 84709-25-1 | Purity: ≥98% | d-Epigalbacin | ESD-934692-5MG |
| Cas.: 38784-73-5 | Purity: ≥98% | Tectoruside | ESD-934693-5MG |
| Cas.: 21446-35-5 | Purity: ≥98% | Guattegaumerine | ESD-934694-5MG |
| Cas.: 102421-42-1 | Purity: ≥95% | yuanamide | ESD-934695-5MG |
| Cas.: 73292-93-0 | Purity: ≥98% | Micromarin F | ESD-934696-5MG |
| Cas.: 790673-00-6 | Purity: ≥95% | Neosalvianen | ESD-934697-5MG |
| Cas.: 7336-40-5 | Purity: ≥98% | N-Acetylcolchamine | ESD-934698-5MG |
| Cas.: 121927-71-7 | Purity: ≥98% | Rosmanolquinone | ESD-934699-5MG |
| Cas.: 182261-83-2 | Purity: ≥98% | Clausine E | ESD-934700-5MG |
| Cas.: 23943-93-3 | Purity: ≥98% | Lappaconine | ESD-934701-5MG |
| Cas.: 1950581-97-1 | Purity: ≥98% | Celosin L | ESD-934702-2MG |
| Cas.: 7336-33-6 | Purity: ≥98% | (-)-3-Demethylcolchicine | ESD-934703-5MG |
| Cas.: 26146-28-1 | Purity: ≥98% | Linderene acetate | ESD-934704-5MG |
| Cas.: 34425-22-4 | Purity: ≥98% | Pelargonidin | ESD-934705-2MG |
| Cas.: 7020-34-0 | Purity: ≥98% | Betulone | ESD-934706-2MG |
| Cas.: 96648-59-8 | Purity: ≥98% | Decuroside V | ESD-934707-2MG |
| Cas.: 131623-13-7 | Purity: ≥95% | Bergaptolo-β-D-gluco-ryranoside | ESD-934708-2MG |
| Cas.: 22413-78-1 | Purity: ≥98% | Anthroyllycoctonine | ESD-934709-1MG |
| Cas.: 139163-15-8 | Purity: ≥98% | Uralenol | ESD-934710-2MG |
| Cas.: 29913-71-1 | Purity: ≥98% | licraside | ESD-934711-5MG |
| Cas.: 2284-31-3 | Purity: ≥98% | Pratensein | ESD-934712-5MG |
| Cas.: 155073-73-7 | Purity: ≥98% | 11-Deoxyalisol B | ESD-934713-5MG |
| Cas.: 61281-20-7 | Purity: ≥98% | Trans-Emodin bianthrone | ESD-934714-2MG |
| Cas.: 366814-43-9 | Purity: ≥98% | Pulsatilloside E | ESD-934715-2MG |
| Cas.: 214681-62-6 | Purity: ≥95% | 25R-Spirostan-4-ene-3,6,12-trione | ESD-934716-5MG |
| Cas.: 50888-49-8 | Purity: ≥98% | (25R)-Spirosta-1,4-diene-3,12-dione | ESD-934717-5MG |
| Cas.: 122677-90-1 | Purity: ≥98% | (25S)-12β-Hydroxyspiros-4-en-3-one | ESD-934718-2MG |
| Cas.: 50888-50-1 | Purity: ≥98% | (25R)-12α-Hydroxyspiros-4-en-3-one | ESD-934719-2MG |
| Cas.: 82872-80-8 | Purity: ≥98% | N-Deacetylranaconitin | ESD-934720-2MG |
| Cas.: 98665-17-9 | Purity: ≥98% | Lucidenic acid E | ESD-934721-5MG |
| Cas.: 71386-38-4 | Purity: ≥98% | Jatropholone B | ESD-934722-5MG |
| Cas.: 173220-07-0 | Purity: ≥98% | Broussonetine A | ESD-934723-5MG |
| Cas.: 1251-84-9 | Purity: ≥94% | 3,5,6,7,3′,4′-Hexamethoxyflavone | ESD-934724-5MG |
| Cas.: 25615-14-9 | Purity: ≥98% | Kaempferol 3,7-di-O-glucoside | ESD-934725-5MG |
| Cas.: 547-17-1 | Purity: ≥98% | Helenien | ESD-934726-1MG |
| Cas.: 89354-45-0 | Purity: ≥98% | Riligustilide | ESD-934727-5MG |
| Cas.: 70420-58-5 | Purity: ≥98% | Fissistigine A | ESD-934728-5MG |
| Cas.: 142449-93-2 | Purity: ≥95% | Myricetin 3-O-β-D-xylopyranosyl(1-2)-β-D-glucopyranoside | ESD-934729-2MG |
| Cas.: 61281-19-4 | Purity: ≥98% | Cis-Emodin bianthrone | ESD-934730-5MG |
| Cas.: 28199-69-1 | Purity: ≥98% | Dihydrodehydrodiconiferyl alcohol | ESD-934731-2MG |
| Cas.: 83327-19-9 | Purity: ≥98% | (-)-Lariciresinol | ESD-934732-2MG |
| Cas.: 125708-06-7 | Purity: ≥98% | Lyciumin A | ESD-934733-5MG |
| Cas.: 125756-66-3 | Purity: ≥98% | Lyciumin B | ESD-934734-5MG |
| Cas.: 4236-48-0 | Purity: ≥98% | Argentinogenin | ESD-934735-5MG |
| Cas.: 28148-89-2 | Purity: ≥93% | Peonidin 3-galactoside chloride | ESD-934736-2MG |
| Cas.: 1392495-12-3 | Purity: ≥98% | kaempferol-3-O-β-D-glucopyranosyl-(1→4)-α-L-rhamnopyranosyl-7-O-β-D-glucopyranosyl(1→4)-α-L-rhamnopyranoside | ESD-934737-2MG |
| Cas.: 1152168-63-2 | Purity: ≥95% | 11(α)-hydroxyNepasaikosaponin k | ESD-934738-2MG |
| Cas.: 2221029-54-3 | Purity: ≥95% | 16β-hydroperoxyalisol B 23-acetate | ESD-934739-2MG |
| Cas.: 898827-00-4 | Purity: ≥98% | Gymnoside IX | ESD-934740-5MG |
| Cas.: 1402242-53-8 | Purity: ≥98% | Acetyllycoposerramine M | ESD-934741-5MG |
| Cas.: 1072789-37-7 | Purity: ≥98% | HirudonucleodisulfideA | ESD-934742-5MG |
| Cas.: 1072789-38-8 | Purity: ≥98% | Hirudonucleodisulfide B | ESD-934743-5MG |
| Cas.: 7224-66-0 | Purity: ≥98% | Coryneine | ESD-934744-10MG |
| Cas.: 28360-49-8 | Purity: ≥97% | Mahanine | ESD-934745-2MG |
| Cas.: 27214-72-8 | Purity: ≥98% | Cyanidin-3-arabinoside | ESD-934746-5MG |
| Cas.: 117405-48-8 | Purity: ≥98% | 4-O-beta-Glucopyranosyl-cis-coumaric acid | ESD-934747-5MG |
| Cas.: 141256-04-4 | Purity: ≥90% | QS-21 | ESD-934748-5MG |
| Cas.: 1146045-40-0 | Purity: ≥98% | 6-hydroxyapigenin-6-O-β-D-glucoside-7-O-β-D-glucuronide | ESD-934749-2MG |
| Cas.: 82841-67-6 | Purity: ≥98% | Pingbeimine A | ESD-934750-5MG |
| Cas.: 97411-46-6 | Purity: ≥98% | Tanshindiol A | ESD-934751-2MG |
| Cas.: 169626-16-8 | Purity: ≥98% | Trichosanatine | ESD-934752-2MG |
| Cas.: 4236-73-1 | Purity: ≥98% | Buxtamine | ESD-934753-5MG |
| Cas.: 51771-49-4 | Purity: ≥98% | Valechlorine | ESD-934754-0.1ML |
| Cas.: 6003-11-8 | Purity: ≥98% | Alizarin 2-methyl ether | ESD-934755-5MG |
| Cas.: 20958-15-0 | Purity: ≥98% | Isotanshinone IIA | ESD-934756-5MG |
| Cas.: 350602-21-0 | Purity: ≥98% | 4-Epi-curcumenol | ESD-934757-5MG |
| Cas.: 76296-73-6 | Purity: ≥98% | Polyphyllin E | ESD-934758-5MG |
| Cas.: 76296-74-7 | Purity: ≥98% | Polyphyllin F | ESD-934759-5MG |
| Cas.: 76296-71-4 | Purity: ≥98% | Polyphyllin C | ESD-934760-5MG |
| Cas.: 66779-34-8 | Purity: ≥98% | Platycodin A | ESD-934761-5MG |
| Cas.: 38647-10-8 | Purity: ≥98% | Tripdiolide | ESD-934762-10MG |
| Cas.: 6920-38-3 | Purity: ≥98% | Luteolin-4′-O-glucoside | ESD-934763-5MG |
| Cas.: 474-60-2 | Purity: ≥98% | Campestanol | ESD-934764-2MG |
| Cas.: 174286-23-8 | Purity: ≥98% | Caohuoside E | ESD-934765-5MG |
| Cas.: 174286-13-6 | Purity: ≥98% | Epimedin K | ESD-934766-5MG |
| Cas.: 133137-58-3 | Purity: ≥98% | Epimedin B1 | ESD-934767-5MG |
| Cas.: 41758-69-4 | Purity: ≥98% | Evonimine | ESD-934768-5MG |
| Cas.: 97399-71-8 | Purity: ≥98% | 3alpha-Hydroxytanshinone IIA | ESD-934769-2MG |
| Cas.: 90-69-7 | Purity: ≥98% | Lobeline | ESD-934770-5MG |
| Cas.: 68144-21-8 | Purity: ≥98% | Jujuboside B1 | ESD-934771-5MG |
| Cas.: 169736-93-0 | Purity: ≥98% | Angelol K | ESD-934772-5MG |
| Cas.: 118325-22-7 | Purity: ≥98% | Licoricesaponin A3 | ESD-934773-5MG |
| Cas.: 119417-96-8 | Purity: ≥98% | Licoricesaponin E2 | ESD-934774-5MG |
| Cas.: 62956-47-2 | Purity: ≥98% | Gomisin F | ESD-934775-5MG |
| Cas.: 28279-72-3 | Purity: ≥98% | Baicalein 6-O-glucoside | ESD-934776-5MG |
| Cas.: 480-79-5 | Purity: ≥98% | Integerrimine | ESD-934777-5MG |
| Cas.: 86450-77-3 | Purity: ≥95% | Sanggenone K | ESD-934778-5MG |
| Cas.: 32455-46-2 | Purity: ≥98% | Cantleyoside | ESD-934779-10MG |
| Cas.: 1067510-31-9 | Purity: ≥98% | 24-Deacetylalisol O | ESD-934780-5MG |
| Cas.: 928148-51-0 | Purity: ≥98% | Alisol O | ESD-934781-5MG |
| Cas.: 194861-70-6 | Purity: ≥98% | Ginsenoside Rs3 | ESD-934782-5MG |
| Cas.: 150135-35-6 | Purity: ≥98% | Qianhucoumarin A | ESD-934783-2MG |
| Cas.: 156041-02-0 | Purity: ≥98% | Qianhucoumarin E | ESD-934784-5MG |
| Cas.: 130464-55-0 | Purity: ≥98% | Peucedanocoumarin I | ESD-934785-5MG |
| Cas.: 1262326-46-4 | Purity: ≥98% | Uralsaponin C | ESD-934786-2MG |
| Cas.: 22212-26-6 | Purity: ≥98% | Dehydroglaucine | ESD-934787-5MG |
| Cas.: 851713-74-1 | Purity: ≥98% | Curculigoside C | ESD-934788-5MG |
| Cas.: 65931-92-2 | Purity: ≥98% | Esculentoside C | ESD-934789-5MG |
| Cas.: 4324-55-4 | Purity: ≥98% | 6-Hydroxykaempferol | ESD-934790-2MG |
| Cas.: 18887-18-8 | Purity: ≥98% | Hydroxytanshinone IIA | ESD-934791-5MG |
| Cas.: 22550-15-8 | Purity: ≥98% | Isocryptotanshinone | ESD-934792-5MG |
| Cas.: 775351-90-1 | Purity: ≥98% | Corylifol B | ESD-934793-5MG |
| Cas.: 38971-41-4 | Purity: ≥97% | Ophiopogonin B | ESD-934794-5MG |
| Cas.: 1078708-72-1 | Purity: ≥98% | Onjisaponin Z | ESD-934795-5MG |
| Cas.: 73069-26-8 | Purity: ≥98% | Praeruptorin D | ESD-934796-5MG |
| Cas.: 23027-91-0 | Purity: ≥98% | Physalin A | ESD-934797-5MG |
| Cas.: 23133-56-4 | Purity: ≥98% | Physalin B | ESD-934798-2MG |
| Cas.: 27503-33-9 | Purity: ≥98% | Physalin C | ESD-934799-2MG |
| Cas.: 54980-22-2 | Purity: ≥98% | Physalin D | ESD-934800-5MG |
| Cas.: 76045-38-0 | Purity: ≥98% | Physalin G | ESD-934801-5MG |
| Cas.: 70241-09-7 | Purity: ≥98% | Physalin H | ESD-934802-2MG |
| Cas.: 1363398-67-7 | Purity: ≥98% | Isophysalin A | ESD-934803-5MG |
| Cas.: 79120-40-4 | Purity: ≥98% | Hannokinol | ESD-934804-5MG |
| Cas.: 117038-80-9 | Purity: ≥98% | Licopyranocoumarin | ESD-934805-5MG |
| Cas.: 197304-01-1 | Purity: ≥98% | Glycyrrhiza flavonol A | ESD-934806-5MG |
| Cas.: 20554-95-4 | Purity: ≥98% | Farradiol | ESD-934807-5MG |
| Cas.: 18525-35-4 | Purity: ≥98% | Stigmast-7-en-3-ol | ESD-934808-2MG |
| Cas.: 20085-85-2 | Purity: ≥98% | Epicurzerenone | ESD-934809-5MG |
| Cas.: 56365-38-9 | Purity: ≥98% | Capillarisin | ESD-934810-5MG |
| Cas.: 86377-53-9 | Purity: ≥98% | Ganoderic acid X | ESD-934811-5MG |
| Cas.: 130430-97-6 | Purity: ≥98% | Pungiolide A | ESD-934812-5MG |
| Cas.: 133882-74-3 | Purity: ≥98% | Soyosaponin Ac | ESD-934813-5MG |
| Cas.: 135272-91-2 | Purity: ≥98% | Soyasaponin Bd | ESD-934814-5MG |
| Cas.: 117210-14-7 | Purity: ≥98% | Soyasaponin Be | ESD-934815-5MG |
| Cas.: 117210-13-6 | Purity: ≥98% | Soyasaponin Be methyl ester | ESD-934816-5MG |
| Cas.: 65604-99-1 | Purity: ≥98% | Diosgenin-3-O-β-D-xylosyl-(1→3)-β-glucoside | ESD-934817-2MG |
| Cas.: 1983-72-8 | Purity: ≥98% | Medicagol | ESD-934818-5MG |
| Cas.: 93551-00-9 | Purity: ≥98% | 17-Hydroxyisolathyrol | ESD-934819-5MG |
| Cas.: 823214-06-8 | Purity: ≥98% | Styraxlignolide F | ESD-934820-5MG |
| Cas.: 1419478-52-6 | Purity: ≥95% | 2,3,4,5-Tetracaffeoyl-D-Glucaric acid | ESD-934821-5MG |
| Cas.: 4965-97-3 | Purity: ≥98% | Bryodulcosigenin | ESD-934822-2MG |
| Cas.: 98942-06-4 | Purity: ≥98% | 3-Feruloyl-1-Sinapoyl sucrose | ESD-934823-5MG |
| Cas.: 137359-82-1 | Purity: ≥98% | 14,15beta-Dihydroxyklaineanone | ESD-934824-5MG |
| Cas.: 173867-04-4 | Purity: ≥98% | Gambogelic acid | ESD-934825-5MG |
| Cas.: 649758-25-8 | Purity: ≥98% | Thalictricoside | ESD-934826-5MG |
| Cas.: 343780-69-8 | Purity: ≥98% | Ginsenoside Rh8 | ESD-934827-5MG |
| Cas.: 83104-86-3 | Purity: ≥98% | (-)-Epicatechin-3-(3”-O-methyl) gallate | ESD-934828-5MG |
| Cas.: 41849-35-8 | Purity: ≥98% | 10-Hydroxy aconitine | ESD-934829-5MG |
| Cas.: 102681-52-7 | Purity: ≥98% | Schisanhenol B | ESD-934830-5MG |
| Cas.: 1311473-28-5 | Purity: ≥98% | Perisesaccharide C | ESD-934831-5MG |
| Cas.: 18016-58-5 | Purity: ≥98% | Quercetin 3-O-glucoside-7-O-rhamnoside | ESD-934832-5MG |
| Cas.: 403861-33-6 | Purity: ≥98% | 6-Methoxykaempferol 3-O-rutinoside | ESD-934833-5MG |
| Cas.: 757202-11-2 | Purity: ≥98% | Eupalinilide C | ESD-934834-5MG |
| Cas.: 757202-14-5 | Purity: ≥98% | Eupalinilide D | ESD-934835-5MG |
| Cas.: 55954-61-5 | Purity: ≥98% | Pseudohypericin | ESD-934836-5MG |
| Cas.: 313054-32-9 | Purity: ≥98% | Deacetyl ophiopojaponin A | ESD-934837-5MG |
| Cas.: 362472-81-9 | Purity: ≥98% | Withanoside IV | ESD-934838-5MG |
| Cas.: 163089-71-2 | Purity: ≥98% | Huperzine C | ESD-934839-5MG |
| Cas.: 950910-16-4 | Purity: ≥98% | 4-methyloxy-Genistin | ESD-934840-5MG |
| Cas.: 88664-08-8 | Purity: ≥98% | 11-Hydroxy-sugiol | ESD-934841-2MG |
| Cas.: 185145-34-0 | Purity: ≥98% | Chrysin 6-C-glucoside 8-C-arabinoside | ESD-934842-2MG |
| Cas.: 147396-02-9 | Purity: ≥95% | Ligupurpuroside B | ESD-934843-5MG |
| Cas.: 96315-53-6 | Purity: ≥98% | Huzhangoside D | ESD-934844-5MG |
| Cas.: 1352001-09-2 | Purity: ≥98% | 3β-acetoxy-eupha-7,25-dien-24(R)-ol | ESD-934845-5MG |
| Cas.: 145134-62-9 | Purity: ≥98% | 6-Hydroxykaempferol-3,6,7-triglucoside | ESD-934846-2MG |
| Cas.: 145134-63-0 | Purity: ≥98% | 6-Hydroxykaempferol 3-Rutinoside-6-glucoside | ESD-934847-2MG |
| Cas.: 96562-88-8 | Purity: ≥98% | Polyschistine A | ESD-934848-5MG |
| Cas.: 144606-83-7 | Purity: ≥98% | Schisanlignone C | ESD-934849-5MG |
| Cas.: 144606-84-8 | Purity: ≥98% | Schisanlignone D | ESD-934850-5MG |
| Cas.: 60008-02-8 | Purity: ≥98% | Glabrone | ESD-934851-5MG |
| Cas.: 951677-22-8 | Purity: ≥95% | Herpetone | ESD-934852-5MG |
| Cas.: 1417789-75-3 | Purity: 97% | (3S,4S)-Tert-butyl3-(hydroxymethyl)-4-methylpyrrolidine-1-carboxylate | ESD-934853-250MG |
| Cas.: 1279034-51-3 | Purity: 98% | ((3S,4S)-4-Methylpyrrolidin-3-yl)methanol | ESD-934854-100MG |
| Cas.: 956293-27-9 | 6-Phenylpyrrolo[2,1-b]thiazole-7-carboxylicacid | ESD-934855-100MG | |
| Cas.: 250674-48-7 | Purity: 97% | 2,7-Naphthyridine-3-carboxylicacid | ESD-934856-250MG |
| Cas.: 298189-53-4 | Purity: 95% | 2-Phenyl-1,8-naphthyridine-4-carboxylicacid | ESD-934857-100MG |
| Cas.: 1267675-85-3 | (2-(Pyridin-4-yl)thiazol-5-yl)methanol | ESD-934858-100MG | |
| Cas.: 640291-96-9 | Purity: 95% | (5-(4-Bromophenyl)isoxazol-3-yl)methanol | ESD-934859-1G |
| Cas.: 958443-39-5 | Purity: ≥98% | 4-Methyl-2-(pyridin-3-yl)thiazole-5-carbaldehyde | ESD-934860-100MG |
| Cas.: 912270-39-4 | Purity: 98% | tert-Butyl 7-formyl-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxylate | ESD-934861-50MG |
| Cas.: 877384-16-2 | Purity: ≥95% | Benzyl((1R,2S)-1-(3,5-bis(trifluoromethyl)phenyl)-1-hydroxypropan-2-yl)carbamate | ESD-934862-100MG |
| Cas.: 925432-73-1 | Purity: 95% | 3,4,5-Trimethoxy-N-(2-(3-((piperazin-1-yl)methyl)imidazo[2,1-b]thiazol-6-yl)phenyl)benzamide | ESD-934863-100MG |
| Cas.: 2741044-00-6 | (R)-2-(Aminomethyl)-4-methylpentan-1-ol | ESD-934864-100MG | |
| Cas.: 74070-10-3 | (E)-4-(4-Cyanophenyl)-2-oxobut-3-enoicacid | ESD-934865-100MG | |
| Cas.: 205805-13-6 | (3R,4R)-Methyl4-(4-chlorophenyl)-1-methylpiperidine-3-carboxylate | ESD-934866-100MG | |
| Cas.: 36770-74-8 | Purity: 97% | 3-Chloro-N-(3,4-dimethoxyphenethyl)-N-methylpropan-1-amine | ESD-934867-100MG |
| Cas.: 121347-07-7 | 4-(3-Isopropyl-1-methyl-1H-indol-2-ylsulfonyl)phenol | ESD-934868-100MG | |
| Cas.: 121346-32-5 | Purity: 95% | N-(3,4-dimethoxyphenethyl)-3-(4-(3-isopropyl-1-methyl-1H-indol-2-ylsulfonyl)phenoxy)-N-methylpropan-1-amine | ESD-934869-10MG |
| Cas.: 191217-24-0 | (1-(3-(4-Methoxyphenyl)propyl)piperidin-4-yl)methanol hydrochloride | ESD-934870-100MG | |
| Cas.: 769892-52-6 | 4-(Trifluoromethyl)-N1-(5-(trifluoromethyl)-2-methoxyphenyl)benzene-1,2-diamine | ESD-934871-100MG | |
| Cas.: 185855-91-8 | 1-Benzyl-N-pentylquinolin-4-iminehydrochloride | ESD-934872-25MG | |
| Cas.: 1485427-12-0 | Purity: 97% | 4-(Aminomethyl)tetrahydro-2H-pyran-4-carboxylicacidhydrochloride | ESD-934873-100MG |
| Cas.: 1222069-16-0 | (S)-2-Amino-N-(2,2-diethoxyethyl)-2-phenyl-N-((pyridin-4-yl)methyl)acetamide | ESD-934874-100MG | |
| Cas.: 1222069-20-6 | (S)-2-Amino-N-(2,2-diethoxyethyl)-3-(naphthalen-1-yl)-N-((pyridin-4-yl)methyl)propanamide | ESD-934875-100MG | |
| Cas.: 179096-71-0 | Purity: 98% | 2-(Tetrahydro-2H-pyran-4-yl)propan-2-amine | ESD-934876-100MG |
| Cas.: 1214369-90-0 | 2-Methyl-3-nitro-5-phenylpyridine | ESD-934877-100MG | |
| Cas.: 1206248-54-5 | Purity: 98% | tert-Butyl3-amino-5H-pyrrolo[3,4-b]pyridine-6(7H)-carboxylate | ESD-934878-100MG |
| Cas.: 1267806-54-1 | (E)-4-(3-Bromophenyl)-2-oxobut-3-enoic acid | ESD-934879-100MG | |
| Cas.: 13333-79-4 | Purity: 97% | 3-Fluoro-4-(methylthio)phenol | ESD-934880-100MG |
| Cas.: 1163692-73-6 | 4-Cyclopropyl-1H-1,2,3-triazole | ESD-934881-100MG | |
| Cas.: 1346948-93-3 | 5-Bromo-4-cyclopropyl-1H-1,2,3-triazole | ESD-934882-100MG | |
| Cas.: 905273-36-1 | Purity: 95% | 3-Bromo-6,7-dihydro-5H-pyrrolo[3,4-b]pyridine | ESD-934883-100MG |
| Cas.: 1195782-84-3 | 2-(4-fluorophenyl)-1,5-dimethyl-3-oxo-2,3-dihydro-1H-pyrazole-4-carboxylicacid | ESD-934884-100MG | |
| Cas.: 185035-28-3 | 6-Formyl-2,3-dihydrobenzo[b][1,4]dioxine-2-carboxylicacid | ESD-934885-1G | |
| Cas.: 13822-06-5 | Purity: 97% | 3-Methylbut-2-en-1-amine | ESD-934886-100MG |
| Cas.: 120404-76-4 | 2-(Hydroxymethyl)-1,5-bis((4-methoxybenzyl)oxy)pyridin-4(1H)-one | ESD-934887-100MG | |
| Cas.: 1158357-67-5 | Purity: 97% | 3-(Trifluoromethyl)-6,7-dihydro-5H-pyrrolo[3,4-b]pyridine hydrochloride | ESD-934888-250MG |
| Cas.: 752213-27-7 | Purity: 95% | 9-Methyl-9H-pyrido[3,4-b]indolehydrochloride | ESD-934889-100MG |
| Cas.: 209215-55-4 | 2,2′-(Pyridine-2,6-diyl)diaceticacid | ESD-934890-100MG | |
| Cas.: 1394121-41-5 | (S)-tert-Butyl4-(3-amino-2-oxopyridin-1(2H)-yl)-5-(cycloheptylamino)-5-oxopentylcarbamate | ESD-934891-100MG | |
| Cas.: 756875-51-1 | Purity: ≥98% | N-(1,3-Dihydroxypropan-2-yl)-2-hexyl-3-oxodecanamide | ESD-934892-25MG |
| Cas.: 795310-12-2 | Imidazo[1,5-a][1,3,5]triazine-2,4(1H,3H)-dione | ESD-934893-100MG | |
| Cas.: 35577-09-4 | Selenophene-3-carboxylicacid | ESD-934894-1G | |
| Cas.: 7651-61-8 | Selenophene-3-carbonitrile | ESD-934895-1G | |
| Cas.: 93780-04-2 | (R)-2-Benzylpent-4-enoicacid | ESD-934896-1G | |
| Cas.: 93780-03-1 | (S)-2-Benzylpent-4-enoicacid | ESD-934897-1G | |
| Cas.: 178306-49-5 | (R)-2-Hydroxy-3-methoxy-3,3-diphenylpropanoicacid | ESD-934898-100MG | |
| Cas.: 1487457-13-5 | N-(1,3-Dihydroxypropan-2-yl)-2-((Z)-hexadec-7-enyl)-3-oxoicos-11-enamide | ESD-934899-1G | |
| Cas.: 173288-96-5 | 16-Methoxyhexadecanoicacid | ESD-934900-1G | |
| Cas.: 369364-52-3 | 18-Methoxyoctadecanoicacid | ESD-934901-1G | |
| Cas.: 55515-78-1 | 14,15,17,18,20,21,23,24-Octahydrodinaphtho[2,1-n:1′,2′-p][1,4,7,10,13]pentaoxacycloheptadecine | ESD-934902-100MG | |
| Cas.: 159213-19-1 | (R)-Ethyl2,5-dioxo-3-(1H-pyrrol-1-yl)pyrrolidine-3-carboxylate | ESD-934903-100MG | |
| Cas.: 184047-29-8 | (2S,3R)-2-(Benzyloxy)pentan-3-yl4-chlorobenzenesulfonate | ESD-934904-1G | |
| Cas.: 114418-32-5 | (2S,3R)-2-(Benzyloxy)pentan-3-ol | ESD-934905-100MG | |
| Cas.: 1895867-66-9 | (S)-2-Methyl-1-(6-nitropyridin-3-yl)piperazine | ESD-934906-1G | |
| Cas.: 41084-80-4 | Purity: 98% | 3-Methylpent-4-en-2-yl benzoate | ESD-934907-250MG |
| Cas.: 1948273-06-0 | Purity: 97% | (2R,4S)-1-((S)-2-Amino-3,3-dimethylbutanoyl)-4-hydroxy-N-((S)-1-(4-(4-methylthiazol-5-yl)phenyl )ethyl)pyrrolidine-2-carboxamide hydrochloride | ESD-934908-250MG |
| Cas.: 623565-12-8 | Purity: 95% | 5-(((4-Nitrobenzyl)Oxy)Carbonyl)-3,3a,4,5,6,7-Hexahydro-[1,2,3]Oxadiazolo[3,4-a]Pyrazin-8-Ium-3 -Olate | ESD-934909-250MG |
| Cas.: 502157-73-5 | Purity: 98% | Tetraphenylphosphonium 3-hydroxynaphthalen-2-olate-naphthalene-2,3-diol | ESD-934910-250MG |
| Cas.: 1198398-71-8 | Purity: ≥98% | Coptisine Sulfate | ESD-934911-25MG |
| Cas.: 18483-17-5 | Purity: ≥98% | 1,3,6-Tri-O-galloyl-beta-D-glucose | ESD-934912-10MG |
| Cas.: 103629-71-6 | Purity: ≥95% | Saikosaponin I | ESD-934913-10MG |
| Cas.: 97871-44-8 | Purity: ≥98% | isotoosendanin | ESD-934914-5MG |
| Cas.: 6859-1-4 | Purity: ≥98% | Isorhychophylline | ESD-934915-20MG |
| Cas.: 1168-42-9 | Purity: ≥95% | Tetramethylscutellarein | ESD-934916-10MG |
| Cas.: 94987-09-4 | Purity: ≥98% | Gypenoside L | ESD-934917-5MG |
| Cas.: 94987-10-7 | Purity: ≥98% | Gypenoside LI | ESD-934918-10MG |
| Cas.: 1707161-17-8 | Purity: ≥98% | 11-Deoxymogroside V | ESD-934919-5MG |
| Cas.: 2146088-12-0 | Purity: ≥98% | 11-epi-morgroside V | ESD-934920-10MG |
| Cas.: 88901-43-3 | Purity: ≥98% | Mogroside III A2 | ESD-934921-5MG |
| Cas.: 6014-42-2 | Purity: ≥98% | aL-Rhamnopyranose | ESD-934922-100MG |
| Cas.: 83459-42-1 | Purity: ≥95% | Ginsenoside Ra2 | ESD-934923-1MG |
| Cas.: 90985-77-6 | Purity: ≥98% | Ginsenoside Ra3 | ESD-934924-1MG |
| Cas.: 1268459-68-2 | Purity: ≥98% | 5,6-Dehydrogensenoside Rd | ESD-934925-10MG |
| Cas.: 299-39-8 | Purity: ≥98% | Sparteine sulfate | ESD-934926-250MG |
| Cas.: 802918-57-6 | Purity: ≥98% | Silymarin | ESD-934927-100MG |
| Cas.: 194851-84-8 | Purity: ≥98% | Jujuboside D | ESD-934928-1MG |
| Cas.: 77757-14-3 | Purity: ≥98% | 13-Dehydroxyindaconintine | ESD-934929-20MG |
| Cas.: 531-58-8 | Purity: ≥98% | cichoriin | ESD-934930-20MG |
| Cas.: 132210-34-5 | Purity: ≥98% | Sanguinarine citrate | ESD-934931-20MG |
| Cas.: 36284-77-2 | Purity: ≥98% | Hedera saponin B | ESD-934932-5MG |
| Cas.: 112448-39-2 | Purity: ≥98% | 3′-Demethylnobiletin | ESD-934933-5MG |
| Cas.: 38337-25-6 | Purity: ≥98% | 3-O-β-D-Glucopyranosylplatycodigenin | ESD-934934-5MG |
| Cas.: 125265-68-1 | Purity: ≥98% | Asiaticoside B | ESD-934935-5MG |
| Cas.: 82601-41-0 | Purity: ≥98% | Pseudolaric Acid C | ESD-934936-10MG |
| Cas.: 98665-22-6 | Purity: ≥98% | Ganoderic acid G | ESD-934937-5MG |
| Cas.: 1085273-49-9 | Purity: ≥98% | 23S-hydroxyl-11,15-dioxo-ganoderic acid DM | ESD-934938-5MG |
| Cas.: 548-03-8 | Purity: ≥95% | Protohypericin | ESD-934939-5MG |
| Cas.: 911819-08-4 | Purity: ≥98% | ophiopojaponin C | ESD-934940-5MG |
| Cas.: 82475-03-4 | Purity: ≥98% | Baicalin methyl ester | ESD-934941-10MG |
| Cas.: 1004988-75-3 | Purity: ≥95% | Nodoginsenoside FP2 | ESD-934942-5MG |
| Cas.: 524-20-9 | Purity: ≥98% | Armepavine | ESD-934943-5MG |
| Cas.: 19275-46-8 | Purity: ≥98% | 3-Isomangostin | ESD-934944-5MG |
| Cas.: 59653-37-1 | Purity: ≥98% | Sarracenin | ESD-934945-5MG |
| Cas.: 219944-39-5 | Purity: ≥98% | Aescin C | ESD-934946-5MG |
| Cas.: 219944-46-4 | Purity: ≥95% | Isoescin IB | ESD-934947-5MG |
| Cas.: 23725-05-5 | Purity: ≥98% | Chebulic acid | ESD-934948-5MG |
| Cas.: 55696-57-6 | Purity: ≥98% | Quercetin 3-O-rutinoside-(1→2)-O-rhamnoside | ESD-934949-5MG |
| Cas.: 490-67-5 | Purity: ≥98% | Gaultherin | ESD-934950-20MG |
| Cas.: 18309-73-4 | Purity: ≥98% | Fabiatrin | ESD-934951-5MG |
| Cas.: 19906-72-0 | Purity: ≥98% | Bakkenolide A | ESD-934952-20MG |
| Cas.: 179464-23-4 | Purity: ≥98% | Terrestrosin D | ESD-934953-5MG |
| Cas.: 109008-28-8 | Purity: ≥98% | Mauritianin | ESD-934954-5MG |
| Cas.: 81991-99-3 | Purity: ≥98% | Lancerin | ESD-934955-5MG |
| Cas.: 335354-79-5 | Purity: ≥98% | Raddeanoside 20 | ESD-934956-5MG |
| Cas.: 214146-75-5 | Purity: ≥98% | 26-Deoxycimicifugoside | ESD-934957-5MG |
| Cas.: 62687-22-3 | Purity: ≥98% | Handelin | ESD-934958-5MG |
| Cas.: 80358-06-1 | Purity: ≥98% | Tinnevellin glucoside | ESD-934959-5MG |
| Cas.: 52250-35-8 | Purity: ≥98% | Isomucronulatol | ESD-934960-5MG |
| Cas.: 174391-64-1 | Purity: ≥98% | Tsugaric acid A | ESD-934961-5MG |
| Cas.: 149457-83-0 | Purity: ≥98% | Hypocrellin C | ESD-934962-5MG |
| Cas.: 6659-45-6 | Purity: ≥96% | dihydrorotenone | ESD-934963-5MG |
| Cas.: 67968-40-5 | Purity: ≥98% | Sipeimine-3β-D-glucoside | ESD-934964-10MG |
| Cas.: 27740-96-1 | Purity: ≥98% | Salsolinol | ESD-934965-10MG |
| Cas.: 5171-37-9 | Purity: ≥98% | Rhynchophylline E | ESD-934966-5MG |
| Cas.: 115712-88-4 | Purity: 98% | Adonifoline | ESD-934967-5G |
| Cas.: 6028-07-5 | Purity: ≥98% | HARMALOL HCL | ESD-934968-5MG |
| Cas.: 83218-34-2 | Purity: ≥98% | Dehydrocorydaline | ESD-934969-5MG |
| Cas.: 123483-19-2 | Purity: ≥98% | 3-O-Caffeoylquinic acid methyl ester | ESD-934970-10MG |
| Cas.: 60037-39-0 | Purity: ≥98% | Nuezhenoside G13 | ESD-934971-5MG |
| Cas.: 4375-07-9 | Purity: ≥98% | (-)-Epipodophyllotoxin | ESD-934972-10MG |
| Cas.: 6743-92-6 | Purity: ≥98% | Isorhamnetin-3-O-galactoside | ESD-934973-5MG |
| Cas.: 1435488-35-9 | Purity: ≥95% | Shancigusin I | ESD-934974-20MG |
| Cas.: 53007-06-0 | Purity: ≥98% | N-Formylcytisine | ESD-934975-1MG |
| Cas.: 915792-03-9 | Purity: ≥98% | Acanthopanaxoside B | ESD-934976-5MG |
| Cas.: 72229-42-6 | Purity: ≥98% | Neolinustatin | ESD-934977-5MG |
| Cas.: 123694-03-1 | Purity: ≥98% | Osmundacetone | ESD-934978-10MG |
| Cas.: 66036-38-2 | Purity: ≥98% | (±)-EQUOL | ESD-934979-20MG |
| Cas.: 58175-87-4 | Purity: ≥98% | Hydroxychloroquine sulfate Impurity 23 | ESD-934980-10MG |
| Cas.: 58175-86-3 | Purity: ≥98% | Hydroxychloroquine sulfate Impurity 24 | ESD-934981-10MG |
| Cas.: 68422-01-5 | Purity: ≥98% | Hapepunine | ESD-934982-5MG |
| Cas.: 96997-98-7 | Purity: ≥98% | Delavinone | ESD-934983-5MG |
| Cas.: 30219-16-0 | Purity: ≥98% | Arenobufagin 3-hemisuberate | ESD-934984-5MG |
| Cas.: 24512-59-2 | Purity: ≥95% | 19-Oxocinobufagin | ESD-934985-5MG |
| Cas.: 17008-65-0 | Purity: ≥98% | Bufarenogin | ESD-934986-5MG |
| Cas.: 212701-97-8 | Purity: ≥98% | Xanthiazone | ESD-934987-2MG |
| Cas.: 508-01-0 | Purity: ≥98% | Soyasapogenol A | ESD-934988-5MG |
| Cas.: 1195968-02-5 | Purity: ≥98% | Daidzein 7-O-beta-D-glucoside 4”-O-methylate | ESD-934989-5MG |
| Cas.: 94898-61-0 | Purity: ≥98% | Glycoside O-4 | ESD-934990-2MG |
| Cas.: 60451-47-0 | Purity: ≥98% | Cauloside F | ESD-934991-5MG |
| Cas.: 149155-01-1 | Purity: ≥95% | Cratoxylone | ESD-934992-5MG |
| Cas.: 72361-67-2 | Purity: ≥95% | Laetanine | ESD-934993-5MG |
| Cas.: 92935-94-9 | Purity: ≥98% | Angelicide | ESD-934994-5MG |
| Cas.: 136171-87-4 | Purity: ≥95% | Lobetyol | ESD-934995-5MG |
| Cas.: 142451-65-8 | Purity: ≥98% | Kaempferol-3-O-β-D-glucosyl(1-2)rhamnoside | ESD-934996-5MG |
| Cas.: 1206615-69-1 | Purity: ≥98% | Geranyl ferulate | ESD-934997-5MG |
| Cas.: 20853-58-1 | Purity: ≥98% | Hederoside D2 | ESD-934998-5MG |
| Cas.: 23496-43-7 | Purity: ≥98% | Isoverticine | ESD-934999-1MG |
| Cas.: 345954-00-9 | Purity: ≥98% | Wilfornine A | ESD-935000-5MG |
| Cas.: 20279-06-5 | Purity: ≥98% | Homodihydrocapsaicin I | ESD-935001-5MG |
| Cas.: 205687-01-0 | Purity: ≥98% | Capsiate | ESD-935002-10MG |
| Cas.: 36948-77-3 | Purity: ≥98% | Oroxylin A-7-O-glucoside | ESD-935003-5MG |
| Cas.: 19056-75-8 | Purity: ≥98% | 2-(2,4-dimethoxyphenyl)-5-hydroxy-3,7-dimethoxy-4H-chromen-4-one | ESD-935004-5MG |
| Cas.: 343780-68-7 | Purity: ≥95% | Gensenoside Rh7 | ESD-935005-5MG |
| Cas.: 87733-67-3 | Purity: ≥98% | Ginsenoside Rs1 | ESD-935006-5MG |
| Cas.: 87733-66-2 | Purity: ≥98% | Ginsenoside Rs2 | ESD-935007-5MG |
| Cas.: 98474-74-9 | Purity: ≥98% | Pseudoginsenoside RT1 | ESD-935008-5MG |
| Cas.: 53584-69-3 | Purity: ≥95% | Isorhamnetin-3-O-robinobioside | ESD-935009-5MG |
| Cas.: 887606-04-4 | Purity: ≥98% | Epigambogic acid | ESD-935010-5MG |
| Cas.: 271579-12-5 | Purity: ≥98% | Thonningianin B | ESD-935011-5MG |
| Cas.: 69256-15-1 | Purity: ≥98% | (+)-Leucocyanidin | ESD-935012-5MG |
| Cas.: 1147861-80-0 | Purity: ≥93% | D-Gluconic acid, 6-[(2E)-3-(3,4-dihydroxyphenyl)-2-propenoate] | ESD-935013-5MG |
| Cas.: 40242-06-6 | Purity: ≥98% | 5-O-Ferruloylquinic acid | ESD-935014-5MG |
| Cas.: 20987-24-0 | Purity: ≥98% | Resibufagin | ESD-935015-5MG |
| Cas.: 24512-60-5 | Purity: ≥98% | 19-Oxocinobufotalin | ESD-935016-5MG |
| Cas.: 465-90-7 | Purity: ≥98% | Bufotalidin | ESD-935017-5MG |
| Cas.: 39844-86-5 | Purity: ≥98% | 19-Hydroxybufalin | ESD-935018-5MG |
| Cas.: 866366-86-1 | Purity: ≥98% | Xanthiside | ESD-935019-5MG |
| Cas.: 38226-84-5 | Purity: ≥98% | Filixic acid ABA | ESD-935020-5MG |
| Cas.: 1324005-51-7 | Purity: ≥97% | β-D-Glucopyranoside,(3β,6α,16β,20R,24S)-3-[(3,4-di-O-acetyl-β-D-xylopyranosyl)oxy]-20, 24-epoxy-16,25 -dihydroxy-9,19-cyclolanostan-6-yl | ESD-935021-5MG |
| Cas.: 142674-16-6 | Purity: ≥98% | 6-Hydroxykaempferol 3,6-diglucoside | ESD-935022-5MG |
| Cas.: 145134-61-8 | Purity: ≥98% | 6-Hydroxykaempferol 3-O-β-D-glucoside | ESD-935023-5MG |
| Cas.: 205527-00-0 | Purity: ≥98% | 6-Hydroxykaempferol 3-β-rutinoside | ESD-935024-5MG |
| Cas.: 392274-22-5 | Purity: ≥98% | Oxyresveratrol 2-O-β-D-glucopyranoside | ESD-935025-5MG |
| Cas.: 144525-40-6 | Purity: ≥95% | Oxyresveratrol 3′-O-β-D-glucopyranoside | ESD-935026-5MG |
| Cas.: 98665-15-7 | Purity: ≥95% | Ganoderic acid F | ESD-935027-5MG |
| Cas.: 95311-97-0 | Purity: ≥98% | Ganoderic acid C1 | ESD-935028-5MG |
| Cas.: 97653-94-6 | Purity: ≥95% | Ganoderic acid D2 | ESD-935029-2MG |
| Cas.: 98665-20-4 | Purity: ≥98% | Ganoderic acid I | ESD-935030-5MG |
| Cas.: 110241-19-5 | Purity: ≥98% | Ganoderic acid N | ESD-935031-5MG |
| Cas.: 508182-41-0 | Purity: ≥99% | Ganoderic acid LM2 | ESD-935032-5MG |
| Cas.: 100665-41-6 | Purity: ≥98% | Ganoderenic acid B | ESD-935033-5MG |
| Cas.: 942950-96-1 | Purity: ≥98% | 12-Hydroxyganoderic acid D | ESD-935034-5MG |
| Cas.: 400604-12-8 | Purity: ≥98% | 20-Hydroxyganoderic acid G | ESD-935035-5MG |
| Cas.: 1961358-02-0 | Purity: ≥95% | (3β,7β,12β,20Z )- 3,7,12-trihydroxy-11,15,23-trioxo-lanost-8,20-dien-26-oic acid | ESD-935036-5MG |
| Cas.: 125150-67-6 | Purity: ≥98% | OJV-VI | ESD-935037-5MG |
| Cas.: 125225-63-0 | Purity: ≥98% | 25(S)-Ruscogenin 1-O-α-L-rhamnopyranosyl-(1→2)-β-D-xylopyranoside | ESD-935038-5MG |
| Cas.: 1111088-89-1 | Purity: ≥98% | 14α-hydroxy Sprengerinin C | ESD-935039-5MG |
| Cas.: 74805-90-6 | Purity: ≥98% | Methylophiopogonone A | ESD-935040-5MG |
| Cas.: 487-93-4 | Purity: ≥98% | Bufotenin | ESD-935041-10MG |
| Cas.: 15983-86-5 | Purity: 97% | BUTENYLMETHYLDICHLOROSILANE | ESD-935042-10G |
| Cas.: 68957-05-1 | Purity: viscosity 70-75cSt(25 °C) | 2-[Chloro(phenyl)methyl]-1,2-oxasilinane | ESD-935043-100G |
| Cas.: 68037-82-1 | Purity: viscosity 80-150cSt(25 °C) | VINYLPHENYLMETHYLTERMINATED(30-40%PHENYLMETHYLSILOXANE)-VINYLPHENYLSILOXANECOPOLYMER | ESD-935044-100G |
| Cas.: 104780-61-2 | Purity: average Mw 8000-10000 | (METHACRYLOXYPROPYL)METHYLSILOXANE, DIMETHYLSILOXANE COPOLYMER | ESD-935045-10G |
| Cas.: 1614238-37-7 | Purity: average Mw 650-1000 | (methacryloxypropyl)methylsiloxane, homopolymer | ESD-935046-25G |
| Cas.: 67923-18-6 | Purity: average Mw 570-620 | MethacryloxypropylT-StructureSiloxane | ESD-935047-25G |
| Cas.: 69861-02-5 | Purity: 98% | N-(3-METHACRYLOXY-2-HYDROXYPROPYL)-3-AMINOPROPYLTRIETHOXYSILANE | ESD-935048-5G |
| Cas.: 67762-97-4 | Purity: 97% | Poly(Methylsilsesquioxane), Ethoxy Terminated | ESD-935049-5G |
| Cas.: 314270-00-3 | Purity: 97% | PROPYLTRIETHOXYSILANE | ESD-935050-100G |
| Cas.: 1385031-14-0 | Purity: 97% | POLY(OCTYLSILSESQUIOXANE), ETHOXY TERMINATED | ESD-935051-25G |
| Cas.: 160185-24-0 | Purity: average Mw 1200-2500 | METHACRYL-POSS CAGE MIXTURE | ESD-935052-25G |
| Cas.: 1403369-35-6 | Purity: 97% | (80-85% Octylsilsesquioxane) – (15-20% Mercaptopropylsilsesquioxane) Copolymer,Ethoxy Terminated | ESD-935053-25G |
| Cas.: 102783-03-9 | Purity: average Mw 6000-8000 | (MERCAPTOPPROPYL)METHYLSILOXANE – DIMETHYLSILOXANE COPOLYMERS | ESD-935054-25G |
| Cas.: 778577-34-7 | Purity: average Mw 4000-7000 | (MERCAPTOPPROPYL)METHYLSILOXANEHOMOPOLYMER | ESD-935055-100G |
| Cas.: 10519-97-8 | Purity: 96% | ALLYLAMINOTRIMETHYLSILANE | ESD-935056-1G |
| Cas.: 202483-49-6 | Purity: 97% | (15-20% Dimethylsiloxane)(Bisphenol-A Carbonate) Copolymer | ESD-935057-100G |
| Cas.: 952595-39-0 | Purity: 97% | (POLYDIMETHYLSILOXANE)-[(MDI/PHMO)URETHANE] block copolymer | ESD-935058-100G |
| Cas.: 70131-69-0 | Purity: average Mw 1200-1600 | POLY(PHENYLSILSESQUIOXANE) | ESD-935059-100G |
| Cas.: 18387-26-3 | Purity: 97% | 1-ALLYL-1,1,3,3-TETRAMETHYLDISILOXANE | ESD-935060-5G |
| Cas.: 73138-88-2 | Purity: 97% | (PHENYLSILSESQUIOXANE)-(DIMETHYLSILOXANE) COPOLYMER | ESD-935061-100G |
| Cas.: 181186-36-7 | Purity: average Mw 1400-1600 | PHENYL-METHYLSILSESQUIOXANE-PHENYLMETHYLSILOXANE-DIPHENYLSILOXANE TETRAPOLYMER | ESD-935062-100G |
| Cas.: 68037-90-1 | Purity: average Mw 1500-1800 | POLY(PHENYL-PROPYLSILESQUIOXANE) | ESD-935063-100G |
| Cas.: 1353244-79-7 | Purity: 97% | POLY[(OCTADECYLDIMETHYLAMMONIUMCHLORIDE)PROPYLSILSESQUIOXANE] | ESD-935064-100G |
| Cas.: 214362-07-9 | Purity: 97% | N,N’-BIS(HYDROXYETHYL)-N,N’-BIS(TRIMETHOXYSILYLPROPYL)ETHYLENEDIAMINE | ESD-935065-25G |
| Cas.: 1274903-53-5 | Purity: 97% | N-(ACETYLGLYCYL)-3-AMINOPROPYLTRIMETHOXYSILANE | ESD-935066-25G |
| Cas.: 851814-19-2 | Purity: 97% | Trifluoropropyl POSS Cage Mixture | ESD-935067-10G |
| Cas.: 182635-99-0 | (TETRAMETHYLPIPERIDINYL)OXYPROPYLMETHYLSILOXANE-DIMETHYLSILOXANE COPOLYMER, TRIMETHYLSILOXY TERMINATED | ESD-935068-100G | |
| Cas.: 158061-40-6 | Purity: 97% | (ACRYLOXYPROPYL)METHYLSILOXANE-DIMETHYLSILOXANE COPOLYMER | ESD-935069-100G |
| Cas.: 67923-19-7 | Purity: average Mw 550-650 | VINYLMETHYLSILOXANE – DIMETHYLSILOXANE COPOLYMERS, TRIMETHYLSILOXY TERMINATED, SILANOL TERMINATED | ESD-935070-100G |
| Cas.: 68083-18-1 | Purity: viscosity 800-1200 cSt(25 °C) | VINYLMETHYLSILOXANE, DIMETHYLSILOXANE COPOLYMER, VINYL TERMINATED | ESD-935071-100G |
| Cas.: 29434-25-1 | Purity: 97% | VINYLETHOXYSILOXANE HOMOPOLYMER | ESD-935072-100G |
| Cas.: 68952-02-3 | Purity: 97% | Siloxanes and Silicones, Me 3,3,3-trifluoropropyl, Me vinyl, hydroxy-terminated | ESD-935073-100G |
| Cas.: 68037-87-6 | Purity: average Mw 1000-1500 | VINYLMETHYLSILOXANE HOMOPOLYMER | ESD-935074-100G |
| Cas.: 68584-83-8 | Purity: 50%inxylene | VINYL Q RESIN | ESD-935075-100G |
| Cas.: 126581-51-9 | Purity: viscosity 5-8cSt(25 °C) | VINYL T-STRUCTURE POLYMER | ESD-935076-100G |
| Cas.: 68440-84-6 | Purity: 25%inisopropanol | METHOXYMETHYLSILOXANE, DIMETHYLSILOXANE COPOLYMER | ESD-935077-100G |
| Cas.: 179005-02-8 | Purity: viscosity 150-300cSt(25 °C) | (N-PYRROLIDONEPROPYL)METHYLSILOXANE-DIMETHYLSILOXANE COPOLYMER | ESD-935078-100G |
| Cas.: 179005-03-9 | Purity: viscosity 400-600cSt(25 °C) | (N-Pyrrolidonepropyl)methylsiloxane | ESD-935079-100G |
| Cas.: 67762-86-1 | Purity: viscosity 800-1400cSt(25 °C) | POLY(CYANOPROPYLMETHYLSILOXANE) | ESD-935080-10G |
| Cas.: 18163-34-3 | Purity: 97% | 2-ACETOXYETHYLMETHYLDICHLOROSILANE | ESD-935081-25G |
| Cas.: 22538-45-0 | Purity: 97% | ACETOXYETHYLTRIETHOXYSILANE | ESD-935082-25G |
| Cas.: 1356113-09-1 | Purity: 97% | ACETOXYETHYLTRIS(DIMETHYLAMINO)SILANE | ESD-935083-10G |
| Cas.: 14697-86-0 | Purity: 97% | ACETOXYHEPTAMETHYLCYCLOTETRASILOXANE | ESD-935084-25G |
| Cas.: 627882-90-0 | Purity: 97% | ACETOXYPHENETHYLTRICHLOROSILANE | ESD-935085-10G |
| Cas.: 18044-09-2 | Purity: 97% | 3-(3-ACETOXYPROPYL)HEPTAMETHYLTRISILOXANE | ESD-935086-25G |
| Cas.: 5290-24-4 | Purity: 97% | 3-ACETOXYPROPYL METHYL DICHLOROSILANE | ESD-935087-25G |
| Cas.: 53605-77-9 | Purity: 97% | 11-ACETOXYUNDECYLTRICHLOROSILANE | ESD-935088-10G |
| Cas.: 959053-85-1 | Purity: 97% | 11-ACETOXYUNDECYLTRIETHOXYSILANE | ESD-935089-1G |
| Cas.: 41591-87-1 | Purity: 97% | TETRADECYLDIMETHYL(3-TRIMETHOXYSILYLPROPYL)AMMONIUM CHLORIDE | ESD-935090-25G |
| Cas.: 136856-91-2 | Purity: 50%inisopropanol | TRIMETHOXYSILYLPROPYL MODIFIED POLYETHYLENIMINE | ESD-935091-100G |
| Cas.: 57577-96-5 | Purity: 95% | 3-ACRYLAMIDOPROPYLTRIMETHOXYSILANE | ESD-935092-10G |
| Cas.: 115258-10-1 | Purity: 95% | 3-ACRYLAMIDOPROPYLTRIS(TRIMETHYLSILOXY)SILANE | ESD-935093-10G |
| Cas.: 18269-99-3 | Purity: 97% | 2-(ACRYLOXYETHOXY)TRIMETHYLSILANE | ESD-935094-25G |
| Cas.: 21134-38-3 | Purity: 97% | ACRYLOXYMETHYL TRIMETHOXYSILANE | ESD-935095-25G |
| Cas.: 141813-19-6 | Purity: 95% | (Acryloxymethyl)phenethyltrimethoxysilanestore | ESD-935096-10G |
| Cas.: 67186-35-0 | Purity: 97% | ACRYLOXYMETHYLTRIMETHYLSILANE | ESD-935097-10G |
| Cas.: 146666-71-9 | Purity: 95% | (3-ACRYLOXYPROPYL)METHYLDIETHOXYSILANE | ESD-935098-25G |
| Cas.: 68959-20-6 | Purity: 97% | N,N-DIDECYL-N-METHYL-N-(3-TRIMETHOXYSILYLPROPYL)AMMONIUM CHLORIDE | ESD-935099-25G |
| Cas.: 618914-49-1 | Purity: 97% | N-ALLYL-AZA-2,2-DIMETHOXYSILACYCLOPENTANE | ESD-935100-10G |
| Cas.: 1871-21-2 | Purity: 95% | TRIVINYLCHLOROSILANE | ESD-935101-10G |
| Cas.: 166970-54-3 | Purity: 97% | ALLYL(CHLOROPROPYL)DICHLOROSILANE | ESD-935102-5G |
| Cas.: 18147-35-8 | Purity: 97% | ALLYLDIMETHOXYSILANE | ESD-935103-5G |
| Cas.: 106948-24-7 | Purity: 97% | ALLYL(DIISOPROPYLAMINO)DIMETHYLSILANE | ESD-935104-10G |
| Cas.: 1300591-79-0 | Purity: 97% | 3-(N-ACETYL-4-HYDROXYPROLYLOXY)PROPYLTRIETHOXYSILANE | ESD-935105-5G |
| Cas.: 68469-60-3 | Purity: 98% | ALLYL(4-METHOXYPHENYL)DIMETHYLSILANE | ESD-935106-1ML |
| Cas.: 1367348-25-1 | Purity: 97% | N-(N-ACETYLLEUCYL)-3-AMINOPROPYLTRIETHOXYSILANE | ESD-935107-1G |
| Cas.: 1114235-08-3 | Purity: 97% | Allyl Octadecyl Methylsilane | ESD-935108-1G |
| Cas.: 162781-70-6 | Purity: 97% | HYDROXYMETHYLTRIETHOXYSILAN | ESD-935109-25G |
| Cas.: 1196453-35-6 | Purity: 97% | 11-ALLYLOXYUNDECYLTRIMETHOXYSILANE | ESD-935110-5G |
| Cas.: 7719-03-1 | Purity: 95% | ALLYLPHENYLDICHLOROSILANE | ESD-935111-50G |
| Cas.: 1356114-60-7 | Purity: 97% | m-ALLYLPHENYLPROPYLTRIETHOXYSILANE | ESD-935112-5G |
| Cas.: 137125-44-1 | Purity: average Mw 3000-5000 | Poly(Hydridosilsesquioxane) | ESD-935113-10G |
| Cas.: 18752-21-1 | Purity: 97% | ALLYLTRIPHENYLSILANE | ESD-935114-1G |
| Cas.: 31024-49-4 | Purity: 95% | (AMINOETHYLAMINO)-3-ISOBUTYLDIMETHYLMETHOXYSILANE | ESD-935115-25G |
| Cas.: 1621184-23-3 | Purity: 95% | 1-[3-(2-aminoethyl)-3-aminoisobutyl]-1,1,3,3,3-pentaethoxy-1,3-disilapropane | ESD-935116-10G |
| Cas.: 68400-09-9 | Purity: 97% | N-(2-AMINOETHYL)-3-AMINOPROPYL-SILANTRIOL | ESD-935117-100G |
| Cas.: 18246-33-8 | Purity: 97% | N-AMINOETHYL-AZA-2,2,4-TRIMETHYLSILACYCLOPENTANE | ESD-935118-10G |
| Cas.: 70411-42-6 | Purity: 95% | M-AMINOPHENYLTRIMETHOXYSILANE | ESD-935119-5G |
| Cas.: 153487-58-2 | Purity: 95% | 3-AMINOPROPYLDIMETHYLFLUOROSILANE | ESD-935120-10G |
| Cas.: 23029-21-2 | Purity: 97% | 3-AMINOPROPYLPENTAMETHYLDISILOXANE | ESD-935121-5G |
| Cas.: 87994-64-7 | Purity: 95% | -AMINOPROPYLTRIS(METHOXYETHOXYETHOXY)SILANE | ESD-935122-25G |
| Cas.: 116821-45-5 | Purity: 97% | 11-AMINOUNDECYLTRIETHOXYSILANE | ESD-935123-1G |
| Cas.: 3768-55-6 | Purity: 97% | N-TRIMETHYLSILYLANILINE | ESD-935124-25G |
| Cas.: 1189556-60-2 | Purity: 95% | 9-Anthracenyl Trimethoxysilane | ESD-935125-25G |
| Cas.: 58572-15-9 | Purity: 97% | APOPHYLLITE, PIECES | ESD-935126-250G |
| Cas.: 2079045-60-4 | Purity: 97% | AZIDOETHYLPOLY(ETHYLENEOXY)PROPYLTRIETHOXYSILANE(16-20EO) | ESD-935127-100MG |
| Cas.: 1245946-78-4 | Purity: 90% | (AZIDOMETHYL)PHENETHYLTRIMETHOXYSILANE | ESD-935128-5G |
| Cas.: 83315-74-6 | Purity: 90% | p-AZIDOMETHYLPHENYLTRIMETHOXYSILANE | ESD-935129-1G |
| Cas.: 96550-26-4 | Purity: 95% | 6-AZIDOSULFONYLHEXYLTRIETHOXYSILANE | ESD-935130-25G |
| Cas.: 97057-70-0 | Purity: 0.5Mincyclohexane | 3-T-BUTYLDIMETHYLSILOXYPROPYLLITHIUM | ESD-935131-50G |
| Cas.: 917773-12-7 | Purity: 90% | Triethoxsilylbutyraldehyde | ESD-935132-10G |
| Cas.: 862822-32-0 | Purity: 95% | N-(3-Trimethoxysilylpropyl)Palmitamide | ESD-935133-5G |
| Cas.: 199111-50-7 | Purity: 5%aqueous solution | 1-Octadecanaminium, N,N-dimethyl-N-[3-(trihydroxysilyl)propyl] chloride | ESD-935134-100G |
| Cas.: 20152-11-8 | Purity: 97% | 1,1,4,4-TETRAMETHYLDISILETHYLENE | ESD-935135-5G |
| Cas.: 26903-85-5 | Purity: 97% | 2,2-DIMETHOXY-1-THIA-2-SILACYCLOPENTANE | ESD-935136-25G |
| Cas.: 104780-63-4 | Purity: viscosity 600-1000cSt(25 °C) | α-MONOVINYL-Ω-MONOHYDRIDE TERMINATED POLYDIMETHYLSILOXANE | ESD-935137-100G |
| Cas.: 13596-23-1 | Purity: 96% | octachlorotrisilane | ESD-935138-10G |
| Cas.: 383189-04-6 | Purity: 97% | BORON VINYLDIMETHYLSILOXIDE | ESD-935139-10G |
| Cas.: 131298-48-1 | Purity: 97% | VINYLMETHYLSILOXANE HOMOPOLYMER | ESD-935140-100G |
| Cas.: 51772-85-1 | Purity: 90% | 3-[tris(acetoxy)silyl]propyl methacrylate | ESD-935141-25G |
| Cas.: 60871-86-5 | Purity: 97% | 3-(TRIETHOXYSILYLPROPYL)-P-NITROBENZAMIDE | ESD-935142-25G |
| Cas.: 68323-30-8 | Purity: 95% | (BICYCLOHEPTENYL)ETHYL]TRIMETHOXYSILANE | ESD-935143-25G |
| Cas.: 68909-20-6 | Purity: 97% | SILICA | ESD-935144-500G |
| Cas.: 3937-30-2 | Purity: 95% | ALLYLDIMETHYLSILANE | ESD-935145-5G |
| Cas.: 39443-39-5 | Purity: 97% | SILICLAD | ESD-935146-100G |
| Cas.: 80906-67-8 | Purity: 97% | N-(3-TRIMETHOXYSILYLPROPYL)PYRROLE | ESD-935147-5G |
| Cas.: 18171-59-0 | Purity: 95% | (DICHLOROMETHYL)DIMETHYLCHLOROSILANE | ESD-935148-25G |
| Cas.: 131206-15-0 | Purity: 97% | (R)-N-1-PHENYLETHYL-N’-TRIETHOXYSILYLPROPYLUREA | ESD-935149-25G |
| Cas.: 29159-37-3 | Purity: 97% | AMINOPROPYLSILANETRIOL | ESD-935150-100G |
| Cas.: 71783-41-0 | Purity: 95% | 3-(2,4-DINITROPHENYLAMINO)PROPYLTRIETHOXYSILANE | ESD-935151-25G |
| Cas.: 877593-17-4 | Purity: 95% | 11-MERCAPTOUNDECYLTRIMETHOXYSILANE | ESD-935152-1G |
| Cas.: 259727-10-1 | Purity: 97% | N,N-DIOCTYL-N’-TRIETHOXYSILYLPROPYLUREA | ESD-935153-25G |
| Cas.: 68479-60-7 | Purity: 97% | 4-[2-(trimethoxysilyl)ethyl]benzene-1-sulphonyl azide | ESD-935154-25G |
| Cas.: 54076-73-2 | Purity: 95% | NORBORNENYLETHYLTRICHLOROSILANE | ESD-935155-25G |
| Cas.: 4364-07-2 | Purity: 97% | 1,4-DISILABUTANE | ESD-935156-5G |
| Cas.: 885275-56-9 | Purity: 90% | (1H,1H,2H,2H-Perfluorotetradecyl)tris(ethoxy)silane | ESD-935158-5G |
| Cas.: 70851-50-2 | DIMETHOXYMETHYL-N-OCTADECYLSILANE | ESD-935159-500G | |
| Cas.: 19116-61-1 | Purity: 97% | 3-(HEPTAFLUOROISOPROPOXY)PROPYLTRIMETHOXYSILANE | ESD-935160-10G |
| Cas.: 17963-32-5 | Purity: 97% | 11-CHLOROUNDECYLTRICHLOROSILANE | ESD-935161-10G |
| Cas.: 5851-07-0 | Purity: 95% | Hexamethoxydisilane | ESD-935162-5G |
| Cas.: 689252-00-1 | Purity: 97% | MONO VINYL FUNCTIONAL POLYDIMETHYLSILOXANE-SYMMETRIC | ESD-935163-100G |
| Cas.: 75009-88-0 | Purity: average Mw 600-800 | BIS[(3-METHYLDIMETHOXYSILYL)PROPYL]POLYPROPYLENE OXIDE | ESD-935164-100G |
| Cas.: 19309-90-1 | Purity: 95% | METHACRYLOXYPROPYLBIS(TRIMETHYLSILOXY)METHYLSILANE | ESD-935165-10G |
| Cas.: 429-67-4 | Purity: 97% | Tetramethyl tetra-3-trifluoropropyl cyclotetrasiloxane | ESD-935166-1G |
| Cas.: 181186-29-8 | Purity: 97% | POLY(PHENYL-METHYLSILSESQUIOXANE) | ESD-935167-100G |
| Cas.: 98299-74-2 | Purity: 97% | 2-(4-PYRIDYLETHYL)TRIETHOXYSILANE | ESD-935168-10G |
| Cas.: 558-63-4 | Purity: 97% | di-t-butyldifluorosilane | ESD-935169-5G |
| Cas.: 116047-42-8 | Purity: 95% | 11-(TRIETHOXYSILYL)UNDECANAL | ESD-935170-5G |
| Cas.: 526204-46-6 | Purity: 97% | 11-PHENOXYUNDECYLTRICHLOROSILANE | ESD-935171-5G |
| Cas.: 17082-69-8 | Purity: 97% | 2-[2-(TRICHLOROSILYL)ETHYL]PYRIDINE | ESD-935172-25G |
| Cas.: 85807-85-8 | Purity: 97% | ALLYL(TERT-BUTYLDIMETHY1)SILYLETHER | ESD-935173-10G |
| Cas.: 121225-98-7 | Purity: 95% | tetrakis[(epoxycyclohexyl)ethyl]tetramethylcyclotetrasiloxane | ESD-935174-25G |
| Cas.: 349656-50-4 | Purity: 97% | POLY(2-ACETOXYETHYLSILSESQUIOXANE) | ESD-935175-100G |
| Cas.: 1314639-86-5 | Purity: 97% | DI-t-BUTYLISOBUTYLSILYL TRIFLUOROMETHANESULFONATE | ESD-935176-10G |
| Cas.: 5796-98-5 | Purity: 97% | BIS(TRIMETHYLSILYL)PEROXIDE | ESD-935177-5G |
| Cas.: 188969-12-2 | Purity: average Mw 800-1400 | POLY(2-CHLOROETHYLSILSESQUIOXANE) | ESD-935178-100G |
| Cas.: 666829-33-0 | Purity: 97% | BIS(3-TRIETHOXYSILYLPROPYL)POLYETHYLENE OXIDE(25-30EO) | ESD-935179-25G |
| Cas.: 84494-81-5 | Purity: 97% | P-(T-BUTYLDIMETHYLSILOXY)STYRENE | ESD-935180-10G |
| Cas.: 17096-10-5 | Purity: 95% | 3-METHACRYLOXYPROPYLTRIS(VINYLDIMETHYLSILOXY)SILANE | ESD-935181-50G |
| Cas.: 1411854-75-5 | Purity: average Mw 250-500 | AMINOPROPYLSILSESQUIOXANE IN AQUEOUS SOLUTION | ESD-935182-100G |
| Cas.: 201603-69-2 | Purity: 97% | 4,4′-BIS(DIMETHYLETHOXYSILYL)BIPHENYL | ESD-935183-1G |
| Cas.: 119386-82-2 | Purity: 97% | dimethyl(3,3,4,4,5,5,6,6,6-nonafluorohexyl)chlorosilane | ESD-935184-10G |
| Cas.: 17948-05-9 | Purity: 97% | 11-CHLOROUNDECYLTRIMETHOXYSILANE | ESD-935185-10G |
| Cas.: 18159-55-2 | Purity: 95% | TRI-T-BUTYLSILANE | ESD-935186-1G |
| Cas.: 17947-91-0 | Purity: 95% | 3,8-Dioxa-4,7-disiladec-5-yne, 4,4,7,7-tetraethoxy- | ESD-935187-5G |
| Cas.: 72905-90-9 | Purity: 50%involatilesilicone | TRIETHOXYSILYL MODIFIED POLY-1,2-BUTADIENE | ESD-935188-100G |
| Cas.: 1364140-50-0 | Purity: 97% | 2-(3-TRIMETHOXYSILYLPROPYLTHIO)THIOPHENE | ESD-935189-10G |
| Cas.: 154380-34-4 | Purity: 97% | N-(3-Trimethoxysilylpropyl)Perfluorohexanamide | ESD-935190-10G |
| Cas.: 17998-59-3 | Purity: 97% | (1-NAPHTHYLMETHYL)TRICHLOROSILANE | ESD-935191-10G |
| Cas.: 620987-03-3 | Purity: 97% | 1,2-BIS(TRICHLOROSILYL)DECANE | ESD-935192-25G |
| Cas.: 29098-72-4 | Purity: 97% | 2-(2-PYRIDYLETHYL)THIOPROPYLTRIMETHOXYSILANE | ESD-935193-10G |
| Cas.: 35192-54-2 | Purity: 97% | 1,6-BIS(TRICHLOROSILYLETHYL)DODECAFLUOROHEXANE | ESD-935194-5G |
| Cas.: 6591-26-0 | Purity: 97% | N-(DICHLOROBORYL)HEXAMETHYLDISILAZANE | ESD-935195-10G |
| Cas.: 33525-68-7 | Purity: 90% | TRIETHOXYSILYLPROPYLMALEAMIC ACID | ESD-935196-25G |
| Cas.: 13270-97-8 | Purity: 95% | 3,5-DIPHENYLOCTAMETHYLTETRASILOXANE | ESD-935197-25G |
| Cas.: 1309595-29-6 | Purity: 97% | N-(TRIMETHOXYSILYLPROPYL)ETHYLENEDIAMINETRIACETATE, TRIPOTASSIUM SALT | ESD-935198-25G |
| Cas.: 56275-01-5 | Purity: 97% | Trimethylsioxysilicate | ESD-935199-100G |
| Cas.: 17882-06-3 | Purity: 97% | TRIMETHYLSILYLBENZENESULFONATE | ESD-935200-25G |
| Cas.: 86138-01-4 | Purity: 97% | 5,6-Epoxyhexyltriethoxysilane | ESD-935201-10G |
| Cas.: 107602-27-7 | Purity: 95% | BIS(TRICHLOROSILYLETHYL)BENZENE | ESD-935202-25G |
| Cas.: 198570-38-6 | Purity: 95% | NORBORNENYL ETHYL METHYL DICHLOROSILANE | ESD-935203-25G |
| Cas.: 117046-42-1 | Purity: 97% | 2-(BICYCLOHEPTYL)DIMETHYLCHLOROSILANE | ESD-935204-25G |
| Cas.: 106996-32-1 | Purity: 95% | N-[5-(TRIMETHOXYSILYL)-2-AZA-1-OXOPENTYL]CAPROLACTAM | ESD-935205-25G |
| Cas.: 1184179-50-7 | Purity: 90% | (1-(3-TRIETHOXYSILYL)PROPYL)-2,2-DIETHOXY-1-AZA-2-SILACYCLOPENTANE | ESD-935206-25G |
| Cas.: 773893-02-0 | Purity: 97% | 5-BROMOPENTYLTRIMETHOXYSILANE | ESD-935207-10G |
| Cas.: 18171-56-7 | Purity: 95% | BIS(CHLOROMETHYL)METHYLCHLOROSILANE | ESD-935208-25G |
| Cas.: 98789-40-3 | Purity: 97% | DIMETHYLTETRAMETHOXYDISILETHYLENE | ESD-935209-10G |
| Cas.: 151778-80-2 | Purity: 97% | 3-{[DIMETHYL(3-TRIMETHOXYSILYL)PROPYL]AMMONIO}PROPANE-1-SULFONATE | ESD-935210-25G |
| Cas.: 18171-50-1 | Purity: 97% | 1,3-BIS(TRICHLOROSILYL)PROPANE | ESD-935211-10G |
| Cas.: 871-41-0 | Purity: 97% | N-HEPTYLTRICHLOROSILANE | ESD-935212-25G |
| Cas.: 3410-32-0 | Purity: 97% | 3-(DIMETHYLSILOXY)-1,1,5,5-TETRAMETHYL-3-(3,3,3-TRIFLUOROPROPYL) TRISILOXANE | ESD-935213-25G |
| Cas.: 330457-42-6 | Purity: 95% | 11-BROMOUNDECYLDIMETHYLCHLOROSILANE | ESD-935214-10G |
| Cas.: 87290-97-9 | Purity: 97% | PHENYLETHYNYLDIMETHYLSILANE | ESD-935215-5G |
| Cas.: 943349-49-3 | Purity: 97% | METHOXYETHOXYUNDECYLTRICHLOROSILANE | ESD-935216-5G |
| Cas.: 865811-59-2 | Purity: 97% | 1,5-BIS(GLYCIDOXYPROPYL)-3-PHENYL-1,1,3,5,5-PENTAMETHYLTRISILOXANE | ESD-935217-25G |
| Cas.: 15721-05-8 | Purity: 95% | HEPTAMETHYL CYCLOTETRASILOXANE | ESD-935218-10G |
| Cas.: 207308-27-8 | Purity: average Mw 250-500 | SILSESQUIOXANE OLIGOMER, AMINOPROPYL, VINYL TERMINATED | ESD-935219-100G |
| Cas.: 13508-63-9 | Purity: 97% | (3-chloropropyl)ethoxydimethylsilane | ESD-935220-25G |
| Cas.: 3371-62-8 | Purity: 96% | bis[3-(trimethoxysilyl)propyl] fumarate | ESD-935221-25G |
| Cas.: 931-70-4 | Purity: 97% | P-TOLYLSILANE | ESD-935222-10G |
| Cas.: 16712-25-7 | Purity: 97% | COPPER(II) TRIFLUOROACETATE HYDRATE | ESD-935223-5G |
| Cas.: 4170-50-7 | Purity: 97% | 1,2-DIBROMOETHYLTRICHLOROSILANE | ESD-935224-10G |
| Cas.: 17196-12-2 | Purity: 95% | 7-OCTENYLDIMETHYLCHLOROSILANE | ESD-935225-25G |
| Cas.: 1873-92-3 | Purity: 95% | ALLYLDICHLOROMETHYLSILANE | ESD-935226-25ML |
| Cas.: 17878-39-6 | Purity: 97% | METHYLPHENYLVINYLSILANE | ESD-935227-10G |
| Cas.: 76490-69-2 | Purity: 97% | Bis(Dimethylmethoxysilyl)Ethane | ESD-935228-10G |
| Cas.: 18001-60-0 | Purity: 95% | 1,1,3,3-TETRAETHOXY-1,3-DIMETHYLDISILOXANE | ESD-935229-25G |
| Cas.: 69519-51-3 | Purity: 97% | 1,3-DI-N-OCTYLTETRAMETHYLDISILAZANE | ESD-935230-10G |
| Cas.: 4099-46-1 | Purity: 97% | [BIS(TRIMETHYLSILYL)]SELENIDE | ESD-935231-1G |
| Cas.: 35312-82-4 | Purity: 97% | 3,3,7,7-Tetramethoxy-2,8-dioxa-3,7-disilanonane | ESD-935232-100G |
| Cas.: 18817-29-3 | Purity: 95% | 5-HEXENYLTRICHLOROSILANE | ESD-935233-10G |
| Cas.: 68156-13-8 | Purity: 97% | Diphenyl(4-phenylthio)phenylsufonium hexafluorophosphate | ESD-935234-25G |
| Cas.: 35239-30-6 | Purity: 97% | P-TOLYLDIMETHYLCHLOROSILANE | ESD-935235-5G |
| Cas.: 807-28-3 | Purity: 97% | 1,1,3,3-TETRAPHENYL-1,3-DIMETHYLDISILOXANE | ESD-935236-25G |
| Cas.: 68583-49-3 | Purity: 97% | 2,2,4,4,6,6,8,8-octamethyl-1,3,5,7,2,4,6,8-tetraoxatetrasilocane | ESD-935237-500G |
| Cas.: 123198-57-2 | Purity: 50%inethanol | N-(3-ACRYLOXY-2-HYDROXYPROPYL)-3-AMINOPROPYLTRIETHOXYSILANE | ESD-935238-25G |
| Cas.: 201615-10-3 | Purity: average Mw 600-1000 | Siloxanes and silicones, ethoxy Pr, ethoxy vinyl, ethoxy terminated | ESD-935239-100G |
| Cas.: 12627-14-4 | Purity: 97% | LITHIUMPOLYSILICATE | ESD-935240-100G |
| Cas.: 29528-30-1 | Purity: 96% | 2-(pyridin-2-yl)aniline | ESD-935241-5G |
| Cas.: 1219429-81-8 | Purity: 96% | 2-amino-2-cyclopropylaceticacidhydrochloride | ESD-935242-5G |
| Cas.: 444620-69-3 | Purity: ≥95% | tert-butyl4-(isoquinolin-5-yl)piperazine-1-carboxylate | ESD-935243-1G |
| Cas.: 1666734-64-1 | Purity: 98% | (S)-2-aminohept-6-enoicacid | ESD-935244-1G |
| Cas.: 166734-94-1 | Purity: 98% | 1-benzyl-1,2,3,4-tetrahydroisoquinoline | ESD-935245-1G |
| Cas.: 155413-72-2 | Purity: 95% | 1-benzyl-1,2,3,4-tetrahydroisoquinoline | ESD-935246-1G |
| Cas.: 1022985-41-6 | Purity: ≥95% | (R)-2-methyl-4-nitrobutan-1-ol | ESD-935247-1G |
| Cas.: 75776-67-9 | Purity: ≥95% | (S)-4-oxopyrrolidine-2-carboxylicacidhydrobromide | ESD-935248-1G |
| Cas.: 382637-47-0 | Purity: 97% | 3-(4-fluorobenzyl)piperidine | ESD-935249-1G |
| Cas.: 745817-38-3 | Purity: 97% | 3-(4-fluorobenzyl)piperidinehydrochloride | ESD-935250-1G |
| Cas.: 382637-45-8 | Purity: ≥98% | tert-butyl3-(4-fluorobenzyl)piperidine-1-carboxylate | ESD-935251-1G |
| Cas.: 59049-84-2 | Purity: 98% | 1,3-bis(benzo[d]oxazol-2-yl)benzene | ESD-935252-1G |
| Cas.: 1190315-89-9 | Purity: ≥95% | 8-bromoquinoline-4-carbonitrile | ESD-935253-1G |
| Cas.: 1190315-99-1 | Purity: 98% | (8-bromoquinolin-4-yl)methanol | ESD-935254-1G |
| Cas.: 1190320-17-2 | Purity: 97% | (8-bromoquinolin-4-yl)methanamine | ESD-935255-1G |
| Cas.: 1190320-18-3 | Purity: ≥95% | (8-bromoquinolin-4-yl)methanamine2,2,2-trifluoroacetate | ESD-935256-1G |
| Cas.: 5944-41-2 | Purity: ≥98% | 2-tert-butylpyridine | ESD-935257-1G |
| Cas.: 39919-58-9 | Purity: ≥98% | 5-bromo-2-tert-butylpyridine | ESD-935258-1G |
| Cas.: 192323-44-7 | Purity: 98% | 2-chloro-6-fluoroquinazolin-4-amine | ESD-935259-1G |
| Cas.: 20028-72-2 | Purity: 97% | 6-fluoroquinazolin-2-amine | ESD-935260-1G |
| Cas.: 105658-49-9 | Purity: ≥95% | 3-(3-methylisoxazol-5-yl)propan-1-ol | ESD-935261-1G |
| Cas.: 87875-48-7 | Purity: ≥95% | 4-hydroxy-4-(nitromethyl)cyclohexanone | ESD-935262-1G |
| Cas.: 1629477-47-9 | Purity: 98% | (9H-fluoren-9-yl)methyl3-aminophenylcarbamate | ESD-935263-1G |
| Cas.: 139644-77-2 | Purity: 98% | 2-amino-3-phenylpropane-1-sulfonicacid | ESD-935264-1G |
| Cas.: 40217-17-2 | Purity: ≥98% | 4-benzyloxazolidin-2-one | ESD-935265-5G |
| Cas.: 195622-41-4 | Purity: ≥95% | 2-methyl-5-(trifluoromethoxy)benzoicacid | ESD-935266-1G |
| Cas.: 2222573-30-8 | Purity: 98% | (3R,4S)-4-(3-ethoxy-4-methoxyphenyl)tetrahydrofuran-3-ol | ESD-935267-1G |
| Cas.: 478829-34-4 | Purity: 97% | 1H-indazole-5-carboxamide | ESD-935268-1G |
| Cas.: 45776-13-4 | Purity: 95% | 4-amino-1-methyl-1H-pyrrole-2-carboxylicacid | ESD-935269-1G |
| Cas.: 1023710-54-4 | Purity: 98% | tert-butyl(R)-1-((R)-5-(cyclopropylmethyl)-1-(2,2,2-trifluoroethyl)-2,3,4,5-tetrahydro-2-oxo-1H-benzo[ b][1,4]diazepin-3-ylcarbamoyl)-2-phenylethylcarbamate | ESD-935270-1G |
| Cas.: 114165-30-9 | Purity: 97% | 1-(5-bromo-3-hydroxy-1H-indol-1-yl)ethanone | ESD-935271-1G |
| Cas.: 1223748-47-7 | Purity: 95% | tert-butyl4-formylbenzo[d]thiazol-2-ylcarbamate | ESD-935272-1G |
| Cas.: 39129-54-9 | Purity: ≥95% | 2,4-dibromo-3,5-dimethylthiophene | ESD-935273-1G |
| Cas.: 36955-33-6 | Purity: 98% | 3-bromo-5-(methylthio)-1,2,4-thiadiazole | ESD-935274-1G |
| Cas.: 208517-75-3 | Purity: ≥95% | 4-oxocyclopent-2-enecarboxylicacid | ESD-935275-1G |
| Cas.: 146984-79-4 | Purity: ≥95% | 3-chloro-6-hydroxy-2-methoxybenzoicacid | ESD-935276-1G |
| Cas.: 47448-66-8 | Purity: ≥95% | 3-(1-benzyl-1H-indazol-3-yloxy)-N,N-diethylpropan-1-amine | ESD-935277-50MG |
| Cas.: 61-94-9 | Purity: ≥95% | ethyl1-methyl-1,2,5,6-tetrahydropyridine-3-carboxylatehydrochloride | ESD-935278-5MG |
| Cas.: 4279-81-6 | Purity: 97% | 3,3-diphenylpropanal | ESD-935279-1G |
| Cas.: 1092563-81-9 | Purity: 98% | 8-bromo-3,4-dihydronaphthalen-2(1H)-one | ESD-935280-1G |
| Cas.: 1260674-83-6 | Purity: ≥95% | 2-(6-BroMopyridin-2-yl)aceticacidhydrochloride | ESD-935281-1G |
| Cas.: 76330-16-0 | Purity: ≥95% | 5-(hydroxymethyl)furan-2-carbaldehyde | ESD-935282-1G |
| Cas.: 914639-05-7 | Purity: ≥95% | methyl2-(bromomethyl)isonicotinate | ESD-935283-1G |
| Cas.: 960235-22-7 | Purity: 95% | ethyl5-formylthiazole-2-carboxylate | ESD-935284-1G |
| Cas.: 960235-24-9 | Purity: ≥95% | ethyl5-(bromomethyl)thiazole-2-carboxylate | ESD-935285-1G |
| Cas.: 65146-54-5 | Purity: 97% | 2-amino-1-(2,4-dichlorophenyl)ethanonehydrochloride | ESD-935286-1G |
| Cas.: 59820-92-7 | Purity: 98% | 6-bromo-7-nitro-2,3-dihydrobenzo[b][1,4]dioxine | ESD-935287-1G |
| Cas.: 1253850-61-1 | Purity: ≥95% | 3-(dimethylamino)-4-methoxybenzoicacidhydrochloride | ESD-935288-1G |
| Cas.: 1414958-77-2 | Purity: ≥95% | 6,7-Dihydro-5H-cyclopenta[c]pyridin-5-onehydrochloride | ESD-935289-1G |
| Cas.: 203508-62-7 | Purity: 98% | 1-((3S)-6-methyl-7-oxabicyclo[4,1,0]heptan-3-yl)ethanone | ESD-935290-1G |
| Cas.: 111613-38-8 | Purity: ≥95% | 1-((1R,3S,6S)-6-methyl-7-oxa-bicyclo[4,1,0]heptan-3-yl)ethanone | ESD-935291-1G |
| Cas.: 111613-37-7 | Purity: 98% | 1-((1S,3S,6R)-6-methyl-7-oxa-bicyclo[4,1,0]heptan-3-yl)ethanone | ESD-935292-1G |
| Cas.: 1380680-16-9 | Purity: 98% | tert-butyl2-(3-hydroxyphenyl)cyclopropylcarbamate | ESD-935293-1G |
| Cas.: 456527-46-1 | Purity: 98% | (S)-tert-butyl1-(benzylamino)-4-hydroxy-1-oxobutan-2-ylcarbamate | ESD-935294-1G |
| Cas.: 1196052-98-8 | Purity: 97% | N-((2S)-4-(3-(2-aminocyclopropyl)phenoxy)-1-(benzylamino)-1-oxobutan-2-yl)benzamidehydrochloride | ESD-935295-1G |
| Cas.: 1196119-03-5 | Purity: 98% | N-((S)-1-(benzylcarbamoyl)-3-(3-(2-aminocyclopropyl)phenoxy)propyl)benzamide | ESD-935296-1G |
| Cas.: 1147222-02-3 | Purity: ≥95% | 1,3-dimethyl-1H-pyrazol-4-aminehydrochloride | ESD-935297-1G |
| Cas.: 934475-93-1 | Purity: ≥95% | 4-(aminomethyl)cyclohexanone | ESD-935298-1G |
| Cas.: 1205750-10-2 | Purity: 97% | 4-(aminomethyl)cyclohexanonehydrochloride | ESD-935299-1G |
| Cas.: 1080644-24-1 | Purity: ≥95% | 2-(2-(2-fluorophenyl)-5-hydroxy-8-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidine-6-carboxamido)aceticacid | ESD-935300-1G |
| Cas.: 1101864-58-7 | Purity: ≥98% | 2-hydroxyquinolin-3-ylboronicacid | ESD-935301-1G |
| Cas.: 909187-40-2 | Purity: ≥95% | (2-Fluoro-6-(methylamino)pyridin-3-yl)boronic acid | ESD-935302-1G |
| Cas.: 21573-15-9 | Purity: ≥95% | 4-cyclopropylpyrimidin-2-amine | ESD-935303-1G |
| Cas.: 885326-87-4 | Purity: ≥95% | methyl4-bromo-6-((tert-butoxycarbonyl)amino)picolinate | ESD-935304-1G |
| Cas.: 941293-00-1 | Purity: 98% | 3-(4-tert-butoxyphenyl)propanal | ESD-935305-1G |
| Cas.: 896721-70-3 | Purity: 98% | (S)-N-benzyl-N-(methoxymethyl)-1-phenylethanamine | ESD-935306-1G |
| Cas.: 1265891-83-5 | Purity: ≥95% | (R)-3-(((9H-fluoren-9-yl)methoxy)carbonylamino)-2-(4-tert-butoxybenzyl)propanoicacid | ESD-935307-1G |
| Cas.: 1820583-17-2 | Purity: 95% | (3R,7aR)-3-phenyltetrahydropyrrolo[1,2-c]oxazol-5(3H)-one | ESD-935308-1G |
| Cas.: 82000-58-6 | Purity: 95% | 3-methylthieno[2,3-c]isothiazole-5-carboxylicacid | ESD-935309-250MG |
| Cas.: 98141-78-7 | Purity: 95% | 6,7-dihydro-6-oxo-1H-purine-8-carboxylicacid | ESD-935310-1G |
| Cas.: 74598-12-2 | Purity: 95% | thieno[3,2-d]isothiazole-5-carboxylicacid | ESD-935311-1G |
| Cas.: 38104-45-9 | Purity: ≥95% | 4H-1,2,4-triazole-3,4-diamine | ESD-935312-1G |
| Cas.: 57351-80-1 | Purity: 95% | 7-oxo-7,8-dihydro-[1,2,4]triazolo[4,3-b][1,2,4]triazine-6-carboxylicacid | ESD-935313-1G |
| Cas.: 99066-71-4 | Purity: ≥98% | 1,8-naphthyridine-4-carboxylicacid | ESD-935314-1G |
| Cas.: 1253792-58-3 | Purity: ≥95% | 2-benzyl-5-(pyrrolidin-2-yl)-1,3,4-oxadiazole | ESD-935315-1G |
| Cas.: 933754-48-4 | Purity: ≥95% | 2-(5-(pyridin-3-yl)-1,3,4-oxadiazol-2-yl)ethanamine | ESD-935316-1G |
| Cas.: 933756-55-9 | Purity: ≥95% | (5-benzyl-1,3,4-oxadiazol-2-yl)methanamine | ESD-935317-1G |
| Cas.: 5247-25-6 | Purity: 97% | 2-(3-nitrophenyl)acetic acid | ESD-935318-1G |
| Cas.: 1909316-35-3 | Purity: 95% | 5-(tert-butyl)pyridine-2-carboxylicacidhydrochloride | ESD-935319-1G |
| Cas.: 35715-85-6 | Purity: ≥95% | 2-(6-chloro-1H-indazol-3-yl)aceticacid | ESD-935320-1G |
| Cas.: 35845-23-9 | Purity: ≥95% | 2-(7-chloro-1H-indazol-3-yl)aceticacid | ESD-935321-1G |
| Cas.: 56355-20-5 | Purity: ≥95% | 4-(thiazol-2-yloxy)benzoicacid | ESD-935322-1G |
| Cas.: 766556-62-1 | Purity: 97% | 4-(2-oxo-1,3-oxazinan-3-yl)benzoicacid | ESD-935323-1G |
| Cas.: 197367-75-2 | Purity: ≥95% | 4,7-dihydro-7-oxopyrazolo[1,5-a]pyrimidine-6-carboxylicacid | ESD-935324-1G |
| Cas.: 886755-18-6 | Purity: ≥95% | 3-((11-((S)-tetrahydro-2-oxofuran-3-ylcarbamoyl)-10-oxoundecyloxy)carbonyl)propanoicacid | ESD-935325-1G |
| Cas.: 35470-53-2 | Purity: 95% | (6aR,9R,10aR)-methyl7-allyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxylate | ESD-935326-1G |
| Cas.: 71290-65-8 | Purity: ≥98% | 2-(5-cyano-1-methyl-1H-pyrrol-2-yl)aceticacid | ESD-935327-1G |
| Cas.: 2369-31-5 | Purity: ≥95% | 2,2,2-trifluoro-4′-phenylacetophenone | ESD-935328-1G |
| Cas.: 90097-49-7 | Purity: 95% | 3,4-dihydro-7-(hydroxymethyl)quinolin-2(1H)-one | ESD-935329-1G |
| Cas.: 51068-07-6 | Purity: 95% | 2-(3,7-dihydro-7-oxo-2H-thiazolo[3,2-a]pyrimidin-6-yl)aceticacid | ESD-935330-100MG |
| Cas.: 69785-97-3 | Purity: ≥95% | ethyl5H-pyrimido[4,5-b][1,4]thiazine-6-carboxylate | ESD-935331-1G |
| Cas.: 925917-49-3 | Purity: 95% | 4,5-dihydro-1-methyl-4-oxo-1H-pyrrolo[3,2-c]pyridine-7-carboxylicacid | ESD-935332-100MG |
| Cas.: 156335-30-7 | Purity: 98% | 1,4-dihydro-4-oxopyrrolo[1,2-b]pyridazine-3-carboxylicacid | ESD-935333-1G |
| Cas.: 203661-13-6 | Purity: 97% | methyl5-amino-6-thioxo-1,6-dihydropyridine-3-carboxylate | ESD-935334-1G |
| Cas.: 935687-88-0 | Purity: 98% | 5-amino-1,6-dihydro-6-thioxopyridine-3-carboxylicacid | ESD-935335-1G |
| Cas.: 332099-50-0 | Purity: ≥95% | ethyl3-bromo-4H-furo[3,2-b]pyrrole-5-carboxylate | ESD-935336-1G |
| Cas.: 149184-22-5 | Purity: ≥98% (HPLC) | CGP 55845 hydrochloride | ESD-920926-1MG |
| Cas.: 34041-09-3 | Purity: 15% Mo | Molybdenum(IV) 2-ethylhexanoate | ESD-922359-25G |
| Cas.: 34041-09-3 | Purity: 15% Mo | Molybdenum(IV) 2-ethylhexanoate | ESD-922359-5G |
| Cas.: 34041-09-3 | Purity: 15% Mo | Molybdenum(IV) 2-ethylhexanoate | ESD-922359-1G |
| Cas.: 11139-85-8 | Purity: 15-50 mesh | IMINODIACETIC ACID-EPOXY ACTIVATED*SEPHA ROSE 6B FAS | ESD-902511-2.5KG |
| Cas.: 61789-91-1 | Purity: ≥90% | Jojoba oil | ESD-885961-2.5KG |
| Cas.: 1062368-49-3 | Purity: 99% | LDN-193719 | ESD-873235-5MG |
| Cas.: 61-73-4 | Purity: ≥98% | Methylene Blue | ESD-859249-2.5KG |
| Cas.: 177036-94-1 | Purity: 99% | Ambrisentan | ESD-822308-5G |
| Cas.: 55779-32-3 | AMINO ACID HYDROXAMATES DL-SERINE HYDROXAMATE | ESD-919901-50MG | |
| Cas.: 81-60-7 | Purity: 98% | 1,4,5,8-Tetrahydroxyanthra-9,10-quinone | ESD-921866-1G |
| Cas.: 99904-16-2 | MW 1000 | Poly(dimethylsiloxane)etherimide | ESD829525-500G |
| Cas.: 106685-40-9 | Purity: 98% | Adapalene | ESD-801527-25G |
| Cas.: 121-00-6 | Purity: 98% | 3-|tert|-Butyl-4-hydroxyanisole | ESD-801853-2.5KG |
| Cas.: 174899-83-3 | Purity: 99% | 1-Butyl-3-methylimidazolium bis(trifluoromethylsulfonyl)imide | ESD-801930-500G |
| Cas.: 872-31-1 | Purity: 97% | 3-Bromothiophene | ESD-802144-2.5KG |
| Cas.: 127-19-5 | Purity: Use For GC headspace test, ≥99.9% | NN-Dimethylacetamide (DMAC) | ESD-808104-500ML |
| Cas.: 127-19-5 | Purity: Use For GC headspace test, ≥99.9% | NN-Dimethylacetamide (DMAC) | ESD-808104-4L |
| Cas.: 73183-34-3 | Purity: 98% | Bis (pinacolato) diboron | ESD-802410-2.5KG |
| Cas.: 944251-24-5 | Azido-PEG4-NHS Ester | ESD-862593-500MG | |
| Cas.: 16937-99-8 | Purity: 98% | Boc-D-Leu-OH | ESD-803194-500G |
| Cas.: 5976-61-4 | Purity: 98% | 4-Hydroxy-17β-estradiol | ESD-923540-5MG |
| Cas.: 16881-77-9 | Purity: 97% | Dimethoxy(methyl)silane | ESD-869590-100ML |
| Cas.: 165660-27-5 | Purity: ACS | Hydroxy naphthol blue disodium salt | ESD-811453-100G |
| Cas.: 3094-87-9 | Purity: 95%, Fe 21% min | Iron(II) Acetate tetrahydrate | ESD-830146-500G |
| Cas.: 26675-46-7 | Purity: 98% | Isoflurane | ESD-833359-1KG |
| Cas.: 1731-92-6 | Purity: 97% | Methyl heptadecanoate | ESD-813244-100G |
| Cas.: 1123-09-7 | Purity: 98% | 3,5-Dimethyl-2-cyclohexen-1-one | ESD-923279-1G |
| Cas.: 149022-15-1 | Purity: 98% | MBTH hydrochloride hydrate | ESD-813269-500G |
| Cas.: 1309-48-4 | Purity: 99% | Magnesium oxide | ESD-824208-10KG |
| Cas.: 4338-98-1 | Purity: 98% | 3-Methyl-2-benzothiazolinonehydrazone Hydrochloride | ESD-835002-100G |
| Cas.: 1317-33-5 | Purity: ≥99.5%, 100nm | Molybdenum sulfide | ESD-888683-500G |
| Cas.: 7783-28-0 | Purity: 99.9% metals basis | Ammonium phosphate dibasic | ESD-801051-2.5KG |
| Cas.: 11028-71-0 | Purity: BR, Freeze-dried powder | Concanavalin A | ESD-804225-1G |
| Cas.: 1458-98-6 | Purity: 95% | 3-Bromo-2-methylpropene | ESD-801940-500G |
| Cas.: 787-70-2 | Purity: 97% | Biphenyl-4,4′-dicarboxylic acid | ESD-802080-2.5KG |
| Cas.: 13139-15-6 | Purity: 98,5% | Boc-Leu-OH | ESD-802310-2.5KG |
| Cas.: 1324-80-7 | Purity: biotech grade | Alkali Blue 6B | ESD-6056-1G |
| Cas.: 55-98-1 | Purity: 98% | Busulfan | ESD-803922-500G |
| Cas.: 51826-90-5 | Purity: 95% | (3-Bromopropyl)trimethoxysilane | ESD-875151-100G |
| Cas.: 18263-25-7 | Purity: ≥97.0%(GC) | 2-Bromohexadecanoic acid | ESD-915167-5G |
| Cas.: 482-89-3 | Purity: Analysis control | Indigotin | ESD-823543-100MG |
| Cas.: 458-37-7 | Purity: AR | Curcumin | ESD-805205-2.5KG |
| Cas.: 80307-12-6 | Purity: 98% | 2,5-Dioxopyrrolidin-1-yl 4-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)butanoate | ESD-843550-5G |
| Cas.: 27625-35-0 | Purity: ≥98% | Isopentyl 2-Methylbutyrate | ESD-858717-5G |
| Cas.: NONE201 | Purity: AR | Ammonium alcohol polyvinyl phosphate | ESD821234-2.5KG |
| Cas.: 626-86-8 | Purity: 97% | Adipic acid monoethyl ester | ESD-800108-2.5KG |
| Cas.: 723-62-6 | Purity: 98% | 9-Anthracenecarboxylic acid | ESD-800159-500G |
| Cas.: 6368-20-3 | Purity: 98% | Boc-D-Ser-OH | ESD-802342-500G |
| Cas.: 84358-13-4 | Purity: 98% | 1-Boc-isonipecotic acid | ESD-803345-500G |
| Cas.: 134029-92-8 | Purity: 97% | 6-(Ferrocenyl)hexanethiol | ESD-832860-50MG |
| Cas.: 581-47-5 | Purity: 98% | 2,4′-Bipyridine | ESD-831437-25G |
| Cas.: 1193-54-0 | Purity: 95% | 3,4-Dichloro-1H-pyrrole-2,5-dione | ESD-935337-1G |
| Cas.: 1193-54-0 | Purity: 95% | 3,4-Dichloro-1H-pyrrole-2,5-dione | ESD-935337-250MG |
| Cas.: 1193-54-0 | Purity: 95% | 3,4-Dichloro-1H-pyrrole-2,5-dione | ESD-935337-100MG |
| Cas.: 589-15-1 | Purity: 98% | 4-Bromobenzyl bromide | ESD-831497-2.5KG |
| Cas.: 15486-96-1 | Purity: 95% | 3-Bromopropionyl chloride | ESD-831546-500G |
| Cas.: 135206-76-7 | Purity: 96% | 3-(Chloromethyl)-1-methyl-1H-1,2,4-triazolehydrochloride | ESD-831821-5G |
| Cas.: 135206-76-7 | Purity: 96% | 3-(Chloromethyl)-1-methyl-1H-1,2,4-triazolehydrochloride | ESD-831821-100MG |
| Cas.: 52289-93-7 | Purity: 98% | 1-(bromomethyl)-2-methoxybenzene | ESD-922780-100MG |
| Cas.: 135242-93-2 | Purity: ≥95% | (1-Methyl-1H-[1,2,4]triazol-3-yl)methanol | ESD-886122-25G |
| Cas.: 135242-93-2 | Purity: 98% | (1-Methyl-1H-[1,2,4]triazol-3-yl)methanol | ESD-831822-5G |
| Cas.: 135242-93-2 | Purity: 98% | (1-Methyl-1H-[1,2,4]triazol-3-yl)methanol | ESD-831822-1G |
| Cas.: 135242-93-2 | Purity: 98% | (1-Methyl-1H-[1,2,4]triazol-3-yl)methanol | ESD-831822-250MG |
| Cas.: 928-51-8 | Purity: 97% | 4-Chloro-1-butanol | ESD-805778-2.5KG |
| Cas.: 375368-83-5 | Purity: 97% | 3-bromo-6-fluoro-2-methylpyridine | ESD-827732-100G |
| Cas.: 375368-83-5 | Purity: 97% | 3-bromo-6-fluoro-2-methylpyridine | ESD-827732-500G |
| Cas.: 882679-96-1 | Purity: 97% | Methyl 4-bromo-1H-indole-6-carboxylate | ESD-845059-25G |
| Cas.: 315-22-0 | Purity: 98% | Crotaline | ESD-835792-5G |
| Cas.: 12007-99-7 | Purity: 98% | Calcium bore | ESD-914198-500G |
| Cas.: 1197953-47-1 | Purity: 98% | (2-Aminophenyl)dimethylphosphine oxide | ESD-821958-250MG |
| Cas.: 1197953-47-1 | Purity: 98% | (2-Aminophenyl)dimethylphosphine oxide | ESD-821958-25G |
| Cas.: 700-84-5 | Purity: 99% | 5-Fluoro-1-indanone | ESD-810247-25G |
| Cas.: 34846-90-7 | Purity: 95% | Methyl 3-methoxyacrylate | ESD-813154-5ML |
| Cas.: 34846-90-7 | Purity: 98% | Methyl 3-Methoxyacrylate | ESD-935338-500ML |
| Cas.: 34846-90-7 | Purity: 98% | Methyl 3-Methoxyacrylate | ESD-935338-100ML |
| Cas.: 34846-90-7 | Purity: 98% | Methyl 3-Methoxyacrylate | ESD-935338-25ML |
| Cas.: 34846-90-7 | Purity: 98% | Methyl 3-Methoxyacrylate | ESD-935338-5ML |
| Cas.: 11041-94-4 | Purity: 95% | 6,7-Dihydroxy-1-(4-Hydroxybenzyl)-1,2,3,4-tetrahydroisoquinoline Hydrochloride | ESD-850923-25G |
| Cas.: 149104-88-1 | Purity: 98% | 4-(Methanesulfonyl)phenylboronic acid | ESD-814079-25G |
| Cas.: 149104-88-1 | Purity: 98% | 4-(Methanesulfonyl)phenylboronic acid | ESD-814079-100G |
| Cas.: 1314-23-4 | Purity: 99.9%, 200 Mesh, square phase | Zirconium dioxide | ESD-917329-25G |
| Cas.: 30827-99-7 | Purity: 98% | 4-(2-Aminoethyl)benzenesulfonyl fluoride hydrochloride | ESD-800782-25G |
| Cas.: 2208-41-5 | Purity: 98% | 6-hydroxymelatonin | ESD-912215-5MG |
| Cas.: 4165-61-1 | Purity: 98 atom% D | Aniline-2,3,4,5,6-d5 | ESD-859961-25G |
| Cas.: 4165-61-1 | Purity: 98 atom% D | Aniline-2,3,4,5,6-d5 | ESD-859961-250G |
| Cas.: NONE6694 | Purity: 50% solution | Alkylpolyglycoside | ESD-864769-2.5KG |
| Cas.: 7784-22-7 | Purity: ≥98% | Aluminum hypophosphite | ESD-875846-2.5KG |
| Cas.: 7188-38-7 | Purity: 98% | tert-Butyl isocyanide | ESD-802412-100ML |
| Cas.: 32926-43-5 | Purity: 98% | Boc-His(Trt)-OH | ESD-803177-500G |
| Cas.: 90076-65-6 | Purity: 99,9% | bistrifluoromethanesulfonimidate | ESD-822764-2.5KG |
| Cas.: 693-07-2 | Purity: 97% | 2-Chloroethyl ethyl sulfide | ESD-804408-500G |
| Cas.: 1312-76-1 | Purity: 28% in water | Potassium silicate | ESD-890226-2.5KG |
| Cas.: 88419-56-1 | Purity: ≥98% | 2,4,5-Trifluorobenzoyl Chloride | ESD-867826-5G |
| Cas.: 88419-56-1 | Purity: ≥98% | 2,4,5-Trifluorobenzoyl Chloride | ESD-867826-25G |
| Cas.: 65405-70-1 | Purity: 96% | trans-4-Decenal | ESD-849431-100G |
| Cas.: 30931-67-0 | Purity: 99%biotech grade | Diammonium 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonate) | ESD-6133-100G |
| Cas.: 30931-67-0 | Purity: 98% | 2,2′-Azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt (ABTS) | ESD-800765-100G |
| Cas.: 22839-47-0 | Purity: 98% | Aspartame | ESD-801110-2.5KG |
| Cas.: 84380-01-8 | Purity: 99% | α-Arbutin | ESD-821854-500G |
| Cas.: 616-79-5 | Purity: 98% | 2-Amino-5-nitrobenzoic acid | ESD-843377-500G |
| Cas.: 6627-55-0 | Purity: 97% | 2-Bromo-4-methylphenol | ESD-830207-500G |
| Cas.: 66003-78-9 | Triphenylsulfonium triflate | ESD-909764-25G | |
| Cas.: 7440-44-0 | Purity: Use For Air Purification, Diameter: 6mm, Cylindrical | Activated charcoal | ESD-935339-5KG |
| Cas.: 7440-44-0 | Purity: Use For Air Purification, Diameter: 6mm, Cylindrical | Activated charcoal | ESD-935339-1KG |
| Cas.: 30515-28-7 | Purity: 97% | 7-Bromoheptanoic acid | ESD-840470-100G |
| Cas.: 7647-14-5 | Purity: 0.9% solution | Sodium Chloride Solution | ESD-885177-500ML |
| Cas.: 29509-30-6 | Purity: 98% | 2-Phenoxy-1-phenylpropan-1-ol | ESD-842646-250MG |
| Cas.: 3030-80-6 | Zinc 2-mercaptobenzimidazole | ESD-836412-500G | |
| Cas.: 3030-80-6 | Zinc 2-mercaptobenzimidazole | ESD-836412-2.5KG | |
| Cas.: 637-88-7 | Purity: 99% | 1,4-Cyclohexanedione | ESD-805242-2.5KG |
| Cas.: 1989-52-2 | Purity: >98% | Cholesterol myristate | ESD-860648-1G |
| Cas.: 1989-52-2 | Purity: >98% | Cholesterol myristate | ESD-860648-5G |
| Cas.: 608-37-7 | Purity: 97% | Dibromomaleic acid | ESD-923337-1G |
| Cas.: 13529-17-4 | Purity: 98% | 5-Formylfuran-2-carboxylic acid | ESD-842246-5G |
| Cas.: 9001-37-0 | Purity: 100 U/mg | Glucose oxidase | ESD-810486-25G |
| Cas.: 492-98-8 | Purity: 97% | 1H,1’H-2,2′-Bimimidazole | ESD-844861-100G |
| Cas.: 126-71-6 | Purity: 98% | Triisobutyl phosphate | ESD-834116-2.5L |
| Cas.: 126-71-6 | Purity: 98% | Triisobutyl phosphate | ESD-834116-10L |
| Cas.: 2511-22-0 | Purity: 95% | Methyl 3,5-di-tert-butyl-4-hydroxybenzoate | ESD-922747-100G |
| Cas.: 360-92-9 | Purity: ≥97% | N,N-Diethyl-2,2,2-trifluoroacetamide | ESD-857869-25G |
| Cas.: 14846-47-0 | Purity: ≥98% | n-Octylamine Hydrobromide | ESD-866016-25G |
| Cas.: 35621-01-3 | Purity: 99% | piperidin-4-amine,dihydrochloride | ESD-856571-50G |
| Cas.: 9006-26-2 | Purity: average Mw 100, 000-500, 000, powder | Polyethylene-graft-maleic anhydride | ESD-931361-500G |
| Cas.: 2003234-63-5 | Purity: ≥98% | (R)-GNE-140 | ESD-873496-5MG |
| Cas.: 1030377-33-3 | Purity: ≥98% | Suvorexant (MK-4305) | ESD-833032-100MG |
| Cas.: 149213-65-0 | Purity: 98% | Sodium tetrakis(perfluorophenyl)borate | ESD-922444-250MG |
| Cas.: 149213-65-0 | Purity: 98% | Sodium tetrakis(perfluorophenyl)borate | ESD-922444-1G |
| Cas.: 29671-92-9 | Purity: ≥98% | Chloroformamidine Hydrochloride | ESD-859831-500G |
| Cas.: 50995-95-4 | Purity: ≥98.0% | 2-Propylimidazole | ESD-822779-2.5KG |
| Cas.: 5337-03-1 | Purity: ≥98% | Tetrahydropyran-4-carboxylic acid | ESD-822776-100G |
| Cas.: 73-24-5 | Purity: ≥99.5%(HPLC) | Adenine | ESD-800686-2.5KG |
| Cas.: 924-49-2 | Purity: ≥98% | 4-Amino-3-hydroxybutyric Acid | ESD-865132-25G |
| Cas.: 1611-83-2 | Purity: ≥98% | N-Phenylmethacrylamide | ESD-867529-25G |
| Cas.: 58957-92-9 | Purity: 98% | Idarubicin | ESD-856241-5MG |
| Cas.: 106-53-6 | Purity: 97% | 4-Bromothiophenol | ESD-801976-500G |
| Cas.: 597-82-0 | Purity: ≥99% | O,O,O-triphenyl phosphorothioate | ESD-906965-5G |
| Cas.: 597-82-0 | Purity: ≥99% | O,O,O-triphenyl phosphorothioate | ESD-906965-25G |
| Cas.: 597-82-0 | Purity: ≥99% | O,O,O-triphenyl phosphorothioate | ESD-906965-100G |
| Cas.: 13991-08-7 | Purity: >98.0%(GC) | 1,2-BIS(DIPHENYLPHOSPHINO)BENZENE | ESD-822229-25G |
| Cas.: 596-43-0 | Purity: 98% | Bromotriphenylmethane | ESD-823255-500G |
| Cas.: 83948-53-2 | Purity: 98% | 3-(Boc-Amino)propylbromide | ESD-844291-100G |
| Cas.: 544-02-5 | Purity: 98% | Diisopentyl sulfide | ESD-921887-100ML |
| Cas.: 544-02-5 | Purity: 98% | Diisopentyl sulfide | ESD-921887-25ML |
| Cas.: 14338-82-0 | Purity: 90%(NMR) | Dibutyl Methylenebis(thioglycolate) | ESD-863339-25G |
| Cas.: 14338-82-0 | Purity: 90%(NMR) | Dibutyl Methylenebis(thioglycolate) | ESD-863339-100G |
| Cas.: 14338-82-0 | Purity: 90%(NMR) | Dibutyl Methylenebis(thioglycolate) | ESD-863339-500G |
| Cas.: 76-86-8 | Purity: 98% | Chlorotriphenylsilane | ESD-804480-500G |
| Cas.: 1694-29-7 | Purity: 95% | 3-Chloroacetylacetone | ESD-823761-500G |
| Cas.: 39547-16-5 | Purity: 95% | 3-(5-Methoxy-1H-indol-3-yl)propanoic acid | ESD-891270-25MG |
| Cas.: 1306-38-3 | Purity: 99,99% | Cerium oxide | ESD-804517-10KG |
| Cas.: 1333-86-4 | Purity: cabot vulcan xc-72R, Particle size : 10-20 nm | Carbon, mesopor | ESD-915133-2.5KG |
| Cas.: 126-80-7 | Purity: 95% | 1,3-BIS(3-GLYCIDOXYPROPYL)TETRAMETHYLDISILOXANE | ESD-888397-500G |
| Cas.: 81090-53-1 | Purity: 98% | 4,4′-Dibromotriphenylamine | ESD-808205-100G |
| Cas.: 875-74-1 | Purity: 95% | D-2-Phenylglycine | ESD-816069-2.5KG |
| Cas.: 21679-14-1 | Purity: 98% | Fludarabine | ESD-810232-5G |
| Cas.: 711-79-5 | Purity: 98% | 1′-Hydroxy-2′-acetonaphthone | ESD-858183-25G |
| Cas.: 165800-03-3 | Purity: 99% | Linezolid | ESD-830357-100G |
| Cas.: 39687-95-1 | Purity: 95% | Methyl isocyanoacetate | ESD-829799-100G |
| Cas.: 59-26-7 | Purity: 97% | N,N-Diethylnicotinamide | ESD-858242-2.5KG |
| Cas.: 1314-36-9 | Purity: 40nm, 99.5% | Yttrium oxide | ESD-820612-500G |
| Cas.: 2782-91-4 | Purity: 98% | Tetramethylthiourea | ESD-832190-2.5KG |
| Cas.: 471-53-4 | Purity: 97% | 18β-Glycyrrhetinic acid | ESD-810499-500G |
| Cas.: 36396-99-3 | Purity: ≥99% | N6-Cyclohexyladenosine | ESD-879343-250MG |
| Cas.: 53053-08-0 | Purity: ≥95%(LC) | N-Hydroxysuccinimide 4-azidobenzoate | ESD-918388-50MG |
| Cas.: 142808-44-4 | Purity: 98% | 5′-O-DMT-N4-Benzoyl-2′,2′-difluoro-2′-deoxycytidine 3′-CE phosphoramidite | ESD-929445-25MG |
| Cas.: 154630-93-0 | Purity: 97% | 2-(Trifluoromethyl)piperidine | ESD-852182-50MG |
| Cas.: 3639-21-2 | Purity: 99% | 2-ethyl-2-hydroxybutanoic acid | ESD-923328-1G |
| Cas.: 170165-79-4 | Purity: 97% | 1,3-Di(pyridin-4-yl)benzene | ESD-902065-1G |
| Cas.: 108347-97-3 | Purity: 85% | Succinyl coenzyme A sodium | ESD-923475-1MG |
| Cas.: 584-03-2 | Purity: 98% | 1,2-Butanediol | ESD-830267-2.5KG |
| Cas.: 9003-42-3 | Purity: average Mw~515, 000 by GPC | Poly(ethyl methacrylate) | ESD-922078-50G |
| Cas.: 1126-79-0 | Purity: 99% | Butyl Phenyl Ether | ESD-871396-500ML |
| Cas.: 16669-27-5 | Purity: 85% | Behenyl Methacrylate | ESD-921915-2.5KG |
| Cas.: 10035-04-8 | Purity: 99.99% metals basis | Calcium chloride dihydrate | ESD-804984-2.5KG |
| Cas.: 6952-93-8 | Purity: ≥97% | Cyclopropanecarboxylic hydrazide | ESD-859153-5G |
| Cas.: 6952-93-8 | Purity: ≥97% | Cyclopropanecarboxylic hydrazide | ESD-859153-25G |
| Cas.: 122-39-4 | Purity: 99% | Diphenylamine | ESD-807527-25G |
| Cas.: 626-15-3 | Purity: 97% | α, α-Dibromo-m-xylene | ESD-823972-500G |
| Cas.: 76-54-0 | Purity: CP | 2′,7′-Dichlorofluorescein | ESD-828331-100G |
| Cas.: 480-54-6 | Purity: 98% | Retrorsine | ESD-922923-5MG |
| Cas.: 9006-65-9 | Dimethicone | ESD-849785-100G | |
| Cas.: 610-30-0 | Purity: 98% | 2,4-Dinitrobenzoic acid | ESD-864268-25G |
| Cas.: 1069-79-0 | Purity: ≥99% | 1,2-distearoyl-sn-glycero-3-phosphoethanolamine | ESD-890283-250MG |
| Cas.: 9072-19-9 | Purity: ≥95%, From:Brown Seaweed | Fucoidan | ESD-885877-500G |
| Cas.: 110-81-6 | Purity: 99%, MkSeal | Diethyl Disulfide | ESD-854616-500ML |
| Cas.: 62571-86-2 | Purity: 98% | Captopril | ESD-837214-500G |
| Cas.: 1127442-82-3 | Purity: 99% | IWR-1-endo | ESD-872801-25MG |
| Cas.: 13081-97-5 | Purity: ≥95% | Pentaerythritol Distearate (so called) [Lubricants] | ESD-867288-25G |
| Cas.: 13081-97-5 | Purity: ≥95% | Pentaerythritol Distearate (so called) [Lubricants] | ESD-867288-100G |
| Cas.: 877-24-7 | Purity: PT | Potassium biphthalate | ESD-816392-2.5KG |
| Cas.: 55-43-6 | Purity: 98% | N-(2-Chloroethyl)dibenzylamine Hydrochloride | ESD-870301-1G |
| Cas.: 1228571-53-6 | Purity: 98% | (R)-2-(1-Aminoethyl)-4-chlorophenol | ESD-935340-25G |
| Cas.: 1228571-53-6 | Purity: 98% | (R)-2-(1-Aminoethyl)-4-chlorophenol | ESD-935340-5G |
| Cas.: 1228571-53-6 | Purity: 98% | (R)-2-(1-Aminoethyl)-4-chlorophenol | ESD-935340-1G |
| Cas.: 1228571-53-6 | Purity: 98% | (R)-2-(1-Aminoethyl)-4-chlorophenol | ESD-935340-250MG |
| Cas.: 1228569-39-8 | Purity: 97% | (S)-2-(1-Aminoethyl)-4-chlorophenol | ESD-935341-5G |
| Cas.: 1228569-39-8 | Purity: 97% | (S)-2-(1-Aminoethyl)-4-chlorophenol | ESD-935341-1G |
| Cas.: 1228569-39-8 | Purity: 97% | (S)-2-(1-Aminoethyl)-4-chlorophenol | ESD-935341-250MG |
| Cas.: NONE10128 | Purity: GR | Manganese chloride monohydrate | ESD-935342-100G |
| Cas.: NONE10128 | Purity: GR | Manganese chloride monohydrate | ESD-935342-25G |
| Cas.: NONE10128 | Purity: GR | Manganese chloride monohydrate | ESD-935342-5G |
| Cas.: NONE10128 | Purity: GR | Manganese chloride monohydrate | ESD-935342-1G |
| Cas.: NONE10129 | 1% misoprostol hydroxypropyl methylcellulose | ESD-935343-250MG | |
| Cas.: NONE10129 | 1% misoprostol hydroxypropyl methylcellulose | ESD-935343-50MG | |
| Cas.: NONE10129 | 1% misoprostol hydroxypropyl methylcellulose | ESD-935343-10MG | |
| Cas.: 81778-06-5 | Purity: 98% | 3-Chloro-N-hydroxy-2,2-dimethylpropanamide | ESD-935344-25G |
| Cas.: 81778-06-5 | Purity: 98% | 3-Chloro-N-hydroxy-2,2-dimethylpropanamide | ESD-935344-5G |
| Cas.: 81778-06-5 | Purity: 98% | 3-Chloro-N-hydroxy-2,2-dimethylpropanamide | ESD-935344-1G |
| Cas.: 1829-00-1 | Purity: indicator | Titan yellow | ESD-819617-500G |
| Cas.: 193274-02-1 | Purity: 98% | tert-Butyl 3a-benzyl-2-methyl-3-oxo-3a,4,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridine-5(3H)-carboxylate | ESD-935345-1G |
| Cas.: 193274-02-1 | Purity: 98% | tert-Butyl 3a-benzyl-2-methyl-3-oxo-3a,4,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridine-5(3H)-carboxylate | ESD-935345-250MG |
| Cas.: 193274-02-1 | Purity: 98% | tert-Butyl 3a-benzyl-2-methyl-3-oxo-3a,4,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridine-5(3H)-carboxylate | ESD-935345-100MG |
| Cas.: 2050-08-0 | Purity: analytical standard ≥98.0% | Amyl salicylate | ESD-922141-1G |
| Cas.: 1012057-47-4 | Purity: 95% | 7-Methoxy-6-nitroquinazolin-4(3H)-one | ESD-935346-5G |
| Cas.: 1012057-47-4 | Purity: 95% | 7-Methoxy-6-nitroquinazolin-4(3H)-one | ESD-935346-1G |
| Cas.: 1012057-47-4 | Purity: 95% | 7-Methoxy-6-nitroquinazolin-4(3H)-one | ESD-935346-250MG |
| Cas.: 91775-62-1 | Purity: 95% | 3-Bromo-8-methoxyimidazo[1,2-a]pyrazine | ESD-935347-250MG |
| Cas.: 10485-09-3 | Purity: 98%(GC) | 2-Bromoindene | ESD-804069-100G |
| Cas.: 5337-79-1 | Purity: 98% | 3-(Pyridin-4-yl)acrylic acid | ESD-935348-100G |
| Cas.: 5337-79-1 | Purity: 98% | 3-(Pyridin-4-yl)acrylic acid | ESD-935348-25G |
| Cas.: 5337-79-1 | Purity: 98% | 3-(Pyridin-4-yl)acrylic acid | ESD-935348-5G |
| Cas.: 5337-79-1 | Purity: 98% | 3-(Pyridin-4-yl)acrylic acid | ESD-935348-1G |
| Cas.: 4238-71-5 | Purity: 98% | 1-Benzylimidazole | ESD-822759-500G |
| Cas.: 7440-36-0 | Purity: 99.9%, 300 Mesh | Antimony | ESD-875370-2.5KG |
| Cas.: 2686-86-4 | Purity: 98% | 3-Aminopiperidine-2,6-dione hydrochloride | ESD-875662-500G |
| Cas.: 4761-93-7 | Purity: 97% | Biguanidehydrochloride | ESD-899239-25G |
| Cas.: 77350-52-8 | Purity: 98% | N,N-Diethyl-4-iodobenzamide | ESD-935349-5G |
| Cas.: 77350-52-8 | Purity: 98% | N,N-Diethyl-4-iodobenzamide | ESD-935349-1G |
| Cas.: 77350-52-8 | Purity: 98% | N,N-Diethyl-4-iodobenzamide | ESD-935349-250MG |
| Cas.: 77350-52-8 | Purity: 98% | N,N-Diethyl-4-iodobenzamide | ESD-935349-100MG |
| Cas.: 56-95-1 | Purity: 98% | Chlorhexidine acetate | ESD-804845-2.5KG |
| Cas.: 17865-54-2 | Purity: 98% | Cyclohexyltrimethoxysilane | ESD-824627-100G |
| Cas.: 13049-40-6 | Purity: 98% | 4,4′-Diethylbiphenyl | ESD-870936-1G |
| Cas.: 184901-84-6 | Purity: ≥99% | DL-4-Hydroxymandelic acid monohydrate | ESD-935350-5G |
| Cas.: 184901-84-6 | Purity: ≥99% | DL-4-Hydroxymandelic acid monohydrate | ESD-935350-1G |
| Cas.: 184901-84-6 | Purity: ≥99% | DL-4-Hydroxymandelic acid monohydrate | ESD-935350-250MG |
| Cas.: 23110-15-8 | Purity: 98% | Fumagillin | ESD-823129-5MG |
| Cas.: 1198-84-1 | Purity: 97% | 2-Hydroxy-2-(4-hydroxyphenyl)acetic acid | ESD-843065-25MG |
| Cas.: 1198-84-1 | Purity: 97% | 2-Hydroxy-2-(4-hydroxyphenyl)acetic acid | ESD-843065-100MG |
| Cas.: 193217-39-9 | Purity: 96% | tert-Butyl 4-benzoylpiperidine-1-carboxylate | ESD-935351-25G |
| Cas.: 193217-39-9 | Purity: 96% | tert-Butyl 4-benzoylpiperidine-1-carboxylate | ESD-935351-5G |
| Cas.: 193217-39-9 | Purity: 96% | tert-Butyl 4-benzoylpiperidine-1-carboxylate | ESD-935351-1G |
| Cas.: 193217-39-9 | Purity: 96% | tert-Butyl 4-benzoylpiperidine-1-carboxylate | ESD-935351-250MG |
| Cas.: 51094-17-8 | Purity: 95% | 5,10,15,20-Tetrakis(4-hydroxyphenyl)-21H,23H-porphine | ESD-821816-1G |
| Cas.: 9035-81-8 | Purity: biotech grade | Trypsin inhibitor, soybean | ESD-6350-1G |
| Cas.: 60966-26-9 | Purity: 98% | 2′-Amino-2′-deoxyguanosine | ESD-801673-50MG |
| Cas.: 147253-69-8 | Purity: 97% | (-)-1,2-Bis[(2S,5S)-2,5-diisopropylphospholano]benzene | ESD-914422-25MG |
| Cas.: 210826-40-7 | Purity: ≥99% | MCC950 | ESD-880513-50MG |
| Cas.: 256373-96-3 | Purity: 99% | CP-456773 sodium | ESD-872501-25MG |
| Cas.: 256373-96-3 | Purity: 99% | CP-456773 sodium | ESD-872501-100MG |
| Cas.: 112822-85-2 | Purity: 97% | 2,4,5-Trifluoro-3-methylbenzoic acid | ESD-935352-5G |
| Cas.: 112822-85-2 | Purity: 97% | 2,4,5-Trifluoro-3-methylbenzoic acid | ESD-935352-1G |
| Cas.: 112822-85-2 | Purity: 97% | 2,4,5-Trifluoro-3-methylbenzoic acid | ESD-935352-250MG |
| Cas.: 57702-65-5 | Purity: 95% | Tributyl-n-octylphosphonium Bromide | ESD-854970-25G |
| Cas.: 181038-98-2 | Purity: 97% | 5-(Bromomethyl)benzo[d]oxazole | ESD-935353-1G |
| Cas.: 181038-98-2 | Purity: 97% | 5-(Bromomethyl)benzo[d]oxazole | ESD-935353-250MG |
| Cas.: 181038-98-2 | Purity: 97% | 5-(Bromomethyl)benzo[d]oxazole | ESD-935353-100MG |
| Cas.: 118292-40-3 | Purity: ≥98% | Tazarotene | ESD-868272-50MG |
| Cas.: 63148-64-1 | Purity: 1% in 1, 2-dichloroethane | Formvar solution | ESD-922454-25ML |
| Cas.: 2041-56-7 | Purity: 98% | (1-(Aminomethyl)cyclobutyl)methanol | ESD-935354-5G |
| Cas.: 2041-56-7 | Purity: 98% | (1-(Aminomethyl)cyclobutyl)methanol | ESD-935354-1G |
| Cas.: 2041-56-7 | Purity: 98% | (1-(Aminomethyl)cyclobutyl)methanol | ESD-935354-250MG |
| Cas.: 2041-56-7 | Purity: 98% | (1-(Aminomethyl)cyclobutyl)methanol | ESD-935354-100MG |
| Cas.: 4506-66-5 | Purity: 97% | 1,2,4,5-Benzenetetramine tetrahydrochloride | ESD-886095-25G |
| Cas.: 13466-20-1 | Purity: ≥99% | barium dihydrogen phosphate | ESD-886526-2.5KG |
| Cas.: 26496-94-6 | Purity: 98% | 4-Bromobenzoic acid ethyl ester | ESD-908364-500G |
| Cas.: 62482-26-2 | Purity: 98% | Methyl 2-chloroquinoline-4-carboxylate | ESD-935355-1G |
| Cas.: 62482-26-2 | Purity: 98% | Methyl 2-chloroquinoline-4-carboxylate | ESD-935355-250MG |
| Cas.: 62482-26-2 | Purity: 98% | Methyl 2-chloroquinoline-4-carboxylate | ESD-935355-100MG |
| Cas.: 106-92-3 | Purity: 99% | Allyl glycidyl ether | ESD-800496-2.5L |
| Cas.: 562-74-3 | Purity: 98% | 4-Carvomenthenol | ESD-805270-2.5KG |
| Cas.: 4569-45-3 | Purity: 98% | 9,9-Dimethylfluorene | ESD-806472-500G |
| Cas.: 132073-82-6 | Purity: 95% | (S)-4-Benzyl-2-(hydroxymethyl)morpholine | ESD-935356-5G |
| Cas.: 132073-82-6 | Purity: 95% | (S)-4-Benzyl-2-(hydroxymethyl)morpholine | ESD-935356-1G |
| Cas.: 132073-82-6 | Purity: 95% | (S)-4-Benzyl-2-(hydroxymethyl)morpholine | ESD-935356-250MG |
| Cas.: 132073-82-6 | Purity: 95% | (S)-4-Benzyl-2-(hydroxymethyl)morpholine | ESD-935356-100MG |
| Cas.: 149715-47-9 | Purity: 95% | (R)-Piperazin-2-ylmethanol | ESD-935357-1G |
| Cas.: 149715-47-9 | Purity: 95% | (R)-Piperazin-2-ylmethanol | ESD-935357-250MG |
| Cas.: 149715-47-9 | Purity: 95% | (R)-Piperazin-2-ylmethanol | ESD-935357-100MG |
| Cas.: 775-01-9 | Purity: 98% | DL-3,4-Dihydroxymandelic Acid | ESD-869744-50MG |
| Cas.: 1256958-34-5 | Purity: 96% | Methyl 2-amino-5-iodo-4-methoxybenzoate | ESD-935358-1G |
| Cas.: 1256958-34-5 | Purity: 96% | Methyl 2-amino-5-iodo-4-methoxybenzoate | ESD-935358-250MG |
| Cas.: 1256958-34-5 | Purity: 96% | Methyl 2-amino-5-iodo-4-methoxybenzoate | ESD-935358-100MG |
| Cas.: 10031-26-2 | Purity: 98% | Iron(III) bromide | ESD-822349-2.5KG |
| Cas.: 9004-61-9 | Purity: 97% | Hyaluronic acid | ESD-823436-500G |
| Cas.: 112-89-0 | Purity: 97% | 1-Bromooctadecane | ESD-802420-1KG |
| Cas.: NONE10130 | Purity: ≥99% | PEG400DS | ESD-935359-5KG |
| Cas.: NONE10130 | Purity: ≥99% | PEG400DS | ESD-935359-1KG |
| Cas.: NONE10130 | Purity: ≥99% | PEG400DS | ESD-935359-500G |
| Cas.: NONE10130 | Purity: ≥99% | PEG400DS | ESD-935359-100G |
| Cas.: 2817-71-2 | Purity: 95% | 1-Ethyl-1H-pyrazole | ESD-838860-500G |
| Cas.: 305-84-0 | Purity: 98% | L-Carnosine | ESD-804822-500G |
| Cas.: 2110-78-3 | Purity: 98% | Methyl α-hydroxyisobutyrate | ESD-812727-2.5KG |
| Cas.: 600-18-0 | Purity: 97% | 2-Ketobutyric acid | ESD-812225-100G |
| Cas.: 531-53-3 | Purity: Biological stain | Azure A chloride | ESD-800821-5G |
| Cas.: 1072945-86-8 | Purity: 98% | (6-(Methoxycarbonyl)pyridin-3-yl)boronic acid | ESD-935360-100MG |
| Cas.: 1072945-86-8 | Purity: 98% | (6-(Methoxycarbonyl)pyridin-3-yl)boronic acid | ESD-935360-250MG |
| Cas.: 1072945-86-8 | Purity: 98% | (6-(Methoxycarbonyl)pyridin-3-yl)boronic acid | ESD-935360-1G |
| Cas.: 1072945-86-8 | Purity: 98% | (6-(Methoxycarbonyl)pyridin-3-yl)boronic acid | ESD-935360-5G |
| Cas.: 1066-51-9 | Purity: 99% | (Aminomethyl)phosphonic acid | ESD-833518-100G |
| Cas.: 926-06-7 | Purity: 97% | Isopropyl methanesulfonate | ESD-843997-100G |
| Cas.: 926-06-7 | Purity: 97% | Isopropyl methanesulfonate | ESD-843997-500G |
| Cas.: 35854-86-5 | Purity: 95% | |cis|-6-Nonen-1-ol | ESD-814975-1ML |
| Cas.: 150824-47-8 | Purity: PESTANAL, analytical standard | NITENPYRAM PESTANAL, 100 MG | ESD-838212-100G |
| Cas.: 13062-76-5 | Purity: 95% | N-Methyltyramine hydrochloride | ESD-914926-5G |
| Cas.: 13062-76-5 | Purity: 95% | N-Methyltyramine hydrochloride | ESD-914926-25G |
| Cas.: 13062-76-5 | Purity: 95% | N-Methyltyramine hydrochloride | ESD-914926-100G |
| Cas.: 134272-64-3 | Purity: ≥97% | N-(2-Aminoethyl)maleimide Hydrochloride | ESD-926193-5G |
| Cas.: 38609-97-1 | Purity: ≥98%(HPLC) | 9-Oxo-10(9H)-acridineacetic acid | ESD-832244-100G |
| Cas.: 55625-40-6 | Purity: 98% | Methyl 2-methylquinoline-4-carboxylate | ESD-935362-5G |
| Cas.: 55625-40-6 | Purity: 98% | Methyl 2-methylquinoline-4-carboxylate | ESD-935362-1G |
| Cas.: 55625-40-6 | Purity: 98% | Methyl 2-methylquinoline-4-carboxylate | ESD-935362-250MG |
| Cas.: 25312-34-9 | Purity: 90% | α-Ionol | ESD-923339-1ML |
| Cas.: 7784-23-8 | Purity: 95% | Aluminum iodide | ESD-822900-25G |
| Cas.: 4431-00-9 | Purity: practical grade, ≥85% (titration), powder | Aurintricarboxylic acid | ESD-914660-25G |
| Cas.: 274693-27-5 | Purity: 99% | TICAGRELOR | ESD-822290-250MG |
| Cas.: 274693-27-5 | Purity: 99% | TICAGRELOR | ESD-822290-1G |
| Cas.: 274693-27-5 | Purity: 99% | TICAGRELOR | ESD-822290-5G |
| Cas.: 13425-92-8 | Purity: 97% | 6,7-Dimethoxyquinolin-4-amine | ESD-935363-1G |
| Cas.: 1101822-79-0 | Purity: 97% | Sodium 3-chloro-4-fluorobenzenesulfinate | ESD-935364-5G |
| Cas.: 1101822-79-0 | Purity: 97% | Sodium 3-chloro-4-fluorobenzenesulfinate | ESD-935364-1G |
| Cas.: 1101822-79-0 | Purity: 97% | Sodium 3-chloro-4-fluorobenzenesulfinate | ESD-935364-250MG |
| Cas.: 1101822-79-0 | Purity: 97% | Sodium 3-chloro-4-fluorobenzenesulfinate | ESD-935364-100MG |
| Cas.: 13425-92-8 | Purity: 97% | 6,7-Dimethoxyquinolin-4-amine | ESD-935363-250MG |
| Cas.: 13425-92-8 | Purity: 97% | 6,7-Dimethoxyquinolin-4-amine | ESD-935363-100MG |
| Cas.: 630-76-2 | Purity: ≥95% | Tetraphenylmethane | ESD-834841-25G |
| Cas.: 21149-26-8 | Purity: 95% | 6-Amino-7H-purin-8-ol | ESD-923947-50MG |
| Cas.: 75-22-9 | Purity: 98% | Borane-trimethylamine complex | ESD-829571-500G |
| Cas.: 85838-94-4 | Purity: 99% | 1-Boc-1,2,3,6-tetrahydropyridine | ESD-829575-100G |
| Cas.: 22160-26-5 | Purity: 55% in water | glucosylglycerol | ESD-935365-1G |
| Cas.: 22160-26-5 | Purity: 55% in water | glucosylglycerol | ESD-935365-5G |
| Cas.: 22160-26-5 | Purity: 55% in water | glucosylglycerol | ESD-935365-25G |
| Cas.: 1068-63-9 | Purity: ≥99.9% trace metals basis | Cesium oxalate | ESD-923356-1G |
| Cas.: 75449-26-2 | Purity: 98% | [2,2′-Bipyridine]-3,3′-diamine | ESD-935366-1G |
| Cas.: 75449-26-2 | Purity: 98% | [2,2′-Bipyridine]-3,3′-diamine | ESD-935366-250MG |
| Cas.: 75449-26-2 | Purity: 98% | [2,2′-Bipyridine]-3,3′-diamine | ESD-935366-100MG |
| Cas.: 17841-68-8 | Purity: ≥95% | Methyl 3-(Aminomethyl)benzoate Hydrochloride | ESD-851185-25G |
| Cas.: 57-04-5 | Purity: 95% | Dihydroxyacetone phosphate hemimagnesium salt hydrate | ESD-922248-25MG |
| Cas.: 1673534-76-3 | Purity: 98% | CA-170 (AUPM-170)|PDL1 inhibitor | ESD-910395-5MG |
| Cas.: 341010-36-4 | Purity: 95% | 3-(Piperazin-1-yl)-1,2,4-triazine | ESD-935367-1G |
| Cas.: 341010-36-4 | Purity: 95% | 3-(Piperazin-1-yl)-1,2,4-triazine | ESD-935367-250MG |
| Cas.: 341010-36-4 | Purity: 95% | 3-(Piperazin-1-yl)-1,2,4-triazine | ESD-935367-100MG |
| Cas.: 341010-36-4 | Purity: 95% | 3-(Piperazin-1-yl)-1,2,4-triazine | ESD-935367-50MG |
| Cas.: 2261-99-6 | Purity: 98% | 1H,1H,7H-Dodecafluoroheptyl methacrylate | ESD-832119-500G |
| Cas.: 1565-80-6 | Purity: 98% | (|S|)-(-)-2-Methyl-1-butanol | ESD-813247-500ML |
| Cas.: 179324-87-9 | Purity: 98% | (R)-BoroLeu-(+)-Pinanediol trifluoroacetate | ESD-889434-5G |
| Cas.: 10124-65-9 | Purity: 98% | Potassium Laurate | ESD-923293-25G |
| Cas.: 1201-91-8 | Purity: 98% | N-Methyl-N-(2-hydroxyethyl)-4-aminobenzaldehyde | ESD-854816-100G |
| Cas.: 26982-20-7 | Purity: mol wt 5,000-15,000 | Poly-L-arginine hydrochloride | ESD-923032-50MG |
| Cas.: 28380-24-7 | Purity: 97% | Nigericin | ESD-849348-100MG |
| Cas.: 26982-20-7 | Purity: mol wt 5,000-15,000 | Poly-L-arginine hydrochloride | ESD-923032-100MG |
| Cas.: 26023-30-3 | Purity: pale yellow water beads | Polylactic acid | ESD-921578-5G |
| Cas.: 1071-83-6 | Purity: 95% | Glyphosate | ESD-817058-500G |
| Cas.: 534-73-6 | Purity: 97% | Isomaltitol | ESD-812110-1G |
| Cas.: 534-73-6 | Purity: 97% | Isomaltitol | ESD-812110-250MG |
| Cas.: 203861-62-5 | Purity: 97% | 4-Iodo-2-methoxyphenol | ESD-919828-1G |
| Cas.: 91987-74-5 | Purity: 98% | ((1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetrayl)tetrakis(methylene))tetraphosphonic acid | ESD-890371-1G |
| Cas.: 681435-27-8 | Purity: 97% | 5′-Uridylic acid disodium salt xhydrate | ESD-848490-50G |
| Cas.: 681435-27-8 | Purity: 97% | 5′-Uridylic acid disodium salt xhydrate | ESD-848490-250G |
| Cas.: 52243-87-5 | Purity: 97% | 1,1′-Dipropyl-[4,4′-bipyridine]-1,1′-diium bromide | ESD-935368-5G |
| Cas.: 52243-87-5 | Purity: 97% | 1,1′-Dipropyl-[4,4′-bipyridine]-1,1′-diium bromide | ESD-935368-1G |
| Cas.: 52243-87-5 | Purity: 97% | 1,1′-Dipropyl-[4,4′-bipyridine]-1,1′-diium bromide | ESD-935368-250MG |
| Cas.: 13435-20-6 | Purity: 94% | Tetraethylammonium cyanide | ESD-920363-1G |
| Cas.: 13435-20-6 | Purity: 94% | Tetraethylammonium cyanide | ESD-920363-5G |
| Cas.: 73844-02-7 | Purity: 95% | N,5-Dimethyl-1H-pyrazol-3-amine | ESD-935369-1G |
| Cas.: 73844-02-7 | Purity: 95% | N,5-Dimethyl-1H-pyrazol-3-amine | ESD-935369-250MG |
| Cas.: 73844-02-7 | Purity: 95% | N,5-Dimethyl-1H-pyrazol-3-amine | ESD-935369-100MG |
| Cas.: 18514-84-6 | Purity: 95% | Cinnolin-4(1H)-one | ESD-841026-25G |
| Cas.: 368870-06-8 | Purity: 95% | 1-(4-Chlorophenethyl)-5-oxopyrrolidine-3-carboxylic acid | ESD-935370-5G |
| Cas.: 368870-06-8 | Purity: 95% | 1-(4-Chlorophenethyl)-5-oxopyrrolidine-3-carboxylic acid | ESD-935370-1G |
| Cas.: 368870-06-8 | Purity: 95% | 1-(4-Chlorophenethyl)-5-oxopyrrolidine-3-carboxylic acid | ESD-935370-250MG |
| Cas.: 368870-06-8 | Purity: 95% | 1-(4-Chlorophenethyl)-5-oxopyrrolidine-3-carboxylic acid | ESD-935370-100MG |
| Cas.: 191171-55-8 | Purity: 97% | 2-Aminobenzeneboronic acid pinacol ester | ESD-801547-100G |
| Cas.: 113049-35-7 | Purity: 98% | 1-(1-Methyl-1H-imidazol-2-yl)piperazine | ESD-935371-1G |
| Cas.: 113049-35-7 | Purity: 98% | 1-(1-Methyl-1H-imidazol-2-yl)piperazine | ESD-935371-250MG |
| Cas.: 113049-35-7 | Purity: 98% | 1-(1-Methyl-1H-imidazol-2-yl)piperazine | ESD-935371-100MG |
| Cas.: 58479-61-1 | Purity: 98% | tert-Butyl(chloro)diphenylsilane | ESD-802805-2.5KG |
| Cas.: 89-78-1 | Purity: 99% | DL-Menthol | ESD-813158-2.5L |
| Cas.: 1918-00-9 | Purity: 97% | 3,6-Dichloro-2-methoxybenzoic acid | ESD-807737-500G |
| Cas.: 1297538-32-9 | Purity: 99% | BAY-1841788 | ESD-872842-100MG |
| Cas.: 37853-59-1 | Purity: 95% | 1,2-Bis(tribromophenoxy)-ethane | ESD-907138-1G |
| Cas.: 1160490-11-8 | Purity: 98% | Methyl 2-(methylthio)benzo[d]oxazole-6-carboxylate | ESD-935372-5G |
| Cas.: 1160490-11-8 | Purity: 98% | Methyl 2-(methylthio)benzo[d]oxazole-6-carboxylate | ESD-935372-1G |
| Cas.: 1160490-11-8 | Purity: 98% | Methyl 2-(methylthio)benzo[d]oxazole-6-carboxylate | ESD-935372-250MG |
| Cas.: 1160490-11-8 | Purity: 98% | Methyl 2-(methylthio)benzo[d]oxazole-6-carboxylate | ESD-935372-100MG |
| Cas.: 581-50-0 | Purity: 98% | 2,3′-Bipyridine | ESD-830275-25G |
| Cas.: 826-62-0 | Purity: 99% | Nadic anhydrous | ESD-814630-10KG |
| Cas.: 714951-87-8 | Purity: 98% | Di(1-adamantyl)-n-butylphosphine hydriodide | ESD-828348-25G |
| Cas.: 1046478-89-0 | Purity: 95% | tert-Butyl 4-(2-tosylhydrazono)piperidine-1-carboxylate | ESD-935373-1G |
| Cas.: 1046478-89-0 | Purity: 95% | tert-Butyl 4-(2-tosylhydrazono)piperidine-1-carboxylate | ESD-935373-250MG |
| Cas.: 58-18-4 | Purity: 98% | Methyltestosterone solution | ESD-830054-500G |
| Cas.: 500-65-2 | Purity: ≥98% | Rhapontigenin | ESD-868223-50MG |
| Cas.: 2670-38-4 | Purity: ≥98% | 3,4-Dichlorobenzamide | ESD-858799-5G |
| Cas.: 2670-38-4 | Purity: ≥98% | 3,4-Dichlorobenzamide | ESD-858799-25G |
| Cas.: 13379-98-1 | Purity: 95% | N-(3-Hydroxypropyl)-4-methylbenzenesulfonamide | ESD-935374-1G |
| Cas.: 13379-98-1 | Purity: 95% | N-(3-Hydroxypropyl)-4-methylbenzenesulfonamide | ESD-935374-250MG |
| Cas.: 13379-98-1 | Purity: 95% | N-(3-Hydroxypropyl)-4-methylbenzenesulfonamide | ESD-935374-100MG |
| Cas.: 7790-60-5 | Purity: 98% | Potassium tungstate Dihydrate | ESD-815812-2.5KG |
| Cas.: 1124-20-5 | Purity: ≥97% | alpha,3-Dimethylstyrene | ESD-861678-1G |
| Cas.: 14059-33-7 | Purity: 99.9% trace metals basis | Bismuth vanadate | ESD-836152-500G |
| Cas.: 1703-46-4 | Purity: 98% | 4-(Dimethylamino)benzyl Alcohol | ESD-869730-25G |
| Cas.: 75081-21-9 | Purity: 97%, mixture of 2- and 4-isomers | Isopropyl-9H-thioxanthen-9-one | ESD-909753-25G |
| Cas.: 79-77-6 | Purity: 95% | beta-Ionone | ESD-830245-2.5KG |
| Cas.: 961-29-5 | Purity: Analysis control | Isoliquiritigenin | ESD-811912-100MG |
| Cas.: 25068-26-2 | Purity: low MW | Poly(4-methyl-1-pentene) | ESD-909478-100G |
| Cas.: 26837-42-3 | Purity: average Mw ~(162.21)n, beige | Poly(vinyl sulfate) potassium salt | ESD-916680-1G |
| Cas.: 9001-90-5 | Purity: ≥2.0 units/mg protein | Plasmin, from human plasma | ESD-920012-500ΜG |
| Cas.: 29443-23-0 | Purity: 97% | Allyltriethylammonium bromide | ESD-935375-100G |
| Cas.: 29443-23-0 | Purity: 97% | Allyltriethylammonium bromide | ESD-935375-25G |
| Cas.: 29443-23-0 | Purity: 97% | Allyltriethylammonium bromide | ESD-935375-5G |
| Cas.: 7761-76-4 | Purity: 95% | Cyclopropyl 4-methylbenzenesulfonate | ESD-935376-1G |
| Cas.: 7761-76-4 | Purity: 95% | Cyclopropyl 4-methylbenzenesulfonate | ESD-935376-250MG |
| Cas.: 7761-76-4 | Purity: 95% | Cyclopropyl 4-methylbenzenesulfonate | ESD-935376-100MG |
| Cas.: 34993-56-1 | Purity: >98.0%(GC) | 1-Ethynylpyrene | ESD-861635-100MG |
| Cas.: 104518-24-3 | Purity: 98%, stabilized with Copper chip | 16-Iodo-2,5,8,11,14-pentaoxahexadecane | ESD-935377-250MG |
| Cas.: 104518-24-3 | Purity: 98%, stabilized with Copper chip | 16-Iodo-2,5,8,11,14-pentaoxahexadecane | ESD-935377-1G |
| Cas.: 104518-24-3 | Purity: 98%, stabilized with Copper chip | 16-Iodo-2,5,8,11,14-pentaoxahexadecane | ESD-935377-5G |
| Cas.: 21810-34-4 | Purity: 97% | Potassium 6-hydroxyhexanoate | ESD-847199-25G |
| Cas.: 21810-34-4 | Purity: 97% | Potassium 6-hydroxyhexanoate | ESD-847199-5G |
| Cas.: 712-97-0 | Purity: 98% | 6-Nitropiperonal | ESD-849794-25G |
| Cas.: 82410-32-0 | Purity: ≥99 % HPLC, powder | GANCICLOVIR | ESD-838239-1G |
| Cas.: 82410-32-0 | Purity: ≥99 % HPLC, powder | GANCICLOVIR | ESD-838239-5G |
| Cas.: 82410-32-0 | Purity: ≥99 % HPLC, powder | GANCICLOVIR | ESD-838239-25G |
| Cas.: 82410-32-0 | Purity: ≥99 % HPLC, powder | GANCICLOVIR | ESD-838239-100G |
| Cas.: 8002-80-0 | Purity: AR | Gluten from Wheat | ESD-862565-2.5KG |
| Cas.: 21652-58-4 | Purity: 98% | 1H,1H,2H-Perfluoro-1-decene | ESD-817027-500G |
| Cas.: 4371-91-9 | Purity: 95% | Hexamethyl diorthosilicate | ESD-824682-25G |
| Cas.: 574-96-9 | Purity: 97% | 1-Hydroxy-2-naphthaldehyde | ESD-858250-5G |
| Cas.: 574-96-9 | Purity: 97% | 1-Hydroxy-2-naphthaldehyde | ESD-858250-25G |
| Cas.: 33619-33-9 | Purity: 95% | N,N’-(Pentane-1,5-diyl)bis(2-chloroacetamide) | ESD-935378-5G |
| Cas.: 33619-33-9 | Purity: 95% | N,N’-(Pentane-1,5-diyl)bis(2-chloroacetamide) | ESD-935378-1G |
| Cas.: 33619-33-9 | Purity: 95% | N,N’-(Pentane-1,5-diyl)bis(2-chloroacetamide) | ESD-935378-250MG |
| Cas.: 263162-13-6 | Purity: 95% | tert-Butyl (2-((2-aminoethyl)(methyl)amino)ethyl)carbamate | ESD-935379-1G |
| Cas.: 263162-13-6 | Purity: 95% | tert-Butyl (2-((2-aminoethyl)(methyl)amino)ethyl)carbamate | ESD-935379-250MG |
| Cas.: 263162-13-6 | Purity: 95% | tert-Butyl (2-((2-aminoethyl)(methyl)amino)ethyl)carbamate | ESD-935379-100MG |
| Cas.: 100915-97-7 | Purity: for molecular biology, BioReagent | Mixed Bed Resin | ESD-920210-25G |
| Cas.: 100915-97-7 | Purity: for molecular biology, BioReagent | Mixed Bed Resin | ESD-920210-5G |
| Cas.: 18471-41-5 | Purity: 95% | 1-Phenylpyrrolidin-3-amine | ESD-935380-1G |
| Cas.: 18471-41-5 | Purity: 95% | 1-Phenylpyrrolidin-3-amine | ESD-935380-250MG |
| Cas.: 18471-41-5 | Purity: 95% | 1-Phenylpyrrolidin-3-amine | ESD-935380-100MG |
| Cas.: 937-02-0 | Purity: 95% | 5-tert-Butyl-1,2,4-triazin-3-amine | ESD-935381-1G |
| Cas.: 937-02-0 | Purity: 95% | 5-tert-Butyl-1,2,4-triazin-3-amine | ESD-935381-250MG |
| Cas.: 937-02-0 | Purity: 95% | 5-tert-Butyl-1,2,4-triazin-3-amine | ESD-935381-100MG |
| Cas.: 17924-92-4 | Purity: ≥98% | Zearalenone | ESD-820663-500MG |
| Cas.: 902589-96-2 | Purity: 98% | YMU1 | ESD-913014-25MG |
| Cas.: 873996-85-1 | Purity: 95% | 4-Phenylbutane-1-sulfonamide | ESD-935382-1G |
| Cas.: 873996-85-1 | Purity: 95% | 4-Phenylbutane-1-sulfonamide | ESD-935382-250MG |
| Cas.: 873996-85-1 | Purity: 95% | 4-Phenylbutane-1-sulfonamide | ESD-935382-100MG |
| Cas.: 979-88-4 | Purity: 98% | 2,2′-Biquinoline-4,4′-dicarboxylic acid disodium salt hydrate | ESD-802494-500G |
| Cas.: 123614-86-8 | Purity: 95% | 2-Chloro-4-fluorobenzohydrazide | ESD-935383-5G |
| Cas.: 123614-86-8 | Purity: 95% | 2-Chloro-4-fluorobenzohydrazide | ESD-935383-1G |
| Cas.: 123614-86-8 | Purity: 95% | 2-Chloro-4-fluorobenzohydrazide | ESD-935383-250MG |
| Cas.: 1633-83-6 | Purity: 97% | 1,4-Butane sultone | ESD-823135-2.5KG |
| Cas.: 391901-45-4 | Purity: 97% | (R)-2-((4-Aminophenethyl)amino)-1-phenylethanol | ESD-891284-25G |
| Cas.: 391901-45-4 | Purity: 97% | (R)-2-((4-Aminophenethyl)amino)-1-phenylethanol | ESD-891284-100G |
| Cas.: 67637-83-6 | Purity: 95% | 4-Phenylthiophen-2-amine | ESD-935384-1G |
| Cas.: 67637-83-6 | Purity: 95% | 4-Phenylthiophen-2-amine | ESD-935384-250MG |
| Cas.: 67637-83-6 | Purity: 95% | 4-Phenylthiophen-2-amine | ESD-935384-100MG |
| Cas.: 2800-80-8 | Purity: indicator grade | Bromophenol red | ESD-876001-500G |
| Cas.: 98040-93-8 | Purity: 97% | tert-Butyl 2,3,4,5,6-pentafluorobenzoate | ESD-935385-5G |
| Cas.: 98040-93-8 | Purity: 97% | tert-Butyl 2,3,4,5,6-pentafluorobenzoate | ESD-935385-1G |
| Cas.: 98040-93-8 | Purity: 97% | tert-Butyl 2,3,4,5,6-pentafluorobenzoate | ESD-935385-250MG |
| Cas.: 98040-93-8 | Purity: 97% | tert-Butyl 2,3,4,5,6-pentafluorobenzoate | ESD-935385-100MG |
| Cas.: 143127-81-5 | Purity: 98%, stabilized with Copper chip | 13-Iodo-2,5,8,11-tetraoxatridecane | ESD-935386-5G |
| Cas.: 143127-81-5 | Purity: 98%, stabilized with Copper chip | 13-Iodo-2,5,8,11-tetraoxatridecane | ESD-935386-1G |
| Cas.: 143127-81-5 | Purity: 98%, stabilized with Copper chip | 13-Iodo-2,5,8,11-tetraoxatridecane | ESD-935386-250MG |
| Cas.: 544-19-4 | Purity: 97% | Copper(II) formate hydrate | ESD-832307-25G |
| Cas.: 544-19-4 | Purity: 97% | Copper(II) formate hydrate | ESD-832307-100G |
| Cas.: 37868-26-1 | Purity: 97% | 2-(2,3-Dihydro-1H-inden-2-yl)acetic acid | ESD-935387-5G |
| Cas.: 37868-26-1 | Purity: 97% | 2-(2,3-Dihydro-1H-inden-2-yl)acetic acid | ESD-935387-1G |
| Cas.: 37868-26-1 | Purity: 97% | 2-(2,3-Dihydro-1H-inden-2-yl)acetic acid | ESD-935387-250MG |
| Cas.: 37868-26-1 | Purity: 97% | 2-(2,3-Dihydro-1H-inden-2-yl)acetic acid | ESD-935387-100MG |
| Cas.: 41051-80-3 | Purity: 98% | N,N-Diethyl-3-(trimethoxysilyl)propan-1-amine | ESD-834066-2.5KG |
| Cas.: 12001-79-5 | Purity: ≥98% | Vitamin K | ESD-884044-500MG |
| Cas.: 4080-98-2 | Purity: 98% | Dodecanedioic Dihydrazide | ESD-870580-100G |
| Cas.: 4080-98-2 | Purity: 98% | Dodecanedioic Dihydrazide | ESD-870580-500G |
| Cas.: NONE6784 | Purity: 0.2M, pH5.0 | Succinate Buffer | ESD-885330-500ML |
| Cas.: NONE6894 | Purity: 0.5M, pH9.0 | CHES Buffer | ESD-885547-500ML |
| Cas.: 27192-91-2 | Purity: ≥98% | 2,2′,7,7′-Tetrabromo-9,9′-bifluorenylidene | ESD-868536-1G |
| Cas.: 123-01-3 | Purity: 99,5% | 1-Phenyldodecane | ESD-910189-100ML |
| Cas.: 885519-19-7 | Purity: 97% | Methyl 4-chloro-1H-indazole-6-carboxylate | ESD-935388-1G |
| Cas.: 885519-19-7 | Purity: 97% | Methyl 4-chloro-1H-indazole-6-carboxylate | ESD-935388-250MG |
| Cas.: 885519-19-7 | Purity: 97% | Methyl 4-chloro-1H-indazole-6-carboxylate | ESD-935388-100MG |
| Cas.: 37470-83-0 | Purity: 95% | 5-Ethyl-2,4-dihydroxybenzaldehyde | ESD-935389-1G |
| Cas.: 37470-83-0 | Purity: 95% | 5-Ethyl-2,4-dihydroxybenzaldehyde | ESD-935389-250MG |
| Cas.: 37470-83-0 | Purity: 95% | 5-Ethyl-2,4-dihydroxybenzaldehyde | ESD-935389-100MG |
| Cas.: 69441-09-4 | Purity: >99% | 1-Palmitoyl, 2-myristoyl-sn-Glycero-3–phosphocholine | ESD-875705-5MG |
| Cas.: 110187-42-3 | Purity: ≥99 atom %13C, ≥99% (CP) | D-Glucose-13C6 | ESD-922504-250MG |
| Cas.: 123-73-9 | Purity: AR, 98% | (E)-2-Butenal | ESD-802199-2.5L |
| Cas.: 120381-42-2 | Purity: 98% | 5-Fluoro-N-methyl-2-nitroaniline | ESD-935390-5G |
| Cas.: 120381-42-2 | Purity: 98% | 5-Fluoro-N-methyl-2-nitroaniline | ESD-935390-1G |
| Cas.: 120381-42-2 | Purity: 98% | 5-Fluoro-N-methyl-2-nitroaniline | ESD-935390-250MG |
| Cas.: 120381-42-2 | Purity: 98% | 5-Fluoro-N-methyl-2-nitroaniline | ESD-935390-100MG |
| Cas.: 103-31-1 | Purity: ≥98% | 4-Styrylpyridine | ESD-866500-5G |
| Cas.: 18881-04-4 | Purity: ≥95% | (S)-cis-Verbenol | ESD-915332-5G |
| Cas.: 12034-41-2 | Purity: 99,9% | Sodium telluride | ESD-923528-10G |
| Cas.: 379270-37-8 | Purity: 98% | GS-7340 | ESD-846455-1G |
| Cas.: 465-99-6 | Purity: Analysis control | Hederagenin | ESD-811170-100MG |
| Cas.: 3453-83-6 | Purity: 95% | 2,4,6-Trimethylbenzenesulfonic acid | ESD-924345-5G |
| Cas.: 3453-83-6 | Purity: 95% | 2,4,6-Trimethylbenzenesulfonic acid | ESD-924345-25G |
| Cas.: 475-00-3 | Purity: Analysis control, >98% | VERATROSINE | ESD-889700-5MG |
| Cas.: 69397-93-9 | Purity: 95% | 5-Methoxy-N-methyl-2-nitroaniline | ESD-935391-5G |
| Cas.: 69397-93-9 | Purity: 95% | 5-Methoxy-N-methyl-2-nitroaniline | ESD-935391-1G |
| Cas.: 69397-93-9 | Purity: 95% | 5-Methoxy-N-methyl-2-nitroaniline | ESD-935391-250MG |
| Cas.: 137-88-2 | Purity: ≥98% | Amprolium HCl | ESD-832802-500G |
| Cas.: 1421373-98-9 | Purity: 99% | AZ5104 | ESD-872618-25MG |
| Cas.: 669073-77-2 | Purity: 95% | 2-ethylpyrrolidine hydrochloride | ESD-935392-250MG |
| Cas.: 669073-77-2 | Purity: 95% | 2-ethylpyrrolidine hydrochloride | ESD-935392-1G |
| Cas.: 1070-11-7 | Purity: ≥98.0% | Ethambutol HCl | ESD-832917-500G |
| Cas.: 62932-94-9 | Purity: ≥96% | 2-BROMO-1-[4-HYDROXY-3-(HYDROXYMETHYL)PHENYL]ETHAN-1-ONE | ESD-888462-25G |
| Cas.: 62932-94-9 | Purity: ≥96% | 2-BROMO-1-[4-HYDROXY-3-(HYDROXYMETHYL)PHENYL]ETHAN-1-ONE | ESD-888462-100G |
| Cas.: 9051-29-0 | Purity: ≥85% (PAGE), does not contain calcium | α-Lactalbumin | ESD-914919-25MG |
| Cas.: 127046-45-1 | Pazufloxacin hydrochloride | ESD-935393-100MG | |
| Cas.: 1536-23-8 | Purity: ≥98% | 2,3,4,5,6-Pentafluorobenzophenone | ESD-867663-5G |
| Cas.: 127046-45-1 | Pazufloxacin hydrochloride | ESD-935393-500MG | |
| Cas.: 73465-43-7 | Purity: 98% | 1-Deoxymannojirimycin hydrochloride | ESD-807798-25MG |
| Cas.: 6325-91-3 | Purity: 97% | 2-Mercapto-5-nitrobenzimidazole | ESD-834838-1G |
| Cas.: 40828-54-4 | Purity: ≥98% | 1H-Benzimidazole-2-Sulfonic Acid | ESD-859954-5G |
| Cas.: 29176-55-4 | Purity: 97% | 2,9-Dichloro-1,10-phenanthroline | ESD-808433-5G |
| Cas.: 14382-91-3 | Purity: ≥97% | 2-Hydroxy-4,5-dimethoxybenzaldehyde | ESD-852138-5G |
| Cas.: 2016-88-8 | Purity: ≥98% | Amiloride hydrochloride | ESD-832893-25G |
| Cas.: 1317-80-2 | Purity: 18nm, 18 wt% | TiO2 paste | ESD-914090-5G |
| Cas.: 35203-49-7 | Purity: 98% | N1-Methyl-4-(trifluoromethyl)benzene-1,2-diamine | ESD-935394-5G |
| Cas.: 5455-98-1 | Purity: ≥95% | N-(2,3-Epoxypropyl)phthalimide | ESD-920418-100G |
| Cas.: 35203-49-7 | Purity: 98% | N1-Methyl-4-(trifluoromethyl)benzene-1,2-diamine | ESD-935394-1G |
| Cas.: 35203-49-7 | Purity: 98% | N1-Methyl-4-(trifluoromethyl)benzene-1,2-diamine | ESD-935394-250MG |
| Cas.: 3321-92-4 | Purity: 98% | 3′,5′-Dichloro-2′-hydroxyacetophenone | ESD-870383-5G |
| Cas.: 244092-76-0 | Purity: 97% | (R)-tert-Butyl (1-phenylbut-3-en-2-yl)carbamate | ESD-935395-1G |
| Cas.: 244092-76-0 | Purity: 97% | (R)-tert-Butyl (1-phenylbut-3-en-2-yl)carbamate | ESD-935395-250MG |
| Cas.: 106-29-6 | Purity: ≥97% | Geranyl butyrate natural | ESD-859119-100G |
| Cas.: 244092-76-0 | Purity: 97% | (R)-tert-Butyl (1-phenylbut-3-en-2-yl)carbamate | ESD-935395-100MG |
| Cas.: 106-29-6 | Purity: ≥97% | Geranyl butyrate natural | ESD-859119-500G |
| Cas.: 106-29-6 | Purity: ≥97% | Geranyl butyrate natural | ESD-859119-2.5KG |
| Cas.: 179474-81-8 | Purity: ≥99% | Prucalopride | ESD-833194-250MG |
| Cas.: 4038-14-6 | Purity: 98% | (3,4-Dimethoxyphenyl)(phenyl)methanone | ESD-892259-500G |
| Cas.: 491-45-2 | Purity: 95% | Phloroglucide | ESD-914678-5G |
| Cas.: 1445-75-6 | Purity: ≥98% | Diisopropyl Methylphosphonate | ESD-915036-25G |
| Cas.: 358730-89-9 | Purity: analytical standard analytical standard | Di-n-pentyl Phthalate-3456-d4 | ESD-923007-5MG |
| Cas.: 227609-85-0 | Purity: 98% | 2-Fluoro-5-(hydroxymethyl)benzonitrile | ESD-935396-25G |
| Cas.: 227609-85-0 | Purity: 98% | 2-Fluoro-5-(hydroxymethyl)benzonitrile | ESD-935396-5G |
| Cas.: 227609-85-0 | Purity: 98% | 2-Fluoro-5-(hydroxymethyl)benzonitrile | ESD-935396-1G |
| Cas.: 1631-82-9 | Purity: ≥93.0% (GC) | Phenylmethylchlorosilane | ESD-923317-1ML |
| Cas.: 17689-77-9 | Purity: 96% | Ethyltriacetoxysilane | ESD-832796-2.5KG |
| Cas.: 1474-78-8 | Purity: 98% | Ethyl Diethoxyphosphinylformate | ESD-870216-25G |
| Cas.: 13321-61-4 | Purity: 95% | Ethyl 2-oxo-3-(triphenylphosphoranylidene)propanoate | ESD-924083-5G |
| Cas.: 859155-89-8 | Purity: 97% | 4-Boc-3-Carboxymethylmorpholine | ESD-935397-1G |
| Cas.: 859155-89-8 | Purity: 97% | 4-Boc-3-Carboxymethylmorpholine | ESD-935397-250MG |
| Cas.: 859155-89-8 | Purity: 97% | 4-Boc-3-Carboxymethylmorpholine | ESD-935397-100MG |
| Cas.: 73573-87-2 | Purity: 98% | Formoterol | ESD-858041-500MG |
| Cas.: 374067-95-5 | Purity: 95% | 2-Methyl-2-(4-sulfamoylphenyl)propionic acid | ESD-935398-100MG |
| Cas.: 374067-95-5 | Purity: 95% | 2-Methyl-2-(4-sulfamoylphenyl)propionic acid | ESD-935398-250MG |
| Cas.: 374067-95-5 | Purity: 95% | 2-Methyl-2-(4-sulfamoylphenyl)propionic acid | ESD-935398-1G |
| Cas.: 7440-16-6 | Purity: 99.95% metals basis | Rhodium | ESD-817280-50MG |
| Cas.: 857565-71-0 | Purity: 95% | 1-(3,4-Dimethoxy-2-nitrophenyl)ethanone | ESD-935399-1G |
| Cas.: 857565-71-0 | Purity: 95% | 1-(3,4-Dimethoxy-2-nitrophenyl)ethanone | ESD-935399-250MG |
| Cas.: 857565-71-0 | Purity: 95% | 1-(3,4-Dimethoxy-2-nitrophenyl)ethanone | ESD-935399-100MG |
| Cas.: 14649-03-7 | Purity: 98% | (S)-(-)-1-Phenylethyl isocyanate | ESD-836183-100G |
| Cas.: 101219-39-0 | Purity: 95% | Ethyl 5-methylbenzo[b]thiophene-2-carboxylate | ESD-935400-100MG |
| Cas.: 101219-39-0 | Purity: 95% | Ethyl 5-methylbenzo[b]thiophene-2-carboxylate | ESD-935400-250MG |
| Cas.: 101219-39-0 | Purity: 95% | Ethyl 5-methylbenzo[b]thiophene-2-carboxylate | ESD-935400-1G |
| Cas.: 10294-26-5 | Purity: 99.9% metals basis | Silver sulfate | ESD-861572-500G |
| Cas.: 223797-47-5 | Purity: 95% | tert-Butyl 4-(pyridin-3-yl)piperazine-1-carboxylate | ESD-935401-100MG |
| Cas.: 223797-47-5 | Purity: 95% | tert-Butyl 4-(pyridin-3-yl)piperazine-1-carboxylate | ESD-935401-250MG |
| Cas.: 1009075-43-7 | Purity: 95% | (3S,4S)-tert-Butyl 3-amino-4-fluoropyrrolidine-1-carboxylate | ESD-935402-1G |
| Cas.: 1009075-43-7 | Purity: 95% | (3S,4S)-tert-Butyl 3-amino-4-fluoropyrrolidine-1-carboxylate | ESD-935402-250MG |
| Cas.: 1009075-43-7 | Purity: 95% | (3S,4S)-tert-Butyl 3-amino-4-fluoropyrrolidine-1-carboxylate | ESD-935402-100MG |
| Cas.: 2387-08-8 | Purity: 98% | 4,5-Dichloro-2-methylaniline | ESD-935403-5G |
| Cas.: 2387-08-8 | Purity: 98% | 4,5-Dichloro-2-methylaniline | ESD-935403-1G |
| Cas.: 2387-08-8 | Purity: 98% | 4,5-Dichloro-2-methylaniline | ESD-935403-250MG |
| Cas.: 74788-45-7 | Purity: 95% | 1-(3-Fluorophenyl)ethanamine | ESD-935404-5G |
| Cas.: 74788-45-7 | Purity: 95% | 1-(3-Fluorophenyl)ethanamine | ESD-935404-1G |
| Cas.: 74788-45-7 | Purity: 95% | 1-(3-Fluorophenyl)ethanamine | ESD-935404-250MG |
| Cas.: 62492-42-6 | Purity: 97% | 4-Chloro-5-methoxy-2-methylaniline | ESD-935405-1G |
| Cas.: 62492-42-6 | Purity: 97% | 4-Chloro-5-methoxy-2-methylaniline | ESD-935405-250MG |
| Cas.: 62492-42-6 | Purity: 97% | 4-Chloro-5-methoxy-2-methylaniline | ESD-935405-50MG |
| Cas.: 1263286-09-4 | Purity: 97% | Methyl 2-chloro-6-formylnicotinate | ESD-935406-5G |
| Cas.: 1263286-09-4 | Purity: 97% | Methyl 2-chloro-6-formylnicotinate | ESD-935406-1G |
| Cas.: 1263286-09-4 | Purity: 97% | Methyl 2-chloro-6-formylnicotinate | ESD-935406-250MG |
| Cas.: 943323-55-5 | Purity: 95% | 4-Bromo-1H-pyrrolo[2,3-b]pyridin-6-amine | ESD-935407-1G |
| Cas.: 943323-55-5 | Purity: 95% | 4-Bromo-1H-pyrrolo[2,3-b]pyridin-6-amine | ESD-935407-250MG |
| Cas.: 943323-55-5 | Purity: 95% | 4-Bromo-1H-pyrrolo[2,3-b]pyridin-6-amine | ESD-935407-100MG |
| Cas.: 1192004-62-8 | Purity: 98% | 4-Bromo-5-methoxy-1H-indazole | ESD-935408-5G |
| Cas.: 1192004-62-8 | Purity: 98% | 4-Bromo-5-methoxy-1H-indazole | ESD-935408-1G |
| Cas.: 1192004-62-8 | Purity: 98% | 4-Bromo-5-methoxy-1H-indazole | ESD-935408-250MG |
| Cas.: 1192004-62-8 | Purity: 98% | 4-Bromo-5-methoxy-1H-indazole | ESD-935408-100MG |
| Cas.: 944328-71-6 | Purity: 95% | 4,4-Difluoro-but-2-enoic acid | ESD-935409-1G |
| Cas.: 944328-71-6 | Purity: 95% | 4,4-Difluoro-but-2-enoic acid | ESD-935409-250MG |
| Cas.: 944328-71-6 | Purity: 95% | 4,4-Difluoro-but-2-enoic acid | ESD-935409-50MG |
| Cas.: 24331-94-0 | Purity: 98% | 1,4-Dihydro-3(2H)-isoquinolinone | ESD-935410-1G |
| Cas.: 24331-94-0 | Purity: 98% | 1,4-Dihydro-3(2H)-isoquinolinone | ESD-935410-250MG |
| Cas.: 24331-94-0 | Purity: 98% | 1,4-Dihydro-3(2H)-isoquinolinone | ESD-935410-100MG |
| Cas.: 56012-38-5 | Purity: 95% | (2-Methylthiazol-5-yl)methanol | ESD-935411-5G |
| Cas.: 56012-38-5 | Purity: 95% | (2-Methylthiazol-5-yl)methanol | ESD-935411-1G |
| Cas.: 56012-38-5 | Purity: 95% | (2-Methylthiazol-5-yl)methanol | ESD-935411-250MG |
| Cas.: 56012-38-5 | Purity: 95% | (2-Methylthiazol-5-yl)methanol | ESD-935411-100MG |
| Cas.: 886372-47-0 | Purity: 95% | 4-Bromo-6-methylpicolinic acid | ESD-935412-1G |
| Cas.: 886372-47-0 | Purity: 95% | 4-Bromo-6-methylpicolinic acid | ESD-935412-250MG |
| Cas.: 886372-47-0 | Purity: 95% | 4-Bromo-6-methylpicolinic acid | ESD-935412-100MG |
| Cas.: 159326-66-6 | Purity: 95% | 1-Amino-1H-pyrrole-2-carbonitrile | ESD-935413-5G |
| Cas.: 159326-66-6 | Purity: 95% | 1-Amino-1H-pyrrole-2-carbonitrile | ESD-935413-1G |
| Cas.: 159326-66-6 | Purity: 95% | 1-Amino-1H-pyrrole-2-carbonitrile | ESD-935413-250MG |
| Cas.: 850411-07-3 | Purity: 98% | Ethyl 2-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)acetate | ESD-935414-1G |
| Cas.: 850411-07-3 | Purity: 98% | Ethyl 2-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)acetate | ESD-935414-250MG |
| Cas.: 850411-07-3 | Purity: 98% | Ethyl 2-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)acetate | ESD-935414-100MG |
| Cas.: 127-82-2 | Purity: 99% | ZINC PHENOLSULFONATE | ESD-888948-2.5KG |
| Cas.: 9029-33-8 | Purity: lyophilized powder, ≥15 units/mg solid, secondary activity: ≥10 units/mg solid NADPH diaphorase | Ferredoxin-NADP+ Reductase, from Spinacia oleracea (spinach) | ESD-921678-10U |
| Cas.: 9047-50-1 | Purity: 98% | Polydialdehyde Starch (Polymeric Dialdehyde) | ESD-921921-1G |
| Cas.: 39906-04-2 | Purity: 98% | 5-Amino-4,6-dichloro-2-methylpyrimidine | ESD-831351-25G |
| Cas.: 105202-02-6 | Purity: ≥98% | 3-Amino-4-iodobenzotrifluoride | ESD-858822-5G |
| Cas.: 64742-48-9 | ISOPARAFFIN L | ESD-885925-2.5KG | |
| Cas.: 10293-06-8 | Purity: ≥97 % sum of enantiomers | (+)-3-Bromocamphor | ESD-838166-100G |
| Cas.: 27466-83-7 | Purity: 98% | 4-Bromo-N-methylbenzamide | ESD-841688-5G |
| Cas.: 16532-02-8 | Purity: 95% | (Bromomethyl)chlorodimethylsilane | ESD-875200-100G |
| Cas.: 534-17-8 | Purity: 99%, Particle size <10μm | Caesium carbonate | ESD-915824-100G |
| Cas.: 544-64-9 | Purity: 98% | Myristoleic Acid | ESD-912486-100MG |
| Cas.: 1750-12-5 | Purity: 99% | 4-Amino-3-hydrazino-5-mercapto-1,2,4-triazole | ESD-800081-500G |
| Cas.: 544-64-9 | Purity: 98% | Myristoleic Acid | ESD-912486-1G |
| Cas.: 25214-70-4 | Purity: 98% | Formaldehyde, polymer with benzenamine | ESD-888409-100G |
| Cas.: 874219-45-1 | Purity: 98% | 4-Chloro-3-(methoxycarbonyl)phenylboronic acid | ESD-842761-5G |
| Cas.: 9067-32-7 | Purity: 95%, Source: Streptococcus equi | Hyaluronic acid sodium salt from rooster comb | ESD-832248-500G |
| Cas.: 13499-05-3 | Purity: 99%, yellow to brown powder | Hafnium chloride | ESD-875556-500G |
| Cas.: 10102-68-8 | Purity: 99,999% | CALCIUM IODIDE | ESD-888835-25G |
| Cas.: 88930-15-8 | Purity: >98% | Mogrol | ESD-860597-25MG |
| Cas.: 88930-15-8 | Purity: >98% | Mogrol | ESD-860597-100MG |
| Cas.: 88930-15-8 | Purity: >98% | Mogrol | ESD-860597-1MG |
| Cas.: 174813-81-1 | Purity: ≥90% | RuCl[(S,S)-Tsdpen](mesitylene) | ESD-868114-1G |
| Cas.: 83-73-8 | Purity: 98% | 5,7-Diiodo-8-hydroxyquinoline | ESD-808231-1G |
| Cas.: 8014-09-3 | Purity: contains patchouliol(26%~33%) | Patchouli oil | ESD-815541-100ML |
| Cas.: 7384-98-7 | Purity: 95% | Propane-1,2-diyl dioctanoate | ESD-891941-5G |
| Cas.: 89-02-1 | Purity: 98% | 2,4-Dinitrobenzenesulfonic acid hydrate | ESD-806687-100MG |
| Cas.: 89-02-1 | Purity: 98% | 2,4-Dinitrobenzenesulfonic acid hydrate | ESD-806687-500MG |
| Cas.: 356-86-5 | Purity: 98% | 2,2,3,3,3-Pentafluoropropyl Acrylate (stabilized with TBC) | ESD-923433-25G |
| Cas.: 12024-22-5 | Purity: 99.99% trace metals basis | Gallium(III) sulfide | ESD-836028-5G |
| Cas.: 12024-22-5 | Purity: 99.99% trace metals basis | Gallium(III) sulfide | ESD-836028-25G |
| Cas.: 83783-77-1 | 3-[bis(benzyl)amino]hexahydro-2H-azepin-2-one | ESD-927191-1G | |
| Cas.: 1334177-95-5 | Purity: 98% | NHS-PEG4-SPDP | ESD-869706-100MG |
| Cas.: 96-05-9 | Purity: Include 50-185 ppm MEHQstabilizer, 98% | Allyl methacrylate | ESD-800502-10L |
| Cas.: 3483-12-3 | Purity: 97% | DL-1,4-Dithiothreitol | ESD-935415-100G |
| Cas.: 3483-12-3 | Purity: 97% | DL-1,4-Dithiothreitol | ESD-935415-25G |
| Cas.: 3483-12-3 | Purity: 97% | DL-1,4-Dithiothreitol | ESD-935415-5G |
| Cas.: 3483-12-3 | Purity: 97% | DL-1,4-Dithiothreitol | ESD-935415-1G |
| Cas.: 14187-14-5 | Purity: 95% | Pt(II) meso-Tetraphenylporphine | ESD-922256-250MG |
| Cas.: 1664-54-6 | Purity: 97% | 3-(3-Aminophenyl)propanoic acid | ESD-842227-25G |
| Cas.: 42292-18-2 | Purity: 95% | Aminopropylbis(trimethylsiloxy)methylsilane | ESD-934315-1ML |
| Cas.: 1838-08-0 | Purity: ≥98% | Octadecylamine Hydrochloride | ESD-867423-25G |
| Cas.: 65605-36-9 | MW 500 | O,O’-Bis(2-aminopropyl) polypropylene glycol-block-polyethylene glycol-block-polypropylene glycol1O,O’-Bis(2-aminopropyl) polypropylene glycol-block-polyethylene glycol-block-polypropylene glycol1 | ESD-921879-100ML |
| Cas.: 81925-81-7 | Purity: 98% | Natural 5-Methyl-2-hepten-4-one | ESD-861091-1G |
| Cas.: 5382-18-3 | Purity: ≥97% | 4-Chloropiperidine | ESD-865432-250MG |
| Cas.: 18078-86-9 | Purity: ≥98% | Tris(acetylacetonato)(1,10-phenanthroline)terbium(III) | ESD-868576-25MG |
| Cas.: 18078-86-9 | Purity: ≥98% | Tris(acetylacetonato)(1,10-phenanthroline)terbium(III) | ESD-868576-500MG |
| Cas.: 29096-93-3 | Purity: Carbon 36.0 – 38.6% | 2,5-Dibromo-6-isopropyl-3-methyl-1,4-benzoquinone | ESD-922114-50MG |
| Cas.: 924-41-4 | Purity: 95% | 1,5-Hexadien-3-ol | ESD-920489-1G |
| Cas.: 78056-28-7 | Purity: 97% | 1-Amino-3-methyladamantane | ESD-855643-10MG |
| Cas.: 49705-26-2 | Purity: 99 atom %13C | L-Methionine-13C | ESD-924055-250MG |
| Cas.: 64169-34-2 | Purity: 98% | 5-Bromoisobenzofuran-1(3H)-one | ESD-842650-100G |
| Cas.: 64169-34-2 | Purity: 98% | 5-Bromoisobenzofuran-1(3H)-one | ESD-842650-500G |
| Cas.: 17141-63-8 | Purity: 98% | Manganese(II) nitrate hexahydrate | ESD-836255-2.5KG |
| Cas.: 41239-10-5 | Purity: 97% | (2-bromoethyl)(methyl)amine | ESD-923696-5G |
| Cas.: 868-18-8 | Purity: ≥98% | Sodium Tartrate | ESD-859168-2.5KG |
| Cas.: 2785-87-7 | Purity: 98% | 2-Methoxy-4-(1-propyl)phenol | ESD-828619-2.5KG |
| Cas.: 78686-77-8 | Purity: 98% | Methyl 5-bromo-6-chloropyridine-3-carboxylate | ESD-822722-100G |
| Cas.: 278788-66-2 | Purity: 95% | (R)-3-HYDROXYMETHYL-PIPERAZINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER | ESD-822080-25G |
| Cas.: 146796-02-3 | Purity: 97% | (2,3-Dihydrothieno[3,4-b][1,4]dioxin-2-yl)methanol | ESD-869313-25G |
| Cas.: 29394-58-9 | (S)-(+)-1-Iodo-2-methylbutane | ESD-920708-1G | |
| Cas.: 1419179-26-2 | Purity: AR | Chlorobis[dicyclohexyl(phenyl)phosphino](o-tolyl)nickel(II) | ESD-871512-250MG |
| Cas.: 6175-45-7 | Purity: ≥95% | 2,2-Diethoxyacetophenone | ESD-834857-1ML |
| Cas.: 380430-65-9 | Purity: 98% | (3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanamine hydrochloride | ESD-919515-5G |
| Cas.: 460-08-2 | Purity: 95% | 2-Fluoroethanamine hydrochloride | ESD-844230-25G |
| Cas.: 8007-69-0 | Purity: AR | Sweet Almond Oil | ESD-885963-2.5KG |
| Cas.: 82469-79-2 | Purity: ≥92%(GC) | Trihexyl O-Butyrylcitrate | ESD-918133-25G |
| Cas.: 73590-85-9 | Purity: 98% | Ufiprazole | ESD-834555-100G |
| Cas.: 2751-09-9 | Purity: Analysis control | Troleandomycin | ESD-922688-1MG |
| Cas.: 953848-21-0 | Purity: 98% | 2-(5-bromopyridin-3-yl)-1H-benzo[d]imidazole | ESD-855532-500MG |
| Cas.: 72025-60-6 | Purity: 250 ug/ml in Ethanol | Leukotriene C4 (LTC4) | ESD-912679-40ΜL |
| Cas.: 578-66-5 | Purity: 98% | 8-Aminoquinoline | ESD-800399-500G |
| Cas.: 128595-07-3 | Purity: 98% | N-(Cyclopentyloxycarbonyloxy)succinimide | ESD-835365-100G |
| Cas.: 100-79-8 | Purity: ≥95% | DL-1,2-Isopropylideneglycerol | ESD-833522-10KG |
| Cas.: 655249-87-9 | Purity: 98% | 1-Allyl-3-Methylimidazolium Bis(Trifluoromethylsulfonyl)Imide | ESD-857253-100G |
| Cas.: 1616693-72-1 | Purity: 95% | tert-butyl (5-(2-chloroacetamido)pentyl)carbamate | ESD-935416-250MG |
| Cas.: 591-68-4 | Purity: ≥95% | Butyl valerate | ESD-803109-500G |
| Cas.: 170491-63-1 | Purity: 97% | 1-Boc-2-pyrrolidinemethanol | ESD-803696-25G |
| Cas.: 1362243-53-5 | Purity: 95% | 2-(2-cyclopropylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-935417-100MG |
| Cas.: 1362243-53-5 | Purity: 95% | 2-(2-cyclopropylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-935417-250MG |
| Cas.: 621-72-7 | Purity: ≥99% | 2-Benzyl-1H-benzoimidazole | ESD-822947-25G |
| Cas.: 621-72-7 | Purity: ≥99% | 2-Benzyl-1H-benzoimidazole | ESD-822947-100G |
| Cas.: 412348-27-7 | Purity: 95% | tert-Butyl 4-(6-bromopyridin-3-yl)piperazine-1-carboxylate | ESD-935418-100MG |
| Cas.: 412348-27-7 | Purity: 95% | tert-Butyl 4-(6-bromopyridin-3-yl)piperazine-1-carboxylate | ESD-935418-250MG |
| Cas.: 412348-27-7 | Purity: 95% | tert-Butyl 4-(6-bromopyridin-3-yl)piperazine-1-carboxylate | ESD-935418-1G |
| Cas.: 1415312-45-6 | Purity: 95% | 2-(Oxan-2-yl)-4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-2H-1,2,3-triazole | ESD-935419-100MG |
| Cas.: 97-78-9 | Purity: ≥98% | N-Lauroylsarcosine | ESD-860394-5G |
| Cas.: 13161-30-3 | Purity: 98% | 2-Pyridinol N-oxide | ESD-815567-2.5KG |
| Cas.: 6590-91-6 | Purity: 97% | 2,6-DICHLOROPHENYLTHIOUREA | ESD-888908-250MG |
| Cas.: 60531-36-4 | Purity: 97% | 4-(2-AMINOETHYL)BENZOIC ACID HYDROCHLORIDE | ESD-923861-250MG |
| Cas.: 13777-25-8 | Purity: 99% | Zirconium(IV) bromide | ESD-923036-2G |
| Cas.: 80353-94-2 | Purity: 95% | 7-Methylimidazo[1,2-a]pyridine-2-carboxylic acid | ESD-844726-5G |
| Cas.: 69655-76-1 | Purity: 98% | PSS-Octavinyl substituted | ESD-823097-100G |
| Cas.: 73218-79-8 | Purity: 97% | 2,6-Dichloro-N1-(4,5-dihydro-1H-imidazol-2-yl)benzene-1,4-diamine hydrochloride | ESD-846612-5MG |
| Cas.: 26864-56-2 | Purity: 99% | Penfluridol | ESD-830348-200MG |
| Cas.: 9027-96-7 | Purity: ammonium sulfate suspension, ≥100units/mg protein | Citrate Synthase from porcine heart ammonium sulfate suspension | ESD-922185-50U |
| Cas.: 72886-42-1 | Purity: 95% | Methyl 3-mercaptobenzoate | ESD-935420-100MG |
| Cas.: 617-65-2 | Purity: 99% | DL-Glutamic acid | ESD-830808-2.5KG |
| Cas.: 1273-89-8 | Purity: 95% | Ethylferrocene | ESD-935421-1G |
| Cas.: 1273-89-8 | Purity: 95% | Ethylferrocene | ESD-935421-5G |
| Cas.: 1273-89-8 | Purity: 95% | Ethylferrocene | ESD-935421-25G |
| Cas.: 1273-89-8 | Purity: 95% | Ethylferrocene | ESD-935421-100G |
| Cas.: 1069-79-0 | Purity: >97% | 1,2-distearoyl-sn-glycero-3-phosphoethanolamine | ESD-832795-5G |
| Cas.: 14215-97-5 | Purity: 98% | D-Ribofuranose, 1-acetate 2,3,5-tribenzoate | ESD-843976-25G |
| Cas.: 38385-95-4 | Purity: 95% | 2-(Piperidin-4-yl)-1H-benzo[d]imidazole | ESD-843406-5G |
| Cas.: 38385-95-4 | Purity: 95% | 2-(Piperidin-4-yl)-1H-benzo[d]imidazole | ESD-843406-25G |
| Cas.: 7783-28-0 | Purity: 99% | Ammonium phosphate dibasic | ESD-801048-100G |
| Cas.: 1344-28-1 | Purity: 20-30 nm Particle size , 20 wt. % water solution | Aluminum oxide | ESD-935422-2.5L |
| Cas.: 1344-28-1 | Purity: 20-30 nm Particle size , 20 wt. % water solution | Aluminum oxide | ESD-935422-500ML |
| Cas.: 1344-28-1 | Purity: 20-30 nm Particle size , 20 wt. % water solution | Aluminum oxide | ESD-935422-100ML |
| Cas.: 3512-17-2 | Purity: 95% | 2,4,6-Trifluoropyridine | ESD-838832-5G |
| Cas.: 1344-28-1 | Purity: 20-30 nm Particle size , 20 wt. % water solution | Aluminum oxide | ESD-935422-25ML |
| Cas.: 127913-44-4 | Purity: 97% | (S)-4-Chloro-3-hydroxybutyronitrile | ESD-829737-2.5KG |
| Cas.: 2564-83-2 | Purity: 98% | TEMPO | ESD-819130-2.5KG |
| Cas.: 149-73-5 | Purity: 99.56%, no water grade | Trimethyl orthoformate | ESD-818864-10L |
| Cas.: 539-80-0 | Purity: 97% | Tropone | ESD-914686-5G |
| Cas.: 2628-17-3 | 4-Vinylphenol, min 10% soln. in propylene glycol | ESD-849331-5G | |
| Cas.: 2628-17-3 | 4-Vinylphenol, min 10% soln. in propylene glycol | ESD-849331-25G | |
| Cas.: 1477-55-0 | Purity: 99% | |m|-Xylylenediamine (MXDA) | ESD-820570-10L |
| Cas.: 18794-84-8 | Purity: 95% | trans-β-Farnesene | ESD-885944-25ML |
| Cas.: 139756-02-8 | Purity: ≥98% | 1H-Pyrazole-5-carboxamide,4-amino-1-methyl-3-n-propyl | ESD-817108-25G |
| Cas.: 139756-02-8 | Purity: ≥98% | 1H-Pyrazole-5-carboxamide,4-amino-1-methyl-3-n-propyl | ESD-817108-100G |
| Cas.: 679787-08-7 | Purity: for spectrophotometric det. of Zn(II), Cu(II), Fe(II), Co(II), H2O2, ≥95% | 5-Bromo-PAPS | ESD-909463-25MG |
| Cas.: 69271-98-3 | Purity: 98% | BIS[(BENZO-15-CROWN-5)-15-YLMETHYL] PIMELATE | ESD-908270-25MG |
| Cas.: 153404-60-5 | Purity: 97% | Bis(3-bromophenyl)acetylene | ESD-869681-5G |
| Cas.: 160255-06-1 | Purity: 98% | 3-(Ethyldimethylammonio)propane-1-sulfonate | ESD-935424-25G |
| Cas.: 160255-06-1 | Purity: 98% | 3-(Ethyldimethylammonio)propane-1-sulfonate | ESD-935424-5G |
| Cas.: 160255-06-1 | Purity: 98% | 3-(Ethyldimethylammonio)propane-1-sulfonate | ESD-935424-1G |
| Cas.: 606-06-4 | Purity: 10mg/ml in Ethanol | Coenzyme Q2 | ESD-911436-79MG |
| Cas.: 107-92-6 | Purity: AR, 99% | Butyric acid | ESD-802732-100ML |
| Cas.: 80460-73-7 | Purity: 97% | 4-Aminophenylboronic acid hydrochloride | ESD-801530-100G |
| Cas.: 301687-57-0 | Purity: ≥98.5% | Delta-TRISPHAT Delta-TRISPHAT tetrabutylammonium salt | ESD-920110-50MG |
| Cas.: 301687-57-0 | Purity: ≥98.5% | Delta-TRISPHAT Delta-TRISPHAT tetrabutylammonium salt | ESD-920110-10MG |
| Cas.: 58160-99-9 | Purity: 22-25% aqueous solution | 3-Aminopropylsilanetriol | ESD-934205-500G |
| Cas.: 90915-18-7 | Purity: 97% | 1,2-Dimethylbenzodiazole-5-carboxylic acid | ESD-935425-100MG |
| Cas.: 20582-85-8 | Purity: 97% | 4-(Methylthio)butanol | ESD-921344-5G |
| Cas.: 133081-25-1 | Purity: 95% | 6-(2-(tert-Butoxycarbonyl)hydrazinyl)nicotinic acid | ESD-845217-5G |
| Cas.: 20582-85-8 | Purity: 97% | 4-(Methylthio)butanol | ESD-921344-25G |
| Cas.: 72922-60-2 | Purity: 98% | Methyl 3-amino-4-methyl-5-nitrobenzoate | ESD-935426-100MG |
| Cas.: 871329-52-1 | Purity: 97% | (2-Chloro-3-fluorophenyl)boronic acid | ESD-841295-5G |
| Cas.: 6980-09-2 | Purity: 97% | 2-Chloro-4-methoxy-3-nitropyridine | ESD-841336-5G |
| Cas.: 139512-70-2 | Purity: 97% | 4-Chloro-5-fluorobenzene-1,2-diamine | ESD-841375-5G |
| Cas.: 19690-13-2 | Purity: 98% | N-Methyl-2-(pyridin-3-yl)ethanamine | ESD-839524-1G |
| Cas.: 828-01-3 | Purity: ≥98.0% | DL-3-Phenyllactic acid | ESD-816507-25G |
| Cas.: 3934-86-9 | Purity: 99% | Methyl 3,4-dihydroxy-5-methoxybenzoate | ESD-935428-100MG |
| Cas.: 1210-39-5 | Purity: 98% | β-Phenylcinnamaldehyde | ESD-832943-250MG |
| Cas.: 2715-43-7 | Purity: ≥95% | Ethyl 4-Vinylbenzoate | ESD-935429-250MG |
| Cas.: 6100-20-5 | Purity: AR, 99.0% | Potassium tetraoxalate dihydrate | ESD-815368-10KG |
| Cas.: 1072951-54-2 | Purity: 95% | (2,6-Dichloropyridin-4-yl)boronic acid | ESD-842959-5G |
| Cas.: 9050-36-6 | Purity: AR | Maltodextrin | ESD-830179-10KG |
| Cas.: 2004-39-9 | Purity: 98% | 1-Heptacosanol | ESD-922363-25MG |
| Cas.: 2247-88-3 | Purity: 98% | 4-Amino-3-fluoropyridine | ESD-801509-25G |
| Cas.: 105-31-7 | Purity: 96% | 1-Hexyn-3-ol | ESD-810798-1ML |
| Cas.: 13006-59-2 | Purity: 98% | 3-Methyl-1H-indole-2-carbonitrile | ESD-842223-1G |
| Cas.: 563-45-1 | Purity: 12.5% in tetrahydrofuran, 1.5mol/L | 3-Methyl-1-butenethis | ESD-875104-100ML |
| Cas.: 86620-70-4 | Purity: 95% | 4-(Piperazin-1-ylmethyl)benzoic acid dihydrochloride | ESD-847361-5G |
| Cas.: 681-84-5 | Purity: 98% | Tetramethoxysilane | ESD-819505-10KG |
| Cas.: 527-54-8 | Purity: 97% | 3,4,5-Trimethylphenol | ESD-919837-1G |
| Cas.: 527-54-8 | Purity: 97% | 3,4,5-Trimethylphenol | ESD-919837-5G |
| Cas.: 13930-88-6 | Purity: Sublimation 99% | Vanadyl phthalocyanine | ESD-857070-250MG |
| Cas.: 7440-31-5 | Purity: 1.0mm diameter, 99.9% metals basis | Thermal Analysis-Tin | ESD-837390-1M |
| Cas.: 7440-31-5 | Purity: 1.0mm diameter, 99.9% metals basis | Thermal Analysis-Tin | ESD-837390-5M |
| Cas.: 108-90-7 | Purity: for HPLC, ≥99.5% | Chlorobenzene | ESD-805739-500ML |
| Cas.: 1117-19-7 | Purity: >98.0%(GC) | Dipropyl Malonate | ESD-854883-5G |
| Cas.: 1117-19-7 | Purity: >98.0%(GC) | Dipropyl Malonate | ESD-854883-1G |
| Cas.: 55149-84-3 | Purity: 98% | 3,4-Dimethoxy-2-nitrobenzaldehyde | ESD-935431-1G |
| Cas.: 55149-84-3 | Purity: 98% | 3,4-Dimethoxy-2-nitrobenzaldehyde | ESD-935431-250MG |
| Cas.: 55149-84-3 | Purity: 98% | 3,4-Dimethoxy-2-nitrobenzaldehyde | ESD-935431-100MG |
| Cas.: 133565-43-2 | Purity: 96% | Boc-O-benzyl-L-threoninol | ESD-803239-25G |
| Cas.: 562-46-9 | Purity: >97.0%(GC) | 4,4-Dimethyl-1,3-cyclohexanedione | ESD-863926-1G |
| Cas.: 137350-66-4 | Purity: 97% | Methyl 10-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-9-methoxy-3-oxo-3H-benzo[f]chromene-2-carboxylate | ESD-849031-10MG |
| Cas.: 67853-37-6 | Purity: 98% | 2-Bromo-1-methoxy-3-nitrobenzene | ESD-840311-5G |
| Cas.: 67853-37-6 | Purity: 98% | 2-Bromo-1-methoxy-3-nitrobenzene | ESD-840311-25G |
| Cas.: 317595-54-3 | Purity: 98% | tert-Butyl (2-aminocyclohexyl)carbamate | ESD-841521-5G |
| Cas.: 17361-44-3 | Purity: 95% | Ditetradecylamine | ESD-932464-5G |
| Cas.: 159603-42-6 | Purity: 95% | 1-Benzhydrylazetidin-3-amine hydrochloride | ESD-844170-5G |
| Cas.: 146679-66-5 | Purity: 98% | (3-Bromopyridin-4-yl)methanol | ESD-845282-5G |
| Cas.: 4370-59-6 | Purity: 98% | Bromanilic Acid | ESD-869873-25G |
| Cas.: 120-53-6 | Purity: ≥96% | 6-Ethoxy-2-Mercaptobenzothiazole | ESD-859034-250MG |
| Cas.: 102-76-1 | Purity: AR, 98.5% | Glyceryl triacetate | ESD-810357-100G |
| Cas.: 7681-65-4 | Purity: 99.9% metals basis | Cuprous iodide | ESD-804590-500G |
| Cas.: 89-02-1 | Purity: 98% | 2,4-Dinitrobenzenesulfonic acid hydrate | ESD-806687-1G |
| Cas.: 9004-34-6 | Purity: Particle size: 90μm | α-Cellulose | ESD-822132-5KG |
| Cas.: 5142-22-3 | Purity: 98% | 1-methyladenine | ESD-850065-5MG |
| Cas.: 14126-37-5 | Purity: 99% | Dibromobis(triphenylphosphine)nickel(II) | ESD-806482-500G |
| Cas.: 1637-73-6 | Purity: 93% | DL-Isocitric acid trisodium salt hydrate | ESD-811780-25G |
| Cas.: 64145-51-3 | Purity: 97% | 3-Phenylcyclopentanone | ESD-922468-250MG |
| Cas.: 57915-78-3 | Purity: 98% | 2,3-Dichlorobenzyl Bromide | ESD-834897-25G |
| Cas.: 487-68-3 | Purity: 95% | Mesitaldehyde | ESD-813533-2.5KG |
| Cas.: 16282-16-9 | Purity: 98% | 1,2-Diphenylbutan-1-one | ESD-841887-50G |
| Cas.: 16282-16-9 | Purity: 98% | 1,2-Diphenylbutan-1-one | ESD-841887-250G |
| Cas.: 17450-34-9 | Purity: ≥95% | Ethyl 2-(1-Imidazolyl)acetate | ESD-850985-25G |
| Cas.: 1350514-68-9 | Purity: 98% | MK5172 | ESD-872317-5MG |
| Cas.: 1350514-68-9 | Purity: 98% | MK5172 | ESD-872317-25MG |
| Cas.: 2979-22-8 | Purity: ≥98% | 2-Methoxy-2-Phenylethanol | ESD-859835-5G |
| Cas.: 2979-22-8 | Purity: ≥98% | 2-Methoxy-2-Phenylethanol | ESD-859835-25G |
| Cas.: 53981-24-1 | Purity: 97% | 2-Amino-5-fluorophenol | ESD-801656-25G |
| Cas.: 1109-28-0 | Purity: 98% | Maltotriose hydrate | ESD-913560-100G |
| Cas.: 1685-19-4 | Purity: 95% | 1-(2-Amino-5-chlorophenyl)ethanone | ESD-841069-1G |
| Cas.: 1685-19-4 | Purity: 95% | 1-(2-Amino-5-chlorophenyl)ethanone | ESD-841069-5G |
| Cas.: 823-58-5 | Purity: 97% | 4-Amino-3,6-dichloropyridazine | ESD-848931-100G |
| Cas.: 55480-45-0 | Purity: ≥97% | 3-(4-Methyl-1-piperazinyl)propanoic Acid | ESD-851960-250MG |
| Cas.: 1147-43-9 | Purity: 98% | 2′-Aminobenzophenone-2-carboxylic Acid | ESD-870707-100G |
| Cas.: 25456-76-2 | Purity: 95% | D-Glutamic acid 1-tert-butyl ester | ESD-854790-250MG |
| Cas.: 4343-75-3 | Purity: 97% | 4-Amino-4H-1,2,4-triazole-3-thiol | ESD-923602-5G |
| Cas.: 14938-42-2 | Purity: 98% | Dipotassium Anthraquinone-1,8-disulfonate | ESD-870651-1G |
| Cas.: 16116-92-0 | Purity: ≥98% | (4-Ethynylphenyl)trimethylsilane | ESD-866459-50MG |
| Cas.: 981-34-0 | Purity: 97% | (4aS,4bS,5aS,6aS,7R,8S,9aS,9bS)-7-Hydroxy-7-(2-hydroxyacetyl)-4a,6a,8-trimethyl-5a,6,6a,7,8,9, 9a,9b,10,11-decahydrocyclopenta[1,2]phenanthro[4,4a-b]oxiren-2(4aH)-one | ESD-843843-25G |
| Cas.: 1184-88-9 | Purity: 98% | Sodium pivalate | ESD-844279-25G |
| Cas.: 40133-07-1 | Purity: 98% | 4,5,6,7-Tetrahydrobenzo[b]thiophene-2-carboxylic acid | ESD-845938-25G |
| Cas.: 78-78-4 | Purity: 95% | Isopentane | ESD-813378-10L |
| Cas.: 13482-22-9 | Purity: 98% | 4-Hydroxycyclohexanone | ESD-839474-25G |
| Cas.: 19840-99-4 | Purity: 98% | Carbostyril 124 | ESD-838684-1G |
| Cas.: 2637-34-5 | Purity: 98% | 2-Mercaptopyridine | ESD-812839-2.5KG |
| Cas.: 26560-38-3 | Purity: 98% | Calcium N5-methyltetrahydrofolate | ESD-879915-100MG |
| Cas.: 98-61-3 | Purity: 95% | 4-Iodobenzenesulfonyl chloride | ESD-837866-250MG |
| Cas.: 92525-10-5 | Purity: 97% | 3-Iodo-1-methyl-1H-pyrazole | ESD-839482-25G |
| Cas.: 2553-19-7 | Purity: 98% | Diethoxydiphenylsilane | ESD-808281-2.5KG |
| Cas.: 6106-07-6 | Purity: 98% | L-Thyroxine Sodium Salt Pentahydrate | ESD-873425-1G |
| Cas.: 1009-61-6 | Purity: 99% | 1,4-DIACETYLBENZENE | ESD-830477-100G |
| Cas.: 10025-82-8 | Purity: 99.9% metals basis | Indium chloride | ESD-811751-1KG |
| Cas.: 344298-81-3 | Purity: BR | Butanoic-2,2,3,4,4,4-d6acid, 3-(methyl-d3)- (9CI) | ESD-874672-50MG |
| Cas.: 344298-81-3 | Purity: BR | Butanoic-2,2,3,4,4,4-d6acid, 3-(methyl-d3)- (9CI) | ESD-874672-1G |
| Cas.: 61070-99-3 | Purity: 98% | Pyridazine-3,6-diamine | ESD-846660-5G |
| Cas.: 1311-93-9 | Purity: 99.999% trace metals basis | Ammonium tungstate pentahydrate | ESD-836094-100G |
| Cas.: 81742-10-1 | Purity: 97% | 3,6-Dichlorotrimellitic anhydride | ESD-877245-100MG |
| Cas.: 81742-10-1 | Purity: 97% | 3,6-Dichlorotrimellitic anhydride | ESD-877245-250MG |
| Cas.: 81742-10-1 | Purity: 95% | 3,6-Dichlorotrimellitic anhydride | ESD-935432-5G |
| Cas.: 81742-10-1 | Purity: 95% | 3,6-Dichlorotrimellitic anhydride | ESD-935432-1G |
| Cas.: 81742-10-1 | Purity: 95% | 3,6-Dichlorotrimellitic anhydride | ESD-935432-250MG |
| Cas.: 81742-10-1 | Purity: 95% | 3,6-Dichlorotrimellitic anhydride | ESD-935432-50MG |
| Cas.: 123441-03-2 | Purity: ≥99% | Rivastigmine | ESD-833093-1G |
| Cas.: 623-58-5 | Purity: 95% | Acetoacetic acid sodium salt | ESD-890184-100MG |
| Cas.: 15788-16-6 | Purity: 98% | 5-Benzimidazolecarboxylic acid | ESD-802472-500G |
| Cas.: 2488-15-5 | Purity: 99% | Boc-L-Methionine | ESD-802900-500G |
| Cas.: 85699-62-3 | Purity: 97% | α-Conidendrin | ESD-876996-1MG |
| Cas.: 22532-62-3 | Purity: >98.0%(GC) | 4-Bromo-2-hydroxybenzaldehyde | ESD-804053-500G |
| Cas.: 193402-48-1 | Purity: ≥90% | Stearoyl coenzyme A lithium salt | ESD-921019-1MG |
| Cas.: 188824-37-5 | Purity: ≥90% (HPLC) | Oleoyl coenzyme A lithium salt | ESD-920991-1MG |
| Cas.: 17082-61-0 | Purity: >94.0%(GC) | 1,2-Bis(trimethylsilyloxy)cyclobutene | ESD-856919-25G |
| Cas.: 108031-79-4 | Purity: 98% | Bis[(2S,3aR,4S,7aR)-octahydro-7,8,8-trimethyl-4,7-methanobenzofuran-2-yl] Ether | ESD-871055-250MG |
| Cas.: 497931-76-7 | Purity: 98% | 3-[[(Benzylthio)carbonothioyl]thio]propionic Acid | ESD-909252-25G |
| Cas.: 75-90-1 | Purity: 65% in H2O | Trifluoracetaldehyde | ESD-924321-25G |
| Cas.: 187389-52-2 | Purity: >98% | Z-VAD-FMK | ESD-860403-25MG |
| Cas.: 59016-56-7 | Purity: 98% | 1-Cyano-4-dimethylaminopyridinium tetrafluoroborate | ESD-805991-5G |
| Cas.: 781661-94-7 | Purity: ≥98% | YM155 (Sepantronium Bromide) | ESD-864171-25MG |
| Cas.: 60734-65-8 | Purity: 98% | DAI | ESD-904385-1G |
| Cas.: 5075-92-3 | Purity: 95% | 1,5-Dimethyl-2-pyrrolidinone | ESD-923133-250MG |
| Cas.: 760990-08-7 | Purity: ≥98% | 3-Fluoro-4-Hydroxybenzeneboronic Acid Pinacol Ester | ESD-857662-250MG |
| Cas.: 308068-56-6 | Purity: >90%, ID:0.8-1.6nm, OD:1-2nm, Length:5-30μm, -COOH:~2.73wt% | Carboxyl Purified Single-walled carbon nanotubes | ESD-835715-5G |
| Cas.: 2757-23-5 | Purity: 96% | Chlorocarbonylsulfenyl Chloride | ESD-838384-100G |
| Cas.: 35154-45-1 | Purity: 97% | |cis|-3-Hexenyl 3-methylbutanoate | ESD-811404-1ML |
| Cas.: 3099-29-4 | Purity: 98% | 2-(Chloromethyl)-6-methylpyridine | ESD-839134-50G |
| Cas.: 636-94-2 | Purity: ≥98.0%(HPLC) | 2-hydroxybenzene-1,4-dioic acid | ESD-826184-100G |
| Cas.: 7664-66-6 | Purity: ≥97% | 4-Isopropoxyaniline | ESD-860233-250MG |
| Cas.: 915394-28-4 | Purity: 98% | 2-Methyl-2-(3-nitrophenyl)propanenitrile | ESD-841126-50MG |
| Cas.: 90471-79-7 | Purity: ≥98% | L-Carnitine fumarate | ESD-859295-100G |
| Cas.: 90471-79-7 | Purity: ≥98% | L-Carnitine fumarate | ESD-859295-25G |
| Cas.: 90471-79-7 | Purity: ≥98% | L-Carnitine fumarate | ESD-859295-500G |
| Cas.: 18156-67-7 | Purity: ≥98.0%(T) | (2-Bromoethyl)trimethylsilane (stabilized with NaHCO3) | ESD-864637-1ML |
| Cas.: 18156-67-7 | Purity: ≥98.0%(T) | (2-Bromoethyl)trimethylsilane (stabilized with NaHCO3) | ESD-864637-10ML |
| Cas.: 3058-01-3 | Purity: ≥99%(T) | 3-Methyladipic Acid | ESD-862719-1G |
| Cas.: 14617-86-8 | Purity: 95% | 4-Nitrophenyl stearate | ESD-890891-250MG |
| Cas.: 14617-86-8 | Purity: 95% | 4-Nitrophenyl stearate | ESD-890891-100MG |
| Cas.: NONE10131 | Crystal Violet Ammonium Oxalate Solution | ESD-935433-100ML | |
| Cas.: NONE10131 | Crystal Violet Ammonium Oxalate Solution | ESD-935433-500ML | |
| Cas.: 943742-86-7 | Purity: 97% | Ethyl 2-(4-bromophenyl)butanoate | ESD-893828-50MG |
| Cas.: NONE7920 | Proclin 300 | ESD-903551-25ML | |
| Cas.: NONE7920 | Proclin 300 | ESD-903551-5ML | |
| Cas.: 22948-94-3 | Purity: HPLC≥98% | 1-ACETYL-3-INDOLECARBOXALDEHYDE | ESD-832351-100MG |
| Cas.: 3529-82-6 | Purity: 98% | 3-Nitrophenyl isothiocyanate | ESD-863667-5G |
| Cas.: NONE6590 | Purity: 29:1 | 40% Acryl/Bis Solution | ESD-853858-2.5L |
| Cas.: 1158838-45-9 | Purity: 99% | Aurora A Inhibitor I (TC-S 7010) | ESD-872342-5MG |
| Cas.: 110-13-4 | Purity: 99% | 2,5-Hexanedione | ESD-935434-100ML |
| Cas.: 110-13-4 | Purity: 99% | 2,5-Hexanedione | ESD-935434-500ML |
| Cas.: 110-13-4 | Purity: 99% | 2,5-Hexanedione | ESD-935434-25ML |
| Cas.: 7440-65-5 | Purity: Ingot, 99.9% metals basis | Yttrium | ESD-820640-60G |
| Cas.: 130-86-9 | Purity: 98% | Protopine | ESD-816173-500MG |
| Cas.: 85547-56-4 | Purity: GR | Piperaquine phosphate | ESD-873625-25MG |
| Cas.: 85547-56-4 | Purity: GR | Piperaquine phosphate | ESD-873625-100MG |
| Cas.: 85547-56-4 | Purity: GR | Piperaquine phosphate | ESD-873625-500MG |
| Cas.: 56522-24-8 | Purity: 97% | TERT-BUTYLDIMETHYLSILYL CYANIDE | ESD-921201-250MG |
| Cas.: NONE7968 | Purity: Epoxy Degree: 25% | Epoxy natural rubber | ESD-909527-31KG |
| Cas.: 35958-30-6 | Purity: 95% | 2,2′-ethylidenebis[4,6-di-tert-butylphenol] | ESD-908963-50MG |
| Cas.: 28456-54-4 | Purity: 97% | 5,6-DIMETHYL-2-THIOURACIL | ESD-921434-250MG |
| Cas.: 20603-00-3 | Purity: 97% | N-(2-Hydroxyethyl)hexamethyleneimine | ESD-831100-100G |
| Cas.: 542-69-8 | Purity: >98%(GC) , contains copper as stabilizer | 1-Iodobutane | ESD-935435-500G |
| Cas.: 542-69-8 | Purity: >98%(GC) , contains copper as stabilizer | 1-Iodobutane | ESD-935435-100G |
| Cas.: 542-69-8 | Purity: >98%(GC) , contains copper as stabilizer | 1-Iodobutane | ESD-935435-25G |
| Cas.: NONE6164 | Purity: 99.99% (REO) | Terbium(III) nitrate hydrate | ESD-837126-25G |
| Cas.: 12224-06-5 | Purity: Strength: 100% | Fluorescent brightener VBL | ESD-832544-2.5KG |
| Cas.: 5415-44-1 | Purity: 98% | 1,3,7-Trimethyluric Acid | ESD-912468-50MG |
| Cas.: 465-02-1 | Purity: 97% | Germanicol | ESD-878965-1MG |
| Cas.: 2749-59-9 | Purity: 96% | 1,3-Dimethyl-5-pyrazolone | ESD-806862-2.5KG |
| Cas.: 528-71-2 | Purity: >95.0%(GC) | 1-Hydroxyphenazine | ESD-861709-1G |
| Cas.: 98061-39-3 | Purity: ≥95% | 2-(4-Hydroxymethylphenyl)pyridine | ESD-909070-5G |
| Cas.: 12083-48-6 | Purity: ≥98% | Vanadinocene Dichloride | ESD-867937-50MG |
| Cas.: 1729-67-5 | Purity: ≥99.5% | Methyl 2,3-Dibromopropionate | ESD-837843-25ML |
| Cas.: 1729-67-5 | Purity: ≥99.5% | Methyl 2,3-Dibromopropionate | ESD-837843-1ML |
| Cas.: 139756-04-0 | Purity: 97% | 1-Methyl-4-(2-propoxybenzamido)-3-propyl-1H-pyrazole-5-carboxamide | ESD-928450-25G |
| Cas.: 326794-48-3 | Purity: ≥97% | Hyperbranched bis-MPA polyester-64-hydroxyl, generation 4 | ESD-920530-1G |
| Cas.: 1308672-74-3 | Purity: 98% | N-(2-(diMethylaMino)ethyl)-1-(3-((4-((2-Methyl-1H-indol-5-yl)oxy)pyriMidin-2-yl)aMino)phenyl)MethanesulfonaMide | ESD-830101-50MG |
| Cas.: 1005-64-7 | Purity: 97% | (E)-1-Phenyl-1-butene | ESD-833468-100MG |
| Cas.: 73536-95-5 | Purity: ≥80% (HPLC) | Adenosine 5′-[β-thio]diphosphate trilithium salt | ESD-919349-1MG |
| Cas.: 56746-19-1 | Purity: 98% | 4-Bromo-2,6-diethylaniline | ESD-871057-5G |
| Cas.: 56746-19-1 | Purity: 98% | 4-Bromo-2,6-diethylaniline | ESD-871057-25G |
| Cas.: 239074-27-2 | Purity: 97% | tert-Butyl (4-(bromomethyl)phenyl)carbamate | ESD-844719-25G |
| Cas.: 107834-03-7 | Purity: 98% | 4-(2-THIENYL)BENZALDEHYDE | ESD-833654-5G |
| Cas.: 1550-50-1 | Purity: 95% | 1,1,2,2-Tetrafluoro-N,N-dimethylethanamine | ESD-843991-25G |
| Cas.: 25713-23-9 | Purity: Abundance: 10atom%; Chemical purity: ≥98.5% | L-Alanine-<<15>>N | ESD-801387-100MG |
| Cas.: 2832-19-1 | Purity: 99% | N-Methylolchloroacetamide | ESD-830242-2.5KG |
| Cas.: NONE8094 | Purity: Linear type, Viscosity: 500 mPa s | Vinyl silicone oil | ESD-909621-10KG |
| Cas.: 124276-67-1 | Purity: 95% | 1-(4-bromophenyl)cyclopropane-1-carbonitrile | ESD-859508-25G |
| Cas.: 68516-39-2 | 2,2-di(hydroxymethyl)-acetic acid | ESD-927103-1G | |
| Cas.: 124276-67-1 | Purity: 97% | 1-(4-bromophenyl)cyclopropane-1-carbonitrile | ESD-935437-25G |
| Cas.: 124276-67-1 | Purity: 97% | 1-(4-bromophenyl)cyclopropane-1-carbonitrile | ESD-935437-5G |
| Cas.: 124276-67-1 | Purity: 97% | 1-(4-bromophenyl)cyclopropane-1-carbonitrile | ESD-935437-1G |
| Cas.: 86604-80-0 | Purity: 95% | 4-Methoxy-2,3,5-trimethylpyride-N-oxide | ESD-922356-250MG |
| Cas.: 7758-95-4 | Purity: AR, 99.5% | Lead chloride | ESD-812468-10KG |
| Cas.: 55289-05-9 | Purity: 97% | Methyl 3-hydroxy-2-methylbenzoate | ESD-897137-25G |
| Cas.: 55289-05-9 | Purity: 97% | Methyl 3-hydroxy-2-methylbenzoate | ESD-897137-100G |
| Cas.: 56074-20-5 | Purity: ≥98% | N-Boc-Iminodiacetic Acid | ESD-857992-1G |
| Cas.: 488832-69-5 | Purity: ≥98% | Elesclomol (STA-4783) | ESD-864530-100MG |
| Cas.: 2345-24-6 | Purity: ≥98% | Neryl Isobutyrate | ESD-859274-5G |
| Cas.: 276872-89-0 | Purity: 98% | tert-butyl 3-methylenepiperidine-1-carboxylate | ESD-935438-5G |
| Cas.: 276872-89-0 | Purity: 98% | tert-butyl 3-methylenepiperidine-1-carboxylate | ESD-935438-1G |
| Cas.: 276872-89-0 | Purity: 98% | tert-butyl 3-methylenepiperidine-1-carboxylate | ESD-935438-250MG |
| Cas.: 32863-32-4 | Purity: 97% | 4-Formyl-2,1,3-benzoxadiazole | ESD-840387-5G |
| Cas.: 1126-34-7 | Purity: 60% in water | Metanilic Acid Sodium Salt | ESD-923844-100G |
| Cas.: 1126-34-7 | Purity: 60% in water | Metanilic Acid Sodium Salt | ESD-923844-500G |
| Cas.: 5137-46-2 | Purity: technical, 0.5-1.5 M in diethylene glycol diethyl ether | SODIUM BIPHENYL | ESD-919807-15ML |
| Cas.: 1843-03-4 | Purity: 95% | 1,1,3-tris(2-methyl-4-hydroxy-5-tert-butylphenyl) | ESD-921896-2.5KG |
| Cas.: 67-78-7 | Purity: >98%(LC) | Triamcinolone Diacetate | ESD-918528-250MG |
| Cas.: 12671-00-0 | Purity: basichydrate | Zirconium carbonate oxide | ESD-921886-100G |
| Cas.: 2494-89-5 | Purity: 96% | 2-((4-Aminophenyl)sulfonyl)ethyl hydrogen sulfate | ESD-908768-2.5KG |
| Cas.: 6627-88-9 | Purity: 95% | 4-Allyl-2,6-dimethoxyphenol | ESD-916567-1G |
| Cas.: 17804-35-2 | Purity: CP | Benomyl | ESD-828273-500G |
| Cas.: 52522-49-3 | Purity: 97% | 2,3,5-Tri-o-benzyl-1-o-(4-nitrobenzoyl)-D-arabinofuranose | ESD-844298-5G |
| Cas.: 502693-09-6 | Purity: 95%, NMR | Bis(isothiocyanato)(2,2′-bipyridyl-4,4′-dicarboxylato)(4,4′-dinonyl-2,2′-bipyridyl)ruthenium(II) | ESD-835582-25MG |
| Cas.: 85551-10-6 | Purity: Ethanol solution | 12-oxo Phytodienoic Acid | ESD-935440-1MG |
| Cas.: 611-59-6 | Purity: ≥97% | 1,7-Dimethylxanthine | ESD-864706-250MG |
| Cas.: 35884-42-5 | Purity: 98% | 1-(3-butoxypropoxy)propan-1-ol | ESD-889099-2.5KG |
| Cas.: 6651-43-0 | Purity: 98% | 1-TRIMETHYLSILOXY-1,3-BUTADIENE | ESD-920513-1G |
| Cas.: 2182-55-0 | Purity: ≥95.0%(GC), contains stabilizer potassium hydroxide | Cyclohexyl Vinyl Ether | ESD-832786-2.5L |
| Cas.: 321883-54-9 | Purity: >99% | 1,2-dioctanoyl-sn-glycero-3-phosphate (sodium salt) | ESD-864745-1MG |
| Cas.: 100581-42-8 | Tetradodecylammonium tetrakis(4-chlorophenyl)borate | ESD-923821-100MG | |
| Cas.: 3709-43-1 | Purity: 98% | Disodium 4,4′-Dinitrostilbene-2,2′-disulfonate | ESD-831278-100G |
| Cas.: 9029-06-5 | Purity: buffered aqueous glycerol solution, ~30units/mg protein (Lowry) | L-Alanine Dehydrogenase from Bacillus subtilis | ESD-920138-25U |
| Cas.: 397308-78-0 | Purity: 97% | 4-Hydroxy-2-(methylthio)pyrimidine-5-carboxylic acid | ESD-845050-5G |
| Cas.: 85650-52-8 | Purity: 98% | Mirtazapine | ESD-837220-5G |
| Cas.: 680-05-7 | Purity: ≥98%(GC) | Methyl Heptafluoroisobutyrate | ESD-863456-1G |
| Cas.: 644-97-3 | Purity: 98% | Phenylphosphonous dichloride | ESD-815569-10KG |
| Cas.: NONE7138 | Purity: E-51 | Epoxide resin | ESD-871958-10KG |
| Cas.: 26988-72-7 | Purity: 97% | 1-Methyl-DL-tryptophan | ESD-915717-1G |
| Cas.: 40292-82-8 | Purity: ≥98% | Neodecanoyl chloride | ESD-849990-100ML |
| Cas.: 28447-20-3 | Purity: ≥98% | 3-Vinylbenzoic acid | ESD-857703-250MG |
| Cas.: 1192027-04-5 | Purity: 99,5% | N,N-Dimethyl-N’-(3-thioxo-3H-1,2,4-dithiazol-5-yl)formimidamide | ESD-888395-5G |
| Cas.: 104484-71-1 | Purity: 98% | Sodium 3-(1-Naphthylamino)propanesulfonate | ESD-818460-25G |
| Cas.: 1066-40-6 | Purity: ≥95.0%(GC) | Trimethylsilanol | ESD-820219-500G |
| Cas.: 1107663-03-5 | Purity: 97% | Ethyl 2-iodooxazole-4-carboxylate | ESD-845828-1G |
| Cas.: 521-31-3 | Purity: 98% | luminol | ESD-812365-500G |
| Cas.: 136237-36-0 | Purity: solid | (6-Bromohexyl)ferrocene | ESD-919917-100MG |
| Cas.: 628-41-1 | Purity: 97% | 1,4-Cyclohexadiene | ESD-805084-1ML |
| Cas.: 7758-97-6 | Purity: ACS, ≥98.0% (RT) | Lead chromate | ESD-812497-2.5KG |
| Cas.: 7758-97-6 | Purity: ACS, ≥98.0% (RT) | Lead chromate | ESD-812497-100G |
| Cas.: 2024602-96-6 | Purity: 98% | Oleylammonium Bromide | ESD-904404-1G |
| Cas.: 2024602-96-6 | Purity: 98% | Oleylammonium Bromide | ESD-904404-5G |
| Cas.: 2024602-96-6 | Purity: 98% | Oleylammonium Bromide | ESD-904404-25G |
| Cas.: 872-50-4 | Purity: Use For Peptide Synthesis, ≥99.5%(GC) | 1-Methyl-2-pyrrolidinone (NMP) | ESD-813017-100ML |
| Cas.: 4264-83-9 | Purity: Use For ELISA, ≥99.0% | 4-Nitrophenyl phosphate disodium salt hexahydrate | ESD-816804-100G |
| Cas.: 298-12-4 | Purity: 50% in water | Glyoxylic acid anhydrous | ESD-823274-10L |
| Cas.: 188300-19-8 | Purity: 96% | Massonianoside B | ESD-881010-1MG |
| Cas.: 18463-25-7 | Purity: 98% | Nigracin | ESD-881078-1MG |
| Cas.: 588706-66-5 | Purity: 95% | Ophiopogonanone E | ESD-878318-1MG |
| Cas.: 14025-15-1 | Purity: ≥98% | Copper Disodium Edta dihydrate | ESD-859578-100G |
| Cas.: 14025-15-1 | Purity: ≥98% | Copper Disodium Edta dihydrate | ESD-859578-500G |
| Cas.: 7432-28-2 | Purity: Analysis control | Schizandrol A | ESD-818322-100MG |
| Cas.: 18787-63-8 | Purity: 98% | 2-Hexadecanone | ESD-915143-50MG |
| Cas.: 1192491-61-4 | Purity: 99% | AVE-1330A | ESD-872903-5G |
| Cas.: 100-66-3 | Purity: AR, 99% | Anisole | ESD-800315-10L |
| Cas.: 210826-40-7 | Purity: ≥99% | MCC950 | ESD-880513-100MG |
| Cas.: 1034-39-5 | Purity: 95% | Triphenylphosphine dibromide | ESD-831130-500G |
| Cas.: 546141-08-6 | Purity: 98% | URB-597 | ESD-843794-5G |
| Cas.: 1350653-20-1 | Purity: ≥99% | Vericiguat | ESD-883086-25MG |
| Cas.: 1350653-20-1 | Purity: ≥99% | Vericiguat | ESD-883086-100MG |
| Cas.: 19939-82-3 | Purity: 98% | 1-Naphthyl bD-glucopyranoside | ESD-921994-1G |
| Cas.: 18818-30-9 | Purity: 98% | 1-(4-Methyl-1H-pyrrol-3-yl)ethanone | ESD-935441-1G |
| Cas.: 18818-30-9 | Purity: 98% | 1-(4-Methyl-1H-pyrrol-3-yl)ethanone | ESD-935441-250MG |
| Cas.: 18818-30-9 | Purity: 98% | 1-(4-Methyl-1H-pyrrol-3-yl)ethanone | ESD-935441-50MG |
| Cas.: 22118-09-8 | Purity: 98% | Bromoacetyl chloride | ESD-830964-500G |
| Cas.: 10199-61-8 | Purity: ≥95% | Ethyl 2-(1-Pyrazolyl)acetate | ESD-935442-25G |
| Cas.: 10199-61-8 | Purity: ≥95% | Ethyl 2-(1-Pyrazolyl)acetate | ESD-935442-5G |
| Cas.: 10199-61-8 | Purity: ≥95% | Ethyl 2-(1-Pyrazolyl)acetate | ESD-935442-1G |
| Cas.: 914-00-1 | Purity: 95% | Methacycline | ESD-935443-5MG |
| Cas.: 946593-67-5 | Purity: 95% | (1S,3S)-3-Aminocyclopentan-1-ol | ESD-935444-1G |
| Cas.: 914-00-1 | Purity: 95% | Methacycline | ESD-935443-25MG |
| Cas.: 946593-67-5 | Purity: 95% | (1S,3S)-3-Aminocyclopentan-1-ol | ESD-935444-250MG |
| Cas.: 946593-67-5 | Purity: 95% | (1S,3S)-3-Aminocyclopentan-1-ol | ESD-935444-100MG |
| Cas.: 31633-72-4 | Purity: ≥95% | Methyl 3-methyl-4-oxopiperidine-1-carboxylate | ESD-935445-5G |
| Cas.: 31633-72-4 | Purity: ≥95% | Methyl 3-methyl-4-oxopiperidine-1-carboxylate | ESD-935445-1G |
| Cas.: 31633-72-4 | Purity: ≥95% | Methyl 3-methyl-4-oxopiperidine-1-carboxylate | ESD-935445-250MG |
| Cas.: 209858-74-2 | Purity: ≥95% | 6-Chloro-4-methylpicolinonitrile | ESD-935446-250MG |
| Cas.: 209858-74-2 | Purity: ≥95% | 6-Chloro-4-methylpicolinonitrile | ESD-935446-1G |
| Cas.: 58543-16-1 | Purity: 96% | Rebaudioside A | ESD-817269-5G |
| Cas.: 71098-88-9 | Purity: white powder | N-(Phenylseleno)phthaliMide | ESD-921155-500MG |
| Cas.: 609-99-4 | Purity: 98% | 3,5-Dinitro salicylic acid | ESD-807261-2.5KG |
| Cas.: NONE8193 | Light Green SF Yellowish Stain Solution, 1% w/v | ESD-914689-1L | |
| Cas.: 2353-33-5 | Purity: 98% | 5-Aza-2′-deoxycytidine | ESD-801498-1G |
| Cas.: 2353-33-5 | Purity: 98% | 5-Aza-2′-deoxycytidine | ESD-801498-5G |
| Cas.: 51811-82-6 | Purity: BS | Giemsa stain | ESD-810333-5G |
| Cas.: 2130-56-5 | Purity: 97% | 4,4′-Diamino-[1,1′-biphenyl]-3,3′-dicarboxylic acid | ESD-927873-5G |
| Cas.: 2130-56-5 | Purity: 97% | 4,4′-Diamino-[1,1′-biphenyl]-3,3′-dicarboxylic acid | ESD-927873-250MG |
| Cas.: 7440-44-0 | Purity: 20-50 Mesh | Activated charcoal | ESD-805340-10KG |
| Cas.: 216974-75-3 | Purity: ≥95%, ~25mg/ml(in buffer, PH6.2) | bevacizumab | ESD-873506-5MG |
| Cas.: NONE002 | Purity: 3-5mgwater/ml | One-component reagent for volumetric Karl Fischer titration(pyridine-free titrating agent) | ESD-820874-2.5L |
| Cas.: NONE002 | Purity: 3-5mgwater/ml | One-component reagent for volumetric Karl Fischer titration(pyridine-free titrating agent) | ESD-820874-10L |
| Cas.: NONE002 | Purity: 5mgwater/ml | One-component reagent for volumetric Karl Fischer titration(pyridine-free titrating agent) | ESD-822133-2.5L |
| Cas.: 821-06-7 | Purity: 99% | |trans|-1,4-Dibromo-2-butene | ESD-820088-2.5KG |
| Cas.: 9011-18-1 | MW 500000 | Dextran sulfate sodium salt | ESD-806298-1KG |
| Cas.: 530115-96-9 | Purity: 98% | tert-Butyl 4-cyano-4-methylpiperidine-1-carboxylate | ESD-935447-1G |
| Cas.: 530115-96-9 | Purity: 98% | tert-Butyl 4-cyano-4-methylpiperidine-1-carboxylate | ESD-935447-250MG |
| Cas.: 94-62-2 | Purity: 97% | Piperine | ESD-815923-500G |
| Cas.: 6674-22-2 | Purity: 99% | 1,8-Diazabicyclo[5.4.0]undec-7-ene | ESD-807028-10KG |
| Cas.: 114935-92-1 | Purity: ≥95% | Methyl 4-Chloroquinoline-2-carboxylate | ESD-935448-250MG |
| Cas.: 615568-24-6 | Purity: 97% | 2,3-Dihydro-[1,4]dioxino[2,3-b]pyridine-6-carbaldehyde | ESD-935449-500MG |
| Cas.: 615568-24-6 | Purity: 97% | 2,3-Dihydro-[1,4]dioxino[2,3-b]pyridine-6-carbaldehyde | ESD-935449-100MG |
| Cas.: 842-18-2 | Purity: ≥98% | Dipotassium 2-Naphthol-6,8-disulfonate Hydrate | ESD-867275-100G |
| Cas.: 1228258-40-9 | Purity: 97% | 2-(2,2-Dimethoxyethoxy)ethanamine | ESD-914232-5G |
| Cas.: 23726-91-2 | Purity: 90% | #NAME? | ESD-923663-5ML |
| Cas.: 9003-39-8 | Purity: Average MW 10000, K13-18 | Polyvinylpyrrolidone | ESD-816210-10KG |
| Cas.: 194804-84-7 | Purity: 97% | 4-Amino-2-fluoro-3-methylbenzoic acid | ESD-935450-1G |
| Cas.: 194804-84-7 | Purity: 97% | 4-Amino-2-fluoro-3-methylbenzoic acid | ESD-935450-250MG |
| Cas.: 194804-84-7 | Purity: 97% | 4-Amino-2-fluoro-3-methylbenzoic acid | ESD-935450-100MG |
| Cas.: 19611-45-1 | Purity: 95% | 2H-PYRAN-2-CARBOXALDEHYDE, TETRAHYDRO- | ESD-908486-250MG |
| Cas.: 27685-92-3 | Purity: ≥95% | 4-Hydroxythieno[3,2-c]pyridine | ESD-935451-25G |
| Cas.: 27685-92-3 | Purity: ≥95% | 4-Hydroxythieno[3,2-c]pyridine | ESD-935451-5G |
| Cas.: 27685-92-3 | Purity: ≥95% | 4-Hydroxythieno[3,2-c]pyridine | ESD-935451-1G |
| Cas.: 27685-92-3 | Purity: ≥95% | 4-Hydroxythieno[3,2-c]pyridine | ESD-935451-250MG |
| Cas.: 4559-70-0 | Purity: 98% | Diphenylphosphine oxide | ESD-807376-2.5KG |
| Cas.: 880094-83-7 | Purity: 97% | 5-bromo-3,4-dihydroquinolin-2(1H)-one | ESD-824847-5G |
| Cas.: 1247628-40-5 | Purity: 97% | 2-(3-Cyano-1H-1,2,4-triazol-1-yl)acetic acid | ESD-926723-250MG |
| Cas.: 175205-48-8 | Purity: 95% | 5-(3-(Trifluoromethyl)phenyl)oxazole | ESD-840197-1G |
| Cas.: 175205-48-8 | Purity: 95% | 5-(3-(Trifluoromethyl)phenyl)oxazole | ESD-840197-5G |
| Cas.: 175205-48-8 | Purity: 95% | 5-(3-(Trifluoromethyl)phenyl)oxazole | ESD-840197-25G |
| Cas.: 6529-53-9 | Purity: 97% | 4-Chlorophenethyl bromide | ESD-806023-25G |
| Cas.: 6529-53-9 | Purity: 97% | 4-Chlorophenethyl bromide | ESD-806023-100G |
| Cas.: 20782-91-6 | Purity: 97% | 2-(Bromomethyl)-5-nitrofuran | ESD-919819-1G |
| Cas.: 20782-91-6 | Purity: 97% | 2-(Bromomethyl)-5-nitrofuran | ESD-919819-5G |
| Cas.: 137281-39-1 | Purity: 98% | 4-(2-(2-Amino-4-oxo-4,7-dihydro-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzoic acid | ESD-843904-5G |
| Cas.: 137281-39-1 | Purity: 98% | 4-(2-(2-Amino-4-oxo-4,7-dihydro-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzoic acid | ESD-843904-25G |
| Cas.: 137281-39-1 | Purity: 98% | 4-(2-(2-Amino-4-oxo-4,7-dihydro-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzoic acid | ESD-843904-100G |
| Cas.: 2045-00-3 | Purity: 98% | 2-Aminobenzenearsonic acid | ESD-800051-100G |
| Cas.: 149263-94-5 | Purity: ≥95% | MPT-NAG | ESD-835542-25G |
| Cas.: 54571-66-3 | Purity: 97% | Methyl DL-pyroglutamate | ESD-844066-25G |
| Cas.: 54571-66-3 | Purity: 97% | Methyl DL-pyroglutamate | ESD-844066-5G |
| Cas.: 124276-61-5 | Purity: 97% | 1-(4-(Trifluoromethyl)phenyl)cyclopropanecarbonitrile | ESD-935452-1G |
| Cas.: 124276-61-5 | Purity: 97% | 1-(4-(Trifluoromethyl)phenyl)cyclopropanecarbonitrile | ESD-935452-250MG |
| Cas.: 15763-06-1 | Purity: ≥98% | 1-Methyladenosine | ESD-881932-250MG |
| Cas.: 518-82-1 | Purity: ≥96% (HPLC) | Emodin | ESD-886075-25G |
| Cas.: 16115-68-7 | Purity: 98% | H-ASP(OET)-OET HCL | ESD-822050-500G |
| Cas.: 120902-45-6 | Purity: 98% | 5-Bromo-3,3-dimethylindolin-2-one | ESD-935453-5G |
| Cas.: 120902-45-6 | Purity: 98% | 5-Bromo-3,3-dimethylindolin-2-one | ESD-935453-1G |
| Cas.: 120902-45-6 | Purity: 98% | 5-Bromo-3,3-dimethylindolin-2-one | ESD-935453-250MG |
| Cas.: 170456-80-1 | Purity: 97% | 3-Iodo-1-tosyl-1H-indole | ESD-935454-5G |
| Cas.: 170456-80-1 | Purity: 97% | 3-Iodo-1-tosyl-1H-indole | ESD-935454-1G |
| Cas.: 170456-80-1 | Purity: 97% | 3-Iodo-1-tosyl-1H-indole | ESD-935454-250MG |
| Cas.: 170456-80-1 | Purity: 97% | 3-Iodo-1-tosyl-1H-indole | ESD-935454-100MG |
| Cas.: NONE8210 | Purity: ≥98% | Acridine hydrazide NSP-SA-ADH | ESD-915616-1MG |
| Cas.: 14130-05-3 | Purity: 96% | 1-Aminoonadecane | ESD-869160-5G |
| Cas.: 253-50-9 | Purity: 95% | 2,6-Naphthyridine | ESD-932897-25MG |
| Cas.: 74-94-2 | Purity: 96% | Borane dimethylamine complex (DMAB) | ESD-802453-2.5KG |
| Cas.: 104-23-4 | Purity: 97% | 4′-Aminoazobenzene-4-sulphonic acid | ESD-923176-1G |
| Cas.: 104-23-4 | Purity: 97% | 4′-Aminoazobenzene-4-sulphonic acid | ESD-923176-250MG |
| Cas.: 1121-05-7 | Purity: 95% | 2,3-DiMethyl-2-cyclopenten-1-one | ESD-921570-250MG |
| Cas.: 3563-14-2 | Purity: 95% | Sulfasuccinamide | ESD-928936-1G |
| Cas.: 91037-75-1 | Purity: 98% | GRGDSP | ESD-876435-25MG |
| Cas.: 133261-06-0 | Purity: 98% | Ethyl 5-cyclopropyl-1H-pyrazole-3-carboxylate | ESD-935456-100MG |
| Cas.: 91037-75-1 | Purity: 98% | GRGDSP | ESD-876435-100MG |
| Cas.: 91037-75-1 | Purity: 98% | GRGDSP | ESD-876435-250MG |
| Cas.: 133261-06-0 | Purity: 98% | Ethyl 5-cyclopropyl-1H-pyrazole-3-carboxylate | ESD-935456-250MG |
| Cas.: 133261-06-0 | Purity: 98% | Ethyl 5-cyclopropyl-1H-pyrazole-3-carboxylate | ESD-935456-1G |
| Cas.: 13569-63-6 | Purity: 99.99% metals basis | Rhenium(III) chloride | ESD-836135-5G |
| Cas.: 7758-80-7 | Purity: 99,9% | Monosodium phosphate | ESD-888174-10KG |
| Cas.: 70431-34-4 | Purity: 98% | Colominic acid sodium salt from Escherichia coli | ESD-922212-100MG |
| Cas.: 70431-34-4 | Purity: 98% | Colominic acid sodium salt from Escherichia coli | ESD-922212-1G |
| Cas.: 9003-05-8 | Purity: Anionic, 14-16 million MW | Polyacrylamide | ESD-888718-10KG |
| Cas.: 958359-96-1 | Purity: 97% | 2-Amino-5-fluoronicotinamide | ESD-935457-1G |
| Cas.: 958359-96-1 | Purity: 97% | 2-Amino-5-fluoronicotinamide | ESD-935457-250MG |
| Cas.: 958359-96-1 | Purity: 97% | 2-Amino-5-fluoronicotinamide | ESD-935457-50MG |
| Cas.: 1022931-73-2 | Purity: 98% | tert-Butyl 3-(trifluoromethyl)-6,7-dihydro-1H-pyrazolo[4,3-c]pyridine-5(4H)-carboxylate | ESD-935458-1G |
| Cas.: 1022931-73-2 | Purity: 98% | tert-Butyl 3-(trifluoromethyl)-6,7-dihydro-1H-pyrazolo[4,3-c]pyridine-5(4H)-carboxylate | ESD-935458-250MG |
| Cas.: 50551-57-0 | Purity: 97% | Ethyl 6-methoxybenzofuran-2-carboxylate | ESD-935459-1G |
| Cas.: 50551-57-0 | Purity: 97% | Ethyl 6-methoxybenzofuran-2-carboxylate | ESD-935459-250MG |
| Cas.: 50551-57-0 | Purity: 97% | Ethyl 6-methoxybenzofuran-2-carboxylate | ESD-935459-100MG |
| Cas.: 906448-92-8 | Purity: ≥95% | Methyl 1-Methyl-2-oxopyrrolidine-4-carboxylate | ESD-935460-1G |
| Cas.: 906448-92-8 | Purity: ≥95% | Methyl 1-Methyl-2-oxopyrrolidine-4-carboxylate | ESD-935460-250MG |
| Cas.: 168279-54-7 | Purity: 95% | Ethyl 3-(methylthio)-4-oxo-4,5,6,7-tetrahydrobenzo[c]thiophene-1-carboxylate | ESD-935461-5G |
| Cas.: 168279-54-7 | Purity: 95% | Ethyl 3-(methylthio)-4-oxo-4,5,6,7-tetrahydrobenzo[c]thiophene-1-carboxylate | ESD-935461-1G |
| Cas.: 168279-54-7 | Purity: 95% | Ethyl 3-(methylthio)-4-oxo-4,5,6,7-tetrahydrobenzo[c]thiophene-1-carboxylate | ESD-935461-250MG |
| Cas.: 174485-72-4 | Purity: 98% | 5-(Trifluoromethyl)pyridine-2-sulfonyl chloride | ESD-935462-1G |
| Cas.: 174485-72-4 | Purity: 98% | 5-(Trifluoromethyl)pyridine-2-sulfonyl chloride | ESD-935462-250MG |
| Cas.: 174485-72-4 | Purity: 98% | 5-(Trifluoromethyl)pyridine-2-sulfonyl chloride | ESD-935462-100MG |
| Cas.: 259809-46-6 | Purity: ≥95% | 6-Boc-5,6,7,8-tetrahydro-1,6-naphthyridine-2-carbonitrile | ESD-935463-1G |
| Cas.: 259809-46-6 | Purity: ≥95% | 6-Boc-5,6,7,8-tetrahydro-1,6-naphthyridine-2-carbonitrile | ESD-935463-250MG |
| Cas.: 167263-11-8 | Purity: 97% | 4-Benzyl-1-(tert-butoxycarbonyl)piperidine-4-carboxylic acid | ESD-935464-1G |
| Cas.: 167263-11-8 | Purity: 97% | 4-Benzyl-1-(tert-butoxycarbonyl)piperidine-4-carboxylic acid | ESD-935464-250MG |
| Cas.: 167263-11-8 | Purity: 97% | 4-Benzyl-1-(tert-butoxycarbonyl)piperidine-4-carboxylic acid | ESD-935464-100MG |
| Cas.: NONE6385 | Purity: 95%, MW: 2000 | AlKyne-PEG-OH | ESD-850252-100MG |
| Cas.: NONE6385 | Purity: 95%, MW: 2000 | AlKyne-PEG-OH | ESD-850252-500MG |
| Cas.: NONE6385 | Purity: 95%, MW: 2000 | AlKyne-PEG-OH | ESD-850252-1G |
| Cas.: 39620-04-7 | Purity: 98% | 2-Amino-3-chloropyridine | ESD-830501-5G |
| Cas.: 39620-04-7 | Purity: 98% | 2-Amino-3-chloropyridine | ESD-830501-25G |
| Cas.: 39720-27-9 | Purity: 98% | 4-(ChloroMethyl)phenyl acetate | ESD-920634-1G |
| Cas.: NONE6385 | Purity: 95%, MW: 5000 | AlKyne-PEG-OH | ESD-935465-100MG |
| Cas.: NONE6385 | Purity: 95%, MW: 5000 | AlKyne-PEG-OH | ESD-935465-500MG |
| Cas.: 133261-06-0 | Purity: 98% | Ethyl 5-cyclopropyl-1H-pyrazole-3-carboxylate | ESD-935456-5G |
| Cas.: NONE6385 | Purity: 95%, MW: 5000 | AlKyne-PEG-OH | ESD-935465-1G |
| Cas.: NONE6385 | Purity: 95%, MW: 10000 | AlKyne-PEG-OH | ESD-935466-100MG |
| Cas.: NONE6385 | Purity: 95%, MW: 10000 | AlKyne-PEG-OH | ESD-935466-500MG |
| Cas.: NONE6385 | Purity: 95%, MW: 10000 | AlKyne-PEG-OH | ESD-935466-1G |
| Cas.: NONE6385 | Purity: 95%, MW: 20000 | AlKyne-PEG-OH | ESD-935467-100MG |
| Cas.: 83405-70-3 | Purity: 98% | Ethyl 5-(tert-butyl)-1H-pyrazole-3-carboxylate | ESD-935468-1G |
| Cas.: NONE6385 | Purity: 95%, MW: 20000 | AlKyne-PEG-OH | ESD-935467-500MG |
| Cas.: NONE6385 | Purity: 95%, MW: 20000 | AlKyne-PEG-OH | ESD-935467-1G |
| Cas.: 83405-70-3 | Purity: 98% | Ethyl 5-(tert-butyl)-1H-pyrazole-3-carboxylate | ESD-935468-5G |
| Cas.: 83405-70-3 | Purity: 98% | Ethyl 5-(tert-butyl)-1H-pyrazole-3-carboxylate | ESD-935468-10G |
| Cas.: 86625-25-4 | Purity: 97% | Methyl 5-oxo-2,5-dihydro-1H-pyrazole-3-carboxylate | ESD-935469-100MG |
| Cas.: 86625-25-4 | Purity: 97% | Methyl 5-oxo-2,5-dihydro-1H-pyrazole-3-carboxylate | ESD-935469-250MG |
| Cas.: 86625-25-4 | Purity: 97% | Methyl 5-oxo-2,5-dihydro-1H-pyrazole-3-carboxylate | ESD-935469-1G |
| Cas.: 86625-25-4 | Purity: 97% | Methyl 5-oxo-2,5-dihydro-1H-pyrazole-3-carboxylate | ESD-935469-5G |
| Cas.: 1335-30-4 | Purity: grade 135 | Silicic acid, aluminum salt | ESD-921402-250G |
| Cas.: 27935-87-1 | Purity: 98% | (Iodomethyl)cyclopentane | ESD-935470-100MG |
| Cas.: 27935-87-1 | Purity: 98% | (Iodomethyl)cyclopentane | ESD-935470-250MG |
| Cas.: 27935-87-1 | Purity: 98% | (Iodomethyl)cyclopentane | ESD-935470-1G |
| Cas.: 27935-87-1 | Purity: 98% | (Iodomethyl)cyclopentane | ESD-935470-5G |
| Cas.: 25086-62-8 | Purity: analytical standard, for GPC, 483,000, Mn ~429000, Mp ~549000, Mw ~483000 | Poly(methacrylic acid sodium salt) | ESD-922013-50MG |
| Cas.: 78790-82-6 | Purity: 95% | 1-(3-Chloropyridin-4-yl)ethanone | ESD-935471-100MG |
| Cas.: 78790-82-6 | Purity: 95% | 1-(3-Chloropyridin-4-yl)ethanone | ESD-935471-250MG |
| Cas.: 78790-82-6 | Purity: 95% | 1-(3-Chloropyridin-4-yl)ethanone | ESD-935471-1G |
| Cas.: 924869-27-2 | Purity: 97% | tert-Butyl 6,7-dihydro-2H-pyrazolo[4,3-c]pyridine-5(4H)-carboxylate | ESD-935472-250MG |
| Cas.: 924869-27-2 | Purity: 97% | tert-Butyl 6,7-dihydro-2H-pyrazolo[4,3-c]pyridine-5(4H)-carboxylate | ESD-935472-1G |
| Cas.: 924869-27-2 | Purity: 97% | tert-Butyl 6,7-dihydro-2H-pyrazolo[4,3-c]pyridine-5(4H)-carboxylate | ESD-935472-5G |
| Cas.: 143654-59-5 | Purity: 97% | Methyl 3-(2-fluorophenyl)propanoate | ESD-935473-250MG |
| Cas.: 143654-59-5 | Purity: 97% | Methyl 3-(2-fluorophenyl)propanoate | ESD-935473-1G |
| Cas.: 143654-59-5 | Purity: 97% | Methyl 3-(2-fluorophenyl)propanoate | ESD-935473-5G |
| Cas.: 100590-43-0 | Purity: 98% | Methyl benzo[b]thiophene-4-carboxylate | ESD-935474-100MG |
| Cas.: 100590-43-0 | Purity: 98% | Methyl benzo[b]thiophene-4-carboxylate | ESD-935474-250MG |
| Cas.: 100590-43-0 | Purity: 98% | Methyl benzo[b]thiophene-4-carboxylate | ESD-935474-1G |
| Cas.: 67120-38-1 | Purity: 98% | 6-Chloro-2,3-dihydro-1H-inden-1-amine | ESD-935475-100MG |
| Cas.: 67120-38-1 | Purity: 98% | 6-Chloro-2,3-dihydro-1H-inden-1-amine | ESD-935475-250MG |
| Cas.: 67120-38-1 | Purity: 98% | 6-Chloro-2,3-dihydro-1H-inden-1-amine | ESD-935475-1G |
| Cas.: 80537-14-0 | Purity: 95% | Ethyl pyrazolo[1,5-a]pyridine-2-carboxylate | ESD-935476-100MG |
| Cas.: 80537-14-0 | Purity: 95% | Ethyl pyrazolo[1,5-a]pyridine-2-carboxylate | ESD-935476-250MG |
| Cas.: 80537-14-0 | Purity: 95% | Ethyl pyrazolo[1,5-a]pyridine-2-carboxylate | ESD-935476-1G |
| Cas.: 4039-32-1 | Purity: 20% in Tetrahydrofuran, MKSeal | Lithium bis(trimethylsilyl)amide | ESD-935477-500ML |
| Cas.: 4039-32-1 | Purity: 20% in Tetrahydrofuran, MKSeal | Lithium bis(trimethylsilyl)amide | ESD-935477-5L |
| Cas.: 420-04-2 | Purity: 95% | Cyanamide | ESD-823122-2.5KG |
| Cas.: 79-11-8 | Purity: 98% | Chloroacetic acid | ESD-832200-10KG |
| Cas.: 259794-53-1 | Purity: 95% | tert-Butyl 3-amino-2,2-dimethylpropanoate | ESD-935478-100MG |
| Cas.: 259794-53-1 | Purity: 95% | tert-Butyl 3-amino-2,2-dimethylpropanoate | ESD-935478-250MG |
| Cas.: 1333400-84-2 | Purity: 95% | 3-Bromo-4-(((tert-butoxycarbonyl)amino)methyl)benzoic acid | ESD-935479-100MG |
| Cas.: 1333400-84-2 | Purity: 95% | 3-Bromo-4-(((tert-butoxycarbonyl)amino)methyl)benzoic acid | ESD-935479-250MG |
| Cas.: 1516-96-7 | Purity: 98% | 5-Bromo-1,3-di-tert-butyl-2-methoxybenzene | ESD-841065-5G |
| Cas.: 1516-96-7 | Purity: 98% | 5-Bromo-1,3-di-tert-butyl-2-methoxybenzene | ESD-841065-25G |
| Cas.: 40391-99-9 | Purity: ≥98% | Pamidronic acid | ESD-879156-250MG |
| Cas.: 40391-99-9 | Purity: ≥98% | Pamidronic acid | ESD-879156-1G |
| Cas.: 80-04-6 | Purity: 95% | 4,4′-Isopropylidenedicyclohexanol, mixture of isomers | ESD-811635-10KG |
| Cas.: 599183-36-5 | Purity: 98% | 3-Iodo-1H-indazol-5-amine | ESD-935480-100MG |
| Cas.: 599183-36-5 | Purity: 98% | 3-Iodo-1H-indazol-5-amine | ESD-935480-250MG |
| Cas.: 33036-62-3 | Purity: >80.0% | 4-Bromo-1-butanol | ESD-823668-100G |
| Cas.: 26177-86-6 | Purity: 98% | D-Fructose 6-phosphate disodium salt hydrate | ESD-809740-1G |
| Cas.: 599183-36-5 | Purity: 98% | 3-Iodo-1H-indazol-5-amine | ESD-935480-1G |
| Cas.: 123439-80-5 | Purity: Dye content 85% | Copper phthalocyanine-3,4′,4″,4″‘-tetrasulfonic acid tetrasodium salt | ESD-924340-250MG |
| Cas.: 561-63-7 | Purity: 98% | 19-hydroxy Cholesterol | ESD-912537-1MG |
| Cas.: 9001-03-0 | Purity: ≥3, 000 units/mg dry weight | Carbonic Anhydrase from bovine erythrocytes | ESD-837230-250MG |
| Cas.: 10026-22-9 | Purity: 99.99% metals basis | Cobalt nitrate hexahydrate | ESD-805392-10KG |
| Cas.: 10022-68-1 | Purity: AR, 99% | Cadmium nitrate tetrahydrate | ESD-804399-10KG |
| Cas.: 5117-12-4 | Purity: 98% | 4-Acryloylmorpholine | ESD-858282-10KG |
| Cas.: 9001-90-5 | Purity: ≥2.0 units/mg protein | Plasmin, from human plasma | ESD-920012-50ΜG |
| Cas.: NONE10133 | Purity: 0.5wt%La, 300 Mesh | Cu La alloy powder | ESD-935481-500G |
| Cas.: 7440-50-8 | Purity: 99.9% metals basis, 300 Mesh, nearly spherical | Copper superfine powder | ESD-935482-500G |
| Cas.: 4136-95-2 | Purity: 97% | 2,4,6-Trichlorobenzoyl Chloride | ESD-835475-100G |
| Cas.: 25498-49-1 | Purity: 96% | Tripropylene Glycol Methyl Ether | ESD-837847-500G |
| Cas.: 652-32-4 | Purity: ≥97% | 2,3,5,6-Tetrafluoro-4-methylbenzoic Acid | ESD-867705-1G |
| Cas.: 7440-50-8 | Purity: 99.9% metals basis, 300 Mesh, nearly spherical | Copper superfine powder | ESD-935482-2.5KG |
| Cas.: 7440-50-8 | Purity: 99.9% metals basis, 300 Mesh, nearly spherical | Copper superfine powder | ESD-935482-100G |
| Cas.: NONE10133 | Purity: 0.5wt%La, 300 Mesh | Cu La alloy powder | ESD-935481-100G |
| Cas.: NONE10133 | Purity: 0.5wt%La, 300 Mesh | Cu La alloy powder | ESD-935481-25G |
| Cas.: 7783-20-2 | Purity: 99%biotech grade | Ammonium Sulfate | ESD-6297-10KG |
| Cas.: 120511-73-1 | Purity: ≥99% | Anastrozole | ESD-833084-25G |
| Cas.: 132234-68-5 | Purity: 97% | tert-Butyl N-[(3-exo)-8-azabicyclo[3.2.1]octan-3-yl]carbamate | ESD-935484-100G |
| Cas.: 132234-68-5 | Purity: 97% | tert-Butyl N-[(3-exo)-8-azabicyclo[3.2.1]octan-3-yl]carbamate | ESD-935484-250G |
| Cas.: 132234-68-5 | Purity: 97% | tert-Butyl N-[(3-exo)-8-azabicyclo[3.2.1]octan-3-yl]carbamate | ESD-935484-1G |
| Cas.: 132234-68-5 | Purity: 97% | tert-Butyl N-[(3-exo)-8-azabicyclo[3.2.1]octan-3-yl]carbamate | ESD-935484-5G |
| Cas.: 2039-82-9 | Purity: 95%, contains 100-500 ppm TBCstabilizer | 4-Bromostyrene | ESD-802022-500G |
| Cas.: 25939-87-1 | Purity: 98% | Pyrazolo[1,5-a]pyrimidine-3-carbonitrile | ESD-935485-100MG |
| Cas.: 25939-87-1 | Purity: 98% | Pyrazolo[1,5-a]pyrimidine-3-carbonitrile | ESD-935485-250MG |
| Cas.: 25939-87-1 | Purity: 98% | Pyrazolo[1,5-a]pyrimidine-3-carbonitrile | ESD-935485-1G |
| Cas.: 1634-04-4 | Purity: AR | |tert|-Butyl methyl ether | ESD-802538-10L |
| Cas.: 1105665-34-6 | Purity: 97% | Methyl 2-(oxetan-3-ylidene)acetate | ESD-935486-250MG |
| Cas.: 1105665-34-6 | Purity: 97% | Methyl 2-(oxetan-3-ylidene)acetate | ESD-935486-1G |
| Cas.: 1105665-34-6 | Purity: 97% | Methyl 2-(oxetan-3-ylidene)acetate | ESD-935486-5G |
| Cas.: 80-05-7 | Purity: >99.0%(GC) | Bisphenol A | ESD-802576-25KG |
| Cas.: 1172067-95-6 | Purity: 98% | 5-Bromo-4-fluoro-1H-pyrrolo[2,3-b]pyridine | ESD-935487-100MG |
| Cas.: 1172067-95-6 | Purity: 98% | 5-Bromo-4-fluoro-1H-pyrrolo[2,3-b]pyridine | ESD-935487-250MG |
| Cas.: 1172067-95-6 | Purity: 98% | 5-Bromo-4-fluoro-1H-pyrrolo[2,3-b]pyridine | ESD-935487-1G |
| Cas.: 13520-78-0 | Purity: 98% | Tungsten(VI) oxychloride | ESD-923390-1G |
| Cas.: 106685-41-0 | Purity: ≥95% | Methyl 6-(3-(adamantan-1-yl)-4-methoxyphenyl)-2-naphthoate | ESD-890639-100G |
| Cas.: 916325-84-3 | Purity: 98% | Methyl 5-bromo-1H-pyrazolo[3,4-b]pyridine-3-carboxylate | ESD-935488-100MG |
| Cas.: 916325-84-3 | Purity: 98% | Methyl 5-bromo-1H-pyrazolo[3,4-b]pyridine-3-carboxylate | ESD-935488-250MG |
| Cas.: 916325-84-3 | Purity: 98% | Methyl 5-bromo-1H-pyrazolo[3,4-b]pyridine-3-carboxylate | ESD-935488-500MG |
| Cas.: 916325-84-3 | Purity: 98% | Methyl 5-bromo-1H-pyrazolo[3,4-b]pyridine-3-carboxylate | ESD-935488-1G |
| Cas.: 4419-39-0 | Purity: 1.00mg/ml | Beclomethasone Solution | ESD-803718-1.2ML |
| Cas.: 872619-43-7 | Purity: 97% | Methyl 5-bromo-1H-pyrrolo[2,3-b]pyridine-3-carboxylate | ESD-935489-100MG |
| Cas.: 872619-43-7 | Purity: 97% | Methyl 5-bromo-1H-pyrrolo[2,3-b]pyridine-3-carboxylate | ESD-935489-250MG |
| Cas.: 872619-43-7 | Purity: 97% | Methyl 5-bromo-1H-pyrrolo[2,3-b]pyridine-3-carboxylate | ESD-935489-1G |
| Cas.: 872619-43-7 | Purity: 97% | Methyl 5-bromo-1H-pyrrolo[2,3-b]pyridine-3-carboxylate | ESD-935489-5G |
| Cas.: 2627-35-2 | Purity: tech. 90% | mono-n-Dodecyl phosphate | ESD-915700-5G |
| Cas.: 13453-80-0 | Purity: 99.95% metals basis | Lithium phosphate monobasic | ESD-935423-5KG |
| Cas.: 13453-80-0 | Purity: 99.95% metals basis | Lithium phosphate monobasic | ESD-935423-1KG |
| Cas.: 13453-80-0 | Purity: 99.95% metals basis | Lithium phosphate monobasic | ESD-935423-250G |
| Cas.: 13453-80-0 | Purity: 99.95% metals basis | Lithium phosphate monobasic | ESD-935423-50G |
| Cas.: 213670-35-0 | Purity: ≥95% | Methyl 2,3-dioxoindoline-6-carboxylate | ESD-935490-100MG |
| Cas.: 213670-35-0 | Purity: ≥95% | Methyl 2,3-dioxoindoline-6-carboxylate | ESD-935490-250MG |
| Cas.: 213670-35-0 | Purity: ≥95% | Methyl 2,3-dioxoindoline-6-carboxylate | ESD-935490-1G |
| Cas.: 78919-26-3 | Purity: 95% | 3β-Ursodeoxycholic Acid | ESD-924699-5MG |
| Cas.: 1008526-71-3 | Purity: 95% | tert-Butyl 3-(aminomethyl)-3-hydroxyazetidine-1-carboxylate | ESD-935491-100MG |
| Cas.: 1008526-71-3 | Purity: 95% | tert-Butyl 3-(aminomethyl)-3-hydroxyazetidine-1-carboxylate | ESD-935491-250MG |
| Cas.: 1008526-71-3 | Purity: 95% | tert-Butyl 3-(aminomethyl)-3-hydroxyazetidine-1-carboxylate | ESD-935491-1G |
| Cas.: 1008526-71-3 | Purity: 95% | tert-Butyl 3-(aminomethyl)-3-hydroxyazetidine-1-carboxylate | ESD-935491-5G |
| Cas.: 107-21-1 | Purity: Spectrally pure , ≥99% polyester grade | Ethylene glycol | ESD-808737-10L |
| Cas.: 1008526-70-2 | Purity: 95% | tert-Butyl 3-hydroxy-3-(nitromethyl)azetidine-1-carboxylate | ESD-935492-1G |
| Cas.: 78919-26-3 | Purity: 98% | 3β-Ursodeoxycholic Acid | ESD-923727-10MG |
| Cas.: 1008526-70-2 | Purity: 95% | tert-Butyl 3-hydroxy-3-(nitromethyl)azetidine-1-carboxylate | ESD-935492-5G |
| Cas.: 4790-08-3 | Purity: ≥95% | 5,6-Dihydroxy-1H-indole-2-carboxylic acid | ESD-890665-25MG |
| Cas.: 78919-26-3 | Purity: 98% | 3β-Ursodeoxycholic Acid | ESD-923727-5MG |
| Cas.: 1008526-70-2 | Purity: 95% | tert-Butyl 3-hydroxy-3-(nitromethyl)azetidine-1-carboxylate | ESD-935492-25G |
| Cas.: 5048-19-1 | Purity: ≥95%(GC) | 5-Hexenenitrile | ESD-863089-1ML |
| Cas.: 16156-53-9 | Purity: ≥98%(GC) | Isobutyl Methanesulfonate | ESD-862317-5G |
| Cas.: 102-51-2 | Purity: ≥95% | 4-methoxybenzene-1,2-diamine | ESD-828056-100G |
| Cas.: 84468-24-6 | Purity: ≥99% | HA-100 | ESD-877115-50MG |
| Cas.: 125304-04-3 | Purity: 95.0%(total of isomers) | 2-(2H-Benzotriazol-2-yl)-6-dodecyl-4-methylphenol | ESD-921824-500G |
| Cas.: 1256788-23-4 | Purity: 97% | 2-Bromo-3-cyclopropylpyridine | ESD-895360-1G |
| Cas.: 33985-71-6 | Purity: ≥98%(GC) | 9-Julolidinecarboxaldehyde | ESD-862289-5G |
| Cas.: 16219-75-3 | Purity: 98% | 5-Ethylidene-2-norbornene | ESD-835876-5ML |
| Cas.: 13499-05-3 | Purity: 99.9%, particles, zirconium≤0.15% | hafnium tetrachloride | ESD-886517-500G |
| Cas.: 939759-26-9 | Purity: 98% | Benzyl 3-iodoazetidine-1-carboxylate | ESD-935493-100MG |
| Cas.: 939759-26-9 | Purity: 98% | Benzyl 3-iodoazetidine-1-carboxylate | ESD-935493-250MG |
| Cas.: 939759-26-9 | Purity: 98% | Benzyl 3-iodoazetidine-1-carboxylate | ESD-935493-1G |
| Cas.: 939759-26-9 | Purity: 98% | Benzyl 3-iodoazetidine-1-carboxylate | ESD-935493-5G |
| Cas.: 6373-93-9 | Purity: 60% | Supraacet Brilliant Red BD | ESD-935494-25G |
| Cas.: 6373-93-9 | Purity: 60% | Supraacet Brilliant Red BD | ESD-935494-5G |
| Cas.: 6373-93-9 | Purity: 60% | Supraacet Brilliant Red BD | ESD-935494-1G |
| Cas.: 9012-76-4 | MW=200000 | Chitosan | ESD-875440-2.5KG |
| Cas.: 7782-42-5 | Purity: 99.95% metals basis, 10000 Mesh | Graphite powder | ESD-935495-5KG |
| Cas.: 7782-42-5 | Purity: 99.95% metals basis, 10000 Mesh | Graphite powder | ESD-935495-2.5KG |
| Cas.: 7782-42-5 | Purity: 99.95% metals basis, 10000 Mesh | Graphite powder | ESD-935495-500G |
| Cas.: 7782-42-5 | Purity: 99.95% metals basis, 10000 Mesh | Graphite powder | ESD-935495-100G |
| Cas.: 74307-75-8 | Purity: 97% | trans-3-Aminocyclobutanecarboxylic acid | ESD-935496-50MG |
| Cas.: 1132-21-4 | Purity: 99% | 3,5-Dimethoxybenzoic acid | ESD-808441-2.5KG |
| Cas.: 74307-75-8 | Purity: 97% | trans-3-Aminocyclobutanecarboxylic acid | ESD-935496-100MG |
| Cas.: 74307-75-8 | Purity: 97% | trans-3-Aminocyclobutanecarboxylic acid | ESD-935496-250MG |
| Cas.: 74307-75-8 | Purity: 97% | trans-3-Aminocyclobutanecarboxylic acid | ESD-935496-1G |
| Cas.: 64742-94-5 | Purity: D60 | Solvent naphtha | ESD-875958-10KG |
| Cas.: 160743-62-4 | Purity: ≥99% | 1,2-dimyristoyl-rac-glycero-3-methoxypolyethylene glycol-2000 | ESD-890331-5G |
| Cas.: 1232431-81-0 | Purity: 98% | 3-Bromoimidazo[1,2-a]pyridin-8-amine | ESD-935497-100MG |
| Cas.: 1232431-81-0 | Purity: 98% | 3-Bromoimidazo[1,2-a]pyridin-8-amine | ESD-935497-250MG |
| Cas.: XBPY | Purity: 1M, pH7.0 | HEPES Buffer | ESD-885798-1L |
| Cas.: 2503-46-0 | Purity: 97% | 1-(4-Hydroxy-3-methoxyphenyl)propan-2-one | ESD-929371-5G |
| Cas.: 7440-44-0 | Purity: Medicine decolorization injection grade; 767 injection activated carbon | Activated charcoal | ESD-885818-2.5KG |
| Cas.: 7440-44-0 | Purity: Medicine decolorization injection grade; 767 injection activated carbon | Activated charcoal | ESD-885818-10KG |
| Cas.: 373596-08-8 | Purity: 98% | TIPS-pentacene (6,13-Bis(triisopropylsilylethynyl)pentacene) | ESD-856443-250MG |
| Cas.: NONE8594 | Purity: for cell culture | L-Glutamine | ESD-917757-250G |
| Cas.: 889658-85-9 | Purity: 95% | 3-Bromo-1H-pyrrolo[3,2-b]pyridine-2-carboxylic acid ethyl ester | ESD-935483-1G |
| Cas.: 889658-85-9 | Purity: 95% | 3-Bromo-1H-pyrrolo[3,2-b]pyridine-2-carboxylic acid ethyl ester | ESD-935483-250MG |
| Cas.: 889658-85-9 | Purity: 95% | 3-Bromo-1H-pyrrolo[3,2-b]pyridine-2-carboxylic acid ethyl ester | ESD-935483-100MG |
| Cas.: 2495-35-4 | Purity: 97%, contains 150ppm 4-Methoxyphenol stabilizer | Benzyl acrylate | ESD-803856-2.5KG |
| Cas.: 3352-87-2 | Purity: ≥99% | N,N-Diethyldodecanamide | ESD-859865-5G |
| Cas.: 22013-33-8 | Purity: 98% | 1,4-Benzodioxan-6-Amine | ESD-823463-100G |
| Cas.: 50847-09-1 | Purity: 97% | 2-Bromo-1H-imidazole-4,5-dicarbonitrile | ESD-843787-5G |
| Cas.: 50847-09-1 | Purity: 97% | 2-Bromo-1H-imidazole-4,5-dicarbonitrile | ESD-843787-1G |
| Cas.: 54999-07-4 | Purity: 98% | Ergolide | ESD-913546-50MG |
| Cas.: 118-65-0 | Purity: 80% | Isocaryophyllene | ESD-922402-25MG |
| Cas.: 9004-67-5 | Purity: 450mPa.s | Methyl cellulose | ESD-935498-10KG |
| Cas.: 130-40-5 | Purity: USP grade | Riboflavin sodium phosphate | ESD-817259-500G |
| Cas.: 9004-67-5 | Purity: 450mPa.s | Methyl cellulose | ESD-935498-2.5KG |
| Cas.: 9004-67-5 | Purity: 450mPa.s | Methyl cellulose | ESD-935498-500G |
| Cas.: 9004-67-5 | Purity: 450mPa.s | Methyl cellulose | ESD-935498-100G |
| Cas.: 172695-33-9 | Purity: 98% | Fmoc-L-beta-Homovaline | ESD-811351-100MG |
| Cas.: 172695-33-9 | Purity: 98% | Fmoc-L-beta-Homovaline | ESD-811351-250MG |
| Cas.: 4494-16-0 | Purity: ≥95% | Octadec-9-enedioic acid | ESD-891507-10MG |
| Cas.: 12036-43-0 | Purity: nanopowder, <100nm particle size (BET), 99% trace metals basis | Zinc titanate | ESD-922671-5G |
| Cas.: 1187586-58-8 | Montelukast EP IMpurity E | ESD-927065-50MG | |
| Cas.: 1187586-58-8 | Montelukast EP IMpurity E | ESD-927065-10MG | |
| Cas.: 930-73-4 | Purity: 95% | 1-Methylpyridin-1-ium iodide | ESD-897649-5G |
| Cas.: 75-09-2 | Purity: for GC, ≥99.8% | Dichloromethane | ESD-807827-10L |
| Cas.: 50906-77-9 | Purity: ≥95% | 3,3′-dithiobis(propionohydrazide) | ESD-822752-5G |
| Cas.: 5080-50-2 | Purity: ≥99% | Acetyl-L-carnitine Hydrochloride | ESD-834961-500G |
| Cas.: 51169-05-2 | Purity: 97% | 2-Hydrazinylpyridine hydrochloride | ESD-899422-25G |
| Cas.: 168102-05-4 | Purity: 95% | Ethyl 3-fluoro-1H-pyrrole-2-carboxylate | ESD-935500-100MG |
| Cas.: 168102-05-4 | Purity: 95% | Ethyl 3-fluoro-1H-pyrrole-2-carboxylate | ESD-935500-250MG |
| Cas.: 168102-05-4 | Purity: 95% | Ethyl 3-fluoro-1H-pyrrole-2-carboxylate | ESD-935500-1G |
| Cas.: 1038-66-0 | Purity: ≥97% | 4,4′-Diaminooctafluorobiphenyl | ESD-866154-5G |
| Cas.: 516474-01-4 | Purity: ≥98%(HPLC) | 1-Ethyl-3-methylimidazolium Methyl Sulfate | ESD-862832-25G |
| Cas.: 61546-01-8 | Purity: ≥96%(T&LC) | 1-Hexadecyl-3-methylimidazolium Chloride | ESD-918371-1G |
| Cas.: 4052-92-0 | Purity: 95% | 3-(Chlorosulfonyl)benzoyl chloride | ESD-923320-1G |
| Cas.: 153259-31-5 | Purity: ≥95% | 4-(3-methoxypropoxy)-2-(chloromethyl)-3-methylpyridine hydrochlorid | ESD-827902-100G |
| Cas.: 153259-31-5 | Purity: ≥95% | 4-(3-methoxypropoxy)-2-(chloromethyl)-3-methylpyridine hydrochlorid | ESD-827902-5G |
| Cas.: 873-74-5 | Purity: 98% | 4-Aminobenzonitrile | ESD-800569-2.5KG |
| Cas.: 2582-30-1 | Purity: 98,5% | Aminoguanidine bicarbonate | ESD-800908-10KG |
| Cas.: 13545-04-5 | Purity: 99% | 2,3-Dimethylsuccinic acid | ESD-923530-250MG |
| Cas.: 123-01-3 | Purity: 98%, Mixture of Isomers | 1-Phenyldodecane | ESD-924688-5ML |
| Cas.: 46710-42-3 | Purity: 98% | anthracene-2,6-diamine | ESD-887508-5G |
| Cas.: 49559-83-3 | Purity: 95% | 5-Methoxybenzo[d]oxazole-2(3H)-thione | ESD-919207-250MG |
| Cas.: 49559-83-3 | Purity: 95% | 5-Methoxybenzo[d]oxazole-2(3H)-thione | ESD-919207-50MG |
| Cas.: 15015-57-3 | Purity: 98% | Bis(4-hydroxyphenyl) Disulfide | ESD-835316-100G |
| Cas.: 194656-75-2 | Purity: ≥98% (HPLC) | ABH hydrochloride | ESD-920846-1MG |
| Cas.: 7681-84-7 | Purity: 95% | tetrahydro-furan-2-carbaldehyde | ESD-924050-250MG |
| Cas.: 7681-84-7 | Purity: 95% | tetrahydro-furan-2-carbaldehyde | ESD-924050-50MG |
| Cas.: 341-88-8 | Purity: 97% | 2-Heptyl-4-hydroxyquinolin-1-ium-1-olate | ESD-933297-5MG |
| Cas.: 7575-23-7 | Purity: 90% | Pentaerythritol Tetra(3-mercaptopropionate) , 90% | ESD-830712-2.5L |
| Cas.: 518-67-2 | Purity: 95% | Dimidium bromide | ESD-807598-25G |
| Cas.: 538-65-8 | Purity: 98% | L07362n-Butyl cinnamate | ESD-922665-250G |
| Cas.: 796963-92-3 | Purity: 99% | L-α-phosphatidylglycerol (E. coli) (sodium salt) | ESD-923083-5MG |
| Cas.: 7558-63-6 | Purity: 98% | L-Glutamic Acid Monoammonium Salt | ESD-924259-25G |
| Cas.: 185990-03-8 | Purity: 95% | 2-(Dimethylphenylsilyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-834044-5G |
| Cas.: 162102-79-6 | Purity: 98% | Dimethyl 4-bromopyridine-2,6-dicarboxylate | ESD-842496-250MG |
| Cas.: 16188-30-0 | Purity: ≥95% | 4-Thiazolemethanamine | ESD-853705-5G |
| Cas.: 945-30-2 | Purity: 95% | 2,5-Diaminoterephthalic acid | ESD-856194-50MG |
| Cas.: 945-30-2 | Purity: 95% | 2,5-Diaminoterephthalic acid | ESD-856194-5G |
| Cas.: 18918-31-5 | Purity: ≥95% | 4-Nitrophenyl α-L-Rhamnopyranoside | ESD-915333-250MG |
| Cas.: 877822-40-7 | Purity: Analytical Standards, 98% | Eupalinolide A | ESD-873525-50MG |
| Cas.: 41354-48-7 | Purity: 95% | (2-Aminoacetoxy)dihydroxyaluminum | ESD-923375-25G |
| Cas.: 41354-48-7 | Purity: 95% | (2-Aminoacetoxy)dihydroxyaluminum | ESD-923375-100G |
| Cas.: 41354-48-7 | Purity: 95% | (2-Aminoacetoxy)dihydroxyaluminum | ESD-923375-500G |
| Cas.: 13573-17-6 | Purity: AR | Reinecke Salt Monohydrate | ESD-871567-500G |
| Cas.: 55094-52-5 | Purity: 98% | (3R,4R,5R)-3,4-Bis(benzyloxy)-5-((benzyloxy)methyl)dihydrofuran-2(3H)-one | ESD-845158-500G |
| Cas.: 171596-36-4 | Purity: ≥98% | Pyrazino[1′,2′:1,6]pyrido[3,4-b]indole-1,4-dione, 6-(1,3-benzodioxol-5-yl)-2,3,6,7, 12,12a-hexahydro-, (6R,12aR)- | ESD-861104-5G |
